booking_id,MDDiagnosis_code,MDDiagnosis_name,chronic_group
EA149BC8-BFBC-4703-B34A-E4BB546EC114,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3C374977-6526-4612-80FD-D53BE6CDF499,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
3C374977-6526-4612-80FD-D53BE6CDF499,T88.1,"Other complications following immunization, not elsewhere classified",-
48958FEF-8052-4624-AEAD-792568C230D0,K12.3,Oral mucositis (ulcerative),-
4013B73D-C9A7-45FC-8A4A-817D68EC3E06,R21,Rash and other nonspecific skin eruption,-
6BF25F05-F16A-4ABC-93AA-49218518D40F,A09.9,Gastroenteritis and colitis of unspecified origin,-
DC76679C-3D1F-4BEA-BB95-B857D0E8AEDC,H57.9,"Disorder of eye and adnexa, unspecified",-
CA824412-DEE6-46F1-BA17-D7BD226475C1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
05B218B4-7BD9-4DD1-9842-9220B1A5B435,Z02.9,"Examination for administrative purposes, unspecified",-
A22B8F79-C6CC-4120-A257-C135ABA013BD,J06,Acute upper respiratory infections of multiple and unspecified sites,-
14638A45-8C9E-4777-8B5D-A4C712FDF902,J04.0,Acute laryngitis,-
D3567FDE-EAF9-4F94-89C8-55C6D99BC2BD,Z76.0,Issue of repeat prescription,-
D3567FDE-EAF9-4F94-89C8-55C6D99BC2BD,H57.8,Other specified disorders of eye and adnexa,-
D3567FDE-EAF9-4F94-89C8-55C6D99BC2BD,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
14638A45-8C9E-4777-8B5D-A4C712FDF902,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
A4BA1596-C8FC-49A3-9E1A-15B4E673890B,J06.9,"Acute upper respiratory infection, unspecified",-
6AB50E7E-B110-489B-BA93-26296045B9DF,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
060D3F53-1DDB-47A4-92B6-CE6A6A9F2FDD,J06.9,"Acute upper respiratory infection, unspecified",-
055824C5-10C7-43BF-B580-708FA70905A0,J06,Acute upper respiratory infections of multiple and unspecified sites,-
72A67100-A613-4320-A761-3D65DD6E6E16,A09.9,Gastroenteritis and colitis of unspecified origin,-
A458566D-C54E-4DD6-9C7C-BB74ECBBA13F,M54.5,Low back pain,-
F66B4A6E-AA22-4E64-B83A-2BA3036120C4,A09.9,Gastroenteritis and colitis of unspecified origin,-
F33B65F7-67DA-4D93-8A64-05DFAA3CCFE5,R22.9,"Localized swelling, mass and lump, unspecified",-
F33B65F7-67DA-4D93-8A64-05DFAA3CCFE5,L50.9,"Urticaria, unspecified",-
813580B6-9BBF-4F93-9231-22008B0BB9ED,J06.9,"Acute upper respiratory infection, unspecified",-
BA973A6D-17D0-4921-B3C8-9536091DF85C,O91.2,Nonpurulent mastitis associated with childbirth,-
BA973A6D-17D0-4921-B3C8-9536091DF85C,R07.0,Pain in throat,-
F526C650-89F2-4299-A5DB-FB442E99C448,M79.1,Myalgia,-
CA500CF3-ACAB-4A38-82AA-06A5EFB5C13C,J06.9,"Acute upper respiratory infection, unspecified",-
9D1D1B04-7956-4786-B46E-C85B60DEACD6,M10,Gout,Gout
D0BA0F2E-EB69-448A-AB2E-CF2E6E7F7DF3,Z71.2,Person consulting for explanation of investigation findings,-
FC6E213C-67FA-4C48-8BEA-9FFC86513C4C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6AF42345-B53F-436D-AB6A-1FA53FE75A9F,A09.9,Gastroenteritis and colitis of unspecified origin,-
1B4DB9EC-F5ED-4B95-BAC7-1C12F4E20244,A09.9,Gastroenteritis and colitis of unspecified origin,-
5F233FCD-F964-48D4-BC39-CC5C594C6CDC,R51,Headache,-
16411BEF-7F6D-496C-9395-7709D9FA1FAB,N94.6,"Dysmenorrhoea, unspecified",-
6121A2E4-C5BC-4576-BEE2-5F7177A26BCC,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
B9D1DA09-A349-43B5-A5CA-D5B4AD123BE8,J06.9,"Acute upper respiratory infection, unspecified",-
A4E54938-66F1-4841-AEC4-71462A1E6478,J06.9,"Acute upper respiratory infection, unspecified",-
0580A421-5D76-43A4-BCE2-7B63D9D34E9C,K29.6,Other gastritis,-
0580A421-5D76-43A4-BCE2-7B63D9D34E9C,K12.0,Recurrent oral aphthae,-
A38B860A-7314-44BB-A095-9577D071358B,B37,Candidiasis,-
1E42363A-A661-4905-93CD-517DDD99BEF3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1E42363A-A661-4905-93CD-517DDD99BEF3,R50.9,"Fever, unspecified",-
E9C3F90B-8CEE-4642-8B3D-19FA4C07252F,N39.0,"Urinary tract infection, site not specified",-
AAA26523-4647-47CE-A42F-CD595149A983,N39,Other disorders of urinary system,-
690AC219-92FD-4AB5-9DA3-FECDD85C1C22,R51,Headache,-
690AC219-92FD-4AB5-9DA3-FECDD85C1C22,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
984836BC-7889-40E6-B049-FA3689A2354C,J06.9,"Acute upper respiratory infection, unspecified",-
29C0AB8E-7C6C-4D1C-A600-F7850FF77A0E,R21,Rash and other nonspecific skin eruption,-
0273B526-980E-45FC-8127-8E69EE0C6F86,J06.9,"Acute upper respiratory infection, unspecified",-
AC00C198-3762-4039-8895-D76024B0DEE5,K29.7,"Gastritis, unspecified",-
AC00C198-3762-4039-8895-D76024B0DEE5,B00.1,Herpesviral vesicular dermatitis,-
46B2AFF0-9F9A-48E0-84BA-11522627613F,L70,Acne,-
63FE1D91-C896-43A4-9904-ECA056CE07EF,R51,Headache,-
A69D0D09-DCF5-417B-B6F7-626588A691C0,R14,Flatulence and related conditions,-
A69D0D09-DCF5-417B-B6F7-626588A691C0,K29.7,"Gastritis, unspecified",-
937FA8AC-42CA-4178-99D9-6D6B329A86B8,J06.9,"Acute upper respiratory infection, unspecified",-
689FBA48-DEBA-4B15-BE9B-C86070943AB1,J06.9,"Acute upper respiratory infection, unspecified",-
689FBA48-DEBA-4B15-BE9B-C86070943AB1,A09.9,Gastroenteritis and colitis of unspecified origin,-
94D251E4-992C-42AF-BDCA-A42C096B9B52,H00,Hordeolum and chalazion,-
3C781C81-83AE-44B2-97EF-898CE7476434,K30,Functional dyspepsia,-
11673037-EF8C-4048-BAA1-7FFCEC630FD9,J06.9,"Acute upper respiratory infection, unspecified",-
A1E17CDD-2ACC-4650-B906-8C0617C7C6A8,K29.7,"Gastritis, unspecified",-
7AE35DA1-45F4-4F4B-BFCC-3D67F44BB8E0,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
775F610D-459F-4595-BF0A-4FF60DCB563B,K29.7,"Gastritis, unspecified",-
A1EA9F01-E092-45C6-B60A-44082494766D,U07.1,"COVID-19, virus identified",-
03071294-23C6-47E8-8912-FEB97B5CA450,U07.1,"COVID-19, virus identified",-
93A550C3-9C69-4A87-8377-2F8F0049B11F,R51,Headache,-
D77FEFF3-703D-412B-BED9-E58306D60190,R50.9,"Fever, unspecified",-
04C5F82B-DDA2-4475-A19E-C9CF1E0F3BD2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E7522FF2-ADCB-4C89-9261-4AF2004C1621,R51,Headache,-
1DCB8901-E38D-4B57-88CD-14D44325B48B,J06.9,"Acute upper respiratory infection, unspecified",-
B5A5C22A-553E-4BFA-AC75-284100110293,M75.1,Rotator cuff syndrome,-
A54FFD48-466E-4468-B396-A14A9F132CEE,R45.7,"State of emotional shock and stress, unspecified",-
28F3F14C-6364-4E9A-9435-B757F4B5CCB0,J06.9,"Acute upper respiratory infection, unspecified",-
C170F1A3-2979-4861-BE10-53893F13CDAD,Z71.2,Person consulting for explanation of investigation findings,-
3ABFE040-6341-4835-8633-5EBED7FD86FE,J06.9,"Acute upper respiratory infection, unspecified",-
FEFE0F04-A105-4C86-BD45-22C0CD8D5E44,N94.6,"Dysmenorrhoea, unspecified",-
74A33A16-8877-4652-BA56-97986A47491C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DBE38EF7-B945-4894-9F9A-4ED01D73FC54,J06.9,"Acute upper respiratory infection, unspecified",-
8E9874D2-CCC4-4B10-8F80-0380E9F3023F,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
8FC41786-D38C-411C-9BCF-DD2FD5C0719E,J06.9,"Acute upper respiratory infection, unspecified",-
F68CE255-056B-41C4-9533-EF90D913386B,R05,Cough,-
7FE7CB13-6234-4A08-8905-B4BC5042B21E,R63.5,Abnormal weight gain,-
E0F3CF57-8E10-4D8B-BBD2-F2BE7E5BDC0B,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
B6E5167C-E564-458A-B9CA-CA1B8C6E539A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C224B8BA-D423-4207-A392-0921A062CE9F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
424E82A2-0472-4318-B821-16F2107D748E,A09.9,Gastroenteritis and colitis of unspecified origin,-
424E82A2-0472-4318-B821-16F2107D748E,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
424E82A2-0472-4318-B821-16F2107D748E,J39.3,"Upper respiratory tract hypersensitivity reaction, site unspecified",-
6F955BAD-F1A7-4F57-83BE-BB2C672DD8A5,J02,Acute pharyngitis,-
42CD9D3B-65D7-481B-BD8B-E96335C43138,A09.9,Gastroenteritis and colitis of unspecified origin,-
42CD9D3B-65D7-481B-BD8B-E96335C43138,L02.4,"Cutaneous abscess, furuncle and carbuncle of limb",-
66A02CB3-81D8-4D1C-855E-CC807D3AA846,T88.1,"Other complications following immunization, not elsewhere classified",-
23E80D3C-A6FD-4CF2-87B9-EA34065471B0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F304BE58-9DDB-4901-90B0-0DAB1F2ADF8A,L02.3,"Cutaneous abscess, furuncle and carbuncle of buttock",-
C5B908B5-A438-4897-8A3A-D102F5B11819,I10,Essential (primary) hypertension,Hypertension
34E2BC09-E463-46EC-AD06-2911B2CC9339,L20,Atopic dermatitis,Atopic dermatitis
6B5DDEFB-8AC1-45B2-8055-477BE986657C,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
BCBF4971-3A8E-4B35-948E-BC498F653D4E,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
BCBF4971-3A8E-4B35-948E-BC498F653D4E,R51,Headache,-
EABAEF2E-FFED-42CC-A641-14DA764B749E,J20,Acute bronchitis,-
F3DA2AEF-7D83-4B43-B3AF-3F47ECBF557A,H02,Other disorders of eyelid,-
B738C46A-6172-4687-9C8A-ED4377B21E9A,T88.1,"Other complications following immunization, not elsewhere classified",-
35D66FDF-952C-451A-BA18-3EBB1B727931,L03,Cellulitis,-
1584A1FE-AFDF-4E86-B6B2-3F289BF8D6E5,R50.9,"Fever, unspecified",-
BBFF4FEB-2F3B-4815-907E-4DADAB6216FC,M76.6,Achilles tendinitis,-
4492DF7B-76D9-4B75-A9CF-47F03F1B1EC0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C6773CFB-A867-407A-9A81-9E7A44B33D59,T88.1,"Other complications following immunization, not elsewhere classified",-
33BB0085-4196-4CE8-9DB9-4E5D8055BF32,K29.1,Other acute gastritis,-
127A349E-8EE8-431C-9454-F06FC16CD538,A09.9,Gastroenteritis and colitis of unspecified origin,-
3477989D-90C9-4AC0-BDDE-B15FE2BE7A52,K29.7,"Gastritis, unspecified",-
3477989D-90C9-4AC0-BDDE-B15FE2BE7A52,J06.9,"Acute upper respiratory infection, unspecified",-
F3A309B1-73A6-4191-93CC-15778E21597D,A09.9,Gastroenteritis and colitis of unspecified origin,-
F90F58D8-ED17-4D96-8043-7EB8ABA59ABE,M62.6,Muscle strain,-
57F8CA7E-7518-4460-A303-BAC336199AA1,R51,Headache,-
57F8CA7E-7518-4460-A303-BAC336199AA1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9BFADE83-2D94-4F1E-BC5C-F0A9D68CF47C,J06.9,"Acute upper respiratory infection, unspecified",-
8E421A1B-998A-4D72-8689-4F6DD79068D1,A09.9,Gastroenteritis and colitis of unspecified origin,-
E0D99E78-317C-4CC6-8825-3E9532B25BAF,U07.1,"COVID-19, virus identified",-
3FB94277-547B-4CCD-B0AA-A755DD3F4ECD,T88.1,"Other complications following immunization, not elsewhere classified",-
1615DE79-8EFB-45EA-9D7A-31CB03F7613B,M62.6,Muscle strain,-
AE5BF64E-E0F0-4835-84D1-7640854F75D3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
10191BA0-6A41-401D-A72A-2E8965CFB755,T88.1,"Other complications following immunization, not elsewhere classified",-
7CBD5299-CC2E-4C8F-98F1-BD2E3A6A242F,T88.1,"Other complications following immunization, not elsewhere classified",-
ECF71CD6-7186-4D38-A0BA-3704F1FEAAEA,J06.9,"Acute upper respiratory infection, unspecified",-
A633096D-82D1-4661-BE05-5E4AA1405C14,U07.1,"COVID-19, virus identified",-
3661E65F-AC67-4B1B-B95A-926C0C6971E1,H00.1,Chalazion,-
FB8D50BC-3A62-4716-B0EA-9D7D9144F982,H10.9,"Conjunctivitis, unspecified",-
01F886AE-7793-4F60-8853-7D43DC923D8C,L24.9,"Irritant contact dermatitis, unspecified cause",-
8835170A-B1FB-463E-89C0-5FA52E42612B,Z02,Examination and encounter for administrative purposes,-
719804D8-5323-4376-B3EC-ECA455870BF5,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
1709824A-AD39-4FB8-9FCD-E1C796E9FF38,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B69D1B15-503F-404F-8683-8EA28400FC0D,N94.6,"Dysmenorrhoea, unspecified",-
F2DCD822-216D-4FA3-9B36-05C4930E5222,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B1C4544D-C7A8-4C31-B691-9A851AD58498,T88.1,"Other complications following immunization, not elsewhere classified",-
E4F3CDA8-A0DB-4ABC-B61F-38007525B609,A09.9,Gastroenteritis and colitis of unspecified origin,-
B91CAC40-BE50-43C2-A7C8-2AF2C65ECC95,K12.3,Oral mucositis (ulcerative),-
B91CAC40-BE50-43C2-A7C8-2AF2C65ECC95,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
ADDAFB31-5715-41D6-B0E6-BFC3D5961BB0,R42,Dizziness and giddiness,-
44DC1A93-1A83-400F-9A0B-33BAF03B942B,M62.6,Muscle strain,-
44DC1A93-1A83-400F-9A0B-33BAF03B942B,J06.9,"Acute upper respiratory infection, unspecified",-
38F29025-C1A5-498B-A61E-BF3B55002310,T88.1,"Other complications following immunization, not elsewhere classified",-
F4CD17E8-2670-41B1-93A0-0DE036CDBE30,J06.9,"Acute upper respiratory infection, unspecified",-
531EA867-FD13-444A-A2C1-BB20474E43B2,N94.6,"Dysmenorrhoea, unspecified",-
C8908E1B-7D48-4AA8-8269-3734808A7556,N94.6,"Dysmenorrhoea, unspecified",-
C8908E1B-7D48-4AA8-8269-3734808A7556,L50.9,"Urticaria, unspecified",-
325B7782-6624-499B-BADC-EBE22F17DCFC,A09.9,Gastroenteritis and colitis of unspecified origin,-
5436EEB4-354C-40C0-B5B7-8C82A306DAB0,N94.6,"Dysmenorrhoea, unspecified",-
E778702F-244E-4EDC-A8C1-8D05CDB3AB81,R50.9,"Fever, unspecified",-
E778702F-244E-4EDC-A8C1-8D05CDB3AB81,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D65F828B-5DEC-46F5-A2A2-31FB576724E5,R51,Headache,-
8A6C814F-B8E9-4C95-955F-9221E6AFF3C1,R51,Headache,-
90AA5821-28B3-4964-BB7F-5025011487E2,A09.9,Gastroenteritis and colitis of unspecified origin,-
728B5B69-B4FA-412B-A472-A998352E2813,A09.9,Gastroenteritis and colitis of unspecified origin,-
C8257D03-3099-4317-81A5-731624C49A30,R07.0,Pain in throat,-
C8257D03-3099-4317-81A5-731624C49A30,A09.9,Gastroenteritis and colitis of unspecified origin,-
D838A6A2-39E4-45B1-8DB8-840FBCB3B91C,K30,Functional dyspepsia,-
84C3709B-F73A-413D-BC6A-0F194C09786C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
12393245-714C-468E-BAB7-B254F0DCBE7B,J06.9,"Acute upper respiratory infection, unspecified",-
4188E791-EE41-4A9D-98FE-2CE0E721D0F9,L30.1,Dyshidrosis [pompholyx],-
4188E791-EE41-4A9D-98FE-2CE0E721D0F9,L20,Atopic dermatitis,Atopic dermatitis
B1FFACE2-2419-441C-AD63-DD6E9F73BA57,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B1FFACE2-2419-441C-AD63-DD6E9F73BA57,R50.9,"Fever, unspecified",-
D1E9E885-4B3F-4086-98E8-92ED66B0AB47,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
D1E9E885-4B3F-4086-98E8-92ED66B0AB47,R51,Headache,-
5F0CCBAB-01D7-46E0-B36B-0F09AEDCDF0D,Y42.4,Oral contraceptives,-
DD3F3F15-490A-4173-B84E-57A912E005C9,J06.9,"Acute upper respiratory infection, unspecified",-
24B6614B-89E7-4D36-A665-54802D1E4933,Z71.2,Person consulting for explanation of investigation findings,-
5C3E1D5F-7B66-40DA-A117-76EAD9C5ACC4,K07.6,Temporomandibular joint disorders,-
0243DC45-2362-42F8-A3D9-2FC17608D94F,R21,Rash and other nonspecific skin eruption,-
5C3E1D5F-7B66-40DA-A117-76EAD9C5ACC4,R21,Rash and other nonspecific skin eruption,-
5787D780-CEBD-4128-9148-BF493EA20B82,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
B2D5C158-B65A-4096-8EAD-79618D39E1B5,A09.9,Gastroenteritis and colitis of unspecified origin,-
7528D75A-CA51-4494-A955-67B5858318DD,J06.9,"Acute upper respiratory infection, unspecified",-
8F654C9D-165C-45BE-A229-F45472243282,R21,Rash and other nonspecific skin eruption,-
E6D5D9BB-88FC-4F7A-9F79-68CCBC249721,J06.9,"Acute upper respiratory infection, unspecified",-
8C8B61E1-5966-4737-B3BA-97298BAE4245,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
0DA96D69-BC37-4606-81D3-222030EFC313,A09.9,Gastroenteritis and colitis of unspecified origin,-
5AC42DDE-91CA-4F26-A00F-8D407694A0C2,T88.1,"Other complications following immunization, not elsewhere classified",-
7A577306-4C80-4EC6-80CC-460E3E2D6A11,R50.9,"Fever, unspecified",-
7A577306-4C80-4EC6-80CC-460E3E2D6A11,R51,Headache,-
55A529E5-4318-4845-BB62-783D408D4385,K64.9,"Haemorrhoids, unspecified",-
4DF3D9B8-3CB4-457C-A2C1-F686C3B68E86,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F9420AB6-B62E-43EB-B429-993035D80814,M62.6,Muscle strain,-
3BA4A36A-6793-4FD4-B51F-F26781508944,J45,Asthma,Asthma
F0F14FB4-2801-4000-8319-91B175EA9E97,S90.0,Contusion of ankle,-
5756849F-898B-4983-92DA-84E01B80C202,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2923EE06-3AA5-43BD-8474-3AB6BD10E28F,A09.9,Gastroenteritis and colitis of unspecified origin,-
8DE476C3-461A-488B-BA1C-DE077E77C328,M10,Gout,Gout
2923EE06-3AA5-43BD-8474-3AB6BD10E28F,R50.9,"Fever, unspecified",-
9D3743DC-3C31-4D09-ACD8-F21CDAAC96C5,J06.9,"Acute upper respiratory infection, unspecified",-
A404D6C7-53C0-40CF-914B-7CDCA7BECB1F,N39.0,"Urinary tract infection, site not specified",-
E552AE85-EA4C-4550-AB43-96C677712D46,G43,Migraine,Migraine
C5E4F450-A2BC-4BA2-ACB2-7C7660588EC7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2EAC8C97-D812-49DC-A99C-3414A251C351,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CD4249C2-7399-474B-9257-C4D40A40945B,J06.9,"Acute upper respiratory infection, unspecified",-
5D5DF274-C15E-4468-87DE-0E632C3BCD6B,J06.9,"Acute upper respiratory infection, unspecified",-
12E5729A-FAC3-4E94-85FC-260056FCA970,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
F55C7B2E-B206-4FE1-9B63-504354C2BDD6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
49844AF9-C2F3-4AEC-AE41-D3AB113CF711,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B761118D-00EF-4E74-A3B9-EB0E2A459D30,J06.9,"Acute upper respiratory infection, unspecified",-
B74B4656-0969-4A4A-ACC2-5DCE8DB6A7E1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
02A4ED1A-214C-4271-85CB-0D6516728F7C,R21,Rash and other nonspecific skin eruption,-
7DAF980A-9B02-4C24-AB16-EBF64EC4F066,B08.4,Enteroviral vesicular stomatitis with exanthem,-
98FE11E0-D774-4A97-86A5-3660E9B553AF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
90B016A0-BD9D-4808-9B82-696CEBCA75A4,M79.1,Myalgia,-
73D4329E-BB74-417A-A954-7DDA539C6C74,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
07919EC4-853B-4692-8FF0-63F677DE9569,Z71.2,Person consulting for explanation of investigation findings,-
8A046571-2BF7-4837-A949-5E31B6E10469,N94.6,"Dysmenorrhoea, unspecified",-
705B8E77-6467-41DF-AA64-581CD2124113,A09.9,Gastroenteritis and colitis of unspecified origin,-
8FDA8162-4B52-4357-AA39-7A76D55CD5C8,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
E1468025-E046-4EBC-9FC2-DE31FF7CE8E6,T78.4,"Allergy, unspecified",-
E1468025-E046-4EBC-9FC2-DE31FF7CE8E6,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
30D6D1BC-0DCC-4FB3-BD4E-32248A46433C,R21,Rash and other nonspecific skin eruption,-
3D0046F9-5508-4B34-9EE8-DD831D53C3D5,L20,Atopic dermatitis,Atopic dermatitis
6C281BFE-92A9-43D3-BA47-2F2FBACB1737,U07.1,"COVID-19, virus identified",-
C8E86852-8BD6-4F4F-97C1-F00AD393F019,U08,Personal history of COVID-19,-
C8E86852-8BD6-4F4F-97C1-F00AD393F019,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
801983BF-71CA-4CA5-8977-C52060C21283,R21,Rash and other nonspecific skin eruption,-
08166C92-6DB9-4674-A8A1-00895839EE91,K29.7,"Gastritis, unspecified",-
5A65A323-F04C-4F12-920E-06683D011293,A09.9,Gastroenteritis and colitis of unspecified origin,-
49B1967C-D9EB-4193-A2C1-8234A9F6F988,K12.0,Recurrent oral aphthae,-
776C35C0-40C4-4B08-B2C7-C25F7CBA70A6,M62.6,Muscle strain,-
49B1967C-D9EB-4193-A2C1-8234A9F6F988,H57,Other disorders of eye and adnexa,-
49B1967C-D9EB-4193-A2C1-8234A9F6F988,H10.1,Acute atopic conjunctivitis,-
50D2DF09-E9B0-4BA3-AAE3-846B2E6C24B4,U07.1,"COVID-19, virus identified",-
696DC8C9-AED8-4850-A2F1-B34DB86EB9B4,U07.1,"COVID-19, virus identified",-
50D2DF09-E9B0-4BA3-AAE3-846B2E6C24B4,J06.9,"Acute upper respiratory infection, unspecified",-
D78DE1BE-42B4-440E-976F-2C7DFD2AD1B4,J06.9,"Acute upper respiratory infection, unspecified",-
DC00ECDD-3256-4620-9491-BF428BD226A6,Y42.4,Oral contraceptives,-
03232613-F307-4695-848B-9B13809930D7,H81.1,Benign paroxysmal vertigo,-
03232613-F307-4695-848B-9B13809930D7,K30,Functional dyspepsia,-
D4673B57-7FDC-4855-8DD2-760F6760EF13,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
5B901244-9FB6-44EF-B593-DB6076279F09,G44.2,Tension-type headache,-
5B901244-9FB6-44EF-B593-DB6076279F09,M79.1,Myalgia,-
0229BF9E-2508-4A2D-A3F9-801B9B3C7174,R51,Headache,-
6301AEDA-167C-4FA3-9E4F-B3C3F7E79D02,R51,Headache,-
6B68FA8F-9683-49A8-AD26-D3BD261C005C,M54.5,Low back pain,-
60D15454-0AA8-4FC7-ADE3-A5FCF32E52BE,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
60D15454-0AA8-4FC7-ADE3-A5FCF32E52BE,H57.9,"Disorder of eye and adnexa, unspecified",-
4E5913C6-170B-471E-9878-E82504FBAB3A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B947F8EB-E4AC-496F-9813-2D9189AD9098,J06,Acute upper respiratory infections of multiple and unspecified sites,-
B947F8EB-E4AC-496F-9813-2D9189AD9098,U07.1,"COVID-19, virus identified",-
2660EC45-CA68-4DE6-87A8-888DEB6402F4,M79.1,Myalgia,-
2660EC45-CA68-4DE6-87A8-888DEB6402F4,T88.1,"Other complications following immunization, not elsewhere classified",-
CE438C46-F968-44B1-A696-6D10CC8D9A64,A09.9,Gastroenteritis and colitis of unspecified origin,-
AB565921-340E-4908-A5B6-3CB8841F411D,J06.9,"Acute upper respiratory infection, unspecified",-
2C22C9C7-FD65-4AB2-8C86-DA38DB8CE952,R51,Headache,-
2C22C9C7-FD65-4AB2-8C86-DA38DB8CE952,N92.6,"Irregular menstruation, unspecified",-
2C22C9C7-FD65-4AB2-8C86-DA38DB8CE952,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
A466BDB9-F322-4287-BE3D-3BEB5199DFB0,R51,Headache,-
4B508D67-345E-4425-898F-D4DD5AC9946D,R50.9,"Fever, unspecified",-
4B508D67-345E-4425-898F-D4DD5AC9946D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6861C681-797E-4F6C-B0EA-FABE32C89506,T88.1,"Other complications following immunization, not elsewhere classified",-
DE1D544B-574B-4BAF-8488-60E8276C0E1D,J06.9,"Acute upper respiratory infection, unspecified",-
DE1D544B-574B-4BAF-8488-60E8276C0E1D,J01.8,Other acute sinusitis,-
1022B4F3-F64E-4FF1-913B-4A9FBB324887,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4E4BDC61-F84E-416C-9FA0-5DCB0AE7ED2B,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
539F44FB-E786-4002-A062-017738298814,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
F05EFB7B-2642-4D55-BAD2-F50CE9776375,N94.6,"Dysmenorrhoea, unspecified",-
7C83A0B8-4F97-4A9E-9F8A-548A95D9044B,E11,Type 2 diabetes mellitus,Diabetes
8A2FBE96-1BD2-4179-95E1-FCCFE032F253,B35.4,Tinea corporis,-
0774F150-0199-435E-B1F6-D55E43DECBB1,A09.9,Gastroenteritis and colitis of unspecified origin,-
E4E2A4F3-EB3D-448A-8976-527B543E31A7,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
D96324F0-32A5-42D6-B502-B5454D9A3BC9,G44.1,"Vascular headache, not elsewhere classified",-
910D158D-6546-4A60-8331-A17CC0BD8E0C,K30,Functional dyspepsia,-
910D158D-6546-4A60-8331-A17CC0BD8E0C,K29.7,"Gastritis, unspecified",-
AE612064-FCD1-4EEE-8D39-62819DB1BBA9,A09.9,Gastroenteritis and colitis of unspecified origin,-
45447509-B647-4633-B380-8F990A1060B6,L24.9,"Irritant contact dermatitis, unspecified cause",-
9CA9E706-A96F-4E2B-964E-7EB2C775F22B,M62.6,Muscle strain,-
84DCF1D8-07F7-4E9F-87DF-CE64C314F63E,M25.5,Pain in joint,-
2BB86B8C-F06B-497E-AE06-F3A83C0A9E97,H10.1,Acute atopic conjunctivitis,-
2BB86B8C-F06B-497E-AE06-F3A83C0A9E97,L20,Atopic dermatitis,Atopic dermatitis
43723048-8EC9-4272-A187-4D790ECBBAE4,L30.9,"Dermatitis, unspecified",-
CB6BF181-F10A-485F-9980-C998EFC7CA3B,N94.6,"Dysmenorrhoea, unspecified",-
E28B917F-B498-464E-9BA4-014D3B2F8323,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
DCD9D9F2-F4B3-40A5-85CB-7B74BCD9DE26,M10,Gout,Gout
685BF11A-CC39-43CD-86EE-29B9ADDD1A3E,K29.7,"Gastritis, unspecified",-
D17993CF-EBFE-4A5A-B64E-95E11C3D2992,J02,Acute pharyngitis,-
1CD20EB7-994C-4DA3-AFF3-52EB2CFA7F9C,A09.9,Gastroenteritis and colitis of unspecified origin,-
7463A8A7-FB13-47F8-A9AD-3183751B533A,J06,Acute upper respiratory infections of multiple and unspecified sites,-
E96DFD3A-8708-4E07-B63B-C51EF2564306,A09.9,Gastroenteritis and colitis of unspecified origin,-
D1D6D828-E491-4CD6-AF29-42CDB109FF35,U07.2,"COVID-19, virus not identified",-
5EB5A333-7C94-45D1-9540-8CC5169478F0,N94.6,"Dysmenorrhoea, unspecified",-
85B036FB-0CA5-4647-9C1D-6E21DB3F2CDF,F38.0,Other single mood [affective] disorders,-
48329850-5C95-4179-917F-59BC3CA8D280,A09.9,Gastroenteritis and colitis of unspecified origin,-
89ADB779-EDF8-4831-AAAE-E5E7E7F04D72,J06.9,"Acute upper respiratory infection, unspecified",-
635EC539-E520-4372-85BB-3161946742A9,N39.0,"Urinary tract infection, site not specified",-
E05ABC3C-4B0E-470A-A219-F05EBD5896AD,H01.0,Blepharitis,-
BE435206-7056-4795-905C-23C2408A3D8C,N94.6,"Dysmenorrhoea, unspecified",-
1D15644C-EB9A-46E7-8874-55EB47712A13,Z71.2,Person consulting for explanation of investigation findings,-
127DCFCC-2BBB-48F5-9930-E3006367262D,G71.8,Other primary disorders of muscles,-
F8EAF927-376D-4EE6-ADC9-F6C083E5DEEF,R51,Headache,-
58572309-F282-46B6-961C-A2A8CEB2F436,A09.9,Gastroenteritis and colitis of unspecified origin,-
EF756877-8062-4E9E-B787-5F9370832EF0,H57,Other disorders of eye and adnexa,-
EF756877-8062-4E9E-B787-5F9370832EF0,G44.2,Tension-type headache,-
CE43E2A2-3C9D-4259-B697-F27460E5EDC6,N92.6,"Irregular menstruation, unspecified",-
C08B576D-BBCE-45FF-B222-50C12231F33C,J06,Acute upper respiratory infections of multiple and unspecified sites,-
2AD6E064-2259-49CE-97A1-C9A0334EE96B,T88.1,"Other complications following immunization, not elsewhere classified",-
3655C5E7-3D41-48E1-B2CD-79531E17398D,J06.9,"Acute upper respiratory infection, unspecified",-
9AA1067B-C9A9-4E72-B5C0-86DDC317902C,J06.9,"Acute upper respiratory infection, unspecified",-
9EA946D7-64F0-4CDE-9D4E-EB4200514A3D,J06.9,"Acute upper respiratory infection, unspecified",-
8E9037E6-CA9D-4DC8-A798-EBEDA9B5E4A3,G43,Migraine,Migraine
9096F9F3-DDE9-454F-AE4C-C9CB0CDA57CB,A09.9,Gastroenteritis and colitis of unspecified origin,-
DEAB6217-EFC4-49CB-97FF-6FB20B724A58,H01.0,Blepharitis,-
00EF1B5C-E23F-4D26-97B3-3F12C7D62EF6,H81.1,Benign paroxysmal vertigo,-
840334A9-ACC8-415E-99CF-38D4459A3962,R50.9,"Fever, unspecified",-
DF4BC7DC-CD7C-41ED-A8E4-855C0BBC3117,N94.6,"Dysmenorrhoea, unspecified",-
0C4214C1-760F-4F81-BA67-1F16138996A3,A09.9,Gastroenteritis and colitis of unspecified origin,-
C42E4908-73E6-4CB2-99B7-401DE7C94439,J06.9,"Acute upper respiratory infection, unspecified",-
F306D8E9-FD1B-4249-BF3D-7CB136D7B821,J06.9,"Acute upper respiratory infection, unspecified",-
1CAAE8AD-A789-4ADB-9DD2-F1A425895451,L02,"Cutaneous abscess, furuncle and carbuncle",-
F11FCA94-73F8-4A08-A03F-98CA2162DBBD,R53,Malaise and fatigue,-
462EFBA4-8C22-48C0-A18B-607E92CF5613,M23.5,Chronic instability of knee,-
3FD82950-3224-43E6-8A63-E86AA969BB6B,A09.9,Gastroenteritis and colitis of unspecified origin,-
C95FC61C-3EB8-4570-BF9A-FDF2AC35B9DE,A09.9,Gastroenteritis and colitis of unspecified origin,-
114E2298-A34B-4660-9216-F07AA2321FC3,S13,"Dislocation, sprain and strain of joints and ligaments at neck level",-
3FE72E57-3278-47E9-9D83-052A373C7481,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
3FE72E57-3278-47E9-9D83-052A373C7481,J06.9,"Acute upper respiratory infection, unspecified",-
A477FA28-FFC3-40B7-82D3-3B729281E47C,A09.9,Gastroenteritis and colitis of unspecified origin,-
46439B8D-265C-40E6-A29F-A18C79088353,A09.9,Gastroenteritis and colitis of unspecified origin,-
46439B8D-265C-40E6-A29F-A18C79088353,S00.5,Superficial injury of lip and oral cavity,-
E4832504-C494-43C7-A09E-1B5DAE353D08,M54.5,Low back pain,-
E4832504-C494-43C7-A09E-1B5DAE353D08,M62.6,Muscle strain,-
CF801924-D891-4BA5-BA5B-85C510D49409,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
85FB382D-F68E-4B12-9644-BBA7F2DB378E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
85FB382D-F68E-4B12-9644-BBA7F2DB378E,M79.1,Myalgia,-
0FDBF6D2-A52B-43DC-9228-9BEA0238E10E,N39.0,"Urinary tract infection, site not specified",-
8F662F9B-40C7-4782-93FC-E22F7E454365,R51,Headache,-
8F662F9B-40C7-4782-93FC-E22F7E454365,J45,Asthma,Asthma
087D39E4-159C-4624-A465-D23B3B5C1D67,M54.5,Low back pain,-
74577EC9-183D-4B58-A3D6-37517A174B18,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
CD8FB794-5DE6-4399-8138-2040E3824AC1,R50.9,"Fever, unspecified",-
403D90B3-A112-42E0-8DF8-F0781B295D38,K59.0,Constipation,-
403D90B3-A112-42E0-8DF8-F0781B295D38,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
B733D1F1-54D8-42FE-BB39-07362D75E225,J06.9,"Acute upper respiratory infection, unspecified",-
80AF3C65-B877-4E79-8EEE-7FC5E6BBB686,J06.9,"Acute upper respiratory infection, unspecified",-
896259A6-4D22-4A58-B547-545ABA926E6F,U07.1,"COVID-19, virus identified",-
5FDEC403-F253-481A-BF1E-11DC8F8EB519,U09.9,"Post COVID-19 condition, unspecified",-
939C30CC-835F-4701-BB0D-239124A28931,J39.3,"Upper respiratory tract hypersensitivity reaction, site unspecified",-
AF72DA59-4BDC-4C67-B14D-46F8C5D39B22,A09.9,Gastroenteritis and colitis of unspecified origin,-
DD1ECEDD-9CEA-48FA-9AE8-0CF3BD60762C,H93,"Other disorders of ear, not elsewhere classified",-
FD9B60C4-CFD6-4738-B792-DFCAF5907988,B36.0,Pityriasis versicolor,-
FD9B60C4-CFD6-4738-B792-DFCAF5907988,S60.0,Contusion of finger(s) without damage to nail,-
2815417A-6A4E-492E-ADF9-8110A0B3E0B0,A09.9,Gastroenteritis and colitis of unspecified origin,-
6EB4BCDA-6C02-4E04-BC55-64C2A20AF833,J06.9,"Acute upper respiratory infection, unspecified",-
2815417A-6A4E-492E-ADF9-8110A0B3E0B0,E61.1,Iron deficiency,-
6659C8C4-D051-4DDE-ADF4-2263A0EB5BE6,R52,"Pain, not elsewhere classified",-
2B5C7029-320D-4A29-895F-DF7A7EF81D00,H60,Otitis externa,-
F5FB2580-84D9-48C9-9470-211EFD5FE3CC,M17,Gonarthrosis [arthrosis of knee],-
36BEBD46-BF93-4BD7-A5BE-DB21195ECB65,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
18E6E7FD-834F-4E0B-99F3-CE5573A3DF75,R51,Headache,-
A17CDB69-CAA7-4E59-9693-0C5D6E18F7B9,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
ACD9686C-6CBD-4B88-863E-CBB473DE8C3B,L20,Atopic dermatitis,Atopic dermatitis
ACD9686C-6CBD-4B88-863E-CBB473DE8C3B,G44.1,"Vascular headache, not elsewhere classified",-
A146B9A7-8EA4-45F1-AB04-D44ADBBF92FE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9035C42A-70BF-4382-8DB3-BFE9F466DA6C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
253326F3-DDA6-4FC0-873C-848C6870E5A8,A09.9,Gastroenteritis and colitis of unspecified origin,-
3D342C1A-4DA9-4B8A-90BC-D685167375F8,A09.9,Gastroenteritis and colitis of unspecified origin,-
3D342C1A-4DA9-4B8A-90BC-D685167375F8,K29.7,"Gastritis, unspecified",-
16A7DA30-8B67-4A73-BA63-B6CB339B517B,K30,Functional dyspepsia,-
16A7DA30-8B67-4A73-BA63-B6CB339B517B,R51,Headache,-
A7BCDC42-31DB-4AF8-8E41-DCE1D3401EF7,R50.9,"Fever, unspecified",-
117D5D8C-A127-440C-9A36-EF91DF9029C8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
117D5D8C-A127-440C-9A36-EF91DF9029C8,R50.9,"Fever, unspecified",-
12D1E275-25D7-498B-8286-D14C2704522B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CCB7CCDD-1941-4B81-AC53-1F54C3E2F2A4,R51,Headache,-
7F517B5C-EF70-4EE9-AD62-ECF98EB4FF94,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2110FDD6-5F8D-466C-BF10-1AD7CC4FCF50,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
4EA83017-538D-455E-8C5F-5102372A0310,M79.1,Myalgia,-
4EA83017-538D-455E-8C5F-5102372A0310,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4AA8768C-F42D-44C2-B537-02C11A5E1F31,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
D54E1BB5-7834-4A22-92AA-F902F63CD5C7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F78E5469-D681-42AA-AA1F-6BB4F7C36E9C,R50.9,"Fever, unspecified",-
468D82C3-4B2B-410E-A956-5AACF57AB2EE,Z71.2,Person consulting for explanation of investigation findings,-
786A3F84-9DD7-4050-91B0-4F3C64C340EA,J06.9,"Acute upper respiratory infection, unspecified",-
ECC15BA0-4E11-4407-B727-75593E236D6A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
70AD529F-13AB-40B6-A81A-83890105D672,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EF54FDA0-A570-44EF-99D6-16B975B5E30C,M62.6,Muscle strain,-
FDDBE601-3235-47C9-9472-1E1FA5E7234B,R06.2,Wheezing,-
3E142EE9-7DD3-4FD0-84FD-9F90F89D8003,N64.5,Other signs and symptoms in breast,-
3E142EE9-7DD3-4FD0-84FD-9F90F89D8003,J06.9,"Acute upper respiratory infection, unspecified",-
8DBFF223-9340-4446-A0D2-224D3CBCB683,Z71.2,Person consulting for explanation of investigation findings,-
3B09C16F-A922-4A0A-B09E-D8B4BD1AE13F,A09.9,Gastroenteritis and colitis of unspecified origin,-
F7EC5C6A-0FAF-4694-A2B2-4653DC0A4946,J06.9,"Acute upper respiratory infection, unspecified",-
8A7FEAF1-7846-4C70-9830-F107C5A317E7,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
74FCDC8C-01F4-4BB2-9570-833EE47DD8F2,R51,Headache,-
6503A32C-5A69-4CEA-8680-36AE57AFEE9F,N94.6,"Dysmenorrhoea, unspecified",-
8C04D6AA-40F4-4D68-8178-6181A8201235,J06.9,"Acute upper respiratory infection, unspecified",-
0871142D-D42C-4843-AE4D-A5B50A4D729B,Z71.2,Person consulting for explanation of investigation findings,-
8A6F9AD6-D618-4932-B468-6C7D2D6F00AF,R10.4,Other and unspecified abdominal pain,-
F7941386-659E-4B14-B5A0-73F74B63A883,Z71.2,Person consulting for explanation of investigation findings,-
29A1D6ED-EB26-4AA5-84CD-3420E5135E1A,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
E118D483-9BEF-4340-A0A8-B6CC251FD377,N39.0,"Urinary tract infection, site not specified",-
BE011E8F-AD24-4F26-A45E-C1AE4EB86642,J06,Acute upper respiratory infections of multiple and unspecified sites,-
81BF224F-411F-40E9-8B40-3FBAAFBA263B,M10,Gout,Gout
3DA6E3B4-7D9B-453C-92B6-1404A4766AF6,R51,Headache,-
3DA6E3B4-7D9B-453C-92B6-1404A4766AF6,J06.9,"Acute upper respiratory infection, unspecified",-
87D4ADCF-923B-4D54-9753-44AB99D2C855,J45,Asthma,Asthma
7B3905A2-F90D-4D88-BE4F-B5338B268EE6,R51,Headache,-
C54E4422-A1A9-4331-9879-83800FA6B6DA,J45,Asthma,Asthma
6951D857-C83A-4C9B-B43A-D618408BF6FF,M54.5,Low back pain,-
DF1B66EC-4716-4A4A-946A-6D0CCB89120C,K59.0,Constipation,-
C0A2FAA8-2E5A-4D4A-9331-BCE06B1426EC,A09.9,Gastroenteritis and colitis of unspecified origin,-
C0A2FAA8-2E5A-4D4A-9331-BCE06B1426EC,R11,Nausea and vomiting,-
9C47259C-6A90-41C1-AC37-165B0CD24D91,L50.9,"Urticaria, unspecified",-
29C605A7-BD27-4EB6-A218-B82D30E6868A,B35.3,Tinea pedis,-
29C605A7-BD27-4EB6-A218-B82D30E6868A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
21059A12-6AD0-41D2-89A8-B4BA6792C661,K29.7,"Gastritis, unspecified",-
4E526B82-FC1D-4720-8004-563288D1D320,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
FF6D986C-F318-44E4-A8DB-E19BEE75F55F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DFFC8D0F-16D6-4D47-9FC6-2B0A53214C73,J06.9,"Acute upper respiratory infection, unspecified",-
71D75B37-C2E6-41FE-8067-9A19D58FD60C,L20,Atopic dermatitis,Atopic dermatitis
173CF2F7-EC12-4B54-8814-544216C771F0,O91.0,Infection of nipple associated with childbirth,-
0D68FE15-373A-4ED0-9579-8709A0090540,A09.9,Gastroenteritis and colitis of unspecified origin,-
981A49E1-5BD1-41D8-ADA9-4C5AB954AF2C,Z71.2,Person consulting for explanation of investigation findings,-
D920836C-ABD6-4D00-87FE-C44B249EB93D,E03.9,"Hypothyroidism, unspecified",Thyroid
67EE9F8B-4424-45E2-B802-EEC9ACFC73B3,R51,Headache,-
1B1B3095-43AD-4E0D-B445-894DFECE8925,T88.1,"Other complications following immunization, not elsewhere classified",-
8DC2358F-0F72-4C41-9835-B9322923E412,T88.1,"Other complications following immunization, not elsewhere classified",-
2D2D333D-F6DD-4346-BCAA-131D2B5F9B7F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
057A824B-76F4-45DA-AA89-10DF9E8FB705,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
32F750FB-B7BC-472D-AF4D-8C4F5EB61D62,N94.6,"Dysmenorrhoea, unspecified",-
F1765666-587F-4BB7-932F-5DE0A542A674,R51,Headache,-
DA1FE6A7-599C-4A87-B4CA-3AFAC680AADA,K59.1,Functional diarrhoea,-
A0628407-78F9-4B80-8F8B-ED76942AD5D0,R51,Headache,-
6DB42A17-996C-455F-8CEB-7410A91FA9A1,M54.4,Lumbago with sciatica,-
D32EADAA-B139-4046-97A8-51223D2A1177,S33.5,Sprain and strain of lumbar spine,-
09344182-9B70-485F-9B0E-05EA876F07F9,M10,Gout,Gout
4FBB7613-E424-4E6E-8B5F-9A7CFEF5200E,R14,Flatulence and related conditions,-
4FBB7613-E424-4E6E-8B5F-9A7CFEF5200E,R10.4,Other and unspecified abdominal pain,-
4FBB7613-E424-4E6E-8B5F-9A7CFEF5200E,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
2AE82C4F-98DE-4DBF-8560-0C3AA7326077,R51,Headache,-
E9643A4F-CDDE-4A16-8409-FD6B4F150A90,R51,Headache,-
306B0667-F1AB-49BD-9B77-4CE22DA94655,J06.9,"Acute upper respiratory infection, unspecified",-
16BA3D17-0E74-4FDE-898B-225DA95D613B,J06.9,"Acute upper respiratory infection, unspecified",-
D44F6F6F-74A8-4F4C-8BEB-C94CF5036BBE,R21,Rash and other nonspecific skin eruption,-
C2AAB628-ADF0-4616-8E48-CC74BBBCF836,Z76.0,Issue of repeat prescription,-
55EF9206-0EE1-431B-A942-DB696B3D50E4,Y42.4,Oral contraceptives,-
C2AAB628-ADF0-4616-8E48-CC74BBBCF836,B00,Herpesviral [herpes simplex] infections,-
C2AAB628-ADF0-4616-8E48-CC74BBBCF836,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
40834F0F-A25A-4EEF-9B8A-22A58B524242,J03.9,"Acute tonsillitis, unspecified",-
E63727D6-AA93-4C89-B269-5A2762A17210,Z13.9,"Special screening examination, unspecified",-
BAE941A0-13AB-4E36-A369-C8FD5673E7CC,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
BAE941A0-13AB-4E36-A369-C8FD5673E7CC,L29,Pruritus,-
BAE941A0-13AB-4E36-A369-C8FD5673E7CC,J06.9,"Acute upper respiratory infection, unspecified",-
04CEAF9C-DAC1-4548-A4EA-F0BD0E47247F,A09.9,Gastroenteritis and colitis of unspecified origin,-
3BAEA283-D3B3-4960-B326-2A36ADF73590,R51,Headache,-
76424675-88FB-4FEE-9B79-AB52151F8BAF,R51,Headache,-
5F957ADA-F046-438A-BB64-EA72334BF2A6,K29.7,"Gastritis, unspecified",-
611A0D4F-EC13-4C58-8F41-0638E0C3C2F8,M62.6,Muscle strain,-
3D7E3DFF-8E8F-4116-9064-31EA199B636C,K29.7,"Gastritis, unspecified",-
D4D68D30-E257-4D45-BBCD-5C366F4B1F85,K29.7,"Gastritis, unspecified",-
917575AF-7FEC-4E34-A407-30868A813A79,T88.1,"Other complications following immunization, not elsewhere classified",-
454BAFF1-4ADD-459B-B5BA-6BDC855C3D2C,R51,Headache,-
454BAFF1-4ADD-459B-B5BA-6BDC855C3D2C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
454BAFF1-4ADD-459B-B5BA-6BDC855C3D2C,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
94C8F770-D105-46F5-B073-2D7E2402E74F,K29.7,"Gastritis, unspecified",-
56383076-1C91-40AD-A44C-623833B37C2D,K30,Functional dyspepsia,-
56383076-1C91-40AD-A44C-623833B37C2D,R21,Rash and other nonspecific skin eruption,-
ED4BC3B4-ECF3-48F2-A2E9-B6B76B8F75E4,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
119D7CF7-0F35-4611-89C1-48A1107FB850,J06.9,"Acute upper respiratory infection, unspecified",-
6E846A7D-47B1-42B3-8D2E-EDBAEB00797C,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
6E846A7D-47B1-42B3-8D2E-EDBAEB00797C,I10,Essential (primary) hypertension,Hypertension
AEA56558-DF23-40DB-A5C0-691AFA97E82F,Z76,Persons encountering health services in other circumstances,-
4178F693-CCC6-4D0C-98BD-23A0F8D76423,R51,Headache,-
72EF1815-7CD7-4EAC-82CC-0D7E657BAE9A,R51,Headache,-
FCB89DB6-24B3-4FD9-AF9F-3140935E1C74,S23.3,Sprain and strain of thoracic spine,-
DE86F60A-DA07-470C-9613-8E9B0D719BA8,L20,Atopic dermatitis,Atopic dermatitis
629AFCA5-9D67-499B-B5B5-A3E8CAFC1385,R51,Headache,-
8359B311-BF71-4635-A005-42193E28C3D7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3E9BDFB8-0804-438C-976F-93E45689581A,T88.1,"Other complications following immunization, not elsewhere classified",-
8A375DCD-9366-494E-908A-66DDDA60F016,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FE6AE46B-4B7B-4B73-AF94-45F537287A3D,J06.9,"Acute upper respiratory infection, unspecified",-
C4236106-4B9C-432C-8DE6-F1005881C691,J06.9,"Acute upper respiratory infection, unspecified",-
C4236106-4B9C-432C-8DE6-F1005881C691,R21,Rash and other nonspecific skin eruption,-
E4CF4F0F-22C6-42E6-A21A-6ABD85441D28,H57.9,"Disorder of eye and adnexa, unspecified",-
87EF35DC-C713-40C6-8C10-7FDA90DF1198,U07.1,"COVID-19, virus identified",-
225D45DD-8B3D-47FE-92C7-BC9BFC1ECECF,J06.9,"Acute upper respiratory infection, unspecified",-
D578774F-4C73-47E1-BB04-32F104F37C18,N94.6,"Dysmenorrhoea, unspecified",-
24FB58C7-8307-49EF-BFBC-8F5DE479FAE6,Z71.2,Person consulting for explanation of investigation findings,-
7961AE3E-E9BA-4626-A5A0-FB74047A85F7,K59.0,Constipation,-
4B5B2790-5826-4D78-8621-515D5FBAEE4F,M25.5,Pain in joint,-
24204A33-4C3A-424A-9630-F19754F5078C,K64.9,"Haemorrhoids, unspecified",-
4B5B2790-5826-4D78-8621-515D5FBAEE4F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7961AE3E-E9BA-4626-A5A0-FB74047A85F7,K29.7,"Gastritis, unspecified",-
AF6CD49F-7D8E-4A61-94F2-4C1FF1277E42,A09.9,Gastroenteritis and colitis of unspecified origin,-
EA93596A-20E1-4B31-A8FC-12BA59647E86,J06.9,"Acute upper respiratory infection, unspecified",-
1A671AA1-6E1B-4356-8330-5F50005F7899,R21,Rash and other nonspecific skin eruption,-
CA84BF55-0DA8-4E9E-99A8-C6CC82AD09C9,T88.1,"Other complications following immunization, not elsewhere classified",-
E45B3272-019C-4E5E-BCD0-0ED6D9C78FE0,K29.1,Other acute gastritis,-
1552C971-5838-43D6-897D-563274DC4E9B,A09.9,Gastroenteritis and colitis of unspecified origin,-
6C0BFD30-8083-420D-8DD7-971435A39E9A,L50.1,Idiopathic urticaria,-
B702DBCD-A760-409F-B328-B86139A1F900,R51,Headache,-
7894676B-37B1-4E33-8202-D9CD0F1F5ED3,Z71.2,Person consulting for explanation of investigation findings,-
4E62D3A0-603A-41EB-AF8E-580B44FB1450,A09.9,Gastroenteritis and colitis of unspecified origin,-
BBED338E-1EFA-4E61-ADA1-3DB9F01E3FBE,N94.6,"Dysmenorrhoea, unspecified",-
4198E541-2E51-4AD3-8803-924B4CC41BC8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3BE80F33-CC37-4A2C-9ECA-45C056DC606F,K29.6,Other gastritis,-
452F168C-E344-4C02-A857-7DCF8A5C896D,A09.9,Gastroenteritis and colitis of unspecified origin,-
40AC4E8A-955B-445B-8C1B-131F48300BFF,K30,Functional dyspepsia,-
6AD889A2-19F9-4018-954A-011C5D5BAD90,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
4F6DB7E7-5ACA-40FC-BA3D-FC13B9F49AE7,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
B6A386C0-91F9-4B76-A206-5890F833A30F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5348DA6F-BC88-4851-AADA-559746A3BF28,N39.0,"Urinary tract infection, site not specified",-
123E3B14-E92A-406E-91D4-E6FFBBD9D6B3,N39.0,"Urinary tract infection, site not specified",-
C43FF70F-AC87-42E6-8EA2-AF7C83BECB55,N94.6,"Dysmenorrhoea, unspecified",-
B2F1920B-EF5B-46FB-BAAF-26A6EAD15929,G44.2,Tension-type headache,-
5E228B25-6069-40DB-982D-CE4C439C8979,Z71.2,Person consulting for explanation of investigation findings,-
05A11D2A-C774-4EE3-955C-6AFF14D7F39B,R51,Headache,-
E800011E-92AD-45FF-85B7-39C794A08A40,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
1D955549-6994-4C5C-AF00-05B8C642C761,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
50D2CA7C-8C85-496F-A55C-53AC74B09F07,S93,"Dislocation, sprain and strain of joints and ligaments at ankle and foot level",-
29B995BA-47A2-44C6-8ADF-468D187AFCBC,R21,Rash and other nonspecific skin eruption,-
29B995BA-47A2-44C6-8ADF-468D187AFCBC,J02,Acute pharyngitis,-
AA9DC4AC-851F-4567-B57E-2E08B02CF354,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
07416DD9-AE32-47BE-87B8-AFB1B3FD7DD6,F41.9,"Anxiety disorder, unspecified",-
24D6EEEC-6231-452A-A58A-98280412E946,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
187F5C2E-51FC-4A74-81BF-A00C177BCACA,N64,Other disorders of breast,-
7BA825F6-AAD0-43C1-BA05-1DAFB5D7607D,M62.6,Muscle strain,-
DE414CB3-9AF5-42E0-AEA0-FF534AC146AA,L50.9,"Urticaria, unspecified",-
80052520-FB5E-4028-AF33-20EE635D2B4D,L30.9,"Dermatitis, unspecified",-
F9A967E3-3AB1-4E5A-8DF0-1768DF8B0371,R51,Headache,-
34D8E575-59A3-48B6-8113-3C92005A8D5B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
34D8E575-59A3-48B6-8113-3C92005A8D5B,M79.1,Myalgia,-
551E66DE-3D09-4C01-BD7F-BCA831F1FF56,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
2F9B5B41-709D-4257-872F-D7EEBC5FB92F,N39.0,"Urinary tract infection, site not specified",-
547DE905-4A8C-4915-BAA5-1EA0C03B08D5,L02.9,"Cutaneous abscess, furuncle and carbuncle, unspecified",-
FC7EDE3D-7B7B-4A95-9D42-285B5C6DF173,M62.6,Muscle strain,-
FC7EDE3D-7B7B-4A95-9D42-285B5C6DF173,M54.5,Low back pain,-
5AAE1CB7-046D-498F-9E7A-CEAB97988EA9,N94.6,"Dysmenorrhoea, unspecified",-
D9DA3315-0A10-426F-B4AD-FF2EDCDD6721,R50.9,"Fever, unspecified",-
28E3309F-EA0A-4B50-B408-D62D42AA0912,G43,Migraine,Migraine
B30E555F-EE11-4920-90BA-49A0BCBAB8DE,M62.6,Muscle strain,-
B30E555F-EE11-4920-90BA-49A0BCBAB8DE,G44.2,Tension-type headache,-
1A7ADBA1-02E2-48EB-8A4D-6992257B06DC,Z71.2,Person consulting for explanation of investigation findings,-
3436E67E-5762-468A-A40A-ACE1FC84B04D,J45,Asthma,Asthma
3436E67E-5762-468A-A40A-ACE1FC84B04D,H01.0,Blepharitis,-
5F285FEA-9BE6-43E6-A906-764E9F763897,J06.9,"Acute upper respiratory infection, unspecified",-
99592B01-3B79-4725-8050-219AF6ECDD11,J06.9,"Acute upper respiratory infection, unspecified",-
99592B01-3B79-4725-8050-219AF6ECDD11,H57,Other disorders of eye and adnexa,-
409FBA36-DE7E-4F56-9F36-4881F1CA75C3,T88.1,"Other complications following immunization, not elsewhere classified",-
18EBB499-621D-437A-9F32-1C3557791C94,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3AB038AD-AD53-43DE-8147-80712D57ABAD,A09.9,Gastroenteritis and colitis of unspecified origin,-
411869E6-EE06-4308-87B0-53AAC1895606,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9AEE8BCB-E268-457D-8BEC-9505550E8F28,K30,Functional dyspepsia,-
43B07CBC-1C51-4086-A2B0-77A4A3EAFDE9,L50,Urticaria,-
2C5FB22F-38B5-4080-A73F-C235AA8FD6E2,G44.2,Tension-type headache,-
1C2F4282-5E6E-46BA-894F-A6C84D6B4853,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8493E942-DB25-47E1-9A08-A89EDB71C6A9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FEA68642-7C67-44EF-87B2-DD1698063A5F,J06.9,"Acute upper respiratory infection, unspecified",-
D6F6A75B-B85A-46C2-86DE-1E691596B7F4,R51,Headache,-
780FC40C-CE70-4D88-BC43-C541BA27F0FA,R50.9,"Fever, unspecified",-
B7B94826-ACAA-46F2-8A51-0E16E86AC87B,R51,Headache,-
A8D9FF19-3BC3-4302-9862-5E1CFD40443E,I10,Essential (primary) hypertension,Hypertension
1BB930B1-8FF0-4870-AFAF-C0D08C9CB5AB,R51,Headache,-
0D81E690-84ED-435A-A7F4-02754A007E21,R51,Headache,-
88C605A8-8077-4324-B8EF-900B935DF760,J06.9,"Acute upper respiratory infection, unspecified",-
0F4176E1-2712-4658-BA2C-396774BA4333,H57,Other disorders of eye and adnexa,-
E0013380-7270-48DB-A08C-35525AD87E17,A09.9,Gastroenteritis and colitis of unspecified origin,-
7D158FE5-DF77-46FD-BFDA-72E17A445E50,A09.9,Gastroenteritis and colitis of unspecified origin,-
5B676058-3B1C-41DE-8C2B-F4B16ECBB437,T88.1,"Other complications following immunization, not elsewhere classified",-
95D8D3D4-7C2C-43D2-A69E-7A46A599BA2F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
88822842-52AB-4070-BE68-72DE1661AB47,R04.0,Epistaxis,-
D33A095E-F004-437A-A6FF-91578666A884,R51,Headache,-
8B07BFF5-AF76-4D30-8679-E32BB4C273E8,J06,Acute upper respiratory infections of multiple and unspecified sites,-
D8399E4B-72EF-4D00-8F87-0F2EE5425A84,T88.1,"Other complications following immunization, not elsewhere classified",-
78251420-B2F3-4669-BE93-E198141AE3A2,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
05876F33-B295-46C3-9EBD-33570E82710D,R51,Headache,-
3FD5A6DF-8721-4B0C-92F6-EB893FB33D90,R21,Rash and other nonspecific skin eruption,-
5BEEEFFD-3C8C-4340-9732-F9CCBF4C02DD,T88.1,"Other complications following immunization, not elsewhere classified",-
3B08E748-A9BE-4B82-8212-52F1AB0162F5,U07.1,"COVID-19, virus identified",-
69CC85DC-77EC-44AD-B7A0-6DB3923E7E98,N94.6,"Dysmenorrhoea, unspecified",-
FC4B77DC-834B-47A1-B188-7B47B665F967,H10.8,Other conjunctivitis,-
68D9BD92-7F40-4F83-B541-01089B81D71C,J06.9,"Acute upper respiratory infection, unspecified",-
5F6F1E33-4446-460E-A347-6A80B3D7A53D,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
8A3D57C7-24C2-4852-9859-543506336FF8,L20,Atopic dermatitis,Atopic dermatitis
8A3D57C7-24C2-4852-9859-543506336FF8,L70,Acne,-
B7BEDCFF-FCCF-4C83-A6BF-71B10A6798EF,R50.9,"Fever, unspecified",-
8F4A2D7E-BB87-4263-996C-C7D71F9C30AE,U07.1,"COVID-19, virus identified",-
F6A54455-661D-49D5-8026-A1727683849A,U07.1,"COVID-19, virus identified",-
8F4A2D7E-BB87-4263-996C-C7D71F9C30AE,R05,Cough,-
F6A54455-661D-49D5-8026-A1727683849A,J06.9,"Acute upper respiratory infection, unspecified",-
49EB82CA-F732-4CF6-9F8B-037DD4479CE7,J06.9,"Acute upper respiratory infection, unspecified",-
74A09933-C368-49D6-B631-C8770672AC4B,A09.9,Gastroenteritis and colitis of unspecified origin,-
908F98C5-1507-4BA6-BDA7-339ABF920EB3,T88.1,"Other complications following immunization, not elsewhere classified",-
B673E426-9F14-424E-8CD6-66B2F0CAF449,R51,Headache,-
4ED8FCC0-3B51-4E81-A398-5A96CA0887E8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
24D5D0CF-BEBE-48D6-BD07-1D8B40270F7C,J06.9,"Acute upper respiratory infection, unspecified",-
A219AE4A-B1CE-448E-A780-E456FE274597,G44,Other headache syndromes,-
D1DA8D4D-FDB9-4250-8B6F-2BC56DEE24B1,R51,Headache,-
97B4EEB4-BEAD-4506-B25C-8DBD3A73D66E,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
76D49CCF-BAF7-4139-8BE6-CC0EEAA971D6,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
F9E99285-3824-4058-BE44-670EAB9B9197,E28.2,Polycystic ovarian syndrome,-
F540DD15-7556-4F73-9DDF-3DD219069412,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
C91E6157-0477-4715-BCA6-AD9781BE68A8,G71,Primary disorders of muscles,-
219830A5-C41C-4282-A83D-D77A5A304B38,M25.5,Pain in joint,-
5D37DD24-DAEB-4284-A66B-AFC338B00FDA,J06.9,"Acute upper respiratory infection, unspecified",-
B6DDC9DA-5F4A-4F6C-8E3D-47DFB25093E2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
29B640A7-FE36-4BC6-968C-FC2C55ABEB9E,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
29B640A7-FE36-4BC6-968C-FC2C55ABEB9E,B35.4,Tinea corporis,-
29B640A7-FE36-4BC6-968C-FC2C55ABEB9E,G44.2,Tension-type headache,-
60EB2D5A-09FB-4224-B891-B2EEC35E5308,J45,Asthma,Asthma
60EB2D5A-09FB-4224-B891-B2EEC35E5308,G44.1,"Vascular headache, not elsewhere classified",-
60EB2D5A-09FB-4224-B891-B2EEC35E5308,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
60EB2D5A-09FB-4224-B891-B2EEC35E5308,J06.9,"Acute upper respiratory infection, unspecified",-
167B7EDF-DC9D-4E92-A91A-6A8E3687464B,A09.9,Gastroenteritis and colitis of unspecified origin,-
E04E5E1D-522B-4E29-AE18-B5182957FB18,J22,Unspecified acute lower respiratory infection,-
CDFF0C39-BA31-4C85-9655-91002CE80782,S33.5,Sprain and strain of lumbar spine,-
68E1539C-714F-4673-BEB0-38FD6E50C18C,L50.9,"Urticaria, unspecified",-
9CDD9DD5-17A4-41C5-A559-7AE582DAABA8,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
6E3F9FCC-739D-4122-84A1-DA900601AF25,K64.9,"Haemorrhoids, unspecified",-
ED9BC443-29B6-494F-A581-FAA97DF75FCF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9170BDDD-102F-4A03-A150-CEAFE9B5C036,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EC501822-2C0F-44AF-9AD3-E65070FED8B6,J06,Acute upper respiratory infections of multiple and unspecified sites,-
084447D2-B302-4066-9042-1B7AB79B82E8,H10.1,Acute atopic conjunctivitis,-
084447D2-B302-4066-9042-1B7AB79B82E8,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
0B4B6AA9-71A9-4830-85DC-CD63382335E4,H00,Hordeolum and chalazion,-
0B4B6AA9-71A9-4830-85DC-CD63382335E4,H57.9,"Disorder of eye and adnexa, unspecified",-
2AF3CEFD-87B9-497B-9B50-39A99846D4E1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8878520C-1F56-4B9C-A8FF-C24D136C5D19,A09.9,Gastroenteritis and colitis of unspecified origin,-
F3130DE1-4AAB-4D52-AE61-C6E96BD15386,R51,Headache,-
066DF5A8-AA2C-46DD-889D-0CCE41959338,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
749C6011-B90F-461D-BAA3-221789D281D3,M54.5,Low back pain,-
8ADB0758-A3BE-4ABA-BF64-6FC74A85D4FA,R51,Headache,-
CBFC9EC2-0A16-4185-A4BE-0864C4E8FD36,R22.9,"Localized swelling, mass and lump, unspecified",-
19279755-826E-4ED3-A390-C1D0853B3B5B,R51,Headache,-
4A2E02B9-9220-4884-8E95-3B740CE867CF,Z71.2,Person consulting for explanation of investigation findings,-
1BFAEF8C-EE31-44BF-BD25-80EF712389C5,Z53,"Persons encountering health services for specific procedures, not carried out",-
C57B625D-CF54-43EB-9201-85ECEF46FD63,J06.9,"Acute upper respiratory infection, unspecified",-
6BDD4EB1-DFD2-40E2-8FDD-940780C5773F,K29.7,"Gastritis, unspecified",-
A8A9C6B7-2AD5-4B94-B3A7-DCD6AC4890AA,H57,Other disorders of eye and adnexa,-
F5C8EE6E-D32E-4A13-A667-FDC92487FAC7,N02,Recurrent and persistent haematuria,-
F5C8EE6E-D32E-4A13-A667-FDC92487FAC7,E78.4,Other hyperlipidaemia,Hyperlipidaemia
FC97EF78-E383-4CFB-B97E-A0313377DB81,S63.5,Sprain and strain of wrist,-
384C886E-2209-499F-86B6-2E3783D06048,R51,Headache,-
CF46A7AB-950C-45DB-888F-B964EC2D5F64,L29,Pruritus,-
9C697CFA-590B-4E62-93AE-C427C6156472,S13.4,Sprain and strain of cervical spine,-
F3A97588-75D7-422E-BC92-FEBA88E97575,M10,Gout,Gout
04EDCDFE-0AD7-485E-8B2B-A26A6E9D21B3,J06.9,"Acute upper respiratory infection, unspecified",-
04EDCDFE-0AD7-485E-8B2B-A26A6E9D21B3,A09.9,Gastroenteritis and colitis of unspecified origin,-
C6AB1AFC-1026-4088-B5E0-D6C7D08C05D2,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
2BC31E97-A9B1-4AA3-993C-232693463BA1,H10.1,Acute atopic conjunctivitis,-
D9A01099-2ADA-4A91-94E7-4C985E6A037D,J06.9,"Acute upper respiratory infection, unspecified",-
1418D4BA-B85A-421A-9945-08A163F1A8F5,K30,Functional dyspepsia,-
A2C2950F-C0D9-4002-BB41-D98A3603A3D8,A09.9,Gastroenteritis and colitis of unspecified origin,-
3D771D85-E9F7-4DDE-B495-A65463369957,R51,Headache,-
2AFA0017-CFCC-49AD-A941-697FF3B950A6,R51,Headache,-
BF557843-CFFE-47DD-A492-63F39BEC6025,G44,Other headache syndromes,-
96E170E7-0D13-4202-8FF7-7EEC1C9D32C9,B30,Viral conjunctivitis,-
FFBBBA0C-6A39-426E-9139-DE58A229FD78,U07.1,"COVID-19, virus identified",-
0CE2FB03-C744-403F-9CC3-A3839033B7A4,J06.9,"Acute upper respiratory infection, unspecified",-
99959074-EEE2-4354-BE1E-1F4838E210FA,A09.9,Gastroenteritis and colitis of unspecified origin,-
9DABF85D-1AAF-487D-9C3D-C6052A1D3ED0,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
11307B83-FAE9-454D-95EE-324D4951E95A,J06.9,"Acute upper respiratory infection, unspecified",-
B477F9BC-BBD9-46AB-B44E-CB50A78C3D29,B00,Herpesviral [herpes simplex] infections,-
D82CBBB1-FC0E-4FC0-8D20-17779935864A,R51,Headache,-
1EE8428E-CC9C-4D85-B995-61D67EDC5676,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
1EE8428E-CC9C-4D85-B995-61D67EDC5676,J45,Asthma,Asthma
E15EEE70-34A6-4559-B001-C6107B89B08F,N94.6,"Dysmenorrhoea, unspecified",-
14847838-A8EF-49A4-90CF-C637357235B7,N94.6,"Dysmenorrhoea, unspecified",-
4B54DFAD-DA15-4396-BE23-05704FCF6CB7,A09.9,Gastroenteritis and colitis of unspecified origin,-
05F076DF-AF6C-4268-BA4D-F049B595F11C,J06.9,"Acute upper respiratory infection, unspecified",-
12478DCE-8FD6-44FE-995D-DD2FBA1C26E6,M54.5,Low back pain,-
BA10AE13-9E66-46A6-8846-1A9BDDD32C49,Y42.4,Oral contraceptives,-
7F959B42-B16E-453B-AB98-BDBCACADB7ED,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
7F959B42-B16E-453B-AB98-BDBCACADB7ED,H10.1,Acute atopic conjunctivitis,-
E675D7B7-7D6A-4398-AFD1-A59836D3712F,Z76.0,Issue of repeat prescription,-
E675D7B7-7D6A-4398-AFD1-A59836D3712F,L30.9,"Dermatitis, unspecified",-
E675D7B7-7D6A-4398-AFD1-A59836D3712F,J45,Asthma,Asthma
18E67580-E61B-444A-98EC-1AD7233FD9D2,T88.1,"Other complications following immunization, not elsewhere classified",-
9877B878-BFDD-4333-83F3-732B7CAF4AA8,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
9877B878-BFDD-4333-83F3-732B7CAF4AA8,A09.9,Gastroenteritis and colitis of unspecified origin,-
A36AC66B-3066-481E-824E-528447EE7BFF,E78.2,Mixed hyperlipidaemia,Hyperlipidaemia
A36AC66B-3066-481E-824E-528447EE7BFF,E11,Type 2 diabetes mellitus,Diabetes
9CEE5493-C038-4DE1-A915-20D8050E2E9B,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
771B501E-6858-4705-B43B-3B36DB24BDE8,A09.9,Gastroenteritis and colitis of unspecified origin,-
4506CFC3-5E70-4E28-8FB6-366F45099AC1,K29.6,Other gastritis,-
BDC18B43-32A5-4CE8-A80D-7A56402045F0,T88.1,"Other complications following immunization, not elsewhere classified",-
6BBEA9B3-F8E3-4C00-B693-1ABFFF9BB81C,E05,Thyrotoxicosis [hyperthyroidism],Thyroid
37E05EE8-221C-4DD6-B0D6-CD1B53A324C2,R21,Rash and other nonspecific skin eruption,-
4D2FF0B5-787F-4928-A361-B31EB52B5378,H58,Other disorders of eye and adnexa in diseases classified elsewhere,-
E5AAA9B4-EBD2-41FD-A0BE-1B7416F1CE48,M25.5,Pain in joint,-
3657E333-A647-4543-A192-572F2EA80D57,T88.1,"Other complications following immunization, not elsewhere classified",-
760FECF7-6006-4997-8E0A-48BB91A82E15,H57,Other disorders of eye and adnexa,-
EDFD1134-F516-416E-A912-C385DC14C7D0,R11,Nausea and vomiting,-
9F9EE943-C183-4168-8D4B-186A02AC1CBF,G44,Other headache syndromes,-
7ED921C3-D46E-46E2-909F-707DBF3B8445,R51,Headache,-
4027214D-9B0B-4E6B-8666-A043A3958E96,R51,Headache,-
26A07DA5-270C-4C94-9664-C1CE5AD588BE,K21.0,Gastro-oesophageal reflux disease with oesophagitis,Gastro-oesophageal reflux disease
3A2131D4-4258-476E-B9D4-C2C00B5ACAA0,L30.9,"Dermatitis, unspecified",-
A65EAD58-DD0E-4D95-A6D1-2FB23579E8DE,J06,Acute upper respiratory infections of multiple and unspecified sites,-
6B703694-2044-442C-A2B2-958DB30ED35C,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
C40A3F7B-526D-49F9-A431-E7BB4E2F21CC,H00.1,Chalazion,-
525F0FAE-5247-4A94-BEF4-BCF20BB2A628,R51,Headache,-
ED96F51A-223B-4ADE-8321-28BDE4E7A82C,J06.9,"Acute upper respiratory infection, unspecified",-
44E6B95E-7347-48D6-AED4-E621C0F6120F,J06.9,"Acute upper respiratory infection, unspecified",-
8D50F329-1604-44BB-88C4-B8D3C2E0A65D,K07.6,Temporomandibular joint disorders,-
8D50F329-1604-44BB-88C4-B8D3C2E0A65D,R51,Headache,-
BFBDCE57-B19D-4821-87D2-7FFD95431698,Z71.2,Person consulting for explanation of investigation findings,-
7D16696F-4D4D-4546-B38D-8226BA7FABEA,A09.9,Gastroenteritis and colitis of unspecified origin,-
B232E274-58B6-4A7F-A978-373CA2D4DBA7,J06.9,"Acute upper respiratory infection, unspecified",-
9E097FA3-5422-4D49-99C2-14C284D2582B,M79.1,Myalgia,-
3BC73537-AB04-4CAF-878E-57111D7DC266,K30,Functional dyspepsia,-
8931ACA7-E42B-4845-844E-E9E21F9EDA79,N94.6,"Dysmenorrhoea, unspecified",-
2DE75203-71A3-4F74-A972-A0B408307BAC,A09.9,Gastroenteritis and colitis of unspecified origin,-
357C9B00-CC12-4E31-94BB-739E7EA8304B,J06.9,"Acute upper respiratory infection, unspecified",-
F1E9F6BC-77AC-4AE5-9527-38F2F954F719,J06,Acute upper respiratory infections of multiple and unspecified sites,-
9E029303-B960-4787-AF25-54DB6BB1AF76,N94.6,"Dysmenorrhoea, unspecified",-
02322C2D-4A49-4397-9AE5-5D70415D5D57,A09.9,Gastroenteritis and colitis of unspecified origin,-
03E6146C-1342-4D45-9E8B-B1AC08720869,A09.9,Gastroenteritis and colitis of unspecified origin,-
85FC878B-929A-4115-859E-AFED90ADF5DC,J06.9,"Acute upper respiratory infection, unspecified",-
C236B314-8F3A-490E-89D0-6CD011DED03C,M10,Gout,Gout
C236B314-8F3A-490E-89D0-6CD011DED03C,M72.2,Plantar fascial fibromatosis,-
94563512-70C6-470A-AC55-0B3353562014,J06.9,"Acute upper respiratory infection, unspecified",-
F59EBB98-33AC-483F-B80A-73552ADDEE56,Z71,"Persons encountering health services for other counselling and medical advice, not elsewhere classified",-
F24F8641-E2D0-454A-A98A-18C803CE7E70,Z71.2,Person consulting for explanation of investigation findings,-
9146578D-6ECE-4F34-82E4-AFE8F11CBAA5,T88.1,"Other complications following immunization, not elsewhere classified",-
2B6DD122-BECD-4665-93E6-5F9B94FA2EA7,T88.1,"Other complications following immunization, not elsewhere classified",-
8A5E8C58-4218-4BAB-AB3B-4BADA2FD3DFC,J06.9,"Acute upper respiratory infection, unspecified",-
BDF992FC-B749-432E-B2CC-4525391BC6E1,P39.0,Neonatal infective mastitis,-
26FC76D3-34CF-44EE-93D9-CE31BE0075A8,K12.0,Recurrent oral aphthae,-
26FC76D3-34CF-44EE-93D9-CE31BE0075A8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
26FC76D3-34CF-44EE-93D9-CE31BE0075A8,M79.1,Myalgia,-
BA0CD8AC-58E0-48E3-BBDA-C6BEB6545F6B,H60,Otitis externa,-
5C89575A-4D70-423C-8E80-F150F0C1F4CA,J06.9,"Acute upper respiratory infection, unspecified",-
EFECA62B-7B96-4063-930B-13D1EA1697C8,L30.9,"Dermatitis, unspecified",-
98115B4C-DE06-486C-939F-568041F92BB8,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
3C659A3E-C42D-4BBE-9099-E3356B9A8AA6,K30,Functional dyspepsia,-
1D4637DF-51E3-49AB-92E1-72F345A7F487,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E0C520E5-1091-460F-8AA2-73354302AA15,J06.9,"Acute upper respiratory infection, unspecified",-
56EAEEBD-FC04-4492-AA81-62E761F8C9F5,J06.9,"Acute upper respiratory infection, unspecified",-
B8AA28A1-1371-4934-B970-B7CCBAE1DB47,A09.9,Gastroenteritis and colitis of unspecified origin,-
0DFE80A6-347F-430A-A75C-956F163B6BFE,T88.1,"Other complications following immunization, not elsewhere classified",-
507B925D-E998-40BF-BDA7-462E45B71F4D,J06,Acute upper respiratory infections of multiple and unspecified sites,-
9AF6FE1F-4352-4B0F-9373-CBE420358FA8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BE13E8DD-2354-4D6C-91D1-51F513BFC381,J06.9,"Acute upper respiratory infection, unspecified",-
0C7EF4CB-00D2-41BB-833A-40092108C92F,R51,Headache,-
0C7EF4CB-00D2-41BB-833A-40092108C92F,J01.9,"Acute sinusitis, unspecified",-
975F7CC1-3CE9-436C-86A0-7C6F15827433,M62.6,Muscle strain,-
7CEA594F-D725-49EB-9D88-634EBCDFA262,I10,Essential (primary) hypertension,Hypertension
AE6C772B-4080-45A2-9892-14FB5D256D7E,N39.0,"Urinary tract infection, site not specified",-
9C5EE53D-5C24-4E9A-8C8A-A32BC18A0F80,N39.0,"Urinary tract infection, site not specified",-
43FDD732-7C46-4ECA-BC35-3277355B2B16,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3F83456B-6DF7-4AF8-ADE5-A23C3800BBD6,T88.1,"Other complications following immunization, not elsewhere classified",-
E1965E56-6FA5-4B43-AEA3-7C14853FEFF9,J06.9,"Acute upper respiratory infection, unspecified",-
EC3B3955-6CEC-485D-8BF2-501C66E91E0D,P39.0,Neonatal infective mastitis,-
10037ADB-64D7-48EF-B72B-6AEB3B0D49E9,P39.0,Neonatal infective mastitis,-
51F1D0DE-891A-474D-BB4D-F3B000C66184,T88.1,"Other complications following immunization, not elsewhere classified",-
7C484EEA-5ECC-4896-9936-6F4EFF981AB4,J06.9,"Acute upper respiratory infection, unspecified",-
91695D18-1FE0-4B96-ADEA-E7A9A8083C4D,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
F088F75D-5E5E-448D-8DBA-873AC08B8D91,B08.5,Enteroviral vesicular pharyngitis,-
D49C54FE-8D53-46F7-AA81-E6B47EFDBEF8,A09.9,Gastroenteritis and colitis of unspecified origin,-
6867EFEE-8925-4516-9C91-527CC54309DF,B08,"Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified",-
05B3E4B9-255A-420B-935D-D6F8626FCAD4,J06.9,"Acute upper respiratory infection, unspecified",-
63B66074-452A-4A57-89E1-08212AF22752,B35.4,Tinea corporis,-
C4ECE8A7-EFC5-4063-8C55-D5C47A7F4FD9,N39.0,"Urinary tract infection, site not specified",-
3FC61BE5-59D5-47EB-9B22-F02B784F2A40,S83,"Dislocation, sprain and strain of joints and ligaments of knee",-
636BE717-D2C7-416F-8928-CD56FE8BF363,T88.1,"Other complications following immunization, not elsewhere classified",-
56496A87-5148-4A66-B797-03B078A9A71B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FD765BCE-7DBA-4F25-AF93-E8AFFA881815,A09.9,Gastroenteritis and colitis of unspecified origin,-
F8AD344E-A37A-4FCC-96D0-1071F0F287BF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CC521905-D1D4-4707-8822-04E6C7787E4A,L20,Atopic dermatitis,Atopic dermatitis
50F30079-280D-4616-BD2A-71B9CB7FFE7E,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
F4D97CFA-11E3-4180-8F53-D9A4FA83EB32,Z02.9,"Examination for administrative purposes, unspecified",-
DEBBA959-AA8C-40AC-834C-EFBC2973DA4D,R50.9,"Fever, unspecified",-
AEB7C631-3186-4416-BC76-BE881CC2D09D,H57,Other disorders of eye and adnexa,-
92C171CC-9BE8-4942-AAE4-10F616717EC2,L20,Atopic dermatitis,Atopic dermatitis
6BF6AB72-0447-4B9B-A843-370CE51ECC94,L20,Atopic dermatitis,Atopic dermatitis
9B84E2ED-7C08-453F-AD6D-586247E7508C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A53C4EC6-F9A5-471E-947E-07567EF3F430,T88.1,"Other complications following immunization, not elsewhere classified",-
BA979438-0C0E-4381-BEB4-269CF19398D5,U07.2,"COVID-19, virus not identified",-
B656540C-9495-415F-9EBB-6D5A50D7338D,J06.9,"Acute upper respiratory infection, unspecified",-
82DF709D-BCCF-47A3-9E31-19E115286E33,R51,Headache,-
82DF709D-BCCF-47A3-9E31-19E115286E33,A09.9,Gastroenteritis and colitis of unspecified origin,-
391CF8B9-CEF7-4851-9406-8ACDEFF95C8D,A09.9,Gastroenteritis and colitis of unspecified origin,-
158CBA34-3E3D-4C71-B063-7B718BED1492,B37,Candidiasis,-
4B2C686A-0F5D-410C-B9CA-5D0946BE9AF8,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
EA07B873-AEBF-4F35-AADA-4386AA4E0913,J06.9,"Acute upper respiratory infection, unspecified",-
27163C6B-7475-427E-AEEA-8D689EBE681C,Y42.4,Oral contraceptives,-
AA4C0560-A4B8-4BF5-8655-B5CF34A38297,A09.9,Gastroenteritis and colitis of unspecified origin,-
4D482A65-071F-4FC3-A4ED-FE59BF0FC480,H00,Hordeolum and chalazion,-
53F8CF79-71AC-4FAB-B078-6D4485E6B91D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5A7DA980-3AD8-4291-85AA-3EF3759B85CF,A09.9,Gastroenteritis and colitis of unspecified origin,-
04CE4F8D-D0FF-4029-AA32-9818CC1387EC,R53,Malaise and fatigue,-
04CE4F8D-D0FF-4029-AA32-9818CC1387EC,R51,Headache,-
A760009C-1E1F-433D-A19A-4A142C8AF97F,J06.9,"Acute upper respiratory infection, unspecified",-
39DC6009-E54D-403F-8006-2442FDA93B9A,J06.9,"Acute upper respiratory infection, unspecified",-
39DC6009-E54D-403F-8006-2442FDA93B9A,U07.1,"COVID-19, virus identified",-
0AD2F453-8D64-4720-A892-9020D6C59483,U07.1,"COVID-19, virus identified",-
0F7D23E2-1144-4F01-9505-F51801404CBC,R51,Headache,-
03C5A674-7782-48CA-8E17-06718E08328C,A09.9,Gastroenteritis and colitis of unspecified origin,-
718595C5-27C2-4CEC-95A4-D8A9F8957153,R10,Abdominal and pelvic pain,-
AA16EC63-989C-44BA-B4C7-39E2CE278B4C,R42,Dizziness and giddiness,-
AA16EC63-989C-44BA-B4C7-39E2CE278B4C,R51,Headache,-
2A114495-6199-4CC7-A059-5C3454CEBA71,M62.6,Muscle strain,-
97CCFDEE-87A8-4187-96B2-1D3F98DD591A,A09.9,Gastroenteritis and colitis of unspecified origin,-
E37C7088-B3A5-45DE-BC70-83C4770A56E4,J45,Asthma,Asthma
8CC75304-6D3A-4083-AA89-721D14BB487E,N64.9,"Disorder of breast, unspecified",-
8D24D7BE-E2F9-4B13-A5E7-4A395CC0832E,S13,"Dislocation, sprain and strain of joints and ligaments at neck level",-
42EE525C-255A-4BD6-9033-8A57FCF4DE54,J45,Asthma,Asthma
8F303C5E-51D0-486D-AE6A-65840533C86B,R51,Headache,-
A7A3175E-FD57-4192-B081-E424C2722DE1,L85.8,Other specified epidermal thickening,-
A7A3175E-FD57-4192-B081-E424C2722DE1,A09.9,Gastroenteritis and colitis of unspecified origin,-
04AE6A84-C22E-44C1-A5E1-A0D0AF9567F0,K29.7,"Gastritis, unspecified",-
04AE6A84-C22E-44C1-A5E1-A0D0AF9567F0,R52.9,"Pain, unspecified",-
04AE6A84-C22E-44C1-A5E1-A0D0AF9567F0,J06.9,"Acute upper respiratory infection, unspecified",-
96EB1B78-C8DF-41E1-ABE6-A140F18BC3B7,R51,Headache,-
0719D39D-7646-4AF1-BBBC-733338E8DAB9,N76.0,Acute vaginitis,-
F0E38DD1-DC07-41BD-9115-206B13934F82,R50.9,"Fever, unspecified",-
BDC5D727-A339-414E-9550-575C6C4DA091,N39.0,"Urinary tract infection, site not specified",-
0A649966-C404-4946-AD76-73773E41B504,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
53C108FC-512E-4881-B74C-86D6729BEF02,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
D0D55A9C-8027-4A7B-BA0E-714DFE62B0A2,L21.0,Seborrhoea capitis,-
11E2BDAD-2CF7-4863-88C3-6FD27BA551A5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
AC284DB9-6414-4976-97FE-65A2B21706EA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
35B2911B-E002-4253-A97D-CEE9988589C5,A09.9,Gastroenteritis and colitis of unspecified origin,-
F7CF4D1E-6E09-4D1D-A8BF-3572E6970EAE,U08,Personal history of COVID-19,-
F7CF4D1E-6E09-4D1D-A8BF-3572E6970EAE,J45,Asthma,Asthma
12B83555-8B02-495D-A8B9-8C3D98C112B7,A09.9,Gastroenteritis and colitis of unspecified origin,-
4D12450B-721C-458A-88A9-0358F5A6F8AA,Y58.4,Tetanus vaccine,-
20A6E76D-7BDA-4966-9F67-18E1BFB3C9DE,K13,Other diseases of lip and oral mucosa,-
1CFFB2AB-1AE7-444D-ACDA-5A3C6DE7C9C4,R51,Headache,-
39C766C3-754A-45D6-B1C1-CDC4AFA56CF2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
04B4D3A5-2EB3-4A39-B027-9A1EC2A42A20,T78.4,"Allergy, unspecified",-
04B4D3A5-2EB3-4A39-B027-9A1EC2A42A20,L50.9,"Urticaria, unspecified",-
CDFFE9CC-044A-4316-B18C-D0C86E9143AB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
682350A4-CE45-4FAE-922C-3F2F7546F0C2,Y60.3,During injection or immunization,-
D6DFB234-4300-452E-90D3-D327DEEC1488,Z30,Contraceptive management,-
1784AA5E-CBAB-498C-B22E-1E055E21E3E0,M79.1,Myalgia,-
1784AA5E-CBAB-498C-B22E-1E055E21E3E0,T88.1,"Other complications following immunization, not elsewhere classified",-
252B7184-06BE-45E3-B88F-62EAEFF4795D,J06.9,"Acute upper respiratory infection, unspecified",-
252B7184-06BE-45E3-B88F-62EAEFF4795D,M54.5,Low back pain,-
1D81DCED-5ED6-4B9C-B871-F76DF204359E,A09.9,Gastroenteritis and colitis of unspecified origin,-
11A5C551-CE48-4446-8796-726F61132271,K59.0,Constipation,-
403A73D1-B15C-4ADD-9794-D29A41D9F5B0,A09.9,Gastroenteritis and colitis of unspecified origin,-
1765E17E-919C-4F3F-A07F-D64154D4BA81,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
1765E17E-919C-4F3F-A07F-D64154D4BA81,R51,Headache,-
A59F66C4-345E-40B2-88F3-13F1B96A30BD,M25.5,Pain in joint,-
8970DA25-10EA-47C8-95CC-9E23856F921F,Z71.2,Person consulting for explanation of investigation findings,-
D5228BB1-51F4-4479-8E72-994B5EA1CDFB,K29.7,"Gastritis, unspecified",-
687F04AE-A08C-4B18-A545-6A3B7CAA44EB,N39.0,"Urinary tract infection, site not specified",-
687F04AE-A08C-4B18-A545-6A3B7CAA44EB,A09.9,Gastroenteritis and colitis of unspecified origin,-
32292321-BD87-43C4-A2DC-1C75C1AF4B9D,M54.5,Low back pain,-
EFE20F92-62EE-4675-8837-B49B0EDB0CDC,R51,Headache,-
5846964B-8735-44BB-A206-79FFF5D1B464,T88.1,"Other complications following immunization, not elsewhere classified",-
C850DBA2-BB76-40C6-9C0E-9F8B00609096,M62.6,Muscle strain,-
74105758-C1DB-4B01-9631-C3374F6271A3,N94.6,"Dysmenorrhoea, unspecified",-
C99352C9-726A-44A4-A3BE-FFE406999815,R51,Headache,-
B5DCB153-6087-45F1-A697-229302ABB678,A09.9,Gastroenteritis and colitis of unspecified origin,-
E1D5C502-47D9-483C-B6C3-3037B5100646,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
74941CDC-EE6A-4D09-AD2C-528B4FEFEBC1,A09.9,Gastroenteritis and colitis of unspecified origin,-
7BE34849-6F72-4EAE-9796-24B8F59CF259,R51,Headache,-
7BE34849-6F72-4EAE-9796-24B8F59CF259,R42,Dizziness and giddiness,-
7CAE2D90-644C-45EA-BCA2-00CC869802E6,N94.6,"Dysmenorrhoea, unspecified",-
7CAE2D90-644C-45EA-BCA2-00CC869802E6,R51,Headache,-
68955640-FA05-4E6B-B80B-9C6284C722F5,J06.9,"Acute upper respiratory infection, unspecified",-
73DE38EA-DD2E-41D5-887E-0086F72FA233,M62.6,Muscle strain,-
BC335531-8955-47A6-AD6A-0F8CF094571D,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
BF92BFE5-2E20-4847-9110-7ED3C8903820,U08,Personal history of COVID-19,-
BD9F5C40-1D9E-414E-82B9-C5A3A2F82C66,J06.9,"Acute upper respiratory infection, unspecified",-
56146644-0A8E-42C2-B852-67164A069475,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DD195028-922E-4C87-AC42-34E1443D4B06,J06.9,"Acute upper respiratory infection, unspecified",-
9E298EC1-1E43-433B-85E8-AF1C9261B612,J06.9,"Acute upper respiratory infection, unspecified",-
7FDBCE66-212B-499E-A6B2-43864DF46BFF,N94.6,"Dysmenorrhoea, unspecified",-
CBA63AED-416E-4C8A-B343-4156650A487B,A09.9,Gastroenteritis and colitis of unspecified origin,-
7378320C-1956-4D05-B1B8-4F038850A66D,N51.2,Balanitis in diseases classified elsewhere,-
92273273-22AB-41A6-BF33-23E943C9A03A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4488DF6D-FB10-4A9B-B8B3-CD70E5079408,J06.9,"Acute upper respiratory infection, unspecified",-
BAE63D3A-4E4E-4B09-A615-A654A70EFE31,R51,Headache,-
4D117393-0F4B-4E73-8B76-AF28917B2F06,J45.9,"Asthma, unspecified",Asthma
A5FE633D-BB0A-4AD9-8F38-47318A410A0E,R21,Rash and other nonspecific skin eruption,-
BECBE269-7E02-4764-BE2C-B96BB41AF16A,J06.9,"Acute upper respiratory infection, unspecified",-
7F213972-683E-432D-A780-B2F40DD15C46,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
8B9690B7-28C0-4E5C-9567-8E46492DB45F,N94.6,"Dysmenorrhoea, unspecified",-
C8996172-00CD-4997-AF9D-16A7490CB99C,R51,Headache,-
A7139B96-BADF-4E63-A141-D99119A6913C,R51,Headache,-
04776AD9-79D3-421D-96F4-5F89BD466384,T88.1,"Other complications following immunization, not elsewhere classified",-
40DBED7C-2253-4F2D-85D5-34B41526B656,M10,Gout,Gout
B38C1A2E-9E58-4A95-8EF7-251DAF1D25AB,R51,Headache,-
473786D4-5141-4303-A694-C451E772E1D6,A09.9,Gastroenteritis and colitis of unspecified origin,-
28D33C37-6B80-4BDD-9F3D-C59B13BE861F,A09.9,Gastroenteritis and colitis of unspecified origin,-
EC004DA2-3CA6-4748-A208-3062937CB6E5,R51,Headache,-
C96226F7-0A52-478C-8D0B-DF3ACE1E4E37,J06,Acute upper respiratory infections of multiple and unspecified sites,-
E3649339-6F8D-448F-9196-401AEBBEE184,H01.0,Blepharitis,-
78E37F90-0E85-4932-AA77-949FB2FA3A8C,J06.9,"Acute upper respiratory infection, unspecified",-
78E37F90-0E85-4932-AA77-949FB2FA3A8C,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
65068CE9-1F4E-4346-98D7-190B99D3F65A,A09.9,Gastroenteritis and colitis of unspecified origin,-
0D00865E-C6C4-40F4-82FB-FB31E6476FDA,N39,Other disorders of urinary system,-
891F0FF0-6B6D-4FB1-B165-DD11E66D5582,R51,Headache,-
D399064F-1B4B-4B17-92F5-B65B40ED55EC,J06.9,"Acute upper respiratory infection, unspecified",-
C3D4F497-9D7E-4E3A-9916-45F7ABAB7AB7,G44.2,Tension-type headache,-
93772565-6B0E-4BE6-90E8-72E6D60FDC96,Z02,Examination and encounter for administrative purposes,-
894392BA-67F4-455A-92FE-AF07E29E9073,M54.5,Low back pain,-
4B81E13D-ADA9-46AA-8A6C-7D2988661CE8,K29.1,Other acute gastritis,-
B0A396C2-138D-4EBA-BEB9-FCCF97541C80,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
5FF30C72-FD5C-45E9-A131-38E46E23864E,T88.1,"Other complications following immunization, not elsewhere classified",-
6112A2A1-050C-4B96-A430-EFC3BBE57357,A09.9,Gastroenteritis and colitis of unspecified origin,-
77A93B13-DC9E-412D-879D-E87DC5D1AB51,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
0E03D89E-8220-4365-BB0E-251D714AB7C2,S13,"Dislocation, sprain and strain of joints and ligaments at neck level",-
C91E3615-9980-4C41-B3D9-577535B9821E,J06.9,"Acute upper respiratory infection, unspecified",-
71D72DCB-071D-4493-BFB0-5EBF63925F41,J06.9,"Acute upper respiratory infection, unspecified",-
74091146-94B9-4E52-BB9A-463C999ACCC2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EA994956-884F-49DE-81BC-0CE4CF5EA087,R50.9,"Fever, unspecified",-
0BD658B1-BBF3-4593-9C39-EDE40AB72EF8,R51,Headache,-
1B24B734-D2DF-4CE8-B915-0C147F3C24BB,N94.6,"Dysmenorrhoea, unspecified",-
804120CC-9219-47EC-93FE-EF1D47849FF5,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
99F8FC09-D22F-4164-BAA4-8611246A1F09,J06.9,"Acute upper respiratory infection, unspecified",-
99F8FC09-D22F-4164-BAA4-8611246A1F09,A09.9,Gastroenteritis and colitis of unspecified origin,-
21F7BE24-8A23-4ABF-A822-5065A37A2C54,J06.9,"Acute upper respiratory infection, unspecified",-
908BA726-BAD8-4FD9-B643-5DCC8DD50E19,A09.9,Gastroenteritis and colitis of unspecified origin,-
E6E9CE65-D014-4186-A955-3124CE75FB11,A09.9,Gastroenteritis and colitis of unspecified origin,-
373AFD48-B0CF-41EA-87B2-923B7E97D4CC,K30,Functional dyspepsia,-
3AB19B99-64AE-4C84-A76E-2DE2BF763CF5,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
E929462D-24B8-4624-B7B3-5FA83436A074,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E929462D-24B8-4624-B7B3-5FA83436A074,R50.9,"Fever, unspecified",-
94DF590B-AAEA-4B83-9FB8-02725D082561,J02,Acute pharyngitis,-
8DC4445A-E354-4756-87D1-F7AF26CD2857,H93.9,"Disorder of ear, unspecified",-
AD42DF83-0F29-4A49-924C-EABB3563BABB,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
522889B2-F9C3-4A06-8002-39E08762677D,K11.6,Mucocele of salivary gland,-
1B49DBBE-1368-4361-8837-938323368064,J03.9,"Acute tonsillitis, unspecified",-
ED9E9906-79F6-486C-8AAA-B3D321129857,T88.1,"Other complications following immunization, not elsewhere classified",-
ED9E9906-79F6-486C-8AAA-B3D321129857,M79.1,Myalgia,-
A4CBEFE4-0A26-489E-B8D0-4E9BE8EC257A,T88.1,"Other complications following immunization, not elsewhere classified",-
A3154F7D-CF95-4C60-B7D5-C6CE5AF24A7B,H57.9,"Disorder of eye and adnexa, unspecified",-
A3154F7D-CF95-4C60-B7D5-C6CE5AF24A7B,H00,Hordeolum and chalazion,-
CF63AFF4-4CE3-4C21-BCB7-207BC76C3C65,P39.0,Neonatal infective mastitis,-
C136267B-AF87-48AA-982B-9C8B33C5172E,K30,Functional dyspepsia,-
C136267B-AF87-48AA-982B-9C8B33C5172E,K59.1,Functional diarrhoea,-
F68B1207-5A63-4FF3-8788-2FE5D408AF21,T88.1,"Other complications following immunization, not elsewhere classified",-
F945069D-FE03-43A1-8B5B-5EBED552A0FD,B35.3,Tinea pedis,-
F945069D-FE03-43A1-8B5B-5EBED552A0FD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
71F809E9-AC7C-41D3-806C-2699183A98DE,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
71F809E9-AC7C-41D3-806C-2699183A98DE,I10,Essential (primary) hypertension,Hypertension
71F809E9-AC7C-41D3-806C-2699183A98DE,E03.9,"Hypothyroidism, unspecified",Thyroid
1F1F98C0-182C-4A34-874F-0C55D31741DB,J06.9,"Acute upper respiratory infection, unspecified",-
03491311-043A-4A45-9016-EF6A88F04C61,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C9875B29-01B2-4451-938E-9C5DCB22594B,A09.9,Gastroenteritis and colitis of unspecified origin,-
43B07CBC-1C51-4086-A2B0-77A4A3EAFDE9,L20,Atopic dermatitis,Atopic dermatitis
48F4E8D5-5AE5-470F-824C-F2017B99477C,N39.0,"Urinary tract infection, site not specified",-
099413A1-DDFD-4A59-9BB4-B45F6D9FE60D,J06.9,"Acute upper respiratory infection, unspecified",-
165F9E72-136C-4871-82AE-10FE7A7B209A,M54.5,Low back pain,-
9FC79300-5E01-4DA8-9DB7-FC2554B96534,R51,Headache,-
38921658-267D-4999-B3F6-58DB629232CA,S81.0,Open wound of knee,-
57086223-0BF7-414B-971A-DEA753E73D94,T11.0,"Superficial injury of upper limb, level unspecified",-
F12715A4-C189-43F1-BA4C-FEB7D094ECDD,R51,Headache,-
DAD5D045-C294-4390-A80D-F1CFA34E8624,Z71.2,Person consulting for explanation of investigation findings,-
AEE624DC-3E35-43C9-BC5E-EE6656DF04CB,J06.9,"Acute upper respiratory infection, unspecified",-
AEE624DC-3E35-43C9-BC5E-EE6656DF04CB,U07.1,"COVID-19, virus identified",-
D99B39CA-D1B2-430E-BD03-17E4CFE2C81D,R51,Headache,-
FB1E3EBD-268E-4A77-B1A1-A97FD9BE45DE,M62.6,Muscle strain,-
5EB4BBAD-A4D8-4E2A-B84E-CEF2CB661557,M75,Shoulder lesions,-
4E475C1D-D103-4F68-BA4F-EB7A56BB340F,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
4E475C1D-D103-4F68-BA4F-EB7A56BB340F,R50.9,"Fever, unspecified",-
24159367-C71C-4819-A09A-281D3488BD8B,H02,Other disorders of eyelid,-
4EE1C9C2-5C8F-4882-AA1B-6DA8709C4C20,J06.9,"Acute upper respiratory infection, unspecified",-
342ACECD-FD70-43AC-B00A-FA200BA11A93,T88.1,"Other complications following immunization, not elsewhere classified",-
DD8D55B1-6970-4782-8EF0-356CA7CD3706,A09.9,Gastroenteritis and colitis of unspecified origin,-
D76238B8-BEDB-446E-8376-4BFBDE0803F2,A09.9,Gastroenteritis and colitis of unspecified origin,-
B9768C0D-3054-4A9D-ADF5-2928D04F8DAE,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
C3316A63-568E-4A54-ABA4-ED8C2D9B72DF,H02.6,Xanthelasma of eyelid,-
99C36034-7DB3-40C2-8570-4CB080898507,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
71E2885C-1A08-47A3-AC0C-C2F8ECB9756D,A09.9,Gastroenteritis and colitis of unspecified origin,-
68B2D6C2-BCDD-4B64-82D9-2E1C48626DAC,U07.1,"COVID-19, virus identified",-
8F2436C7-9AA0-4DA9-89DC-66A5004779E1,S13.4,Sprain and strain of cervical spine,-
79561F06-BE17-44A3-A90E-5A154E215ECB,J06.9,"Acute upper respiratory infection, unspecified",-
09612D6C-6C34-4D17-BBBF-049F9E481AF3,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
F6ABB551-4A5D-4297-A8D3-C34383EFC69A,J06.9,"Acute upper respiratory infection, unspecified",-
3FF5DCB4-1912-489C-8FCD-FC0448CFB150,L50,Urticaria,-
3FF5DCB4-1912-489C-8FCD-FC0448CFB150,K59.0,Constipation,-
83F46C09-2651-409E-BBCB-F05076E19120,G44.2,Tension-type headache,-
54FA91A5-97AD-4385-98DE-1558597DDE69,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
54FA91A5-97AD-4385-98DE-1558597DDE69,R51,Headache,-
635BD955-573E-4728-9B2B-C04F928766D5,N39.0,"Urinary tract infection, site not specified",-
13A21341-B26D-4104-B84E-E1DEBCE347C8,J06.9,"Acute upper respiratory infection, unspecified",-
CF77785C-7B6E-442C-B3B3-37D0F5BE819F,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
2726D814-BD04-465F-946E-28F2FD085E6D,R51,Headache,-
ACBACCEA-9659-4D9E-9C5F-C243E215F2E7,R51,Headache,-
ACBACCEA-9659-4D9E-9C5F-C243E215F2E7,J06.9,"Acute upper respiratory infection, unspecified",-
ABA505C5-9C66-4FFD-89F3-704DFAAF30C2,T88.1,"Other complications following immunization, not elsewhere classified",-
9F0D13F1-5CC7-4D7C-925C-C8F3B840688A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
518505F2-C83A-478C-8C1D-93E1581A8A71,A09.9,Gastroenteritis and colitis of unspecified origin,-
153ACDB9-F3B2-4503-BF87-283F042AD11B,J06.9,"Acute upper respiratory infection, unspecified",-
3CF0BFDB-C937-4962-81F4-470BA4C9A968,J06.9,"Acute upper respiratory infection, unspecified",-
B3B42394-4200-403A-B1E5-B4345E30EF00,J06.9,"Acute upper respiratory infection, unspecified",-
FD53C36E-4C92-4FB6-9BA9-1C71836A0FBB,U07.2,"COVID-19, virus not identified",-
FD53C36E-4C92-4FB6-9BA9-1C71836A0FBB,H57.9,"Disorder of eye and adnexa, unspecified",-
B4A8DF43-F81C-4B93-8A21-F21735BF30B6,M79.1,Myalgia,-
E1D9A2C2-E386-40C8-B8DB-9343018D1A06,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
54B617E1-0284-43F4-8754-C935A31FA3DB,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
6BC8D488-66F1-4DF6-A73A-DDEDC5D8E59F,R51,Headache,-
9A99D2AD-A2CD-4A63-B3C6-0D0AB3B8E949,T88.1,"Other complications following immunization, not elsewhere classified",-
9A99D2AD-A2CD-4A63-B3C6-0D0AB3B8E949,R21,Rash and other nonspecific skin eruption,-
1E7F7DC7-9F51-4145-8D3A-702746B3EF4A,J06.9,"Acute upper respiratory infection, unspecified",-
07EBBAAB-238A-4E98-88EE-1719EEA028DA,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
07EBBAAB-238A-4E98-88EE-1719EEA028DA,K30,Functional dyspepsia,-
E86826E3-EE74-4C1D-86DB-B706A33F89B2,L30.9,"Dermatitis, unspecified",-
8424CF1E-496D-4554-B013-846E2BF03992,B37,Candidiasis,-
39C50AAA-F5C2-4DBA-A200-F4D26BC7260A,M10,Gout,Gout
0F555CEB-3848-4493-A275-06CB20ADFDF3,T88.1,"Other complications following immunization, not elsewhere classified",-
04AFFEE3-801F-48F5-BC06-248DA3CEB585,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
361BB744-6EE0-4153-BA8C-22610FDBDD45,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EA9E8E8E-82F8-40A7-AABA-AF53D4AB75E1,J06.9,"Acute upper respiratory infection, unspecified",-
2EB38823-528E-48B4-BE53-32D7332F890B,T88.1,"Other complications following immunization, not elsewhere classified",-
6D98E1A0-CD91-4D3A-A250-F4C740B780CD,F41.9,"Anxiety disorder, unspecified",-
097F85C7-47F5-426C-8A38-9A475873FDDE,A09.9,Gastroenteritis and colitis of unspecified origin,-
9089B3B5-5C76-4B83-AD89-967DCB77A17B,J06.9,"Acute upper respiratory infection, unspecified",-
D31D3792-C0AB-4E05-91CB-E96CFC6CCF3D,Z71.2,Person consulting for explanation of investigation findings,-
9C4C9BA7-6975-4874-B43A-C5E43B0662DB,N77.1,"Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere",-
846DDDD1-42B1-4D77-B80D-85D4FF5985F1,R51,Headache,-
E551F77D-27C6-4049-A474-711FCE77A33E,S83.7,Injury to multiple structures of knee,-
E551F77D-27C6-4049-A474-711FCE77A33E,L20,Atopic dermatitis,Atopic dermatitis
3C63B71E-36CC-4F40-8D81-48B608B6A87B,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
3C63B71E-36CC-4F40-8D81-48B608B6A87B,G44.2,Tension-type headache,-
3C63B71E-36CC-4F40-8D81-48B608B6A87B,A09.9,Gastroenteritis and colitis of unspecified origin,-
98063699-89B2-417B-9DC8-6A943EEA5B37,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
774208C0-5604-4FC5-89A1-8188C95E868A,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F0A277B0-46D6-4564-A262-D2AF19C1A9E5,U07.2,"COVID-19, virus not identified",-
67FC333A-62DC-4C3A-BF73-73A00AA560FE,J02,Acute pharyngitis,-
67FC333A-62DC-4C3A-BF73-73A00AA560FE,U07.1,"COVID-19, virus identified",-
DED57829-5F47-485C-B3E6-1706DBBA9134,H10.9,"Conjunctivitis, unspecified",-
9415FDA4-5206-4465-B113-564CE08A3144,H10.9,"Conjunctivitis, unspecified",-
2E3A25A8-22F1-4160-857B-5F2D58DB61B6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EED1B9F4-EA00-4785-9BFE-356FA7C7B703,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B526CE0F-50D8-4278-89AD-60A63D1C4D52,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
BA19F4BA-DD69-40D2-A0FD-94426087EDD9,R51,Headache,-
891F4F42-DEF1-4099-B8E6-FA84EA45062D,R51,Headache,-
18BBD1CF-FB65-47D3-964E-70EA2260DC60,R51,Headache,-
F7FF024D-E846-4AEA-AF45-3D4E40D98E2D,A09.9,Gastroenteritis and colitis of unspecified origin,-
13851EA8-FE93-496F-8285-510983F0642E,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F29918AC-346F-4CFD-B2CD-9170EE2177AC,Z71.2,Person consulting for explanation of investigation findings,-
5EFBFF56-953C-4442-A18F-CF0808DF29E8,H81.1,Benign paroxysmal vertigo,-
68F2FE2C-7D26-48CF-B31F-5A66F7D118DD,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
16FD92F1-330B-4CDC-982E-67604284630F,A09.9,Gastroenteritis and colitis of unspecified origin,-
B0696B02-60A2-44C4-BCFF-864F493BE8D7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A5AAB061-53A7-47EC-93D3-E11D7000CEFA,J06.9,"Acute upper respiratory infection, unspecified",-
C1BB279B-FE3B-471F-BA1C-92E570FC2629,J06.9,"Acute upper respiratory infection, unspecified",-
D983F1E1-B110-43BD-A52D-02CE52E46160,B00,Herpesviral [herpes simplex] infections,-
B668F708-CC32-416F-BC34-1437C99FD357,F41.9,"Anxiety disorder, unspecified",-
24E9FDB2-D9FC-4E16-AD6A-BE661ABF18BC,O91.2,Nonpurulent mastitis associated with childbirth,-
EF71EB17-05F0-47FB-A09C-AC45AF482FE8,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
2F421E67-B244-44DC-BB29-EA9E0165F5E7,N94.6,"Dysmenorrhoea, unspecified",-
9D51DB9B-EB7B-4D2D-9FA0-7174A932AD3E,U07.2,"COVID-19, virus not identified",-
9D51DB9B-EB7B-4D2D-9FA0-7174A932AD3E,J06.9,"Acute upper respiratory infection, unspecified",-
39155D7D-CB30-46AE-AB84-412BC319F3E2,N39.0,"Urinary tract infection, site not specified",-
694CA73C-9AB7-4953-9F37-827F4BF48845,H01,Other inflammation of eyelid,-
39155D7D-CB30-46AE-AB84-412BC319F3E2,Z71.2,Person consulting for explanation of investigation findings,-
71F357B8-CFE6-4F0A-85F5-1E309569002F,J06.9,"Acute upper respiratory infection, unspecified",-
F86268F8-AC7C-4116-AA9F-8E1065919B58,I10,Essential (primary) hypertension,Hypertension
04785980-9969-4BB1-87EE-3C731F2AC0B5,H81.1,Benign paroxysmal vertigo,-
04785980-9969-4BB1-87EE-3C731F2AC0B5,H02,Other disorders of eyelid,-
7B320C65-3328-4DD5-9710-84D88A9A942B,A09.9,Gastroenteritis and colitis of unspecified origin,-
A048E97A-9E77-4C22-B9E5-5CDAA1D18BD6,B35.1,Tinea unguium,-
A048E97A-9E77-4C22-B9E5-5CDAA1D18BD6,B35.3,Tinea pedis,-
2DC60014-B253-4AA0-80D9-9FA2757F181F,H93.9,"Disorder of ear, unspecified",-
2DC60014-B253-4AA0-80D9-9FA2757F181F,R21,Rash and other nonspecific skin eruption,-
7CB908D0-C0C9-4141-B4D7-3FF062CD87ED,J45,Asthma,Asthma
CFA5D002-E0CE-4095-9796-7B0C7A2FD8B8,M54.5,Low back pain,-
CFA5D002-E0CE-4095-9796-7B0C7A2FD8B8,L50.9,"Urticaria, unspecified",-
AFD5A151-61F8-440A-B909-5A0F92562D6B,G44,Other headache syndromes,-
54FA530E-4C83-455E-9BCC-93ADCF3FFAD3,M54.5,Low back pain,-
875D4EE4-726A-4716-901B-92115B05B32D,N39.0,"Urinary tract infection, site not specified",-
C225B3AA-667D-4AB1-B547-6A0796AB2963,A09.9,Gastroenteritis and colitis of unspecified origin,-
90369C22-243F-40EE-8569-F033AB5F3605,B37.3,Candidiasis of vulva and vagina,-
54151CCB-082F-4BBD-9054-3E2EBA23C160,K29.7,"Gastritis, unspecified",-
54151CCB-082F-4BBD-9054-3E2EBA23C160,N92.1,Excessive and frequent menstruation with irregular cycle,-
BAFB706C-0746-4041-BA35-A10FD5F85DBC,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
8A20FD3D-EE88-461F-BFC6-9CB4895A5B54,R51,Headache,-
7D316F3F-7D82-4590-B37A-62863EF4AFEF,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
65A8909B-3D8C-4820-BFE1-58C1F6409A6D,A09.9,Gastroenteritis and colitis of unspecified origin,-
ABE16272-422D-447F-A156-667B01B9C559,K29.7,"Gastritis, unspecified",-
CFB7AB30-FE53-4C1F-BC7D-26E419C3A243,J06.9,"Acute upper respiratory infection, unspecified",-
B28FC814-5BBF-4D9E-995C-04464C71FF88,A09.9,Gastroenteritis and colitis of unspecified origin,-
058F6B7F-BF78-4BE8-B9D6-152234BB7CD0,Z71.2,Person consulting for explanation of investigation findings,-
1C9707C3-8962-4189-9CD2-1A23202CB523,T88.1,"Other complications following immunization, not elsewhere classified",-
0D632EE2-78C5-4645-9A4B-E81BC3A414DC,J06.9,"Acute upper respiratory infection, unspecified",-
0DCA9B9D-F1EF-48BA-AD95-7C1FE5EA7CB4,R53,Malaise and fatigue,-
0DCA9B9D-F1EF-48BA-AD95-7C1FE5EA7CB4,G44.2,Tension-type headache,-
56AADB24-F87F-4E47-BDE1-3F1AC013E491,U07.1,"COVID-19, virus identified",-
56AADB24-F87F-4E47-BDE1-3F1AC013E491,J06.9,"Acute upper respiratory infection, unspecified",-
E577D20E-054A-4EF2-B17D-D8992E0010EA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3BE869FD-3514-4CDA-8B8E-F7C2CF112004,T88.1,"Other complications following immunization, not elsewhere classified",-
B81EF9E8-596D-4EEE-B003-F577EE5BF4F7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
25021E4D-9149-4C3E-8790-CF1A4ED344CB,R21,Rash and other nonspecific skin eruption,-
E6B6D19C-367A-4A98-A538-DED6B08EC9D6,U07.1,"COVID-19, virus identified",-
1FDE228F-E62D-4A98-8F07-D45DE100F80B,U07.1,"COVID-19, virus identified",-
E524F962-15A7-4CD3-A556-E9887522BEC7,O92.7,Other and unspecified disorders of lactation,-
9B2A761C-9D23-4707-803C-409CFCF2C3BB,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
F68A0285-7BDE-4419-A981-45A486EDB5C6,A09.9,Gastroenteritis and colitis of unspecified origin,-
0662622F-CFDC-4503-BABC-CE60FD163EE8,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
18E0E0F3-ABBB-48BD-B7EC-540ED4C22402,R51,Headache,-
A1F6E493-EF8B-4142-A950-AA173350951A,U07.1,"COVID-19, virus identified",-
90661CDD-0FC4-43E7-A1A2-5C9BCDB7AA0C,G44.2,Tension-type headache,-
91657162-F2FC-4F96-BCB1-0DB6FA319172,N94.6,"Dysmenorrhoea, unspecified",-
D9BD411C-2758-4D5C-9D4F-1A74AF58F181,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
15DB1D5A-3C9F-469E-9A77-5EE3EF7BD1EA,R21,Rash and other nonspecific skin eruption,-
FED21BB5-E9B2-4579-ACDF-D5AC8BA8D828,L84,Corns and callosities,-
BA7B9D40-5E7B-494F-8E8A-D478880CFC68,R06,Abnormalities of breathing,-
C27A12A8-7114-4089-8BDC-A37513A0B217,G43,Migraine,Migraine
02601B23-9C20-470F-9CE8-43BCF8387EF1,A09.9,Gastroenteritis and colitis of unspecified origin,-
C09EAD3F-535B-4B74-9B98-F0F7E7EE112E,J02,Acute pharyngitis,-
7BE29F95-1962-4F31-A048-777C8F169A1C,J06.9,"Acute upper respiratory infection, unspecified",-
FDE3B51D-4E3B-4CFA-ACC6-DB3338F654D2,A09.9,Gastroenteritis and colitis of unspecified origin,-
1559BA3F-2D47-40B6-B851-07D6821A9472,J45,Asthma,Asthma
E8F68C4D-A8F2-4686-95D3-580E137B8768,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C2AC1B2C-D76E-4BE9-85F8-04FBE3F0BAD8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CF589A2B-BA89-4907-BFAD-7755075985B1,Z71.2,Person consulting for explanation of investigation findings,-
D55E2FF2-40D9-4F90-969B-00F31F379A8C,T78.4,"Allergy, unspecified",-
DC722EDC-5EEE-478E-BC85-917BE9901B52,J02,Acute pharyngitis,-
85D26476-5132-444D-96AB-64E49CE309D2,R51,Headache,-
2B7F4B5C-9C53-46CA-B2F8-8846EC031A35,N94.6,"Dysmenorrhoea, unspecified",-
5ABD85A5-3818-46BF-9E44-37C2DC11F22D,Y42.4,Oral contraceptives,-
40FC5C08-F2D8-4562-9205-2BDFC267C53B,Z71.2,Person consulting for explanation of investigation findings,-
052BE07F-AA9B-44EE-B914-0F2833ED0A1D,M54.5,Low back pain,-
50210874-776F-40AB-A4FC-4FA471196728,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
50210874-776F-40AB-A4FC-4FA471196728,B37.3,Candidiasis of vulva and vagina,-
7F0EC682-7F32-4C6C-B8C4-7012ECD55DD7,H57,Other disorders of eye and adnexa,-
7F0EC682-7F32-4C6C-B8C4-7012ECD55DD7,A09.9,Gastroenteritis and colitis of unspecified origin,-
BC268118-C6C9-4359-9B0C-8C94A9970EED,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
1B71AA87-A12A-439F-B5D4-0E8E058105BD,L20,Atopic dermatitis,Atopic dermatitis
74DE4A54-97AA-47F5-9655-8FE497675B5A,R51,Headache,-
D026DF8D-9BFA-4FCD-9D39-BA8196A73BC0,Z71.2,Person consulting for explanation of investigation findings,-
077FB063-A8EB-4B3E-BDE7-D56C82E8F3C3,K64.9,"Haemorrhoids, unspecified",-
0A1163BC-6EBC-44B7-AFBD-A5A7F17CFABD,K30,Functional dyspepsia,-
8234C7EA-FFF3-4EC2-BBBA-48549D4917F2,R51,Headache,-
0A1163BC-6EBC-44B7-AFBD-A5A7F17CFABD,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
F9C4C772-EA54-479C-8333-079492264500,H10.9,"Conjunctivitis, unspecified",-
FA3F0FFF-50CC-4AA3-8D10-FA75B57B59E4,G44.2,Tension-type headache,-
272E5E1E-1176-4371-9986-02AF66D931F8,R51,Headache,-
20A66B54-788E-41E2-8BCD-3913659A9564,A09.9,Gastroenteritis and colitis of unspecified origin,-
477D30CF-DFFA-46C6-836A-8DEDABCAE87E,J06.9,"Acute upper respiratory infection, unspecified",-
E09B7FC6-3AFB-44E3-B824-E80CBB542229,J06.9,"Acute upper respiratory infection, unspecified",-
D1107921-F37A-42F0-B0F4-9793E364AB41,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7815B769-5139-465C-B407-DEB8A19DD643,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E9D7B69F-F07B-4BD1-BB85-46E5A348D7A5,N94.6,"Dysmenorrhoea, unspecified",-
EC1BB904-9579-4A69-A4DD-92882004A16E,G43,Migraine,Migraine
985514FF-9658-4D10-AE35-FEEFB0AAB9AA,J06.9,"Acute upper respiratory infection, unspecified",-
1AB87A55-C036-4A8D-A65E-F4C31C4BD89D,L50,Urticaria,-
C8DF2AD8-A96F-4F0D-8BA1-E4994AA7237F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
50FE680E-2461-4FFD-8699-72A7013B94EF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
50FE680E-2461-4FFD-8699-72A7013B94EF,M79.1,Myalgia,-
38650BA0-B475-45D1-B69C-6143FCE7F0DB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
02FE1D36-B7E2-4B57-97D7-52AE00B7EC4A,A68,Relapsing fevers,-
6AD5EDCA-FBC5-409C-B7E1-7E5BB82C96EA,J06,Acute upper respiratory infections of multiple and unspecified sites,-
8AC1902A-662C-4610-8048-5BE455A9016C,K12.3,Oral mucositis (ulcerative),-
733E7F77-BD9A-4AF0-BF99-9CA7DF99FBEF,K29.7,"Gastritis, unspecified",-
8188EE83-B8C8-4CE7-B0A4-AA0C09D9B0DB,T88.1,"Other complications following immunization, not elsewhere classified",-
0F73EF68-AEF2-4D42-AC24-CB3FD8900423,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5B6BF0CD-0026-44DF-BC65-29ED41CA8BCE,H00.1,Chalazion,-
97F24461-F287-4C74-8CFE-A29F9B904108,J06,Acute upper respiratory infections of multiple and unspecified sites,-
CE949BA9-5B81-4549-B88C-BDD847BE7CD1,R10.4,Other and unspecified abdominal pain,-
C24CA022-2F08-405C-A07C-B34931E9DF55,G44.2,Tension-type headache,-
C24CA022-2F08-405C-A07C-B34931E9DF55,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
A87D1D1E-D118-4194-8DBC-75ECA875B4A6,J06.9,"Acute upper respiratory infection, unspecified",-
55BDFC2A-F1BB-4A38-A7CE-19506E4303EA,J06,Acute upper respiratory infections of multiple and unspecified sites,-
6D7E92DB-6175-4402-87AE-8983F021B08D,R50.9,"Fever, unspecified",-
E29B4E06-739F-4E63-A721-934EB186323C,J06.9,"Acute upper respiratory infection, unspecified",-
9C9B72C0-7C17-463C-A1AC-C9E59CFA54B4,R53,Malaise and fatigue,-
9673950F-F23B-4F2E-A3A4-7D3554C7AEA6,N94.4,Primary dysmenorrhoea,-
86C50380-2FB5-4F46-B2CE-BC94F64190CD,J06.9,"Acute upper respiratory infection, unspecified",-
6D055BC9-351F-41C0-9DFF-C1CB28F71D8C,R51,Headache,-
6D055BC9-351F-41C0-9DFF-C1CB28F71D8C,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
2FBCDD86-688F-41DC-AF60-E220B8F0FF82,J06.9,"Acute upper respiratory infection, unspecified",-
5B51A4C4-70D5-44DC-AEFB-A7F4C73A4790,R51,Headache,-
5B51A4C4-70D5-44DC-AEFB-A7F4C73A4790,R50.9,"Fever, unspecified",-
65729081-1AAE-4631-AD77-2AADE7CC4E7C,Z02.9,"Examination for administrative purposes, unspecified",-
BE2B5113-CAEE-4D7E-A7A8-BA30AFB30564,T88.1,"Other complications following immunization, not elsewhere classified",-
8F0D962D-FE8B-4975-8C11-65B4FBB49DC5,T88.1,"Other complications following immunization, not elsewhere classified",-
F0BC4E00-63FD-4BFE-A0AC-D3973FC2042B,T88.1,"Other complications following immunization, not elsewhere classified",-
EDF0D1B6-D927-44E2-8131-D41257453F9B,Z71.2,Person consulting for explanation of investigation findings,-
45C6B738-E7AA-42DF-AEFA-DDEE20FA9CF3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
45C6B738-E7AA-42DF-AEFA-DDEE20FA9CF3,R51,Headache,-
A1FB729B-3109-41EB-9AD0-074913319AFA,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
FFBBBA0C-6A39-426E-9139-DE58A229FD78,J06.9,"Acute upper respiratory infection, unspecified",-
CD2865C5-1DBD-4C21-8B31-5B49ADEC33A3,H81.0,Mnire disease,-
C03501EC-C9A9-4D4C-A8B9-9114544B205F,H57.9,"Disorder of eye and adnexa, unspecified",-
ACD4AAE5-1240-4894-B319-F95439F6FDDE,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
19961CD9-A5AA-4AE2-8E44-7192A1EC7A23,J06.9,"Acute upper respiratory infection, unspecified",-
19961CD9-A5AA-4AE2-8E44-7192A1EC7A23,U07.1,"COVID-19, virus identified",-
95511989-258C-4BEE-8FBE-DEE221F40BAD,A09.9,Gastroenteritis and colitis of unspecified origin,-
95511989-258C-4BEE-8FBE-DEE221F40BAD,M62.6,Muscle strain,-
B00FCC24-1E52-44E9-97C9-D3D5D7A507FF,R55,Syncope and collapse,-
2999F604-AAE7-416A-A5AC-52330CE88AC3,A09.9,Gastroenteritis and colitis of unspecified origin,-
2999F604-AAE7-416A-A5AC-52330CE88AC3,R50.9,"Fever, unspecified",-
A137353E-9A74-4B58-B403-F8C1592A90B2,L71.0,Perioral dermatitis,-
A137353E-9A74-4B58-B403-F8C1592A90B2,H00,Hordeolum and chalazion,-
0EA51AE6-B869-4914-9DFE-1D1E557AAA7A,A09.9,Gastroenteritis and colitis of unspecified origin,-
ABB6E567-909B-42AD-B917-480C46DEB5AE,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
03A7CAE6-5AB7-4BCA-ADBF-848B812E35A2,Z71.2,Person consulting for explanation of investigation findings,-
25992370-8878-4978-BC9C-29D9029179CD,R51,Headache,-
7C250E23-FE38-43AA-8B68-47CE704221A9,J06.9,"Acute upper respiratory infection, unspecified",-
2821C355-646A-4ECA-9226-B4342BCD8AC3,N94.6,"Dysmenorrhoea, unspecified",-
126AB027-D433-4250-8877-978B0A541E7A,N94.6,"Dysmenorrhoea, unspecified",-
8369A94D-6986-48DE-A4BA-997F05366951,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2821C355-646A-4ECA-9226-B4342BCD8AC3,N85.1,Endometrial adenomatous hyperplasia,-
F158E8F6-B135-4AC0-87E1-7C2531A37E6B,A09.9,Gastroenteritis and colitis of unspecified origin,-
A319B4E4-621A-40F1-9474-45E7D66ECCCA,G43,Migraine,Migraine
A554558C-1D88-481B-B2D4-6ACAF23C43DE,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
A554558C-1D88-481B-B2D4-6ACAF23C43DE,R50.9,"Fever, unspecified",-
B9238D6D-97DE-4441-AFE6-2BECF00AF558,J06.9,"Acute upper respiratory infection, unspecified",-
F733A9CE-49A3-4FCA-A537-C3CCBB04FE69,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
5FDEA608-8255-42EE-A498-40BA74FEF7F9,H57.9,"Disorder of eye and adnexa, unspecified",-
3D850D21-D027-4E0B-9B82-924AF635F954,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
2B4C389E-10C5-4B71-916F-282C7F12BCAF,M75.5,Bursitis of shoulder,-
5F4F58DA-6E90-46DB-9B9F-B87AE4B714D4,H10.3,"Acute conjunctivitis, unspecified",-
33DA5F9A-5ACD-46B6-A60A-3042BEDB6A00,R51,Headache,-
6CEF8216-CB13-40BC-9D00-3BEE32B8795F,A09.9,Gastroenteritis and colitis of unspecified origin,-
5B0B1F94-A939-42BD-9A87-37AB0A2B19C8,K29.7,"Gastritis, unspecified",-
AF393367-4267-4162-8FA6-F84A6202EB2D,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
99D70249-EDE3-4F0F-89CC-C01ECCC719B1,K30,Functional dyspepsia,-
DDD48C1A-4300-49FE-983B-FF22C2FC8719,T88.1,"Other complications following immunization, not elsewhere classified",-
140A7E02-D92B-4A75-A8A0-6B0E72B3BE9B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6EBDB74B-4A69-4E5B-A5AE-E0CC1E6BB1EB,J06.9,"Acute upper respiratory infection, unspecified",-
5C9554D9-DAA6-4077-BBA4-BA2F1A21C019,G44,Other headache syndromes,-
2F9275D1-9443-4D98-92FC-58FE5964F273,S89.9,Unspecified injury of lower leg,-
1591F064-7C19-49C3-B5FC-63BB7647E467,R21,Rash and other nonspecific skin eruption,-
7A9B4B23-EFCB-4B75-814F-B29BF9FD14A2,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
82A2D05E-A5ED-4522-ACB0-B1D6F1B95CAB,J06.9,"Acute upper respiratory infection, unspecified",-
5F0344D4-1721-4484-AF16-B6891608DDA9,B35.4,Tinea corporis,-
F47FAB0F-AD1D-4DF7-87A5-6D4A0152E97A,R51,Headache,-
EEF3C9E0-1B27-42F0-94A6-5BDE97CDC65B,N39.0,"Urinary tract infection, site not specified",-
0BA52A28-8969-43D6-8FD5-51B4FE5F7475,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
240F28DD-D8B0-4082-AEE1-3FF30B1EDF8F,J45,Asthma,Asthma
B9A6A100-A082-4B71-B230-BE4FD3F87C97,T23.0,Burn of unspecified degree of wrist and hand,-
1D6A1A49-653D-458B-9BFE-72F627951FA1,J06.9,"Acute upper respiratory infection, unspecified",-
E998ABEC-30A1-4801-AF02-7D6890DD0981,T78.4,"Allergy, unspecified",-
E0AD8649-2C7B-4B11-B17C-E39A6106B33E,R51,Headache,-
1441EB07-CA7A-4E5C-9A51-F61AB5DC0AA8,B08,"Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified",-
82D61967-207E-446C-8F26-DEAA8BE1935C,J06.9,"Acute upper respiratory infection, unspecified",-
F69AF90A-5A7F-4C16-9D2A-63E66CDD8D87,L30.9,"Dermatitis, unspecified",-
F26F8567-0614-4ACA-8120-98D2DA9C83C7,A09.9,Gastroenteritis and colitis of unspecified origin,-
7D5DC739-6045-4281-B822-487B3D761815,B02,Zoster [herpes zoster],-
37CD346F-F8A9-44A8-9677-2305A25881B1,B02,Zoster [herpes zoster],-
A3037BEE-77F5-4F48-9CCB-A04D9E12EB44,T88.1,"Other complications following immunization, not elsewhere classified",-
75365119-D2EE-41A5-AEA9-15738EA340F9,B02,Zoster [herpes zoster],-
A3A5EC72-6754-4D53-A3A7-5286F48E2B55,A09.9,Gastroenteritis and colitis of unspecified origin,-
0BFC37E7-674D-4367-9E89-0CEDBEAA929C,H00.1,Chalazion,-
0228822D-A279-4150-A525-67E224887C21,T88.1,"Other complications following immunization, not elsewhere classified",-
3A830C2E-AEC5-44F6-B53D-247E90A572FB,M62.6,Muscle strain,-
283EF877-1A4B-4C46-9A2F-F029BCA31701,T88.1,"Other complications following immunization, not elsewhere classified",-
283EF877-1A4B-4C46-9A2F-F029BCA31701,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
EC255EC2-0A33-4811-9104-C3949A590C96,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E0CF70F5-2E91-483A-BF57-4F70AD2F86CD,T88.1,"Other complications following immunization, not elsewhere classified",-
A09AE2D0-7C63-4689-BAFC-1828BA8A706E,A09.9,Gastroenteritis and colitis of unspecified origin,-
660ACA76-DA7E-4531-A215-FBEA4395C6C4,Z71.2,Person consulting for explanation of investigation findings,-
9F1B1762-35D7-4FB6-9C08-290FAFCD327F,M25.5,Pain in joint,-
706A7F6B-5B17-48AE-8308-B1CEC95A4594,J06.9,"Acute upper respiratory infection, unspecified",-
B59674BD-0DF2-4508-820F-F9629CCFB219,J06,Acute upper respiratory infections of multiple and unspecified sites,-
E45FB9EB-A46F-4908-9B09-0B7458EB73F4,Z71.2,Person consulting for explanation of investigation findings,-
D01AEA18-D293-43B6-9615-784BBF5F9C1C,J06.9,"Acute upper respiratory infection, unspecified",-
113C0A48-959F-4921-8A53-84E24C6EAF02,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
80740605-1131-47BD-B629-E7C379FF9486,R51,Headache,-
0C33EEAF-AF8B-43E5-B579-1D5553B7AAEB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
91BF9F92-69E2-48FB-86FA-4502D432CE07,A09.9,Gastroenteritis and colitis of unspecified origin,-
91BF9F92-69E2-48FB-86FA-4502D432CE07,L50.9,"Urticaria, unspecified",-
91BF9F92-69E2-48FB-86FA-4502D432CE07,R21,Rash and other nonspecific skin eruption,-
1AAF3D3C-5DE4-466A-9F52-F673475D8EC5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3E3E3E8E-CF42-4AA1-87D5-D31FB90B7899,J06.9,"Acute upper respiratory infection, unspecified",-
A94C03ED-ECBD-466A-961F-C4191CE6B1EF,J45,Asthma,Asthma
E1F10F7D-970B-4CCD-B35D-24F34C7FF0B0,N94.6,"Dysmenorrhoea, unspecified",-
2ACCDE9B-1FE0-4A1F-A360-B113E39FD07C,M79,"Other soft tissue disorders, not elsewhere classified",-
632AD2E2-811E-4286-81C4-060DBA519677,R51,Headache,-
22751F24-37F1-463A-A5C0-FFC24B4E2489,N76.0,Acute vaginitis,-
E07DE560-7B03-4B26-A3C9-B3E24B4A8394,R11,Nausea and vomiting,-
E07DE560-7B03-4B26-A3C9-B3E24B4A8394,K30,Functional dyspepsia,-
75327C09-2B86-45F9-8AEB-442239A6434A,O21.9,"Vomiting of pregnancy, unspecified",-
82100F8F-9754-4D40-B6A2-CCF72D666102,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
95AFD81A-F2D3-45C1-BCAB-D4C12A2D1908,A09.9,Gastroenteritis and colitis of unspecified origin,-
0BADC98D-E6F0-48DB-BFE2-6091B806A7FD,Z71.2,Person consulting for explanation of investigation findings,-
19D7D8CC-B902-4978-844C-947C3D4AF754,A09.9,Gastroenteritis and colitis of unspecified origin,-
C5CA23A2-7318-47B0-B1B8-5C7DD63A45B5,M79.1,Myalgia,-
4489A4F8-F1DF-4B97-85C3-52781E8C9B2F,K29.7,"Gastritis, unspecified",-
2F7E5C9E-EBF1-41FD-8510-F6D654743580,Z71.2,Person consulting for explanation of investigation findings,-
478515B1-04D4-4EDF-B0A0-E7135E29E1F8,M79.1,Myalgia,-
568915F9-9AA6-465A-803D-9AF8ED4FC139,M79.1,Myalgia,-
A4D3A483-5BED-4475-91DF-CB6F37664036,A09.9,Gastroenteritis and colitis of unspecified origin,-
28449D66-AD9F-42AF-AA66-411B7018FF21,A09.9,Gastroenteritis and colitis of unspecified origin,-
0C41E406-EAAC-4164-A5C3-3E534E9174DC,N94.6,"Dysmenorrhoea, unspecified",-
394B0F4A-7577-450A-BB66-AEA1EAAE1FF9,T88.1,"Other complications following immunization, not elsewhere classified",-
7BC26594-FFB8-4D1B-BC0A-EA4E0AFAAE32,K29.7,"Gastritis, unspecified",-
7BC26594-FFB8-4D1B-BC0A-EA4E0AFAAE32,K30,Functional dyspepsia,-
313E2A44-A7FF-40B4-9572-C9CCFF01E56F,N39.0,"Urinary tract infection, site not specified",-
37A65518-07DD-43E5-B300-BAC80107D6D4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D930EB79-BD10-4CA1-91A6-8ABB5AF44F1E,A09.9,Gastroenteritis and colitis of unspecified origin,-
6EED085E-BE7C-4E30-A78A-CF58A8A7504C,H02,Other disorders of eyelid,-
DA279079-E6AB-40CB-8183-E42AE602C0B8,Z71.2,Person consulting for explanation of investigation findings,-
435FA531-0183-4A76-A0A0-4E8709E0AED3,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
DF4F8A88-35EF-4E81-BC06-16F7F70F81A7,G44.2,Tension-type headache,-
DF4F8A88-35EF-4E81-BC06-16F7F70F81A7,K29.7,"Gastritis, unspecified",-
C4E3F5E8-8741-44DD-BEF1-2D42107316C0,T88.1,"Other complications following immunization, not elsewhere classified",-
6AAF597B-C99F-4609-A86C-E10627D8B6ED,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F3875C75-5F0D-4497-9D00-586C66C13156,J06.9,"Acute upper respiratory infection, unspecified",-
80B04FF3-2E19-4959-B28C-70116EC44E29,N94.6,"Dysmenorrhoea, unspecified",-
E65F9AB5-7423-4AE4-B901-7BA40BE670B6,H01.0,Blepharitis,-
333C1667-FEFA-41F3-A6CE-DBCF974F575F,R11,Nausea and vomiting,-
333C1667-FEFA-41F3-A6CE-DBCF974F575F,K30,Functional dyspepsia,-
EC52BFFC-5BDC-4C64-A166-C9AA39E754F0,J06.9,"Acute upper respiratory infection, unspecified",-
6A6C11F8-2CF6-4364-8E9C-4BB61805E1E8,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
6A6C11F8-2CF6-4364-8E9C-4BB61805E1E8,K29.7,"Gastritis, unspecified",-
9D99FBDD-02C6-4E08-BBD7-061D5AF29904,M79.6,Pain in limb,-
7C059C51-8F14-47D7-9EF4-9F4F991DE6D1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
96C0C2E5-BF9E-4033-9B56-BEBE71B79BCE,K30,Functional dyspepsia,-
CBA92A49-5EE4-476F-952D-1D149DE9986C,R21,Rash and other nonspecific skin eruption,-
0108CB9A-2E86-45E1-9723-772C62FA7819,A09.9,Gastroenteritis and colitis of unspecified origin,-
E098B7E5-CB02-473C-97A9-00B92809EF58,A09.9,Gastroenteritis and colitis of unspecified origin,-
5E541070-F22A-41BF-9EE0-D7AAE4272F36,R51,Headache,-
EDA23C8F-0CB5-4D92-B3C5-45D8D5D84505,J06.9,"Acute upper respiratory infection, unspecified",-
0C66026F-2FAA-4378-BC5F-3172350C1288,M10,Gout,Gout
6282FB48-756A-42ED-B6EA-FC9A93A6A152,T78.4,"Allergy, unspecified",-
5443D96A-A1C0-46D8-A74D-DD844152C22A,S63,"Dislocation, sprain and strain of joints and ligaments at wrist and hand level",-
4E95E97E-3F5B-412A-95B1-34FE4A848594,A09.9,Gastroenteritis and colitis of unspecified origin,-
3E6ACDE4-BF03-43D6-B06C-8DE9B6858F9C,K30,Functional dyspepsia,-
3E6ACDE4-BF03-43D6-B06C-8DE9B6858F9C,R11,Nausea and vomiting,-
5695A0D8-88D6-4394-BC56-13D1163B9BC1,L30.9,"Dermatitis, unspecified",-
6DEB9837-C0BC-4B1B-97E2-BE9D1A900C52,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7D462575-4BE9-439C-B422-49790C4833CB,M62.6,Muscle strain,-
192EE5A7-A87C-4102-AAEA-FC3E6231BCA8,R11,Nausea and vomiting,-
192EE5A7-A87C-4102-AAEA-FC3E6231BCA8,A09.9,Gastroenteritis and colitis of unspecified origin,-
5962F990-F6A8-47EF-9BC1-8F91F4FF31A7,M10,Gout,Gout
0AB80F42-6ABF-479A-B26A-E4DCA13FD3AF,U07.1,"COVID-19, virus identified",-
0AB80F42-6ABF-479A-B26A-E4DCA13FD3AF,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
5E7D2423-C036-4D95-B25C-F00EEB7C35DA,Z71.2,Person consulting for explanation of investigation findings,-
DBAA162E-5868-401E-B49E-CCD072D08EBD,H04.0,Dacryoadenitis,-
7C5A947A-A8AB-42B9-8A4A-30338F7CEAC2,M79.1,Myalgia,-
54F6614E-0C3D-4E05-8802-B12A5CA2647E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
88E6385E-5CB3-4DC8-930C-9226AF7B76C2,A09.9,Gastroenteritis and colitis of unspecified origin,-
1E15D7D0-FFE9-47A9-91CF-A85360EF6D74,A09.9,Gastroenteritis and colitis of unspecified origin,-
68390E8E-EC01-4E21-A0B5-72EA15C5810F,R51,Headache,-
DFC5EBE5-7A79-408B-9801-DD3069734E6F,R51,Headache,-
A74EEAF9-1322-455B-9AB3-8C5A5FD23DF8,O91.2,Nonpurulent mastitis associated with childbirth,-
6472B5F9-E1C2-42A3-BCC5-3137C68D8B6E,L50.0,Allergic urticaria,-
9C36A705-C11F-4CC8-85FB-29C7F91B806D,R51,Headache,-
3A62E184-01B8-4177-8CE1-CCAD95B3B18C,K13,Other diseases of lip and oral mucosa,-
3A62E184-01B8-4177-8CE1-CCAD95B3B18C,R21,Rash and other nonspecific skin eruption,-
BEE3DFCD-663E-4D46-A35F-9B80142138C9,J06.9,"Acute upper respiratory infection, unspecified",-
0FAE801C-7FB0-4F79-8FF2-AEA0EBC9416C,J06.9,"Acute upper respiratory infection, unspecified",-
BEE3DFCD-663E-4D46-A35F-9B80142138C9,U07.1,"COVID-19, virus identified",-
0FAE801C-7FB0-4F79-8FF2-AEA0EBC9416C,U07.1,"COVID-19, virus identified",-
65F90598-B181-4846-B7DD-F47054FF23ED,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A975808E-B205-40A7-849D-FED3C3992269,A09.9,Gastroenteritis and colitis of unspecified origin,-
6EC40340-3ED5-4655-9F49-8D635DC11CB8,R21,Rash and other nonspecific skin eruption,-
067807B2-F76F-406E-A745-41835A5388BB,T88.1,"Other complications following immunization, not elsewhere classified",-
067807B2-F76F-406E-A745-41835A5388BB,B35.3,Tinea pedis,-
EDDCEFAF-D8AC-43F1-BFA5-6026C04C59F6,N39.0,"Urinary tract infection, site not specified",-
33E7A8C2-D2CE-4F36-9C85-CD7D3CC8D541,L50.9,"Urticaria, unspecified",-
4559F2EF-A97B-4A47-8F2E-738EA783B69E,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
4559F2EF-A97B-4A47-8F2E-738EA783B69E,T88.1,"Other complications following immunization, not elsewhere classified",-
A1F70A3C-8BF8-4916-B122-17BCA522440F,J06.9,"Acute upper respiratory infection, unspecified",-
7B3773EA-5706-4EFE-A30B-62C18A1FAD64,T88.1,"Other complications following immunization, not elsewhere classified",-
881881CD-DFC9-423F-A0A9-0167F5546C43,N39.0,"Urinary tract infection, site not specified",-
E6F70E74-6DCF-47BB-B44E-729C3352E8C2,T88.1,"Other complications following immunization, not elsewhere classified",-
A157C0C4-CC3C-481E-8656-22D50D329D1C,M62.6,Muscle strain,-
E62B2D2A-9D68-430B-AA10-FA7A0E9183F6,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
E62B2D2A-9D68-430B-AA10-FA7A0E9183F6,R21,Rash and other nonspecific skin eruption,-
9129EC8F-0845-46C0-B696-377B7F14E3FB,K12.0,Recurrent oral aphthae,-
8F303485-1C94-46D6-8E4C-1D79F97CE396,J02,Acute pharyngitis,-
B7971846-EF24-4AFD-846C-4696DF2B9B47,J06.9,"Acute upper respiratory infection, unspecified",-
7DD86E4F-1213-4831-B05F-E2DF39716CCC,J06.9,"Acute upper respiratory infection, unspecified",-
EAB804FD-D569-4519-AAAC-6427D7C7B52B,U07.2,"COVID-19, virus not identified",-
F99CD909-B90C-4186-8605-9D038741A658,J01,Acute sinusitis,-
763681B0-A8CB-4519-AB25-ACA308C998A8,N94.6,"Dysmenorrhoea, unspecified",-
6F11DE1D-7DB4-4492-B508-4737D12FE5CF,N94.6,"Dysmenorrhoea, unspecified",-
31C4CDAA-F84A-412B-AEED-90C6222DBABC,R11,Nausea and vomiting,-
31C4CDAA-F84A-412B-AEED-90C6222DBABC,A09.9,Gastroenteritis and colitis of unspecified origin,-
19568D60-5928-40CB-915D-B7D9E6A08F81,J06.9,"Acute upper respiratory infection, unspecified",-
AD4FA112-B451-4888-8946-C903EDA5A60F,A09.9,Gastroenteritis and colitis of unspecified origin,-
46254101-29A7-4A88-B032-1A9A2F96F1CE,A09.9,Gastroenteritis and colitis of unspecified origin,-
8E7C2FBB-B52E-44CF-AAAE-8F904C08649E,N94.6,"Dysmenorrhoea, unspecified",-
92E9C594-5751-4B87-800F-171BDAF951D7,U07.2,"COVID-19, virus not identified",-
F028455B-BD4D-411C-9467-73BAF72D2BDC,A09.9,Gastroenteritis and colitis of unspecified origin,-
AD962CBF-D2BB-4F90-9A5B-ACA544C60F2C,A09.9,Gastroenteritis and colitis of unspecified origin,-
92E9C594-5751-4B87-800F-171BDAF951D7,L71.0,Perioral dermatitis,-
AD962CBF-D2BB-4F90-9A5B-ACA544C60F2C,L71.0,Perioral dermatitis,-
7E47DF2D-DDFF-46E1-A601-63722EE1CCAE,R51,Headache,-
F0FC641C-FAB2-4F3A-A247-19E346D4A3A0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1D54518C-274F-48E1-96F5-13B55CB35A8D,A09.9,Gastroenteritis and colitis of unspecified origin,-
14BE01D1-EFDF-47C7-B0A8-B5C0950EF370,A09.9,Gastroenteritis and colitis of unspecified origin,-
F1F5C133-14D3-45A0-8423-8773F52310EA,B30,Viral conjunctivitis,-
3D5C5889-C8F9-42B3-B9DD-CCAA7DCEE7CF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
26841B82-2438-4B14-9358-65C3F47BF747,T78.4,"Allergy, unspecified",-
F854D5B6-CDCE-4653-A96E-87C96B6D589A,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
E26E6F12-B443-4AD7-9AD6-C68A2F7EE573,H57.9,"Disorder of eye and adnexa, unspecified",-
B4FF3292-97EA-4829-A5CF-9C160BA80259,H81.1,Benign paroxysmal vertigo,-
070238CC-42BA-4E16-8F37-029060468D4A,R51,Headache,-
CE7F8F5D-8911-462E-BCB0-0E7BED497179,L71.0,Perioral dermatitis,-
EF522D98-877A-4464-A37E-D26502EBE591,A09.9,Gastroenteritis and colitis of unspecified origin,-
58D10460-7474-44E9-B29C-4925885573B5,I10,Essential (primary) hypertension,Hypertension
1ECE08B1-AFE9-4D6C-9A0A-51A40D71290F,N94.6,"Dysmenorrhoea, unspecified",-
0B7570FC-098F-4005-91AB-661BF7A33F5C,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
DBE2BD3E-25F8-485B-96C2-0C7E763A456D,J30.3,Other allergic rhinitis,Vasomotor and allergic rhinitis
0B7570FC-098F-4005-91AB-661BF7A33F5C,J06.9,"Acute upper respiratory infection, unspecified",-
DBE2BD3E-25F8-485B-96C2-0C7E763A456D,J06.9,"Acute upper respiratory infection, unspecified",-
DBE2BD3E-25F8-485B-96C2-0C7E763A456D,K59.0,Constipation,-
8F36BEF1-6EE7-4A87-8DDE-DAD1B5DDDC11,N39.0,"Urinary tract infection, site not specified",-
9590F537-C5F1-43B5-96CF-6C6919ED9D43,J06.9,"Acute upper respiratory infection, unspecified",-
CCE7669D-753D-48B8-8DC6-A831602E596A,I10,Essential (primary) hypertension,Hypertension
BDD96C87-51CF-40BF-9711-5C1E691F1FAE,Z71.2,Person consulting for explanation of investigation findings,-
A24D45DC-F114-487B-AFBC-4783CE4EEFB5,J06.9,"Acute upper respiratory infection, unspecified",-
D8677A35-0CE6-400E-9FEC-1E560C7FFC3D,R51,Headache,-
D8677A35-0CE6-400E-9FEC-1E560C7FFC3D,J06.9,"Acute upper respiratory infection, unspecified",-
05FA8A43-2E31-4163-AFDA-3B45CBEB611B,R51,Headache,-
9FD261FD-4D98-4ADC-AA0E-E57A14702348,R51,Headache,-
FD8A2B2E-C0C6-45EB-9D21-429FD84A8FE8,H60.1,Cellulitis of external ear,-
CB9E3A7A-F369-499C-9441-D299D4CEC475,J06.9,"Acute upper respiratory infection, unspecified",-
579DB259-44A9-43A6-965E-EFCB367ED48A,J06.9,"Acute upper respiratory infection, unspecified",-
4843AC4E-3A49-4DF2-8813-FE4C2D765464,J06.9,"Acute upper respiratory infection, unspecified",-
83640290-1E70-4F8C-A963-7E1BABF47DD3,J06.9,"Acute upper respiratory infection, unspecified",-
F5BB4877-1AC4-4619-A4A2-638A9129BD1D,L20,Atopic dermatitis,Atopic dermatitis
F5BB4877-1AC4-4619-A4A2-638A9129BD1D,Y42.4,Oral contraceptives,-
FE0B768E-7A78-43F1-90ED-CBA0048E01FA,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
FE0B768E-7A78-43F1-90ED-CBA0048E01FA,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
579BFF9C-553F-43E3-B5EE-70A31AB0403E,A09.9,Gastroenteritis and colitis of unspecified origin,-
FC058828-40E9-4F66-A441-BA08065A4846,M54.5,Low back pain,-
3BA98790-C683-43A8-BE6D-92E97B4EB2FA,U07.1,"COVID-19, virus identified",-
3BA98790-C683-43A8-BE6D-92E97B4EB2FA,J06.9,"Acute upper respiratory infection, unspecified",-
206014CF-81CF-4056-B532-B1DCCFB8C376,J06.9,"Acute upper respiratory infection, unspecified",-
A57A7A7C-95BB-46E1-9667-9A035F14C057,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
72BF2FC3-5C08-40F4-9663-70778E951C0A,T88.1,"Other complications following immunization, not elsewhere classified",-
3B8B61BD-45E1-4C4F-B680-A9975BB6A5FE,U11,Need for immunization against COVID-19,-
3B8B61BD-45E1-4C4F-B680-A9975BB6A5FE,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
7FF17297-20B3-4E06-BE34-0E3EC72A411E,T88.1,"Other complications following immunization, not elsewhere classified",-
CD554B93-1F17-4E1A-AF11-82637902F252,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3E9F5C13-A683-40D3-AB44-A6D6E090997E,H00.0,Hordeolum and other deep inflammation of eyelid,-
825D1328-93F8-4157-9710-FE21DE2DE5C6,N94.6,"Dysmenorrhoea, unspecified",-
825D1328-93F8-4157-9710-FE21DE2DE5C6,R51,Headache,-
3D319784-CD86-4621-9B1B-5EEF171EAEEC,J06.9,"Acute upper respiratory infection, unspecified",-
3D319784-CD86-4621-9B1B-5EEF171EAEEC,M10,Gout,Gout
19A42A4D-67FD-4C9D-9DAD-78043EA997EC,H00.0,Hordeolum and other deep inflammation of eyelid,-
E9BCE0FC-F2C2-4981-930A-43A83D005EFF,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
FA7B7A82-9B8A-4218-B059-AB13E0123F8B,A09.9,Gastroenteritis and colitis of unspecified origin,-
D0EF421A-6A27-4756-BDC9-7CF71B117928,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D0EF421A-6A27-4756-BDC9-7CF71B117928,R51,Headache,-
649129D3-9207-4D6F-B21C-C05555148F3B,A09.9,Gastroenteritis and colitis of unspecified origin,-
C1736AEA-1C86-4B1D-A8EA-6784B8ACCE73,M79.1,Myalgia,-
C6A3318E-F4EB-4B06-9337-1098F5B94DCD,T88.1,"Other complications following immunization, not elsewhere classified",-
F6A0FCBB-289D-40EB-988B-AFC04486D2C4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
726D3629-F4AE-48EB-8AAB-1D1209AC42D4,T88.1,"Other complications following immunization, not elsewhere classified",-
7937A02A-29FB-47A1-8A5B-5329DD286493,A09.9,Gastroenteritis and colitis of unspecified origin,-
735AD03E-F032-449B-A714-CA6634EC80CA,N94.6,"Dysmenorrhoea, unspecified",-
7CD7FFB4-FF06-4D20-90E1-888F166C8E76,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
7CD7FFB4-FF06-4D20-90E1-888F166C8E76,Z71.2,Person consulting for explanation of investigation findings,-
B143700F-AD54-4717-8448-C4C3558033FE,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
91F3DD49-3684-4F85-BCEE-C45BF11CE6F2,R51,Headache,-
91F3DD49-3684-4F85-BCEE-C45BF11CE6F2,H81.1,Benign paroxysmal vertigo,-
DCCCC234-CD47-4612-866C-DBE470E38BA8,Z71.2,Person consulting for explanation of investigation findings,-
C00E4710-F50B-4A01-BD67-0F1278A57013,H57,Other disorders of eye and adnexa,-
1AC0E06B-DDA3-45C7-9A15-CB143384FDB3,A09.9,Gastroenteritis and colitis of unspecified origin,-
0E8D2112-6782-4E6B-99CC-44D299C5D11C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7D3EA24B-BAD1-415B-AD9C-2CE2A399FA0B,H00,Hordeolum and chalazion,-
58899B4A-A237-4F80-9518-2664ABA2566D,J06.9,"Acute upper respiratory infection, unspecified",-
654F7601-4222-457B-916C-442B396E0906,R10.4,Other and unspecified abdominal pain,-
48162633-8798-4D0F-829B-87890A52790B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8A053796-B383-4159-AAFA-BA00BB2AA246,K59.0,Constipation,-
8A053796-B383-4159-AAFA-BA00BB2AA246,M62.6,Muscle strain,-
8A053796-B383-4159-AAFA-BA00BB2AA246,R51,Headache,-
6FB09F3A-85C3-44D7-B375-32B5CC436648,T88.1,"Other complications following immunization, not elsewhere classified",-
C33BF118-85DB-43F0-B58D-91DDFB0936F7,R51,Headache,-
192867DA-FE4C-46C6-A28A-72FD73B1CA4F,U07.1,"COVID-19, virus identified",-
85925BB1-729B-4749-9F3F-3F6A154572F0,R50.9,"Fever, unspecified",-
776C2664-5411-43DD-874F-76DEE8D315E8,M62.6,Muscle strain,-
5C79796F-D460-4F4A-B023-7F1E28172DBD,T22,"Burn and corrosion of shoulder and upper limb, except wrist and hand",-
2992800E-B264-40F5-A4AD-B9913A57D890,J06.9,"Acute upper respiratory infection, unspecified",-
52908370-4115-43B5-BA1C-039FB5B274B5,A09.9,Gastroenteritis and colitis of unspecified origin,-
287DA504-D18B-474F-9093-082EB39C25D4,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
7887BE3E-64CF-4830-B3DF-87D21534B76A,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
35DB2B8C-7B80-443A-800D-3C2E09CE955C,A09.9,Gastroenteritis and colitis of unspecified origin,-
478E01C3-0D9A-46EA-BBA3-C67EF65B2775,Z02,Examination and encounter for administrative purposes,-
5F658BCD-BFCC-4337-B4BA-0A68A65002A6,N94.6,"Dysmenorrhoea, unspecified",-
A3CBE0D8-0B83-4A56-9408-2B6C1573B224,T88.1,"Other complications following immunization, not elsewhere classified",-
3E839CEA-81DF-401F-A9BB-B6BED31AFC05,R51,Headache,-
F42426C1-AD48-40B8-9363-05CCF3516AB9,R10.4,Other and unspecified abdominal pain,-
81CEA1DE-EBCF-4BA2-9542-A426C15B6D31,T00.9,"Multiple superficial injuries, unspecified",-
F66D2F1A-542B-4AC0-9862-87FBA3FEB2E0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F66D2F1A-542B-4AC0-9862-87FBA3FEB2E0,L20,Atopic dermatitis,Atopic dermatitis
E42791A1-4CC9-4558-A4AE-681ED619F416,U09,Post COVID-19 condition,-
E42791A1-4CC9-4558-A4AE-681ED619F416,J45,Asthma,Asthma
81128952-8C82-4620-A309-5D8B19F79C4E,A09.9,Gastroenteritis and colitis of unspecified origin,-
976CDDF8-02A0-47A7-B8AB-E83199520A9B,Z71.2,Person consulting for explanation of investigation findings,-
976CDDF8-02A0-47A7-B8AB-E83199520A9B,E11,Type 2 diabetes mellitus,Diabetes
B12DDBBA-0652-41B5-82CC-BC26FE238656,M54.5,Low back pain,-
B12DDBBA-0652-41B5-82CC-BC26FE238656,R51,Headache,-
225E52C1-5C17-4E64-BF0D-FA258C2AE8A8,R51,Headache,-
225E52C1-5C17-4E64-BF0D-FA258C2AE8A8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F9958B2C-376A-41C6-9E8F-79C3FCBD2F69,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0043B671-253E-4BAE-8FEE-40D32F581871,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0043B671-253E-4BAE-8FEE-40D32F581871,R50.9,"Fever, unspecified",-
335EE28F-7C16-4394-88E7-5E2976276500,A09.9,Gastroenteritis and colitis of unspecified origin,-
EABAEF2E-FFED-42CC-A641-14DA764B749E,A09.9,Gastroenteritis and colitis of unspecified origin,-
0AE1117D-4656-474A-BCA6-6402E79FC7A4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8D1C795E-DE63-401D-8538-E823DEE98606,T23.2,Burn of second degree of wrist and hand,-
D1B82D54-17F2-4806-8B94-14FBB686362B,R51,Headache,-
D1B82D54-17F2-4806-8B94-14FBB686362B,M79.1,Myalgia,-
75DA2A8A-4C9C-46C3-A9FD-17352F884661,R50.9,"Fever, unspecified",-
985795E7-7EE3-4207-87E4-559CF9685A90,N94.6,"Dysmenorrhoea, unspecified",-
330B96B8-CCCD-447F-BA5A-E140C4275203,N94.6,"Dysmenorrhoea, unspecified",-
B66A8103-6088-423F-9697-020D2038648D,N94.6,"Dysmenorrhoea, unspecified",-
8A784E9D-35DC-4BE0-A219-6A50DA6928F8,N76.0,Acute vaginitis,-
8A784E9D-35DC-4BE0-A219-6A50DA6928F8,N92.6,"Irregular menstruation, unspecified",-
5064FE5E-D144-4EFF-9806-19CF10E920BA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EB58DBA4-6443-4166-B697-166C04BD6759,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A44D6FAE-1539-4F51-9674-3981962F16EB,K30,Functional dyspepsia,-
655CCD77-BBD5-4DF1-BB2C-1678103D9B6B,M10,Gout,Gout
73CB3756-8980-4D51-B7D0-9B3D18361241,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
185DFE97-6D5C-4254-9967-3591330850CF,N39.0,"Urinary tract infection, site not specified",-
6C2B43E3-A32D-47A4-9BB2-7F77D880024A,R53,Malaise and fatigue,-
6F6B4647-FE9A-4A81-912F-E2BC417FA893,N76.0,Acute vaginitis,-
5C590D90-0A67-4559-B83A-7ADA41C9A217,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C91AB5EC-700D-4AAE-989C-0881964B53E2,R51,Headache,-
C91AB5EC-700D-4AAE-989C-0881964B53E2,M79.1,Myalgia,-
2EFBBD8B-5930-4A4B-AA5C-FC8D303A851D,J01.9,"Acute sinusitis, unspecified",-
3E4F1AFE-620D-4977-A43A-F88A53E9255C,G43,Migraine,Migraine
6E22CF74-D108-4E57-95DB-0B02D7667BF8,U07.1,"COVID-19, virus identified",-
D97F5482-E602-4E04-B773-5BD7A6E40715,T88.1,"Other complications following immunization, not elsewhere classified",-
BC28BC9F-E849-4B10-9AF1-B15BD54BFF15,R21,Rash and other nonspecific skin eruption,-
F66CB5C7-D5EF-42B6-B17E-4A3CF061373E,G43,Migraine,Migraine
31C9F909-A48A-4ABA-89BA-48A56FE32FA4,M62.6,Muscle strain,-
1D29AC8D-2844-4F4D-A408-8B29A07640C2,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
B9DE510E-C89D-44F7-B4EF-A433BBBB8C29,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CD8039FA-F7BE-49A3-850E-DBE949516283,R23.8,Other and unspecified skin changes,-
9ED613BF-709F-43A0-A368-65D0D4D43812,A09.9,Gastroenteritis and colitis of unspecified origin,-
A847773C-0D28-4309-A801-34ADF6AC8593,U07.1,"COVID-19, virus identified",-
A847773C-0D28-4309-A801-34ADF6AC8593,J06.9,"Acute upper respiratory infection, unspecified",-
E30ACD1A-4F9D-45BB-8B74-0750D2900613,T88.1,"Other complications following immunization, not elsewhere classified",-
81984264-A1CB-4806-B340-EF6F6D8E3419,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6C79C996-0626-48B2-97B6-A6B426678E31,Z71.2,Person consulting for explanation of investigation findings,-
BF3FA372-0B9A-4359-BD43-738E1C9CF34D,H57,Other disorders of eye and adnexa,-
BF3FA372-0B9A-4359-BD43-738E1C9CF34D,L30.9,"Dermatitis, unspecified",-
C3D519AD-96A1-4053-B2F3-D9EE257F3EF2,J06.9,"Acute upper respiratory infection, unspecified",-
0BE3767C-8E51-4A0C-B27C-FFB23588433B,J06.9,"Acute upper respiratory infection, unspecified",-
693185FB-747F-4704-94D5-826BC72A7A98,Y42.4,Oral contraceptives,-
085C8680-CA04-4A51-89D0-B5DFD50EEC52,U07.2,"COVID-19, virus not identified",-
F4991906-507C-4071-8591-02018E05255B,J06.9,"Acute upper respiratory infection, unspecified",-
23583826-48CD-4C31-A5CD-31C01C6E0ACC,U07.1,"COVID-19, virus identified",-
425B78FB-673E-49FB-A5C8-A25365DE8865,U07.1,"COVID-19, virus identified",-
3C740BBB-885B-4AEF-A1D8-18A9EC7923BE,J06.9,"Acute upper respiratory infection, unspecified",-
38D20711-95EF-4ACB-BD9F-B6FB28B6FB09,J06.9,"Acute upper respiratory infection, unspecified",-
BABF2E69-A703-4A49-9ADC-E047D3AB3B0E,R21,Rash and other nonspecific skin eruption,-
BABF2E69-A703-4A49-9ADC-E047D3AB3B0E,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
489CCDF8-2087-4668-A4F6-48E797234549,M79.1,Myalgia,-
127A1BCA-DC11-429C-8AD9-773F31348A6E,M79.6,Pain in limb,-
96EB1B78-C8DF-41E1-ABE6-A140F18BC3B7,R42,Dizziness and giddiness,-
96EB1B78-C8DF-41E1-ABE6-A140F18BC3B7,T88.1,"Other complications following immunization, not elsewhere classified",-
DEEBD5D1-4B60-4814-908A-E4F258E4DE84,S93.4,Sprain and strain of ankle,-
25AA2CF9-5777-4C68-9CD3-F11A489D8A11,T88.1,"Other complications following immunization, not elsewhere classified",-
25AA2CF9-5777-4C68-9CD3-F11A489D8A11,R11,Nausea and vomiting,-
75936981-A050-4789-8EA9-A092FAFF8B31,A09.9,Gastroenteritis and colitis of unspecified origin,-
6D80EA66-136B-4EAD-8FD5-68DD4F240A5B,G44.2,Tension-type headache,-
6D80EA66-136B-4EAD-8FD5-68DD4F240A5B,H81.3,Other peripheral vertigo,-
E6985482-2AAA-4A20-9B1E-0FB00B521926,J06,Acute upper respiratory infections of multiple and unspecified sites,-
E6985482-2AAA-4A20-9B1E-0FB00B521926,H57,Other disorders of eye and adnexa,-
BFD766A5-ED9B-487F-B097-CB4CA9E1C2B6,G53.0,Postzoster neuralgia,-
F6B21F63-F41F-494E-919B-C36DF32E2AA2,J06.9,"Acute upper respiratory infection, unspecified",-
F2F1CB7C-50E3-46BB-A128-A6A6FAD4479D,N94.8,Other specified conditions associated with female genital organs and menstrual cycle,-
3F39D98F-862F-47D0-9496-7506D50C802B,J06.9,"Acute upper respiratory infection, unspecified",-
CFA0AD3F-6658-4E06-8145-DD8FC2017232,J06.9,"Acute upper respiratory infection, unspecified",-
AD0DB998-8948-40F5-B815-C37E8CC82779,J45,Asthma,Asthma
FF32A092-6FA3-44B5-98CE-13CBBDD23FFC,R51,Headache,-
DD77AEDC-D16B-4D95-AF33-FAE17FE1BC07,K30,Functional dyspepsia,-
88A84D33-D2A4-4C9E-BE3E-71BFC274BF56,A09.9,Gastroenteritis and colitis of unspecified origin,-
7BB796BE-B8B8-4A20-B694-CC076F110A81,K29.7,"Gastritis, unspecified",-
457DE625-0B8D-4324-9964-EBFA71669F77,G44.2,Tension-type headache,-
457DE625-0B8D-4324-9964-EBFA71669F77,M62.6,Muscle strain,-
87453BE7-2F6D-4468-A497-209DB93048BF,R50.9,"Fever, unspecified",-
2E9245C8-BE0F-4F16-8C0A-D1AA0B44B29F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2197B20A-46DF-43CF-B6D9-57BE154B7A10,H00,Hordeolum and chalazion,-
8F189290-B5E9-402A-AA72-611EF6D7B7DF,J06.9,"Acute upper respiratory infection, unspecified",-
6065742A-8C96-4F19-A1A1-E7E3CC5E9168,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
6065742A-8C96-4F19-A1A1-E7E3CC5E9168,R21,Rash and other nonspecific skin eruption,-
4B4071D6-72A5-432A-9B40-4866D9B3DC47,H01,Other inflammation of eyelid,-
6E0B58D2-1AD1-4E1F-89ED-5D75C699BF28,M10,Gout,Gout
E99D812B-DEF0-4834-8B08-213A65F5B5BE,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
6253A747-4E85-4CB7-927C-BEA003E95C6A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6253A747-4E85-4CB7-927C-BEA003E95C6A,R50.9,"Fever, unspecified",-
322D3028-2F2E-42E6-9CC8-B1A19D8AF2BC,B35.4,Tinea corporis,-
C970BB9F-F0F2-482A-81B9-304C852FCA97,Z30,Contraceptive management,-
5AE63F96-CC3C-4763-898E-C7E3C13EFC20,R51,Headache,-
2E7CD08A-25F7-4A4A-BADB-745103F35B65,M54.5,Low back pain,-
E02153CD-8D78-4B87-8343-48CD9ADD5C53,S00.5,Superficial injury of lip and oral cavity,-
172B0816-2BCA-4653-AF2B-ADDE7D7729F9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
738DBD43-4C4C-41CB-A139-321FB68199E1,T88.1,"Other complications following immunization, not elsewhere classified",-
A7E1F513-64BA-43E4-AED9-678738F201F9,N39.0,"Urinary tract infection, site not specified",-
3114DDAD-B048-4FF0-AEB7-5DD1018AC175,J06.9,"Acute upper respiratory infection, unspecified",-
D7CAEDAF-C7E4-447B-A444-FC45A641F8FF,R51,Headache,-
4AAE3114-DD0C-4F1F-A94A-7C69BB471DA1,R21,Rash and other nonspecific skin eruption,-
4AAE3114-DD0C-4F1F-A94A-7C69BB471DA1,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
59E1BFC6-6058-4D66-B872-CB13194EEBC5,Z02,Examination and encounter for administrative purposes,-
1A1170C4-6621-43EE-A5C9-FA7F6403C8F9,Z71.2,Person consulting for explanation of investigation findings,-
04CD40D6-C68E-45DE-A77B-6E6DBF00B898,M25.5,Pain in joint,-
04CD40D6-C68E-45DE-A77B-6E6DBF00B898,R60,"Oedema, not elsewhere classified",-
1BC5616C-D107-4B75-B1F3-B785F02BEF52,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
730BE6FF-E63A-4EE0-9851-993890E0F8C6,K29.7,"Gastritis, unspecified",-
5ECE80EE-EDBE-4C98-BBA8-FAC8070F12E1,B35.6,Tinea inguinalis [Tinea cruris],-
2DE75203-71A3-4F74-A972-A0B408307BAC,M79.1,Myalgia,-
90072542-73F3-4404-8BB5-239F22800980,J06.9,"Acute upper respiratory infection, unspecified",-
F4DADBA7-E753-409F-B7BF-616C071C2FE0,K29.7,"Gastritis, unspecified",-
CB43A349-EC2A-4E78-A896-A5FD8BB47B30,A09.9,Gastroenteritis and colitis of unspecified origin,-
C8BE4A61-6DA7-4C07-AC4B-E0754A08A699,A09.9,Gastroenteritis and colitis of unspecified origin,-
C8BE4A61-6DA7-4C07-AC4B-E0754A08A699,R53,Malaise and fatigue,-
FD85D87A-9A0B-434D-BFFB-4832F6D2ED6B,A09.9,Gastroenteritis and colitis of unspecified origin,-
B2A86600-7E4D-4C77-B021-9AAB8E114C02,J06.9,"Acute upper respiratory infection, unspecified",-
D2420285-B271-4114-B9A1-C9FD7E47FB47,J06.9,"Acute upper respiratory infection, unspecified",-
D2420285-B271-4114-B9A1-C9FD7E47FB47,R51,Headache,-
A1494CE4-BF77-471A-9D67-6ED37E8D5F86,J06.9,"Acute upper respiratory infection, unspecified",-
36F4CCC2-89B1-450E-841D-CE23F1296DBE,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
36F4CCC2-89B1-450E-841D-CE23F1296DBE,I10,Essential (primary) hypertension,Hypertension
AAE6E681-5F76-45CE-A0BC-4F2F1D3369A5,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
AAE6E681-5F76-45CE-A0BC-4F2F1D3369A5,Z76.0,Issue of repeat prescription,-
9E0A5E2A-A2C4-4849-BAF0-21B8DD454B81,J06.9,"Acute upper respiratory infection, unspecified",-
9E0A5E2A-A2C4-4849-BAF0-21B8DD454B81,U08,Personal history of COVID-19,-
87CDBC29-7925-4B43-9C4A-E0A21897C13A,J02,Acute pharyngitis,-
F8F7F59F-3B74-4877-AD78-2243D69D71BF,M79.1,Myalgia,-
2DFE4F91-425D-4E33-A0E2-AE4CADC15D09,B08.4,Enteroviral vesicular stomatitis with exanthem,-
F8F7F59F-3B74-4877-AD78-2243D69D71BF,R11,Nausea and vomiting,-
F1C55640-28E1-4B7D-B6A4-ADDC39593633,R51,Headache,-
4DCA7DA6-A000-472F-B083-769D376D1BAA,B37,Candidiasis,-
F6250B4C-CBD7-40CA-8319-8D78900E9782,Z71.2,Person consulting for explanation of investigation findings,-
1E43EC96-AE39-46C1-ADBA-7C65A8CBD21F,J06.9,"Acute upper respiratory infection, unspecified",-
0B4715F3-F614-4B45-8B28-20D500A85FCB,N92,"Excessive, frequent and irregular menstruation",-
4C85EA7C-CB33-4E0C-9392-0A5229BC15D1,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
C8CA5DC9-EB6A-4A7A-B2D2-75601E4B9324,R51,Headache,-
E8715A4F-07AC-4318-AF6B-6564E015374F,K12.0,Recurrent oral aphthae,-
E8715A4F-07AC-4318-AF6B-6564E015374F,K12.1,Other forms of stomatitis,-
8A0201F0-CE9E-439A-8E5B-C8B7C451ED34,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E48C0210-C6CD-4E2D-B18E-7079AF42914D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E48C0210-C6CD-4E2D-B18E-7079AF42914D,M79.1,Myalgia,-
B7BF617E-CF20-4D2B-BB02-26E8ACDF6831,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
74768A0A-8F93-4524-BB53-FA6F63255B9D,T88.1,"Other complications following immunization, not elsewhere classified",-
923B6BDB-D970-4FC0-9C69-8ADD09D75E89,L30.9,"Dermatitis, unspecified",-
519B8544-9AF4-4EF9-898A-931A83A57313,G43,Migraine,Migraine
D50A6EE6-E7D1-49A4-AA16-CDA2B20779BB,J06.9,"Acute upper respiratory infection, unspecified",-
0F0E6ED2-3578-4ECC-B7DA-8FC9EFE33D79,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
B132A171-D120-41BD-8DF6-8A34FFFF5843,K29.1,Other acute gastritis,-
CEE5ACB9-C402-45A7-BE27-35F280A594F5,R03.0,"Elevated blood-pressure reading, without diagnosis of hypertension",Hypertension
7747490E-34A8-40BF-A928-801BF59DD29E,J06.9,"Acute upper respiratory infection, unspecified",-
0779B01F-4B2C-4562-9C73-0E5DE615BDE4,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
B294628C-C474-4987-A389-57D7DE1FD943,K52,Other noninfective gastroenteritis and colitis,-
59156A7F-D46B-4FB4-9395-DD0C70295541,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
794014E6-18E3-4B74-A741-03D8F2599BD9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
794014E6-18E3-4B74-A741-03D8F2599BD9,R51,Headache,-
14D61F9D-3CE8-49C5-91D9-40113ECE8C9D,M79.1,Myalgia,-
14D61F9D-3CE8-49C5-91D9-40113ECE8C9D,T88.1,"Other complications following immunization, not elsewhere classified",-
4AD3BD2F-7136-4559-BE7A-9F531584F8B3,T88.1,"Other complications following immunization, not elsewhere classified",-
51DF5C77-B538-421B-B8A4-AEC841774A5D,K29.7,"Gastritis, unspecified",-
2E49B58A-43A2-41DE-A001-C8209C5E2440,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7182C7BF-AE62-4A88-AE44-78656398C840,T88.1,"Other complications following immunization, not elsewhere classified",-
DF0949EA-5CEF-463F-BE9A-E945C8719D23,R21,Rash and other nonspecific skin eruption,-
602AFE5C-D77D-4E90-87A8-5A3584A686A5,R21,Rash and other nonspecific skin eruption,-
EB782578-DBBF-4D57-95CE-0E1CC79D4BD0,G44.2,Tension-type headache,-
81E699B0-7BBA-4321-8810-2AA50D63F6A6,G44.2,Tension-type headache,-
81E699B0-7BBA-4321-8810-2AA50D63F6A6,D50,Iron deficiency anaemia,-
ADAFC156-4D64-41F8-9F84-092AE37E4FEB,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
79918D73-7A00-4156-BD7B-37C8EA29E480,J06,Acute upper respiratory infections of multiple and unspecified sites,-
E2EFB93C-76D1-45A2-9EA0-2CFFB57FD3C0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6F7DF212-124E-463A-998B-B3B027C7193D,G43,Migraine,Migraine
846C3B7C-B0E3-4FFB-81D7-FA0813FD2D9E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
677531D0-A719-4B7E-961C-5FF5B374D952,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
61B87538-EE2A-4F3B-BACA-8D9D409EC68C,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
61B87538-EE2A-4F3B-BACA-8D9D409EC68C,R51,Headache,-
C9CCA265-2202-4DA9-AD0C-178D7F03922E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9D5ECCF7-B197-46BC-8813-594E339D6744,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A2B170E2-346E-4013-8117-248DF1223A58,K30,Functional dyspepsia,-
F9EE6C99-AB6C-4852-98E5-AA3F78CFFE15,J02,Acute pharyngitis,-
F9EE6C99-AB6C-4852-98E5-AA3F78CFFE15,T88.1,"Other complications following immunization, not elsewhere classified",-
691512A0-56F0-4937-A400-C7F38D7E9208,J06.9,"Acute upper respiratory infection, unspecified",-
62DB3BBB-A7CE-4A9B-A3E0-0E2202125E49,R51,Headache,-
C744F1BB-41B6-45A5-92A5-A49A00E91361,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
16841295-AD14-4573-AA10-87F5FA8E0857,J06.9,"Acute upper respiratory infection, unspecified",-
26D058BD-5D2C-4377-99AD-DF9908319072,J06.9,"Acute upper respiratory infection, unspecified",-
9C6040D0-D4B5-4FBD-AE8F-C1418A6B1F3E,J06.9,"Acute upper respiratory infection, unspecified",-
40F5B4F7-FF64-4746-82AE-FECFE8FA199E,J06.9,"Acute upper respiratory infection, unspecified",-
01185B5F-2C03-48C4-8D99-47AFC34CF9A8,M23.8,Other internal derangements of knee,-
C35A55E4-5CD9-4673-BA2E-FA5AC3AE1BEF,J06.9,"Acute upper respiratory infection, unspecified",-
C1E27821-7CEA-472D-825B-08E54A848ACB,T88.1,"Other complications following immunization, not elsewhere classified",-
32EDB425-A99B-4B01-917A-003D7BD78E92,K13.0,Diseases of lips,-
32EDB425-A99B-4B01-917A-003D7BD78E92,T78.4,"Allergy, unspecified",-
C73A43BC-9B0C-451B-83D1-D6E47A18A310,T88.1,"Other complications following immunization, not elsewhere classified",-
28A1CB57-85A7-4BF8-86EA-58265784AF45,H00,Hordeolum and chalazion,-
548C3851-84C4-4E87-BB76-CCBEFEDF1CC9,J06.9,"Acute upper respiratory infection, unspecified",-
9DE0404C-EDCB-43A8-A4C0-448FFEBF092E,U07.1,"COVID-19, virus identified",-
3E600E04-FF50-410E-8D1A-AA2D7F99733D,R10.1,Pain localized to upper abdomen,-
17263D8C-7480-4627-AC48-65A7371AF4AA,J06.9,"Acute upper respiratory infection, unspecified",-
86CA8E8F-A3E0-4818-905A-2FC5940FFEDD,Z71.2,Person consulting for explanation of investigation findings,-
A0F4DBC9-618A-4A89-BBEE-02C90801F612,J45,Asthma,Asthma
A0F4DBC9-618A-4A89-BBEE-02C90801F612,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
51241B81-F847-47A7-AEA7-A6EAC99B2CE7,H02,Other disorders of eyelid,-
51241B81-F847-47A7-AEA7-A6EAC99B2CE7,L24.0,Irritant contact dermatitis due to detergents,-
82FC9A14-10C5-4468-B443-13D8F9B2FFA5,Z71.2,Person consulting for explanation of investigation findings,-
75C1262D-B6A4-495B-808D-BA8462477502,R51,Headache,-
333FE163-CF03-4F9F-B79E-3B5859509086,M79.1,Myalgia,-
E7729F36-F131-40E3-887F-F74000D4E9CA,A09.9,Gastroenteritis and colitis of unspecified origin,-
E7729F36-F131-40E3-887F-F74000D4E9CA,R50.9,"Fever, unspecified",-
7A6AAA8B-369E-4EFF-8C36-93F22E4F9A8B,K13.0,Diseases of lips,-
12AEEC14-0583-4AEC-841E-00FF05A7E00A,N94.6,"Dysmenorrhoea, unspecified",-
12AEEC14-0583-4AEC-841E-00FF05A7E00A,J06.9,"Acute upper respiratory infection, unspecified",-
1C1AA830-0325-47BA-B9DB-8F34C05416AB,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
1C1AA830-0325-47BA-B9DB-8F34C05416AB,G44.2,Tension-type headache,-
FE91D6CD-2B10-46E0-9C90-64C0517714F3,A09.9,Gastroenteritis and colitis of unspecified origin,-
AA780F02-932A-45CE-927A-1A8F21FDDAF1,A09.9,Gastroenteritis and colitis of unspecified origin,-
9FC9AE75-22B4-4E48-B653-6B237378EDED,R50.9,"Fever, unspecified",-
6E3F15DA-5408-4133-B891-9194AC06006C,R50.9,"Fever, unspecified",-
6E3F15DA-5408-4133-B891-9194AC06006C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
79997F99-9A38-4B03-B2DE-997791612A8C,M62.6,Muscle strain,-
C16E9A4D-590F-4B01-B44C-7F306D491019,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FDBBAA5F-3A5D-4B0F-A148-75D6291B9305,J06.9,"Acute upper respiratory infection, unspecified",-
D6181BF4-FFA6-4FD0-9FA0-836817B6457B,A09.9,Gastroenteritis and colitis of unspecified origin,-
781E7A31-F1CE-4072-9134-26C0F360BA7D,H10.9,"Conjunctivitis, unspecified",-
63B64A53-4C79-47B3-AE9B-856A5867D32C,H10.9,"Conjunctivitis, unspecified",-
9C111FB1-5204-4BE9-A980-FD37EEF649DF,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
C3DCFE37-D3DD-42BC-B8FB-6812DB599E7B,B30,Viral conjunctivitis,-
C3DCFE37-D3DD-42BC-B8FB-6812DB599E7B,H57.9,"Disorder of eye and adnexa, unspecified",-
99997A44-C838-4246-BF27-CE6AC41B5955,M79.1,Myalgia,-
366B0267-AEB5-43AC-A103-5C35660E931C,M54.5,Low back pain,-
AB337721-1C97-44D2-ABFD-22C75208FF44,K64.9,"Haemorrhoids, unspecified",-
AB337721-1C97-44D2-ABFD-22C75208FF44,A09.9,Gastroenteritis and colitis of unspecified origin,-
7EBC2F83-109D-4248-B94C-0D33CAC1016D,T88.1,"Other complications following immunization, not elsewhere classified",-
FBBF53A1-987D-47C3-A7D8-36A1ED61A431,T78.4,"Allergy, unspecified",-
1CD1F27F-C447-4EB3-AFC8-DAE1C3D4BF5C,A09.9,Gastroenteritis and colitis of unspecified origin,-
9A833744-BF38-4631-9779-463C6DFB7F62,Z71.2,Person consulting for explanation of investigation findings,-
E088D8B0-4994-412A-ABC1-7F204A36ACD6,M62.6,Muscle strain,-
E088D8B0-4994-412A-ABC1-7F204A36ACD6,R25.2,Cramp and spasm,-
06876E48-BAB1-445E-B0EF-CAA9FB0F9EEE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E2D29C0A-CE9B-4866-B779-3CDFED5165F4,N94.8,Other specified conditions associated with female genital organs and menstrual cycle,-
323427E4-6848-4280-AEA7-A236E83C22CE,L20,Atopic dermatitis,Atopic dermatitis
5EC74991-69EB-4DD6-832F-67835B394E73,H10.3,"Acute conjunctivitis, unspecified",-
092F5A99-AF64-4677-B0A8-6193E56EAC1E,M62.6,Muscle strain,-
FE101A29-100D-4CD0-B70D-0F5628B10B37,M62.6,Muscle strain,-
092F5A99-AF64-4677-B0A8-6193E56EAC1E,A09.9,Gastroenteritis and colitis of unspecified origin,-
CBF44423-C0B7-4838-8BE6-7572A75F63B9,N94.6,"Dysmenorrhoea, unspecified",-
9A2734F8-F4AF-4011-91EB-BE04C9B00CAE,T88.1,"Other complications following immunization, not elsewhere classified",-
A009AF47-BEEF-4F85-BEF5-B3DFBD1A5D26,Z71.2,Person consulting for explanation of investigation findings,-
611B5DC7-52FC-4560-9EC6-3D83203AA47B,M72.2,Plantar fascial fibromatosis,-
4CD6F812-537B-49A7-ABE7-AFE6730E06CD,R51,Headache,-
4CC287A2-62D8-405B-BB60-6E42CEBFC815,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F19D89DB-47B3-440D-A336-0596A41606D9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BDDC55D5-CC1D-453E-8143-52028D812E44,L64,Androgenic alopecia,-
8690F20F-84A7-4F98-B522-7CD3546097ED,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6F7EFDB6-5154-4B85-98DE-A21C35933492,H00,Hordeolum and chalazion,-
76EE3526-46A7-48D3-8E54-261B7B905575,M10,Gout,Gout
F473F8A1-2FE1-429D-A15C-64B82BE84CF3,A09.9,Gastroenteritis and colitis of unspecified origin,-
BE482F9C-D638-41C7-B184-E350E6288B0B,J06.9,"Acute upper respiratory infection, unspecified",-
F89365A5-FEF0-4934-BD39-6C0FE15FB6B6,N94.9,Unspecified condition associated with female genital organs and menstrual cycle,-
0D335A20-54ED-4FED-9E2D-A390EA2D8A43,J45,Asthma,Asthma
27B0DCE5-913F-49D4-B1A1-A60A073AE2EE,J06.9,"Acute upper respiratory infection, unspecified",-
19DED67E-B139-4BD6-BFDB-8C1244748016,G43,Migraine,Migraine
2ACE8EFD-FC43-4BE3-ADED-4DC24300F444,Z10,Routine general health check-up of defined subpopulation,-
858A0A1A-78B7-4D7C-84B0-ADBCCCE80B5B,R21,Rash and other nonspecific skin eruption,-
858A0A1A-78B7-4D7C-84B0-ADBCCCE80B5B,B35.4,Tinea corporis,-
BC5AA104-AF02-4D43-951A-E59A0AF10D08,Z71.2,Person consulting for explanation of investigation findings,-
53ED700C-5F14-40FE-8E8E-67C7E64F92C6,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
372FA4AA-6235-4987-A7A9-D30D13B5B40B,A09.9,Gastroenteritis and colitis of unspecified origin,-
978F6BD8-3224-40A8-96C2-51433733ADFF,M62.6,Muscle strain,-
655578F3-4BF9-4CB8-9CA5-C74D13DA290F,R21,Rash and other nonspecific skin eruption,-
655578F3-4BF9-4CB8-9CA5-C74D13DA290F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FB265090-2AD6-4A1C-ADF8-5A6071E2277A,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
A2FFC4C1-FDEA-4117-9A4A-FD6C3E9A322E,A09.9,Gastroenteritis and colitis of unspecified origin,-
031A429B-A924-412E-8BF2-F273F0226D17,A09.9,Gastroenteritis and colitis of unspecified origin,-
ED90E776-7B8C-421D-B221-B57BA4525B3D,K30,Functional dyspepsia,-
46310017-2E8B-4444-BFEB-2B51BE49E4D1,R51,Headache,-
CD83839F-1867-49B5-B171-6B5965E901A8,A09.9,Gastroenteritis and colitis of unspecified origin,-
E2722009-6B11-4DCF-8BC0-1F48B28DDB2F,G44,Other headache syndromes,-
6D230DDC-7F94-43DC-8016-65F6F7815EFD,R50.9,"Fever, unspecified",-
6D230DDC-7F94-43DC-8016-65F6F7815EFD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
95815492-D334-4FCD-A085-C12A8E8A4284,A09.9,Gastroenteritis and colitis of unspecified origin,-
C9B41AA7-E42D-4218-A2EF-38C2AA243CCB,A09.9,Gastroenteritis and colitis of unspecified origin,-
6A5913FC-5C90-4C6C-AD90-41091322A3BD,G44.2,Tension-type headache,-
241CDB78-B0FA-476B-B14A-6030FEAE7301,N94.6,"Dysmenorrhoea, unspecified",-
3487530D-18BA-4B20-AACD-60EDBC3C2EF7,Y42.4,Oral contraceptives,-
3C512070-126A-445F-BEB0-915845E97E12,T88.1,"Other complications following immunization, not elsewhere classified",-
FBB561B1-9B2A-47D0-B623-AA8CC3D95120,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
214AC08E-C2D1-4B84-85F6-4AFBC13494E5,A09.9,Gastroenteritis and colitis of unspecified origin,-
26637AB3-BD16-4C61-BC64-F11DAAE46B8F,K13,Other diseases of lip and oral mucosa,-
26637AB3-BD16-4C61-BC64-F11DAAE46B8F,T88.1,"Other complications following immunization, not elsewhere classified",-
C47CB041-6A16-4E61-8CB1-C57FF1F0BBEF,R50.9,"Fever, unspecified",-
C47CB041-6A16-4E61-8CB1-C57FF1F0BBEF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5ECE80EE-EDBE-4C98-BBA8-FAC8070F12E1,L30.9,"Dermatitis, unspecified",-
38B7B02A-8485-444B-8612-8F78D0DB9942,J01.9,"Acute sinusitis, unspecified",-
515A3F6B-C138-42E0-8A1B-D88DC7AE349E,E03.9,"Hypothyroidism, unspecified",Thyroid
86632C3C-8C6C-4B8A-9A0C-9BD52753AA5F,M79.1,Myalgia,-
F3B823D9-1E52-4383-B165-357E8346E040,R42,Dizziness and giddiness,-
4E524253-878F-4D5B-8B70-82B2CE2965F3,H81.1,Benign paroxysmal vertigo,-
4E524253-878F-4D5B-8B70-82B2CE2965F3,H00,Hordeolum and chalazion,-
9028F8A9-2F93-4D0D-A2E1-E6E0E2135ADE,N94.6,"Dysmenorrhoea, unspecified",-
F5CD7F19-36AF-4BEC-B73E-47C082F204AB,R51,Headache,-
F5CD7F19-36AF-4BEC-B73E-47C082F204AB,A09.9,Gastroenteritis and colitis of unspecified origin,-
ED7ADC3D-933C-4181-99D9-4FE4D97BADCD,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
593A28EA-66E3-4E2C-AF8A-E51ED7F7284B,Z71.2,Person consulting for explanation of investigation findings,-
D6118537-ECF1-4FB1-B802-467D9F7EECA0,Y42.4,Oral contraceptives,-
AC99521D-FF50-4298-91F7-8F16D7041F96,R10.4,Other and unspecified abdominal pain,-
AC99521D-FF50-4298-91F7-8F16D7041F96,M54.5,Low back pain,-
404200F2-995D-4550-918F-B5169C6A8BAE,A09.9,Gastroenteritis and colitis of unspecified origin,-
F840200A-3E1F-45E8-8132-736AB2D23646,M25.5,Pain in joint,-
E4595DE9-BD88-484A-9F6D-FA498713215A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
453BE3A6-B057-4567-BB00-F062E1D9C23D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EF7E4AE4-75DB-493F-A5B1-1919E6ABDDD5,J06.9,"Acute upper respiratory infection, unspecified",-
2648FF03-544E-4F64-BFAD-475191AEFFA1,M76.6,Achilles tendinitis,-
0100C681-E499-4047-8F90-7D9867D7DABC,J06,Acute upper respiratory infections of multiple and unspecified sites,-
C94700F1-1259-45BE-A4EF-AA41706858C0,R51,Headache,-
226CF5E6-C196-4E1B-81AC-2588E9250073,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
3FE36692-D87B-4B1A-B5FB-39DB83FDF941,Z71.2,Person consulting for explanation of investigation findings,-
622A072E-B658-4204-AEBC-D2CE64E9DF39,B35.6,Tinea inguinalis [Tinea cruris],-
160A28EA-56E5-4911-95FD-C9FCB759BD3B,Z71.2,Person consulting for explanation of investigation findings,-
06304CD9-D4F7-4CAC-A65E-9633EBC6DCC1,M25.5,Pain in joint,-
D3669D1E-9E72-4254-B896-0B14F9D186A2,M25.5,Pain in joint,-
FB18DFF4-2955-4ED9-80AB-E6343971B671,R50.9,"Fever, unspecified",-
FB18DFF4-2955-4ED9-80AB-E6343971B671,A09.9,Gastroenteritis and colitis of unspecified origin,-
FF53F7F5-675A-4DE9-89F0-F82B87A5977C,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
8E08D95E-CB59-43DE-822A-279B619F2223,K30,Functional dyspepsia,-
2DF85091-D17B-4B86-BF66-8F737ED9DEC7,J06.9,"Acute upper respiratory infection, unspecified",-
72C8CA3A-FF8A-4618-8216-3C6E75A806C6,R21,Rash and other nonspecific skin eruption,-
72C8CA3A-FF8A-4618-8216-3C6E75A806C6,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
09175856-8B28-46E9-BC32-1F2989D76AB6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3A7485BC-E21A-4775-970C-58CE2109AD75,A09.9,Gastroenteritis and colitis of unspecified origin,-
1DCA732C-42EA-4557-BFDA-B61574D5DE90,T88.1,"Other complications following immunization, not elsewhere classified",-
79617A6D-2A0A-4927-9C56-0F9ED10DC52F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
912009DA-7CAE-405B-866C-561F598CE9A2,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
96D4501B-73AA-4587-A5A0-CEFBB9DAB8DB,R51,Headache,-
912009DA-7CAE-405B-866C-561F598CE9A2,R51,Headache,-
57164B4A-6871-479A-85E2-A7BED21B42B3,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
23C34BF5-E11F-4C16-90DD-E7A58BE0D22E,A09.9,Gastroenteritis and colitis of unspecified origin,-
276617BA-0BE5-4A19-B3BC-DCE9DF11518E,G44.2,Tension-type headache,-
BBBED7B1-F54C-40FF-AD78-8189DB083216,R42,Dizziness and giddiness,-
66872BA1-6B3B-40C0-9E20-E960E661EEC8,T88.1,"Other complications following immunization, not elsewhere classified",-
6EC045BE-3DFC-440A-9191-7749D1365BE4,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
0C1E6584-381D-4C5E-9907-6066B6D307B7,R51,Headache,-
1515FFAE-CE83-4221-AC58-5BA739B2AB68,J06.9,"Acute upper respiratory infection, unspecified",-
2F33E568-544F-4FF0-B100-A19F759AC11D,M62.6,Muscle strain,-
2F33E568-544F-4FF0-B100-A19F759AC11D,M25.5,Pain in joint,-
0F0CDD9A-704B-4385-B6CA-0ADE99EE352F,S33.5,Sprain and strain of lumbar spine,-
0F0CDD9A-704B-4385-B6CA-0ADE99EE352F,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
D04F3A02-8237-48F3-9773-70156B30FEB3,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
41196251-D001-42A9-9536-D2896913ABE1,N39.0,"Urinary tract infection, site not specified",-
3C0E20C8-9550-42B0-8E68-FAD26D22C5BF,R51,Headache,-
3C0E20C8-9550-42B0-8E68-FAD26D22C5BF,F43.0,Acute stress reaction,-
E968D58D-375E-4DB9-A27A-F9F8CF34B600,A09.9,Gastroenteritis and colitis of unspecified origin,-
4A248C33-4CEA-4D59-9594-03AC25F5EEF6,A09.9,Gastroenteritis and colitis of unspecified origin,-
4A248C33-4CEA-4D59-9594-03AC25F5EEF6,R21,Rash and other nonspecific skin eruption,-
24A24CB7-FD40-40E1-89A0-EBB535489B80,L03.0,Cellulitis of finger and toe,-
BE93356A-0BB2-43F1-AC8D-382721C95AA2,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
A5DC5DC7-D8F7-4FF0-BC14-5F8527BE9FBC,A09.9,Gastroenteritis and colitis of unspecified origin,-
C47110F4-A66F-43AE-A1AA-6C64C0AB2B9D,Z02,Examination and encounter for administrative purposes,-
5C4EDA7C-5CF7-4E5B-B6FE-F721D07AB580,K29.7,"Gastritis, unspecified",-
B0A83210-0772-43BE-AE6F-1BB3D7F544CC,A09.9,Gastroenteritis and colitis of unspecified origin,-
7F1282E4-BEED-4C0A-9397-56B62BFA410A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D82789EF-F2C9-4BCF-9475-822FE2099093,J06.9,"Acute upper respiratory infection, unspecified",-
5D4DAED6-B1AE-40C0-AB0E-C53757AA7562,J06.9,"Acute upper respiratory infection, unspecified",-
38374ECC-43A2-46F0-87F5-A3D413B1F96F,A09.9,Gastroenteritis and colitis of unspecified origin,-
601DD2D3-A50B-4895-BE20-68A8011A24C8,R21,Rash and other nonspecific skin eruption,-
B445E6CB-8148-4097-80B6-AEF1DD1F3A6E,A09.9,Gastroenteritis and colitis of unspecified origin,-
6C9873D4-C160-43DC-B8C1-A212C720FCC4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4BCEB52F-C3F9-4763-B2CF-998F0FF50B7F,H57,Other disorders of eye and adnexa,-
7A2BBFC4-78AF-4024-9B3C-C483D3F817D8,A09.9,Gastroenteritis and colitis of unspecified origin,-
30B034FB-8308-4351-A400-6019EDD1966B,J06.9,"Acute upper respiratory infection, unspecified",-
E2D29C0A-CE9B-4866-B779-3CDFED5165F4,N94.6,"Dysmenorrhoea, unspecified",-
96AF67D5-8BAB-4E5F-BD98-69E1E75498E1,J06.9,"Acute upper respiratory infection, unspecified",-
C2330B8D-7860-40C4-9EB9-1E67970D6FC8,A09.9,Gastroenteritis and colitis of unspecified origin,-
859A4F74-AFF6-49DA-BFEC-03B163ABE1D6,T88.1,"Other complications following immunization, not elsewhere classified",-
EC6DB261-E02B-44A9-A979-52DAE6B86A5E,A09.9,Gastroenteritis and colitis of unspecified origin,-
CEF31121-A0A0-4FDC-ACFB-70CFD7DB5424,R50.9,"Fever, unspecified",-
33EA65AD-2B20-41ED-97BA-81CE786D45AE,R51,Headache,-
4B24F490-BD14-44AA-A27D-E10D34B81002,R51,Headache,-
4B24F490-BD14-44AA-A27D-E10D34B81002,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
55DC64A5-847E-438F-8AC3-AA1CA8AB4970,G43,Migraine,Migraine
19017016-2E8E-465B-B05C-D633108F8FC4,S93.4,Sprain and strain of ankle,-
AE63C618-D602-49D4-B7F2-B3E969BC3327,R51,Headache,-
18DAFBA4-A51C-4F66-9FF5-EFD2DBB4758F,T88.1,"Other complications following immunization, not elsewhere classified",-
EB989A3F-898A-4FAD-AEF4-E5F871E6E97D,A09.9,Gastroenteritis and colitis of unspecified origin,-
6EB846E8-12CC-48D4-BA40-38761D27F48F,A09.9,Gastroenteritis and colitis of unspecified origin,-
67E4D7BB-1399-4420-B381-AA8EDA3DA588,U07.1,"COVID-19, virus identified",-
5169AC63-092B-45CE-81E1-9A65A2D4A548,M79,"Other soft tissue disorders, not elsewhere classified",-
45B857C1-4CCA-44D1-9640-97C2EE1F3139,Z71.2,Person consulting for explanation of investigation findings,-
DC05B20D-B8CC-4FD9-BE34-E3F072ED2230,H81.1,Benign paroxysmal vertigo,-
B1D409F4-E251-4681-BB58-08CC4D4CBB1B,R21,Rash and other nonspecific skin eruption,-
B1D409F4-E251-4681-BB58-08CC4D4CBB1B,L03,Cellulitis,-
3B0D760E-CF13-4299-9F5A-67A061A47494,T78.4,"Allergy, unspecified",-
3B0D760E-CF13-4299-9F5A-67A061A47494,T88.1,"Other complications following immunization, not elsewhere classified",-
F3BFC4B3-E187-4DF1-AA9C-95622EFA2646,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B247495F-CE89-4EEA-AE57-4345E37E4AF5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1A936835-22D8-4753-95A6-DFF03D1BD78C,Z02.9,"Examination for administrative purposes, unspecified",-
080A1A72-F901-452C-B09D-A54C61B44C82,L60.8,Other nail disorders,-
2CC12022-9F76-49ED-AD51-5F0D2F248280,A09.9,Gastroenteritis and colitis of unspecified origin,-
F4123439-3D02-4230-A7E7-729D6A84C9D6,B30,Viral conjunctivitis,-
F4123439-3D02-4230-A7E7-729D6A84C9D6,H57,Other disorders of eye and adnexa,-
A72874ED-6F17-46E8-AF9E-8448CED82021,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
6BF559CC-9771-471D-8D1C-D23BCA1D25B7,G44,Other headache syndromes,-
4BEF54FB-6F24-4B1D-9C74-8A1D5A3AFF63,J06.9,"Acute upper respiratory infection, unspecified",-
E3799760-10D7-4012-8969-BA0CC26F8024,I10,Essential (primary) hypertension,Hypertension
FDE442E3-DD22-4991-AA4C-A11B7FA760E4,A09.9,Gastroenteritis and colitis of unspecified origin,-
6538568C-F211-43F3-8901-2614E4D75AA7,N94.6,"Dysmenorrhoea, unspecified",-
BA3E5BC1-CF71-42B9-878A-2FC301BAD879,R51,Headache,-
EAE29179-4B14-4372-A0BC-324CC38D6D03,T88.1,"Other complications following immunization, not elsewhere classified",-
5D496213-1163-4BB4-97D5-42E0BA98DBE9,A09.9,Gastroenteritis and colitis of unspecified origin,-
0ADDA39A-49F1-4ABE-B472-8D36E2361E88,H10.9,"Conjunctivitis, unspecified",-
6C324B98-3FA3-489D-9574-8F6FA689EE66,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CE03DA60-767C-4680-8864-B75B74AC7757,T88.1,"Other complications following immunization, not elsewhere classified",-
2D7A0827-825E-40C8-8043-0C3CC4CA3BD3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9BBEA65F-554D-4244-804C-34674BF9518E,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
C190EF55-40BE-4CF6-8309-5D94A153913C,R51,Headache,-
6773AD65-F54E-4902-9B7D-94DC0E5F5FA2,R42,Dizziness and giddiness,-
884150FF-1903-4AD6-91D8-FFD7EA835B87,M10,Gout,Gout
9840BF14-C731-4CD1-A624-44BFD06AF130,M10,Gout,Gout
03E48375-4CB7-4094-A15D-CB7F3A419C08,B35.6,Tinea inguinalis [Tinea cruris],-
03E48375-4CB7-4094-A15D-CB7F3A419C08,R21,Rash and other nonspecific skin eruption,-
24E31C20-975E-4309-9C63-EE11F98597E7,M06,Other rheumatoid arthritis,-
B5FEAA23-E9A8-43E8-8F3C-25F896CD7026,A09.9,Gastroenteritis and colitis of unspecified origin,-
51CEE04F-5265-4374-A2E6-C440C9F63573,N94.6,"Dysmenorrhoea, unspecified",-
78E37F90-0E85-4932-AA77-949FB2FA3A8C,L20,Atopic dermatitis,Atopic dermatitis
1FE08E4F-A20D-41C1-9AF8-346C9AF84E45,T13.1,"Open wound of lower limb, level unspecified",-
E0D7B228-9FBB-4B2D-9234-C978321F7673,Z71.2,Person consulting for explanation of investigation findings,-
6B8137CB-8F54-4985-9FA7-1FE2CBB82EFD,E03.9,"Hypothyroidism, unspecified",Thyroid
3D5FDC0E-A4D8-4025-BE51-25A65D96542A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
580DABC1-E26B-4651-ADD6-2545FFFA2B7F,H00,Hordeolum and chalazion,-
F729DCF5-9542-4F12-A712-B5A296256F67,U07.1,"COVID-19, virus identified",-
970440C5-75F5-4391-A1E6-434FAE8A84D7,H01.0,Blepharitis,-
9CE11AF2-A507-4B98-A121-D412C3681B80,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BB557C0F-AE2E-4B57-AD47-FB298AC16F50,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
FD892ADB-E152-47F1-8E10-3E77CA56F71F,H81.1,Benign paroxysmal vertigo,-
DC306AE6-B399-4286-87F2-5B3ABCDC17AA,S13.4,Sprain and strain of cervical spine,-
DADCBAE9-7EAD-4F41-876B-EA1E465DDA39,R07.4,"Chest pain, unspecified",-
BE001A37-A33E-4043-83F1-5AE4CA76EE14,H57.9,"Disorder of eye and adnexa, unspecified",-
B2CAB3C0-51D7-4A36-9E94-A5D1FBA6E80D,R42,Dizziness and giddiness,-
B2CAB3C0-51D7-4A36-9E94-A5D1FBA6E80D,K29.7,"Gastritis, unspecified",-
09B05E2D-7944-497D-B93A-67C2400EA91F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8DF1CB74-1A11-4CE6-88FE-81E29BC1DE80,K29.7,"Gastritis, unspecified",-
977A2BA6-DAEC-4244-9AF4-D543B21AA59D,S13.4,Sprain and strain of cervical spine,-
977A2BA6-DAEC-4244-9AF4-D543B21AA59D,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
483F974A-1088-40D9-8725-178594A369DB,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
1C131DD2-E36D-4C02-8A78-FD8DD3123A0D,T88.1,"Other complications following immunization, not elsewhere classified",-
D1D40F53-DC68-4EDA-A690-1D289352A4B2,R51,Headache,-
D1D40F53-DC68-4EDA-A690-1D289352A4B2,A09.9,Gastroenteritis and colitis of unspecified origin,-
1198BFF0-44A8-4019-A977-01B2BA071283,I10,Essential (primary) hypertension,Hypertension
08DF78A6-5CD9-4D0C-9158-C45266D0365A,I10,Essential (primary) hypertension,Hypertension
86933880-B266-42A7-8D17-B1E28E0254CF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DBE68E0C-33ED-4A19-8FFD-46266B1318AB,A09.9,Gastroenteritis and colitis of unspecified origin,-
B1E8C3C8-F810-41A8-BAE1-388732706064,L02.9,"Cutaneous abscess, furuncle and carbuncle, unspecified",-
42C476EA-03F3-4200-92E2-1A9758DADF37,K29.7,"Gastritis, unspecified",-
936FBBD1-D721-4B2B-9C5E-378F8569B623,R51,Headache,-
95B03005-1636-4FEC-B1B7-F64A754B47AA,A09.9,Gastroenteritis and colitis of unspecified origin,-
436C2496-1F06-44A1-91C4-F044D7939772,H57.9,"Disorder of eye and adnexa, unspecified",-
479A4A1F-0276-4970-9CBD-4941A6125E89,J06.9,"Acute upper respiratory infection, unspecified",-
10F824BE-5316-4D8A-8BA0-9B969FFCFBFB,T88.1,"Other complications following immunization, not elsewhere classified",-
EC138A62-E467-40FB-9ABC-3C79BF4FEFB2,T88.1,"Other complications following immunization, not elsewhere classified",-
3A577F6B-20C2-40F7-9C13-429E7E3416F5,K29.6,Other gastritis,-
10F824BE-5316-4D8A-8BA0-9B969FFCFBFB,R42,Dizziness and giddiness,-
247811F9-B867-47D0-B7E1-33B8DF06EA9B,Z71.2,Person consulting for explanation of investigation findings,-
9D2EE1DF-70CA-4499-9848-C5D6E813AA6C,A09.9,Gastroenteritis and colitis of unspecified origin,-
BDCB5AFA-CEE0-48FA-937F-F6DD80BF7403,M79.1,Myalgia,-
45AEDBB9-71A2-4217-AA8A-D4FA3109474F,H57,Other disorders of eye and adnexa,-
77A96E0D-A0F3-477C-B326-860C7F372533,M79.1,Myalgia,-
F08F853B-D70A-4D6D-8E56-7C3EEDC6AD2F,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
B462B387-DE8F-483D-800F-7CCD7EE41A5B,J06.9,"Acute upper respiratory infection, unspecified",-
86B2FF1B-C1BD-42E0-A14B-910C31A89674,M79.1,Myalgia,-
FDAD616E-0ACD-4E84-A0ED-F690422E9018,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
CC725B96-463B-4BA9-A194-8EC860276424,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CC725B96-463B-4BA9-A194-8EC860276424,R50.9,"Fever, unspecified",-
E52D5F03-3786-4E69-9FE8-F65725126788,R51,Headache,-
5F91FBCF-71FA-470A-9944-54D3A7E8D989,R51,Headache,-
E808A539-739F-449F-BD50-E66A7E515133,M10,Gout,Gout
F4F22908-4AB8-4350-A720-CA44E124AF42,T88.1,"Other complications following immunization, not elsewhere classified",-
249F684C-4BA8-46C8-8503-93C59B86C5E1,J06,Acute upper respiratory infections of multiple and unspecified sites,-
94399412-A505-422C-AC22-850FE5E3AEC4,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F2295115-3CF4-4A3D-9FB7-483D37D78471,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
F2295115-3CF4-4A3D-9FB7-483D37D78471,H02.9,"Disorder of eyelid, unspecified",-
E7017D84-160A-44FB-BA24-24BB9FE1EF79,Z76.0,Issue of repeat prescription,-
E7017D84-160A-44FB-BA24-24BB9FE1EF79,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
BAA12D6A-0BD1-400E-AAED-95DC1478F7C2,T88.1,"Other complications following immunization, not elsewhere classified",-
04A1212E-9FF9-4976-92C2-8BE44AF3B413,Y42.4,Oral contraceptives,-
AACFDA0B-6522-45BE-B57C-AAA192273E1B,M54.5,Low back pain,-
7E8CB35D-45D7-4C7F-8860-FB41FA976EDE,K30,Functional dyspepsia,-
DA2E4BF1-E3BE-4281-8B3A-E30942858CEB,M54.5,Low back pain,-
54203AAD-A952-46AF-8FD4-325CAC2284AC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1848D6A9-9DAA-4CFB-BFB9-380E9B5CEF4F,N39.0,"Urinary tract infection, site not specified",-
A36C74FB-44FA-40C7-87BF-7BBD84657CE3,N39.0,"Urinary tract infection, site not specified",-
0A1F3F4E-0272-4000-B725-23AB058A063E,J06.9,"Acute upper respiratory infection, unspecified",-
4E935134-AF53-4289-A973-4682F876AB25,H57,Other disorders of eye and adnexa,-
4E935134-AF53-4289-A973-4682F876AB25,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
47FB85EC-97A7-4D5F-8181-9ABCDEA9C3BF,Z71.2,Person consulting for explanation of investigation findings,-
47FB85EC-97A7-4D5F-8181-9ABCDEA9C3BF,I10,Essential (primary) hypertension,Hypertension
47FB85EC-97A7-4D5F-8181-9ABCDEA9C3BF,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
D93FB5EF-5741-4A4D-963B-04AB78CA329C,G44.2,Tension-type headache,-
D93FB5EF-5741-4A4D-963B-04AB78CA329C,H57.9,"Disorder of eye and adnexa, unspecified",-
A9704FD2-DE37-4139-955D-5381691E5207,O91.2,Nonpurulent mastitis associated with childbirth,-
8E858016-AE8C-415A-8107-B796BDD69DA8,J06.9,"Acute upper respiratory infection, unspecified",-
83008BF4-22F7-428F-8B1E-539FAA30B32D,I10,Essential (primary) hypertension,Hypertension
A3B01483-086E-4B88-90DA-CD73A9C0DB3F,A09.9,Gastroenteritis and colitis of unspecified origin,-
B06758B6-F4F6-4D1A-960C-6E683CE3970D,G44.2,Tension-type headache,-
58645C89-7326-49D7-A51A-09BDCF0B94B3,N94.6,"Dysmenorrhoea, unspecified",-
F64BFB76-499F-4FA4-89BC-8D2DBD46D853,T88.1,"Other complications following immunization, not elsewhere classified",-
95A625C3-8E9E-4F19-BDF7-18B15527B8B6,L50,Urticaria,-
7D3D1701-8C9E-4E09-88CC-A81415374F16,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E59B9FA2-F828-4C76-879C-D2CAEF003C8E,R50.9,"Fever, unspecified",-
E59B9FA2-F828-4C76-879C-D2CAEF003C8E,R51,Headache,-
A948CA15-AEB0-40CE-B0CB-90EF663CEC3B,A09.9,Gastroenteritis and colitis of unspecified origin,-
2EE5C866-AD5E-445B-91CE-1CFE21998C8B,J06.9,"Acute upper respiratory infection, unspecified",-
4C9C8F9D-C342-48BE-AD8B-691089305300,J06.9,"Acute upper respiratory infection, unspecified",-
4FF62487-9D65-49BE-9149-0EA6CD3D662E,O92,Other disorders of breast and lactation associated with childbirth,-
4FF62487-9D65-49BE-9149-0EA6CD3D662E,M54.5,Low back pain,-
29DAD311-6B88-4705-85FD-14E32C1DCBE7,R21,Rash and other nonspecific skin eruption,-
F65E5D18-A5E8-46A9-94F3-C9A0002D575B,G44.2,Tension-type headache,-
F65E5D18-A5E8-46A9-94F3-C9A0002D575B,M62.6,Muscle strain,-
CAF15D4E-1F70-49CF-A989-FDAC9FFCB6A2,L70,Acne,-
8E3C2F1B-E761-4993-A765-7CB1AD4C8A4F,K59.1,Functional diarrhoea,-
2C734AF6-32CF-4E43-B24A-1BE91EB8A9C8,M54.5,Low back pain,-
4D3E5794-1FEE-48F0-87A9-5C8ACF9370D3,R51,Headache,-
04300B6C-620D-4894-B8D9-9623852FD035,A09.9,Gastroenteritis and colitis of unspecified origin,-
29F07C6C-CFC7-4FB0-BEDD-B8DA52DA0EC6,T88.1,"Other complications following immunization, not elsewhere classified",-
734FD526-8C4E-4614-B21A-73EE51FED1F6,J06.9,"Acute upper respiratory infection, unspecified",-
79485488-26E1-427C-8461-70D768BE09F7,J06.9,"Acute upper respiratory infection, unspecified",-
75159523-02EB-4C1E-A099-DD375A8C8917,H57,Other disorders of eye and adnexa,-
85DA629C-BB18-4CFE-9799-62FFE5A52328,R51,Headache,-
85DA629C-BB18-4CFE-9799-62FFE5A52328,R42,Dizziness and giddiness,-
8E61CDB4-E42B-498C-BD11-13CA92062191,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
689E3AB8-B381-4A9D-A60A-2868389A5B94,A09.9,Gastroenteritis and colitis of unspecified origin,-
C50B4AB9-7497-4495-B090-EF26926E7687,R11,Nausea and vomiting,-
F15AA9C8-F02A-45EA-A54C-A55DC913ABED,Z71.2,Person consulting for explanation of investigation findings,-
A4E6C372-AC87-4E96-A879-0E159C082D25,T88.1,"Other complications following immunization, not elsewhere classified",-
F82CFFDA-A65A-4DEC-9CA5-BBE5D3CB7C66,H57,Other disorders of eye and adnexa,-
F82CFFDA-A65A-4DEC-9CA5-BBE5D3CB7C66,L50.9,"Urticaria, unspecified",-
F82CFFDA-A65A-4DEC-9CA5-BBE5D3CB7C66,L30.9,"Dermatitis, unspecified",-
543C65AD-8D36-459B-866B-39D3C2FD776F,A09.9,Gastroenteritis and colitis of unspecified origin,-
8043A2BC-0169-4036-8322-9009DC25D29F,R21,Rash and other nonspecific skin eruption,-
3CA0D796-35D1-4E78-8EB3-999F13532E7D,R51,Headache,-
24F0FAE2-3F71-4DD0-9271-122F98A00A4B,J06,Acute upper respiratory infections of multiple and unspecified sites,-
DB56F17E-8D78-4FDA-86AC-7F0846265BF6,T88.1,"Other complications following immunization, not elsewhere classified",-
C54409A2-9123-4443-8BEA-08EBD334DA0D,E11.9,Type 2 diabetes mellitus without complications,Diabetes
C54409A2-9123-4443-8BEA-08EBD334DA0D,I25.9,"Chronic ischaemic heart disease, unspecified",-
C54409A2-9123-4443-8BEA-08EBD334DA0D,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
378E8F15-43B2-48B7-B018-124354C07FE8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C0D8B699-739C-4BE0-8B88-7C29B07641B3,L50.9,"Urticaria, unspecified",-
C0D8B699-739C-4BE0-8B88-7C29B07641B3,H02.9,"Disorder of eyelid, unspecified",-
775D9300-6CCE-4374-8CCB-6A7C420EF9E3,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
FF0A99DE-D3A4-4351-89C6-B2882AE4DC3C,J06.9,"Acute upper respiratory infection, unspecified",-
EA7426BE-323E-4AE2-BC10-7A42426260AD,L50.9,"Urticaria, unspecified",-
9C8FA9EF-7746-40E6-A983-904D133F2031,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E60481A8-ADD2-4E46-B2FE-49EE753B1640,Z71.2,Person consulting for explanation of investigation findings,-
FBAD5D8E-5A37-4F81-A2A0-E184F19105A4,N94.6,"Dysmenorrhoea, unspecified",-
5D2F782B-7790-4BE0-AE87-5D2DA9B3C78A,R51,Headache,-
5D2F782B-7790-4BE0-AE87-5D2DA9B3C78A,N94.6,"Dysmenorrhoea, unspecified",-
93BF01E9-1163-45B7-BD73-86A0AFB9C505,U07.1,"COVID-19, virus identified",-
9FE09D0E-4E80-442A-B0A0-DF1C582F465C,B35.3,Tinea pedis,-
4E60DCB2-AD0C-4420-BBEE-63CC59579DC1,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
5233553D-C299-43F0-8561-6E6F9954B91E,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
39008852-66C0-4958-B6FB-AB086A786CAE,N64,Other disorders of breast,-
06E45AE0-DA88-4F61-86C0-520B8AD1ACAC,N39.0,"Urinary tract infection, site not specified",-
2C0AD65E-221E-4CD0-986C-36057774C65E,A09.9,Gastroenteritis and colitis of unspecified origin,-
DD257740-D98E-4481-8D48-9E5BE85E0339,U08,Personal history of COVID-19,-
467A812E-70A3-430D-B821-1A02BEC0C0AB,R21,Rash and other nonspecific skin eruption,-
4EDD9570-F497-4BDB-B368-F053015527AC,H04,Disorders of lacrimal system,-
4EDD9570-F497-4BDB-B368-F053015527AC,M79.1,Myalgia,-
970BFDA4-36DC-4DA2-88CF-0FA01F022B9D,K29.7,"Gastritis, unspecified",-
A4149DCF-E178-4B69-9069-7A8CCED830FC,J06.9,"Acute upper respiratory infection, unspecified",-
36030443-51AE-41E2-BB93-9A07B11A74C5,Z71.2,Person consulting for explanation of investigation findings,-
00580318-8A68-4D52-BB59-194FC566F3E1,S60.9,"Superficial injury of wrist and hand, unspecified",-
FBFABEFF-D782-492D-9559-48C9AAD9D057,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
4EB78620-40A4-4772-9EFE-A4E5343F25CE,Z02.9,"Examination for administrative purposes, unspecified",-
299ABFB7-C554-4B5B-A7D6-49A553B9E4DC,T88.1,"Other complications following immunization, not elsewhere classified",-
22E6620F-1BA8-46B3-8D67-3F0EA76635F5,A09.9,Gastroenteritis and colitis of unspecified origin,-
48D94DA1-1405-42DE-8DC7-820092E78D5B,A09.9,Gastroenteritis and colitis of unspecified origin,-
991904E9-2D73-4A4F-8E04-4009E784B4F9,J06,Acute upper respiratory infections of multiple and unspecified sites,-
C9523499-0C61-4B01-BE73-897E1694E55D,M54.5,Low back pain,-
EC0D5205-710E-44D4-8668-1A24F0D1B9B7,M54.5,Low back pain,-
467A65EF-0957-44CC-9D5A-A8EF03859884,J06,Acute upper respiratory infections of multiple and unspecified sites,-
08DF78A6-5CD9-4D0C-9158-C45266D0365A,M54.5,Low back pain,-
430E7AD2-043A-4C22-A652-05EB805F2BCF,E61.1,Iron deficiency,-
430E7AD2-043A-4C22-A652-05EB805F2BCF,R42,Dizziness and giddiness,-
02CD023C-EF57-4252-AD8B-71146450D957,J06.9,"Acute upper respiratory infection, unspecified",-
EA8E2825-5254-41C8-A81F-9C99253BE550,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7B8B90FD-1C16-4DC6-B5F3-317B9E97831F,T88.1,"Other complications following immunization, not elsewhere classified",-
0541782A-F708-4C8F-8A3E-26E77006301E,B37.3,Candidiasis of vulva and vagina,-
66CFC538-89CB-4539-8654-2D54C16D2560,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
66CFC538-89CB-4539-8654-2D54C16D2560,M79.1,Myalgia,-
7C4B8943-F627-4BE1-8805-EB1B11F18A99,A09.9,Gastroenteritis and colitis of unspecified origin,-
73F3EFED-A785-4FD8-9C6B-AAB985AE25EA,K29.7,"Gastritis, unspecified",-
DBD166F7-036B-4CBE-BFE6-C50BFAC1C123,M10,Gout,Gout
0422B6FA-2EB3-435C-B7BC-CFF2BAF2A324,M54.5,Low back pain,-
6A052646-CC65-45D5-ACD1-1DDC1AF19B66,R21,Rash and other nonspecific skin eruption,-
BDA6831A-28B8-4118-A86E-13181F4DE448,L30.1,Dyshidrosis [pompholyx],-
BDA6831A-28B8-4118-A86E-13181F4DE448,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FFB88A14-0459-46DE-BFFA-6CE082F0AEB7,K30,Functional dyspepsia,-
FFB88A14-0459-46DE-BFFA-6CE082F0AEB7,R51,Headache,-
939FCE5C-407A-40C0-841C-95B9027186B7,M54.5,Low back pain,-
03302B5A-EF7C-4FAC-9891-32BFAC713C29,T88.1,"Other complications following immunization, not elsewhere classified",-
CE75262C-AF0E-4828-9EEB-70F7699341A7,K64,Haemorrhoids and perianal venous thrombosis,-
C5D9027C-CFD8-4F89-BADB-E1FAB1A00C85,B35.6,Tinea inguinalis [Tinea cruris],-
C5D9027C-CFD8-4F89-BADB-E1FAB1A00C85,B35.3,Tinea pedis,-
5F252BA7-6E19-40C9-9531-C226E765A865,R09.3,Abnormal sputum,-
5F252BA7-6E19-40C9-9531-C226E765A865,M62.6,Muscle strain,-
35504324-2A41-4582-962D-5DF27691F19C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7A8AA04A-E09A-4359-95CF-EC0D712FB1C9,A09.9,Gastroenteritis and colitis of unspecified origin,-
1C1AA830-0325-47BA-B9DB-8F34C05416AB,R09.3,Abnormal sputum,-
1C1AA830-0325-47BA-B9DB-8F34C05416AB,I10,Essential (primary) hypertension,Hypertension
D0EBDBF8-1241-406B-B55A-7FA5E83AEC47,M54.5,Low back pain,-
07DBAA3E-A01A-4F3D-A485-E9C741371935,A09.9,Gastroenteritis and colitis of unspecified origin,-
DAE2F063-6B74-45FE-A34B-7E40627F10A7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FD2ADDD5-C1AF-404B-845F-E5DEAC201306,A09.9,Gastroenteritis and colitis of unspecified origin,-
AAE6F9D2-FFCD-4EFA-8C76-7F05AF2D5A8F,R51,Headache,-
AAE6F9D2-FFCD-4EFA-8C76-7F05AF2D5A8F,T78.4,"Allergy, unspecified",-
2B4153E6-8B43-4379-9498-B4A9C7E6785B,R51,Headache,-
F75ECDB6-825A-4527-AB27-29A1A681BD25,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A755AF68-73DE-406D-BB96-F2360438735B,L30.9,"Dermatitis, unspecified",-
28C093A5-12B7-4989-9334-FC3073D8C2F9,T88.1,"Other complications following immunization, not elsewhere classified",-
30E77BC4-45AF-4CE9-8D8F-0E67E435777C,Z71.2,Person consulting for explanation of investigation findings,-
F1E746CF-487B-465F-9112-CE6955C9A135,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F1E746CF-487B-465F-9112-CE6955C9A135,R50.9,"Fever, unspecified",-
AAA631FC-DE00-41F8-9F62-AF119314E035,M54.5,Low back pain,-
C24EF9A4-BA7A-4C04-9D9A-2EC15C1E5218,M54.5,Low back pain,-
FF5BC155-BF1D-4B26-B959-A75AAAD698C9,K59.0,Constipation,-
B64BBE2A-9AF2-4435-B497-1421FC97A758,R21,Rash and other nonspecific skin eruption,-
B841B4B1-B67F-4F8C-ACEC-BD7653BFB3E0,R21,Rash and other nonspecific skin eruption,-
00D18651-0848-47FB-8EE8-6D6C61640F1C,A09.9,Gastroenteritis and colitis of unspecified origin,-
C182942C-7E63-4E13-9068-7D3A19512551,N94.6,"Dysmenorrhoea, unspecified",-
B9C7C696-602F-44A3-9C7A-4ACD2C593605,R51,Headache,-
07ADD840-445D-44CB-B542-06B54F9F7C6F,J06.9,"Acute upper respiratory infection, unspecified",-
12B24ED0-73CC-4368-AEBC-D0071B665056,R21,Rash and other nonspecific skin eruption,-
4AECF9CE-E002-4E9E-8FE0-A741249FC6EE,A09.9,Gastroenteritis and colitis of unspecified origin,-
0EAE67D5-7F6C-439F-B3DE-13F308B2EC8C,H57,Other disorders of eye and adnexa,-
AD794D0A-B17D-4D24-83B8-CA553A99A7AC,J06,Acute upper respiratory infections of multiple and unspecified sites,-
48CF785F-6C87-46C3-A900-F0ABFE11981C,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
19035C18-B030-40D4-8D81-DCBDB365485A,S50.0,Contusion of elbow,-
71573203-843A-49AB-B6F9-129860D566DF,A09.9,Gastroenteritis and colitis of unspecified origin,-
71573203-843A-49AB-B6F9-129860D566DF,R50.9,"Fever, unspecified",-
5DEC8AAA-A9DC-49F5-827F-D62ED31E2F80,S83.6,Sprain and strain of other and unspecified parts of knee,-
6CF1D663-D0DB-496A-A920-6D14939DA97C,Z71.2,Person consulting for explanation of investigation findings,-
8EC310A6-95F6-4C78-B96A-81845ED3FCEA,Z30.0,General counselling and advice on contraception,-
E32307EF-2573-4FE3-8B31-D795E0B15019,Z71.2,Person consulting for explanation of investigation findings,-
D186E466-D807-4FAF-A00A-F7543EF0F613,R50.9,"Fever, unspecified",-
D482829B-C80F-4D98-8993-707C080C7E07,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
5CF0139E-EF1A-4D0A-9B9E-C990CB1E7177,J06.9,"Acute upper respiratory infection, unspecified",-
B9BBB30D-2856-4A89-9D44-5DC28343BFA8,T88.1,"Other complications following immunization, not elsewhere classified",-
1808C26D-BB16-4CEC-8A5E-1FC614C411E4,L30.9,"Dermatitis, unspecified",-
73CFC2E1-4143-41F4-830F-0B0413350A78,A09.9,Gastroenteritis and colitis of unspecified origin,-
4C369975-C487-4CF3-9762-D3E288C394B5,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
4C369975-C487-4CF3-9762-D3E288C394B5,H10.1,Acute atopic conjunctivitis,-
88A34FA4-32DF-4D35-A97C-3EED77A1FBAF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
05591186-4CA6-44E1-876E-69BF7363A738,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7A428BE9-235C-44B5-8AF8-7D35278131AB,J06.9,"Acute upper respiratory infection, unspecified",-
27DD9292-57A3-4529-9D7E-B252FC3E10C7,J06.9,"Acute upper respiratory infection, unspecified",-
EC9B587D-EE5A-4C77-BB46-F9815FD3EF70,R51,Headache,-
1A44A5E1-8072-4977-8BC2-8F3B1D8BD87B,M62.6,Muscle strain,-
F4EBDEBF-EB69-4F89-B5EC-070820BE2B92,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2673B371-066F-4532-B841-43AE192633FD,T22.2,"Burn of second degree of shoulder and upper limb, except wrist and hand",-
2AE955BF-AA3F-491C-8772-F44EFED0B5ED,A09.9,Gastroenteritis and colitis of unspecified origin,-
777B2DEE-B957-491A-9BFA-39BF9C470D03,H00,Hordeolum and chalazion,-
17F9B233-7415-434E-A6BF-7188E5E56D22,A09.9,Gastroenteritis and colitis of unspecified origin,-
D2541649-8566-45D7-A441-FFAF22FFCBB7,T88.1,"Other complications following immunization, not elsewhere classified",-
D2541649-8566-45D7-A441-FFAF22FFCBB7,R51,Headache,-
B4E0DECD-7A07-4F20-9939-D3EBC33FB66E,Z02.9,"Examination for administrative purposes, unspecified",-
22E5414D-C9D6-4EE8-BF4C-EE3FA82C971E,J06.9,"Acute upper respiratory infection, unspecified",-
641BEE8B-F029-4783-B2FF-EDBA445DBCE1,M54.5,Low back pain,-
809A0D21-852B-45D2-A516-1E7DFDE64618,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E4532264-76C5-439A-BAE8-3DF3372BFB58,M79.1,Myalgia,-
B7CD825E-4F14-4B98-A637-0E5E5BB424F8,M62.6,Muscle strain,-
B6470654-6D12-46CC-95AD-B856E65C8E4A,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
FCB958DF-9A2B-4B80-9B61-D4EC38DF33A1,I10,Essential (primary) hypertension,Hypertension
FCB958DF-9A2B-4B80-9B61-D4EC38DF33A1,J45,Asthma,Asthma
09DE394D-F4A1-45FB-9849-6C2E4DAFFCAE,M77.1,Lateral epicondylitis,-
D6373F59-A24D-42EC-AAB6-30CCBE56DF2D,K12.0,Recurrent oral aphthae,-
D0D885AA-46A1-415B-9BCD-8B93877B7E68,B08.5,Enteroviral vesicular pharyngitis,-
AE1EFA08-A942-44FD-94DF-1BE59DF59617,R50.9,"Fever, unspecified",-
AE1EFA08-A942-44FD-94DF-1BE59DF59617,J06.9,"Acute upper respiratory infection, unspecified",-
AE1EFA08-A942-44FD-94DF-1BE59DF59617,R21,Rash and other nonspecific skin eruption,-
4007B708-C1A6-4541-BC3D-ED0613A04A4D,T88.1,"Other complications following immunization, not elsewhere classified",-
2A88970A-C8EA-4AB8-8233-9DC5F99CE711,A09.9,Gastroenteritis and colitis of unspecified origin,-
4D250B8A-0CBD-4A65-B18A-B6CF2A35FC34,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
631A2F05-DF88-4324-97B3-298F82072D80,J06,Acute upper respiratory infections of multiple and unspecified sites,-
4C8D696B-1BA2-49C2-8964-F11A8E97BBA1,S43.0,Dislocation of shoulder joint,-
BE47FE97-DA1E-489A-B0A8-7DBEC809CFA5,T88.1,"Other complications following immunization, not elsewhere classified",-
138A2A32-404E-4487-B3C1-E58415F4FC7A,A09.9,Gastroenteritis and colitis of unspecified origin,-
004A7D29-9142-414B-9033-4CECAF3EB053,A09.9,Gastroenteritis and colitis of unspecified origin,-
EC821697-8A1F-45AF-9A7D-73EB1F85432B,M10,Gout,Gout
128A1D31-5F85-4FEF-869B-5BFDC7695B7A,M10,Gout,Gout
E065229A-A9F1-4C46-9944-EC07E49A1100,J06.9,"Acute upper respiratory infection, unspecified",-
1714478F-D5FE-498B-AEA7-54377E1CAB11,J06.9,"Acute upper respiratory infection, unspecified",-
EFBD4E2A-C7B8-41E0-9A1C-1E502BC71A84,R52.9,"Pain, unspecified",-
D7EB309C-29AD-429B-A5A0-12AC9FDF3DE2,J06.9,"Acute upper respiratory infection, unspecified",-
3ADF1A66-D161-403C-B9E6-6DD5C5A5CA55,J06.9,"Acute upper respiratory infection, unspecified",-
DFDCAB21-E6B4-4BA8-823B-E35F44D60400,A09.9,Gastroenteritis and colitis of unspecified origin,-
7B7AC566-931F-4EC3-8234-28AA8A116A33,A09.9,Gastroenteritis and colitis of unspecified origin,-
2A6A4E86-F6A5-4540-B821-9479AD8A1D83,A09.9,Gastroenteritis and colitis of unspecified origin,-
E12A8C47-2987-476D-8E0B-CF578EB93DA0,H00,Hordeolum and chalazion,-
8CFBBB33-0E98-40EA-B0B9-3B4D8EF10FEE,J06.9,"Acute upper respiratory infection, unspecified",-
D540903E-3CE0-451D-96BD-A00707C3DDD0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9F404172-B49A-4A86-A443-4C75E1618B40,R21,Rash and other nonspecific skin eruption,-
D540903E-3CE0-451D-96BD-A00707C3DDD0,B35,Dermatophytosis,-
104777F0-DF49-407F-8040-4CE6465994B1,J06.9,"Acute upper respiratory infection, unspecified",-
CBC24763-2E64-40F6-99E5-5358ED67F386,J30.3,Other allergic rhinitis,Vasomotor and allergic rhinitis
AE227BA1-5C3F-4DC8-9FFF-9DEC30344FA8,K29.7,"Gastritis, unspecified",-
D5591176-5D57-4D0D-AC16-C559427555C3,K29.7,"Gastritis, unspecified",-
36015700-CF16-4391-973C-C659B620073C,A09.9,Gastroenteritis and colitis of unspecified origin,-
8E6217FB-E1E8-4F2D-86AE-5BD19DD43E94,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
11AFA3FC-B046-4973-81D9-2B53164E3943,R42,Dizziness and giddiness,-
6F7499B2-404A-4C90-80F5-049387B44373,A09.9,Gastroenteritis and colitis of unspecified origin,-
5165A480-BB6C-4C08-8459-BED2FF897B92,A68.9,"Relapsing fever, unspecified",-
5161E84D-4B3C-4500-8AD6-7C159CA6CD1E,N94.6,"Dysmenorrhoea, unspecified",-
FC7D3EBB-3240-4D8A-853A-D4BD57417520,J06.9,"Acute upper respiratory infection, unspecified",-
0E35A388-2316-431C-B250-223FF24EF1C0,A09.9,Gastroenteritis and colitis of unspecified origin,-
DA7840C9-2340-4AF5-90D8-4E22DC7C7C13,N39.0,"Urinary tract infection, site not specified",-
97DD93C4-4C60-441F-858E-426546B24296,H00,Hordeolum and chalazion,-
34CA8BB8-A701-4ABD-980D-58DCE56641D6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
03E24253-D475-48B0-9774-9695D38544FF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7773ADE3-C7A0-4CA3-BAD9-390C863A283F,T23.0,Burn of unspecified degree of wrist and hand,-
1D313B9B-5D1E-4C11-8BF4-CC62C29805F5,T23,Burn and corrosion of wrist and hand,-
C6824D26-3DC2-4D47-BCBA-0EF198216BBD,M54.5,Low back pain,-
9D738134-378F-4228-949E-089438CFA881,A09.9,Gastroenteritis and colitis of unspecified origin,-
5A45A1C3-0561-4451-AD5B-D0F2CD24A026,R53,Malaise and fatigue,-
F9737CC5-8F76-4F7B-ACCA-3A3C3D0B0487,L20,Atopic dermatitis,Atopic dermatitis
6A2101C2-8C98-459C-B54D-584E0B786D3C,J06,Acute upper respiratory infections of multiple and unspecified sites,-
B489ADB4-D76E-47C0-9D8E-DC329C9BA57D,A09.9,Gastroenteritis and colitis of unspecified origin,-
A4FAB9E1-D8CF-48DD-8D11-A9796A15DACE,K12.3,Oral mucositis (ulcerative),-
A4FAB9E1-D8CF-48DD-8D11-A9796A15DACE,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
EC58D4F7-454F-48C2-B545-C74D7C57E0B8,R51,Headache,-
1EF2AA5A-91EA-47E1-AFEC-B797E2859E2F,J06.9,"Acute upper respiratory infection, unspecified",-
D98C5AF6-D069-4D7F-A068-D335B391C738,R51,Headache,-
0545A265-78EB-42CC-BAF6-EFBE31004285,Z71.2,Person consulting for explanation of investigation findings,-
748CFD29-E2DC-437B-B01D-137D8B4B19D6,R51,Headache,-
748CFD29-E2DC-437B-B01D-137D8B4B19D6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CE9ED796-3D39-4862-A506-19AAE53BDBA6,R51,Headache,-
6A6D5F58-A9A7-4666-ABDF-9F66B3D818F9,J06,Acute upper respiratory infections of multiple and unspecified sites,-
EADB33F0-FE54-4721-8BE0-3272DDB375C0,R00.2,Palpitations,-
29DCB9A4-BCF4-434A-B060-B87F8F1409D0,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
29DCB9A4-BCF4-434A-B060-B87F8F1409D0,Z76.0,Issue of repeat prescription,-
29DCB9A4-BCF4-434A-B060-B87F8F1409D0,J45,Asthma,Asthma
ADEF90FD-A190-4940-9F74-AE5DB86A08CF,J06.9,"Acute upper respiratory infection, unspecified",-
589D96B7-C65F-4735-ADC8-CB2BCCBE05E8,M62.6,Muscle strain,-
5977E291-D491-4921-BA0E-9D07BFB32CA7,R82,Other abnormal findings in urine,-
F1BF05CF-B5EF-4D95-AF7E-DBE76144F2DB,M62.6,Muscle strain,-
C0356F64-CB56-4109-BB0A-0D39B9C909BE,K12,Stomatitis and related lesions,-
267692EC-D5D3-4896-85B4-CF78C67E2023,J06.9,"Acute upper respiratory infection, unspecified",-
D78B9AC3-7194-4853-871F-FC0809966BDB,A09.9,Gastroenteritis and colitis of unspecified origin,-
F2E0B3AB-745B-4275-9C58-B10FB8031886,R21,Rash and other nonspecific skin eruption,-
2E9EDB2E-DE60-4D5E-AE29-566186FF617B,G43,Migraine,Migraine
46332AA7-8A42-4626-B20F-D803E2785016,K13,Other diseases of lip and oral mucosa,-
E2C8E02C-34F3-41F5-A27A-0B310CB66871,N94.4,Primary dysmenorrhoea,-
8820C5A6-5128-4839-AFC4-380395ADFFF6,H00,Hordeolum and chalazion,-
B42CC31B-1C4B-487E-B603-3578B30208DF,T88.1,"Other complications following immunization, not elsewhere classified",-
C7B61367-BA98-4F4F-AF1B-DD334BC933CC,A09.9,Gastroenteritis and colitis of unspecified origin,-
A9331AED-452B-48FD-8C06-5F41E2554A94,J06.9,"Acute upper respiratory infection, unspecified",-
9A6CFC63-6288-453F-BF0A-4D8AABECD754,S81.0,Open wound of knee,-
CDC06918-9586-45B1-B9C1-1E4E5E0D1108,K12.0,Recurrent oral aphthae,-
046A2B66-15DE-42EE-B136-1C9A18038D56,J06,Acute upper respiratory infections of multiple and unspecified sites,-
DD546BA3-FD52-42C0-ADD8-CED48A0CD71F,M54.5,Low back pain,-
FBAA835C-BB3F-432E-ACD1-708A15C83913,L02,"Cutaneous abscess, furuncle and carbuncle",-
80217D07-DAFB-4C06-83CC-815726BEC1DA,R51,Headache,-
A40FA4AE-2EE3-45BA-ABC2-9688BA5C2246,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C54CC271-6F38-441D-8E27-CABE7D9EAD20,M62.6,Muscle strain,-
D8EFA41B-ECF3-457E-BA31-8017B43654EE,G44,Other headache syndromes,-
F3CB8F85-5429-489D-AF5F-AA24E636D5BE,Z71.2,Person consulting for explanation of investigation findings,-
4239D602-CC30-4715-A551-F02E3165EA1D,M54.5,Low back pain,-
FB229531-7F90-4BC1-BC37-DA94A832C1D5,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
F17D2CDF-AC6E-4765-8D5C-EB2CDEBFABB7,R51,Headache,-
13ECE9E6-8389-48BC-8CCA-FF04E1744C45,H00,Hordeolum and chalazion,-
40DD7A35-B5CA-41C7-86A2-4F87122D11D3,R50.9,"Fever, unspecified",-
40DD7A35-B5CA-41C7-86A2-4F87122D11D3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C91F7500-47D7-43CC-9B79-FCDDA68C18CB,S93,"Dislocation, sprain and strain of joints and ligaments at ankle and foot level",-
3BE1D64F-B78E-40D2-8C75-8DB476380A25,T78.4,"Allergy, unspecified",-
3BE1D64F-B78E-40D2-8C75-8DB476380A25,L50,Urticaria,-
D00BF924-4C4F-4640-AAF9-2EBB2B71508B,H81.1,Benign paroxysmal vertigo,-
DAE585E8-7119-41F8-8E4E-362F9DA6E81B,H81.1,Benign paroxysmal vertigo,-
D00BF924-4C4F-4640-AAF9-2EBB2B71508B,R42,Dizziness and giddiness,-
F85028CD-1779-4EDF-B243-549069D522A3,M76.6,Achilles tendinitis,-
5654FBFE-1CA3-4B8B-A3E2-41DD43AFE301,R51,Headache,-
84F86DA6-F5B2-4F45-A93E-2C7BCC367289,J06.9,"Acute upper respiratory infection, unspecified",-
1F4B9039-7FE0-4E80-A061-E371D4915AC6,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
73C7451F-93F0-4B30-A798-E744ABE64E54,R51,Headache,-
34082016-EAD5-420D-99EE-084E669E2A88,A09.9,Gastroenteritis and colitis of unspecified origin,-
0A68F0C4-C430-4B78-AE69-E3F8551E4268,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
E1340F59-D254-49AA-9BA5-1788D1842BC6,P39.0,Neonatal infective mastitis,-
E424477C-0CEA-4156-B897-4BB6D0B74C78,M62.6,Muscle strain,-
B15C3390-02F1-4905-B3B3-090C432BDED5,R21,Rash and other nonspecific skin eruption,-
2C1F4137-C590-4806-88F6-BB9CDC7C2E91,K07.6,Temporomandibular joint disorders,-
46240539-587A-4DD0-80EC-972E2141B66D,J06.9,"Acute upper respiratory infection, unspecified",-
88D48CE2-7EDB-4ABA-B540-24B0FAA8EAED,A09.9,Gastroenteritis and colitis of unspecified origin,-
6F10AE4C-270B-412E-85EF-2EF6DD565493,A09.9,Gastroenteritis and colitis of unspecified origin,-
DCF6A8A9-5E03-4AE2-A04C-D31BA077883B,M25.5,Pain in joint,-
ABB70D76-1188-4D0C-98DD-336E5998D1FE,G56.0,Carpal tunnel syndrome,-
70008448-5104-49C3-9665-2E4942951683,R50.9,"Fever, unspecified",-
70008448-5104-49C3-9665-2E4942951683,J02,Acute pharyngitis,-
864C32E1-983B-4A40-AB7E-A809D0E67B11,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
864C32E1-983B-4A40-AB7E-A809D0E67B11,K59.0,Constipation,-
57EA5E58-108D-4080-8E32-B2201F7AC464,N94.6,"Dysmenorrhoea, unspecified",-
860F39D4-142C-4CF3-AEC3-EE4098A511F8,G44,Other headache syndromes,-
8261DECD-EA2C-4325-B79D-F3B071B5D730,J06.9,"Acute upper respiratory infection, unspecified",-
8587F66F-7B42-4561-83D4-A855D776CD66,J06.9,"Acute upper respiratory infection, unspecified",-
CB57BE08-8397-48D0-89F4-8863E82C9378,H00,Hordeolum and chalazion,-
56C9C901-3B1B-4B68-BAD1-AFC2AD42DBC3,H00,Hordeolum and chalazion,-
56C9C901-3B1B-4B68-BAD1-AFC2AD42DBC3,Y42.4,Oral contraceptives,-
CB57BE08-8397-48D0-89F4-8863E82C9378,H01.0,Blepharitis,-
97959319-CD49-4ED0-8252-4E082BEB3A8F,U07.1,"COVID-19, virus identified",-
97959319-CD49-4ED0-8252-4E082BEB3A8F,J06.9,"Acute upper respiratory infection, unspecified",-
8C56758F-C6EF-41E5-993F-9C0A928CCE95,Z71.2,Person consulting for explanation of investigation findings,-
70869AFA-182B-4C3C-8616-3EAED307CD78,J06.9,"Acute upper respiratory infection, unspecified",-
A9BE25D4-5D96-481C-8BB8-8520E5E84E2A,M75.1,Rotator cuff syndrome,-
29E9C85F-DB46-4B28-A794-8C6BA1C37BCB,I10,Essential (primary) hypertension,Hypertension
29E9C85F-DB46-4B28-A794-8C6BA1C37BCB,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
928E9860-1E13-4948-8FFF-3BE18293FD51,R51,Headache,-
928E9860-1E13-4948-8FFF-3BE18293FD51,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
9A09F0CA-E9E3-47F3-9F20-44AB275C9C25,N94.6,"Dysmenorrhoea, unspecified",-
D59F660B-3A3B-401B-A8C9-9AB9D0783B5A,R21,Rash and other nonspecific skin eruption,-
D59F660B-3A3B-401B-A8C9-9AB9D0783B5A,L50,Urticaria,-
72E009A4-4BAC-4176-90BD-D015135A4FF0,L50.0,Allergic urticaria,-
AECFE31B-927B-40BD-9CA1-4B341A04B4E7,J06,Acute upper respiratory infections of multiple and unspecified sites,-
CC7271FB-40F7-4BD2-96A5-CE8E8BE22119,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
0A3EFEB3-C721-4739-BF73-EB4383ACE894,R51,Headache,-
F1C3A76B-E904-4D7B-A99D-45BAB03CBEA5,K30,Functional dyspepsia,-
34598F68-36A2-47E5-9D9C-0F84751B19D7,H57.9,"Disorder of eye and adnexa, unspecified",-
F1C3A76B-E904-4D7B-A99D-45BAB03CBEA5,H57.9,"Disorder of eye and adnexa, unspecified",-
EA965877-E130-49C6-B843-788420A58252,U07.1,"COVID-19, virus identified",-
EA965877-E130-49C6-B843-788420A58252,J06.9,"Acute upper respiratory infection, unspecified",-
5B9CE379-2C62-4BC5-98EF-D4E8117CF3C7,T88.1,"Other complications following immunization, not elsewhere classified",-
0D5C911E-5463-4897-96F7-F4E8D5C735AF,A09.9,Gastroenteritis and colitis of unspecified origin,-
17B9D58E-B8EE-4550-9131-1EE26FA8F547,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
54E7B24A-767F-4C47-BDC2-B0DE34FBA4CE,A09.9,Gastroenteritis and colitis of unspecified origin,-
6B2BD497-5949-4894-BDE3-97CB960C93E2,A09.9,Gastroenteritis and colitis of unspecified origin,-
7507B8B5-FFA5-4622-9F01-1EAFC8D6D611,A09.9,Gastroenteritis and colitis of unspecified origin,-
03A24AE5-9EB3-4DE1-A6AB-C10E292897CE,T88.1,"Other complications following immunization, not elsewhere classified",-
7DAF64A4-93E7-4781-A304-D4075EEE681F,T88.1,"Other complications following immunization, not elsewhere classified",-
DE67DB8D-BF1A-42B0-AC5B-CBDE65C859ED,M62.6,Muscle strain,-
6B748290-DD42-4879-B696-60B9CBDBE4DA,J06.9,"Acute upper respiratory infection, unspecified",-
CC387263-1212-4F77-AB7C-51BEFC7FEB10,T88.1,"Other complications following immunization, not elsewhere classified",-
24F24823-1B28-4161-B8E9-06CB44D46037,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
7AB6CBF9-E719-4EA3-8B82-6421703E3EFD,A09.9,Gastroenteritis and colitis of unspecified origin,-
87383EC4-1806-4587-BF69-B2FE3F1DFB1F,H60.1,Cellulitis of external ear,-
450E4C3E-0A32-4680-A0F6-C948804BAD9E,M79.1,Myalgia,-
5F3BDD0F-9AAF-4051-9033-34FA2814A5FB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
AB8ABC90-99B6-4A69-A8D4-52DBD425584D,J06.9,"Acute upper respiratory infection, unspecified",-
AB8ABC90-99B6-4A69-A8D4-52DBD425584D,T88.1,"Other complications following immunization, not elsewhere classified",-
039492E2-9246-4D19-82E4-878BD81DB3A5,J06.9,"Acute upper respiratory infection, unspecified",-
95039987-5719-4FD6-9615-39F557E601C1,A09.9,Gastroenteritis and colitis of unspecified origin,-
56F3D694-155E-477F-914B-15F03E1F37AA,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
07053E00-6663-4984-9B0D-405930338995,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D26BA89B-986C-41F7-AC06-00CE3D1FCE57,J02,Acute pharyngitis,-
E4163B00-0FD7-4B2C-A534-3F568FA674A6,T88.1,"Other complications following immunization, not elsewhere classified",-
FB22EF75-4EBA-441C-B2A4-56B6CE1CC9C7,H81.1,Benign paroxysmal vertigo,-
34EF0EC3-9636-4C88-9FA0-B7D8DB04C318,J06,Acute upper respiratory infections of multiple and unspecified sites,-
E6107D02-C0FE-4A35-A387-15A804A79359,K13,Other diseases of lip and oral mucosa,-
552FF15E-6ECA-4180-9236-6531A55812C9,M79.1,Myalgia,-
2F96CB17-1DA7-46A3-95CE-D185C9A2557F,R51,Headache,-
4B8C4203-F3DF-4FF1-AE03-F49F54194581,R21,Rash and other nonspecific skin eruption,-
39498F39-E4E1-4BFB-9E29-8559D1C75E61,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
39498F39-E4E1-4BFB-9E29-8559D1C75E61,K29.7,"Gastritis, unspecified",-
11CE911D-C040-4849-9A77-1A3537891276,N94.6,"Dysmenorrhoea, unspecified",-
11CE911D-C040-4849-9A77-1A3537891276,A09.9,Gastroenteritis and colitis of unspecified origin,-
F4283078-AB0E-4A8D-99DF-C1D1C16F3AC5,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
F4283078-AB0E-4A8D-99DF-C1D1C16F3AC5,T75.3,Motion sickness,-
2D3B9984-B83A-4A3B-A612-9C114D9CF5A8,U07.1,"COVID-19, virus identified",-
22249449-4C41-4E17-B07D-E6D110B19337,M79.1,Myalgia,-
22249449-4C41-4E17-B07D-E6D110B19337,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D4973E45-0C53-4156-B9B2-160CD87B48D8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
891D02A2-4FA0-49E0-B6F4-0406DFAFAB6F,P39.0,Neonatal infective mastitis,-
3A734E3F-5E3F-4609-A02D-322F08B9D461,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
328B6CE4-C35F-4E98-AA8E-0FF9AE89C6BA,R10.4,Other and unspecified abdominal pain,-
FF1BA215-020C-4281-97F5-EAAC07AD5206,I10,Essential (primary) hypertension,Hypertension
7EE0E60B-DB92-442D-9715-D3EED566441D,A09.9,Gastroenteritis and colitis of unspecified origin,-
965C735C-EED9-4304-B2F2-732450FFB335,A09.9,Gastroenteritis and colitis of unspecified origin,-
02289500-E54A-4EF2-878A-E0D9889F52CA,A09.9,Gastroenteritis and colitis of unspecified origin,-
4E65B5C1-1AF8-4C29-9E8D-462BD820C0BF,U08,Personal history of COVID-19,-
6A9FAF12-8D9D-4CCE-825A-AC09772560A0,U07.1,"COVID-19, virus identified",-
4E65B5C1-1AF8-4C29-9E8D-462BD820C0BF,K00.6,Disturbances in tooth eruption,-
52CB2913-71AC-41E5-88E7-0111312B0A55,M10,Gout,Gout
987D1E3F-CF1B-4A50-9770-A9C871C0E84E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
51AFB6A7-53DC-42DC-92B6-C1B91B7F5AE2,M25.5,Pain in joint,-
39550E72-E4E1-4090-89A6-847A5DFA20FE,N94.6,"Dysmenorrhoea, unspecified",-
B3472E16-C1B7-4FA9-B6D5-07CF0C61A1F7,N94.6,"Dysmenorrhoea, unspecified",-
CE4D3823-F919-4E1B-853B-D6FE516B512A,G44.2,Tension-type headache,-
CE4D3823-F919-4E1B-853B-D6FE516B512A,H57,Other disorders of eye and adnexa,-
8546A1F4-5BA2-4E8B-A68E-8FD1F76F9537,A09.9,Gastroenteritis and colitis of unspecified origin,-
C0671FB0-7E70-44BC-B2ED-99223489D5D8,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
3FAD6988-846D-4B0E-9547-7BF3518B84E7,J06.9,"Acute upper respiratory infection, unspecified",-
09717496-9551-47AA-92C4-4F4038E29D76,A09.9,Gastroenteritis and colitis of unspecified origin,-
49B77F02-9E2E-4F31-AE2F-31B3CACE37EA,J22,Unspecified acute lower respiratory infection,-
5B2BF5E0-35A3-43EE-8DA5-AC8CA6FDA31D,N94.6,"Dysmenorrhoea, unspecified",-
10819A88-FB15-4FB4-81AB-78B3C8FCDC62,M54.5,Low back pain,-
0C2193D3-74F7-47C7-BEC7-4EC5A294A6E2,J06.9,"Acute upper respiratory infection, unspecified",-
773D69D8-586F-483E-B748-2A2B065BB024,L20,Atopic dermatitis,Atopic dermatitis
5945AB2A-EF5A-4D35-9138-153F602A529E,H57,Other disorders of eye and adnexa,-
2B6E1639-8DE1-405C-A4F9-A7A75F60FCF8,R21,Rash and other nonspecific skin eruption,-
2B6E1639-8DE1-405C-A4F9-A7A75F60FCF8,L30.9,"Dermatitis, unspecified",-
5547EDDB-9276-41AD-937F-9F7730555B41,U07.1,"COVID-19, virus identified",-
66E37132-8036-4A39-BDDA-57F5EBA8BAD4,Z71.2,Person consulting for explanation of investigation findings,-
A6C42182-8E66-43A4-8FD2-DD143AF39649,K30,Functional dyspepsia,-
4C85EA7C-CB33-4E0C-9392-0A5229BC15D1,I10,Essential (primary) hypertension,Hypertension
4C85EA7C-CB33-4E0C-9392-0A5229BC15D1,E11.9,Type 2 diabetes mellitus without complications,Diabetes
47863F65-986E-4C97-BAE7-01B6D420DCAB,H00.1,Chalazion,-
077F4D83-273D-4435-9886-CB76316EC54C,M62.6,Muscle strain,-
A6FC1FE1-8594-48CD-B872-EF8F1876EBFB,U07.1,"COVID-19, virus identified",-
46FEA00E-479D-4423-8AA4-DFBBB5700A6C,J06.9,"Acute upper respiratory infection, unspecified",-
5D33E128-C88B-4320-889C-9B589E8C070B,K12.0,Recurrent oral aphthae,-
643DD659-5DF3-4A52-AECC-175B85DC491D,K12.0,Recurrent oral aphthae,-
3236F684-3E77-4A9E-A90E-84DB942621C6,M10,Gout,Gout
12CB1BA4-CF0F-4F17-AC85-BA94F2AD643A,J34,Other disorders of nose and nasal sinuses,-
0FEAB9B0-43A9-4B2A-8E3C-FB23C722416B,J06,Acute upper respiratory infections of multiple and unspecified sites,-
11DE7B8D-474C-4439-AA06-91F389076578,R50.9,"Fever, unspecified",-
6241489E-3A23-451E-AE57-012B50DBEDBB,A09.9,Gastroenteritis and colitis of unspecified origin,-
3019C722-3758-4226-9E76-06887744912E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
419540BE-185B-47DB-AD25-4E05F6E009DB,J06.9,"Acute upper respiratory infection, unspecified",-
D7C86679-4912-4F0E-85E5-61BBB904167C,K30,Functional dyspepsia,-
B86B9973-5814-4E70-802E-E332D64F7DEA,A09.9,Gastroenteritis and colitis of unspecified origin,-
5B6FE920-A934-4ECC-A5E2-B04A13B1E3C7,Z71.2,Person consulting for explanation of investigation findings,-
D18FBD9A-89B4-4209-8787-6D4E9D32AEB0,R51,Headache,-
78FF58F7-6CEE-421E-99C7-EC772160482C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
083EB41D-73CC-49DC-994F-B59EC7A397D3,M62.6,Muscle strain,-
083EB41D-73CC-49DC-994F-B59EC7A397D3,M54.5,Low back pain,-
53DD4194-4B10-443F-AF0D-D04FEA8E6D27,L30.9,"Dermatitis, unspecified",-
FA50F0CD-7620-4E2F-98D6-49103B7A0C7F,R42,Dizziness and giddiness,-
FFC243F1-349E-4ED1-9301-19C49E90FF6F,H81.1,Benign paroxysmal vertigo,-
27DB3850-3078-4A69-9B6C-AB8BCC66FD4B,A09.9,Gastroenteritis and colitis of unspecified origin,-
DC0720AE-283F-425E-A11B-0AB88C84D386,R51,Headache,-
2F77ECCB-0080-4DA3-98DB-4B9684E55600,Z71.2,Person consulting for explanation of investigation findings,-
66264E06-AD6E-4C7A-A40C-6711114F44F4,A09.9,Gastroenteritis and colitis of unspecified origin,-
1287B3AF-6F21-415B-B688-106CD336574F,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
1287B3AF-6F21-415B-B688-106CD336574F,H10.1,Acute atopic conjunctivitis,-
C6CB2B18-840A-4BD2-BE5D-A51686D61502,I80.2,Phlebitis and thrombophlebitis of other deep vessels of lower extremities,-
5AF2F977-1D5C-42EE-859E-6B2214892088,U07.2,"COVID-19, virus not identified",-
3DD35CEB-7D95-474D-8F4A-191A21050C3D,G44.2,Tension-type headache,-
150D5320-861F-4368-925E-A243D5635708,J06.9,"Acute upper respiratory infection, unspecified",-
F4E692A9-502C-4EDB-B1F0-C11061104F2A,T88.1,"Other complications following immunization, not elsewhere classified",-
4C8AAC0E-684F-4343-BD2F-4AE2D46B5CC3,A09.9,Gastroenteritis and colitis of unspecified origin,-
DAD7BA6A-0434-4CBE-BD23-711B0C9CB038,A09.9,Gastroenteritis and colitis of unspecified origin,-
DB18CD62-921D-40F5-B49A-8A154D24C999,J06.9,"Acute upper respiratory infection, unspecified",-
A5A66887-2451-4DA2-8070-BDC787ABEEE1,J06.9,"Acute upper respiratory infection, unspecified",-
3486FD65-389E-434C-AE48-FB3CD0D2F826,J06.9,"Acute upper respiratory infection, unspecified",-
9427CA05-6B1D-45E7-9441-126A78021089,E28.2,Polycystic ovarian syndrome,-
9427CA05-6B1D-45E7-9441-126A78021089,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
9427CA05-6B1D-45E7-9441-126A78021089,R51,Headache,-
9427CA05-6B1D-45E7-9441-126A78021089,I10,Essential (primary) hypertension,Hypertension
81B570F0-D4B8-4BCA-BA5B-5DF9FEF83A8D,Y42.4,Oral contraceptives,-
62E1F785-3F15-471B-ADE2-48026F7604C9,A09.9,Gastroenteritis and colitis of unspecified origin,-
1B8CA616-9962-4D90-8C13-5869A24122C2,A09.9,Gastroenteritis and colitis of unspecified origin,-
C207EF1D-412E-4A60-8D21-C8C158D0FB64,F32,Depressive episode,-
C148BEF4-A40D-4EC2-8C5D-0BFD4C56E24E,J06,Acute upper respiratory infections of multiple and unspecified sites,-
60D0CE74-7BBD-45DF-BE38-AA3DF3DDB9B2,H00,Hordeolum and chalazion,-
3AE24824-95F9-4630-87A0-69E0037C523C,J06.9,"Acute upper respiratory infection, unspecified",-
7AE73CAE-AAF3-4799-BBE4-A9F52798E719,R51,Headache,-
06800B64-DB91-414A-B343-3607547548D3,N64,Other disorders of breast,-
3369959F-69C7-44A6-ADCF-30233A3B7B62,U07.1,"COVID-19, virus identified",-
30C95A04-55EB-4F5F-B0C8-12FEDA2B78D0,M54,Dorsalgia,-
26CFA44A-E869-4B76-BFD7-4B9E2A946D70,M25.5,Pain in joint,-
30C95A04-55EB-4F5F-B0C8-12FEDA2B78D0,N94.6,"Dysmenorrhoea, unspecified",-
26CFA44A-E869-4B76-BFD7-4B9E2A946D70,T88.1,"Other complications following immunization, not elsewhere classified",-
32656A49-F0F0-4EC6-A69B-61DC261B62A2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
90FAB5CE-E559-4EA2-ADEF-3E6324929E0A,J06.9,"Acute upper respiratory infection, unspecified",-
E2014E4E-F232-41A3-96BB-456BF4E2C0DC,A09.9,Gastroenteritis and colitis of unspecified origin,-
B2D915A9-55A5-42BF-9E5E-6326D4149F02,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B2D915A9-55A5-42BF-9E5E-6326D4149F02,L20,Atopic dermatitis,Atopic dermatitis
24C74550-CA02-4C31-9E74-89AF607DD119,K29.9,"Gastroduodenitis, unspecified",-
7C260B01-B737-44FF-AB64-50EDD0DED770,M54.5,Low back pain,-
3115793B-9524-4C32-8792-F4CB811C7F1D,K29.7,"Gastritis, unspecified",-
4695D265-8D5E-4AB5-A88C-9DE182CA4ACF,B37.3,Candidiasis of vulva and vagina,-
4695D265-8D5E-4AB5-A88C-9DE182CA4ACF,L50.9,"Urticaria, unspecified",-
4695D265-8D5E-4AB5-A88C-9DE182CA4ACF,M62.6,Muscle strain,-
5F3711C8-3D75-4658-AB3B-B48A3BBF7BC8,S93.4,Sprain and strain of ankle,-
10875A6F-5EFE-418C-8D0C-65476AE62FB3,M62.6,Muscle strain,-
7135BA25-90E7-48E5-849B-FE33FB5F1E1A,I10,Essential (primary) hypertension,Hypertension
421881CD-C971-49CC-B624-9A0EF03F0740,J06.9,"Acute upper respiratory infection, unspecified",-
B244DA5F-AAF9-455E-A619-54024DCC7AA7,J06.9,"Acute upper respiratory infection, unspecified",-
D95FCFD6-F7B3-47C7-9D50-3CD9E8FC94EA,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
5EC73B63-8FC1-43F9-A2DF-B566C3465B76,A09.9,Gastroenteritis and colitis of unspecified origin,-
A7D557C9-691E-4482-A63E-0AC5A1F8BC39,K59.1,Functional diarrhoea,-
A7D557C9-691E-4482-A63E-0AC5A1F8BC39,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6880B5E3-020C-4719-9901-B72240D3228E,L20,Atopic dermatitis,Atopic dermatitis
1E0A6870-C4C2-419A-8BC9-87429619696E,A09.9,Gastroenteritis and colitis of unspecified origin,-
C9A89669-8031-41CA-B910-97E47CBDE977,S30.0,Contusion of lower back and pelvis,-
2A4B856C-2ED2-4555-BCF1-04389A2E61B4,K30,Functional dyspepsia,-
2A4B856C-2ED2-4555-BCF1-04389A2E61B4,L30.1,Dyshidrosis [pompholyx],-
259BE0F9-7925-4BA6-9A4A-51C23B20634C,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
453B5AAD-337B-4DDB-9244-5CB36234A494,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
32BF92F7-2F5B-4042-A085-B0E6607D76BB,T88.1,"Other complications following immunization, not elsewhere classified",-
21AF055C-3677-4D34-ADB9-E5E6307C837D,M54.5,Low back pain,-
EBC28019-9ECA-4064-ABD1-2030F323BF5A,R21,Rash and other nonspecific skin eruption,-
EBC28019-9ECA-4064-ABD1-2030F323BF5A,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
A4DB61EC-12B5-4BDF-B467-20823691CE4F,A09.9,Gastroenteritis and colitis of unspecified origin,-
47663AE0-79CB-41E3-828A-59D6A04B394E,J06.9,"Acute upper respiratory infection, unspecified",-
7A78F55D-FF3F-4E3A-9D69-C953D3DCC3DB,H10.1,Acute atopic conjunctivitis,-
CFDACD3C-A2E8-4A04-9442-FAA2F70BBEA1,R51,Headache,-
93945492-A0CC-497B-B294-3524B1BB532A,N94.4,Primary dysmenorrhoea,-
E7E5C684-4114-48D5-91CB-550A86675A20,T88.1,"Other complications following immunization, not elsewhere classified",-
794CB059-67FA-4E05-A620-8B028D2D67F9,R51,Headache,-
3D32DFFD-12C7-4228-ACCD-A3FDC5BAE28F,J06.9,"Acute upper respiratory infection, unspecified",-
D96B0676-3887-4E86-B9AD-7802E5CB4C77,K05,Gingivitis and periodontal diseases,-
579162AE-F482-4809-86F1-4524AAEFEC98,K29.7,"Gastritis, unspecified",-
F1069EE2-CBED-4E37-BA08-4A00B8EDA43F,B00,Herpesviral [herpes simplex] infections,-
87F0320E-78C1-479C-AB8C-1E0A5CF406F3,K00,Disorders of tooth development and eruption,-
F1069EE2-CBED-4E37-BA08-4A00B8EDA43F,R21,Rash and other nonspecific skin eruption,-
5B6F0C08-61FD-49D8-A357-741924D97F32,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
62FFA223-C6A5-4800-B6A0-84392FC1CCF4,A09.9,Gastroenteritis and colitis of unspecified origin,-
4F2D0EE7-3AE0-445E-B180-8AABB3DFE84F,B35.3,Tinea pedis,-
BF0C007A-B0F9-4EF3-BEFC-7E560CA6E140,A09.9,Gastroenteritis and colitis of unspecified origin,-
E4F371F6-5A34-41D1-9874-913B8A09D136,A09.9,Gastroenteritis and colitis of unspecified origin,-
304FBA80-66F6-43AE-B3E4-D5064CDBA91D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
304FBA80-66F6-43AE-B3E4-D5064CDBA91D,R50.9,"Fever, unspecified",-
D8CFE749-9CEA-4C52-B771-62128E6105F1,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
D8CFE749-9CEA-4C52-B771-62128E6105F1,I10,Essential (primary) hypertension,Hypertension
D8CFE749-9CEA-4C52-B771-62128E6105F1,R73,Elevated blood glucose level,-
D8CFE749-9CEA-4C52-B771-62128E6105F1,K29.7,"Gastritis, unspecified",-
6B7175E6-F6AA-432A-8D4D-1F55B1D8A22A,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
DB3046E2-CE4B-4F6B-9D82-9085BAD1FC85,Z71.2,Person consulting for explanation of investigation findings,-
2A22AFE8-B6C6-4688-908F-258704B5B176,K30,Functional dyspepsia,-
2A22AFE8-B6C6-4688-908F-258704B5B176,A09.9,Gastroenteritis and colitis of unspecified origin,-
1D35A281-9B93-4DFE-B403-E2A802742172,R21,Rash and other nonspecific skin eruption,-
6A192582-5B96-4B9F-A9FD-F5C67DB5ACB2,Z71.2,Person consulting for explanation of investigation findings,-
300CD008-AE4C-41EB-942D-EF1806E2AD1E,S83,"Dislocation, sprain and strain of joints and ligaments of knee",-
300CD008-AE4C-41EB-942D-EF1806E2AD1E,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
7FE609E6-ED46-4D92-8930-0140ADF88465,N94.6,"Dysmenorrhoea, unspecified",-
43F652AC-0E2E-4315-81F1-D2EA3FDBBC28,G44.2,Tension-type headache,-
B9BE2BA3-2094-457B-9D60-CD5954F8166A,B00,Herpesviral [herpes simplex] infections,-
B02213FE-E16C-4416-B3B9-B01A7771D255,B00,Herpesviral [herpes simplex] infections,-
69780F87-1AE9-4620-98FA-AE94423B7414,M54.5,Low back pain,-
CB36449B-22DE-4288-968B-1027D046FE1F,N94.6,"Dysmenorrhoea, unspecified",-
F557CC65-B5EF-4CD9-8BFB-C1FF74629FC8,N92,"Excessive, frequent and irregular menstruation",-
5FC2053B-B14A-47D4-810E-B367FD0F12FF,N94.6,"Dysmenorrhoea, unspecified",-
77DA0F8C-C534-4DE3-A7B2-2F70AA91D5D6,Z71.2,Person consulting for explanation of investigation findings,-
7E6EA5B0-25D2-4CE8-8DDF-46B9FCD23554,R51,Headache,-
31465A48-5E7A-4DC8-BAFC-C54B5B34C4DB,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
E7844F66-DBF5-4635-B986-6AF6C17B54E3,N39.0,"Urinary tract infection, site not specified",-
6E06ACE7-11F7-4026-98A4-F41F71109C54,A09.9,Gastroenteritis and colitis of unspecified origin,-
215D8003-E9A8-4D8E-9E0C-70C145743FB6,R21,Rash and other nonspecific skin eruption,-
AF4A020C-9BFD-4E22-B941-C218B1FB3632,R50.9,"Fever, unspecified",-
1A9F56CE-4DCF-4B37-9608-C5E263D47ED3,J06.9,"Acute upper respiratory infection, unspecified",-
4E31FAF3-62A1-4EE7-9048-B5F3B7DD7EF4,E03.9,"Hypothyroidism, unspecified",Thyroid
C22DB291-52FB-4D36-BB3C-BE1F5DAC3B67,A09.9,Gastroenteritis and colitis of unspecified origin,-
CC105C54-FF25-48D1-B5C0-2E99D96E7401,Z71.2,Person consulting for explanation of investigation findings,-
B82A1E37-52DC-411F-AFAD-6B345E0D6B48,M54.5,Low back pain,-
B82A1E37-52DC-411F-AFAD-6B345E0D6B48,R51,Headache,-
E21E0374-2661-4792-BAEA-1158D1704D27,R53,Malaise and fatigue,-
3E3B8C98-052E-4BD0-8C14-133B04C5EFBB,R51,Headache,-
23981BC7-4D47-4C17-A2EC-528BAE4BDD08,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
2376E1CF-F1F2-4884-BA27-22C4E0D8326F,R51,Headache,-
C6BC6B31-E802-464B-A382-218D504FF5AC,G44,Other headache syndromes,-
589FA6E7-4CF6-456E-85EF-CCC184199788,A09.9,Gastroenteritis and colitis of unspecified origin,-
589FA6E7-4CF6-456E-85EF-CCC184199788,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2AF19C3C-8AE3-4364-B459-FC572EEAD841,R21,Rash and other nonspecific skin eruption,-
34294098-3C74-42F4-9452-8E8CA3EBD4E1,A09.9,Gastroenteritis and colitis of unspecified origin,-
0DDD0B70-3B8C-4DAE-88DF-6DAEC38ED001,R51,Headache,-
1E91FEC7-D4F3-430C-9B2E-C34A93790465,U07.1,"COVID-19, virus identified",-
A872F89A-AE03-4644-8216-F5ABF7FE2BCE,U07.1,"COVID-19, virus identified",-
63FC9190-75E4-49FB-838B-893B5CA25D9E,J06.9,"Acute upper respiratory infection, unspecified",-
8999EFEF-BD72-4DFA-BCD9-67E1E03C07EC,K29.7,"Gastritis, unspecified",-
77E22E02-0732-4539-9C58-9865A9ED45F1,H81.1,Benign paroxysmal vertigo,-
1412B6E5-A4C7-4CED-873C-6CBAF717F889,N94.6,"Dysmenorrhoea, unspecified",-
C22166D0-0202-4B86-8B7A-4999B20EA719,R50.9,"Fever, unspecified",-
C22166D0-0202-4B86-8B7A-4999B20EA719,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A3606098-D894-4B26-B5EA-9A73F4F95277,J03.9,"Acute tonsillitis, unspecified",-
45ACEEB6-B76D-4CE4-881F-FB6D2089FB17,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3BA6CA7E-8E33-449C-A6D0-98B0AD675E00,R51,Headache,-
8B2FEB1C-EBF3-43E6-8318-3299B66D30AA,M54.5,Low back pain,-
8C9B59F1-B307-4D74-A951-6442C729F59C,A09.9,Gastroenteritis and colitis of unspecified origin,-
5C96F0E4-3F37-4515-8896-3DAAB0DD7426,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
188958C8-B7DE-4246-A276-9572EC67B686,R21,Rash and other nonspecific skin eruption,-
BFA63DB2-4DCD-4BE0-8A27-5BCB14E31507,R51,Headache,-
E942DD16-4D47-4D4E-8355-A0C70A2BC27D,E11,Type 2 diabetes mellitus,Diabetes
D8123100-CA29-4273-8A64-031B042A61AD,K29.7,"Gastritis, unspecified",-
D8123100-CA29-4273-8A64-031B042A61AD,A09.9,Gastroenteritis and colitis of unspecified origin,-
5EF6908F-2CCE-4052-881A-E1A4B41B7F74,M10,Gout,Gout
3DE4E4D8-58EE-4F0A-B61C-A1B6C505DE32,R42,Dizziness and giddiness,-
3DE4E4D8-58EE-4F0A-B61C-A1B6C505DE32,H02.9,"Disorder of eyelid, unspecified",-
7C6E6CD3-7738-4680-A437-5FC29521E704,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D0969C87-21E8-4B6E-9DED-E6CC3FE4AD98,J01,Acute sinusitis,-
D0969C87-21E8-4B6E-9DED-E6CC3FE4AD98,B35.3,Tinea pedis,-
C4AD06EC-B548-4E98-8C30-E2CA864EFB43,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
32B5D63F-F881-413B-BF45-08135D9BF641,N39.0,"Urinary tract infection, site not specified",-
A0543845-B75E-41BB-8248-DBF683B7C5D5,Z71.2,Person consulting for explanation of investigation findings,-
697C429A-0987-434E-8809-CF52BF8E363C,J06.9,"Acute upper respiratory infection, unspecified",-
F73F287D-0165-46A8-9777-3DE9A544A45F,J06.9,"Acute upper respiratory infection, unspecified",-
E63A5466-7E64-48E3-9736-58CB3B20402E,M62.6,Muscle strain,-
0DF1DDC4-DFCE-4C05-8F0B-535A09EB4D92,R51,Headache,-
16B5DDC8-596C-48D0-9784-AACD6FB3AFAE,H00.1,Chalazion,-
D39271C0-30D3-41E0-A225-DD86A754AD64,K30,Functional dyspepsia,-
D39271C0-30D3-41E0-A225-DD86A754AD64,R51,Headache,-
F2E82103-2476-49FB-B41E-15D1A944590C,N39.0,"Urinary tract infection, site not specified",-
B0BD4CF4-4B7A-47ED-A5F4-2F32FEEFE88B,N39.0,"Urinary tract infection, site not specified",-
D9F793F2-4914-4C2A-9E3F-BDFBFA5D3B4A,K29.7,"Gastritis, unspecified",-
CD135069-45BA-4B00-9A68-051655CE8710,R51,Headache,-
AF6DA672-CFBA-45DF-B24D-37C583CD3443,N39.0,"Urinary tract infection, site not specified",-
1F46030B-E39B-455D-B6F6-789EE1CF1906,A09.9,Gastroenteritis and colitis of unspecified origin,-
C35D8CB8-1F58-4147-B02F-D0303506EB84,N94.6,"Dysmenorrhoea, unspecified",-
F2192FA6-7CD3-488D-9C0C-632A06C36219,J06.9,"Acute upper respiratory infection, unspecified",-
E966C422-8256-4E49-9725-367CB18B068B,K12.0,Recurrent oral aphthae,-
E966C422-8256-4E49-9725-367CB18B068B,K64.9,"Haemorrhoids, unspecified",-
4E96879F-E60F-4FA8-BE46-4AA413BC38B9,Z53,"Persons encountering health services for specific procedures, not carried out",-
3ED679E8-6523-4AF6-A62D-0AC95BE9DC8C,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
A7865CCB-1731-4DEB-B461-A22C5F105BF0,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
A7865CCB-1731-4DEB-B461-A22C5F105BF0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CCADB036-B88E-482D-BE33-589D9D4176C7,J06,Acute upper respiratory infections of multiple and unspecified sites,-
BEC1A763-51DA-48B1-8759-ACC309A9EC6A,N39.0,"Urinary tract infection, site not specified",-
6CA160C0-8D15-40DB-9B83-A878834AB87C,Z02,Examination and encounter for administrative purposes,-
11970A3C-3322-42DD-A0A9-B8B2802EFE13,R51,Headache,-
5A83DF47-4874-465B-B078-B8EB170B8A1D,R51,Headache,-
A11F6BDC-8DC2-4237-AE37-1A879F5C006B,T88.1,"Other complications following immunization, not elsewhere classified",-
77847825-0D7C-45E1-8358-44F45E6CCDC0,M10,Gout,Gout
ED1B8E68-2083-4069-A0C1-72525C2807A6,Z02.9,"Examination for administrative purposes, unspecified",-
6394ACA0-E837-423A-8264-06C87EA7C080,R51,Headache,-
783D636C-FE4F-4444-A59C-8A3FD8873F68,T78.4,"Allergy, unspecified",-
5AF3A063-4982-4264-BE3F-03F7A2EF8345,J02,Acute pharyngitis,-
FA5A826F-0298-4265-989C-38F5ED518965,A09.9,Gastroenteritis and colitis of unspecified origin,-
989AFDD0-B0F3-4BFD-BC79-738BEB21F739,A09.9,Gastroenteritis and colitis of unspecified origin,-
4C688CB6-2952-44F3-B13A-E13AA54C81A2,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
73AA5FB4-563A-4A70-AC7A-549EBFE3C58B,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
98F3C96D-E5D6-4E08-8FDF-76F5F8F7ECB1,U07.1,"COVID-19, virus identified",-
98F3C96D-E5D6-4E08-8FDF-76F5F8F7ECB1,J06.9,"Acute upper respiratory infection, unspecified",-
B4B0D602-72CB-4083-9862-B98344019E8C,B02,Zoster [herpes zoster],-
59A5DC9D-749D-4724-A141-AABC416A2E1B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6C808DC4-1914-4197-8DBE-A08711D21182,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
6C808DC4-1914-4197-8DBE-A08711D21182,L30.9,"Dermatitis, unspecified",-
15E4D031-973B-41EA-81AA-D701EAC5E125,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6011C946-F626-4A45-85A9-37C7D38C5685,T88.1,"Other complications following immunization, not elsewhere classified",-
FAB3FF9C-B073-452C-A6F4-1810BE41F3B8,K60.2,"Anal fissure, unspecified",-
FAB3FF9C-B073-452C-A6F4-1810BE41F3B8,N39.0,"Urinary tract infection, site not specified",-
6D42CDD9-727C-458B-8E89-C42EF5BEB006,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
2F1AC525-0737-4CEF-A526-CC004B6A914E,U07.1,"COVID-19, virus identified",-
4BA68757-CA22-4E7C-892B-0B9534CC307C,R51,Headache,-
1F5FDC0D-51DA-4502-A4EF-4D4EF353B695,T88.1,"Other complications following immunization, not elsewhere classified",-
4B36A3D2-C415-4A0C-8DF2-4F42F55E91CC,R51,Headache,-
B4B04365-0324-4AAA-9413-B8A6111C5951,U08,Personal history of COVID-19,-
FA9B482C-134C-4968-9B4A-E6EE69BD2AC4,J06,Acute upper respiratory infections of multiple and unspecified sites,-
AF5CC3F1-A8C3-4ED3-9B6E-05DE1E736EE6,I10,Essential (primary) hypertension,Hypertension
AF5CC3F1-A8C3-4ED3-9B6E-05DE1E736EE6,A09.9,Gastroenteritis and colitis of unspecified origin,-
AF5CC3F1-A8C3-4ED3-9B6E-05DE1E736EE6,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
1B71AA87-A12A-439F-B5D4-0E8E058105BD,L28.0,Lichen simplex chronicus,-
CCCB2C37-4FE6-485B-A4DC-E4A57F3DE176,A09.9,Gastroenteritis and colitis of unspecified origin,-
84F909FA-77D1-4336-BF08-26BD786E9383,J06.9,"Acute upper respiratory infection, unspecified",-
CCCB2C37-4FE6-485B-A4DC-E4A57F3DE176,B35.3,Tinea pedis,-
02C8AE10-9335-4F7A-948E-F6001469E5F6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4A4B8FCB-31DE-4507-A8A2-FFB4395AE0F3,M77.1,Lateral epicondylitis,-
28ECAC6E-D05B-43B4-AEBA-32E5944B3005,Z01,Other special examinations and investigations of persons without complaint or reported diagnosis,-
DA60F0D5-6DF8-4A08-B5FB-9EEBAC5767B0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8BA550EB-8DDD-444D-B9F7-F62DBACE80C2,H00,Hordeolum and chalazion,-
48C6AEA5-9FA4-4363-8012-B9EC3EBF83E2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A446448A-8D9D-44BB-A5DA-E3936723DC10,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0DEE2642-7CB3-446B-A8A4-6E260658CDC2,R51,Headache,-
8835B7C6-41FA-479E-B28C-6736D65466C9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1A9DE390-C7D9-413A-BB8B-90F1E6FC4EEC,N39.0,"Urinary tract infection, site not specified",-
1A9DE390-C7D9-413A-BB8B-90F1E6FC4EEC,D25,Leiomyoma of uterus,-
9AAF5725-EFDC-43AB-8BE6-8F46FBE7B21C,A09.9,Gastroenteritis and colitis of unspecified origin,-
7FA77029-09EB-403C-A3CE-C97B886ABD2E,Z71.2,Person consulting for explanation of investigation findings,-
D68CF9C2-DE7C-4E6F-AEA0-B15D7252EB24,H81.3,Other peripheral vertigo,-
D68CF9C2-DE7C-4E6F-AEA0-B15D7252EB24,G44.2,Tension-type headache,-
678B528F-F3A9-4176-99F3-F61F910E5121,R21,Rash and other nonspecific skin eruption,-
B8151643-34BD-4141-99C8-6B4D97A95581,G44.2,Tension-type headache,-
B8151643-34BD-4141-99C8-6B4D97A95581,I10,Essential (primary) hypertension,Hypertension
B8151643-34BD-4141-99C8-6B4D97A95581,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
FB8C11AC-3049-4814-8AC7-B765C9C64632,Z71.2,Person consulting for explanation of investigation findings,-
BBAAE4FB-FB81-458C-B32D-898265D57AF6,M62.6,Muscle strain,-
B436B417-6963-42B8-BDED-34629788EF89,J06.9,"Acute upper respiratory infection, unspecified",-
6476AD0E-71A4-4168-9AA4-20BABE6DDD35,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6476AD0E-71A4-4168-9AA4-20BABE6DDD35,M62.6,Muscle strain,-
AE9DF655-DF50-442F-93A5-4D0C731D5F82,B07,Viral warts,-
062A7CFE-3235-4710-A0FD-3271C02F9BE3,T88.1,"Other complications following immunization, not elsewhere classified",-
7389B6F8-0268-412E-B712-FA322A9B7E5B,Z71.2,Person consulting for explanation of investigation findings,-
4EF261D4-67B6-4099-8AC8-65718C8E4E34,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
27423D3E-A4CA-4EDC-BCCE-6C17B64B144E,G44.2,Tension-type headache,-
0E0733BC-8A09-4F55-A7F8-FDFB4C5A080D,K30,Functional dyspepsia,-
5EB2AFF1-FC61-4CFA-8213-44B9A1179488,L20,Atopic dermatitis,Atopic dermatitis
C013C156-2CA9-4334-9D7C-E579C2E93326,A09.9,Gastroenteritis and colitis of unspecified origin,-
2D8229F2-5C66-4775-A40E-9C633F0A4128,M54.5,Low back pain,-
17FD2494-E9AB-460F-8A75-DDCE7D4C152B,G44.1,"Vascular headache, not elsewhere classified",-
2105865E-9A66-4C0D-847D-C97226F4B3B5,J06.9,"Acute upper respiratory infection, unspecified",-
C1B9199D-1A34-4B36-BA14-DF5FF8B1E17F,R51,Headache,-
2595DD1D-414D-44A5-83A8-D4425FAA20E8,J06.9,"Acute upper respiratory infection, unspecified",-
20550889-0F75-43E3-A4CF-25AC2F4A452A,K30,Functional dyspepsia,-
20550889-0F75-43E3-A4CF-25AC2F4A452A,A09.9,Gastroenteritis and colitis of unspecified origin,-
C34CBF20-84D0-4A3D-92B8-7A39EF66C48A,R51,Headache,-
90A61178-EA07-4AB0-9002-689A6B0DC9FF,M10,Gout,Gout
5CD4B721-BD68-4EEA-9D9D-D1CB0249200C,R21,Rash and other nonspecific skin eruption,-
5CD4B721-BD68-4EEA-9D9D-D1CB0249200C,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
76AF1026-3D26-4092-9D2F-CA89B03C1E2C,R50.9,"Fever, unspecified",-
7BDF79B8-9A4E-4EC8-9C46-9A029E7E1C5B,S60.0,Contusion of finger(s) without damage to nail,-
7E444DE3-A896-43D6-ADF0-76EA770CB826,L23.9,"Allergic contact dermatitis, unspecified cause",-
3DD3FAB4-BA60-4F0D-A99C-D2E111A72B78,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
38585A4B-443F-45C3-995B-7EABF15DBC73,A09.9,Gastroenteritis and colitis of unspecified origin,-
40F5B4F7-FF64-4746-82AE-FECFE8FA199E,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
12E55E6A-DDB7-4061-980B-92F69AAF9466,H57,Other disorders of eye and adnexa,-
D3AE98D6-EB51-4607-85C2-EADD3EC3162D,A09.9,Gastroenteritis and colitis of unspecified origin,-
D3AE98D6-EB51-4607-85C2-EADD3EC3162D,K29.7,"Gastritis, unspecified",-
19475602-77A9-4EF0-8125-27D234C5FABE,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
87187E1A-4647-43B9-AFA4-0B49F2DD2FEB,M25.5,Pain in joint,-
B35C010B-7ECE-4D86-81FD-D2383956C2F0,R51,Headache,-
F5673ECA-9F40-4209-B436-2C0753A83C06,R51,Headache,-
33DA65E1-B75A-4941-B91E-ECAC47B2541C,R42,Dizziness and giddiness,-
33DA65E1-B75A-4941-B91E-ECAC47B2541C,R51,Headache,-
E61E1789-8237-423A-91D9-8291A89F83EF,R51,Headache,-
5590D906-D727-4191-B941-5785C87B9708,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
5590D906-D727-4191-B941-5785C87B9708,R21,Rash and other nonspecific skin eruption,-
17DBC370-F2DC-479E-B463-65EB8DAC6140,M62.6,Muscle strain,-
2465E3D0-5EB1-4EED-BCA4-C88038848474,K29.6,Other gastritis,-
67A149DD-220D-49B3-9EFD-A2FC6389A955,R51,Headache,-
329B9654-862E-4D02-8A44-430F0EF5AA9B,R21,Rash and other nonspecific skin eruption,-
6B161CCA-0CE3-424F-B210-5A8C8746857E,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
FAC774B0-88E5-44D1-96A7-BA7CD3A98BA8,H02.9,"Disorder of eyelid, unspecified",-
EDDAD9F5-A8CC-4079-B2A9-37D1CDF01E22,L30.9,"Dermatitis, unspecified",-
6057B0BC-C0DB-44E2-A2E3-060F9BF19DF8,A09.9,Gastroenteritis and colitis of unspecified origin,-
557B80AB-FBD8-4082-92DF-04789C8031E0,A09.9,Gastroenteritis and colitis of unspecified origin,-
745AAAF7-2B74-4F9F-835F-E88369762663,B35.2,Tinea manuum,-
B1A3EC1D-AAA4-4DFA-AC2C-12BC68F801A7,K64.9,"Haemorrhoids, unspecified",-
DF0F7165-B68F-447D-8306-44DA22FD8DEC,K59.0,Constipation,-
DF0F7165-B68F-447D-8306-44DA22FD8DEC,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
3DD3FAB4-BA60-4F0D-A99C-D2E111A72B78,L04,Acute lymphadenitis,-
E1A3315B-5468-48B8-ACDC-5C5398A76634,J06.9,"Acute upper respiratory infection, unspecified",-
6C2CF157-8D87-48D9-8368-FCE8276C99D3,M10,Gout,Gout
46D78972-964E-4FAA-8AEB-89670C17BD44,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
46D78972-964E-4FAA-8AEB-89670C17BD44,R51,Headache,-
F70C4CE1-70AE-49A4-A687-D2FF3987FDAB,J06.9,"Acute upper respiratory infection, unspecified",-
E3101AD9-2255-43CB-9989-8448CE7A305C,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
E544F267-F7AB-4D89-9654-39156139E9FC,R07.4,"Chest pain, unspecified",-
0E431B1A-76F9-42E9-A698-1DCDA0F890D7,L30.9,"Dermatitis, unspecified",-
0E431B1A-76F9-42E9-A698-1DCDA0F890D7,H57,Other disorders of eye and adnexa,-
1E9E10EA-536B-40BA-A810-CCD430BF20CE,D75.9,"Disease of blood and blood-forming organs, unspecified",-
252F4ED2-AE6F-4D77-8501-E28D57E9C2D5,T88.1,"Other complications following immunization, not elsewhere classified",-
7ED9E171-DFC1-4EBE-8FA5-9648F1A4587C,R42,Dizziness and giddiness,-
7ED9E171-DFC1-4EBE-8FA5-9648F1A4587C,R51,Headache,-
D1506386-9CCE-4504-8347-FA5966DA035C,R51,Headache,-
BF99765A-3E89-4C15-B4C9-4C03F3A1DF28,T88.1,"Other complications following immunization, not elsewhere classified",-
D1582250-5D84-4BAF-AC1D-92FA7DC28E05,J06.9,"Acute upper respiratory infection, unspecified",-
750D50DA-9DE3-4B36-AF6E-BF0A58A2930B,L91.0,Hypertrophic scar,-
5F2DC7DB-465E-42EA-9DC5-B1C384DF7C8F,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
0E242F59-0EBF-4C99-B78F-537B3E0F60D3,R51,Headache,-
28EB36F2-C309-4590-991B-96F0300236F1,A09.9,Gastroenteritis and colitis of unspecified origin,-
18240948-5607-4CDB-AD99-90D6B4FAD8FD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E9BDB837-26E3-419C-98F3-7826558C7855,S80.0,Contusion of knee,-
70DF742D-1E72-4E10-903B-248977061C6A,K64,Haemorrhoids and perianal venous thrombosis,-
50E95189-8BA6-445E-AC10-0548B614441B,G43,Migraine,Migraine
D9F50CD1-30F0-4B91-9B1F-387440843C97,J06.9,"Acute upper respiratory infection, unspecified",-
B5C7D0F1-084E-4023-9CBB-800DC120A8D6,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
AA8FEAB4-599C-4EF7-84F7-3485218B93E3,I10,Essential (primary) hypertension,Hypertension
AA8FEAB4-599C-4EF7-84F7-3485218B93E3,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
52017F23-BBF0-4C6A-8A7F-E029F425CB90,J06.9,"Acute upper respiratory infection, unspecified",-
186A9DB9-A45A-4B2C-B9DC-F3CDA18621C9,L30.9,"Dermatitis, unspecified",-
186A9DB9-A45A-4B2C-B9DC-F3CDA18621C9,K29.7,"Gastritis, unspecified",-
77576C77-D536-45CB-A0D8-B2871E841FB5,K30,Functional dyspepsia,-
186A9DB9-A45A-4B2C-B9DC-F3CDA18621C9,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
2AC7C396-1FEE-46E2-A5FB-058B025E2BAF,T88.1,"Other complications following immunization, not elsewhere classified",-
BCF0365E-2E41-4245-856D-A51EDD5ED1B4,R21,Rash and other nonspecific skin eruption,-
BCF0365E-2E41-4245-856D-A51EDD5ED1B4,M79.1,Myalgia,-
C6D401A7-A41F-4228-A821-594367506E5E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B032F406-5356-486F-AF97-E7C0FAC9D7E3,A09.9,Gastroenteritis and colitis of unspecified origin,-
70F7B47D-7C95-496B-9427-DC5DE736BD7D,G44.2,Tension-type headache,-
70F7B47D-7C95-496B-9427-DC5DE736BD7D,N94.6,"Dysmenorrhoea, unspecified",-
2FBBA32C-D645-4817-9545-79147ED114E2,R51,Headache,-
DB0E8874-FFCA-46F5-937E-480D09E788D9,J06.9,"Acute upper respiratory infection, unspecified",-
CD913BB8-8513-4DBF-BAF1-2E5D205EABAF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6B92D8A5-1213-4BFE-86A6-DED31E048199,R51,Headache,-
6B92D8A5-1213-4BFE-86A6-DED31E048199,R42,Dizziness and giddiness,-
D21339C4-C792-4C7A-8161-872EC9AB7AEB,R51,Headache,-
0D7A3922-1D51-4FE8-A451-79015341D24D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
760DF635-474C-4670-BF34-07FB63D551BA,Z71.2,Person consulting for explanation of investigation findings,-
EE4EACD3-C694-462D-A365-3A39BF8C6D3B,R05,Cough,-
5E46EFA5-8C31-4FDF-A925-8BCA6D7B262B,N39.0,"Urinary tract infection, site not specified",-
A4885233-D5F4-4416-A5F1-80CC17F856D3,K30,Functional dyspepsia,-
6102F98A-B00A-4DC4-9D6C-E2912A814F33,N94.6,"Dysmenorrhoea, unspecified",-
85CE8D82-B3FE-4A00-B8D7-78C2577A27AA,J06.9,"Acute upper respiratory infection, unspecified",-
DE77CB75-5C82-4D2B-91BE-43474778BCC8,R10.4,Other and unspecified abdominal pain,-
5033344F-5CAC-4004-A9ED-D0CED096AAA3,R11,Nausea and vomiting,-
DE77CB75-5C82-4D2B-91BE-43474778BCC8,H00,Hordeolum and chalazion,-
5033344F-5CAC-4004-A9ED-D0CED096AAA3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C8BDBD2B-9E5B-4B1E-9031-506B30869ED7,T88.1,"Other complications following immunization, not elsewhere classified",-
50F15CB1-F818-464E-9556-5069A8A1DDCA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8F1B7002-CCE3-4F31-AD33-44DA14C6D0E8,K29.1,Other acute gastritis,-
C8D449F6-7C91-4FF2-9878-1D460798EF18,A09.9,Gastroenteritis and colitis of unspecified origin,-
C8D449F6-7C91-4FF2-9878-1D460798EF18,J06.9,"Acute upper respiratory infection, unspecified",-
33EEAAAF-892B-47D4-8FAC-928A52D85455,J06.9,"Acute upper respiratory infection, unspecified",-
980416E4-E861-4306-BC1B-15666ABB473A,B37.3,Candidiasis of vulva and vagina,-
980416E4-E861-4306-BC1B-15666ABB473A,R51,Headache,-
653BF466-135A-4EC9-8A76-50947A4FF62F,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
7B268FF8-C31C-4040-9135-BE69E161B732,A09.9,Gastroenteritis and colitis of unspecified origin,-
718B7275-2664-403D-ACFD-E6C92EDDC234,R51,Headache,-
4FE709C7-2F35-4A84-B254-24CBCA1701AF,J03.9,"Acute tonsillitis, unspecified",-
84547A23-B49C-460F-99E5-0B8CA5AEE1AE,E05,Thyrotoxicosis [hyperthyroidism],Thyroid
8132A9A9-80E4-48CA-BBD7-FA0B4AD4911C,B35.4,Tinea corporis,-
83A823E7-02E5-4164-A756-0D3E893F1AC8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
020DFB5A-767F-430B-AD49-AD6F0146262F,A09.9,Gastroenteritis and colitis of unspecified origin,-
CCB99420-D370-46D7-9334-6315034649FF,N39.0,"Urinary tract infection, site not specified",-
86B9CA88-A073-47B0-8A87-25EAFA8B3671,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
86B9CA88-A073-47B0-8A87-25EAFA8B3671,R50.9,"Fever, unspecified",-
892BAA82-964F-4814-A514-1F1DB566233E,R51,Headache,-
892BAA82-964F-4814-A514-1F1DB566233E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3B311465-8A4C-4692-B3D8-6CC66C5F981F,J06.9,"Acute upper respiratory infection, unspecified",-
2725A53F-8D52-4F0B-9332-2AD4BA3C75F3,H10.9,"Conjunctivitis, unspecified",-
7FCC8A1D-FB92-4874-8F05-0DEA1E9BF20E,M77.1,Lateral epicondylitis,-
0BD352D9-C435-4DF8-A6A0-8952F1F026EB,K30,Functional dyspepsia,-
12F99CD6-3E84-4275-81CF-17CA51C04C77,Z71.2,Person consulting for explanation of investigation findings,-
B8CB6016-8D77-4D66-908E-D00CA91EE81D,R50.9,"Fever, unspecified",-
B8CB6016-8D77-4D66-908E-D00CA91EE81D,A09.9,Gastroenteritis and colitis of unspecified origin,-
6D0C158E-F75D-4ACB-B2FD-07213FDC8A23,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3D1E9F86-8632-4272-A831-1CEC45D40B82,Z71.2,Person consulting for explanation of investigation findings,-
A082AC8A-DCE6-4A74-BE1F-176E36CAD55A,B37.3,Candidiasis of vulva and vagina,-
893CE8BD-99C8-4399-8E04-5E309934A7F0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B475217C-5165-4CB7-BCB2-4FA24CCEE2DC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D3435A31-E34F-47EB-8CED-E9843F0B8279,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
8C2AEFCB-EDB0-43FC-8BFF-0B37A599769E,O21.9,"Vomiting of pregnancy, unspecified",-
E0D39508-0636-4DAE-B2EF-93BC29AD4FDC,A09.9,Gastroenteritis and colitis of unspecified origin,-
59E7DE77-255C-4B8B-A480-F6679472C845,K12.3,Oral mucositis (ulcerative),-
59E7DE77-255C-4B8B-A480-F6679472C845,R51,Headache,-
1CBA2A27-1183-4969-8496-AD02DABF9ED8,T88.1,"Other complications following immunization, not elsewhere classified",-
805F182B-9601-42D1-AAAC-1683BEC18707,T88.1,"Other complications following immunization, not elsewhere classified",-
12AC7A9D-00DB-4209-87BC-890A9A8339C2,R51,Headache,-
1FA8669F-F9E3-4C9F-B4F4-D5FAA562C87C,K00.9,"Disorder of tooth development, unspecified",-
8D0EE453-FEEB-4952-9791-BD27839FAC76,K12.0,Recurrent oral aphthae,-
E68A4EBE-02F6-4216-A1C3-E4B2D6F62BF8,M62.6,Muscle strain,-
66FF9B6E-6A85-4FD8-A3E8-E2C9D9AE08CB,M62.6,Muscle strain,-
909CB4A0-27A5-4FD8-8535-2B513CABB2AB,N94.6,"Dysmenorrhoea, unspecified",-
BFD5047A-0B76-448E-940B-8855CE2299F6,K29,Gastritis and duodenitis,-
FFB0D53E-576D-4CD5-B7C6-F3A7A27D9813,A09.9,Gastroenteritis and colitis of unspecified origin,-
7244FCA0-222F-4A7B-9C6E-A0C94C8F7074,M54.5,Low back pain,-
0C06C499-7275-42F8-9BA4-6097D152456F,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
A3A0EDA0-42E2-4249-8934-21608E727C39,L50,Urticaria,-
DD50AF8C-BEBF-4D3D-B903-6E1B287D673A,P39.0,Neonatal infective mastitis,-
1021AB76-3371-4439-972B-6D5428E8D861,T88.1,"Other complications following immunization, not elsewhere classified",-
40FB639F-F61B-4205-9273-BFF4E69BE1E6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EEC32C94-BAE0-4732-9387-212AA5D74CC9,N94.9,Unspecified condition associated with female genital organs and menstrual cycle,-
E355DEEF-168E-4CF4-9163-AB689E3D9DC2,R11,Nausea and vomiting,-
C8CF8A8F-E105-41F1-AF3A-174A56877577,B35.4,Tinea corporis,-
C8CF8A8F-E105-41F1-AF3A-174A56877577,J06.9,"Acute upper respiratory infection, unspecified",-
C311CFAD-1AA5-40E2-950D-27A30B0DE41C,R51,Headache,-
C6CEAFEE-234E-42D7-969A-92CFA5C1692C,R21,Rash and other nonspecific skin eruption,-
48681FD3-ACF8-42B7-9FDB-4DCB062022CB,Z71.2,Person consulting for explanation of investigation findings,-
E0F754CD-23AF-4E6B-B1E2-6896B0116920,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D3355D7B-121F-45F4-AB3F-98291EFEA937,M62.6,Muscle strain,-
5CE9809A-FDA5-42A5-A255-2A84319D443E,A09.9,Gastroenteritis and colitis of unspecified origin,-
31ED3EE4-D362-4C22-B5BD-C7E2DF19CA65,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
00BFE770-7A34-4940-9975-C36689666768,R21,Rash and other nonspecific skin eruption,-
BF58444B-6D9E-4C74-9F95-C757672B1350,N39.0,"Urinary tract infection, site not specified",-
B0D7557B-0259-4458-A283-D5BBFDCC0010,K29.7,"Gastritis, unspecified",-
0532BBCB-E01F-45A6-91FA-7123078ECEC8,R42,Dizziness and giddiness,-
63F04336-5978-4E7D-B84C-4C55CC87133A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1C210F5D-1A27-4F31-8B34-6AE8A6B3EED5,J06.9,"Acute upper respiratory infection, unspecified",-
65115E4F-A32F-4931-B408-AF9FA9609D9E,K13.7,Other and unspecified lesions of oral mucosa,-
42422424-4DE6-4E68-A7DA-36623448E7D8,A09.9,Gastroenteritis and colitis of unspecified origin,-
42422424-4DE6-4E68-A7DA-36623448E7D8,K30,Functional dyspepsia,-
E459C113-7025-4C26-A21C-B0ECE8D1E1C2,A09.9,Gastroenteritis and colitis of unspecified origin,-
D5C2AB2D-E932-4129-8173-4C540A4DE4BF,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
DF44DFAC-C4BD-4D8F-B1B8-C24C7E34179D,M10,Gout,Gout
B6D7717B-D6ED-4F4E-AD40-FB6F67A25DDE,M79.1,Myalgia,-
991F958B-9015-4C3B-BCF1-2B3139F43E50,N94.6,"Dysmenorrhoea, unspecified",-
5049CFC5-A904-478F-AD17-16CA3D58525D,R21,Rash and other nonspecific skin eruption,-
D49BB80C-94EB-4C01-A740-3B7336F2D130,R21,Rash and other nonspecific skin eruption,-
E0512AFA-FCC2-4391-A90C-90D9BC23C84A,R21,Rash and other nonspecific skin eruption,-
D26631BA-7D35-4CDA-900F-AA4641407EC0,J06.9,"Acute upper respiratory infection, unspecified",-
E66C649E-F6C9-437D-AB0A-978B77BB4D78,Z71.2,Person consulting for explanation of investigation findings,-
E66C649E-F6C9-437D-AB0A-978B77BB4D78,L20,Atopic dermatitis,Atopic dermatitis
E66C649E-F6C9-437D-AB0A-978B77BB4D78,I10,Essential (primary) hypertension,Hypertension
0C90032F-8D99-469C-B1A0-139A9F6F2510,I10,Essential (primary) hypertension,Hypertension
D8837D36-7307-4D95-AEC4-A78BABD5E4CE,R51,Headache,-
6C06CB26-85DF-4EE4-9B9D-D4D1A74183CD,S90.2,Contusion of toe(s) with damage to nail,-
2C9ABF44-B0B7-43BB-9D68-76A9B0B4CD6E,T88.1,"Other complications following immunization, not elsewhere classified",-
2888B1E4-B1E1-4F09-B54C-32C920FE60D3,A09.9,Gastroenteritis and colitis of unspecified origin,-
98736C98-8836-4B93-AEA0-05C6F89206E9,A09.9,Gastroenteritis and colitis of unspecified origin,-
4264BE63-F6A7-4352-9E6A-12ACF5A248D7,J01.8,Other acute sinusitis,-
4264BE63-F6A7-4352-9E6A-12ACF5A248D7,J06.9,"Acute upper respiratory infection, unspecified",-
EF227C9F-AFCB-4364-B1A5-B9746837E760,J06.9,"Acute upper respiratory infection, unspecified",-
2903B25A-A5B0-40F8-936F-7AA27B6F79D9,M62.6,Muscle strain,-
2903B25A-A5B0-40F8-936F-7AA27B6F79D9,U09.9,"Post COVID-19 condition, unspecified",-
B984CB7D-E67A-4B7A-89B1-B7AB7B66C806,U07.1,"COVID-19, virus identified",-
5D3DA4F9-427B-445D-887E-0CE431B69BD4,N39.0,"Urinary tract infection, site not specified",-
66AFA6F8-2F9D-4290-B21A-E7B4D5B1FA95,A09.9,Gastroenteritis and colitis of unspecified origin,-
8343DDC6-15EB-4125-8E53-ACD4709BE1B6,J06.9,"Acute upper respiratory infection, unspecified",-
D0F40911-D450-42D9-B95C-3A35EC9A5D16,T88.1,"Other complications following immunization, not elsewhere classified",-
2EF09920-DFFB-496A-889A-356C0F40E320,T88.1,"Other complications following immunization, not elsewhere classified",-
04EAF0FF-AEF1-4A5D-9D49-812AE76E5A0E,S60.0,Contusion of finger(s) without damage to nail,-
5300525D-577E-4527-A76D-03A4F254760E,R51,Headache,-
32D2C2F9-F961-4FDC-B3A5-CCC1D75C73CA,N39.0,"Urinary tract infection, site not specified",-
052757FF-8F52-4A78-B1BA-91A5CB025314,J06.9,"Acute upper respiratory infection, unspecified",-
639D1AF6-2C08-47FC-BDC1-8E248357E7DE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7B1BB8B0-13EE-405E-984B-36004AB07880,B37.3,Candidiasis of vulva and vagina,-
47B3FE71-B547-4950-8183-E6237BFE9A86,L71.0,Perioral dermatitis,-
47B3FE71-B547-4950-8183-E6237BFE9A86,L30.9,"Dermatitis, unspecified",-
2619DCD4-A8AF-4EE0-8098-F9252C2FD277,J06.9,"Acute upper respiratory infection, unspecified",-
D4E918B6-E3F0-4AAE-B2A8-A85759584AD9,J06.9,"Acute upper respiratory infection, unspecified",-
D58270E7-B2CF-4A03-BE36-BC4BE0DF519A,J06.9,"Acute upper respiratory infection, unspecified",-
E0A2D198-72B4-4E45-8460-B6610DBCBA76,M25.5,Pain in joint,-
38A20924-D742-481C-AE42-206C36D76B7B,T88.1,"Other complications following immunization, not elsewhere classified",-
4C9E37A1-688E-4E35-B233-9940755D2E50,M67.4,Ganglion,-
4C9E37A1-688E-4E35-B233-9940755D2E50,L30.1,Dyshidrosis [pompholyx],-
EE655BE5-8231-4732-9FC1-3EA227DBA3AC,J06.9,"Acute upper respiratory infection, unspecified",-
EE655BE5-8231-4732-9FC1-3EA227DBA3AC,U07.2,"COVID-19, virus not identified",-
B6A9DECA-9D08-48CC-8446-F698D45A9B25,M54.5,Low back pain,-
9F68B98E-2FF5-429D-A94E-F9965A4BBC38,L20,Atopic dermatitis,Atopic dermatitis
2AE102AF-31C3-4C46-B4AE-65B7C323A531,M54.5,Low back pain,-
09D9AD20-3397-43EC-B575-F8311616D016,A09.9,Gastroenteritis and colitis of unspecified origin,-
09D9AD20-3397-43EC-B575-F8311616D016,R50.9,"Fever, unspecified",-
F78183FF-50E2-4794-96E1-83D631FB55BA,J32,Chronic sinusitis,-
F78183FF-50E2-4794-96E1-83D631FB55BA,T88.1,"Other complications following immunization, not elsewhere classified",-
756DE370-F0CC-4A8A-9A85-3D34ACFD0858,A09.9,Gastroenteritis and colitis of unspecified origin,-
C873049F-5FD4-490E-8D2B-64A189DD94E7,I10,Essential (primary) hypertension,Hypertension
AE673B2B-6C99-4BCE-8654-D1355A200648,T88.1,"Other complications following immunization, not elsewhere classified",-
C9B8266D-0464-45A9-9D75-775131D27945,R51,Headache,-
D90BEEC4-86C0-4902-B544-0598DE490790,R51,Headache,-
63778F60-D697-4ADB-880F-B5BD57C16BEA,T88.1,"Other complications following immunization, not elsewhere classified",-
231EADE1-9C9C-4E7D-A9EC-30354BDFA3ED,M54.3,Sciatica,-
57D91A81-245A-4642-9FB2-DB563C279B6B,T75.3,Motion sickness,-
57D91A81-245A-4642-9FB2-DB563C279B6B,R21,Rash and other nonspecific skin eruption,-
57D91A81-245A-4642-9FB2-DB563C279B6B,Z76.0,Issue of repeat prescription,-
BCF16DFF-DF76-4FB5-894F-64D882CC6359,U07.1,"COVID-19, virus identified",-
452B37AE-111D-473B-9810-24B1FB77EAEE,A09.9,Gastroenteritis and colitis of unspecified origin,-
E5E8B0A4-BC1D-47C9-B54E-09E6482BE380,M79.1,Myalgia,-
E5E8B0A4-BC1D-47C9-B54E-09E6482BE380,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EED3CA3F-8ADF-4975-A81A-608AEBBB254D,A09.9,Gastroenteritis and colitis of unspecified origin,-
4840AC62-0974-448F-B9E6-289596D11FFC,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
ADB84E43-444B-47C5-8B68-F124CEFD1162,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DF203FAD-698C-4E78-835D-EA77D6F69737,A09.9,Gastroenteritis and colitis of unspecified origin,-
46B54558-5B18-474C-85E7-3314C9B343D8,A09.9,Gastroenteritis and colitis of unspecified origin,-
11374AF2-3E1A-4C6C-B869-79DB8168E7E5,K06.8,Other specified disorders of gingiva and edentulous alveolar ridge,-
89C80A18-A872-45D8-A502-21B18CE77B18,P39.0,Neonatal infective mastitis,-
0DDF24DB-50A6-40EA-830D-B21FB0FCDECC,Z71.2,Person consulting for explanation of investigation findings,-
9878AC54-A7A2-48D5-83BF-2210E72BC746,N51.2,Balanitis in diseases classified elsewhere,-
17CD415F-3905-427D-ADC2-2CC335F1FA8F,J06,Acute upper respiratory infections of multiple and unspecified sites,-
9049315E-0820-4E79-9243-9356A67BA98B,O91.2,Nonpurulent mastitis associated with childbirth,-
19EDC058-22C8-405F-BD60-B771C18A2E8C,R51,Headache,-
743E3DC0-51D4-4957-B007-A428AEF98593,R51,Headache,-
549F66A8-F50F-4FFC-BFE9-148E001F48E8,H57.9,"Disorder of eye and adnexa, unspecified",-
E9BAC97B-5091-413E-A17D-B07BDA5EADA3,H00.1,Chalazion,-
F6DC178D-B955-4D5D-A383-BD6E0A20DC80,K03,Other diseases of hard tissues of teeth,-
CDE619CA-BAB8-42CF-8DEE-22E1D7BFE8AB,A09.9,Gastroenteritis and colitis of unspecified origin,-
638382A4-5463-499B-8D50-7ABBD6007303,R50.9,"Fever, unspecified",-
ECFB9B2C-C541-40E5-AB63-BBF99F4BDD99,M79.1,Myalgia,-
638382A4-5463-499B-8D50-7ABBD6007303,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
AE05BD23-EECD-4F88-840A-74CC084479D0,H01.0,Blepharitis,-
450D2458-D8B6-42B7-8748-E2CCE24C5D1B,Y42.4,Oral contraceptives,-
8BC7D7F1-171B-49E5-8C43-CE565BDB9F88,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8BC7D7F1-171B-49E5-8C43-CE565BDB9F88,R50.9,"Fever, unspecified",-
C967B206-B40A-4D9B-8118-2E8A0B03AFCF,B37,Candidiasis,-
A1306C00-C346-4CDE-8D84-4C7BDA3B49B6,N76.0,Acute vaginitis,-
EB527854-D87A-43F8-B8FC-3FB9E9AFC1B2,A09.9,Gastroenteritis and colitis of unspecified origin,-
4B8B5686-525F-480F-AB0F-DB63401A7B4F,N94.6,"Dysmenorrhoea, unspecified",-
57E1E9F9-A46C-4CBC-99BB-DAFB9A350618,H57,Other disorders of eye and adnexa,-
57E1E9F9-A46C-4CBC-99BB-DAFB9A350618,R21,Rash and other nonspecific skin eruption,-
F553BA8A-AF00-4530-8C5B-A4D587ACF00D,J06,Acute upper respiratory infections of multiple and unspecified sites,-
843C3D10-1B4E-4E6E-B497-2AEC2443DEC4,N94.6,"Dysmenorrhoea, unspecified",-
843C3D10-1B4E-4E6E-B497-2AEC2443DEC4,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
843C3D10-1B4E-4E6E-B497-2AEC2443DEC4,A09.9,Gastroenteritis and colitis of unspecified origin,-
E7A415A4-71D8-4810-91FA-BAA59E1A698A,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
E7A415A4-71D8-4810-91FA-BAA59E1A698A,Z76.0,Issue of repeat prescription,-
E7A415A4-71D8-4810-91FA-BAA59E1A698A,J45,Asthma,Asthma
7273329E-69D7-4907-933F-593A17AE0214,A09.9,Gastroenteritis and colitis of unspecified origin,-
2BC074EC-F83F-44BF-9DC0-9F1CEF6B6A9A,A09.9,Gastroenteritis and colitis of unspecified origin,-
06CF281F-8A46-4FF4-8EF5-B6EE67A20DFC,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
4C6B8214-FA73-4606-9F13-B495D7CFF8DC,R51,Headache,-
CAC5FA57-64D5-472F-9932-876BB268B647,L20,Atopic dermatitis,Atopic dermatitis
B1831183-7815-4A86-B71C-DD4AF51098AB,A09.9,Gastroenteritis and colitis of unspecified origin,-
ACECEBC6-D193-4280-A89B-2A2C2F23269C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
ACECEBC6-D193-4280-A89B-2A2C2F23269C,J06.9,"Acute upper respiratory infection, unspecified",-
F904E7A0-B6E3-4090-94B4-5A7B1243E056,M23,Internal derangement of knee,-
1CC88F0C-65F6-4B3A-9115-D8192CB9A21A,A09.9,Gastroenteritis and colitis of unspecified origin,-
50F201DD-2825-4981-BE8B-304F53ECFAC6,S53.4,Sprain and strain of elbow,-
4010BC44-32CC-47ED-B460-E5FD60B70ECB,N39.0,"Urinary tract infection, site not specified",-
D12CD277-CBBB-47AD-87B5-5633F2B4677A,A09.9,Gastroenteritis and colitis of unspecified origin,-
C3342C3F-EEC6-48B3-A123-F8E46BBB94E5,T88.1,"Other complications following immunization, not elsewhere classified",-
18C48BE5-D141-48A8-B3DE-40F3C932753B,N39.0,"Urinary tract infection, site not specified",-
CC138C55-6D78-4A6C-84E7-00B701C19611,N94.6,"Dysmenorrhoea, unspecified",-
DDBFC7E2-E609-4DB9-B2CE-5622D9972750,R51,Headache,-
E5C4170B-07B6-4B7F-B90F-9F2CE3100FD0,N39.0,"Urinary tract infection, site not specified",-
FD244AE7-6229-4793-9CF1-4F4C6F95587C,K64.9,"Haemorrhoids, unspecified",-
E0C196FB-019E-4771-A670-116D9EC5D5F0,H10.9,"Conjunctivitis, unspecified",-
E618F37E-5406-4A53-9DFC-F97ACD400BE5,A09.9,Gastroenteritis and colitis of unspecified origin,-
6211C2AE-5CAE-4BD0-9919-3FB69F10C430,M79.6,Pain in limb,-
6211C2AE-5CAE-4BD0-9919-3FB69F10C430,M23,Internal derangement of knee,-
AEA6BBDB-0047-4E39-84FD-A813181DAB16,A09.9,Gastroenteritis and colitis of unspecified origin,-
A299BD87-C2BB-4B00-B2C2-08C2EFD329B8,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
A299BD87-C2BB-4B00-B2C2-08C2EFD329B8,M62.6,Muscle strain,-
A299BD87-C2BB-4B00-B2C2-08C2EFD329B8,R51,Headache,-
5D4BF357-BEBA-40CC-86F9-531477562749,J06.9,"Acute upper respiratory infection, unspecified",-
85DA629C-BB18-4CFE-9799-62FFE5A52328,L50.9,"Urticaria, unspecified",-
E7324465-F8DC-4B42-B067-0B01FFA7B91F,B37.3,Candidiasis of vulva and vagina,-
03D81726-00BE-4F9E-BBBD-788B3A6D5DD2,G44.2,Tension-type headache,-
B7025232-D319-442A-A00B-27237B0772FF,J34,Other disorders of nose and nasal sinuses,-
DAC2A1EF-0CB0-47A6-9D51-8996B9A55D45,R51,Headache,-
824B15DA-4B55-4E5D-B45C-EA070E7166C6,J06.9,"Acute upper respiratory infection, unspecified",-
E8537638-CBAD-4EA2-8E91-8B495DD6784A,U07.1,"COVID-19, virus identified",-
E8537638-CBAD-4EA2-8E91-8B495DD6784A,R00.2,Palpitations,-
1A781222-8174-4F9D-BBBF-290304137EC8,S83,"Dislocation, sprain and strain of joints and ligaments of knee",-
5517908D-FB5E-45EE-A755-0B103CE44C7F,H01.0,Blepharitis,-
B0558C77-B41C-4D30-8F4E-7B0BACE3DB47,R55,Syncope and collapse,-
90345D8E-5ABB-43CF-ADF1-B41494ADA8FC,R51,Headache,-
05CAC099-8F2E-4265-B150-4D5C61B2BE6D,R52.9,"Pain, unspecified",-
50B1E0F9-3108-474F-A421-D9980AFE0A43,A09.9,Gastroenteritis and colitis of unspecified origin,-
14227709-0CAF-43F1-8F2A-824DFE45A9C9,A09.9,Gastroenteritis and colitis of unspecified origin,-
9B27B6D7-C08F-4585-88CB-BEF78DA42073,T88.1,"Other complications following immunization, not elsewhere classified",-
9C5F1D3E-39AF-4EEF-BD8C-B3BCC55F51C8,M54.5,Low back pain,-
59B9A0B1-C750-4521-8797-58065B105B8E,J06,Acute upper respiratory infections of multiple and unspecified sites,-
7EE76CCB-F6AF-4DCE-BB48-EDECAB2D0545,N94.4,Primary dysmenorrhoea,-
8E7E29AB-4A1C-4C00-BE2E-2E8D8039B794,R51,Headache,-
93533FBC-6FB5-4E9A-914A-9725079ED53F,H00,Hordeolum and chalazion,-
D22ACED2-9455-418A-B661-715545A40875,J06.9,"Acute upper respiratory infection, unspecified",-
15D5F602-E847-4281-B56F-2B6899CF042F,A09.9,Gastroenteritis and colitis of unspecified origin,-
4A3293A0-BF72-414A-B47A-FC253AB61FCD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B278A9B3-D7FC-4425-A363-726308B72DE9,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
A2BE9378-D4B7-452C-9CEF-918B6CC16DC3,J98.7,"Respiratory infections, not elsewhere classified",-
FF10D153-9587-4444-9332-7ED1C569BEDD,M23.6,Other spontaneous disruption of ligament(s) of knee,-
E7358B8D-36C9-4937-81AC-DA8BF2AE5D3C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
286A7D59-6AE2-4821-8805-2A2ABE879586,M62.6,Muscle strain,-
89BE928A-C6F8-4101-B3AF-2F3E04A0A1EE,K29.7,"Gastritis, unspecified",-
C548F92E-4196-4A60-AF28-AB3DF80CA6D1,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
F421C6A2-C014-46BB-8E91-012DF919F5FC,T88.1,"Other complications following immunization, not elsewhere classified",-
754ECDB3-EE89-4CEA-BB49-DD83201D9F71,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EA5B5D22-F9DB-4C7C-A648-E4A50BD74DE3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
52136031-BF8F-47E0-BDE5-6AE5B40333C9,R51,Headache,-
26A65DD4-49F7-4F56-9173-5DBEBD26CB62,M62.6,Muscle strain,-
116DF10E-4802-4154-B381-DA861F15998C,N94.6,"Dysmenorrhoea, unspecified",-
9AC14ACB-2B9C-4E7E-8FC9-CEE40A76F09A,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
9AC14ACB-2B9C-4E7E-8FC9-CEE40A76F09A,R21,Rash and other nonspecific skin eruption,-
CB515205-8EDE-451C-BF1D-EE01C1BD30F5,S60.8,Other superficial injuries of wrist and hand,-
9D337C52-1B4A-41BF-A740-3D6CC4732C63,A09.9,Gastroenteritis and colitis of unspecified origin,-
B7EACD69-A47A-420A-B9EE-B9CF36D6056D,U07.1,"COVID-19, virus identified",-
4BA22923-58A7-4C03-9764-76793EF3285F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
59765941-3A84-4F4B-904E-4BD26B8BB94C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
399FFB07-66CD-4042-A8B4-344EC67A59A0,K58.2,Irritable bowel syndrome with predominant constipation [IBS-C],-
5D923182-0AD2-4860-93E6-68A706755064,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A71D7C29-8394-4187-B333-C9CEA2F94776,R07.4,"Chest pain, unspecified",-
A34BED86-3688-4345-BFCC-8C7ECAF95DEB,T88.1,"Other complications following immunization, not elsewhere classified",-
D75B5339-FF01-42BF-A704-561EF8CD7360,R21,Rash and other nonspecific skin eruption,-
89BF2048-0EEA-4EE6-B6DC-924F059B0162,J06.9,"Acute upper respiratory infection, unspecified",-
28472A99-3E93-4466-B925-6F56D6F1491A,M62.6,Muscle strain,-
2226F5D2-1574-4249-888F-226C5F683CE6,J06.9,"Acute upper respiratory infection, unspecified",-
C1CA2F64-EB93-4055-9186-9F359C77F221,A09.9,Gastroenteritis and colitis of unspecified origin,-
E4544B9B-CFA8-4404-8F99-832DBFDD1419,M25.5,Pain in joint,-
E4544B9B-CFA8-4404-8F99-832DBFDD1419,S80.0,Contusion of knee,-
8C7AC282-E4BE-4EA4-8ADA-87DC68967C5C,U07.2,"COVID-19, virus not identified",-
5B4834F2-D665-4E8F-BCBD-ED90033CC3E6,J06.9,"Acute upper respiratory infection, unspecified",-
6407ABAD-6B2F-4941-83E8-BCBC3BFC5200,U08,Personal history of COVID-19,-
DF95CD46-A095-44A0-82F3-576729BE5982,R51,Headache,-
7F7DE34B-ED4E-4513-8DEC-E1DC1D23B355,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
B098CB5B-F690-43B9-8ADD-31F57F18CF31,A09.9,Gastroenteritis and colitis of unspecified origin,-
0A5DB198-BA7F-47D8-9D5A-944CA07056C7,A09.9,Gastroenteritis and colitis of unspecified origin,-
8E5FA76F-3451-4184-AC52-65B779862216,A09.9,Gastroenteritis and colitis of unspecified origin,-
37377DEA-E343-4EDC-B07F-4A712F630EDF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2E9D8E96-06B6-48B9-8C48-C6F04ADFF681,J06.9,"Acute upper respiratory infection, unspecified",-
2E9D8E96-06B6-48B9-8C48-C6F04ADFF681,A09.9,Gastroenteritis and colitis of unspecified origin,-
38BA9648-52F1-4A1F-B5F6-17528717E27F,L30.9,"Dermatitis, unspecified",-
3B4719A4-1149-482A-8E51-9434BE6B01FD,N51.2,Balanitis in diseases classified elsewhere,-
C9C3F2AE-2922-4A43-AB39-82C8F8F53A0C,J06.9,"Acute upper respiratory infection, unspecified",-
036D9EB6-ED9B-43A1-88C9-066D2CA35A6A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
036D9EB6-ED9B-43A1-88C9-066D2CA35A6A,N76.0,Acute vaginitis,-
036D9EB6-ED9B-43A1-88C9-066D2CA35A6A,R50.9,"Fever, unspecified",-
AF1A8F24-285E-4FA4-9DDD-D53B8325887F,R10.4,Other and unspecified abdominal pain,-
1C982C23-8CFD-4D0F-9728-ACD73D0EB22C,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
3D5AC0DE-C131-4EEC-9A06-63D70091A07E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3D5AC0DE-C131-4EEC-9A06-63D70091A07E,R50.9,"Fever, unspecified",-
F7697FA7-5850-4AA7-88BF-721CCE7FFEC0,R51,Headache,-
00E7D712-AD3F-4BA5-A92D-97DE7B4874C6,N94.3,Premenstrual tension syndrome,-
D0D74650-A7F8-4CFD-8F6D-72C68E8D9B1B,M79.1,Myalgia,-
D0D74650-A7F8-4CFD-8F6D-72C68E8D9B1B,K08.9,"Disorder of teeth and supporting structures, unspecified",-
23031EF5-5C7F-430C-8467-9B83D813AD8C,Z71.2,Person consulting for explanation of investigation findings,-
DF370038-873A-4FF5-919F-49ADCBA0F2ED,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
B0C152B1-EF73-4D9B-9041-C901A5063CEF,Y42.4,Oral contraceptives,-
51068AB4-A9C5-46FA-AB9D-44E3325D05CF,N94.6,"Dysmenorrhoea, unspecified",-
AB7757B1-78E4-444D-B34F-95061A7A781D,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
6F233A5E-2A02-4131-A280-916BBB74AF88,R50.9,"Fever, unspecified",-
ADABFCFE-D738-4B95-91EC-0031119A8DEE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BA34DBE4-6EC8-4A80-AC8B-85DDE907933F,R51,Headache,-
22EDB1BD-9046-4F7E-B6A6-AE95C11D2B2E,A09.9,Gastroenteritis and colitis of unspecified origin,-
2DAB7731-0222-4D6B-8F7D-0F787391E663,T88.1,"Other complications following immunization, not elsewhere classified",-
12A3F368-89E9-452E-B4B9-5DA0492F0BB6,U07.1,"COVID-19, virus identified",-
3271DC7C-3E3C-46CD-A7A0-6508B4C7492C,B37,Candidiasis,-
3271DC7C-3E3C-46CD-A7A0-6508B4C7492C,K29.7,"Gastritis, unspecified",-
3271DC7C-3E3C-46CD-A7A0-6508B4C7492C,M62.6,Muscle strain,-
D9EEBC56-8253-4834-9FF7-AC33DE3312BC,R51,Headache,-
A269E185-1B3C-4E1A-96D9-BA1BE090B72C,K59.0,Constipation,-
A269E185-1B3C-4E1A-96D9-BA1BE090B72C,N94.6,"Dysmenorrhoea, unspecified",-
95F1B6C2-9E51-4B7D-BE11-D41450485A74,U07.1,"COVID-19, virus identified",-
0D7D529D-9E66-4BA5-BDA1-8158DB7CCEE9,R51,Headache,-
337B6B8D-F4A6-475B-97A8-223999BB5F01,N84.1,Polyp of cervix uteri,-
F5E2E9E5-5E07-41BD-A884-1B262A729141,R21,Rash and other nonspecific skin eruption,-
1BEDC404-AB95-44E3-B23D-B89D56B7AD32,J06.9,"Acute upper respiratory infection, unspecified",-
7A107705-8E2B-446C-AA48-7CA5DBBE19EB,A09.9,Gastroenteritis and colitis of unspecified origin,-
84618B07-B71B-4228-A5BE-FF01B1142E0D,R51,Headache,-
24CF2A5D-5FB8-4012-B1A2-E95956CD311C,J06.9,"Acute upper respiratory infection, unspecified",-
29F070CF-AA18-4ED2-A2D4-5C0DE07C8957,Z71.2,Person consulting for explanation of investigation findings,-
15AAB34C-02BA-41C2-ACCD-BCCD47934D6C,T88.1,"Other complications following immunization, not elsewhere classified",-
3DF2E9BC-AC97-4DB5-B6BB-8E7A82626B64,N94.6,"Dysmenorrhoea, unspecified",-
677A71AB-BCC6-4752-BD1A-2EECCFDC1259,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9745D231-C99C-4A77-A6C2-BCC03A2153FC,T88.1,"Other complications following immunization, not elsewhere classified",-
ACCC0C60-B954-4444-BD9B-DA24ECD4E7B4,R51,Headache,-
ACCC0C60-B954-4444-BD9B-DA24ECD4E7B4,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
FB43FF4E-910A-4DB4-8558-276E44834118,R53,Malaise and fatigue,-
C4FFA7F5-6540-4BDA-9B8F-9A3B0C3D9916,M54.5,Low back pain,-
41EEC3CF-8F4C-4B29-A59A-4AC89966DA81,Z02.9,"Examination for administrative purposes, unspecified",-
86D7B272-5823-4EF5-87A8-A00E27DB7C00,M62.6,Muscle strain,-
29EF3409-B38A-42D1-9AC2-092B3C69ECE3,M54.5,Low back pain,-
297C2C98-70E7-454E-A35C-D3A639BC4A27,M54.5,Low back pain,-
C3383D02-F55E-4C4A-A76B-94B206A0AFBE,J06.9,"Acute upper respiratory infection, unspecified",-
D5968F4E-C78A-49C6-AD26-07842BED8F25,R51,Headache,-
D5968F4E-C78A-49C6-AD26-07842BED8F25,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
46853574-882D-4235-AB35-A7898F49251E,A09.9,Gastroenteritis and colitis of unspecified origin,-
C0183B12-063C-4594-A8D1-D13E3EB626C3,J06.9,"Acute upper respiratory infection, unspecified",-
DD011D7D-2984-4380-8B09-310610D6498F,E05,Thyrotoxicosis [hyperthyroidism],Thyroid
DD011D7D-2984-4380-8B09-310610D6498F,H57.9,"Disorder of eye and adnexa, unspecified",-
DD011D7D-2984-4380-8B09-310610D6498F,R21,Rash and other nonspecific skin eruption,-
7520FE9E-1399-4E66-9AE9-6BA3DD2BBF54,K30,Functional dyspepsia,-
4B922A77-88EF-4187-9E82-F96275FDCB28,G44,Other headache syndromes,-
E0EBAFC6-04E0-4BC6-A6A6-C852A22CA49C,H81.1,Benign paroxysmal vertigo,-
8A6B46F1-1033-485A-977E-7E27F9876CCF,N94.6,"Dysmenorrhoea, unspecified",-
CA7864B2-0644-4A26-99E3-80246BCC5255,N39.0,"Urinary tract infection, site not specified",-
3A811E48-85E4-466F-90A4-8F4B90654C37,A09.9,Gastroenteritis and colitis of unspecified origin,-
7C64A0C1-95FC-4AED-9F62-AFDD0647CA6F,Z30,Contraceptive management,-
82F55627-15A6-4A6E-BD20-DDB447CCE36A,J06,Acute upper respiratory infections of multiple and unspecified sites,-
95D76360-4B00-42A1-BB49-BC4CE9391418,R51,Headache,-
1142DAE3-6C14-445F-9B5D-884C73C36CD9,S93.4,Sprain and strain of ankle,-
9EA54B6C-31C1-4943-A75A-5F129BD5689F,J06.9,"Acute upper respiratory infection, unspecified",-
18F4A634-BDFA-4CAA-ACFE-C4AF5DAADC45,S53.4,Sprain and strain of elbow,-
D742657D-3511-4424-AA6A-F4E40CC10BC6,J06.9,"Acute upper respiratory infection, unspecified",-
C190F3DD-2436-4F6A-A61E-5FC5278C99D7,J06,Acute upper respiratory infections of multiple and unspecified sites,-
B72281EE-31CE-4014-A93B-6F3C724CEC40,T88.1,"Other complications following immunization, not elsewhere classified",-
66317FC2-AF00-4125-9C6B-4B9B03DC9063,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
66317FC2-AF00-4125-9C6B-4B9B03DC9063,N39.0,"Urinary tract infection, site not specified",-
7C7A9801-B5EE-4B7C-96DA-6398D1201AE3,R51,Headache,-
EB8DD025-5C06-4E89-9B29-16FC7CE7A7A9,O21.0,Mild hyperemesis gravidarum,-
4573CB26-CE75-42D1-B262-BDE531775712,T88.1,"Other complications following immunization, not elsewhere classified",-
F4D2CE70-4BB0-4C86-BA20-364151FFDD89,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
027A5E96-16BD-4EEB-8961-736CA730928A,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
0F077346-802F-4941-A684-77C588FD766D,J02,Acute pharyngitis,-
E0FF2A08-C943-4A99-866D-F05717F5EB06,L20,Atopic dermatitis,Atopic dermatitis
0A08B923-9EF7-4AFB-AF98-FA5B63600DBD,N94.6,"Dysmenorrhoea, unspecified",-
316C82AE-5DCE-426B-9B89-ED36CB2B1708,Z71.2,Person consulting for explanation of investigation findings,-
B293C64A-6CBD-47B2-842B-24196CBA57F3,U07.2,"COVID-19, virus not identified",-
B293C64A-6CBD-47B2-842B-24196CBA57F3,J06.9,"Acute upper respiratory infection, unspecified",-
6C45B1FD-F0DB-4AC9-8EB2-71DA3DF12706,K13,Other diseases of lip and oral mucosa,-
F5CB2656-DF2E-42CC-A2F4-92BF5FD719E7,N94.6,"Dysmenorrhoea, unspecified",-
89F097A7-576A-4C71-B96F-320F2CA4B238,T88.1,"Other complications following immunization, not elsewhere classified",-
EE903D8A-F0C4-4A24-816E-6476B9F635C7,H92.0,Otalgia,-
3B7143FA-90BB-4B66-A388-CB5A58E3115D,U07.1,"COVID-19, virus identified",-
60BBF515-441B-4528-9682-4F8B9D793574,N94.6,"Dysmenorrhoea, unspecified",-
725F31B5-98F4-4A66-82A4-9014CAE02415,R50.9,"Fever, unspecified",-
725F31B5-98F4-4A66-82A4-9014CAE02415,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A7D808D7-2A76-4769-B804-8AB60673BEFC,Z30,Contraceptive management,-
EF611528-8C0D-459B-9345-C7B735BF8AEE,M79.1,Myalgia,-
EF611528-8C0D-459B-9345-C7B735BF8AEE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3D77C232-B2C4-4C1A-858F-14E0D384A0C8,N76.8,Other specified inflammation of vagina and vulva,-
33C23D40-C0AD-4901-81EB-E8021DEF44B3,T88.1,"Other complications following immunization, not elsewhere classified",-
576DD47E-DB59-4F41-942C-744EA62EF19E,A09.9,Gastroenteritis and colitis of unspecified origin,-
B4FB2E31-541C-4090-B9EB-B2F343ECDEAC,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
ABF90F7D-B27C-422E-86F2-B550DC12C1FE,H10.9,"Conjunctivitis, unspecified",-
200BA2A6-FA78-4297-8691-FFED03B75EEE,G44,Other headache syndromes,-
91FD52A2-5157-4CE2-BAB8-D4374E75C462,J06.9,"Acute upper respiratory infection, unspecified",-
292393BC-FF0E-4B62-A6DB-7BEF75EEA007,J02,Acute pharyngitis,-
73BAC4F2-7A00-46DA-8DC7-B1C8DD0E0711,U07.1,"COVID-19, virus identified",-
43E0C63C-D2E0-4EA8-BE5F-270ABD013DA7,N39.0,"Urinary tract infection, site not specified",-
1A6FF65B-221A-44BC-9596-2C72773E46D8,A09.9,Gastroenteritis and colitis of unspecified origin,-
0A4131C9-2A34-4732-B822-7D3DF1C00B63,J06.9,"Acute upper respiratory infection, unspecified",-
023A0D4A-046E-4893-AA37-C63B5B511D19,J06.9,"Acute upper respiratory infection, unspecified",-
2960CB5E-7B30-4C17-9ED8-318606094A5B,J06.9,"Acute upper respiratory infection, unspecified",-
751B8790-C3D6-4658-9F75-54168F719B7E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
97FDCF86-840C-440E-AEDE-E0FD75446B6F,N94.6,"Dysmenorrhoea, unspecified",-
3A479BEC-BED3-4067-AE60-70053C954F7F,Z76.0,Issue of repeat prescription,-
D8E69CB2-7E95-4862-A780-74DD568C7208,A09.9,Gastroenteritis and colitis of unspecified origin,-
73DBFE25-C4AF-4AC0-9518-B54E9C4BAFC3,H57,Other disorders of eye and adnexa,-
5DFE867E-DE2F-4958-A540-5FAF1D69A30E,R51,Headache,-
DD81ACFD-598D-44AD-A3D0-59573440088B,R51,Headache,-
1828560D-1DE9-40C8-964F-A9C6535A9DA3,R10.4,Other and unspecified abdominal pain,-
2EB2EB0D-540B-40AF-A852-1AD6D48A344F,J06.9,"Acute upper respiratory infection, unspecified",-
D9E4F5B5-F0CF-4F8F-B13D-44B8B058EE82,J06.9,"Acute upper respiratory infection, unspecified",-
DAC27E1F-C4C7-4B39-B9E6-226965479004,U08,Personal history of COVID-19,-
DAC27E1F-C4C7-4B39-B9E6-226965479004,K29.6,Other gastritis,-
6553BBBB-97D7-4607-BB2B-6D4CB315F897,R51,Headache,-
6553BBBB-97D7-4607-BB2B-6D4CB315F897,J06.9,"Acute upper respiratory infection, unspecified",-
87B25ECF-1031-4FF3-BB98-FF5980C985D8,N39.0,"Urinary tract infection, site not specified",-
D1357286-F5EB-4CB2-B0C1-0EA041E1381A,J06.9,"Acute upper respiratory infection, unspecified",-
D1357286-F5EB-4CB2-B0C1-0EA041E1381A,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
F4F60107-CBD8-47ED-B124-F62090C00DA4,K59.0,Constipation,-
34109B1F-7B59-499C-94D2-469B9F0EAF12,R51,Headache,-
6D69C1E2-5C27-4802-AD17-2851F9F75B6A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BED2A262-6C0B-47B3-887F-CAA4E7C30DCE,Z71.2,Person consulting for explanation of investigation findings,-
28FBFFB3-ADDB-4BC7-BEAA-A5041C3EEB86,M25.5,Pain in joint,-
0BFA02E9-0F2E-4CD5-B69C-F55A08E3E58B,A09.9,Gastroenteritis and colitis of unspecified origin,-
C9394466-1379-4FF1-83FC-3C8F5325A8BC,M25.5,Pain in joint,-
4019A34E-9467-4D43-8A41-65DD98207CE2,M54.5,Low back pain,-
A2D31CFD-FE1C-4F23-873A-A9EA735A3E4F,Z71.2,Person consulting for explanation of investigation findings,-
A2D31CFD-FE1C-4F23-873A-A9EA735A3E4F,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
E19E250E-2FAC-45C4-AFB8-04D5C712F727,I10,Essential (primary) hypertension,Hypertension
418D273C-0217-4D19-9BE1-AAA8C23D13A5,N94.3,Premenstrual tension syndrome,-
91C6A99B-6173-4159-B2CD-2417718316D0,A09.9,Gastroenteritis and colitis of unspecified origin,-
4845CD68-37C5-4F68-9899-E30B1259C895,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A0FF5026-93D8-4937-8422-2EBFF154B0B2,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
4E24A630-6BD7-4E48-9285-08884D4C1486,N94.6,"Dysmenorrhoea, unspecified",-
4E24A630-6BD7-4E48-9285-08884D4C1486,M62.6,Muscle strain,-
4E24A630-6BD7-4E48-9285-08884D4C1486,S33.5,Sprain and strain of lumbar spine,-
865B6E9F-F280-40CC-9A86-5C6731BE9FB9,R52.9,"Pain, unspecified",-
865B6E9F-F280-40CC-9A86-5C6731BE9FB9,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
883F528E-AB6A-4AB8-B7F6-F18E46D96DCF,A09.9,Gastroenteritis and colitis of unspecified origin,-
BD078A12-DC0A-417A-BE94-95F0873823DE,A09.9,Gastroenteritis and colitis of unspecified origin,-
F208AB25-5114-400D-AB5A-63C232F1529C,K29.7,"Gastritis, unspecified",-
3EBE2AA7-1FBD-49B3-9047-55502C1332FB,K29.7,"Gastritis, unspecified",-
FDA3C8F1-3921-4E6F-971A-A91A0DC3A20F,N94.9,Unspecified condition associated with female genital organs and menstrual cycle,-
08BF5BF5-B212-4B9D-8E59-4DD76FBE98DB,K08.9,"Disorder of teeth and supporting structures, unspecified",-
8A35D4DA-23B6-4B9C-BADD-A583F3A8ED65,U07.1,"COVID-19, virus identified",-
88022A91-7C47-4719-B194-2D6A37B14AAF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
499BFE6D-CCEE-4F82-95E3-4D1475ED6A40,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
F0488A84-65BF-48FD-8BD1-34D16C3B4CA1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D6780571-EAA6-4024-B464-750BADD8C4D3,M62.6,Muscle strain,-
39F980F7-0E0C-4FCA-A2E4-840CC1CE283C,M54.5,Low back pain,-
D6780571-EAA6-4024-B464-750BADD8C4D3,M54.5,Low back pain,-
CA014CB4-31C7-43DA-96C8-CB4CC073F396,G43,Migraine,Migraine
49446D25-7566-45B4-BFED-53F7A9665D2A,A09.9,Gastroenteritis and colitis of unspecified origin,-
9A7E9F5C-7A99-41C6-A9F2-EED093282A07,M79.1,Myalgia,-
0F94BB9C-3D3B-48E6-9D07-46070329FBEB,R51,Headache,-
8C0AEA90-6556-41F0-9188-7381FAB9B2B2,A09.9,Gastroenteritis and colitis of unspecified origin,-
D0EC10D7-CD89-4995-901C-7854A8B7FF1F,R14,Flatulence and related conditions,-
D0EC10D7-CD89-4995-901C-7854A8B7FF1F,K29.7,"Gastritis, unspecified",-
DF7728E0-FAF3-47F3-B18B-4EBFBDAB6A96,G43,Migraine,Migraine
D8E69CB2-7E95-4862-A780-74DD568C7208,R42,Dizziness and giddiness,-
BBCAECC7-A3BF-4639-9CCF-E8FFD6FA0FD8,R21,Rash and other nonspecific skin eruption,-
AAF07AA5-FC34-412E-9BF9-23403D138175,R11,Nausea and vomiting,-
54175FA0-129C-4BD3-898F-6EA72A494425,R51,Headache,-
54175FA0-129C-4BD3-898F-6EA72A494425,N94.6,"Dysmenorrhoea, unspecified",-
18AE3ED7-C736-4086-9261-443C1A8BE411,A09.9,Gastroenteritis and colitis of unspecified origin,-
18AE3ED7-C736-4086-9261-443C1A8BE411,M54.5,Low back pain,-
B6BDBBDB-2B9A-494F-8179-B3204B6DDFF0,H81.1,Benign paroxysmal vertigo,-
589AFB06-BA2C-4CE7-830D-B14149D17820,A09.9,Gastroenteritis and colitis of unspecified origin,-
B577A43F-7F03-4E50-93DB-72C9B50C787F,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
7DA95C55-623D-4AF8-BC81-BC79E0DAFA04,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9D6344BD-FC91-430D-9843-8FE27AAAFC61,H00.1,Chalazion,-
4F5C1BA0-11C3-4757-B02E-A747ADB1F3A1,J06.9,"Acute upper respiratory infection, unspecified",-
B68369D9-77BF-4C0E-8745-5226EF0922AE,M10,Gout,Gout
1081BF84-150E-4037-A375-4D8C9938BEA1,R51,Headache,-
BBF062AB-C21C-4088-9B0B-F6DC3E20E921,H11.0,Pterygium,-
4A1E70E1-77E2-443F-B393-6A3F4DC9213C,L30.9,"Dermatitis, unspecified",-
7083CA1C-D45C-4664-8C6D-74618246CC81,A09.9,Gastroenteritis and colitis of unspecified origin,-
D72C4D37-46D2-43CC-8D7C-77EC5CC0E139,R51,Headache,-
D72C4D37-46D2-43CC-8D7C-77EC5CC0E139,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4207CC3D-5E29-4709-AF44-99FD3FB9D3E0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3D414D37-9516-450B-9137-7864F5BCE26B,J06.9,"Acute upper respiratory infection, unspecified",-
D1CAD372-169E-4A00-8758-E22D18D1D860,M62.6,Muscle strain,-
2C1D0024-7319-473C-B980-62D31D2E2103,J06.9,"Acute upper respiratory infection, unspecified",-
36B70F36-89F9-453D-9FEA-6A0497FCD0AE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
36B70F36-89F9-453D-9FEA-6A0497FCD0AE,M79.1,Myalgia,-
B5CF6043-D1D0-415A-BB9C-A0FA5BD7F32C,N92.0,Excessive and frequent menstruation with regular cycle,-
DCD81C63-F312-4823-8B43-4269BEB72E81,N94.6,"Dysmenorrhoea, unspecified",-
2164DA76-4C22-49E6-843A-DF2825333602,M10,Gout,Gout
7CCB1C12-ED1A-4834-88B9-E917D44F1026,T88.1,"Other complications following immunization, not elsewhere classified",-
6C9092B0-845D-44BA-9884-03EEABE1F83B,T78.4,"Allergy, unspecified",-
6C9092B0-845D-44BA-9884-03EEABE1F83B,R21,Rash and other nonspecific skin eruption,-
2856FFD0-B4CD-468B-9432-0AE40F3B4CFD,M10,Gout,Gout
5D3AC5A6-B4EC-4222-9E56-D75F509BD82F,A09.9,Gastroenteritis and colitis of unspecified origin,-
6DECB65E-33DE-42AE-82EA-FD1614828F19,M10,Gout,Gout
F8CAD1E7-1DFA-4754-8902-71A772D532F6,Z71.2,Person consulting for explanation of investigation findings,-
162BF4CE-90F2-4003-ABC9-7845AF61F41A,G44.2,Tension-type headache,-
2EB219B8-7D5D-42F1-80EE-CDF0D068008E,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
231BBD12-16A1-48CC-9AFD-1BCFCD121527,A09.9,Gastroenteritis and colitis of unspecified origin,-
A75832D3-2AFD-4531-877F-E61557BE43D8,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
A75832D3-2AFD-4531-877F-E61557BE43D8,J45,Asthma,Asthma
42E26304-DE55-4A4B-9DC6-FBFE5DE3CA8E,J06.9,"Acute upper respiratory infection, unspecified",-
2A7036DD-7BE5-40C6-AD5E-BD828BEC3038,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
BC9C315C-94C5-4C3B-890F-351D83CE61D0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BDC9246D-006F-43C8-A99C-6D499BE30A55,A09.9,Gastroenteritis and colitis of unspecified origin,-
D253E7F4-2746-48B0-9C11-22897FD69508,J06.9,"Acute upper respiratory infection, unspecified",-
0F011CBC-D4BB-40EB-9B71-E233DA49738E,R21,Rash and other nonspecific skin eruption,-
D30DADC6-6B3B-4F02-A7A0-8ADB8717899B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CFBDA1F6-28D7-40F6-8D05-4F06E19AE420,M23,Internal derangement of knee,-
2367229A-FF82-46B7-8B9A-AFA0DD4DE004,E11.9,Type 2 diabetes mellitus without complications,Diabetes
2367229A-FF82-46B7-8B9A-AFA0DD4DE004,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
544582F9-D315-4145-BBF3-49815DAFC454,E11,Type 2 diabetes mellitus,Diabetes
967E2A89-B6F2-42C6-96A6-82786A606616,L20,Atopic dermatitis,Atopic dermatitis
DF7728E0-FAF3-47F3-B18B-4EBFBDAB6A96,H93.1,Tinnitus,-
DF7728E0-FAF3-47F3-B18B-4EBFBDAB6A96,H81.1,Benign paroxysmal vertigo,-
B60B7EDF-5086-4FEC-8188-E7ADD6D3E072,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
B60B7EDF-5086-4FEC-8188-E7ADD6D3E072,R21,Rash and other nonspecific skin eruption,-
B60B7EDF-5086-4FEC-8188-E7ADD6D3E072,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
B60B7EDF-5086-4FEC-8188-E7ADD6D3E072,H02.9,"Disorder of eyelid, unspecified",-
95A5D781-B485-4AAC-8480-9496F8D30B8D,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
9BCBC68A-0B1D-4F54-B2D4-52AA47661FE9,R50.9,"Fever, unspecified",-
9BCBC68A-0B1D-4F54-B2D4-52AA47661FE9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
18E8E12A-1C38-4EC4-A70E-642C101C9F79,R51,Headache,-
73818C9C-F3FF-47D0-81CC-D7FA5587BC20,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
382A2B71-2F66-4A08-8D74-F9153A1C5E11,N94.8,Other specified conditions associated with female genital organs and menstrual cycle,-
BAD6C305-037D-4690-B1B8-3DC2D456FA15,L30.9,"Dermatitis, unspecified",-
395DD081-7162-43A0-8AFA-285D59B43477,R21,Rash and other nonspecific skin eruption,-
B5B93CD4-9BA8-40B0-B689-ABB8E3956163,J06.9,"Acute upper respiratory infection, unspecified",-
1531A9F5-773D-4B5A-A2A6-FEE43BCDA3A5,T88.1,"Other complications following immunization, not elsewhere classified",-
A358AEC4-9A61-49A5-BF42-520A1269ACAE,O91.2,Nonpurulent mastitis associated with childbirth,-
4EC26C78-84CE-4AA5-9C41-1A67EB9783F2,R51,Headache,-
4846792E-BDD0-4B36-9AFB-B8FB3CB1D65C,Z71.2,Person consulting for explanation of investigation findings,-
0EFF8372-8A1E-4E54-8C81-53A2290A7480,R51,Headache,-
37CCE76C-562D-4C26-A84D-E821C2180CCE,Z71.2,Person consulting for explanation of investigation findings,-
3EDF5EA0-CF1B-42BF-A565-C2F55DAFC18D,N94.6,"Dysmenorrhoea, unspecified",-
0A390B7C-3BED-461D-8D72-B43375465520,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
0A390B7C-3BED-461D-8D72-B43375465520,K64.9,"Haemorrhoids, unspecified",-
0A390B7C-3BED-461D-8D72-B43375465520,G43,Migraine,Migraine
BEB662FE-A998-4366-8D1C-E1EE6426B8F9,I10,Essential (primary) hypertension,Hypertension
2EE5E1C6-8764-4040-B947-98C2C5F59214,L03.3,Cellulitis of trunk,-
66C7A907-2C79-42CE-B94D-8B95DE0BA2C4,L03.8,Cellulitis of other sites,-
FF1BA215-020C-4281-97F5-EAAC07AD5206,L03.8,Cellulitis of other sites,-
A768E78E-0BCE-413A-9090-B2EE3D8A242F,T78,"Adverse effects, not elsewhere classified",-
2EE5E1C6-8764-4040-B947-98C2C5F59214,K29.7,"Gastritis, unspecified",-
9048FA4F-2BC6-4D55-916E-2E0DA58FA953,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
2EE5E1C6-8764-4040-B947-98C2C5F59214,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
FF1BA215-020C-4281-97F5-EAAC07AD5206,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
734DD79B-F489-4353-9BC0-FD99C5D6744D,T88.1,"Other complications following immunization, not elsewhere classified",-
707623D3-4C19-4231-B235-A6801CC0BAF6,T88.1,"Other complications following immunization, not elsewhere classified",-
707623D3-4C19-4231-B235-A6801CC0BAF6,J06.9,"Acute upper respiratory infection, unspecified",-
707623D3-4C19-4231-B235-A6801CC0BAF6,U07.1,"COVID-19, virus identified",-
707623D3-4C19-4231-B235-A6801CC0BAF6,R50.9,"Fever, unspecified",-
1C35EDED-A807-4A82-B97E-B41A1FC27C95,N92.0,Excessive and frequent menstruation with regular cycle,-
2A457E6C-744E-45E7-84AB-762113857F6D,T88.1,"Other complications following immunization, not elsewhere classified",-
02408136-E01F-4261-B49B-BBA9FF6A7672,A09.9,Gastroenteritis and colitis of unspecified origin,-
A6E00BD4-1CA8-4793-8937-D1A245FFDC0C,A09.9,Gastroenteritis and colitis of unspecified origin,-
7A67D659-D065-48F4-AB7B-E8853BE877AC,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
E961B79E-8F8E-4C4A-98C5-D50B0201A6CF,T88.1,"Other complications following immunization, not elsewhere classified",-
B90814BF-6ABF-4B37-91A2-28CC00392528,Z71.2,Person consulting for explanation of investigation findings,-
1150B444-21D4-4B9A-B2FD-BE96530225CF,R51,Headache,-
C611BB64-971E-4ED1-989C-1DBC3FB72CC5,L50,Urticaria,-
C611BB64-971E-4ED1-989C-1DBC3FB72CC5,J06.9,"Acute upper respiratory infection, unspecified",-
59986643-1DDA-4B90-AF95-4B720C6B74F4,Z71.2,Person consulting for explanation of investigation findings,-
7B280899-BE8A-4721-AAD5-F75613BD3AC2,A09.9,Gastroenteritis and colitis of unspecified origin,-
847DE4CC-8F1C-4DF9-8C97-5B3D851C3AD8,J06.9,"Acute upper respiratory infection, unspecified",-
0665C5CA-E52E-4793-A8AE-40DBA90B9E8D,A09.9,Gastroenteritis and colitis of unspecified origin,-
F1DB4539-A7E5-444F-A68B-A4509E81B696,R51,Headache,-
0C243360-6C1F-4BF1-B3B7-E2D6FDA1F58E,I10,Essential (primary) hypertension,Hypertension
61747160-44CA-46E1-965A-E1B6F761CD5F,M54.5,Low back pain,-
8E91D82F-894D-4102-8CB2-1E726BDB2130,G44.2,Tension-type headache,-
8E91D82F-894D-4102-8CB2-1E726BDB2130,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
AB7DADF2-60E3-49AE-B615-9DD6C999F191,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
AB7DADF2-60E3-49AE-B615-9DD6C999F191,R51,Headache,-
FCDEE3A1-DD5E-42CC-9757-3B8036BEF5F0,A09.9,Gastroenteritis and colitis of unspecified origin,-
FCDEE3A1-DD5E-42CC-9757-3B8036BEF5F0,K29.7,"Gastritis, unspecified",-
E74BA8D6-6F2C-49CF-9C3A-CD62F25FC94E,U07.1,"COVID-19, virus identified",-
A13215E3-1EB9-4213-A53E-A739B8D55FF4,N39.0,"Urinary tract infection, site not specified",-
AC6C5F40-92E8-4A18-A696-D27924A49301,N39.0,"Urinary tract infection, site not specified",-
850C4917-A861-49E1-85FA-24B6C1CA4A68,Y42.4,Oral contraceptives,-
0404944B-33E0-42B9-A1ED-68ABC5372BB0,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
DC8FFB8A-F412-486B-A9D3-BBB2B4BA94D7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
52A22471-DF53-4172-A00B-098D86848C3C,N94.6,"Dysmenorrhoea, unspecified",-
91CDE591-0755-4FA3-A725-55ADB622F73D,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
4355280D-5B2C-4C88-83D0-D6B116E62161,J06.9,"Acute upper respiratory infection, unspecified",-
1F09308A-7339-4A07-BBA4-60BBB38092C4,J06,Acute upper respiratory infections of multiple and unspecified sites,-
9A899645-2657-4B14-846D-E59F359E09F4,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
BBC30AEE-10A8-4E4E-8957-4B590EB79F3C,A09.9,Gastroenteritis and colitis of unspecified origin,-
847CE081-FF11-4ED9-8098-8F861147D342,R53,Malaise and fatigue,-
6B4D157A-A299-41C7-8AF3-D635415045AC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
95E090F6-2868-42B1-ACBC-B3223164A81D,G44.2,Tension-type headache,-
1CDD2AE1-5E79-4FA6-9573-25B472B039F3,J06.9,"Acute upper respiratory infection, unspecified",-
BC4E326B-523A-4D8B-BB80-354F17C56E1F,M62.6,Muscle strain,-
DFCC9430-21B4-49C2-BD8C-04A0BEDCB2E9,G43,Migraine,Migraine
BA27151D-75BD-463B-AE08-27B85E678288,I10,Essential (primary) hypertension,Hypertension
DBF608EC-EFA4-403B-989F-A74F865426ED,J06.9,"Acute upper respiratory infection, unspecified",-
A8778934-D89B-4FA1-AF13-052E24B7D04A,R51,Headache,-
C6CD5EF7-AE9F-4CBA-8B43-0299EBA7B980,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1E4384BE-38BB-4793-AA55-EAB57356C732,J06.9,"Acute upper respiratory infection, unspecified",-
BAC30441-DBE6-43BF-9813-78E456B8E011,U07.1,"COVID-19, virus identified",-
BAC30441-DBE6-43BF-9813-78E456B8E011,J06.9,"Acute upper respiratory infection, unspecified",-
BC4E1BD7-A21A-4A13-A4CE-2C92BED9DEFE,R51,Headache,-
2A956601-7722-4C4E-A247-3D80B7C07F5C,F90.0,Disturbance of activity and attention,-
FE193D2A-8BD6-4026-A68E-509A6B9878A9,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
8F13B61B-B339-4E63-B4A2-1A552F27CCB7,M79.1,Myalgia,-
8F13B61B-B339-4E63-B4A2-1A552F27CCB7,T88.1,"Other complications following immunization, not elsewhere classified",-
8F13B61B-B339-4E63-B4A2-1A552F27CCB7,R51,Headache,-
73C5DD4B-7E6B-4E94-A71D-598C105A14BC,T88.1,"Other complications following immunization, not elsewhere classified",-
C2AB947E-B740-4BCD-BA10-8A2D8D158159,J06.9,"Acute upper respiratory infection, unspecified",-
B08A8257-E8C2-4EAD-8314-0034A5CE7BC4,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
01A7EF85-FF8A-4F94-8DB5-71969DA6700C,J06.9,"Acute upper respiratory infection, unspecified",-
98467B3C-0AAA-4918-8F99-4C6D81EE43E9,A09.9,Gastroenteritis and colitis of unspecified origin,-
FC3B6A02-0864-4D38-BCD9-AEFAED0C536C,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
9E2FA2DB-3BF0-4818-A938-A61662CC823F,M79.1,Myalgia,-
718149F9-9C5B-4D2D-B2D9-4B11FAE281AB,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
ACD9EA04-0A55-453B-A166-806B9C9A58E9,J06.9,"Acute upper respiratory infection, unspecified",-
A2769389-30CF-4DDC-A80D-09D863E059D7,J06.9,"Acute upper respiratory infection, unspecified",-
18F8273A-72B0-4862-9960-79E851AA001D,J06.9,"Acute upper respiratory infection, unspecified",-
F578A2AD-CD29-40C4-90AA-140917048C07,R51,Headache,-
F578A2AD-CD29-40C4-90AA-140917048C07,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
F578A2AD-CD29-40C4-90AA-140917048C07,R21,Rash and other nonspecific skin eruption,-
93D3E62E-54E2-41B4-B2EE-F12F2E42FA0E,R10.4,Other and unspecified abdominal pain,-
8A883843-6D69-47E9-A603-F5B09A35861B,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
CE906D8C-367F-452D-B5CE-F28411576A72,M54.5,Low back pain,-
E81C0FAF-5A93-441C-A073-A4EEEC33AF01,J06.9,"Acute upper respiratory infection, unspecified",-
E3A4E30A-0518-42EA-909C-8DC3CB11DD8E,A09.9,Gastroenteritis and colitis of unspecified origin,-
DDBBAA18-1BFB-4396-9E65-E8C48FBA2E94,J06.9,"Acute upper respiratory infection, unspecified",-
5D06F639-2A16-49DC-83DC-48E7F10B233D,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
5D06F639-2A16-49DC-83DC-48E7F10B233D,M54.5,Low back pain,-
E32E10E0-4BD2-44EC-B2C4-4EB0F1049384,A09.9,Gastroenteritis and colitis of unspecified origin,-
60C20558-808B-4B8E-8281-6DC4C2FD1665,N39.0,"Urinary tract infection, site not specified",-
96659F53-2BA6-4E45-A2D8-5F6919D7891F,A09.9,Gastroenteritis and colitis of unspecified origin,-
6E3FC7EC-D140-4661-88E6-A6C5552282D5,J06.9,"Acute upper respiratory infection, unspecified",-
17B4B4A9-F9DE-4E46-9C08-9D8D15630637,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
A242103F-3022-4860-B105-A52CEE5A5D1E,J06.9,"Acute upper respiratory infection, unspecified",-
A242103F-3022-4860-B105-A52CEE5A5D1E,U07.1,"COVID-19, virus identified",-
B8EBF6C4-8362-4F18-9EFA-4853B489BA06,F41.0,Panic disorder [episodic paroxysmal anxiety],-
357AC503-9EBC-44FD-932D-DD1A2C7593E2,A09.9,Gastroenteritis and colitis of unspecified origin,-
E8A5F908-547E-4206-B59C-3BA6436BC528,J06.9,"Acute upper respiratory infection, unspecified",-
7C58B52C-AC3F-47E0-86A5-BF497E6D914D,K29.7,"Gastritis, unspecified",-
7C58B52C-AC3F-47E0-86A5-BF497E6D914D,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
08F663D3-7C44-4076-A6C2-147C361A7664,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
851AA109-B4C3-4024-8C74-831DDDA58DDF,S60,Superficial injury of wrist and hand,-
D7BA4DFD-99CD-403F-A187-65D765AA0B2E,Z02.9,"Examination for administrative purposes, unspecified",-
652C05D6-C2BB-46E4-844F-1385B2BE605D,J06.9,"Acute upper respiratory infection, unspecified",-
2C52F7C3-1E96-4006-9AB4-9F2D2CB514C0,H00,Hordeolum and chalazion,-
6A941DDB-05FA-4BB9-A450-15B2CCD50935,R51,Headache,-
6E61D3F7-87AD-4E23-B578-BAF4F129D051,R21,Rash and other nonspecific skin eruption,-
86300BA2-509C-4FC5-99BD-1DE3544C708B,A09.9,Gastroenteritis and colitis of unspecified origin,-
840F4CFE-AB62-4C5D-B98E-6187D325A3C5,A09.9,Gastroenteritis and colitis of unspecified origin,-
CD3C54ED-0A8D-4C9D-92DD-FD076454418A,T78.4,"Allergy, unspecified",-
CD3C54ED-0A8D-4C9D-92DD-FD076454418A,H10.9,"Conjunctivitis, unspecified",-
582B6653-7F32-4E20-99EC-44278CB1A731,M12.3,Palindromic rheumatism,-
90611BDC-F212-4DD5-89A2-B3103AD662B7,T88.1,"Other complications following immunization, not elsewhere classified",-
29041AE2-BD71-473D-8AB3-2C1C770AF83C,J06.9,"Acute upper respiratory infection, unspecified",-
88D7CF85-7B27-4FAE-8273-BECBBABB4117,U08.9,"Personal history of COVID-19, unspecified",-
373B83C2-509B-4353-BCE2-AE2F3CA11826,U07.1,"COVID-19, virus identified",-
6CEA1302-BAE2-408F-B3E6-A7C790B79491,F00,Dementia in Alzheimer disease,-
E9033A78-2015-4B2B-AE54-2583B410829D,R21,Rash and other nonspecific skin eruption,-
EF611DC0-3BF0-4185-ABFC-6C72B13B6CE9,R21,Rash and other nonspecific skin eruption,-
884F2D83-F978-4EB2-8703-5194FA14F5D1,R51,Headache,-
C1BC162F-CD18-4B3D-880D-694B01B228B7,R51,Headache,-
2E09F629-B9B7-4891-A259-698A331C1DEF,R51,Headache,-
13A1A7E4-0770-4174-B729-A6A12E8CE6C6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9B9622AA-5DE4-41E8-B86C-1AE5A038831C,J06.9,"Acute upper respiratory infection, unspecified",-
1D7E1BD4-FFA2-4373-8871-520DCC7D7468,Z71.2,Person consulting for explanation of investigation findings,-
4E922C29-6AEA-4A39-AD27-702D0CF6BE49,B35.3,Tinea pedis,-
12AE626D-01F3-48ED-B358-C194BED1AFC3,J06.9,"Acute upper respiratory infection, unspecified",-
1BA6B0E6-26D2-494C-8BFC-CC1F621E72FB,N94.6,"Dysmenorrhoea, unspecified",-
E54CB349-A854-4CAD-9749-0D139BE9CB9D,N94.6,"Dysmenorrhoea, unspecified",-
50D251E2-69DD-4F3A-B6AF-B2540AFAF20F,B00,Herpesviral [herpes simplex] infections,-
F8A1B37C-3B5F-425C-A893-02F98BB8F15E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2564E222-523D-4FC2-90F7-9A2347793472,Z71.2,Person consulting for explanation of investigation findings,-
303EDF35-608E-4E7B-A287-FB0CCD485F93,J06.9,"Acute upper respiratory infection, unspecified",-
844D414F-E526-4612-A574-89A877FD2476,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
49C44355-190E-4B86-BD95-E43DC20FFCD7,N94.6,"Dysmenorrhoea, unspecified",-
A7FDCD2E-9F87-4A3E-BA08-C97B8A77924F,K13,Other diseases of lip and oral mucosa,-
09D30915-F641-4121-9175-D0F894500875,M62.6,Muscle strain,-
DE838A58-DDDC-499F-8816-A361AEBADBE4,H81.1,Benign paroxysmal vertigo,-
F0AC5998-8D4A-44FE-98DA-B04FB4B029EA,K07.6,Temporomandibular joint disorders,-
FC48BBDF-5728-4C8A-8408-A5482D64BE6A,R10.2,Pelvic and perineal pain,-
5DC814E8-BF04-4775-9F09-D072AB38FB54,S93,"Dislocation, sprain and strain of joints and ligaments at ankle and foot level",-
C52BDD20-CADB-40DF-A7B8-44E28A31F4FC,A09.9,Gastroenteritis and colitis of unspecified origin,-
63CC4661-57E2-4DED-9D7F-9CF0C6710C20,J06.9,"Acute upper respiratory infection, unspecified",-
A0458ECB-CD0F-4E86-B571-6618D7D8F1D9,M10,Gout,Gout
6C985F0C-4060-4126-8721-BF8DFF2E0B46,R51,Headache,-
6C985F0C-4060-4126-8721-BF8DFF2E0B46,K59.1,Functional diarrhoea,-
EB55AEB9-C2F3-4902-811D-34C00559AA6E,R21,Rash and other nonspecific skin eruption,-
4A1D2F6B-F7EF-43DD-82A7-9762A691AB0C,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F0E1DCCC-3B8D-445E-AD61-7B21F58E065B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
622415C3-981D-41F0-9176-E348343B9116,T88.1,"Other complications following immunization, not elsewhere classified",-
D78EB183-0B95-4563-89C0-D1EEBCA882C5,L50.9,"Urticaria, unspecified",-
D0AA3578-BA12-47D0-9C09-5C354890F9EB,T88.1,"Other complications following immunization, not elsewhere classified",-
CEF86BAB-4932-4949-B6EF-58B1E6658CDD,J06,Acute upper respiratory infections of multiple and unspecified sites,-
FDE937BB-D509-4799-90B9-139DDD90D8EE,M54.5,Low back pain,-
F36DCD7C-DE26-471D-AAB8-084E18EEFB2A,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
78172C1F-FCE5-4A7B-95E0-97EE462BC6AA,M54.5,Low back pain,-
753D018B-ADBA-497E-B72C-AEBA3367286E,J06.9,"Acute upper respiratory infection, unspecified",-
68840FEF-2432-4D43-878B-73C7C9EDA7CC,I10,Essential (primary) hypertension,Hypertension
03196B36-788B-4846-8413-6060E33F765F,H81.1,Benign paroxysmal vertigo,-
59EE7965-5CF1-4A4E-9841-806D6E7CD89B,H02,Other disorders of eyelid,-
979FD275-9082-4965-AC2D-04A856BD0019,J06.9,"Acute upper respiratory infection, unspecified",-
B354F86A-9B6C-4FF5-B7BC-A102346F73CF,J06.9,"Acute upper respiratory infection, unspecified",-
95203CDD-8B79-4FF0-8ECB-3ED8246AEC3E,L03,Cellulitis,-
3AA1EDB5-475A-4E79-A4ED-C420FE061410,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
85A01676-E213-4265-A5F5-AA3930A66F65,A68.9,"Relapsing fever, unspecified",-
90B9D152-08D3-4A6F-891C-9A752A2DF17B,T88.1,"Other complications following immunization, not elsewhere classified",-
D5A28611-B62F-4355-9216-FA9B987A2BB2,R21,Rash and other nonspecific skin eruption,-
D885AA01-22E5-4EF5-A45A-D610B73AE4D1,J06.9,"Acute upper respiratory infection, unspecified",-
4080CC4E-6341-48A4-93BE-8153E341E7B9,U07.1,"COVID-19, virus identified",-
A190F470-D8D8-4651-A7F5-CBF53B923333,T88.1,"Other complications following immunization, not elsewhere classified",-
A297C16E-BCCC-4BD1-A375-93D36C4C33BC,M50.1,Cervical disc disorder with radiculopathy,-
19D2E596-023F-4A18-B368-987D45D03D78,T31.0,Burns involving less than 10% of body surface,-
9EB154D3-BBD3-4779-AB38-7BD9C758C2C0,T31.0,Burns involving less than 10% of body surface,-
264EB98D-392F-41D6-8D3F-D2BD9456283B,A09.9,Gastroenteritis and colitis of unspecified origin,-
71E345AC-D78A-4411-901B-FFF73A95D1AC,N94.6,"Dysmenorrhoea, unspecified",-
8CC8977C-5BEE-4224-80AE-2B594DB0E36C,F43.1,Post-traumatic stress disorder,-
F7DF4567-9674-4000-9C7F-30DF42DE8046,R50.9,"Fever, unspecified",-
B789BA52-5AA8-4CFD-B087-3D0A94747A1A,R50.9,"Fever, unspecified",-
B789BA52-5AA8-4CFD-B087-3D0A94747A1A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EF70CF9B-6941-47D2-9458-2A58A385B969,R51,Headache,-
ECFDA568-352B-4F7A-88DB-76B05835E607,M62.6,Muscle strain,-
4E8029F6-58A8-4FC6-818B-D1EA1F0812D1,Z76.0,Issue of repeat prescription,-
4E8029F6-58A8-4FC6-818B-D1EA1F0812D1,L20,Atopic dermatitis,Atopic dermatitis
B5C517E3-0E71-4476-BBF1-D3AD53440AA8,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
4E8029F6-58A8-4FC6-818B-D1EA1F0812D1,K29.7,"Gastritis, unspecified",-
B5C517E3-0E71-4476-BBF1-D3AD53440AA8,H02,Other disorders of eyelid,-
4598F44A-FD22-433F-A82A-239E59399F13,N94.4,Primary dysmenorrhoea,-
101A51EE-DA0E-4098-AB49-A326D43A63FC,A09.9,Gastroenteritis and colitis of unspecified origin,-
D8F38C12-CCE4-4AB8-BE7E-143563A1EAC9,M54.5,Low back pain,-
3124B662-34E7-4115-B0BA-C7646B590B8E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D8623BF6-A8BA-4BD3-A94A-3ED0E5F8AA40,Y42.4,Oral contraceptives,-
AE07B017-2950-4350-A300-E4742A170BFA,Y42.4,Oral contraceptives,-
8A88D65D-25F1-4543-88AB-DF98EAFAEA05,R94.3,Abnormal results of cardiovascular function studies,-
B067D4E3-76A4-40B6-B191-8DCAD4E7A298,J06.9,"Acute upper respiratory infection, unspecified",-
B067D4E3-76A4-40B6-B191-8DCAD4E7A298,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6F64178E-4C27-4876-B0B1-15794CE9A283,L02.9,"Cutaneous abscess, furuncle and carbuncle, unspecified",-
572BE333-8BB4-4EED-9A8B-D6436583073F,M54.5,Low back pain,-
CD1E0E04-5299-4D46-8F79-78A7857A86C0,U07.1,"COVID-19, virus identified",-
CD1E0E04-5299-4D46-8F79-78A7857A86C0,J06.9,"Acute upper respiratory infection, unspecified",-
B0200CED-0537-45E7-A873-E3526FE0703C,N94.6,"Dysmenorrhoea, unspecified",-
0D956007-CB30-46DC-9B83-5659D8C1B9CC,J06.9,"Acute upper respiratory infection, unspecified",-
0D1B8E02-C942-43B8-A47E-9C966C2BB46D,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
B97D7A16-2BE7-4E89-A3ED-53EEF0166170,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
DCBB7417-A3B5-4094-83A7-F5D5FEE0F7C3,B02,Zoster [herpes zoster],-
9F2BC280-5CFD-4AF1-BD33-6B90EFF0BB79,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
1B81D4AC-B8EA-4110-9BB7-F2C3A7AF90FC,L29,Pruritus,-
EBE00A06-05C5-4727-B3B1-BFBD30C90B78,N94.6,"Dysmenorrhoea, unspecified",-
0A65EF4F-7DC2-4358-BF61-0F7453B69268,L30.1,Dyshidrosis [pompholyx],-
B5C7D0F1-084E-4023-9CBB-800DC120A8D6,A09.9,Gastroenteritis and colitis of unspecified origin,-
7F19326F-FC3D-4FF5-9DC2-CCF96B382632,Z02,Examination and encounter for administrative purposes,-
6BBC5179-D378-41D9-ACA1-23B5951B8F01,A09.9,Gastroenteritis and colitis of unspecified origin,-
AC458F6D-7655-468F-8DDD-4B2E5CE571FD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3DE8CBEF-6C90-466B-A03A-F680655202D0,M54.5,Low back pain,-
0AAC9865-B0C1-4270-A55A-D3E03D1713E9,R21,Rash and other nonspecific skin eruption,-
A2902791-1DBD-4CA3-9786-10DCF6676DB0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A2902791-1DBD-4CA3-9786-10DCF6676DB0,R50.9,"Fever, unspecified",-
8A45F03D-38FA-41DA-889E-D1066112E173,M62.6,Muscle strain,-
6DCE97BE-8C8B-46AF-BD80-EE35F0AA7BC6,L30.9,"Dermatitis, unspecified",-
A70B489A-DE96-4448-BF22-CFB71B9D041D,A09.9,Gastroenteritis and colitis of unspecified origin,-
6DCE97BE-8C8B-46AF-BD80-EE35F0AA7BC6,R21,Rash and other nonspecific skin eruption,-
186405D3-535F-44E8-BC42-5D2344A28E7B,T88.1,"Other complications following immunization, not elsewhere classified",-
E2FDD4A0-9FD7-4FF8-8297-58EBF098620B,Z02,Examination and encounter for administrative purposes,-
6F19CFA2-279E-4FFC-812A-C1B0377258D4,E11.9,Type 2 diabetes mellitus without complications,Diabetes
51DB40B5-5C90-4130-8A01-155F440DC224,N94.6,"Dysmenorrhoea, unspecified",-
357FEB87-DB49-484C-A005-D2EE02241ECC,A09.9,Gastroenteritis and colitis of unspecified origin,-
4C0CC916-A2AE-44C8-A2AA-9C3800F26AAF,J06.9,"Acute upper respiratory infection, unspecified",-
62B64D4C-6A8A-427E-8760-712181A49751,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
62B64D4C-6A8A-427E-8760-712181A49751,R51,Headache,-
22971BC3-C71D-4710-8204-1BB64629CC5D,R51,Headache,-
22971BC3-C71D-4710-8204-1BB64629CC5D,M62.6,Muscle strain,-
DFA374F7-9F77-4627-897B-E2CD23F02E12,H81.1,Benign paroxysmal vertigo,-
0AB77FC8-BF18-43B5-9B45-4F53794B43D1,M54.5,Low back pain,-
C722EAD2-AC0B-4F03-B694-9380A3669165,R50.9,"Fever, unspecified",-
C722EAD2-AC0B-4F03-B694-9380A3669165,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A193FF0C-06AE-4085-9360-EF90DDDFCE06,J06.9,"Acute upper respiratory infection, unspecified",-
975B0B57-F6AC-4347-990C-2FEF51ED1B5E,R42,Dizziness and giddiness,-
0255CCFA-30D4-418F-A20A-7AD441D26226,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
C5E9CEC2-7EF0-465E-8C15-CDA6700360D2,M79.1,Myalgia,-
1EEF85E0-0225-4576-B833-F36B350540E0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C9EB0684-9399-44AC-A93B-A09B434EA680,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B9672DC5-A3FA-45AF-ADEA-45DDF3504653,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B9672DC5-A3FA-45AF-ADEA-45DDF3504653,R51,Headache,-
748E8F4F-9835-41CF-A10C-826791640183,R50.9,"Fever, unspecified",-
748E8F4F-9835-41CF-A10C-826791640183,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
21AE1A47-2FA4-407E-9A9E-4D2772DCD83A,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
21AE1A47-2FA4-407E-9A9E-4D2772DCD83A,M62.6,Muscle strain,-
21AE1A47-2FA4-407E-9A9E-4D2772DCD83A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F8214B6C-124E-4075-BDE8-A60A2FC32B77,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
053D03AA-3FCE-444C-BE4A-61C31DF65278,I10,Essential (primary) hypertension,Hypertension
053D03AA-3FCE-444C-BE4A-61C31DF65278,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
053D03AA-3FCE-444C-BE4A-61C31DF65278,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
053D03AA-3FCE-444C-BE4A-61C31DF65278,E11,Type 2 diabetes mellitus,Diabetes
BD0B85ED-318B-4790-9B38-6C88FA8002AF,H00.1,Chalazion,-
61829BC1-D328-42A3-AA6F-2E967847F151,L60.9,"Nail disorder, unspecified",-
68361C14-94EE-45D0-A93D-8021D210E263,R10.4,Other and unspecified abdominal pain,-
68361C14-94EE-45D0-A93D-8021D210E263,K29.7,"Gastritis, unspecified",-
09DA7E83-4220-4C66-85B6-980ACBBC3AB0,K29.7,"Gastritis, unspecified",-
09DA7E83-4220-4C66-85B6-980ACBBC3AB0,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
534B1EA0-01E1-41B2-8046-CFC45442B3D4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0722A631-69FB-4507-BF3B-9DD746DCE7C9,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
5A73BFA2-A30E-4886-BA9F-E245E0CC98B3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F81EB875-1C4C-44CD-B636-EEE1535F9F5E,M54.5,Low back pain,-
66D0A1B9-3F85-4D3D-AF2D-9E2C1497D3F7,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
008F5DD6-1E82-44DC-AD2C-6B6F0683F88D,R07.0,Pain in throat,-
4879C65B-20FF-425F-9856-3F87CA50D3A3,J06,Acute upper respiratory infections of multiple and unspecified sites,-
39D070EB-955C-44A2-B427-6E4DD25E1A11,R51,Headache,-
D0E45B8F-7857-44A2-A4FF-14E603F4220A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E76D6547-E018-4E9F-86F3-787415961137,H00.1,Chalazion,-
E76D6547-E018-4E9F-86F3-787415961137,H57,Other disorders of eye and adnexa,-
D825B0F2-F34F-4133-8D86-2E18B909448B,U07.1,"COVID-19, virus identified",-
C7A395B9-DA47-41C0-8304-0149407C6A47,N94.6,"Dysmenorrhoea, unspecified",-
D4D81A98-8006-472D-8347-1FD99814516C,N94.6,"Dysmenorrhoea, unspecified",-
94C7FBE9-E188-4418-A9A1-B34C2D83E151,R51,Headache,-
94C7FBE9-E188-4418-A9A1-B34C2D83E151,L30.9,"Dermatitis, unspecified",-
F37077C9-FE7D-423F-A571-DA39F003CFE0,J06.9,"Acute upper respiratory infection, unspecified",-
ED1E1B22-B59C-4E19-883B-A52E8003F097,J06.9,"Acute upper respiratory infection, unspecified",-
54246123-F4D0-46FB-8C60-353BFC7D5C02,R51,Headache,-
B40D6AA6-A4AE-4F60-BB5C-21C6F6A54E00,J06.9,"Acute upper respiratory infection, unspecified",-
EE8DAB81-C525-43EA-B239-8800A5E122AF,K29.1,Other acute gastritis,-
FBBCEB60-3B76-4E1D-8A26-FEB4732416B9,J06.9,"Acute upper respiratory infection, unspecified",-
AD30E07F-76DB-4225-ACD4-E8E83794DC84,M51.1,Lumbar and other intervertebral disc disorders with radiculopathy,-
AD30E07F-76DB-4225-ACD4-E8E83794DC84,Z76.0,Issue of repeat prescription,-
B6E2570D-F0D6-4B4F-9E5C-2F27CE2D9E48,M79.1,Myalgia,-
B6E2570D-F0D6-4B4F-9E5C-2F27CE2D9E48,R21,Rash and other nonspecific skin eruption,-
134C31B5-2ED8-4CB5-AE0F-10CFBEA24779,J06.9,"Acute upper respiratory infection, unspecified",-
64E28FD0-5546-46F8-9560-147851A8AB8E,J06,Acute upper respiratory infections of multiple and unspecified sites,-
5404AE28-6B5E-45AB-AF31-33253EFCE268,J06.9,"Acute upper respiratory infection, unspecified",-
4AD3A237-5829-4164-8F4C-E3C04CBE6F48,A09.9,Gastroenteritis and colitis of unspecified origin,-
878A1E12-C302-4EF8-B9E8-E0C37D164F2C,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F8A1AA5D-3D0D-4F2C-BAEC-AE4D5041701C,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
AE4D2ABE-30F1-4B39-BA3E-B048AA2F8A6A,H00,Hordeolum and chalazion,-
AE4D2ABE-30F1-4B39-BA3E-B048AA2F8A6A,H18.3,Changes in corneal membranes,-
089E91D0-18AD-410A-9961-040D8FD92B70,J06.9,"Acute upper respiratory infection, unspecified",-
7E1FEFB2-C680-4316-B878-CD63E584580E,M62.6,Muscle strain,-
7CDF8879-5587-4DF5-84C0-9D2B97D2238C,N94.6,"Dysmenorrhoea, unspecified",-
9DE46023-F987-437A-B97A-193070EC15E3,J06.9,"Acute upper respiratory infection, unspecified",-
9DE46023-F987-437A-B97A-193070EC15E3,A09.9,Gastroenteritis and colitis of unspecified origin,-
2C434D59-504F-4F1D-8671-212A98E74E70,J06.9,"Acute upper respiratory infection, unspecified",-
F10F4ADC-54BA-4F4C-9492-2331DC573BFF,N92.0,Excessive and frequent menstruation with regular cycle,-
15BAD215-8B48-4E47-9958-6B8A50F296EE,Z02.8,Other examinations for administrative purposes,-
1B8616A3-7559-41CD-A4B6-504F4F24440A,A09.9,Gastroenteritis and colitis of unspecified origin,-
75095120-61A1-4F55-92B9-4C4FE0E89274,L20,Atopic dermatitis,Atopic dermatitis
D2F8FAFD-03B1-4FD1-A287-FFD5837E6268,R11,Nausea and vomiting,-
D7A0FDD6-3129-47BA-81BB-D9F5EF2BDEA5,K29.7,"Gastritis, unspecified",-
30653CD8-34C0-41F6-8259-7F0A9A128A90,J06.9,"Acute upper respiratory infection, unspecified",-
F2AB5012-25D2-4035-AB17-3710BB9B6B88,N94.4,Primary dysmenorrhoea,-
4D1B70A9-58DF-4C32-8D7A-87C2A82118A9,K29.7,"Gastritis, unspecified",-
49A8CCBB-940C-4DF0-B098-E2CB553439FD,G44.2,Tension-type headache,-
D5E61B14-4E70-47ED-BB66-BCD435849241,J06.9,"Acute upper respiratory infection, unspecified",-
D5E61B14-4E70-47ED-BB66-BCD435849241,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
22B1F896-9C8C-4583-AABE-1675F83E90E5,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
22B1F896-9C8C-4583-AABE-1675F83E90E5,H10.9,"Conjunctivitis, unspecified",-
4C609EF3-E655-489B-AEFA-258D2902B528,H10.1,Acute atopic conjunctivitis,-
F992BFB5-3947-492A-AA00-BC5508E9BBCD,J03.9,"Acute tonsillitis, unspecified",-
08B3225A-6491-4EE8-A499-2506E021BC41,A09.9,Gastroenteritis and colitis of unspecified origin,-
08B3225A-6491-4EE8-A499-2506E021BC41,R50.9,"Fever, unspecified",-
7BA6BBD0-277D-4C9E-8F68-1EA196C14021,P39.0,Neonatal infective mastitis,-
272A3030-E34D-49E1-B53C-C5A0E1D57C35,P39.0,Neonatal infective mastitis,-
2EE3B26B-C7BB-450B-B5EA-A5498183D668,R51,Headache,-
60FBE795-361D-45CF-806F-EDAA7881DF59,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4ACEA109-611C-465C-8ADA-D85573A45572,A09.9,Gastroenteritis and colitis of unspecified origin,-
DDCEAAC1-9074-42A5-BB48-1FD9A66CEDC8,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
3C87BC06-AED5-40AB-B559-6B13C368C017,L24,Irritant contact dermatitis,-
600B0C76-3197-4F73-8C9E-F2AE03B53661,G70.0,Myasthenia gravis,-
45D61A35-FFC4-4C43-84A4-EFCD6AF22A5C,J06.9,"Acute upper respiratory infection, unspecified",-
C177B2BD-E533-4AB7-8D33-CCDC501DC956,R21,Rash and other nonspecific skin eruption,-
96539050-7ACE-4523-978A-F244585213C4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E0E52D16-976F-44CA-A45E-5B0C912225CE,J06.9,"Acute upper respiratory infection, unspecified",-
AFFFB989-77F8-4693-A2ED-777BD1864CB0,M25.5,Pain in joint,-
5111615C-615A-4F28-9680-6A79A89EA034,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
5111615C-615A-4F28-9680-6A79A89EA034,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
11D2AC5D-68EE-4C33-9382-424F85B7A096,M10,Gout,Gout
CABA1544-32CA-4ED3-82C7-E89B205AF40C,J06,Acute upper respiratory infections of multiple and unspecified sites,-
E2228312-097E-42C9-9B71-EEAAE7A0B36E,K07.6,Temporomandibular joint disorders,-
E2228312-097E-42C9-9B71-EEAAE7A0B36E,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
7DF8CA7B-FB1A-4ED7-AFF1-ED92D68EB000,A09.9,Gastroenteritis and colitis of unspecified origin,-
1FB438E7-C620-4838-9ECB-37FBD9F06575,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
F75C70FF-665C-4B17-B003-72EB17CC9545,M62.6,Muscle strain,-
7F9A8AEA-91B4-41F2-8717-DA78286CC2E4,J06,Acute upper respiratory infections of multiple and unspecified sites,-
770C630B-0349-4293-9B17-46005E7B759D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
82B0FAC3-3EE1-48CD-A77A-26804BDEAC4B,H01.0,Blepharitis,-
681FF55B-270E-43FF-974A-D8213E7ECDD6,J06.9,"Acute upper respiratory infection, unspecified",-
A32BBD79-EF02-446B-8B6C-31A840438A3A,G44,Other headache syndromes,-
C6A7C79A-EE02-49C6-90A6-3292AF887FDA,J32.9,"Chronic sinusitis, unspecified",-
C6A7C79A-EE02-49C6-90A6-3292AF887FDA,M75.8,Other shoulder lesions,-
8FDBAE1C-C417-45FB-A9D9-A92393A52148,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A0039B36-5C19-4516-9040-33F50E8DAC81,R51,Headache,-
4E40935C-878A-4BE2-9F69-377D5B49CC43,L20,Atopic dermatitis,Atopic dermatitis
7318E190-2FAC-45E1-9587-51E9D7D7380C,J03,Acute tonsillitis,-
89855795-14D6-49F6-894C-AEA0B21126C9,A09.9,Gastroenteritis and colitis of unspecified origin,-
9F85AA64-78D9-4853-AB35-346B9F085BC4,J06.9,"Acute upper respiratory infection, unspecified",-
6EC11AA4-50E1-45FF-BB99-DF0D1BB98708,K13,Other diseases of lip and oral mucosa,-
15DDAF27-AEE9-4BA3-9287-346D4A32E576,H81.1,Benign paroxysmal vertigo,-
FC5A0A38-8C04-4EB7-A15D-44ADA6E41A12,R50.9,"Fever, unspecified",-
E0BBCF61-CD94-4D17-862F-272EFF47D4E4,R50.9,"Fever, unspecified",-
E0BBCF61-CD94-4D17-862F-272EFF47D4E4,N94.6,"Dysmenorrhoea, unspecified",-
3C948253-C05A-4AEE-83D8-4CD4CD53B13D,H00.1,Chalazion,-
DA0C4B5D-71D5-4F43-B270-1F39F443D0F3,M54.5,Low back pain,-
0DA79355-8121-45B3-93BB-B870BABE4D57,J06.9,"Acute upper respiratory infection, unspecified",-
CE4F9CD4-7986-484D-888F-28096C001725,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
DC035A61-EB90-4E23-A75B-6B2D46C0BAA7,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
CE4F9CD4-7986-484D-888F-28096C001725,B35.3,Tinea pedis,-
6D89F6D8-9A27-4011-A35F-E2859A3AA845,K00,Disorders of tooth development and eruption,-
2572A1DC-338B-42B3-A45C-E24CD37F1F0B,M62.6,Muscle strain,-
0BD347EF-AFB4-450F-A3E2-0D005205B253,L20,Atopic dermatitis,Atopic dermatitis
F2D9D6C8-7E72-4623-B2C9-74C80B59A634,J06,Acute upper respiratory infections of multiple and unspecified sites,-
BC0638E7-57C8-4418-9B2D-74A42AD1E29E,L30.9,"Dermatitis, unspecified",-
BC03CA11-DEC6-48CC-B530-D5101B981DE4,B02,Zoster [herpes zoster],-
94D4975E-3A44-4D70-8D3A-0A9684AB6FA1,R51,Headache,-
94D4975E-3A44-4D70-8D3A-0A9684AB6FA1,T78.4,"Allergy, unspecified",-
54CA45B9-4C92-4A03-98E5-4732240169BB,Y42.4,Oral contraceptives,-
01135219-E883-49FC-B554-BF824407A7D3,M10,Gout,Gout
AE5E00B7-BDD8-4E2F-8C18-8ACCF8BE6B60,R51,Headache,-
88970DF6-AAC0-4FC1-982D-C1B488955F23,L73.9,"Follicular disorder, unspecified",-
93EB2993-73C4-4236-A1C1-FCE02D7CD16B,Z71.0,Person consulting on behalf of another person,-
01F7F1E9-0E7E-4135-842F-7524A221EFB3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EBF061B3-D68D-47EE-B0D3-50EE79D6F12E,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
EBF061B3-D68D-47EE-B0D3-50EE79D6F12E,S61.0,Open wound of finger(s) without damage to nail,-
CC157A9A-F3CE-428D-A31A-B17C071BD651,S81.0,Open wound of knee,-
49AFE279-3351-4B54-9529-94A63E2DB9A9,S81.0,Open wound of knee,-
7085CFFF-776E-4664-B4C2-0BD35E5D97E7,H93.1,Tinnitus,-
3BD6CA35-FC68-48F2-A4B3-6ACAF533C1B1,A09.9,Gastroenteritis and colitis of unspecified origin,-
92708555-C9D6-487B-95A9-2C644A54E608,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
92708555-C9D6-487B-95A9-2C644A54E608,R51,Headache,-
B46AB5E3-1986-4A8C-9DC8-F0516AE0F236,Z71.2,Person consulting for explanation of investigation findings,-
0E201772-95E6-469C-A707-AF35C810A51F,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
B63B1945-2ADF-4EC8-8E4D-A7A553C113CE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0B6D0217-4B98-4DD0-A9AD-5034B62F222E,S13.4,Sprain and strain of cervical spine,-
0B6D0217-4B98-4DD0-A9AD-5034B62F222E,J30.3,Other allergic rhinitis,Vasomotor and allergic rhinitis
0B6D0217-4B98-4DD0-A9AD-5034B62F222E,H01.0,Blepharitis,-
0B6D0217-4B98-4DD0-A9AD-5034B62F222E,N94.6,"Dysmenorrhoea, unspecified",-
F00B8DFA-0E88-4FBA-810C-F05E93DDE51B,R50.9,"Fever, unspecified",-
F00B8DFA-0E88-4FBA-810C-F05E93DDE51B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4268A429-75E0-4D57-8318-93B60F037E75,R50.9,"Fever, unspecified",-
BFD5047A-0B76-448E-940B-8855CE2299F6,A09.9,Gastroenteritis and colitis of unspecified origin,-
DB859407-055A-48DC-AE2E-548A526BDFB5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0352860C-F4C7-4ABF-B0B1-CC6A8D01F8C6,T88.1,"Other complications following immunization, not elsewhere classified",-
247748C6-7137-4503-A533-CCFCF3E2CE7D,N94.6,"Dysmenorrhoea, unspecified",-
475240E8-24B4-401A-9E6A-90EC89FFCD05,R51,Headache,-
EE99B3C9-C34C-4EE5-8FBD-88D7CFD0D7C5,J06.9,"Acute upper respiratory infection, unspecified",-
EE99B3C9-C34C-4EE5-8FBD-88D7CFD0D7C5,U07.1,"COVID-19, virus identified",-
AB1E6963-AE17-443F-A58F-E53AE41DC9EB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
AB1E6963-AE17-443F-A58F-E53AE41DC9EB,J06.9,"Acute upper respiratory infection, unspecified",-
649BC6A2-0DBE-42DB-9356-7ACF9237978E,I10,Essential (primary) hypertension,Hypertension
2AA497E6-9375-42E3-ACE4-6C7EF45C9A43,M62.6,Muscle strain,-
888B51DB-A3C2-47A1-8CEF-0E4680FF1537,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F33A1C2B-272D-4F31-88D0-D572415E2FCF,J06.9,"Acute upper respiratory infection, unspecified",-
888B51DB-A3C2-47A1-8CEF-0E4680FF1537,J35.1,Hypertrophy of tonsils,-
40EBF675-F990-4C5A-B530-9F1B0A639A38,M54.5,Low back pain,-
40EBF675-F990-4C5A-B530-9F1B0A639A38,N94.6,"Dysmenorrhoea, unspecified",-
A153674B-96A6-4C97-9FB3-14B77814B111,M54.5,Low back pain,-
7A83D6B7-8595-4E88-88A1-FBF5902D4695,M22.2,Patellofemoral disorders,-
EF591608-8F92-4D1A-B659-7D091E48675E,J06.9,"Acute upper respiratory infection, unspecified",-
733446D9-0DC5-4962-9401-6A15A7827A52,T88.1,"Other complications following immunization, not elsewhere classified",-
A8543F4E-7B48-42F6-84B6-07F58E03EF8E,J06.9,"Acute upper respiratory infection, unspecified",-
9414DC7E-F92A-40B7-9A0B-3B878A228DD9,N94.6,"Dysmenorrhoea, unspecified",-
34824970-1D14-417E-989B-0685985DD35F,J45,Asthma,Asthma
9D43DA01-C6AE-4E4A-B3B8-A2C9BC5A29EB,J45,Asthma,Asthma
3906AAEE-F0E8-451C-BFE3-8FC68295C32C,L30.9,"Dermatitis, unspecified",-
B1E0D1D2-29B6-4151-A87E-32B1A5EA4DC6,J06.9,"Acute upper respiratory infection, unspecified",-
C0F2F477-71F7-40BB-923B-D983D437E9AE,T88.1,"Other complications following immunization, not elsewhere classified",-
807E11C7-3666-4BDF-AA75-BCC5CCD30B81,R50.9,"Fever, unspecified",-
913440DB-E25A-4D84-9221-2FBD2740849E,J06.9,"Acute upper respiratory infection, unspecified",-
98CB2D30-9DA5-4B08-9794-F2465E5098E5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7EC14725-9D98-4D76-8ED0-61F519AF364F,T88.1,"Other complications following immunization, not elsewhere classified",-
EAE031E2-5967-4013-8004-54DB4BB6ED58,J06.9,"Acute upper respiratory infection, unspecified",-
762BCBAC-8F91-45D1-B3BE-74C5CAA9F44F,R21,Rash and other nonspecific skin eruption,-
762BCBAC-8F91-45D1-B3BE-74C5CAA9F44F,K30,Functional dyspepsia,-
A19B0243-A2D6-438F-ADBC-53E759BA49C4,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
C7B16203-46D1-4F00-800F-8DC533518F65,K29.7,"Gastritis, unspecified",-
3A4BF1B1-99D8-4FB0-8795-52936FF268F7,J06.9,"Acute upper respiratory infection, unspecified",-
B87E30DE-DBD6-4CF7-B8C4-DB5B7E871623,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
D1EED483-F8B4-4B6B-A0CD-5D2600B2D61A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
367BF235-AC40-466D-859A-A2EC3562488C,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
367BF235-AC40-466D-859A-A2EC3562488C,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
7923DB1C-583E-4122-B61D-0D8CB80CAF18,H60.8,Other otitis externa,-
ADC51F21-1D36-4870-AE40-3F0C99C78F39,K59.4,Anal spasm,-
EAA663AF-70F6-41C6-ACBD-91F995F192D9,K08.9,"Disorder of teeth and supporting structures, unspecified",-
BFC67C6A-D5D1-4B7A-B9FA-05DC57CFDA4B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F95DAF92-818C-43CC-85B2-8B86189D6262,A09.9,Gastroenteritis and colitis of unspecified origin,-
A8A8DB2C-C1B9-43D0-A924-0A0DA2E1F8FA,J02,Acute pharyngitis,-
DFDA1966-1338-49BF-BB78-C4D06E29811A,R50.9,"Fever, unspecified",-
30EFC83D-BAB6-4216-883E-2368D1EAFEFF,N94.6,"Dysmenorrhoea, unspecified",-
E228BBE9-6B8A-41C2-A77D-1B341CA64E66,R51,Headache,-
2B6EB008-FA83-40DF-AEAA-79C93DCD2356,N39.0,"Urinary tract infection, site not specified",-
DD2D1C24-C249-4A2D-ACAA-C0DA94D2CA2C,R51,Headache,-
42422424-4DE6-4E68-A7DA-36623448E7D8,T88.1,"Other complications following immunization, not elsewhere classified",-
54BAF962-D631-4D8C-86B0-2BC14A844F2D,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
54BAF962-D631-4D8C-86B0-2BC14A844F2D,J06.9,"Acute upper respiratory infection, unspecified",-
7925F3BD-A180-4BFB-BEF5-FE947808D7FF,N39.0,"Urinary tract infection, site not specified",-
96D1BA0B-611D-4C76-867B-7A4570ACDB72,Z71.2,Person consulting for explanation of investigation findings,-
738BBED1-3320-4574-86AE-F78393A3750B,J06,Acute upper respiratory infections of multiple and unspecified sites,-
169C9556-77C9-476E-8EE0-B238B230DCF3,L71.0,Perioral dermatitis,-
5738CCB4-236D-4BC2-97FF-1101D2A9940E,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
34B40771-1B6D-4509-811B-2866419AF8B1,T88.1,"Other complications following immunization, not elsewhere classified",-
9E129669-7F40-4F23-B22A-F9AA9E105DC6,D10.0,Benign neoplasm: Lip,-
046AE229-9CA9-407C-8F17-021BAA1066B0,J06.9,"Acute upper respiratory infection, unspecified",-
CE94572A-0731-4543-B5BC-6AA4BA699A2F,J06.9,"Acute upper respiratory infection, unspecified",-
68260BC7-39BD-4753-890B-283FA564A43C,U08,Personal history of COVID-19,-
756E2C9D-ACAC-4829-8A86-6288E9A6C77E,J06.9,"Acute upper respiratory infection, unspecified",-
756E2C9D-ACAC-4829-8A86-6288E9A6C77E,T88.1,"Other complications following immunization, not elsewhere classified",-
8C14179E-8C67-47BB-A039-3D3ADB1E83CD,J06.9,"Acute upper respiratory infection, unspecified",-
476DE850-3140-4A38-AEB0-BBD147E41301,R42,Dizziness and giddiness,-
476BC58A-C01B-4AA5-AC81-85C783993869,R42,Dizziness and giddiness,-
476DE850-3140-4A38-AEB0-BBD147E41301,G44.2,Tension-type headache,-
476BC58A-C01B-4AA5-AC81-85C783993869,G44.2,Tension-type headache,-
E50A711B-1605-4B26-8F66-C9512E742727,J04.0,Acute laryngitis,-
E50A711B-1605-4B26-8F66-C9512E742727,J02,Acute pharyngitis,-
B47D4A54-F1FC-4D9F-B263-027D29DF5F44,Z71.2,Person consulting for explanation of investigation findings,-
115E8677-F1F8-4B39-8B05-3524CAE513B6,G44,Other headache syndromes,-
4FEAB897-CB1C-431E-8A5B-143B05FEC9BA,J06.9,"Acute upper respiratory infection, unspecified",-
61A397A1-94A5-4AC5-BB43-5D7D3AF5BE5B,H10.9,"Conjunctivitis, unspecified",-
7B69A98E-CFF2-4139-9F24-40D9B1DB902B,A09.9,Gastroenteritis and colitis of unspecified origin,-
A20E9765-FA82-4BC4-8A15-30B17B9E3263,J06.9,"Acute upper respiratory infection, unspecified",-
02492858-5121-4E1C-A3C1-A46297C7A1C1,Z71.2,Person consulting for explanation of investigation findings,-
539A934E-3F36-48F7-B5CC-51B73E4B08E0,U07.1,"COVID-19, virus identified",-
38CFA7FE-F690-4FE9-B25E-C3FCFB40C49D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8DB5EFA9-A168-43FE-9DAB-21DC90C5547A,H00.1,Chalazion,-
462BD0B4-2314-491F-9F1D-789645B4412F,N94.4,Primary dysmenorrhoea,-
C737618A-C87E-4380-8881-6D531643642E,L29.0,Pruritus ani,-
ADF8ED79-F6C5-466D-85E8-FBF19F9CE4A1,M79.1,Myalgia,-
A7CD81BD-3DA9-484C-8D52-43531BF3789A,S93.4,Sprain and strain of ankle,-
3FA324C7-A8C2-4446-A99D-45EF8F68C8C1,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
FBD02A35-55C2-43F2-A803-9DD89F4BBE96,K30,Functional dyspepsia,-
F14B8A24-44F9-45FC-A542-C8DA2ABC6378,J06.9,"Acute upper respiratory infection, unspecified",-
71A8F40A-FCA0-4719-B581-5D0A7D26B459,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
0BAAD2AB-9277-424C-B5F2-2154B430F4B0,K59.0,Constipation,-
EFCCF75D-E8F2-4BD2-A5A2-CD6213D226C7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5DC365F0-E1D5-4AF7-AF3C-26B5087A9745,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
30CA7D2C-B3BA-45F8-8693-908393645C13,Z02,Examination and encounter for administrative purposes,-
CAF2DD89-536E-40C8-ADA4-01286856851A,R11,Nausea and vomiting,-
CAF2DD89-536E-40C8-ADA4-01286856851A,R51,Headache,-
5B295955-D8A3-41E3-A8C4-7C57EE28DE65,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
645BA8D7-4847-41ED-8D8F-7A80EA7A35D5,N94.6,"Dysmenorrhoea, unspecified",-
E4CFDDF5-287B-4C9B-9D17-F923F9D6DB3B,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
94930A7A-6479-4CB5-96BF-F9AA6743400D,A09.9,Gastroenteritis and colitis of unspecified origin,-
94930A7A-6479-4CB5-96BF-F9AA6743400D,R11,Nausea and vomiting,-
CFA56C4B-7E49-4CF0-A91A-161DCCBADFAA,M10,Gout,Gout
312C8C43-00E8-4442-8281-0AAA63B93C81,M62.6,Muscle strain,-
F240DA2E-0D38-4309-A94C-19D49FA48CF1,A09.9,Gastroenteritis and colitis of unspecified origin,-
B7F847AD-6567-4E93-A873-83D02177FD4B,E11,Type 2 diabetes mellitus,Diabetes
B7F847AD-6567-4E93-A873-83D02177FD4B,I10,Essential (primary) hypertension,Hypertension
B7F847AD-6567-4E93-A873-83D02177FD4B,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
4520032D-31E8-4170-A990-E7A2C69517CB,M67.4,Ganglion,-
3C9BD864-D01A-40E3-AF32-3628B8E29A38,T88.1,"Other complications following immunization, not elsewhere classified",-
23BCE961-B6E9-4F91-BF82-323910615243,G44.2,Tension-type headache,-
0E9C11C8-07C8-425C-9235-C9C6E8C3A94A,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
6E099CF3-5E87-4D6A-98F4-D2C2A5A8B9E1,R11,Nausea and vomiting,-
6E099CF3-5E87-4D6A-98F4-D2C2A5A8B9E1,R51,Headache,-
743B51CE-3691-4EC0-9279-48D34CBC76DF,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
5FCDCE4C-980C-4F9B-AB36-AA1CF58A6641,J06.9,"Acute upper respiratory infection, unspecified",-
156226BC-2893-4030-B414-17C51079338E,U07.2,"COVID-19, virus not identified",-
E53F052B-3568-4B19-B522-BF58E5ADFF3D,M10,Gout,Gout
8F941A43-CEFE-4C11-9A76-517DBED08772,J06.9,"Acute upper respiratory infection, unspecified",-
40AFB9A8-CEC0-4DBE-8178-E46EC433A47B,T88.1,"Other complications following immunization, not elsewhere classified",-
621085F4-FE42-439D-B62C-CEC3DD46B0BA,J06.9,"Acute upper respiratory infection, unspecified",-
02A4C485-202E-4D8D-8B19-B21BB6DD77C6,J06.9,"Acute upper respiratory infection, unspecified",-
02A4C485-202E-4D8D-8B19-B21BB6DD77C6,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
621085F4-FE42-439D-B62C-CEC3DD46B0BA,R51,Headache,-
03D3CFB3-4CD2-4B29-B68D-AB295C712A0D,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
03D3CFB3-4CD2-4B29-B68D-AB295C712A0D,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
7F191E95-E562-4A63-AD49-6C0DB67DD54D,L30.9,"Dermatitis, unspecified",-
B78CF7E3-A046-4F20-9E91-54C409B4CB1B,J06.9,"Acute upper respiratory infection, unspecified",-
4E4D3579-CE58-4086-A803-435A2357DED0,J06.9,"Acute upper respiratory infection, unspecified",-
AB09B51A-6BBB-49B6-885E-BCE5257B67F3,A09.9,Gastroenteritis and colitis of unspecified origin,-
DD2D1C24-C249-4A2D-ACAA-C0DA94D2CA2C,K30,Functional dyspepsia,-
B8C40794-6478-43B1-9524-6A505F8AE54E,Z71.2,Person consulting for explanation of investigation findings,-
5E88E164-406B-473C-A7C9-8D4779A47E44,N94.6,"Dysmenorrhoea, unspecified",-
F7F04B59-B1F4-41DE-8A85-03FC4241622C,Z71.2,Person consulting for explanation of investigation findings,-
14AACCC3-CAA6-42EE-8892-BE7F8A1F7994,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
14AACCC3-CAA6-42EE-8892-BE7F8A1F7994,H81.1,Benign paroxysmal vertigo,-
14AACCC3-CAA6-42EE-8892-BE7F8A1F7994,M62.6,Muscle strain,-
4C53F4F1-AC11-49F7-9A9B-A22A6C4D9FD8,I10,Essential (primary) hypertension,Hypertension
4C53F4F1-AC11-49F7-9A9B-A22A6C4D9FD8,E11.9,Type 2 diabetes mellitus without complications,Diabetes
4C53F4F1-AC11-49F7-9A9B-A22A6C4D9FD8,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
5DBA703C-58AD-4002-B6BB-9F8C057141A3,M54.5,Low back pain,-
5DBA703C-58AD-4002-B6BB-9F8C057141A3,M62.6,Muscle strain,-
6CE8E721-6404-4EB4-A987-32C4A506E829,L30.9,"Dermatitis, unspecified",-
D636D518-B6DA-48CC-92C7-E8A7D412E15D,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
BE8E2E57-B20D-484B-9840-7A36A5262824,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
BE8E2E57-B20D-484B-9840-7A36A5262824,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
BE8E2E57-B20D-484B-9840-7A36A5262824,S46.0,Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder,-
BE8E2E57-B20D-484B-9840-7A36A5262824,M75.0,Adhesive capsulitis of shoulder,-
9E304D22-C252-4256-84D9-7F28F6CEE9AF,S13.4,Sprain and strain of cervical spine,-
85CAD3CF-3ACB-4404-9916-05953E92D6EB,R51,Headache,-
465C2800-EC0B-42D7-AC94-93F40EB6A4B4,M25.5,Pain in joint,-
C47151DD-E7F0-433A-B1E9-D26F81CFB1ED,T88.1,"Other complications following immunization, not elsewhere classified",-
03B3D586-7AF3-4217-A64B-085B0C34B04E,J39.3,"Upper respiratory tract hypersensitivity reaction, site unspecified",-
03B3D586-7AF3-4217-A64B-085B0C34B04E,R05,Cough,-
3FCF70F5-657D-495D-883C-BE237F27A0D8,J06.9,"Acute upper respiratory infection, unspecified",-
2ECB77B2-F8F6-4AB1-AD35-C7A74C92E44B,T88.1,"Other complications following immunization, not elsewhere classified",-
C34E13F3-D8F5-4CEE-A425-25C06F125DF7,N39.0,"Urinary tract infection, site not specified",-
38CE1B4A-2F79-4780-8919-C0C2C3B44CFE,M25.5,Pain in joint,-
99E471FE-7F59-497E-A8FB-018908AC8AFE,J06.9,"Acute upper respiratory infection, unspecified",-
93501ECD-F0FC-4780-A74D-7E77A0286512,G44.2,Tension-type headache,-
F4639E7F-F992-4E1F-B6B5-D851929AE0D1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CC2CCE1B-2E28-4A7C-9CCD-7936B1B2994D,R51,Headache,-
D7A7E6C6-77D9-4E01-95C6-E29AA37C1151,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
42ED470C-404B-4AB1-8DF3-B7F4873057D2,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
BF1AAA75-8761-4ACD-A594-216C6926902A,Z71.2,Person consulting for explanation of investigation findings,-
483956A1-437E-40D1-BF34-C8248DDDB9E1,R51,Headache,-
70E6FE17-9817-4F45-B627-E576E1953392,L20,Atopic dermatitis,Atopic dermatitis
8C618632-AF9A-4687-8CEB-3F0F91D4309D,R51,Headache,-
8EF338DB-6490-44A7-AB34-D1FDDBF8874D,A09.9,Gastroenteritis and colitis of unspecified origin,-
D0E62013-940C-424E-991E-5D84D0AA38CC,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
221E2E74-3C5F-4083-8FF2-9DFDBBBF86CA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5CDDCF29-C8B8-42E4-8634-5E47248EAC03,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
D241631E-71AC-41FC-910F-4551BC1B5BA8,A09.9,Gastroenteritis and colitis of unspecified origin,-
42610100-B67F-46AF-A224-079ED0F77B59,N94.6,"Dysmenorrhoea, unspecified",-
05FB48F5-2350-4F94-B875-1C700D8C595F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BC5F8945-AEB4-488E-9EDA-21F422C5B022,M79.1,Myalgia,-
E1C9EB7B-3462-40CA-99EF-55CD5D383888,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
AA1DEFD2-BB2D-454F-A590-255031E2BB24,M62.6,Muscle strain,-
B07C5238-A3F3-48DE-9634-4353BE477045,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7F0B5DCD-D38B-4BB6-AFD6-D80011EB14B0,R51,Headache,-
F56E9ABE-0974-4BCD-B7D8-6E53E2D0A7ED,J06.9,"Acute upper respiratory infection, unspecified",-
E25789F7-D5A3-47B4-9C90-9948566C6E44,K29.7,"Gastritis, unspecified",-
340C6F40-F5F7-4C6A-910B-08B7DFC334B4,R07.3,Other chest pain,-
4232C81D-23F7-49B5-ACEB-54FBA10CED6D,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
4232C81D-23F7-49B5-ACEB-54FBA10CED6D,M54.5,Low back pain,-
A17729AF-59B7-4E2A-A4E2-4ACA850AE1A0,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
F40AD6C3-9CB4-475A-A77A-878EF65131AA,M79.1,Myalgia,-
F40AD6C3-9CB4-475A-A77A-878EF65131AA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8F754E23-BFC4-4DD8-AB27-512887FF1539,N94.6,"Dysmenorrhoea, unspecified",-
8F754E23-BFC4-4DD8-AB27-512887FF1539,E61.1,Iron deficiency,-
13492FC5-2C2F-4318-9F18-3E5E4C84EBBC,U07.1,"COVID-19, virus identified",-
30B15BFB-D07C-4102-9642-3ED26D8C35F6,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
B2147C1A-6551-4E33-BCB3-F5FD4B3BEC16,Y42.4,Oral contraceptives,-
2F02B9B7-FF4F-428E-AFD1-553F1ACE4A7C,J06.9,"Acute upper respiratory infection, unspecified",-
7C05C139-5670-4B37-B04B-0E0FF76DCA3C,L02.1,"Cutaneous abscess, furuncle and carbuncle of neck",-
7C05C139-5670-4B37-B04B-0E0FF76DCA3C,R51,Headache,-
240CFEEB-57C4-4E7D-84D3-3944E8C551F2,S90,Superficial injury of ankle and foot,-
C047098C-234B-46FE-A7F4-16C4EC484565,K29.7,"Gastritis, unspecified",-
EF552A61-5EB6-4CD0-9D25-7100AFEC1149,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
EF552A61-5EB6-4CD0-9D25-7100AFEC1149,R21,Rash and other nonspecific skin eruption,-
3BCEF1EC-20DA-4BB9-A3F7-E6E5803834D3,T88.1,"Other complications following immunization, not elsewhere classified",-
F4317152-BBE9-4D85-948F-328FD3456E3B,J06.9,"Acute upper respiratory infection, unspecified",-
85E20CF2-2BFB-4367-8916-556F4D92C824,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
C327B28E-2E35-4513-9600-A1DF375F12E7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
787DF7BA-0252-405F-8DA9-DD5B3A6A2A45,L20,Atopic dermatitis,Atopic dermatitis
CC6622A7-1CAB-4C86-9725-AB630290EBAF,K29.7,"Gastritis, unspecified",-
CC6622A7-1CAB-4C86-9725-AB630290EBAF,N94.6,"Dysmenorrhoea, unspecified",-
2916D0D0-AED3-49AA-8A98-08C523304E84,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C851EDC7-BFD9-4D80-A742-00BEBE08CB2F,R51,Headache,-
921CE346-C26B-41DF-ADC1-3BC37A9B212F,R51,Headache,-
5EA0B266-3F48-4D39-85D2-8B8D493C89F5,L73.9,"Follicular disorder, unspecified",-
178EF341-BF99-446F-BC71-2F88DA126EC3,H11.3,Conjunctival haemorrhage,-
4A2BA45B-0F9A-4CB6-94EE-4A0725220C36,R51,Headache,-
798E0C7C-3B1D-455D-B2B3-3159D3FA3745,J06.9,"Acute upper respiratory infection, unspecified",-
9D431E88-E8B2-4A79-89FA-2F3B1BCF4FBA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8A9370F8-0BE4-4957-A937-206B11FB0BFF,A09.9,Gastroenteritis and colitis of unspecified origin,-
EC8A51E8-A1DF-4B3F-8FD3-B1A1C1F20D3E,J06.9,"Acute upper respiratory infection, unspecified",-
E6DEB5E6-39AF-470F-BE3B-86E8FD399722,R51,Headache,-
E6DEB5E6-39AF-470F-BE3B-86E8FD399722,L20,Atopic dermatitis,Atopic dermatitis
8654BB43-C892-4190-BC70-9FB60A36D3D2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6F25279E-4066-451A-9950-727F37318DE4,R51,Headache,-
6F25279E-4066-451A-9950-727F37318DE4,M54.5,Low back pain,-
D2719EEE-CBA9-4138-BEE9-C5018F25D5A4,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
B2F854C5-B42F-4FA9-BD5D-C2A9F6484C9E,R05,Cough,-
813D6B2A-3AC8-42DB-9661-46B8C6E06B79,U07.1,"COVID-19, virus identified",-
AC6A9B63-055C-4A98-BA71-A2823B140094,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
068FE4DF-2054-42B1-B551-A2A7F40BBA74,L20,Atopic dermatitis,Atopic dermatitis
068FE4DF-2054-42B1-B551-A2A7F40BBA74,Z76.0,Issue of repeat prescription,-
03DAF50B-8485-4F70-9A03-DE73D7AAF360,L30.9,"Dermatitis, unspecified",-
CFDE9039-B09B-48E9-B8FD-D5D99D9C017C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0EDA5CB3-E750-46CC-B86E-529CF62C30C0,R21,Rash and other nonspecific skin eruption,-
8A2C61F0-8ADA-4F13-8658-89AD975707E0,R04.0,Epistaxis,-
CF0D6BE0-9A3C-4124-8D15-05DCB82DBB2D,L20,Atopic dermatitis,Atopic dermatitis
2796C1FD-1DA5-48D5-90D4-78E21C119FDE,R50.9,"Fever, unspecified",-
2796C1FD-1DA5-48D5-90D4-78E21C119FDE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
20167A77-22A2-4D54-8C3A-6D913DF24589,H57.9,"Disorder of eye and adnexa, unspecified",-
4C339FEA-5924-4F6D-9AB3-25006BE0ABF9,N39.0,"Urinary tract infection, site not specified",-
7524125B-DA20-4681-B18E-3946DB8CDBD6,G44.2,Tension-type headache,-
06366970-343F-4E14-A63A-CFEA8F1190AE,R05,Cough,-
73A0F7AA-5FEE-4CF5-A35C-D55EA2C74B29,L03.0,Cellulitis of finger and toe,-
BA0CCA7A-7D0A-4163-9997-680D76C92666,U09.9,"Post COVID-19 condition, unspecified",-
EA0748CC-7B88-4D27-8663-D3BE31670492,J04.0,Acute laryngitis,-
EA0748CC-7B88-4D27-8663-D3BE31670492,R05,Cough,-
475C8709-6851-4DE2-A631-C6424B078A88,K14.0,Glossitis,-
475C8709-6851-4DE2-A631-C6424B078A88,K12,Stomatitis and related lesions,-
A532E801-9B4F-4A6A-9B40-691C6E3B9779,N39.0,"Urinary tract infection, site not specified",-
3E5FCBC9-CEF7-49CF-B0F3-3B5D7A1576DF,G44.2,Tension-type headache,-
F378AED3-59D8-4449-91F1-27A697B478C2,I10,Essential (primary) hypertension,Hypertension
D6704EBE-8E20-45BB-A7E7-D04C909172BF,G44.2,Tension-type headache,-
D6704EBE-8E20-45BB-A7E7-D04C909172BF,H57.8,Other specified disorders of eye and adnexa,-
6D27115F-253E-49C2-B559-D4FD85558D44,H00,Hordeolum and chalazion,-
3E9C4AEA-B0A8-4FE6-BF19-79D397B553A8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B26812C2-D7ED-4ADB-A456-F7C846B5BF97,A09.9,Gastroenteritis and colitis of unspecified origin,-
EC6FFDCD-1AFB-4A15-BEEE-2028948DB442,N94.6,"Dysmenorrhoea, unspecified",-
4D28B5E5-9A16-4F68-BFEE-AE2D252C2419,A09.9,Gastroenteritis and colitis of unspecified origin,-
29DF2D32-7FBB-4DA1-9025-49CF7D696262,R21,Rash and other nonspecific skin eruption,-
6B0F5475-1BD0-4E1D-8684-955A80611D87,M10,Gout,Gout
975FF77D-CB38-47C6-95C4-FE9531338EA1,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
975FF77D-CB38-47C6-95C4-FE9531338EA1,Z76.0,Issue of repeat prescription,-
2AEDC885-6D50-4848-8DFC-FD9F1957FE59,H02,Other disorders of eyelid,-
81EB8B42-4216-4770-8923-9CD186590621,L50.9,"Urticaria, unspecified",-
7E653AC2-8A32-4B51-B1DD-E0E88FF695AC,L50,Urticaria,-
246405EF-A64B-46EA-9CBB-324493DCCED5,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
8E8D3E61-FE37-4725-93F2-C50A8EB6FF47,Z02.9,"Examination for administrative purposes, unspecified",-
6E31D83A-D065-454C-BCF7-022893D36257,N94.6,"Dysmenorrhoea, unspecified",-
67651888-6FC6-4EE5-A5CB-5F8D15C92625,J06.9,"Acute upper respiratory infection, unspecified",-
4E00AB25-CA8C-4FFA-A54E-5758CFF553E4,R21,Rash and other nonspecific skin eruption,-
4E00AB25-CA8C-4FFA-A54E-5758CFF553E4,K59.0,Constipation,-
ABE89D4D-CB5A-422C-8AB4-69A9C7C31133,L30.1,Dyshidrosis [pompholyx],-
ABE89D4D-CB5A-422C-8AB4-69A9C7C31133,R50.9,"Fever, unspecified",-
ABE89D4D-CB5A-422C-8AB4-69A9C7C31133,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2370B5B6-9F78-4639-99F5-F5F2F6D22280,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5F713A95-673C-435C-9434-88BE875D2205,A09.9,Gastroenteritis and colitis of unspecified origin,-
9A3C7BBC-3AA6-47FA-855E-6F069EB2D375,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
4C7C85E6-CF70-449D-A05A-D75E90D83E3C,L30.9,"Dermatitis, unspecified",-
2A5801B8-F7C8-4081-B81B-98FE981E03A0,K30,Functional dyspepsia,-
53A68994-4941-4B41-86B0-57764C10D202,G43,Migraine,Migraine
1E5503F2-803B-4B15-8161-4C3DAD49285D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1E5503F2-803B-4B15-8161-4C3DAD49285D,R50.9,"Fever, unspecified",-
751EAE9F-5D2E-40C1-B97F-D4F4620C5B54,M79.1,Myalgia,-
48B84BDF-B4CC-4135-8E16-5BBA87A6FD10,J06,Acute upper respiratory infections of multiple and unspecified sites,-
82AD2FB9-4D8A-4E5A-977F-5D4778FD6E68,B07,Viral warts,-
DA9C10E3-ACF2-4E55-A750-26C7E85D9AF9,J06,Acute upper respiratory infections of multiple and unspecified sites,-
67A818A1-85E2-4A0F-AE5C-12071ECD9DFF,A09.9,Gastroenteritis and colitis of unspecified origin,-
C96AAB61-FC9F-4BDB-8450-7A86DFD492FD,Z01.7,Laboratory examination,-
123A15AD-BE2A-4B2A-9111-6484EDA14150,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
928532F1-D115-4310-87CB-453845F2E468,R53,Malaise and fatigue,-
3EC2A7DC-04CF-4867-BC52-C83FCEC81725,N94.3,Premenstrual tension syndrome,-
5EBB13C6-771F-42DE-BAB3-45CE24F02B6E,J06.9,"Acute upper respiratory infection, unspecified",-
EEB15DAD-A9F0-4C6D-9A31-E3EC8B10140F,R21,Rash and other nonspecific skin eruption,-
A4A54C4E-D1B3-4BDD-8947-976B97B0C563,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
39CE2636-34C7-4AD6-AFEC-057626441A7A,Z71.2,Person consulting for explanation of investigation findings,-
D0AF1D5E-9870-434F-8933-94FDBC47E78F,M54.5,Low back pain,-
8C676123-A700-4C9E-82CF-2571C0B7479A,J06.9,"Acute upper respiratory infection, unspecified",-
831C06E5-CB8F-4066-90D3-26493EF1D487,U07.1,"COVID-19, virus identified",-
A18ACD76-DD30-44B7-870B-9CFA46956BB3,T88.1,"Other complications following immunization, not elsewhere classified",-
D88B0E06-0B8F-461A-B592-21CE99B52E99,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
16580915-A2DD-44BA-A16B-9BC9D3C7E733,N94.6,"Dysmenorrhoea, unspecified",-
949C65DE-5B90-4C7E-960A-6C717B913034,A09.9,Gastroenteritis and colitis of unspecified origin,-
56B2FB39-95B4-4AAC-9950-C5E22619A230,N94.6,"Dysmenorrhoea, unspecified",-
56B2FB39-95B4-4AAC-9950-C5E22619A230,R51,Headache,-
3B3F9C8F-443A-484D-980B-3D423C9EC8E2,B35.3,Tinea pedis,-
549F7A7F-59FA-4947-80F6-FEC2A973112B,H02.9,"Disorder of eyelid, unspecified",-
75910C30-BB74-49B2-A22D-7BF42473352C,I10,Essential (primary) hypertension,Hypertension
CCA37420-8266-4811-90AD-AEA8D753FF63,K29.7,"Gastritis, unspecified",-
60CCDDF0-62CD-462A-A777-0418B77029D8,S00.8,Superficial injury of other parts of head,-
88660D1F-DE42-4B52-AFAE-72CAE2583324,A09.9,Gastroenteritis and colitis of unspecified origin,-
09921754-10DD-48D1-BF1F-2B71DC595B38,A09.9,Gastroenteritis and colitis of unspecified origin,-
6BD6A831-24DE-4C74-BA3A-2B8374BF228B,R51,Headache,-
40543241-3841-4CCB-A25F-BE39BFCF2C16,H10.9,"Conjunctivitis, unspecified",-
BAAEDC96-CF61-4085-833E-EFF480BDDA29,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
96416245-163A-43B8-91D0-42AD5B170C73,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
96416245-163A-43B8-91D0-42AD5B170C73,B35.4,Tinea corporis,-
78F5B03A-F691-4B9B-8D6A-4432C61C9FAE,R51,Headache,-
A90739DD-51D7-42AF-94DA-BC08D73D9F53,P39.0,Neonatal infective mastitis,-
D8FD9464-E90D-432E-8CB2-AD4223EA62FF,Z71.2,Person consulting for explanation of investigation findings,-
41B8A768-9CA0-4A0E-A777-D861C4802634,J06.9,"Acute upper respiratory infection, unspecified",-
89301880-70D0-44C1-AEC8-8BA334A7AD21,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
89301880-70D0-44C1-AEC8-8BA334A7AD21,R50.9,"Fever, unspecified",-
667F30BA-5E66-455F-B2AB-CCA4367090DE,Z71.2,Person consulting for explanation of investigation findings,-
7F2D5720-AF5D-442E-AAD1-0A4856F3575E,G44,Other headache syndromes,-
D673BFAD-6C4D-4BA9-AC5F-77BC9C70BE25,S80.1,Contusion of other and unspecified parts of lower leg,-
28B65FF2-265B-45D9-954A-4A7C5E64126C,R10.4,Other and unspecified abdominal pain,-
2EA0C29B-E421-48C0-8E57-1912A78E937B,N92.5,Other specified irregular menstruation,-
06C81D91-F12F-405B-8184-1E6C096F8169,T88.1,"Other complications following immunization, not elsewhere classified",-
A1E2CAC2-EC22-4ED1-98C4-8EAD39FF4B83,J06.9,"Acute upper respiratory infection, unspecified",-
61F20A6D-3996-4F4B-BA95-A268D5D1BA96,Z02,Examination and encounter for administrative purposes,-
C481A381-F434-467C-89C3-A6B10F34CAC5,O21.9,"Vomiting of pregnancy, unspecified",-
A1681FAE-8487-4ACE-B574-B2A7CE98BDC5,T88.1,"Other complications following immunization, not elsewhere classified",-
299B1CED-D045-4A8D-BCD9-0767615A1FFC,M62.6,Muscle strain,-
EAFE0AEC-B6F2-43AB-8C5B-550BBCA9A8BB,R51,Headache,-
5EA78289-6C55-49DA-B434-30155DD3C713,N94.6,"Dysmenorrhoea, unspecified",-
EAFE0AEC-B6F2-43AB-8C5B-550BBCA9A8BB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9D8514E2-1933-4CB3-95C9-77F16FFAE7E5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C2253CBD-E6C9-4417-B9C1-E5177A88FEA0,U07.1,"COVID-19, virus identified",-
39668496-701A-4B4B-817F-4CD11BF58EA9,N94.6,"Dysmenorrhoea, unspecified",-
38F441C7-A76C-4579-B840-29EA5CCA0373,U09.9,"Post COVID-19 condition, unspecified",-
78DC0EBC-6E76-40E3-BB5E-51F44FF33EE5,L50.9,"Urticaria, unspecified",-
78DC0EBC-6E76-40E3-BB5E-51F44FF33EE5,T78.4,"Allergy, unspecified",-
3FF39870-20DD-409F-894E-EB15A8BBD425,N76.0,Acute vaginitis,-
8D44F44D-9DF5-486F-91E9-95FCB50E4F4A,R51,Headache,-
98F01F9B-1A2A-4379-98C6-D6AC8221A2F4,J06.9,"Acute upper respiratory infection, unspecified",-
FDA0E083-2855-4DEE-A52F-725297ED8E39,T88.1,"Other complications following immunization, not elsewhere classified",-
8397E86E-88AE-4D37-81E1-8D3D243F5400,J06.9,"Acute upper respiratory infection, unspecified",-
C3546E0F-6FE5-45E6-AAFB-2FF9B60F9EE2,N94.6,"Dysmenorrhoea, unspecified",-
5F6CBE4A-975D-49B1-9775-250B6DEE6784,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
CAA01883-F3E0-45C1-989B-CCC8DC4FB3B1,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
CAA01883-F3E0-45C1-989B-CCC8DC4FB3B1,B37,Candidiasis,-
303C00B0-940A-419A-8012-25C4A0DF756F,G44.2,Tension-type headache,-
E2C8E7AE-FFED-4A59-BD35-50CCF777161A,R21,Rash and other nonspecific skin eruption,-
FB8B0471-DEB3-4131-B8BE-C13386275633,T88.1,"Other complications following immunization, not elsewhere classified",-
0ADAA7E9-8DD5-484F-9C0E-9ACDDC188105,J06.9,"Acute upper respiratory infection, unspecified",-
A81DC2E9-1BC7-4584-AFF1-A8DF463645C5,J02.9,"Acute pharyngitis, unspecified",-
A81DC2E9-1BC7-4584-AFF1-A8DF463645C5,M79.1,Myalgia,-
7DCE1A26-8C48-4FAB-A1A5-AAC5EDD15D1E,B35.4,Tinea corporis,-
7DCE1A26-8C48-4FAB-A1A5-AAC5EDD15D1E,B35.3,Tinea pedis,-
0240E352-FCC1-44C4-BACD-8206CAFC6939,B37.3,Candidiasis of vulva and vagina,-
C821C8B6-BC71-497D-9191-21C869C0D999,G43,Migraine,Migraine
4AEB287C-E1A9-4166-9A5C-6F1C45BA53EE,R51,Headache,-
AD5433EC-4E88-4C02-901B-BC4F751CA89A,M10,Gout,Gout
721E38A8-0B16-4EF2-AF40-506548975331,T88.1,"Other complications following immunization, not elsewhere classified",-
23C7A842-D0E0-4EBC-BB20-874CD1884D47,K29.7,"Gastritis, unspecified",-
A5625B15-BF16-4006-A1DD-9F5FC252C51C,A09.9,Gastroenteritis and colitis of unspecified origin,-
92374E2F-E3F5-4391-96AB-641F642B6E0C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
79A53741-3526-40AB-8B09-0DF2A955ECA3,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
D5604864-A93C-4047-8C6C-2D7C09D93052,T88.1,"Other complications following immunization, not elsewhere classified",-
A12EA6EC-E809-44EB-89C9-5A2FE4023A82,N94.6,"Dysmenorrhoea, unspecified",-
94148DF1-36D0-4B1A-8D0A-1F661D94796B,J06.9,"Acute upper respiratory infection, unspecified",-
30CB728C-3A5B-4C2D-9A82-EAE5A2F53EF2,J06.9,"Acute upper respiratory infection, unspecified",-
C93DB864-FD6B-4F40-B1EB-140EDBAA25BC,M79.1,Myalgia,-
6603873C-2E56-4F7E-85C5-7D9E407A7F7E,K29.7,"Gastritis, unspecified",-
E7C10F8C-9679-45E9-B217-7D49159EEFE3,R21,Rash and other nonspecific skin eruption,-
E7C10F8C-9679-45E9-B217-7D49159EEFE3,H57,Other disorders of eye and adnexa,-
033494E6-8328-4422-96DC-90A0354ED3EA,L50,Urticaria,-
C1DFF1BC-5537-42B3-BBD4-628351732741,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
252BA632-5710-4F4F-9148-8E0965F5B311,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
252BA632-5710-4F4F-9148-8E0965F5B311,R51,Headache,-
261A6A04-5C56-4BE8-9A12-3D0258ECB65A,S60.2,Contusion of other parts of wrist and hand,-
766BE7F2-D2BF-4929-9835-4EB6C8AD7EA8,M10,Gout,Gout
766BE7F2-D2BF-4929-9835-4EB6C8AD7EA8,R21,Rash and other nonspecific skin eruption,-
766BE7F2-D2BF-4929-9835-4EB6C8AD7EA8,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
FDD82DD7-F0FC-4CCF-96DF-4160D440FD13,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
C8A0E883-5FE4-4A1F-8C2C-A1819B5E0A3E,R42,Dizziness and giddiness,-
C8A0E883-5FE4-4A1F-8C2C-A1819B5E0A3E,R51,Headache,-
E85C265A-7E92-4E2F-B569-AA604DF447DF,R51,Headache,-
50D8A7C1-177E-4B34-AE87-C6DA1A796E22,R21,Rash and other nonspecific skin eruption,-
FC0D0A7D-B8C8-44F6-8E55-B5358F6DB4E1,L24,Irritant contact dermatitis,-
887447E0-6FC5-407D-908D-5F269A7FA423,R10.4,Other and unspecified abdominal pain,-
74D23138-A614-4EC0-9ECD-B15877953D5F,Z71.2,Person consulting for explanation of investigation findings,-
6418A082-2B48-43C7-9738-FBD03B39D1BF,T88.1,"Other complications following immunization, not elsewhere classified",-
6418A082-2B48-43C7-9738-FBD03B39D1BF,K30,Functional dyspepsia,-
74E49D1C-1EA1-4E59-9FB1-5D7D4AD96D04,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
DF060F6A-58E0-401E-8BBB-227F16F1F5E5,A09.9,Gastroenteritis and colitis of unspecified origin,-
5CCB89FC-5581-4714-ABC0-4AB899EC0C9B,R11,Nausea and vomiting,-
1BBB4301-58F0-4719-ACA9-663DAB3BC003,J06.9,"Acute upper respiratory infection, unspecified",-
803E95D6-E65F-4D5A-AFA7-B8822B41C7CB,J02,Acute pharyngitis,-
AC16ED65-33AF-4B8A-A86F-8D7AC4E6198E,R51,Headache,-
C343E339-901A-4E13-88DF-8A5BC6E16A4B,T88.1,"Other complications following immunization, not elsewhere classified",-
78348323-2F6D-4ECA-8702-6CB700DBD8E2,J06.9,"Acute upper respiratory infection, unspecified",-
1523E32E-F94D-4F5E-B0C8-469CE67C19FF,M62.6,Muscle strain,-
76D17E44-1C61-467A-852A-2BE74CEF2D37,A09.9,Gastroenteritis and colitis of unspecified origin,-
DBEC28C4-4888-4EBA-81C5-7150B99618BF,J06.9,"Acute upper respiratory infection, unspecified",-
14917131-568F-4F9C-8EDE-894D9D685A40,R21,Rash and other nonspecific skin eruption,-
1061FB90-03B7-457F-A4D5-BEE981D24623,I95.8,Other hypotension,-
3AC0BF53-50EB-472A-91B1-EE407510CE5D,A09.9,Gastroenteritis and colitis of unspecified origin,-
374ECC74-E68A-4176-AC5D-0E66E001EC03,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
374ECC74-E68A-4176-AC5D-0E66E001EC03,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FADF7738-BC98-4E6D-BAF7-53B1F89E313E,G43,Migraine,Migraine
E7E57C66-A992-4709-AFCB-DEADA4BB7E80,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
FA6EB0E4-D89B-4FA2-A86D-4531E73BDE7F,H57,Other disorders of eye and adnexa,-
3966FCF4-40A8-4124-B1C0-505EC81567A0,J06,Acute upper respiratory infections of multiple and unspecified sites,-
1ABA1002-779C-40F6-812F-AA6ECA4AC8EE,R50.9,"Fever, unspecified",-
1ABA1002-779C-40F6-812F-AA6ECA4AC8EE,A09.9,Gastroenteritis and colitis of unspecified origin,-
10791B91-6504-4ED6-9CF5-602A7E30D147,S60.8,Other superficial injuries of wrist and hand,-
10791B91-6504-4ED6-9CF5-602A7E30D147,G44.2,Tension-type headache,-
B807A95F-6F6C-46F3-974D-5B1E12BCE015,R51,Headache,-
3A4B6F84-F412-4E04-B2B7-31F53880F242,G43,Migraine,Migraine
3A4B6F84-F412-4E04-B2B7-31F53880F242,J06.9,"Acute upper respiratory infection, unspecified",-
AA27A8F6-FEC2-42D5-AB8B-E0DC7F3DB3F4,J06.9,"Acute upper respiratory infection, unspecified",-
F3A86499-E4D8-4495-9DF5-9E546C8679FF,N94.6,"Dysmenorrhoea, unspecified",-
F3A86499-E4D8-4495-9DF5-9E546C8679FF,R11,Nausea and vomiting,-
21085D48-48B1-49A4-B0F7-4287196101B3,G43,Migraine,Migraine
AA136BE3-1031-4496-8105-8A1A1D5BCC63,J06.9,"Acute upper respiratory infection, unspecified",-
32691D8D-2EBA-4C6A-85A1-31169049E1BE,A09.9,Gastroenteritis and colitis of unspecified origin,-
43EEEB9F-B597-4352-9E98-8FF4A89C20E7,R51,Headache,-
679531C7-E237-4907-B505-6AD26EB45756,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
A7988F5E-AC05-4D8F-86B6-2BCC30EC52CA,H00,Hordeolum and chalazion,-
A7302493-91D9-4CAB-B48E-3E2074CE83FD,N94.6,"Dysmenorrhoea, unspecified",-
D3A2533F-4434-4457-9E78-7990B7B23E8C,R21,Rash and other nonspecific skin eruption,-
7469791B-0F8D-47F4-9179-750BE201A584,Z76.0,Issue of repeat prescription,-
62983DC9-B795-4741-81C6-F64889604024,R22.9,"Localized swelling, mass and lump, unspecified",-
F5D4F2BB-128D-47C4-BA7F-4FCECD3494ED,J06.9,"Acute upper respiratory infection, unspecified",-
D636646B-E9DE-45EE-9A8C-C79BE86B8A67,R51,Headache,-
AC4EF5E2-B605-4AAF-BB82-916CA935DDF5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
07E2C051-F8B4-41F2-A0AB-2B9420B32627,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6D64D647-A23D-45EE-903C-160CE71A6893,N94.4,Primary dysmenorrhoea,-
CA5AA099-005A-44DC-B062-D67A0046F40D,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
36FFD6B5-9FFA-48B2-8047-75FA3A74391F,A09.9,Gastroenteritis and colitis of unspecified origin,-
3C440562-D090-48E7-8C4C-4AEC1A490BA5,J06.9,"Acute upper respiratory infection, unspecified",-
BC445F22-4386-4DC6-9105-C63C2A89D87A,Z71.2,Person consulting for explanation of investigation findings,-
EED9426F-171D-4DCE-B0D7-E16B81F0A865,U07.1,"COVID-19, virus identified",-
88935D83-86C5-46C9-A2BF-0F7B1D967AE6,R51,Headache,-
88935D83-86C5-46C9-A2BF-0F7B1D967AE6,N94.6,"Dysmenorrhoea, unspecified",-
3C17C6BA-23CD-4820-B5F7-59B746FF02CB,N94.6,"Dysmenorrhoea, unspecified",-
352DBB86-6C9E-461B-BED7-297FF21A196E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
352DBB86-6C9E-461B-BED7-297FF21A196E,M79.1,Myalgia,-
6178AA6D-18E7-4305-B70B-0B193652A09A,K12,Stomatitis and related lesions,-
B5CF6043-D1D0-415A-BB9C-A0FA5BD7F32C,G44.2,Tension-type headache,-
7846B83F-A9BD-42BE-977B-BBA7FA74F9D5,A09.9,Gastroenteritis and colitis of unspecified origin,-
19A3185F-4E37-416A-B738-0B2153DF3616,R21,Rash and other nonspecific skin eruption,-
7846B83F-A9BD-42BE-977B-BBA7FA74F9D5,R51,Headache,-
19A3185F-4E37-416A-B738-0B2153DF3616,L50.9,"Urticaria, unspecified",-
6DF80238-952E-46DC-BE31-901928F440EA,U07.1,"COVID-19, virus identified",-
1F7017AA-0235-4161-98BB-EFDC2DCFAE7B,L30.9,"Dermatitis, unspecified",-
93D5EDB6-9E92-4F5E-BEF4-C6D576F97444,A09.9,Gastroenteritis and colitis of unspecified origin,-
7DD1F710-E61A-4686-B0BA-7E13ECFE7F11,A09.9,Gastroenteritis and colitis of unspecified origin,-
90BD2366-FEFD-4E0E-8F5F-F7A54B5803AA,R51,Headache,-
6D0477E3-C0A9-49C3-90EA-D313AE45484E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
036FDF75-9FD8-4346-8CA4-1640C932924C,K29.6,Other gastritis,-
3C5F9BDF-CEF8-44A3-AE58-C8A708317813,L73,Other follicular disorders,-
FCBA3F3F-DE14-4B77-B148-02080C70F058,T88.1,"Other complications following immunization, not elsewhere classified",-
5EC22E57-0CF3-440B-945F-6CEFF48B8E93,A09.9,Gastroenteritis and colitis of unspecified origin,-
5EC22E57-0CF3-440B-945F-6CEFF48B8E93,R51,Headache,-
6F7F3AF3-BEAD-4235-9B3B-B08726EAEB46,J06.9,"Acute upper respiratory infection, unspecified",-
9C0104DF-C4D5-44C2-A982-AE956D0569D7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
73C0941E-0E20-49D4-9E4E-F99CFDD451D9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8A2B1A22-4B00-4E2A-9233-7A3D7DEE5DFD,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
8A2B1A22-4B00-4E2A-9233-7A3D7DEE5DFD,K29.7,"Gastritis, unspecified",-
75F9980F-C1E4-4C92-9B4A-2E4DD32B5BED,A09.9,Gastroenteritis and colitis of unspecified origin,-
CF345864-440B-4986-AF85-F440AEA3469A,G44.2,Tension-type headache,-
4A90297C-4E7C-414F-A849-F8E7F1643653,M79.1,Myalgia,-
4A90297C-4E7C-414F-A849-F8E7F1643653,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CF345864-440B-4986-AF85-F440AEA3469A,N94.6,"Dysmenorrhoea, unspecified",-
E474FAE1-0F53-49C7-A704-3D978DD6F923,Z76.0,Issue of repeat prescription,-
B3D6991A-1EDE-459B-80D0-EE88DA41448C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3C633CB4-FB8F-4136-A600-4BE88EE1E6DA,B35.3,Tinea pedis,-
E8F046FC-FB5D-44F4-BA7D-2F37A3B3BB6B,H91.9,"Hearing loss, unspecified",-
B95D09A5-3A4E-4449-9FAE-AD84780C2648,A09.9,Gastroenteritis and colitis of unspecified origin,-
A1082AFF-BFF9-4D0B-BC6A-BC2EA4B2BF32,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
A1082AFF-BFF9-4D0B-BC6A-BC2EA4B2BF32,L20,Atopic dermatitis,Atopic dermatitis
ED28D81E-7A5D-4B75-9045-57ACE8F266E8,J06.9,"Acute upper respiratory infection, unspecified",-
B7A20549-0033-42D1-A7A8-2DEC2BBA22AF,L50.9,"Urticaria, unspecified",-
6CC864A5-F8AD-4A24-87DE-8BC2BF23D834,Z71.2,Person consulting for explanation of investigation findings,-
4337361D-84CF-47F0-B3B8-E2EE38A43FD9,A09.9,Gastroenteritis and colitis of unspecified origin,-
82E9C1E3-94D9-4836-B9F8-9B95447B74AD,R21,Rash and other nonspecific skin eruption,-
C48A26A1-A93C-4A41-9F1A-B078D92A87F3,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
4120A400-5183-4728-AA49-AD9BF5FA12AF,Z71.2,Person consulting for explanation of investigation findings,-
4120A400-5183-4728-AA49-AD9BF5FA12AF,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
E7B36D4E-35FF-4947-A6B2-6BB9B8B329BC,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
AD88256C-DAC0-4295-BB27-531AB5AAB6D0,N39.0,"Urinary tract infection, site not specified",-
47F6A432-287E-4090-8ECC-5ECD41AF574E,G56.0,Carpal tunnel syndrome,-
47F6A432-287E-4090-8ECC-5ECD41AF574E,M65,Synovitis and tenosynovitis,-
F3A25B3B-C507-4D75-96AA-0A7DB68433DA,G44.1,"Vascular headache, not elsewhere classified",-
7A0CAD5D-0282-49B0-972C-D0E81ED28305,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1F08E320-FEAE-4800-B9D8-C4941B9885DC,J06.9,"Acute upper respiratory infection, unspecified",-
EE1CA78A-A778-423B-8B53-B4AA6984B708,R51,Headache,-
6C65D19A-CDBE-45D2-814D-FFB3104761D4,R51,Headache,-
C99094CF-B8DB-4994-9DD7-60682107BC45,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F91C6726-558C-4622-9B26-B5035296EE15,J06.9,"Acute upper respiratory infection, unspecified",-
921B79AA-EC95-4645-B713-7C072295EE58,J06,Acute upper respiratory infections of multiple and unspecified sites,-
86969EC6-8920-48E7-A4A1-03D8B0086662,A09.9,Gastroenteritis and colitis of unspecified origin,-
784655D7-2A43-4E37-955C-0DDB0591E2B6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E6BEA1DA-3A5F-44CD-A31A-3F1D11AC963A,R51,Headache,-
FFB3AA42-8318-451F-92BC-8A8CE2167E9E,E11.9,Type 2 diabetes mellitus without complications,Diabetes
8170D189-3A88-4F6E-A5C7-63F2ACBD4C3F,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
F7B15A0B-7219-49A9-B15F-4E3A40F5B9AA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
30BB3E3D-4483-4869-8317-95001DA7AD39,L20,Atopic dermatitis,Atopic dermatitis
2402A5B7-324A-4610-942B-1CD8CAAC0BB3,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
80AB51A0-46C0-4C55-B699-554C8A0DA150,A09.9,Gastroenteritis and colitis of unspecified origin,-
C6BED974-5DD4-406C-89DE-3C4EBA89DEA7,N94.6,"Dysmenorrhoea, unspecified",-
0A2BB736-5459-448B-A20F-A5E39455E59B,J06.9,"Acute upper respiratory infection, unspecified",-
0D78253D-DB0D-425B-873C-0B929C36A3CB,A09.9,Gastroenteritis and colitis of unspecified origin,-
976B0737-B6AE-46AA-9A84-0C748C451356,B07,Viral warts,-
0A48637D-F2D5-45CA-BA96-2AF07A0443AB,M62.6,Muscle strain,-
8397862F-14BF-4792-BD6C-F3E684A16DA1,Z71.2,Person consulting for explanation of investigation findings,-
87D00CC5-20D1-4D13-9B8E-5E6335926D37,J02,Acute pharyngitis,-
87D00CC5-20D1-4D13-9B8E-5E6335926D37,R51,Headache,-
E23D08D7-4533-4889-9431-D7C6BE433F35,R51,Headache,-
FBE068B0-75F6-4374-82C8-FAF78AF4B8D7,T88.1,"Other complications following immunization, not elsewhere classified",-
B7C55E97-7F81-4745-8203-58AC4532BE63,Z01.7,Laboratory examination,-
F0ED7546-F309-41D5-A5FC-0211E75B5A34,K59.0,Constipation,-
649D7613-474B-49DA-8CA3-EF9E93DBAC92,M25.5,Pain in joint,-
499F3D10-9663-4CFB-89C8-2DA4ECEADFAF,H57.9,"Disorder of eye and adnexa, unspecified",-
E7CE89A1-270A-4510-B2B6-1CBF16E3FDD6,J34,Other disorders of nose and nasal sinuses,-
22B79386-A13F-4769-9D0E-7C2914F6F21B,T88.1,"Other complications following immunization, not elsewhere classified",-
373C4144-7542-4A53-9C31-E64681FA8B63,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
BEB662FE-A998-4366-8D1C-E1EE6426B8F9,R21,Rash and other nonspecific skin eruption,-
C2D9D285-5079-4A81-912A-5F0974336EC1,N94.6,"Dysmenorrhoea, unspecified",-
A19E34C3-AFFD-4B52-9FBE-4CFC0228E78B,Z71.2,Person consulting for explanation of investigation findings,-
E8813D0E-77A5-40B4-9D30-BBA6E392616E,N94.8,Other specified conditions associated with female genital organs and menstrual cycle,-
962618EF-EEA6-4924-8B0D-C66978C1CEFE,N94.6,"Dysmenorrhoea, unspecified",-
EB8143BD-6298-40B9-9D3D-21038F57F13F,N94.6,"Dysmenorrhoea, unspecified",-
7BA84F8F-768B-4289-BC85-EC19792F26D6,N39.0,"Urinary tract infection, site not specified",-
17F124A8-393B-46DC-B7D4-FF2B09FB8D6F,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
17F124A8-393B-46DC-B7D4-FF2B09FB8D6F,R21,Rash and other nonspecific skin eruption,-
50EBF886-6FF1-4725-98F7-4ADB9266AED9,L84,Corns and callosities,-
581B4760-E4AE-45A0-9F94-A03B1DC0C183,M54.5,Low back pain,-
636F539D-2263-4E15-8F02-AE80FA39DF8A,U07.1,"COVID-19, virus identified",-
0431414F-6ECA-4EB2-B9AF-5B150367F5E8,B35.3,Tinea pedis,-
5B626291-8F11-43BC-9A0A-4D222998C009,R21,Rash and other nonspecific skin eruption,-
2DAE4C10-5833-42A7-8E36-CAC8E675D72E,N39.0,"Urinary tract infection, site not specified",-
42F86680-5551-4EB8-8688-67B2E896F72D,J06.9,"Acute upper respiratory infection, unspecified",-
6A715FAE-7934-4429-8FF1-BFFA7C90191B,J06.9,"Acute upper respiratory infection, unspecified",-
55BDCCDC-CBB7-4C73-9343-F31CA034780F,J06.9,"Acute upper respiratory infection, unspecified",-
2C828BC7-DBA0-4CD5-9E2A-A17571C2C268,R51,Headache,-
9B01D870-5B17-44E3-8525-EB9AC6F5E1E9,J06.9,"Acute upper respiratory infection, unspecified",-
02322A33-7AAB-4238-9A7C-9BE270886B16,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
02322A33-7AAB-4238-9A7C-9BE270886B16,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
581E0291-EA16-47C9-BB04-3F43671AE0C2,L70,Acne,-
1C4FD511-FEC9-40B1-B4AE-EED41EA99869,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
92FD49B3-532A-40BD-9BAD-20D80A38F6CD,J06.9,"Acute upper respiratory infection, unspecified",-
4C39918E-6F58-4FFB-B88E-FDAA28947DD2,J06.9,"Acute upper respiratory infection, unspecified",-
389248F8-FE38-4FE7-86CD-BAE0437FF6EF,J22,Unspecified acute lower respiratory infection,-
0917F4A6-7BA8-427E-AAB5-F16C1A901753,S43.7,Sprain and strain of other and unspecified parts of shoulder girdle,-
CF1018ED-FCC1-463C-A55B-C4F8E50D1B21,S43.7,Sprain and strain of other and unspecified parts of shoulder girdle,-
D5377C3B-1D6B-4C64-90AF-414995A39EC2,H81.1,Benign paroxysmal vertigo,-
B16D15F5-BEE7-42A5-A06E-0EADEF9F7052,A09.9,Gastroenteritis and colitis of unspecified origin,-
6533A615-F193-421A-8CB0-F5BB82AF2965,N76.0,Acute vaginitis,-
6533A615-F193-421A-8CB0-F5BB82AF2965,R51,Headache,-
77045B41-CB45-41CB-9BF6-C4D99DA335C0,K59.0,Constipation,-
AA11B233-E161-4740-A8E6-9AB7D2B45C4A,U07.2,"COVID-19, virus not identified",-
17FD6D4A-6A70-40F1-964B-F181CDDD7816,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
17FD6D4A-6A70-40F1-964B-F181CDDD7816,M79.1,Myalgia,-
4EE5D135-2F24-4AC8-82AA-F736340F21DC,J06.9,"Acute upper respiratory infection, unspecified",-
6B4FBB72-C1DF-466B-925C-A3E418EC7ABA,T88.1,"Other complications following immunization, not elsewhere classified",-
6CEA7477-D598-4834-A75C-610621F8314F,T88.1,"Other complications following immunization, not elsewhere classified",-
837F8EE6-036E-4C25-9295-71D99D109108,L60,Nail disorders,-
837F8EE6-036E-4C25-9295-71D99D109108,H10.8,Other conjunctivitis,-
837F8EE6-036E-4C25-9295-71D99D109108,L20,Atopic dermatitis,Atopic dermatitis
1298C400-3F3B-4277-8DF0-F77456E0A6B6,N94.6,"Dysmenorrhoea, unspecified",-
5526EF6B-AD68-4242-9051-D8D76AFBE850,J06.9,"Acute upper respiratory infection, unspecified",-
64E0A41E-DBB3-47CB-BA0F-BF258D774B1C,L50,Urticaria,-
9FC6FD89-9728-40B6-A215-B8747C1C518C,R00.2,Palpitations,-
E2ABE890-7ACE-4CD5-AC15-26A512202E46,A09.9,Gastroenteritis and colitis of unspecified origin,-
BCDB8BCD-E9F7-4248-B1E2-709C74277160,M54.5,Low back pain,-
0E12292A-CF57-4D7B-8799-D5BB64C72F37,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
43531545-E11B-445E-8DD3-B38692936B7F,L50.9,"Urticaria, unspecified",-
C9BE86F0-70C4-45AA-BD27-1ACC6E9AF3B4,T88.1,"Other complications following immunization, not elsewhere classified",-
135CD79F-D36A-4262-BE82-64F41E21BAF2,R51,Headache,-
544582F9-D315-4145-BBF3-49815DAFC454,L20,Atopic dermatitis,Atopic dermatitis
544582F9-D315-4145-BBF3-49815DAFC454,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
2367229A-FF82-46B7-8B9A-AFA0DD4DE004,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
0ADB6966-3B2C-4CBD-8E7A-90A34659E7B9,S83,"Dislocation, sprain and strain of joints and ligaments of knee",-
D665F968-3944-4F33-8E0E-F9CBF126E19B,A09.9,Gastroenteritis and colitis of unspecified origin,-
53282C78-69B0-4B08-91C7-F3177B574B1D,B36.0,Pityriasis versicolor,-
FEEED884-1CAD-4D40-B7FA-EE98768F583D,J45,Asthma,Asthma
52D6F78E-09BB-455F-84E4-6A88CDE1F07F,N94.9,Unspecified condition associated with female genital organs and menstrual cycle,-
52D6F78E-09BB-455F-84E4-6A88CDE1F07F,G43,Migraine,Migraine
FEEED884-1CAD-4D40-B7FA-EE98768F583D,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
273A8482-896D-4F9C-9C24-0331F72D500C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
53412292-1473-4921-A54F-446B1D678DF6,Z02.9,"Examination for administrative purposes, unspecified",-
13ADA1AA-B81D-4864-A9B6-9A516D3BC68C,H00,Hordeolum and chalazion,-
13ADA1AA-B81D-4864-A9B6-9A516D3BC68C,L20,Atopic dermatitis,Atopic dermatitis
B549B026-2212-4BA2-A715-9029E9332DCC,N92,"Excessive, frequent and irregular menstruation",-
104DD60C-E57E-4C82-A133-791E86856111,U07.1,"COVID-19, virus identified",-
0BC34260-6A32-4BED-BBF9-B17058D4BDDB,L30.9,"Dermatitis, unspecified",-
26BB96FF-6140-45E4-BCEF-F6E0A876C726,B36.0,Pityriasis versicolor,-
8E2EEBDF-A2DB-4971-9C9A-BC41C3C572EA,L20,Atopic dermatitis,Atopic dermatitis
26BB96FF-6140-45E4-BCEF-F6E0A876C726,L20,Atopic dermatitis,Atopic dermatitis
E9DF2838-71FC-461F-8615-80C11F3A1D93,T23.0,Burn of unspecified degree of wrist and hand,-
0A16B646-4AB9-4923-8CA8-49D9955B17B9,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
0A16B646-4AB9-4923-8CA8-49D9955B17B9,U07.1,"COVID-19, virus identified",-
C32DB56E-D051-44BF-A23F-CB5D5B95A2F1,J06.9,"Acute upper respiratory infection, unspecified",-
071CEA01-B5EE-46D7-96C9-800CF926BA85,R21,Rash and other nonspecific skin eruption,-
E7D459ED-EBC8-4BD1-86B4-EAEEFA885633,J06.9,"Acute upper respiratory infection, unspecified",-
1DD5BBFC-5D94-425C-A49F-8162114F05B1,T88.1,"Other complications following immunization, not elsewhere classified",-
8427EF93-1BA2-4838-93F2-EB8F2399E6E4,T88.1,"Other complications following immunization, not elsewhere classified",-
8C8603FF-708C-48E0-B33D-A95CE92E14CB,S00,Superficial injury of head,-
8C8603FF-708C-48E0-B33D-A95CE92E14CB,M54.5,Low back pain,-
0E93FFA4-3374-4E66-9427-A4B049FE0125,I10,Essential (primary) hypertension,Hypertension
35B98267-5821-4ACB-8E77-E7F588DDAA14,M10,Gout,Gout
91C520B3-6B98-41A0-888D-5044B382D512,U08,Personal history of COVID-19,-
ED6A0230-1FAC-43D6-8466-553300959215,U07.1,"COVID-19, virus identified",-
0E93FFA4-3374-4E66-9427-A4B049FE0125,J06.9,"Acute upper respiratory infection, unspecified",-
E0A34034-D8B1-4091-BE7D-401BB3FA0803,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B497F636-4E59-4A1C-A77B-6648A7E2AD45,M25.5,Pain in joint,-
BC7D6C80-D627-4D98-BE51-734B8C70EFC6,A09.9,Gastroenteritis and colitis of unspecified origin,-
BC7D6C80-D627-4D98-BE51-734B8C70EFC6,L20,Atopic dermatitis,Atopic dermatitis
65EACBD3-4CA3-4A3F-98F1-18927941AAD9,Z71.2,Person consulting for explanation of investigation findings,-
D3079A60-2F6B-44C0-8BC3-FA19D32ADB41,T88.1,"Other complications following immunization, not elsewhere classified",-
8D9277C9-BFE1-431B-A842-09CD1B6B4B84,J06.9,"Acute upper respiratory infection, unspecified",-
EDF331E2-87CD-4B60-9006-A46615F9734D,N94.6,"Dysmenorrhoea, unspecified",-
FF6808BC-C1FC-44EE-85C3-A43B11F1F783,J06.9,"Acute upper respiratory infection, unspecified",-
C4D45372-AC04-4C42-B7FF-BE899FBE26B8,M10,Gout,Gout
81849FD4-42AD-46CF-A052-EC4F60C9C6BA,B35.6,Tinea inguinalis [Tinea cruris],-
83C30828-454B-4690-91E7-83A2C790A97D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D94CA8BB-577C-42E1-A131-A6F481DABD3B,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
C470192F-7F14-443E-8664-2897F31E9B8F,E78.2,Mixed hyperlipidaemia,Hyperlipidaemia
C470192F-7F14-443E-8664-2897F31E9B8F,I10,Essential (primary) hypertension,Hypertension
C470192F-7F14-443E-8664-2897F31E9B8F,R21,Rash and other nonspecific skin eruption,-
A8BF9155-5109-419C-B960-97CBAEAF4699,J06.9,"Acute upper respiratory infection, unspecified",-
E7D459ED-EBC8-4BD1-86B4-EAEEFA885633,U07.1,"COVID-19, virus identified",-
2B2E72BF-13B3-4826-ABA4-B709B3A626B2,I10,Essential (primary) hypertension,Hypertension
0B5B4D0F-F5B7-4C14-8635-93D26B70A0AC,T88.1,"Other complications following immunization, not elsewhere classified",-
B7F24F84-F77F-48E0-A5D8-7EE83D527C4D,A09.9,Gastroenteritis and colitis of unspecified origin,-
B7F24F84-F77F-48E0-A5D8-7EE83D527C4D,R51,Headache,-
46F755A9-E811-4797-B531-28FA182935FE,R51,Headache,-
3A0FC555-1381-44A3-8036-1DD89054BFD9,L20,Atopic dermatitis,Atopic dermatitis
46F755A9-E811-4797-B531-28FA182935FE,J06.9,"Acute upper respiratory infection, unspecified",-
3A0FC555-1381-44A3-8036-1DD89054BFD9,T78.4,"Allergy, unspecified",-
3A0FC555-1381-44A3-8036-1DD89054BFD9,R51,Headache,-
AD1F99CE-211E-454F-A6FD-DAD5C4EF7B8E,M62.6,Muscle strain,-
AD1F99CE-211E-454F-A6FD-DAD5C4EF7B8E,N94.6,"Dysmenorrhoea, unspecified",-
5F4DA13C-6B54-4EF2-B402-2393D37D8F03,S33.5,Sprain and strain of lumbar spine,-
202AE074-C6D2-4251-BFA9-F7A24CEB5DEA,R51,Headache,-
D3A6D19A-47A6-40C0-BBF8-5EFC68932AC6,A09.9,Gastroenteritis and colitis of unspecified origin,-
9CB3824F-E619-4D4D-8032-8CCDABF6346B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0234B86D-2932-46A3-8B46-E1F497D3365E,N94.6,"Dysmenorrhoea, unspecified",-
0234B86D-2932-46A3-8B46-E1F497D3365E,R51,Headache,-
E6024790-E588-40C4-8EF6-5CDFA39CAC0E,H81.1,Benign paroxysmal vertigo,-
3E74C387-4633-47F9-BAC9-89A883550667,R10.4,Other and unspecified abdominal pain,-
8C160C94-6D0A-47E3-A3EB-A08AB195D65C,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
B6668215-89F4-4F7A-87A3-E5C5F15C9CCE,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
E96CA782-C06A-45BB-AA84-E2B1659142B8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C3D722AA-969D-47CE-A0F6-8077E6C35E1C,M62.6,Muscle strain,-
168E0719-734C-480F-B75C-0969407C9FC1,R51,Headache,-
2CAB8F22-1E82-48A4-957B-632E731CE41A,T88.1,"Other complications following immunization, not elsewhere classified",-
D241BE13-CC1C-4BF0-8413-09E1D7773E3A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
01CE9B09-FC27-4A18-AC5C-1AADE84DB7C5,T88.1,"Other complications following immunization, not elsewhere classified",-
447EF47C-1312-482B-B8C8-0DF62812E627,R51,Headache,-
52FB797A-0C77-4189-8091-647F96C20CB4,J06.9,"Acute upper respiratory infection, unspecified",-
5DD7802B-BFD2-46AD-99D6-F3AFEF118B7B,J06,Acute upper respiratory infections of multiple and unspecified sites,-
0A69712E-4CAC-4E3B-8A7A-F2B788BA2F85,R51,Headache,-
6A0ABB35-8234-4FB2-8F47-B4B003FBB88C,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
6A0ABB35-8234-4FB2-8F47-B4B003FBB88C,K58.1,Irritable bowel syndrome with predominant diarrhoea [IBS-D],-
9E4F7248-6856-481F-931E-EF14B16D0A37,E61.1,Iron deficiency,-
9E4F7248-6856-481F-931E-EF14B16D0A37,N94.6,"Dysmenorrhoea, unspecified",-
9E4F7248-6856-481F-931E-EF14B16D0A37,R53,Malaise and fatigue,-
D780E3FF-0556-421C-9677-430EA25D494F,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
D780E3FF-0556-421C-9677-430EA25D494F,J45,Asthma,Asthma
EE5CFBA3-8134-418E-9FDA-A225E1E143E9,J02.9,"Acute pharyngitis, unspecified",-
EE5CFBA3-8134-418E-9FDA-A225E1E143E9,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
ABA199E5-4080-441B-BD22-A743B0FF44F3,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
57203E4F-2887-4806-8B57-BC0747977027,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
52ED391B-F665-4BD3-841E-428AFBE5C748,J06.9,"Acute upper respiratory infection, unspecified",-
0568E589-A170-4E4F-8617-6D428DC5A174,M54.5,Low back pain,-
4E51D85A-5719-4D5F-9D0C-8280EC21BF26,A09.9,Gastroenteritis and colitis of unspecified origin,-
69AB3E5A-2378-441E-89DC-49A62E783ADD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8ED2D2B3-92AE-4D00-A30A-24EA7B5C1532,T88.1,"Other complications following immunization, not elsewhere classified",-
2FD90E67-8A98-4C43-94A1-4750347E3EA4,H57,Other disorders of eye and adnexa,-
2FD90E67-8A98-4C43-94A1-4750347E3EA4,R21,Rash and other nonspecific skin eruption,-
B0CFE6D9-D2B1-4021-821C-9CE46F223CC1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2F86FA27-8294-4D96-9258-B8947F692C37,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
95E090F6-2868-42B1-ACBC-B3223164A81D,R51,Headache,-
0C803356-45A0-49C4-BC35-FF9D1C051A1A,H57,Other disorders of eye and adnexa,-
5FB2E3B6-A3C9-4FFB-AC49-5BE71243F3D1,Z71.2,Person consulting for explanation of investigation findings,-
6E5C1F4E-9725-4FA0-9CE3-2A9BBA1E1AF5,L30.9,"Dermatitis, unspecified",-
58D5F14D-4D8A-48DD-9598-B990DC02EDAF,R51,Headache,-
D2C2DBDD-97B0-4B5B-AA28-897584AA8A35,Z71.2,Person consulting for explanation of investigation findings,-
DCB11EB4-828A-4A60-B482-14498D02E992,A09.9,Gastroenteritis and colitis of unspecified origin,-
14344993-7112-4939-BF88-970B1BA92649,J06.9,"Acute upper respiratory infection, unspecified",-
14344993-7112-4939-BF88-970B1BA92649,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
18EE1000-3362-4BF1-BF57-8E175C53650E,H81.1,Benign paroxysmal vertigo,-
6D35F989-FA87-48ED-9121-1CF784A0E634,T88.1,"Other complications following immunization, not elsewhere classified",-
E5BEBC14-6719-4F52-BE43-3147B4321C71,S83,"Dislocation, sprain and strain of joints and ligaments of knee",-
759EA132-A7AA-4C53-B685-A76078AE953A,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
759EA132-A7AA-4C53-B685-A76078AE953A,A09.9,Gastroenteritis and colitis of unspecified origin,-
A6915BE3-491A-4A74-B235-496996DFF913,J06.9,"Acute upper respiratory infection, unspecified",-
49B1A085-02AA-4300-A4BD-773AB9E9399A,Z02.9,"Examination for administrative purposes, unspecified",-
24146E08-A0E7-49B7-AF72-644C34F7AD46,R51,Headache,-
24146E08-A0E7-49B7-AF72-644C34F7AD46,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5702388A-D623-4F93-ACA8-81696899B34E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A7580BE9-547B-4A81-A4C1-C1690444B848,K12.3,Oral mucositis (ulcerative),-
80F832EC-3C47-4CE7-ACD5-3F0298F6A10C,R50.9,"Fever, unspecified",-
80F832EC-3C47-4CE7-ACD5-3F0298F6A10C,O91.2,Nonpurulent mastitis associated with childbirth,-
90A00E3E-F84F-4E14-8E9C-6435427C11D7,L60.0,Ingrowing nail,-
C8864B2A-A4AE-4076-832D-0948C879E3B3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C8864B2A-A4AE-4076-832D-0948C879E3B3,R51,Headache,-
A2769389-30CF-4DDC-A80D-09D863E059D7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8A1B4350-8805-4B52-8F4F-AFD266F614C7,J06,Acute upper respiratory infections of multiple and unspecified sites,-
DC34DF43-494E-4156-82A6-497A8D3AD9EA,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
EB04E938-2641-4DD0-BC83-E275F2388344,M54.5,Low back pain,-
F611CCD6-A958-4477-957D-1E434508DEBD,M62.6,Muscle strain,-
F611CCD6-A958-4477-957D-1E434508DEBD,M54,Dorsalgia,-
6EF592F0-59DD-439C-9A92-097F212F85E2,A09.9,Gastroenteritis and colitis of unspecified origin,-
83028DF7-28AA-4C5B-B6A2-12ACE60706F5,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
770C0713-5C22-41E1-867C-408E96B59735,J06.9,"Acute upper respiratory infection, unspecified",-
01511FF4-F1FC-4DED-BA11-2E34FF7C8313,H10.3,"Acute conjunctivitis, unspecified",-
4FFCD675-953C-4F9B-9704-F55763047397,M79.1,Myalgia,-
4FFCD675-953C-4F9B-9704-F55763047397,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C4E5C046-6C87-441A-B66D-AE7E10400AB0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
47A10DCB-9E00-4BAB-B74F-2EC72FFFBE09,T88.1,"Other complications following immunization, not elsewhere classified",-
32E99654-F819-4DCB-88D7-52005F1CEC66,K30,Functional dyspepsia,-
71ADE73E-ACE4-473C-8541-CD5BD5D8F43F,K29.7,"Gastritis, unspecified",-
32E99654-F819-4DCB-88D7-52005F1CEC66,K29.7,"Gastritis, unspecified",-
8A3F9D39-56AD-406A-AE0F-BB36C73F0670,H57,Other disorders of eye and adnexa,-
1A5A3D49-7F86-4E0B-B90D-48294157F6D7,J06.9,"Acute upper respiratory infection, unspecified",-
3C764238-F2C1-4FFF-8F77-BB7D80D88C59,R51,Headache,-
B314E480-58F5-43B3-937A-A9BAC81F2CE5,K14.9,"Disease of tongue, unspecified",-
50D120A8-F36F-4657-9058-ABDA8B588E96,R51,Headache,-
36724B3D-919B-4101-A814-93D920EC9153,H10.8,Other conjunctivitis,-
998632F3-DFBB-40CD-86AD-8900101364D2,J06.9,"Acute upper respiratory infection, unspecified",-
4F48797F-CF3F-4CF0-B11E-AB78BD16A6B1,M62.6,Muscle strain,-
B5B912E9-D0C5-481F-869E-C856E9852365,N76.0,Acute vaginitis,-
2278501A-0D10-4FF8-B367-CDA127B75B43,Z02,Examination and encounter for administrative purposes,-
0A463D14-D923-4B05-BA68-FC97331D9A93,N94.6,"Dysmenorrhoea, unspecified",-
E54CB349-A854-4CAD-9749-0D139BE9CB9D,R11,Nausea and vomiting,-
0073D73E-7448-4DA8-A189-C7231704E7C0,T88.1,"Other complications following immunization, not elsewhere classified",-
3B5AFAFB-43B5-4F1A-90DD-0973A882199C,T78.4,"Allergy, unspecified",-
5AFB75A8-5804-4C5C-9303-A7FBB873F840,N94.4,Primary dysmenorrhoea,-
ACDD2FE9-4BF2-475F-8AAB-D8726DA2B1C1,Z71.2,Person consulting for explanation of investigation findings,-
3F269660-7485-45E9-BF08-820EB1357850,M54.5,Low back pain,-
E7FB90FF-3BFF-4886-9430-FCFC376FC289,T78.4,"Allergy, unspecified",-
04396723-9978-4AF9-B552-A1708436FCEC,H57,Other disorders of eye and adnexa,-
04396723-9978-4AF9-B552-A1708436FCEC,R22.1,"Localized swelling, mass and lump, neck",-
E9634AD1-EDBD-4314-B66E-6954C5C9BF2B,G44.2,Tension-type headache,-
E9634AD1-EDBD-4314-B66E-6954C5C9BF2B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
47AF0397-A64B-480E-8C2B-FD4101A8ED17,N76.0,Acute vaginitis,-
D582C92C-6556-4C5D-B6F7-8992DDD93DB6,T88.1,"Other complications following immunization, not elsewhere classified",-
96B08EA4-19BC-4D02-AA12-03C8EEB15126,K12.0,Recurrent oral aphthae,-
4459A64E-B150-4C12-90BC-65C69F17B3BC,M10,Gout,Gout
EDB6B469-57FA-4B65-8E9E-81E9CD507BE4,J06.9,"Acute upper respiratory infection, unspecified",-
F16E8FD8-6C32-4CB0-9482-06204AB143CF,A09.9,Gastroenteritis and colitis of unspecified origin,-
DF7FD259-559E-4E93-85BB-A99C6ED27D5D,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
E69F0BA5-0515-4552-8303-5EEC59653352,T88.1,"Other complications following immunization, not elsewhere classified",-
174346BE-54B9-4D7B-9419-EE23302ACF67,L50.0,Allergic urticaria,-
2888CD5B-66D9-4367-BA4F-7147EB3A9965,R51,Headache,-
54ECB0E7-44E9-45DA-A6FB-D5EBDD281C9F,K30,Functional dyspepsia,-
54ECB0E7-44E9-45DA-A6FB-D5EBDD281C9F,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
3CDF4854-8C99-41AC-A3C2-428366F2E34B,J06.9,"Acute upper respiratory infection, unspecified",-
78C9FB73-A55B-4EF6-A7DC-053B2B355C76,N94.6,"Dysmenorrhoea, unspecified",-
154223A0-ADB0-48BA-9756-2F0786C35FC0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
ECFDA568-352B-4F7A-88DB-76B05835E607,G44.2,Tension-type headache,-
C62DCC99-2E24-457E-B536-CD912F47C77B,Z71.2,Person consulting for explanation of investigation findings,-
60F77347-90B3-424E-9167-C85A1FD57600,Y42.4,Oral contraceptives,-
B9EA8BE3-DA79-4816-84A5-5494A4DB46EC,B00,Herpesviral [herpes simplex] infections,-
BC238F13-EC12-494B-8E3A-822518EF1C73,O91.2,Nonpurulent mastitis associated with childbirth,-
2BE1DB05-01C0-41F3-9708-F2A357D871E4,J02,Acute pharyngitis,-
F17835C6-D046-4170-B7F8-32043B2105DB,Z71.2,Person consulting for explanation of investigation findings,-
B2A5DB6E-504E-4014-B876-107B79FBEAE9,M62.6,Muscle strain,-
B2A5DB6E-504E-4014-B876-107B79FBEAE9,K58,Irritable bowel syndrome,-
AC7F90E4-7551-4157-9A7F-21965229F07B,R51,Headache,-
17F74B65-B9B7-4212-B448-9C00641D1FE4,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
140BB6B9-F24F-4B89-8274-DA62CEE81349,J39.9,"Disease of upper respiratory tract, unspecified",-
F4677071-42C1-480E-809F-84D8F7D59CBE,Y42.4,Oral contraceptives,-
690FC020-041D-4021-A942-3AC664102943,A09.9,Gastroenteritis and colitis of unspecified origin,-
690FC020-041D-4021-A942-3AC664102943,L03,Cellulitis,-
726594FC-3652-49D2-B28F-BA9B635F351D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6C5355DB-CC5A-4EC9-AA25-573EC08017E1,A09.9,Gastroenteritis and colitis of unspecified origin,-
098F7153-D709-41DE-8FE0-6F25993F5F8A,R21,Rash and other nonspecific skin eruption,-
C7E2B4DE-5EC9-45D8-BE76-B9045285E818,R21,Rash and other nonspecific skin eruption,-
755EFD42-5125-46AE-B3EC-312C6380FA43,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
23652AC4-FBF5-48E2-8AAB-68A2E72BC16D,A09.9,Gastroenteritis and colitis of unspecified origin,-
404E2B1A-4AC9-4D94-A9CF-12454A850706,K29.1,Other acute gastritis,-
404E2B1A-4AC9-4D94-A9CF-12454A850706,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
79E9BB08-1E83-4298-B395-DB828D4671DB,G44.2,Tension-type headache,-
E240F9C5-6622-4B87-BC6E-B8037D73CEF3,J06,Acute upper respiratory infections of multiple and unspecified sites,-
3AF43EA0-C6F1-4016-B611-6DC1128E69F9,T88.1,"Other complications following immunization, not elsewhere classified",-
A4D2F825-0CCF-46BE-AF20-8DF643D6F1CA,L23,Allergic contact dermatitis,-
3470827A-8E27-4296-9933-C3A5092DF38B,R21,Rash and other nonspecific skin eruption,-
7CF30849-0805-42AE-A881-2BE5FA390F56,K30,Functional dyspepsia,-
6B239E2C-96BA-4614-8B46-083B730CEEE0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6B239E2C-96BA-4614-8B46-083B730CEEE0,M79.1,Myalgia,-
D32F447F-3E09-4013-9AF8-B80C92F7D26E,R21,Rash and other nonspecific skin eruption,-
AEBBEF3D-E177-4788-BE11-E1C576DA2CB3,K59.1,Functional diarrhoea,-
FAD9A3DD-0236-4113-A778-47B9CE584ADD,A09.9,Gastroenteritis and colitis of unspecified origin,-
FAD9A3DD-0236-4113-A778-47B9CE584ADD,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
DECB5857-6EAF-4E6B-9F19-4444C907C803,J06.9,"Acute upper respiratory infection, unspecified",-
FFDBFF3F-A2F3-4A8D-B38F-106CF7A80081,U07.2,"COVID-19, virus not identified",-
A28ADB4A-3C09-4E23-AE80-F8B57C15E510,M10,Gout,Gout
ADC751E1-F692-4A48-A975-1052E5D3500B,M62.6,Muscle strain,-
03ED0D82-7974-468A-9231-302B28E9855A,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
03ED0D82-7974-468A-9231-302B28E9855A,I10,Essential (primary) hypertension,Hypertension
B2C43150-6B71-4893-BD5D-66E3654A433E,U07.1,"COVID-19, virus identified",-
5FE94F69-C9A8-46D4-BE66-E9AD626ED9EF,J06.9,"Acute upper respiratory infection, unspecified",-
EBC6AF1D-88FA-4C21-A11F-19639F60AB1F,J06.9,"Acute upper respiratory infection, unspecified",-
EC6FF902-A60B-468D-969B-F6C5D1E14276,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
34EE3071-EAA2-4B30-8BCE-C1167E8192A0,L30.9,"Dermatitis, unspecified",-
34EE3071-EAA2-4B30-8BCE-C1167E8192A0,Z71.2,Person consulting for explanation of investigation findings,-
D8F96604-5668-4EF8-AD3A-FFC69002C62B,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
53298877-599A-43F4-917D-9576BC6106AD,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
53298877-599A-43F4-917D-9576BC6106AD,R21,Rash and other nonspecific skin eruption,-
685316AA-BF45-4F9E-ABD6-E9B45F3F0D46,J06.9,"Acute upper respiratory infection, unspecified",-
2B86A760-2915-4BB3-9503-F8E759281DEC,K29.7,"Gastritis, unspecified",-
2F86FA27-8294-4D96-9258-B8947F692C37,J30.3,Other allergic rhinitis,Vasomotor and allergic rhinitis
0FE8A066-A114-4CF4-96D9-D9E7AD8DE69C,R51,Headache,-
0FE8A066-A114-4CF4-96D9-D9E7AD8DE69C,A09.9,Gastroenteritis and colitis of unspecified origin,-
64F034ED-6FE4-4BAD-83B6-C36313155D67,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
7825AFCA-2EB0-4FD3-83E4-64403F703A28,J06.9,"Acute upper respiratory infection, unspecified",-
E19DAC18-826E-4225-BD9A-9AE5757A731B,H00,Hordeolum and chalazion,-
B5A033DE-0C23-4BC1-A048-10EF5DF00228,J06.9,"Acute upper respiratory infection, unspecified",-
C9AB9F24-D288-4F8D-9BBF-9E1274E437F8,L70,Acne,-
3C833957-55AB-4378-B3B0-ABE88CE85CAD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1595321B-32A1-4AB4-87D1-DA84C25E7612,T88.1,"Other complications following immunization, not elsewhere classified",-
88FCCD02-5DCA-4633-99CA-175A7A78CF78,J01.9,"Acute sinusitis, unspecified",-
485FC066-88BE-41F4-B40B-8BA24D674055,B02,Zoster [herpes zoster],-
40AA9C32-6B3D-48CA-B7A7-DCB1902C0D4D,B02,Zoster [herpes zoster],-
0CE49391-C20D-4D8B-9998-9A94BC013BE3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0CE49391-C20D-4D8B-9998-9A94BC013BE3,R50.9,"Fever, unspecified",-
14820B92-090A-4779-A875-C4E0B00CDB2E,Z71.2,Person consulting for explanation of investigation findings,-
C5F37728-DC53-4EA5-9FEF-CE9602F906EF,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
C5F37728-DC53-4EA5-9FEF-CE9602F906EF,Z71.2,Person consulting for explanation of investigation findings,-
FEAA2A21-0E9E-4F3A-84DE-3F8DA19845EF,N94.6,"Dysmenorrhoea, unspecified",-
497CE92E-EFEE-4351-B402-5B8E9EC42083,N94.6,"Dysmenorrhoea, unspecified",-
497CE92E-EFEE-4351-B402-5B8E9EC42083,R51,Headache,-
04F488DE-5074-44CA-AEC2-C7AE95AEFE36,R51,Headache,-
04F488DE-5074-44CA-AEC2-C7AE95AEFE36,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A6EE67EA-9E07-45B6-9598-E2163902069A,J06.9,"Acute upper respiratory infection, unspecified",-
F5A141A3-F1C1-42C6-ACA7-26467047063D,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
744AEDE3-33CC-4C94-AD05-3D373DA528F8,A09.9,Gastroenteritis and colitis of unspecified origin,-
D7621EF9-4BBD-4DEC-A909-6B178D18D964,H01.0,Blepharitis,-
351A508C-C897-41EC-8876-012D34217261,T88.1,"Other complications following immunization, not elsewhere classified",-
D7621EF9-4BBD-4DEC-A909-6B178D18D964,H57,Other disorders of eye and adnexa,-
C320E67E-4BDF-4DDF-B47E-6097621D6DB5,N91.2,"Amenorrhoea, unspecified",-
F515381F-7732-42B3-B2AF-0C1B4C8AA0BF,S63.5,Sprain and strain of wrist,-
0AF586AC-17AC-45B2-8BFA-247F424644AC,J06.9,"Acute upper respiratory infection, unspecified",-
75E76806-D12D-4D1D-9E00-E03BB32BA7E3,R51,Headache,-
A41BD003-61BF-4CB2-9D54-A5803A04E86A,T88.1,"Other complications following immunization, not elsewhere classified",-
9C13E5B4-4AAD-471B-B85E-21465490AD68,M62.6,Muscle strain,-
E259CB55-716B-49A1-A2B7-0AF704C2CBC5,R21,Rash and other nonspecific skin eruption,-
9C13E5B4-4AAD-471B-B85E-21465490AD68,B35.6,Tinea inguinalis [Tinea cruris],-
E259CB55-716B-49A1-A2B7-0AF704C2CBC5,N94.6,"Dysmenorrhoea, unspecified",-
07298AB2-EEF3-4228-8FDE-98454E14DDFB,N94.6,"Dysmenorrhoea, unspecified",-
07298AB2-EEF3-4228-8FDE-98454E14DDFB,D50,Iron deficiency anaemia,-
8A310A67-7414-4945-8123-DD4DCE6A8F32,R51,Headache,-
C0E01B86-7CED-41BF-8C43-B20E49B3EECC,R51,Headache,-
614B4462-0CB5-4C6E-93E0-139CEC5A10F3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8E933AB9-CB09-478A-B87A-25808E87EECA,R51,Headache,-
8E933AB9-CB09-478A-B87A-25808E87EECA,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
18813AE8-9D10-4ABC-A1D3-3D0874AAC8A9,G44.2,Tension-type headache,-
6B3C7F65-5BE6-4573-92D1-80B0827FCA87,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DE8388C6-D1D7-4D25-BEA4-32BDF69E1B90,S43,"Dislocation, sprain and strain of joints and ligaments of shoulder girdle",-
CF9BA1DF-246D-4F06-9E54-2D77434054D3,B37.3,Candidiasis of vulva and vagina,-
CF9BA1DF-246D-4F06-9E54-2D77434054D3,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
967D3359-1D6F-4B80-B940-02292A4DF45B,M62.6,Muscle strain,-
318290CD-6918-4E92-B56E-29E25ED00060,K13,Other diseases of lip and oral mucosa,-
E2CB0158-65B0-4D6B-AE5B-51CEBC1572B2,H10.9,"Conjunctivitis, unspecified",-
4C609EF3-E655-489B-AEFA-258D2902B528,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
6D217713-E456-45EF-87E6-B78E8CAF980B,M54.5,Low back pain,-
63C1229F-A007-4648-A218-9ECC3FE68AE4,L73.9,"Follicular disorder, unspecified",-
8C9D067E-32C0-479B-A6EB-ABEFDC7FA8CA,R51,Headache,-
80481A57-CC20-4000-B2D0-FBEBDA942B69,J06.9,"Acute upper respiratory infection, unspecified",-
0A7FEF6C-6CB1-449A-9893-579EC17E7545,K59.0,Constipation,-
2244312D-F33D-4224-AF2B-9D8575D0EC0D,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
A2EC6856-B9FD-4C3A-92CF-7BA8C969A2C7,Z02,Examination and encounter for administrative purposes,-
11C8B532-9DC1-488A-9379-637B4D3AB69E,M79.1,Myalgia,-
11C8B532-9DC1-488A-9379-637B4D3AB69E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BF08D599-24C5-4DB4-92AD-CB4F94FDBFB8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C51C5860-1DBC-4F2C-A02E-8C9D4BEEB0F9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0993C1A9-4F3A-4F1A-92CA-D3BEA136043A,R51,Headache,-
89F0890D-860B-49FE-BB7F-768F0ADB9266,Z71.2,Person consulting for explanation of investigation findings,-
A6F033EF-9AE0-477E-9303-37B8163DDF71,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
22798B07-98F1-40FD-863B-11D6BE4A2C7B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
22798B07-98F1-40FD-863B-11D6BE4A2C7B,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
6FB9FBC7-E58C-484E-B89E-CF11A495EA8D,M54.5,Low back pain,-
F490EC2B-B472-4FC7-8B83-8DC6E88B7506,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
097B26B5-0C37-4C29-AD62-C2BEB6074212,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3AB9107A-F2CE-474C-9405-D209B9EF5809,R10.3,Pain localized to other parts of lower abdomen,-
2BD3531E-BFA4-42D4-8C9B-7CA89C8BEF64,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
627DCAD7-7A9E-470D-9AE0-7367ED608149,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
EE39A4F2-A5E1-42D4-B05A-D33182E99D4D,K52.9,"Noninfective gastroenteritis and colitis, unspecified",-
870F09F2-F906-4048-9D66-1B89B7304A17,R51,Headache,-
37711CDD-D116-4FE4-8A9D-D4BBD4AFB395,R51,Headache,-
7BA43512-1F17-4886-B052-F663B98004CC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
28F00790-3A14-4C04-BE0C-23FD357E45EA,K21.0,Gastro-oesophageal reflux disease with oesophagitis,Gastro-oesophageal reflux disease
5CFD7632-DD69-4C7F-AAA8-1BB4452DE986,N94.6,"Dysmenorrhoea, unspecified",-
6B136CE0-13AC-487A-A3AB-275209753D2E,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
49E73D44-1725-4AA7-9E71-15370E33110E,N94.6,"Dysmenorrhoea, unspecified",-
49E73D44-1725-4AA7-9E71-15370E33110E,R51,Headache,-
A225A45C-8F61-4954-80CD-F8A893BE39E6,M79.1,Myalgia,-
1ADFE4DE-3CAE-4597-A456-B249B957DCB6,R51,Headache,-
379BC95D-F216-488F-9D80-AB62DE233242,G43,Migraine,Migraine
7B6A0C0C-B525-42F4-860C-5F6DE621E0FC,Z71.2,Person consulting for explanation of investigation findings,-
53BF65CF-95D8-4172-A17C-67DC2FB85FBD,R51,Headache,-
95DA851B-229D-427C-8A85-9CC46D7AC34C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
53BF65CF-95D8-4172-A17C-67DC2FB85FBD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
95DA851B-229D-427C-8A85-9CC46D7AC34C,R51,Headache,-
B5557BC0-29A0-4D67-AACB-324DE86B3EED,R51,Headache,-
D4B7B035-86B9-4094-9AC1-55F2702E2BAC,A09.9,Gastroenteritis and colitis of unspecified origin,-
39A04D02-F16D-488D-8A78-309D64E049E2,M79.1,Myalgia,-
D11C5F77-139E-4556-B56C-E0D458E56AD1,E03.9,"Hypothyroidism, unspecified",Thyroid
4E5B3852-ADF5-408D-848C-1821083B833A,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
8D4CD4E4-3DDD-4D51-A483-D5BE534514AA,J06.9,"Acute upper respiratory infection, unspecified",-
6C312BCA-7A33-4393-B117-B7144245C71C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6C312BCA-7A33-4393-B117-B7144245C71C,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
ABEA699E-E078-420E-B249-4FA6F3E86E5B,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
345DFA4D-12F7-4745-951D-C36A3667A6DD,Z01.7,Laboratory examination,-
ABEA699E-E078-420E-B249-4FA6F3E86E5B,I10,Essential (primary) hypertension,Hypertension
5A7FF9E4-BC67-4500-87A9-1290F11FBB74,M62.6,Muscle strain,-
64E2ED33-967C-4262-987F-9EEAC9C19705,J45,Asthma,Asthma
6D30AD70-85EE-4971-BAE6-FA43D72693F5,L20,Atopic dermatitis,Atopic dermatitis
B90B611B-6B04-4AAA-B8E0-6ACF58114D28,H60.1,Cellulitis of external ear,-
C60D970A-71D7-4AED-92EC-77823897F2E3,R51,Headache,-
DAEC8687-1B2B-46C2-A945-E400EDF31AD8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1C3694D0-E767-4156-BD98-20815FD6D7AE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1C3694D0-E767-4156-BD98-20815FD6D7AE,R51,Headache,-
B7DBE8C3-A5EF-4EC7-A9E1-5489B7706D6A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EAA0BEA6-D02D-4407-BF02-C88918D2BFED,G44,Other headache syndromes,-
EAA0BEA6-D02D-4407-BF02-C88918D2BFED,R42,Dizziness and giddiness,-
714B801A-CD63-466A-81BB-B9C988A6ED19,J06,Acute upper respiratory infections of multiple and unspecified sites,-
B9B236F1-8BFC-433F-A293-A8B2D9E0AF45,G44,Other headache syndromes,-
137DED81-53A2-43D6-80FE-D3440311C014,J06.9,"Acute upper respiratory infection, unspecified",-
15A6F564-099E-431C-BE4F-573592964D81,J06.9,"Acute upper respiratory infection, unspecified",-
15A6F564-099E-431C-BE4F-573592964D81,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
5781AB22-635C-4A77-B029-7DBBD78897AE,U07.1,"COVID-19, virus identified",-
132D16BA-DB24-4FCA-B955-2A04090EE1D9,U07.1,"COVID-19, virus identified",-
49D668B6-B898-4A03-BAFC-12066878D03F,U07.1,"COVID-19, virus identified",-
C9AC37D0-DB9E-4EE7-8402-2B2B2EDAE543,R51,Headache,-
8A598F4B-569E-4BB2-B3B1-3ACE533C4E9F,U07.1,"COVID-19, virus identified",-
63740CDF-7A58-4669-8DC1-A419C47DE450,G43,Migraine,Migraine
36C157A1-A4B8-401C-B641-EA515731A4AF,A09.9,Gastroenteritis and colitis of unspecified origin,-
016BA19B-2EFB-4A4C-8C84-9E0CC4FBE818,S13.4,Sprain and strain of cervical spine,-
88E0F7D2-F9E3-412E-A4D6-820BA76D6896,J02,Acute pharyngitis,-
6463E4E8-B294-4656-B24E-2CDFB9487593,J06.9,"Acute upper respiratory infection, unspecified",-
9C62ED61-DD0E-40D8-A1CC-3A5DEF9B5653,J32.9,"Chronic sinusitis, unspecified",-
9C62ED61-DD0E-40D8-A1CC-3A5DEF9B5653,M54.5,Low back pain,-
4552FDFC-7F9C-424C-ACAF-90B228EDD0F2,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
E9471F7A-3C9B-4892-9C02-BEE8B6AD67AE,S53.1,"Dislocation of elbow, unspecified",-
B6E13786-7536-4292-A04C-BA652688B973,J06.9,"Acute upper respiratory infection, unspecified",-
1F41E5D9-AF94-4ED7-879D-3C72BD3C902C,A09.9,Gastroenteritis and colitis of unspecified origin,-
78D501D1-F501-48F8-A39D-C7D802A082A7,J06.9,"Acute upper respiratory infection, unspecified",-
860AC611-D99D-4D31-8A64-0A70FEADF8AD,J06.9,"Acute upper respiratory infection, unspecified",-
73F41621-4675-42F7-980F-8B9B25DE93B9,U07.1,"COVID-19, virus identified",-
1158C0F8-2EDC-4506-A6AB-D407E645C612,J06.9,"Acute upper respiratory infection, unspecified",-
16856742-1211-4734-B4BA-5B89E0F24D76,J06.9,"Acute upper respiratory infection, unspecified",-
25FDE251-413F-430E-A04C-4BDA91D3906C,M79.6,Pain in limb,-
278F223A-C0B4-4489-867A-F1815AC5FA60,R51,Headache,-
0DE4F26F-BA67-482A-8C9C-99F86C604124,N94.6,"Dysmenorrhoea, unspecified",-
E39F34D9-B1CE-45A1-8024-A3C80B0E3AC6,Y42.4,Oral contraceptives,-
927B2160-BF3F-4172-B82D-756622B90D4D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
97ADFD76-04F3-487D-9864-DE61F30BC04E,R21,Rash and other nonspecific skin eruption,-
5D187B26-106F-4F03-8325-02C0DCD02158,L30.1,Dyshidrosis [pompholyx],-
D564943E-A0D2-40E0-8D62-697FD99D3676,N94.6,"Dysmenorrhoea, unspecified",-
B61488F8-E80D-4ED9-A5B3-093F4FFA8E64,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
184171CD-58D1-406E-A4C2-2EB9C09889CA,R21,Rash and other nonspecific skin eruption,-
3A0A0D3C-21A8-4466-81E1-9F3405489FF6,N94.6,"Dysmenorrhoea, unspecified",-
4FA223A9-600F-4B3C-94ED-6F855A20ACD4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B5EC925C-596F-41D9-9ABF-AADE0FC111A2,T88.1,"Other complications following immunization, not elsewhere classified",-
1BD50243-761E-4DAA-BC04-2B4C8A5305F4,A09.9,Gastroenteritis and colitis of unspecified origin,-
1BD50243-761E-4DAA-BC04-2B4C8A5305F4,L30.9,"Dermatitis, unspecified",-
1BD50243-761E-4DAA-BC04-2B4C8A5305F4,R51,Headache,-
EA74BFAD-84F3-4F7E-BD69-D8993CA5D437,T88.1,"Other complications following immunization, not elsewhere classified",-
D9F260AE-7037-454B-8E6C-DCD87306C3ED,U07.1,"COVID-19, virus identified",-
D4FA9163-23DB-4B13-BBE1-3AA03D8CD8B9,J06.9,"Acute upper respiratory infection, unspecified",-
71292EC0-FAD8-40BA-AA5C-89CE647149CB,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
098EB3C0-C3BB-4490-81FD-096FFB3D689E,A09.9,Gastroenteritis and colitis of unspecified origin,-
CDDBE8FA-1030-47E3-B353-3FEAEE5D6357,R51,Headache,-
B9BBD1C8-6FEE-4C38-9131-4A94E9960A94,Y42.4,Oral contraceptives,-
C9D38730-101D-4070-B750-2FE738881974,A09.9,Gastroenteritis and colitis of unspecified origin,-
D7982013-3909-4B36-8663-A24B34B5C5F6,R51,Headache,-
D7982013-3909-4B36-8663-A24B34B5C5F6,R21,Rash and other nonspecific skin eruption,-
5AD71DF2-B8CF-4214-A1AF-8C21415457F4,M79.1,Myalgia,-
19F9F91A-B62E-4CAF-9F12-705ADB112C7E,T88.1,"Other complications following immunization, not elsewhere classified",-
19F9F91A-B62E-4CAF-9F12-705ADB112C7E,N76.0,Acute vaginitis,-
0BBB1062-C521-49F7-B7E3-7A5337BC59C3,A09.9,Gastroenteritis and colitis of unspecified origin,-
0BBB1062-C521-49F7-B7E3-7A5337BC59C3,R51,Headache,-
0A213916-092A-439B-A43B-5E180C8C0A0D,Z71.2,Person consulting for explanation of investigation findings,-
934AA736-AE07-4AC8-8153-C4E1F9772626,K59.0,Constipation,-
64BFFA61-9539-40E4-A67C-2425D7C8F0E7,B00,Herpesviral [herpes simplex] infections,-
ECE4A2E0-CC78-4DA3-944B-D6479258E572,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
ECE4A2E0-CC78-4DA3-944B-D6479258E572,R50.9,"Fever, unspecified",-
784B2CC0-B703-437B-BEAE-BE819347B5BD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
784B2CC0-B703-437B-BEAE-BE819347B5BD,J22,Unspecified acute lower respiratory infection,-
9A4F4F91-0B9D-4FBD-813A-919A38D309FC,K00.9,"Disorder of tooth development, unspecified",-
9A4F4F91-0B9D-4FBD-813A-919A38D309FC,K13,Other diseases of lip and oral mucosa,-
256C957E-405C-4AF4-8E5E-1335F8B5FEE7,R51,Headache,-
01DC99C0-CAD6-4103-89C8-B91552339332,G43,Migraine,Migraine
01DC99C0-CAD6-4103-89C8-B91552339332,H57,Other disorders of eye and adnexa,-
FB079CA9-BB9B-405A-85EE-C4CE66E8EDA3,H57,Other disorders of eye and adnexa,-
F54E2558-0777-40D4-B79B-A9E6D5DE1650,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
B5CD445E-94E3-4E41-9D27-2D226E7BA266,J06.9,"Acute upper respiratory infection, unspecified",-
46ADC898-A19D-4E61-9365-06E6C51A092C,R51,Headache,-
EB0650D3-C272-4EDB-8353-67A6C4B4210C,R21,Rash and other nonspecific skin eruption,-
5E41E649-EEF6-421B-842A-B3D70D2E6526,T78.4,"Allergy, unspecified",-
941D4B41-E998-4326-B3C7-6B091D9AEEA3,N39.0,"Urinary tract infection, site not specified",-
137338FE-F890-4D5D-8C8C-0B56CB73C1B8,J06.9,"Acute upper respiratory infection, unspecified",-
988F4F11-1CF1-4FEA-BFB6-69FBA78CEB95,J06.9,"Acute upper respiratory infection, unspecified",-
05A0F8EF-B51B-4341-9508-FCD063397861,R51,Headache,-
C75C912D-F0C0-437E-946C-3BAB7CAC07F3,R51,Headache,-
C12561D8-4F99-4CDD-97DA-F7BDEB2EB47A,Z76,Persons encountering health services in other circumstances,-
AE226808-1CF5-4D48-80F8-6F5E157E00A3,A09.9,Gastroenteritis and colitis of unspecified origin,-
4789C059-F358-40C3-A6B1-46AD16EF4C3E,R51,Headache,-
00072557-EE97-4170-A374-88FF132A366A,K59.1,Functional diarrhoea,-
00072557-EE97-4170-A374-88FF132A366A,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
0F295903-CF17-47E1-B071-7ED4E5E76322,A09.9,Gastroenteritis and colitis of unspecified origin,-
EBE27F86-AB91-4B97-8BF7-28721FD83B90,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2E65A1FC-7E7E-4D1C-BB43-0A6B2D0C0617,A09.9,Gastroenteritis and colitis of unspecified origin,-
45B8335C-5762-4849-9575-2D6869879742,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DC3B3AF6-B3EA-4A3E-B250-4DFFA070896A,J22,Unspecified acute lower respiratory infection,-
83D1A076-0169-4F4A-83FE-5D19FB07A094,B37,Candidiasis,-
C7753811-147B-44C9-A6D0-87F2C3DE03A5,R51,Headache,-
D345A1FA-0DC7-4649-9B25-07BA6CC1250B,J06.9,"Acute upper respiratory infection, unspecified",-
AC04A6DD-FAF2-4B0B-82F4-2EA1F6A7B751,Z71.2,Person consulting for explanation of investigation findings,-
4DFE50BD-205D-496E-9E69-3D6FDD772029,N39.0,"Urinary tract infection, site not specified",-
1EEBB5FF-08E4-4425-8A04-2195D27D8618,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9DF8826B-D1BA-4B29-A82E-59551552C6C4,J06.9,"Acute upper respiratory infection, unspecified",-
0C4C58F3-7A28-4F3C-B58C-93740CC90A6D,M10,Gout,Gout
DE1F42AC-ED8D-4B3F-B9E8-1AD8D1A7B9C9,M10,Gout,Gout
771488AD-FA6F-4487-AC12-58761AAAC36F,M79.1,Myalgia,-
3D80FF23-B1F2-44AF-83E5-A5BB093F448E,R51,Headache,-
771488AD-FA6F-4487-AC12-58761AAAC36F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C1A9CDC6-83DC-4909-9C6C-B18F1ADED700,R51,Headache,-
57781FC6-662E-474D-9486-0335085BD9BF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
57781FC6-662E-474D-9486-0335085BD9BF,R51,Headache,-
67879739-5124-4E4C-841B-7189E7A7F172,M25.5,Pain in joint,-
053B3585-357B-44F8-978D-5C9074642E8C,R51,Headache,-
42A106FD-A940-4ACE-B6F1-06CE89417285,R51,Headache,-
8C946376-2F01-4919-8C47-AEF5F258AF90,U07.2,"COVID-19, virus not identified",-
2A2EDE38-3E02-4D3B-B037-A0843B381AD9,T78.4,"Allergy, unspecified",-
2A2EDE38-3E02-4D3B-B037-A0843B381AD9,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
A691BB35-E386-4FC0-8A84-23D74A054F7E,J06.9,"Acute upper respiratory infection, unspecified",-
A2BA2A87-6A40-46D2-ACE2-A869C4F967F4,R21,Rash and other nonspecific skin eruption,-
83B3180C-8FD1-41E1-BDE4-C614C315ABD9,J06.9,"Acute upper respiratory infection, unspecified",-
129FA447-DBD5-44DC-9F06-7085A6E67C45,Y42.4,Oral contraceptives,-
473578C3-D217-4A80-8D83-F9998B55E178,L70,Acne,-
75ECF0B3-E085-4A86-B453-EF191A0D6011,N94.6,"Dysmenorrhoea, unspecified",-
38E41E4B-1162-4D00-B0EC-C7C8698C9EF6,Z71.2,Person consulting for explanation of investigation findings,-
BBE4DC18-5851-442E-8600-DF3C44445EB0,M10,Gout,Gout
94688261-BF09-4954-8153-8E2798F57AE9,N94.6,"Dysmenorrhoea, unspecified",-
25372BCF-0CBE-4FCD-82CF-78E3CF73C683,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
25372BCF-0CBE-4FCD-82CF-78E3CF73C683,R05,Cough,-
5CBC9256-575E-4635-87D3-BF1AD88DDADF,M54.5,Low back pain,-
15324157-B87D-4A61-9879-EBC29DE83777,M54.5,Low back pain,-
C4EB99AD-1B58-464E-BC78-80222667124B,A09.9,Gastroenteritis and colitis of unspecified origin,-
BCD4C779-CDCA-47BA-98FF-A4AF19E39368,L24.9,"Irritant contact dermatitis, unspecified cause",-
3B684F13-F6E8-4310-885E-C8D7AFBA0A02,R42,Dizziness and giddiness,-
BC427CB8-5CF1-4244-9950-88D8A2BC20C9,N94.6,"Dysmenorrhoea, unspecified",-
E69B7C0D-0E10-4AEC-BC00-7520C1D77D98,Z71.2,Person consulting for explanation of investigation findings,-
0913A49A-7055-45CD-94C7-5200E57B39F2,M62.6,Muscle strain,-
27B1643E-079B-4DEF-B86D-E8C741FB1489,J30.3,Other allergic rhinitis,Vasomotor and allergic rhinitis
DD77DF1E-ABFB-47F4-ADAF-E78DF28ED649,Z71.2,Person consulting for explanation of investigation findings,-
F5E33F65-1A2E-44B9-8901-3DA35D73356F,J06.9,"Acute upper respiratory infection, unspecified",-
89988664-ACAE-4ADE-80AB-7523979875FC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3792D468-7FD8-4B49-8D36-CEFA68CCA6EE,J22,Unspecified acute lower respiratory infection,-
3792D468-7FD8-4B49-8D36-CEFA68CCA6EE,I10,Essential (primary) hypertension,Hypertension
DA886981-A82B-4C34-85A9-7C5189803202,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
DA886981-A82B-4C34-85A9-7C5189803202,T88.1,"Other complications following immunization, not elsewhere classified",-
83D5A5CA-1FF8-44DD-93D0-D78D51CBDEAB,J06.9,"Acute upper respiratory infection, unspecified",-
888DECAD-E8A4-451A-9C75-FD0A6AAC447A,A09.9,Gastroenteritis and colitis of unspecified origin,-
12FE46C3-9D28-45FA-ADE7-959E76918E1A,H81.1,Benign paroxysmal vertigo,-
5ECC446C-27EA-436B-B67E-AEF1A02D3580,R51,Headache,-
5F183C1C-CCB9-4033-AC58-29BCFFF10976,K30,Functional dyspepsia,-
E0EB5C53-CB92-41A5-8C33-71D9BBD9A2A3,J06.9,"Acute upper respiratory infection, unspecified",-
8E6F57A3-78DC-4795-B74A-1897B848EE1A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8E6F57A3-78DC-4795-B74A-1897B848EE1A,M62.6,Muscle strain,-
8E6F57A3-78DC-4795-B74A-1897B848EE1A,G44.2,Tension-type headache,-
9F0011DF-E705-4F05-94C2-775802F026AD,J06.9,"Acute upper respiratory infection, unspecified",-
9BE06F1B-F5F1-4B56-884C-B029E62AB8B5,K59.0,Constipation,-
23344482-0EF3-4615-889D-757A6149EE78,G44.2,Tension-type headache,-
23344482-0EF3-4615-889D-757A6149EE78,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
42808FD5-BDEC-4B4B-8C88-D7059C6983A0,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
2468BB69-B018-4BF4-84C9-357387D67519,Z02.9,"Examination for administrative purposes, unspecified",-
8BAEECF4-4EF7-4199-8E07-19FAA99093AD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
43547F00-10ED-492A-84B8-11BCD3B17724,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D33477CF-775F-4584-8CA8-25102D637066,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
1EE1F4C9-985E-4A13-9593-33D91CFC8144,K62.5,Haemorrhage of anus and rectum,-
1EE1F4C9-985E-4A13-9593-33D91CFC8144,K59.0,Constipation,-
267CCFCD-2102-4AD2-A12F-F78D7DFB0042,R21,Rash and other nonspecific skin eruption,-
F0C10C66-6AA6-4DCA-AC50-28CE5796520D,R11,Nausea and vomiting,-
F0C10C66-6AA6-4DCA-AC50-28CE5796520D,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
4323AE2E-9DE2-4CD0-93D0-20DD5610EE81,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
4323AE2E-9DE2-4CD0-93D0-20DD5610EE81,K64.9,"Haemorrhoids, unspecified",-
3143AC35-2B2D-4D85-AF4E-636E7E8260DC,A09.9,Gastroenteritis and colitis of unspecified origin,-
C91D7B2E-52D7-4B95-9DFF-51B6B1F92B8C,J06.9,"Acute upper respiratory infection, unspecified",-
1F5D91E4-7AD8-498A-BBD5-7D68359A4035,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D1CC986D-C81E-40EE-9B13-FC265B4FD13C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9C05291D-613D-418E-99BD-BED16B973449,N39.0,"Urinary tract infection, site not specified",-
35D99C57-745E-408F-877C-E429D45D47DE,J06.9,"Acute upper respiratory infection, unspecified",-
34E6FFD6-6061-4243-9BC8-2B9B7BF9B96C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C51D0EBD-968D-4B93-B442-D794705B8AC1,U07.1,"COVID-19, virus identified",-
C2AA933F-2ADC-4557-B1A9-653063808C23,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
C2AA933F-2ADC-4557-B1A9-653063808C23,N94.6,"Dysmenorrhoea, unspecified",-
04896CD5-4A05-4318-AE31-79BEA92447D6,M62.6,Muscle strain,-
742B7293-D49F-4338-9029-4C004561043E,L70,Acne,-
742B7293-D49F-4338-9029-4C004561043E,T23.1,Burn of first degree of wrist and hand,-
742B7293-D49F-4338-9029-4C004561043E,J30.0,Vasomotor rhinitis,-
6C85C603-E0EF-4FA8-822B-BE04575F5244,T88.1,"Other complications following immunization, not elsewhere classified",-
F957BCB0-0D45-42A0-A7C3-0B5CA351BCC0,J06.9,"Acute upper respiratory infection, unspecified",-
96E40D50-0484-414A-83C1-18AD317A8AC6,J06,Acute upper respiratory infections of multiple and unspecified sites,-
03944535-D18A-4333-A02E-CB5DDEE56954,J06,Acute upper respiratory infections of multiple and unspecified sites,-
1038B349-D5EB-478D-A488-167A08E76D4B,S93.4,Sprain and strain of ankle,-
34C0A3B0-5EC1-430B-BF34-24D6442BE4DA,N39.0,"Urinary tract infection, site not specified",-
D8459A43-B105-4CBC-A32A-8A2462374EE0,A09.9,Gastroenteritis and colitis of unspecified origin,-
F22F9E14-3035-4902-9EF0-761084FB988D,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
6126A4AB-1047-4747-9341-8260F83392EB,R51,Headache,-
DCF3324C-0749-400F-8873-FBF97BB929D9,N94.4,Primary dysmenorrhoea,-
213B92CA-91C8-4DF7-BEDC-A22EBB337414,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
59E70B4D-7846-46DF-BDF3-F46227DD9404,J06.9,"Acute upper respiratory infection, unspecified",-
261D4D2F-8090-4A91-9385-126D32D93972,J06,Acute upper respiratory infections of multiple and unspecified sites,-
83367CD9-4FA2-4AD5-9827-0C4B63711121,T88.1,"Other complications following immunization, not elsewhere classified",-
D286E836-359C-42DF-A412-6FA2435F0DF3,J06.9,"Acute upper respiratory infection, unspecified",-
11A26555-D115-4469-947F-2F2B52A569DF,J98.7,"Respiratory infections, not elsewhere classified",-
EE78B6F5-7F94-40A5-82FF-E429EA3921CA,Z71.2,Person consulting for explanation of investigation findings,-
6DA2D9A0-8EA5-43C1-B1E7-F78B6E15F729,A09.9,Gastroenteritis and colitis of unspecified origin,-
756B49A9-987B-4346-8320-7D267AEAA6FC,R51,Headache,-
A3D5CCA2-FF3B-4463-BE7B-BB19B5DBA515,K00,Disorders of tooth development and eruption,-
EA11256E-9D1C-471B-8EA9-6802D05247EF,B37.3,Candidiasis of vulva and vagina,-
8D1D286C-02C4-4CBC-A94E-B8680906AB7F,A09.9,Gastroenteritis and colitis of unspecified origin,-
B2193562-F931-4439-8477-2F8B76ACF444,A09.9,Gastroenteritis and colitis of unspecified origin,-
AF95E605-3C7F-4085-8848-121A4506D6C7,A09.9,Gastroenteritis and colitis of unspecified origin,-
56FF16AF-3BE0-48BA-B44F-A18566A1FEAF,M62.6,Muscle strain,-
24AA4BF6-6ACE-4884-8FA7-4D668545669C,M62.6,Muscle strain,-
24AA4BF6-6ACE-4884-8FA7-4D668545669C,I10,Essential (primary) hypertension,Hypertension
C9459D21-59DA-4E28-B0AB-C924DF11C276,R21,Rash and other nonspecific skin eruption,-
764B78E8-04EB-4111-BCAD-E13A8AD79DC9,J06,Acute upper respiratory infections of multiple and unspecified sites,-
5DE70774-ADDB-4AC7-A202-FE427C2F44A6,L50.0,Allergic urticaria,-
ED572649-3007-47E3-A3DA-6354E35634A8,N39.0,"Urinary tract infection, site not specified",-
77204E91-87BA-4503-A5EB-470D8C6B2447,J06.9,"Acute upper respiratory infection, unspecified",-
EB5174F7-0813-47AB-8AC3-D32E511725B6,M54.5,Low back pain,-
59969FAB-A3CF-4DBC-B353-C69A3963ECAB,T88.1,"Other complications following immunization, not elsewhere classified",-
EEE45F17-5155-46B8-93FC-659C09A212D7,R51,Headache,-
EEE45F17-5155-46B8-93FC-659C09A212D7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8E8FE0BA-2633-48F2-881D-2F8B276F4819,A09.9,Gastroenteritis and colitis of unspecified origin,-
FF343383-2B87-4DB3-8A54-47A615AB2645,L02.9,"Cutaneous abscess, furuncle and carbuncle, unspecified",-
0C42BBC3-C8F2-4CA0-BD8B-98C074066D45,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B9330C94-1E3E-4557-843F-1381DEC98E0D,J06.9,"Acute upper respiratory infection, unspecified",-
91F4E96B-DA14-4E29-AD24-4FA5D4E092B8,A09.9,Gastroenteritis and colitis of unspecified origin,-
86EDA96E-1F29-49CD-BA6E-AD1A34C98D3A,K29.7,"Gastritis, unspecified",-
95487917-9D78-4621-AC1A-D39A160C8113,R51,Headache,-
70E9F2B1-37A7-404C-AEFA-F0E0747C22B7,Z71.2,Person consulting for explanation of investigation findings,-
D5A264B5-CD13-4411-8855-0AFD0C6430CC,G43,Migraine,Migraine
7BA8B7A1-DD9D-41AA-83AB-9EE68610F3DF,R51,Headache,-
D623816D-144D-41A3-AEE8-75B3FFB6649D,J06.9,"Acute upper respiratory infection, unspecified",-
A05D9DF5-1E63-445E-9E42-FAED948E90A3,E03.8,Other specified hypothyroidism,-
BD688DC4-439B-4CA4-ABF2-76F1800508E1,J06.9,"Acute upper respiratory infection, unspecified",-
ABEE7619-AEB3-4E90-86EF-A4A8875AB89B,N94.6,"Dysmenorrhoea, unspecified",-
90EAFDBB-CC36-451F-BDD5-620A54EDB179,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
66C320E7-44A6-4AEC-92D0-88102C570718,J06.9,"Acute upper respiratory infection, unspecified",-
DA99EDD9-9259-4A06-A08E-DC3BDC3F5A27,N94.6,"Dysmenorrhoea, unspecified",-
97D01DA8-12DE-44D3-8E24-8E2F9E357B93,H15.0,Scleritis,-
A396854B-432C-4108-8BC0-CD4B4C040A4F,H10.9,"Conjunctivitis, unspecified",-
94B5A0CB-E4C6-4C1A-8224-44716B18F19B,R51,Headache,-
B1C19F63-C967-4709-BECC-980FBE862618,G44,Other headache syndromes,-
C8EFD2B7-6831-416C-B3B0-7F6F256DA019,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
964F8EA3-4A36-4B5F-AE11-34481F43724A,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
964F8EA3-4A36-4B5F-AE11-34481F43724A,M62.6,Muscle strain,-
7B7F0CF8-8A49-4A66-8961-3D712D34EA55,M62.6,Muscle strain,-
7B7F0CF8-8A49-4A66-8961-3D712D34EA55,R51,Headache,-
501C9693-FC61-4653-BB98-FDD40C6045C0,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
13BD42D5-1B1F-4066-A579-5581865CFDB8,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
99AEB6E9-296B-43BB-9AD9-6B24D5CEFFD8,T88.1,"Other complications following immunization, not elsewhere classified",-
EB7AA77D-EEE9-4D84-B351-7F6FA321C909,J06,Acute upper respiratory infections of multiple and unspecified sites,-
EB7AA77D-EEE9-4D84-B351-7F6FA321C909,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F6E16747-D896-402C-A574-7127209EB16E,A09.9,Gastroenteritis and colitis of unspecified origin,-
62657F6F-0995-4208-A899-D9D540E6BD05,K05,Gingivitis and periodontal diseases,-
CEE0F697-3600-445D-A098-7D09E9859C56,O91.2,Nonpurulent mastitis associated with childbirth,-
672787D2-87F1-4D04-9807-9D69338E302E,M54.5,Low back pain,-
B4E1072F-044D-4F1E-88C2-A64866E67131,A09.9,Gastroenteritis and colitis of unspecified origin,-
30930A0B-F204-4923-869C-B945077D2AE1,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
4054BCB3-956C-4513-8A8A-FF4B48B0E1CA,H00.0,Hordeolum and other deep inflammation of eyelid,-
4054BCB3-956C-4513-8A8A-FF4B48B0E1CA,G58.9,"Mononeuropathy, unspecified",-
4054BCB3-956C-4513-8A8A-FF4B48B0E1CA,H57,Other disorders of eye and adnexa,-
6841CA79-7F90-442C-98D4-BC454BA9EA62,N94.4,Primary dysmenorrhoea,-
FCC7120A-E20C-4D23-ADBB-06F30C9A20DF,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
6B383808-B9AD-4988-8BCC-1B35267F3B2B,R51,Headache,-
6B383808-B9AD-4988-8BCC-1B35267F3B2B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6B383808-B9AD-4988-8BCC-1B35267F3B2B,M79.1,Myalgia,-
176F88A2-E902-4524-9924-15C82015392C,R50.9,"Fever, unspecified",-
176F88A2-E902-4524-9924-15C82015392C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
49E03FD2-35A0-4F01-9FE6-D873C6A8525E,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
8BEF6034-BE5B-43A0-A9CF-C46E33544E94,Z71.2,Person consulting for explanation of investigation findings,-
D70587B9-C3AC-49D0-9B87-266339C72066,N39.0,"Urinary tract infection, site not specified",-
4CF817AC-FA3B-4EA2-B8BF-2EFF7936B4A9,H57,Other disorders of eye and adnexa,-
EE7FDCAF-B73B-4025-8DDF-84518506F3F7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C8F857CB-096A-446E-89C3-810192E044A7,R51,Headache,-
00146DFB-9749-462E-9F63-EADA005CC440,A09.9,Gastroenteritis and colitis of unspecified origin,-
F40CE3DE-6DC0-47EA-AE90-C13D705644A2,H57,Other disorders of eye and adnexa,-
F40CE3DE-6DC0-47EA-AE90-C13D705644A2,R51,Headache,-
BFE895DA-F757-471D-BDD1-2D9EB7D49926,R51,Headache,-
7150633C-C7FB-4CAD-83D6-E651F39050B0,G44,Other headache syndromes,-
74F9FFB0-173C-43B9-AE45-D038ECC8C145,R51,Headache,-
570287EF-E889-4CB9-8AFC-419EE55361FD,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
305327AF-6ED8-4254-8622-5A99D3D566C7,J06.9,"Acute upper respiratory infection, unspecified",-
19193BBD-6E4C-494C-B9B1-5557BEED1A9D,S80.7,Multiple superficial injuries of lower leg,-
4ABCD580-1988-44E6-80C6-ED09D2524D1C,J06.9,"Acute upper respiratory infection, unspecified",-
5938C16C-4184-4EA2-9ADE-A5E2BC052D84,R21,Rash and other nonspecific skin eruption,-
5CC42D9D-AE73-42BA-AC0F-AAC17AEB2D44,H69.9,"Eustachian tube disorder, unspecified",-
3B77B277-631A-42C9-B447-13697823EE31,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4801B6FD-4448-4919-B90A-3697401087C9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CC704480-5823-490D-8479-76282D83C748,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D2DF33C8-60B3-406A-8020-1D2D00F6AA1D,N39.0,"Urinary tract infection, site not specified",-
EF86062F-BC2C-4A27-A5F6-9B631DC2A348,J01,Acute sinusitis,-
BC9E72B9-A047-4650-9448-6A16864CB623,A09.9,Gastroenteritis and colitis of unspecified origin,-
79E31615-E4F9-401E-98E5-E2635A94F8F0,S50.1,Contusion of other and unspecified parts of forearm,-
79E31615-E4F9-401E-98E5-E2635A94F8F0,M25.5,Pain in joint,-
6E71DFC1-D877-422E-A934-179357F721A7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
26A90AFD-07A6-41E8-97C7-700447ABD2BC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D1C315F1-8465-47F4-ACC3-D94E331D3B7C,Z71.2,Person consulting for explanation of investigation findings,-
E1645ADA-E099-4624-8179-E82F60D28D60,J06.9,"Acute upper respiratory infection, unspecified",-
A58257FC-90B0-4EB3-BCBC-2F5A4056DF18,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
7F043603-DDFE-426E-B9A3-C58FA4575190,J06,Acute upper respiratory infections of multiple and unspecified sites,-
77216FBA-69FF-4FBA-ABF4-A15AABDC11DF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0AF55D3C-333B-412A-A282-9E3AF5564653,J06.9,"Acute upper respiratory infection, unspecified",-
F315C52D-F5CF-4671-B990-ABD913109DF7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
96003C43-890D-48DA-9690-FA534A31A75C,R21,Rash and other nonspecific skin eruption,-
A1DE0945-3572-4D24-A36D-BD58A8A7FFB8,J06.9,"Acute upper respiratory infection, unspecified",-
A1DE0945-3572-4D24-A36D-BD58A8A7FFB8,U07.1,"COVID-19, virus identified",-
930A4622-1CEF-415B-AD27-973A42A08529,R21,Rash and other nonspecific skin eruption,-
FE005889-71E4-44FD-9E33-0C7768F91EA6,R51,Headache,-
37543985-D489-43D2-9315-DC1C98A41FE8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
37543985-D489-43D2-9315-DC1C98A41FE8,J06.9,"Acute upper respiratory infection, unspecified",-
D02F7107-0EF8-45F4-A6A8-84AD61D93E19,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DEBDCD8B-0757-4898-A1B5-E935A7C7ACF1,A09.9,Gastroenteritis and colitis of unspecified origin,-
9A21F3F8-3E63-4EE7-B3CA-EE81D62904C3,R21,Rash and other nonspecific skin eruption,-
0671847F-5E1F-49F7-998B-F59AE62273FC,R51,Headache,-
33D24D86-1CA7-45C9-962D-68D67B87FC19,U07.1,"COVID-19, virus identified",-
D095A59C-6E25-46A8-B622-56DCBD71B63F,J06,Acute upper respiratory infections of multiple and unspecified sites,-
7EC29B28-D2C8-48AD-B57F-6B64A72CB3C2,T88.1,"Other complications following immunization, not elsewhere classified",-
BD6305AB-EB87-47A1-A5E9-C09DCA97FC71,J06.9,"Acute upper respiratory infection, unspecified",-
22B2B7F7-4ABF-44CA-AEB7-1C4832AC2E2F,H57.9,"Disorder of eye and adnexa, unspecified",-
2F75BEF0-15A9-45DA-B341-7037EF7DC4BC,J45,Asthma,Asthma
02349734-4E9A-4474-9662-CB751AEACDDA,J06.9,"Acute upper respiratory infection, unspecified",-
66972E39-92FB-4575-AB66-916433935B88,A09.9,Gastroenteritis and colitis of unspecified origin,-
B95E484D-A9B9-48D6-BD7D-9A3131CA4604,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
F24CBE41-EFD6-4D7D-990F-9C199DBFF81A,N94.6,"Dysmenorrhoea, unspecified",-
9316AF9F-C34B-426C-8466-EF443EE1F9D9,R51,Headache,-
A4AD7904-E593-4002-ABB9-D7473F2429AA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5741F83F-7FC4-4557-A7D4-9DE2A4485BF6,N94.6,"Dysmenorrhoea, unspecified",-
C2DE8875-3152-456F-A9D5-C96C0CB87F68,M79.1,Myalgia,-
2079CE7E-2623-45F9-AE99-9B25397A5363,R11,Nausea and vomiting,-
DDD8AAE3-B8A3-49FE-8E8F-FEFF8EC24E29,H10.9,"Conjunctivitis, unspecified",-
921107B3-7148-4656-B693-1A783D04F09B,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
6FB9B12C-9B96-4518-AECC-AAF935E37E97,R51,Headache,-
B34E992D-6904-4640-AC2E-809DA51B35AB,N76.0,Acute vaginitis,-
61FB0D80-FFFB-47F5-8DB6-990C09101D49,I10,Essential (primary) hypertension,Hypertension
86368A53-AEB7-43AE-965A-642D84DC1741,J03.9,"Acute tonsillitis, unspecified",-
B0B947A0-7CE7-4ED1-AE6B-F09EEDAE1581,P39.0,Neonatal infective mastitis,-
E0A2F2A2-44D7-48FE-B6F2-EC0A97C3C2C2,Z71.2,Person consulting for explanation of investigation findings,-
A57CA9D9-8DED-4603-A1FC-A2CAD7C326F4,R11,Nausea and vomiting,-
3C0C9630-791F-4FB3-918C-B59DEE2D5A12,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9D5A4B3E-8026-4BE2-ADCC-C07C4C5E2C4B,R21,Rash and other nonspecific skin eruption,-
9D5A4B3E-8026-4BE2-ADCC-C07C4C5E2C4B,L30.9,"Dermatitis, unspecified",-
DD27896C-6DA1-4D9A-A41B-DB62E3DD4636,J06.9,"Acute upper respiratory infection, unspecified",-
0C8355DD-BFBD-48CF-925A-B65226BF5325,R51,Headache,-
09DA6582-51F6-4DB2-AF7C-272C2C9E7925,A09.9,Gastroenteritis and colitis of unspecified origin,-
81B226F5-C53B-4897-B275-2A3FB808F4D3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CF399B84-1D97-4B66-83E2-6352C7600AF6,A09.9,Gastroenteritis and colitis of unspecified origin,-
39FA38A4-D863-4C7B-BB6B-ADA2FB7C8152,K29.6,Other gastritis,-
4C417864-CACA-4420-B7D2-29085F02A31A,M79.1,Myalgia,-
4C417864-CACA-4420-B7D2-29085F02A31A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BFE65459-E813-4F61-A1BA-3653B021E445,A09.9,Gastroenteritis and colitis of unspecified origin,-
AEB7FF68-861F-42B2-82C0-3F1DE2463873,E11.9,Type 2 diabetes mellitus without complications,Diabetes
040B43F8-2173-4C73-A1F8-309146B247C7,E05,Thyrotoxicosis [hyperthyroidism],Thyroid
040B43F8-2173-4C73-A1F8-309146B247C7,H81.1,Benign paroxysmal vertigo,-
411C9C39-206C-4758-82E9-8B969980072C,G44.2,Tension-type headache,-
411C9C39-206C-4758-82E9-8B969980072C,M79.1,Myalgia,-
751F7E2A-E22B-490E-806C-711079459CA4,J06,Acute upper respiratory infections of multiple and unspecified sites,-
B1DB6232-6A31-4B13-B6CD-AE131D1F682F,R51,Headache,-
4C37B492-CE12-4BF2-88D1-2D727C43F339,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4C37B492-CE12-4BF2-88D1-2D727C43F339,R50.9,"Fever, unspecified",-
506204C7-FFBE-44F0-AFBB-1998618A49C6,J06.9,"Acute upper respiratory infection, unspecified",-
E6309FFF-D4C1-4705-A5B9-D61C0ECA63C9,J06.9,"Acute upper respiratory infection, unspecified",-
428BFC6C-ABE0-4573-B270-24AA7AC0B094,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
7836418F-434E-4869-AEA8-F21093079426,A09.9,Gastroenteritis and colitis of unspecified origin,-
314D84ED-21F3-4501-9BE8-42F14F381BCC,A09.9,Gastroenteritis and colitis of unspecified origin,-
45427297-1013-439C-87CA-FD5E464FC639,L30.1,Dyshidrosis [pompholyx],-
029A0C66-BED1-47C7-B416-49804AC22D1B,J06.9,"Acute upper respiratory infection, unspecified",-
0D71B436-A817-40A0-8D9D-50EE9FB84B47,R11,Nausea and vomiting,-
0D71B436-A817-40A0-8D9D-50EE9FB84B47,M54.5,Low back pain,-
3338C87A-DA75-4EBD-8F5C-7F79CE8E7D8A,K64.9,"Haemorrhoids, unspecified",-
1C6F7B10-E1D0-46BB-9033-4665D55CF936,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
B4DD5C19-F928-413E-840B-07ADB7DEC375,J06.9,"Acute upper respiratory infection, unspecified",-
AA31C5DD-62D4-4014-B409-E51870A1F8FC,A09.9,Gastroenteritis and colitis of unspecified origin,-
9169167F-343D-4066-886D-C677E203E862,R51,Headache,-
9169167F-343D-4066-886D-C677E203E862,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EA4828C3-023C-4786-B95B-1F2B5E6D8231,Z02,Examination and encounter for administrative purposes,-
09C3C67C-A812-484A-8730-A9AF095EDB70,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
E5811228-1C3F-4451-8706-A11C9DA4AD2E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A8C56AB3-A825-4CDC-8B2B-771E97CF6D3D,J06.9,"Acute upper respiratory infection, unspecified",-
A8C56AB3-A825-4CDC-8B2B-771E97CF6D3D,U07.1,"COVID-19, virus identified",-
8EA4369D-9087-42A9-BDF9-C9E4329D535B,R21,Rash and other nonspecific skin eruption,-
1E4C575B-2369-48E0-8CED-6F12FEB734C3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
32F768FA-C0D7-4930-93B7-60B317A931D8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1C2DDBC0-D254-42CA-9685-46D79CB6071F,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
1C2DDBC0-D254-42CA-9685-46D79CB6071F,I10,Essential (primary) hypertension,Hypertension
705EAB95-123E-425A-91E2-6FBF221B4D22,I10,Essential (primary) hypertension,Hypertension
5D565FAF-8419-4A61-8690-1FB638B88685,R52.9,"Pain, unspecified",-
7F3CA12A-8B2B-4159-A31B-489E5267A589,R11,Nausea and vomiting,-
9516B43C-1A32-4674-8FA8-FA965EF2986D,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
CDE3971C-FDFB-4861-A320-F54C9E0FBB3C,A09.9,Gastroenteritis and colitis of unspecified origin,-
CAAFEE0B-EE22-4898-B9DE-5E87A1A2C2BD,L20,Atopic dermatitis,Atopic dermatitis
36553678-3094-42D2-BC90-F438601C66BD,J06.9,"Acute upper respiratory infection, unspecified",-
32754DF7-6684-4AA7-B220-39894B3A8DD4,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
32754DF7-6684-4AA7-B220-39894B3A8DD4,J06.9,"Acute upper respiratory infection, unspecified",-
55DC4ADD-F991-47A6-B4FD-D2E187547972,L60.1,Onycholysis,-
957948F0-0A84-47B8-AFE7-25CBFA4D3578,J06.9,"Acute upper respiratory infection, unspecified",-
58012DBD-34AC-4EBF-9292-CD9ECB93F760,S90.0,Contusion of ankle,-
58012DBD-34AC-4EBF-9292-CD9ECB93F760,S80.0,Contusion of knee,-
EB8BA8CD-9915-4F39-A492-6F73C0140EBF,J06.9,"Acute upper respiratory infection, unspecified",-
3396B25D-84EF-4FCD-8609-76D077EDDE24,S96,Injury of muscle and tendon at ankle and foot level,-
3E23AE1B-9AF0-4C7A-826D-0D2F7C73273C,F41.9,"Anxiety disorder, unspecified",-
6D1905B5-F381-4C42-ACED-ED5108592B7D,J06.9,"Acute upper respiratory infection, unspecified",-
FFD319A9-1124-457E-A611-F958B4C7455E,H00,Hordeolum and chalazion,-
8DFA428B-8CE3-4204-BB18-7122AE6D0C08,M62.6,Muscle strain,-
8DFA428B-8CE3-4204-BB18-7122AE6D0C08,R07.0,Pain in throat,-
CBEEEBEC-C1D3-4E13-B126-6BDC98DD75CA,N39.0,"Urinary tract infection, site not specified",-
6E22E111-3D6D-4FF2-9002-27A031923140,J06.9,"Acute upper respiratory infection, unspecified",-
CBF55F3D-09C6-4BE6-89FE-B4CBE69EEDA3,Z71.2,Person consulting for explanation of investigation findings,-
6599DF52-43B1-4B5E-A0D3-F5C963FAA341,M79.1,Myalgia,-
947AF9DB-98CF-4B71-BA53-7EEAD5EB9853,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D8F4AEE0-17A8-4BE3-89D1-BDFC7AF1631B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CDBB579D-FA06-4EB2-8375-214FDBB9E13A,N39.0,"Urinary tract infection, site not specified",-
CDBB579D-FA06-4EB2-8375-214FDBB9E13A,L20,Atopic dermatitis,Atopic dermatitis
CDBB579D-FA06-4EB2-8375-214FDBB9E13A,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
F8962169-EBA3-48D9-9B49-D10A2CFA1300,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
F8962169-EBA3-48D9-9B49-D10A2CFA1300,G44.2,Tension-type headache,-
5298F4BF-3385-4632-A3B2-319BBD5625DA,U07.1,"COVID-19, virus identified",-
71C9B97D-13EB-4FED-B618-C024FE051D0D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
71C9B97D-13EB-4FED-B618-C024FE051D0D,R50.9,"Fever, unspecified",-
227A0AE0-8C2B-41FE-B966-359C37D78513,K30,Functional dyspepsia,-
227A0AE0-8C2B-41FE-B966-359C37D78513,R10.4,Other and unspecified abdominal pain,-
5EA20162-9CEC-4218-89EC-5EE682EAE53C,J06.9,"Acute upper respiratory infection, unspecified",-
F47ACC22-9DD4-43AA-BD07-8CF9F214B92C,S93.4,Sprain and strain of ankle,-
67F975F9-0118-441C-9DB8-65E234C54F20,M62.6,Muscle strain,-
79423737-C706-46D0-809A-4BAEA17B9748,M62.6,Muscle strain,-
D866A647-4D81-4DB5-8131-BDE093AA58EA,J06,Acute upper respiratory infections of multiple and unspecified sites,-
9C7247B2-B0E9-411E-A26E-8081F6D513C6,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
B506D9BD-0A1F-41B2-8128-BC77123A1289,G44,Other headache syndromes,-
21D62B78-09D0-4A15-861C-A0375D97ED5A,M79.1,Myalgia,-
7A898C0E-C279-49A4-BBBF-E23A41191438,J06.9,"Acute upper respiratory infection, unspecified",-
BA6B26B5-6C8A-48F0-935E-1CD7A43A8321,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
95B88943-B7A1-41D0-A67C-B156A4059D65,G44.2,Tension-type headache,-
F0668E61-7BDF-4C11-B686-BBC7D801C2AE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
AC44B098-4E6F-4D65-BD0F-FA30EC85164D,J06.9,"Acute upper respiratory infection, unspecified",-
AC44B098-4E6F-4D65-BD0F-FA30EC85164D,A68,Relapsing fevers,-
D18C62BA-F5BA-446A-B24F-AFF6BA8E8B62,Z02.9,"Examination for administrative purposes, unspecified",-
B8B06E68-4BB0-400F-8018-86A3D9015A52,J06.9,"Acute upper respiratory infection, unspecified",-
C9376F20-420A-4882-A226-E42F7F0B9E9A,K29.7,"Gastritis, unspecified",-
4BC02F60-157F-44C6-917B-435DD02B2360,M25.5,Pain in joint,-
FD4EF8FC-BE1A-40D0-8700-4BD8E82C0DA3,R51,Headache,-
E78979EF-1A64-4E81-957C-399C8941FE2A,A09.9,Gastroenteritis and colitis of unspecified origin,-
E677BA69-7189-466A-9862-AECB53794083,J06.9,"Acute upper respiratory infection, unspecified",-
4A7B7199-1FB9-4FF0-B63F-5624F7C18AB0,R21,Rash and other nonspecific skin eruption,-
E474FAE1-0F53-49C7-A704-3D978DD6F923,K64,Haemorrhoids and perianal venous thrombosis,-
2A6E1B55-AA34-4070-A2C7-CC6C6CF826C5,J45,Asthma,Asthma
2A6E1B55-AA34-4070-A2C7-CC6C6CF826C5,J06.9,"Acute upper respiratory infection, unspecified",-
DA8F2722-78F7-4FF7-AC1D-D521155882EB,J06.9,"Acute upper respiratory infection, unspecified",-
8C469720-5D05-465C-AE4A-25CB2C8A27AB,Z02.9,"Examination for administrative purposes, unspecified",-
908CE13A-707D-4AE2-9B7C-C90338E70065,Z71.2,Person consulting for explanation of investigation findings,-
A23C5054-2E95-4638-9473-A64A3425D434,A09.9,Gastroenteritis and colitis of unspecified origin,-
E9D0165A-CEE2-41F3-BC6C-015299326383,A09.9,Gastroenteritis and colitis of unspecified origin,-
A9455886-5965-4CD3-9BAE-A3B66ED4BAE2,J06.9,"Acute upper respiratory infection, unspecified",-
4693A55B-EC61-4601-B766-17EFD5C1120C,A09.9,Gastroenteritis and colitis of unspecified origin,-
956FE566-A1CA-4E4B-B620-F97D948B6985,M62.6,Muscle strain,-
C884968B-495A-4ECE-8256-A7D5F0F1730D,J06.9,"Acute upper respiratory infection, unspecified",-
38E5D78C-45B1-4342-8D04-A25E1638A94E,J06.9,"Acute upper respiratory infection, unspecified",-
DFBED16A-AB3F-48A9-9F0F-E8D83234BA65,A09.9,Gastroenteritis and colitis of unspecified origin,-
E64C8045-FA47-4DF9-8CAB-2E6F2FCA0FB7,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
E64C8045-FA47-4DF9-8CAB-2E6F2FCA0FB7,I10,Essential (primary) hypertension,Hypertension
A1E8B1D9-9D6A-4607-8C9A-01B3F932EA96,A09.9,Gastroenteritis and colitis of unspecified origin,-
47DDF05E-3C8A-435C-BD52-7D829640A243,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
40EE9BBF-A23D-49C8-9C85-819CE9CD7E13,J06.9,"Acute upper respiratory infection, unspecified",-
D514ACA2-9CC9-457B-9519-194DFF23AA26,R53,Malaise and fatigue,-
D2E0421C-0B89-470E-A3C8-F21CFF318BDF,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
8E83F281-C72C-4E5A-AC6A-0633BFC50B88,T88.1,"Other complications following immunization, not elsewhere classified",-
7283EAE1-9FBF-458D-9870-808C504F8904,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
796AB471-7E23-4992-BBD3-AF36E26A8F20,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
81F3FF43-756A-42B0-92C7-065C3F1BFB8E,N94.6,"Dysmenorrhoea, unspecified",-
4D8586EE-B5BB-49A7-9FC7-A4A1D61732F7,A09.9,Gastroenteritis and colitis of unspecified origin,-
76FB3F9E-9886-4466-8D8C-24CA57AE7E88,M79.1,Myalgia,-
76FB3F9E-9886-4466-8D8C-24CA57AE7E88,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D02A0E57-58DE-4823-B304-0906699A004A,M10,Gout,Gout
9410F7EA-9369-4971-87B3-CD277AA72368,J06.9,"Acute upper respiratory infection, unspecified",-
9F5A89EB-9E26-44D5-8566-DF0194329666,J06.9,"Acute upper respiratory infection, unspecified",-
9410F7EA-9369-4971-87B3-CD277AA72368,U07.1,"COVID-19, virus identified",-
4E5A7D45-822A-47AE-9D2E-65E39FB7656E,Z02,Examination and encounter for administrative purposes,-
5061BB0A-8C34-462A-B232-F27D01B1B1B2,J06.9,"Acute upper respiratory infection, unspecified",-
A3721B2B-18C3-4EBC-9B25-0C0C36F636B6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A3721B2B-18C3-4EBC-9B25-0C0C36F636B6,R50.9,"Fever, unspecified",-
A2C8EE8C-6724-4FC5-BD9C-BAEF411E1830,J06.9,"Acute upper respiratory infection, unspecified",-
A126F752-E270-41D7-92D7-D23DF5772FF7,N94.6,"Dysmenorrhoea, unspecified",-
76E9559A-E14C-4B43-A2D0-2E54DF4FCB62,S63,"Dislocation, sprain and strain of joints and ligaments at wrist and hand level",-
9C84D474-F62D-4F56-B2FE-8A3C4A75CCCD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9C84D474-F62D-4F56-B2FE-8A3C4A75CCCD,R50.9,"Fever, unspecified",-
17628ADC-933E-4BF7-AB15-7615E962AA2E,K59.0,Constipation,-
57B89ACF-C709-4CCF-A01A-0518651F0EB4,K59.0,Constipation,-
CCB604FE-2FCB-4170-A28B-AFEA57B74E5D,J06.9,"Acute upper respiratory infection, unspecified",-
32ADA148-88E7-49AB-8BF1-64A8BFAC26AD,A09.9,Gastroenteritis and colitis of unspecified origin,-
4DF90A51-ACE3-4B00-99A9-355C9527D892,Z02.9,"Examination for administrative purposes, unspecified",-
16415E52-4D4B-4A4E-A49C-000EDA12E930,A09.9,Gastroenteritis and colitis of unspecified origin,-
A8C84196-CC77-451A-976B-CE895DC5D90D,M62.6,Muscle strain,-
89CB70DF-C06A-436F-9ED8-E00DB144C264,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
3C3F1704-0532-4443-BAA9-8CA5E00A1889,N94.6,"Dysmenorrhoea, unspecified",-
EC5EA2C6-B7A4-432A-BBA7-B09225C8E62D,N94.6,"Dysmenorrhoea, unspecified",-
77E22E02-0732-4539-9C58-9865A9ED45F1,R42,Dizziness and giddiness,-
77E22E02-0732-4539-9C58-9865A9ED45F1,R11,Nausea and vomiting,-
5185D689-6603-48D1-A7D3-FA239415C29F,N39.0,"Urinary tract infection, site not specified",-
F059523F-7B57-4C56-9BD3-6BB1906B628E,H00,Hordeolum and chalazion,-
29F2CEE8-330E-4316-B4FC-BC3C0A287728,R32,Unspecified urinary incontinence,-
F2212F4B-3B2F-4052-AE98-D0104BA99405,Z76.0,Issue of repeat prescription,-
F2212F4B-3B2F-4052-AE98-D0104BA99405,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
C1931DBE-CC30-44B8-B028-BC8A5E8A5564,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
A9E23264-B5A7-4E04-A8A2-6B5AD5AC7008,A09.9,Gastroenteritis and colitis of unspecified origin,-
C1931DBE-CC30-44B8-B028-BC8A5E8A5564,K29.7,"Gastritis, unspecified",-
A9E23264-B5A7-4E04-A8A2-6B5AD5AC7008,R42,Dizziness and giddiness,-
C1931DBE-CC30-44B8-B028-BC8A5E8A5564,G44.2,Tension-type headache,-
8FF27AB1-5C1E-4922-A9AF-A06B79E7BC16,Z76.8,Persons encountering health services in other specified circumstances,-
8EE9CB16-C65A-4D92-96A4-84C658FC305D,J06.9,"Acute upper respiratory infection, unspecified",-
F308F9D5-B4AA-4BF8-9609-B447B9743F02,A09.9,Gastroenteritis and colitis of unspecified origin,-
7415969C-1BF0-4934-A564-09754572FC02,J06.9,"Acute upper respiratory infection, unspecified",-
59244021-E277-4EE2-A2E2-5B6ED3D2BCDD,R51,Headache,-
A7AE7A4A-1F29-4068-A7A2-C01008E6D205,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
A4F8905D-F1AF-468A-985E-E10974AA49CC,N94.6,"Dysmenorrhoea, unspecified",-
A4F8905D-F1AF-468A-985E-E10974AA49CC,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
1EFF7940-9F03-4BE1-90E6-51B445239196,G43,Migraine,Migraine
04C572E0-9A0F-4520-A918-8983BAAECCC6,A09.9,Gastroenteritis and colitis of unspecified origin,-
8AB002FA-5E27-4137-BA1B-EE60B5248EC0,N94.9,Unspecified condition associated with female genital organs and menstrual cycle,-
71F2D324-C866-4B67-9861-31526C7E6BFC,R51,Headache,-
C4B5A09B-8004-48C6-B990-BF7D1E02FF5D,M54.5,Low back pain,-
C15D2E23-8487-41CA-A567-D52E7EE10D18,G43,Migraine,Migraine
D9AF7C88-E7DC-4DE4-A713-E907C9725518,R51,Headache,-
2A50DDE2-F79C-452C-94B2-ED4D7DBB7A50,A09.9,Gastroenteritis and colitis of unspecified origin,-
519E62F9-569E-49FC-BA8C-1FCCFAFBE305,U07.1,"COVID-19, virus identified",-
6C023E68-79C8-4F00-A578-0EE1C70BE857,U07.1,"COVID-19, virus identified",-
5450D630-838E-4A48-9B55-5060431D20E5,J06.9,"Acute upper respiratory infection, unspecified",-
53C155F2-8660-41AE-A8A7-EC5E5ED81128,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
67B8F24E-46CA-4825-8E60-4FE1B9321D86,Z02.9,"Examination for administrative purposes, unspecified",-
74CC85A0-5086-4F47-87AF-BD53ED1F4FA7,L50,Urticaria,-
06C03E99-61EF-4642-B9A5-25E2B5032279,I64,"Stroke, not specified as haemorrhage or infarction",-
BCCCA6F6-42BA-4C98-9242-766DBC640087,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0A295EE9-83BA-46A5-BBDF-FE9DFF50E977,M75.1,Rotator cuff syndrome,-
0A295EE9-83BA-46A5-BBDF-FE9DFF50E977,M75,Shoulder lesions,-
01F93CEE-509E-4C69-A3E8-1D34FD0E7838,M79.1,Myalgia,-
8EB61433-F9AC-474F-8E70-3A6BA27F983A,M79.1,Myalgia,-
8EB61433-F9AC-474F-8E70-3A6BA27F983A,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
7AA5FEB5-8244-487C-805B-83A56051E3D3,A09.9,Gastroenteritis and colitis of unspecified origin,-
B9B2CF69-0481-46CD-90AA-06F87C8F9C94,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B9B2CF69-0481-46CD-90AA-06F87C8F9C94,R21,Rash and other nonspecific skin eruption,-
0552CF90-3BD4-4139-842A-CE5EBEB30D11,N39.0,"Urinary tract infection, site not specified",-
D9EB682E-C457-46E0-9941-C419173854E8,R53,Malaise and fatigue,-
D9EB682E-C457-46E0-9941-C419173854E8,M79.1,Myalgia,-
391A56AC-BF21-4AF5-BE56-356BD74BADB5,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
391A56AC-BF21-4AF5-BE56-356BD74BADB5,L30.9,"Dermatitis, unspecified",-
391A56AC-BF21-4AF5-BE56-356BD74BADB5,R51,Headache,-
FAD02581-4F8D-4B1E-A2FA-38FAFCCC024A,J06.9,"Acute upper respiratory infection, unspecified",-
FAD02581-4F8D-4B1E-A2FA-38FAFCCC024A,U07.1,"COVID-19, virus identified",-
88612D83-9E7B-4847-874D-74BFD810A77F,A09.9,Gastroenteritis and colitis of unspecified origin,-
89F64D1D-561D-4B91-80E9-64603D2DCB74,M54.5,Low back pain,-
81F3FF43-756A-42B0-92C7-065C3F1BFB8E,R21,Rash and other nonspecific skin eruption,-
4F010163-6791-4B5F-8960-8833DCD5E66A,M79.1,Myalgia,-
697FB60A-0B6C-4292-AF0D-5B16DED3FE72,R21,Rash and other nonspecific skin eruption,-
4ED549D0-D200-4ADA-A8F7-F25CF99082F7,Y42.4,Oral contraceptives,-
A4234891-DAA8-46BE-9B7F-EB23EBFEF267,A09.9,Gastroenteritis and colitis of unspecified origin,-
635781B1-97CC-4D9B-AF27-094F0E83948E,R51,Headache,-
8FB324D2-0ED0-4C43-BCF6-749AD7712D74,A09.9,Gastroenteritis and colitis of unspecified origin,-
941ADCB0-FDE2-454D-AA95-19AF943A23E9,M79.1,Myalgia,-
DBD95A30-921D-40BC-84CC-E88EF952DE15,J06.9,"Acute upper respiratory infection, unspecified",-
F959CCEE-3D44-43BD-B0CC-7139C624C494,G44.1,"Vascular headache, not elsewhere classified",-
F959CCEE-3D44-43BD-B0CC-7139C624C494,H57,Other disorders of eye and adnexa,-
7226CD74-5138-4C75-AE0D-9D3B7A5333D7,A09.9,Gastroenteritis and colitis of unspecified origin,-
7226CD74-5138-4C75-AE0D-9D3B7A5333D7,R21,Rash and other nonspecific skin eruption,-
C34C0731-5F38-4CB8-90B0-B0CE830454C7,N92.1,Excessive and frequent menstruation with irregular cycle,-
82715CA8-B247-4176-9721-B9783C8C16BA,T23.1,Burn of first degree of wrist and hand,-
E8C3855D-D198-47BF-944A-BA653DFE8DAB,J06.9,"Acute upper respiratory infection, unspecified",-
CE777775-8D55-40EC-8319-6833D07B1EDB,N94.6,"Dysmenorrhoea, unspecified",-
0B32FDCF-71F7-4388-996F-D375F936059E,J06.9,"Acute upper respiratory infection, unspecified",-
52A8A9FC-C9EC-4C55-87BD-2717B01CD474,R11,Nausea and vomiting,-
2181312E-1399-4DC4-B4C2-0653722E1C12,G44,Other headache syndromes,-
01395B2C-7753-4DBA-A9C3-54B0F15DD643,R51,Headache,-
576C3FAA-6632-4531-A710-EFC791DCB2A6,T88.1,"Other complications following immunization, not elsewhere classified",-
443D14A0-804A-4B19-8BCC-CCE2C4C61C0A,A09.9,Gastroenteritis and colitis of unspecified origin,-
576C3FAA-6632-4531-A710-EFC791DCB2A6,M79.1,Myalgia,-
443D14A0-804A-4B19-8BCC-CCE2C4C61C0A,K29.7,"Gastritis, unspecified",-
8C9453D4-875E-41A1-8620-26D83A84A525,Z71.2,Person consulting for explanation of investigation findings,-
8C9453D4-875E-41A1-8620-26D83A84A525,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
7D1C0C1C-C753-411D-A0E1-DAAA56ADCC8B,R51,Headache,-
0E016AC3-69ED-4596-A21C-F40AED68CCD7,R51,Headache,-
0E016AC3-69ED-4596-A21C-F40AED68CCD7,L30.9,"Dermatitis, unspecified",-
0E016AC3-69ED-4596-A21C-F40AED68CCD7,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
22E0EDB7-7967-4DAB-AE5D-CE644848E680,R51,Headache,-
A102BB98-7368-4CA6-8B69-AE9946ED25CD,J06.9,"Acute upper respiratory infection, unspecified",-
016A0FB2-359E-40CC-BE33-804A8E1DBEEA,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
016A0FB2-359E-40CC-BE33-804A8E1DBEEA,K30,Functional dyspepsia,-
0439411B-FE21-4309-9C49-EE22A80C9197,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
181B94EF-5230-4E59-BAB4-7603E6FC7B60,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
181B94EF-5230-4E59-BAB4-7603E6FC7B60,K29.7,"Gastritis, unspecified",-
B4411A49-4D7B-4FFD-AB75-9B7D453EB03B,K30,Functional dyspepsia,-
A616D98F-013B-492B-B131-118FB784E23D,M23,Internal derangement of knee,-
40858458-CEDB-4A31-8D9C-6B690B295C0A,S66.0,Injury of long flexor muscle and tendon of thumb at wrist and hand level,-
40858458-CEDB-4A31-8D9C-6B690B295C0A,M62.6,Muscle strain,-
40858458-CEDB-4A31-8D9C-6B690B295C0A,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
AF0F7378-C906-4AFD-9400-4F75C4CD82E6,K29.7,"Gastritis, unspecified",-
9EBCAE07-3964-47C0-9CC1-F4007E26CDFD,H10.1,Acute atopic conjunctivitis,-
9EBCAE07-3964-47C0-9CC1-F4007E26CDFD,H57,Other disorders of eye and adnexa,-
70739B79-4366-4FAF-90FD-A7F637625804,H02.9,"Disorder of eyelid, unspecified",-
21B3AB93-07EC-4B26-A3B8-B9C9B3EE0C88,B37.3,Candidiasis of vulva and vagina,-
225082CA-D548-41D3-B1C5-FE5C189C97C6,J06.9,"Acute upper respiratory infection, unspecified",-
7E282492-53E3-4330-8215-6FFB6F5558D8,U07.1,"COVID-19, virus identified",-
ED778716-E2E5-4364-AEF8-A48FE930422B,R51,Headache,-
7C7AF107-C7D9-4424-BF77-9409250A6403,N39.0,"Urinary tract infection, site not specified",-
F7EB9169-20BD-42E3-A6EA-72E0203C4955,A09.9,Gastroenteritis and colitis of unspecified origin,-
CC4EE048-BDE7-4706-BEFD-ACA67007C1C8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
508F27B1-C957-498E-AF71-AA4B2825EDDD,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
B38F1840-D636-472A-9467-D805ADA5A542,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0E4F924F-71FC-491C-B397-25944667A48F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FC0C3F62-8E0D-4A5C-8C1F-56548BEF88A6,R51,Headache,-
536E22CE-7010-4ECC-B929-13A06BF36FAE,A09.9,Gastroenteritis and colitis of unspecified origin,-
4EA57E63-E490-4FCD-B3F8-23B6F078EDD1,R51,Headache,-
3DCF0A4B-6A48-4631-BFFA-660A90CC1738,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FD63CD25-2485-466F-BFB2-07243A244A9A,N94.8,Other specified conditions associated with female genital organs and menstrual cycle,-
7AEBEC70-B218-48F2-8D50-3DB0BBC36A2B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9651BC56-9ECA-4D9D-B566-436B47C7DA46,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
55AA1DC9-FE0B-481C-A297-2EAD32DA3575,H94,Other disorders of ear in diseases classified elsewhere,-
93DDC2BC-9ED8-4F25-A302-DD83E7CD0F6B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
93DDC2BC-9ED8-4F25-A302-DD83E7CD0F6B,R50.9,"Fever, unspecified",-
C4E02C97-7704-4FAF-B16F-37202F46572C,N94.4,Primary dysmenorrhoea,-
ABA61882-8437-4971-A232-6A2B276DDA30,L30.9,"Dermatitis, unspecified",-
7AFB3A23-56B3-4C17-8ED8-B6FD5945F2E0,R51,Headache,-
63587985-1EA2-4C4C-876D-62973F475077,J06.9,"Acute upper respiratory infection, unspecified",-
E179F8BD-70FA-4372-980E-677EF0B1D70C,J06.9,"Acute upper respiratory infection, unspecified",-
E179F8BD-70FA-4372-980E-677EF0B1D70C,U07.1,"COVID-19, virus identified",-
14F7CE6C-FE5C-4809-B3F2-0316508A8D47,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
62394969-5647-4981-A7B8-55E7FCBC9A0E,N94.6,"Dysmenorrhoea, unspecified",-
14F7CE6C-FE5C-4809-B3F2-0316508A8D47,L30.9,"Dermatitis, unspecified",-
5DCDBF1B-A7AE-4ABA-A2F6-51D4C42EB424,J06.9,"Acute upper respiratory infection, unspecified",-
AA553884-368A-4C16-B5F2-15EA55BA5769,R50.9,"Fever, unspecified",-
3756068A-9F2A-464D-BD9B-42B4002DDA7A,L70,Acne,-
C1FBACD4-92E4-44E2-953B-16CDBDAA8BFF,M10,Gout,Gout
312C8C43-00E8-4442-8281-0AAA63B93C81,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
B1CC6574-31C9-4143-99EB-990CE8FF96B1,M54.5,Low back pain,-
834F442F-2775-4CAA-8C6A-69E67E856144,R21,Rash and other nonspecific skin eruption,-
4596F84F-458A-4661-8C47-06FE2FB0AC71,M10,Gout,Gout
34E39CD4-F13A-4D21-B41B-5DCDA5E25034,N94.5,Secondary dysmenorrhoea,-
4087362D-A20E-4E38-96AE-D2B4F27EC777,K12.3,Oral mucositis (ulcerative),-
83D0B36F-D844-4737-A707-C802E257A5A8,R21,Rash and other nonspecific skin eruption,-
6D869EF5-D52B-41A6-B0EB-6ED6E0C7FFA6,U07.1,"COVID-19, virus identified",-
F552EB56-0200-4DBF-ACB9-DCC5DF173335,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
88A26A07-C53F-4E27-8399-6E980D9CFC5E,R51,Headache,-
E39C2100-CBB8-450C-8DB1-E42B75928ED4,M10,Gout,Gout
DAA1DD9D-9EED-4E99-81F4-F52B4CF05A95,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BC7119AD-B85E-430E-B596-CF7C58BCC9E5,J06.9,"Acute upper respiratory infection, unspecified",-
0D4C4626-08DA-4556-8FA0-FC5CE7D8C780,J06.9,"Acute upper respiratory infection, unspecified",-
CB45D5A2-089B-4F73-9079-13F0A00CC029,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
CB45D5A2-089B-4F73-9079-13F0A00CC029,N94.6,"Dysmenorrhoea, unspecified",-
7AA55B2F-1000-4825-9B61-3400BDFD0505,R52.9,"Pain, unspecified",-
EC35BBA3-37E9-4674-9E96-AAAD7DA3C319,T88.1,"Other complications following immunization, not elsewhere classified",-
A3CA08FE-D7A1-44DC-AE97-26725D786702,A09.9,Gastroenteritis and colitis of unspecified origin,-
0677E9A3-CE72-4C94-A979-5AF343F5A572,M54.2,Cervicalgia,-
0677E9A3-CE72-4C94-A979-5AF343F5A572,G44.2,Tension-type headache,-
9C8D2EA9-4EB3-43E3-ABA6-22A1E8C8E8F0,G44.2,Tension-type headache,-
91846CBA-3483-4F58-9E48-5D84DDEFA4CD,A09.9,Gastroenteritis and colitis of unspecified origin,-
0CDBE7A7-E340-456F-BFD5-0665914E7729,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C8D76F89-B479-4FB9-8BB8-729F53EAAD47,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
80748800-9F46-4E2F-9681-691C9DE7E074,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
F2E86BD1-3E84-49A9-9EEB-6DE966A106AF,R51,Headache,-
9D4C514D-97A3-4EB4-8AD5-DB26AEF45F21,K29.7,"Gastritis, unspecified",-
9D4C514D-97A3-4EB4-8AD5-DB26AEF45F21,R51,Headache,-
7DB2345E-3332-4E36-B2D8-F7ECE490B41E,A09.9,Gastroenteritis and colitis of unspecified origin,-
7DB2345E-3332-4E36-B2D8-F7ECE490B41E,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
82528B09-0166-4761-B469-3A2E21E352E7,J06.9,"Acute upper respiratory infection, unspecified",-
82528B09-0166-4761-B469-3A2E21E352E7,T88.1,"Other complications following immunization, not elsewhere classified",-
7EE7C092-0D2B-4D64-868D-A8EBFB49F1DB,J06.9,"Acute upper respiratory infection, unspecified",-
36AACF2C-D5A3-49E1-B08D-1179FE449338,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E38A481C-AAAB-45BF-B1CD-4280E969E687,J30.3,Other allergic rhinitis,Vasomotor and allergic rhinitis
4715C910-319C-4A39-A1C5-CDEEBBB6E132,H10.3,"Acute conjunctivitis, unspecified",-
4715C910-319C-4A39-A1C5-CDEEBBB6E132,R21,Rash and other nonspecific skin eruption,-
8543BED1-7081-4994-82D7-B50CAB60EFD3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5689C070-93C1-48A8-863C-053626DC6067,K30,Functional dyspepsia,-
5689C070-93C1-48A8-863C-053626DC6067,M25.5,Pain in joint,-
4E723F63-D21E-4E26-9B2A-8392D7E599A7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A45A5966-28B4-449F-A39B-5CE09E8455F4,N94.6,"Dysmenorrhoea, unspecified",-
21F78565-27DE-491A-A6EC-5C3CAB18A6FB,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
1E90B9ED-8173-45BB-9814-1C2CBDA6EB30,R21,Rash and other nonspecific skin eruption,-
F4FEAD16-CF55-4002-999D-40579EEFA8DA,G43,Migraine,Migraine
F3FF6DA2-5624-4055-BAFE-980AD74FBF76,T88.1,"Other complications following immunization, not elsewhere classified",-
EA8D80E0-EDFD-4D85-9DFE-55C8F31A4E8F,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F0297E9A-E2E5-40C4-9457-EEC29B1C4D63,J06,Acute upper respiratory infections of multiple and unspecified sites,-
6DE85B25-28D6-48B9-BDD5-8EF81A0B05B5,R10.4,Other and unspecified abdominal pain,-
F47DF7E1-1487-4ECD-AB73-A6902F03BA31,M47.2,Other spondylosis with radiculopathy,-
DDA505DC-C3AF-451C-AFA0-52845A7A29A1,J06,Acute upper respiratory infections of multiple and unspecified sites,-
D08E2F78-3A26-4D20-960D-D5ABEB458FF2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1B5EA268-6615-4A6F-BB0B-8FBF02788548,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
1B5EA268-6615-4A6F-BB0B-8FBF02788548,A09.9,Gastroenteritis and colitis of unspecified origin,-
26508B17-0122-41FF-8187-6CD9C1D438DD,U07.2,"COVID-19, virus not identified",-
C74134F1-E86A-4106-8D36-B9EF321B1455,U07.1,"COVID-19, virus identified",-
26508B17-0122-41FF-8187-6CD9C1D438DD,J06.9,"Acute upper respiratory infection, unspecified",-
BD9F9ECB-CA1A-44C5-B21D-A618B9260B38,I88,Nonspecific lymphadenitis,-
B298B33E-F062-4285-95EB-F2BE7438F022,A09.9,Gastroenteritis and colitis of unspecified origin,-
BF87212F-8A13-4740-B4F9-E4472BF488CA,L50.9,"Urticaria, unspecified",-
BF87212F-8A13-4740-B4F9-E4472BF488CA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
25535683-59BC-4610-BEEE-D20C3BC1A4F0,K64,Haemorrhoids and perianal venous thrombosis,-
705548CF-F5C4-4759-8BA8-D9E4E294923C,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
33BC8D25-C33F-41AF-8750-3E11B672E703,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6734542A-06D8-43DA-BA7A-65F7AAE2D67B,R21,Rash and other nonspecific skin eruption,-
6734542A-06D8-43DA-BA7A-65F7AAE2D67B,T78.4,"Allergy, unspecified",-
3EA57AA2-6770-4376-95B0-8727191A2EE2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BEC1CA0E-8C5F-436A-8805-7BA9F916AA48,Z71.2,Person consulting for explanation of investigation findings,-
5F203B07-F071-4A65-B094-86335B0DC3FF,J06.9,"Acute upper respiratory infection, unspecified",-
D440A5E4-01ED-47DE-A9F4-7A5B5E7688F7,J06.9,"Acute upper respiratory infection, unspecified",-
AE621D8B-38E2-470F-92B2-B11C6480ACFF,G43,Migraine,Migraine
76A9CA7D-0DB8-4D4C-A801-35A9CA36BB9A,T88.1,"Other complications following immunization, not elsewhere classified",-
FA5D81B3-7744-4DFE-90C2-59F1113464E1,M79.1,Myalgia,-
4D968C55-2625-4DDC-882B-6B37DD80B057,M23,Internal derangement of knee,-
C96FDF80-C654-4447-B766-F45F1B3D7A0E,J06.9,"Acute upper respiratory infection, unspecified",-
5C8914EF-0D4A-40C1-84F0-9292A8159B46,L20,Atopic dermatitis,Atopic dermatitis
E08748FB-D1B1-43DF-ADD4-2144963AD041,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
426EB834-9FAC-4FD3-8767-CEED7B9C3B25,G43,Migraine,Migraine
34A63FE5-B307-4EAD-90FC-94E51A7A85A7,Z71.2,Person consulting for explanation of investigation findings,-
3BD6901E-0ABC-4136-9ED7-DC297E43C768,Z71.2,Person consulting for explanation of investigation findings,-
997255C3-BB64-43A3-BDD6-8A1588C2A5AF,B35.6,Tinea inguinalis [Tinea cruris],-
7F639B43-4A7A-4029-BD28-57160F951057,G44,Other headache syndromes,-
FF63FCDA-132F-4B5A-AF3F-696C650A8ABC,M62.6,Muscle strain,-
FC48A160-4EF6-4EF5-AE41-64BFEDA815A1,R51,Headache,-
C9D6A27F-B56F-4050-A827-86369F470E43,B35.4,Tinea corporis,-
C90A1CB8-DB5A-4820-A6D0-91F1E63F3E50,R11,Nausea and vomiting,-
C90A1CB8-DB5A-4820-A6D0-91F1E63F3E50,K59.1,Functional diarrhoea,-
37793351-7681-4AD8-8CD1-879AA6EF4F87,L02.0,"Cutaneous abscess, furuncle and carbuncle of face",-
6A3712C8-4736-49D7-9E6F-CF7960E2C00D,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
71BD3C1D-CF98-4530-9210-2B8C30341F1F,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
BDFF78DB-BA92-4211-9437-2BFEFC963B6B,K29.7,"Gastritis, unspecified",-
65DD7DF0-4F86-4EFB-8F4E-938B29EB5212,R51,Headache,-
1829E95C-1D67-4D3F-848E-F86DD16B494F,H00,Hordeolum and chalazion,-
7C995806-B8CF-45F9-8DF0-B64051A51397,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7C995806-B8CF-45F9-8DF0-B64051A51397,N94.4,Primary dysmenorrhoea,-
46B0520D-7F15-45E5-9A9E-4F94F9D110BD,A09.9,Gastroenteritis and colitis of unspecified origin,-
CA55C88D-7B82-4E70-8B33-67A9BB9B8EE2,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
19580194-61A2-4D5B-BB02-04293F0B8A80,N76.0,Acute vaginitis,-
F421AD4A-1EAA-4266-A1B1-2E593E27123D,R21,Rash and other nonspecific skin eruption,-
0571B989-280D-4AFC-A668-2768CC8D53B8,M62.6,Muscle strain,-
6B91DAC3-D97D-43C2-B442-D4215B063A6F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5E31B418-B0CE-46D8-85D7-582EB313AAF5,M62.6,Muscle strain,-
6A1CC897-431F-4A2F-BFB6-F257604CA7ED,T88.1,"Other complications following immunization, not elsewhere classified",-
2B86A760-2915-4BB3-9503-F8E759281DEC,R14,Flatulence and related conditions,-
9543A668-131D-4101-B6D1-C45E50A449F4,Z71.2,Person consulting for explanation of investigation findings,-
5F778789-63A7-46E9-9CA4-0FD02705C791,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B7040597-C7D5-49B8-A7F5-3DF581558454,Z71.2,Person consulting for explanation of investigation findings,-
90806923-98DE-400B-B554-898AB164E59E,R51,Headache,-
90806923-98DE-400B-B554-898AB164E59E,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
D3F052FF-ACAE-4064-8B30-9B0969840FA9,N94.6,"Dysmenorrhoea, unspecified",-
D3F052FF-ACAE-4064-8B30-9B0969840FA9,R51,Headache,-
5EF5FF90-DFF9-42AF-95DB-C64F98588666,N94.6,"Dysmenorrhoea, unspecified",-
BF270AEC-276E-4C74-9FD0-D9677FD8F75B,M79.1,Myalgia,-
BF270AEC-276E-4C74-9FD0-D9677FD8F75B,G44.2,Tension-type headache,-
64690645-B433-4D25-9FAE-CF8309782F58,L63,Alopecia areata,-
64690645-B433-4D25-9FAE-CF8309782F58,F52,"Sexual dysfunction, not caused by organic disorder or disease",-
8C7FA4C0-0760-4081-9BFE-2669F2F03ABD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
057F9769-F7DA-41D0-A37B-9D6C6C753A3A,I25,Chronic ischaemic heart disease,-
057F9769-F7DA-41D0-A37B-9D6C6C753A3A,Z76.0,Issue of repeat prescription,-
057F9769-F7DA-41D0-A37B-9D6C6C753A3A,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
057F9769-F7DA-41D0-A37B-9D6C6C753A3A,I10,Essential (primary) hypertension,Hypertension
DE58B00C-A68C-4857-B6D6-27A24A2A9E58,A09.9,Gastroenteritis and colitis of unspecified origin,-
F5208FC6-989F-4F91-A733-49F08D5A59FF,A09.9,Gastroenteritis and colitis of unspecified origin,-
6B768EB5-D9B8-4D97-A09D-1B694EE92EFF,A09.9,Gastroenteritis and colitis of unspecified origin,-
D44F4935-7D00-4385-952E-CADCC1E520CE,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
BE503040-3164-496B-B301-47F7E2861B05,J06.9,"Acute upper respiratory infection, unspecified",-
BE503040-3164-496B-B301-47F7E2861B05,U07.1,"COVID-19, virus identified",-
F7A85F8A-6AAA-4A0D-B9A0-F1B62DD34C67,A09.9,Gastroenteritis and colitis of unspecified origin,-
69143F5F-D153-473C-9FDD-C8B53AFBD0F3,N94.6,"Dysmenorrhoea, unspecified",-
2A2AAE77-A5E4-4ECD-98B8-6D12D76B63E9,A09.9,Gastroenteritis and colitis of unspecified origin,-
12A27FD8-C41B-4558-B199-58A25B13B5A4,A09.9,Gastroenteritis and colitis of unspecified origin,-
91287CD4-AB0E-447A-991D-9837D10C1729,Z02.9,"Examination for administrative purposes, unspecified",-
74B5804C-6E73-4105-864A-0F2671FF7562,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2315C0FE-28EB-42E0-A15F-B4BC948CC498,A09.9,Gastroenteritis and colitis of unspecified origin,-
27E02767-3E26-48AF-8EE7-FBD6EFB2D3E4,N39.0,"Urinary tract infection, site not specified",-
B4924D70-0583-4D04-B787-A46556E6718B,A09.9,Gastroenteritis and colitis of unspecified origin,-
4C40C2C7-43C9-42B7-901E-05E458C40ECD,K30,Functional dyspepsia,-
D7012E3A-9274-410E-B62D-46C84FC9671C,A09.9,Gastroenteritis and colitis of unspecified origin,-
CDFDAF1B-E03E-47E0-802C-1C6670610ED3,A09.9,Gastroenteritis and colitis of unspecified origin,-
18F3BDF5-2FF6-46F7-B579-176A986B4BE1,L50.9,"Urticaria, unspecified",-
D016E521-CCFA-4674-864D-27AB1DA1CDDE,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
58E6827B-139D-4708-8A5B-90D133BC5BD6,M25.5,Pain in joint,-
F10CCB7B-CC16-48AD-8255-C43DE1F94CB1,S90,Superficial injury of ankle and foot,-
5471C6ED-274E-49A3-8B0D-4F669DCCCCCE,T88.1,"Other complications following immunization, not elsewhere classified",-
0543329F-F244-49D2-AC7A-7694835AF8D3,T88.1,"Other complications following immunization, not elsewhere classified",-
24E14FA6-B6DC-4C01-B6BD-902B11AA8308,R51,Headache,-
308D703F-FD88-484A-9ECD-6F9D25BC2CEE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
64FDEB08-A680-406D-9209-4164D2841F3F,Z71.2,Person consulting for explanation of investigation findings,-
1B33FDD3-660F-4611-ADA4-3F922756E3EE,R51,Headache,-
A5BD0677-517D-4B2B-BACB-8354FCDADF46,R07.4,"Chest pain, unspecified",-
A5BD0677-517D-4B2B-BACB-8354FCDADF46,M62.6,Muscle strain,-
D2F2EC92-2B02-403F-AF9F-8F923383AB53,R51,Headache,-
83B883AF-9E41-46FC-A813-D8DD8CE01979,J06.9,"Acute upper respiratory infection, unspecified",-
530FC77D-D107-4D52-882B-B1308C45590D,H40,Glaucoma,-
530FC77D-D107-4D52-882B-B1308C45590D,N39.0,"Urinary tract infection, site not specified",-
9499608F-B28A-491D-B1BC-2EE6F601A38C,L70,Acne,-
1071162B-C4B0-4161-9726-CFBC9846EAB5,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
17B81619-A79E-4EDD-A888-D1D1325E597C,A09.9,Gastroenteritis and colitis of unspecified origin,-
EE8F7CFE-1F22-43E4-AB77-0E6589D06826,L02.9,"Cutaneous abscess, furuncle and carbuncle, unspecified",-
B9B978E2-E1C5-4FBB-B8EF-B353DF15BBB1,R51,Headache,-
6F3E5AA1-0C97-4CD2-B7EF-F69491122AA1,J03.9,"Acute tonsillitis, unspecified",-
EB8EBC1A-2E05-4A85-8DF8-4BF072048B09,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
61D11AFD-5C03-436B-AF3A-58EE55270D94,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
61D11AFD-5C03-436B-AF3A-58EE55270D94,M79.1,Myalgia,-
E2014C3A-B714-4903-A956-BEBC81F21B3F,T88.1,"Other complications following immunization, not elsewhere classified",-
86EA880D-54C1-47B3-B1F6-5AE0279FBC1D,J06.9,"Acute upper respiratory infection, unspecified",-
83F338D6-6B5E-46C9-B0D7-77C740B0F84A,J39.3,"Upper respiratory tract hypersensitivity reaction, site unspecified",-
83F338D6-6B5E-46C9-B0D7-77C740B0F84A,R51,Headache,-
83F338D6-6B5E-46C9-B0D7-77C740B0F84A,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
DE5D1D42-A886-4BE0-BC04-89ECE7A5CB27,J03.9,"Acute tonsillitis, unspecified",-
AB00CCEF-1E28-4772-B0B9-EDD956EDF90B,R07.0,Pain in throat,-
A5230BA2-5940-474D-BF64-D502654763AF,M62.6,Muscle strain,-
B0F158B6-219D-464A-86CD-D84FA0ECD90D,K64,Haemorrhoids and perianal venous thrombosis,-
E5E8B917-5C3D-43BB-AF82-E85496D30A49,L50.9,"Urticaria, unspecified",-
E5E8B917-5C3D-43BB-AF82-E85496D30A49,J06.9,"Acute upper respiratory infection, unspecified",-
52BB1029-D767-4F04-AA79-6A5B5834D63A,Z02.9,"Examination for administrative purposes, unspecified",-
155920E5-C4A0-466E-9377-4E0BF340F9AC,H11.3,Conjunctival haemorrhage,-
EA359AB0-897A-4751-8029-6998F04390E9,J06.9,"Acute upper respiratory infection, unspecified",-
D9DBE332-B1AE-4E73-9A52-D131EF31A032,T88.1,"Other complications following immunization, not elsewhere classified",-
3BF1923D-BAC1-4EB1-8A4E-40780EDCCE2C,A09.9,Gastroenteritis and colitis of unspecified origin,-
04810D72-62BB-4C7D-9450-FF449B01B8A4,M10,Gout,Gout
69189BD6-F907-449D-9C24-CBC3F75D18A0,T88.1,"Other complications following immunization, not elsewhere classified",-
97AA76BA-4655-4845-AD34-C3463CB22D6E,J06.9,"Acute upper respiratory infection, unspecified",-
97AA76BA-4655-4845-AD34-C3463CB22D6E,R51,Headache,-
33F97F55-7F20-49DB-A109-A1ACD5D56B43,R51,Headache,-
2FCD0272-BB21-4089-ADC5-7DC5E7BB99D5,J06.9,"Acute upper respiratory infection, unspecified",-
2FCD0272-BB21-4089-ADC5-7DC5E7BB99D5,G43,Migraine,Migraine
D31638EF-AC58-4210-B796-49F9DEF18343,N94.6,"Dysmenorrhoea, unspecified",-
E59F443E-FE18-4BB3-83B9-135C2ABB1A8B,H57.9,"Disorder of eye and adnexa, unspecified",-
DB53AEA8-2D21-4D31-89DF-51D09D5B0913,R51,Headache,-
41349434-3132-4AFC-8770-3C70225D1C28,R50.9,"Fever, unspecified",-
619488B1-167D-49D5-9F91-A2DDE81CB5CB,A09.9,Gastroenteritis and colitis of unspecified origin,-
58BEEBF9-D86D-43EC-A1E0-DD6913175FFB,Y42.4,Oral contraceptives,-
58BEEBF9-D86D-43EC-A1E0-DD6913175FFB,K13,Other diseases of lip and oral mucosa,-
CE12C759-B865-4BC7-AAEC-D1925119C839,J06.9,"Acute upper respiratory infection, unspecified",-
5CB99FA5-F8E4-4123-9990-E36B2E50E744,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
45A9058A-3626-4A4E-AA25-D2FD9677D31D,J06.9,"Acute upper respiratory infection, unspecified",-
1ED2E813-CDE9-44C0-BD66-727FFE0EFD0F,M54.5,Low back pain,-
3BAAD7FB-0A3C-4738-B085-5433A05E52C6,T88.1,"Other complications following immunization, not elsewhere classified",-
2CA23FB2-2809-4115-AA85-29F5183E8AA5,J22,Unspecified acute lower respiratory infection,-
62BB9795-5256-4286-AD0D-D8A89F2C0B01,R21,Rash and other nonspecific skin eruption,-
85C8AB85-C258-4A35-81F5-35BA7C7D7B42,T88.1,"Other complications following immunization, not elsewhere classified",-
1BD44FF1-81B5-43F5-9F16-048B9FFC9BEF,R51,Headache,-
708DC80A-0667-4D80-B1C9-713327A1CA19,O91.2,Nonpurulent mastitis associated with childbirth,-
BAAFE545-02E2-474A-A0ED-0FA022443770,J06.9,"Acute upper respiratory infection, unspecified",-
3BC49E7D-CFA3-4A19-A677-D121CCE37318,M62.6,Muscle strain,-
EEBCE083-1BC0-43AA-B432-9FE80B11DB91,M54.5,Low back pain,-
C8C4D3AA-FF35-4412-B6E8-585A72C0BB03,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
3EEB7839-F4C8-4AE6-801D-D58BA2FB0604,J06,Acute upper respiratory infections of multiple and unspecified sites,-
7FCD21B4-2371-45B2-B932-143D319348D0,H81.1,Benign paroxysmal vertigo,-
0353234E-A417-48C8-BBCA-CC9B51CB01CD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
72CCEB02-0E1B-4B8B-B1A8-9B1E77D74E64,T88.1,"Other complications following immunization, not elsewhere classified",-
21D2341E-656F-49AE-BF1B-CEA4ED956118,J02,Acute pharyngitis,-
BA3F95F6-8C8C-4451-8606-B92C3E25DDC4,G47,Sleep disorders,-
EB834917-0554-47FB-AC4A-C905B2A8BB83,N94.6,"Dysmenorrhoea, unspecified",-
1C6B22A7-8832-4D0A-80EF-12F977B10538,R10.4,Other and unspecified abdominal pain,-
40311D03-C465-4295-8623-34D423CBA191,R42,Dizziness and giddiness,-
40311D03-C465-4295-8623-34D423CBA191,A09.9,Gastroenteritis and colitis of unspecified origin,-
539EE914-F7A4-41EC-9F40-A03F8EA51279,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
2D7662E2-FA9F-49DE-AC0B-E075CE2D5DF3,J06.9,"Acute upper respiratory infection, unspecified",-
2D7662E2-FA9F-49DE-AC0B-E075CE2D5DF3,R51,Headache,-
B74D4C66-B02F-4078-89E3-630F50320C17,N94.6,"Dysmenorrhoea, unspecified",-
1381E1D0-44C7-439B-964D-8644E1B8D9CB,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
129A9D02-810D-44BE-977A-9D8BA0FD4280,N39.0,"Urinary tract infection, site not specified",-
FE86B9EC-3F00-49DB-B461-F604EBAF2871,Z71.2,Person consulting for explanation of investigation findings,-
26D836A6-C519-4612-8417-6708C8D715DB,A09.9,Gastroenteritis and colitis of unspecified origin,-
3A0F90B6-58E9-4FF7-86AF-CE16C711EB34,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3A0F90B6-58E9-4FF7-86AF-CE16C711EB34,G44.2,Tension-type headache,-
3BFAFA67-EC8E-4C34-A536-363F84C06B3F,T88.1,"Other complications following immunization, not elsewhere classified",-
0918589E-BF07-47DE-8954-CF91A9DB6C8E,M79.1,Myalgia,-
0918589E-BF07-47DE-8954-CF91A9DB6C8E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A69AF790-8783-4ECE-B4C5-F8C463FF3D3C,N39.0,"Urinary tract infection, site not specified",-
D3ACC0DA-021C-41C7-9527-D4E1E36E2B65,A09.9,Gastroenteritis and colitis of unspecified origin,-
DAE4E5E4-0965-4D01-96B9-71DBCDA08379,J06.9,"Acute upper respiratory infection, unspecified",-
DAE4E5E4-0965-4D01-96B9-71DBCDA08379,U07.1,"COVID-19, virus identified",-
53C54F95-8070-45BF-AD04-BAE9BB50664A,M54,Dorsalgia,-
53C54F95-8070-45BF-AD04-BAE9BB50664A,M62.6,Muscle strain,-
0746A230-6C37-4946-A5A2-76809624B949,J06,Acute upper respiratory infections of multiple and unspecified sites,-
EC03F8B2-8998-4646-9C6D-09F49A8C6B09,J06,Acute upper respiratory infections of multiple and unspecified sites,-
842F0FFC-284D-4883-AB10-0365C8C46F0E,E87.5,Hyperkalaemia,-
05E99AE8-68C5-4DB9-9A0B-33EA1A94FBED,N94.6,"Dysmenorrhoea, unspecified",-
F2422A3C-609C-40FC-ABAD-C545FD149E96,T88.1,"Other complications following immunization, not elsewhere classified",-
3E16D7C3-7307-46F1-871E-9623C782EEDC,M79.1,Myalgia,-
DC41AF71-541F-487B-B27E-5C9483FB65B8,L20,Atopic dermatitis,Atopic dermatitis
3A905CAB-4DB4-4708-93AB-BD3139E69C84,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E394EF75-C363-4F50-82C4-4E3D69F7F843,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
B6294C38-A48A-4D8B-9D9A-9E15804754DB,A09.9,Gastroenteritis and colitis of unspecified origin,-
09FB0F20-8D11-4266-8F25-E72299FC5660,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
09FB0F20-8D11-4266-8F25-E72299FC5660,J45,Asthma,Asthma
FF4B5ACB-4011-4264-9C13-090913870706,N39.0,"Urinary tract infection, site not specified",-
A7BC600A-AD55-4E06-905C-B3D65026F80A,K29.7,"Gastritis, unspecified",-
6151B0D7-2CCC-4305-83C9-A43460CB7998,K29.7,"Gastritis, unspecified",-
2F6B1616-1435-4F1A-99D9-F2463F555649,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8CC7AFED-26FF-4E48-9231-616170C23A01,J03.9,"Acute tonsillitis, unspecified",-
87287998-7D63-496B-B132-7E0D8508AFCA,H10.9,"Conjunctivitis, unspecified",-
02AC86DE-9749-453F-B6FC-9AF4301BC02F,H57,Other disorders of eye and adnexa,-
87287998-7D63-496B-B132-7E0D8508AFCA,K12.0,Recurrent oral aphthae,-
02AC86DE-9749-453F-B6FC-9AF4301BC02F,K12.3,Oral mucositis (ulcerative),-
3E341B49-C1D3-4B63-A4A5-1ED9F05383CD,G44,Other headache syndromes,-
02AC86DE-9749-453F-B6FC-9AF4301BC02F,K29.7,"Gastritis, unspecified",-
8E765175-F446-43D4-B1E9-6CB935FD1E7B,J06.9,"Acute upper respiratory infection, unspecified",-
F9CCF2A5-33A7-4B48-9B12-E69656312464,K52,Other noninfective gastroenteritis and colitis,-
F6C4D69C-E022-47C4-BE26-5DC08308B4AC,J06.9,"Acute upper respiratory infection, unspecified",-
F453F649-78AD-49F2-84CE-6B205829B7A9,J06.9,"Acute upper respiratory infection, unspecified",-
BE2980C4-0C05-457D-B18C-0E2D84E9D664,R11,Nausea and vomiting,-
BE2980C4-0C05-457D-B18C-0E2D84E9D664,N94.6,"Dysmenorrhoea, unspecified",-
A5A4710F-B13B-43EF-961E-FCA1FF53194B,T88.1,"Other complications following immunization, not elsewhere classified",-
18CD8F5A-FD15-40CF-8A6C-6D6FC9F3E6EB,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
C40826B7-F949-4979-BC58-1339DC477EBE,N92.6,"Irregular menstruation, unspecified",-
4A7C7BCA-50CD-4EE2-86AB-C1B6CFFF2C71,T88.1,"Other complications following immunization, not elsewhere classified",-
66EAF1F6-9111-4912-B880-EEDC3C597AEF,T88.1,"Other complications following immunization, not elsewhere classified",-
E223AEF6-795F-4901-A904-D0E1A674B1FB,R51,Headache,-
49FB5B02-5732-436A-88AF-519F862B92E0,K29.7,"Gastritis, unspecified",-
9DD563CD-9410-42AC-BDA6-861B5F188435,T88.1,"Other complications following immunization, not elsewhere classified",-
4B4A7710-FDC3-4666-99FF-E95E82DF90B0,R42,Dizziness and giddiness,-
4B4A7710-FDC3-4666-99FF-E95E82DF90B0,K29.7,"Gastritis, unspecified",-
9FED302A-2A8C-40F2-90DD-85883B3200D8,A09.9,Gastroenteritis and colitis of unspecified origin,-
E13E0B5E-4281-403E-82DA-646041D46AC9,R51,Headache,-
BA2F1631-7FD9-47FF-8A2D-FA73F51B45D1,G43,Migraine,Migraine
A71A548B-68BC-4AEB-A82F-7E7BBE22A7B9,Z71.2,Person consulting for explanation of investigation findings,-
E46B0669-497A-4ABA-91A9-B755A588A7AF,S81.0,Open wound of knee,-
E46B0669-497A-4ABA-91A9-B755A588A7AF,N39.0,"Urinary tract infection, site not specified",-
97985C5D-B795-4BA8-84FF-DFD824E1D0E9,R21,Rash and other nonspecific skin eruption,-
97985C5D-B795-4BA8-84FF-DFD824E1D0E9,L02,"Cutaneous abscess, furuncle and carbuncle",-
F354ACA9-1913-44FB-B62C-DFEE941A51FC,G43,Migraine,Migraine
A9D6C4E5-B744-403B-AC94-06645459F093,N39.0,"Urinary tract infection, site not specified",-
35BFFD51-3E67-4D8F-B1BD-01C801EEFADA,B30,Viral conjunctivitis,-
A8B9B553-8670-4197-94D7-553B3387CE3C,R22.9,"Localized swelling, mass and lump, unspecified",-
1AE95FAA-1F2F-44B2-A8E1-7EA3E1F25C18,K29.7,"Gastritis, unspecified",-
B19AC741-F624-4576-8E1B-77F391F89268,T88.1,"Other complications following immunization, not elsewhere classified",-
C1479B4D-7A1C-49F9-B84D-4F419008D7E6,J06.9,"Acute upper respiratory infection, unspecified",-
55A7DE69-DA43-48B1-A382-FA5E67E0B6CF,J06.9,"Acute upper respiratory infection, unspecified",-
97EC93C5-3F69-4AB0-808A-F0CEBBA5AD34,J06.9,"Acute upper respiratory infection, unspecified",-
27B7E2DE-2EC7-4095-91CB-F1CD117A47C4,H81.3,Other peripheral vertigo,-
97EC93C5-3F69-4AB0-808A-F0CEBBA5AD34,H57,Other disorders of eye and adnexa,-
97EC93C5-3F69-4AB0-808A-F0CEBBA5AD34,R42,Dizziness and giddiness,-
FF77D526-EF55-473E-BEEA-EA4D5C81FEBD,M65.4,Radial styloid tenosynovitis [de Quervain],-
D4F94B44-77BE-456A-ACB4-3C08E1B5A8A0,A09.9,Gastroenteritis and colitis of unspecified origin,-
D09D1B55-1631-4E2C-93E4-C6A399C5BBB9,A09.9,Gastroenteritis and colitis of unspecified origin,-
F2041E9C-71F1-43FB-9F4C-71904518F651,T88.1,"Other complications following immunization, not elsewhere classified",-
DC8EC2F2-D555-428A-AAC2-64AA9C64D998,J06.9,"Acute upper respiratory infection, unspecified",-
97A86FAC-CD43-46CF-A1B9-8A8497D49A87,T88.1,"Other complications following immunization, not elsewhere classified",-
C7645624-D8F3-429A-B374-B9A9A168EC61,N94.6,"Dysmenorrhoea, unspecified",-
3B0AA161-8697-4434-91F0-EFE0BA638075,S50.9,"Superficial injury of forearm, unspecified",-
19449C91-50BF-43FE-A47C-06411628CA48,R51,Headache,-
F35F2117-FF91-4368-AAEC-F27A783824EF,R51,Headache,-
E2B23349-E4D0-4951-B9B9-176BE1D64685,R51,Headache,-
9172CF03-E27A-4357-8330-3DFC81786118,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B358A842-43CD-4B2C-A1AB-FD6EA151298D,F38,Other mood [affective] disorders,-
5300281F-AC0E-4ADB-B9A2-03D1ACA96B88,H60,Otitis externa,-
E96482AD-760D-45F3-81BB-5BEA93BB7CEE,T88.1,"Other complications following immunization, not elsewhere classified",-
63953D5E-3AA2-4E83-ABDB-1A5894E6B7DF,J06.9,"Acute upper respiratory infection, unspecified",-
380B1680-998D-4986-B86F-398AB2639E7E,J22,Unspecified acute lower respiratory infection,-
380B1680-998D-4986-B86F-398AB2639E7E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
41BD2F01-2DF5-43DF-A542-E60B4C4A3C5A,J06.9,"Acute upper respiratory infection, unspecified",-
3A7F234F-5A32-4B37-AF0A-F1DC0CC3F238,J06.9,"Acute upper respiratory infection, unspecified",-
5E8897CE-0560-458F-9704-92957FE9F80F,A09.9,Gastroenteritis and colitis of unspecified origin,-
C8569346-2241-444F-80E0-F3270A65FFF5,R21,Rash and other nonspecific skin eruption,-
E56C4991-441F-4F80-AEBC-C52CE08C02A2,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
0B621540-FEDF-42E3-9B96-E81564E869C8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0D21292A-AAAB-4B19-A4F0-9375B69CDC54,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6E0B458D-38F6-4604-AFEC-CED05DF8A4F2,U07.1,"COVID-19, virus identified",-
2D7EAA5A-30AB-484B-8A9F-0F0E1D29E516,Z71.2,Person consulting for explanation of investigation findings,-
46F201BF-D976-49E1-9D1C-62E94865BA43,N94.6,"Dysmenorrhoea, unspecified",-
E6CCCA6F-EE80-4AFB-B8F1-4EA4DA70DF9F,M54.5,Low back pain,-
5701DDEF-0CE7-43BA-92FD-77F24081D4BF,R51,Headache,-
DFFE4119-6B46-46CF-A502-D886A992CF2D,R51,Headache,-
DFFE4119-6B46-46CF-A502-D886A992CF2D,M62.6,Muscle strain,-
55B01C27-F2AE-4EAB-9AB2-1974ABC09E00,J06.9,"Acute upper respiratory infection, unspecified",-
F451FA8C-2E47-4F4D-A937-F9121FC012BC,H10.9,"Conjunctivitis, unspecified",-
655CBC5E-7687-421F-AA51-152901118C91,A09.9,Gastroenteritis and colitis of unspecified origin,-
DC107D0C-9A3A-4C45-BBBA-3175ACA0D1A0,R51,Headache,-
A705A71A-FDB5-49A0-9F1F-875B40BF1351,N76.0,Acute vaginitis,-
8B5AC4B8-DE25-419E-B62D-F70009E5C824,N39.0,"Urinary tract infection, site not specified",-
D4B53D54-8169-41C5-BC48-0D0FDB2457BC,N39.0,"Urinary tract infection, site not specified",-
31E5D60A-13FB-4B1B-B942-B32651E5ED8B,R51,Headache,-
31E5D60A-13FB-4B1B-B942-B32651E5ED8B,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
E97B5760-FFA5-40B4-BFC2-75CF55EE88CC,H00,Hordeolum and chalazion,-
B17062A3-9738-40AB-B091-3F7CBD9B495D,M62.6,Muscle strain,-
D04312B2-7A34-44A6-A3ED-608229FAFA18,U07.1,"COVID-19, virus identified",-
7F3A771D-7819-43A8-9A80-1E68407778AC,R50.9,"Fever, unspecified",-
7F3A771D-7819-43A8-9A80-1E68407778AC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
880FE547-D6C6-4698-BB54-ED072B83EF6D,J06.9,"Acute upper respiratory infection, unspecified",-
42B96EF5-8100-4C40-BDC8-DA0A00D13FBC,N94.4,Primary dysmenorrhoea,-
9DCE25B3-2F06-464F-B96F-B20062D53878,R22.9,"Localized swelling, mass and lump, unspecified",-
4EA50461-1DD5-44BE-A778-8156A8E8A175,J06.9,"Acute upper respiratory infection, unspecified",-
8EB00EFF-8B0C-4AB9-B067-595F265B06A4,T78.4,"Allergy, unspecified",-
8EB00EFF-8B0C-4AB9-B067-595F265B06A4,M54.5,Low back pain,-
8EB00EFF-8B0C-4AB9-B067-595F265B06A4,M62.6,Muscle strain,-
9BB51F9E-3CA0-4773-AC36-E030CAC68BF6,J06.9,"Acute upper respiratory infection, unspecified",-
53CF2DAE-3615-45AD-9EFD-B2763558E1D4,J06.9,"Acute upper respiratory infection, unspecified",-
CD0750C1-9660-4500-BB25-1DE8ED66B445,A09.9,Gastroenteritis and colitis of unspecified origin,-
0F91250A-E95C-4164-B348-E61A48C47336,T88.1,"Other complications following immunization, not elsewhere classified",-
337D9329-C38A-4E29-985A-D1A5DBBEFA97,J02,Acute pharyngitis,-
337D9329-C38A-4E29-985A-D1A5DBBEFA97,J04.0,Acute laryngitis,-
7B949ACA-EA37-4075-87BE-97B10F41A8F6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
53CBB2C4-A4FD-44D1-BDE9-F0C37F48AB65,J06.9,"Acute upper respiratory infection, unspecified",-
9643C73B-C292-44C7-9F08-AC4B79A429F4,J06.9,"Acute upper respiratory infection, unspecified",-
53CBB2C4-A4FD-44D1-BDE9-F0C37F48AB65,J03.9,"Acute tonsillitis, unspecified",-
0850F15F-0DCD-4ED7-ABE8-EB5ABFA2343B,J06,Acute upper respiratory infections of multiple and unspecified sites,-
E135E860-56C0-4F2D-AEC3-194E220D3DA9,R21,Rash and other nonspecific skin eruption,-
B75EAD39-0430-4BFE-861E-569D4CBC87D4,M65.4,Radial styloid tenosynovitis [de Quervain],-
DC13C928-EF47-4BF9-9752-59BA5DA02263,Y42.4,Oral contraceptives,-
40D7299A-CB1F-4694-9220-2D46D121321E,B36.0,Pityriasis versicolor,-
A44EF80D-4AD9-4CC8-BFDA-7D606A74AF25,J03.9,"Acute tonsillitis, unspecified",-
F54E2558-0777-40D4-B79B-A9E6D5DE1650,R51,Headache,-
76D6DC82-6CD5-4015-B9A5-1EABEBCEEC03,J06.9,"Acute upper respiratory infection, unspecified",-
2899EAAA-A246-4B2C-BDCE-F33A25919E1A,J06.9,"Acute upper respiratory infection, unspecified",-
AD017199-5CAC-4548-9AAE-EDD1E8D72CC2,J06.9,"Acute upper respiratory infection, unspecified",-
ACFE07D9-67C2-4FBF-951C-EA6B231112C8,O91.2,Nonpurulent mastitis associated with childbirth,-
9A87F943-011E-4920-BAA9-D33E186865DD,A09.9,Gastroenteritis and colitis of unspecified origin,-
1D40F8E7-9341-4BCA-83A3-D789CE506C46,A09.9,Gastroenteritis and colitis of unspecified origin,-
DDE08E88-4AC8-4311-9221-C382881AA389,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D21C0598-EC42-465C-A443-0A5556810C28,A09.9,Gastroenteritis and colitis of unspecified origin,-
FEB4D24B-833E-4E57-A467-5281FD3F825F,M54.5,Low back pain,-
5A6F8DE1-9F1A-40C4-9CCA-E642E2351312,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
E0660C67-64DD-4F9E-8CB7-A66CA1508C6C,R51,Headache,-
965A6406-D001-4DF9-924B-94FB159602BC,T88.1,"Other complications following immunization, not elsewhere classified",-
63C7F14E-7828-43BC-B356-33812A681127,U08,Personal history of COVID-19,-
97B1104E-397E-41AD-AC2B-C9053649B742,N94.6,"Dysmenorrhoea, unspecified",-
5C12F86A-7A48-4B1C-8390-3F0A52D1E27A,A09.9,Gastroenteritis and colitis of unspecified origin,-
5D75C684-89F5-472B-9DFD-2BD631A9CCCF,A09.9,Gastroenteritis and colitis of unspecified origin,-
DCA98954-BA63-4240-ABDB-8B2269196F78,H57,Other disorders of eye and adnexa,-
31834470-A7D2-4566-9F1E-3C3E625ECFE0,H81.1,Benign paroxysmal vertigo,-
DCA98954-BA63-4240-ABDB-8B2269196F78,B30,Viral conjunctivitis,-
B375231B-E1BC-4DA5-8187-32E84FEB430F,K58,Irritable bowel syndrome,-
C54608D4-03CD-4B71-B6E7-095B110BFF49,H00,Hordeolum and chalazion,-
66EF228F-5E7A-4522-9492-0DEE05C2FE62,R42,Dizziness and giddiness,-
66EF228F-5E7A-4522-9492-0DEE05C2FE62,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
D139211D-2FA4-4E42-B287-73FE47185FCD,J06.9,"Acute upper respiratory infection, unspecified",-
9C7F0D64-0677-4991-9A9D-35E5D8F35753,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F4BBBBBA-6E18-4AE4-AFFB-162D7137EA5C,A09.9,Gastroenteritis and colitis of unspecified origin,-
05C35341-7850-464C-B566-D864B21E61B6,T88.1,"Other complications following immunization, not elsewhere classified",-
4FD152A0-CD03-44E8-8FA5-527A6598A010,I10,Essential (primary) hypertension,Hypertension
4FD152A0-CD03-44E8-8FA5-527A6598A010,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
4FD152A0-CD03-44E8-8FA5-527A6598A010,J33,Nasal polyp,-
0375658F-4443-4A1B-8240-49D305946268,J06.9,"Acute upper respiratory infection, unspecified",-
DFBEC9D2-BD3B-4530-95A7-3B4F7981A9AF,J06.9,"Acute upper respiratory infection, unspecified",-
A3C63219-A7E9-41DD-B97D-FD6C15E72A2D,J06.9,"Acute upper respiratory infection, unspecified",-
262525B7-BC4B-446A-A165-D0C55757B79B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1F24187D-4358-445E-AAED-D172F5CFD857,N76.0,Acute vaginitis,-
84B869FE-E216-4858-952D-F1D8AD45CE4D,T88.1,"Other complications following immunization, not elsewhere classified",-
9A8E3397-7C45-471D-87B2-6B38835E64BC,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
E45F198F-D830-4190-B264-9223D119C2D8,R51,Headache,-
E3C33C49-D2E3-4D3A-A2D9-532285BAC41F,A09.9,Gastroenteritis and colitis of unspecified origin,-
E3C33C49-D2E3-4D3A-A2D9-532285BAC41F,K29.7,"Gastritis, unspecified",-
9D70D964-4927-477F-A76C-36F63E6DCA58,R51,Headache,-
A7C732B5-9FE7-498A-ACE9-3371CF3D1F50,K13,Other diseases of lip and oral mucosa,-
A7C732B5-9FE7-498A-ACE9-3371CF3D1F50,A09.9,Gastroenteritis and colitis of unspecified origin,-
190B385E-8AE5-4E62-8DFB-212CC2CD2DD9,Z71.2,Person consulting for explanation of investigation findings,-
7B176C8F-DAE6-4195-91A7-5774A611C32C,Z71.2,Person consulting for explanation of investigation findings,-
819EA464-04BD-450B-830E-0A97C71BF0A5,J06.9,"Acute upper respiratory infection, unspecified",-
66814612-F140-4B09-B494-7CD2CB6BCBF9,J06.9,"Acute upper respiratory infection, unspecified",-
A32FF2C9-5011-432C-B5AA-8386FCD84D6A,M79.1,Myalgia,-
A32FF2C9-5011-432C-B5AA-8386FCD84D6A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
30018DE7-BD6C-4407-9B4B-4EC6FEDFD052,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F2E86BD1-3E84-49A9-9EEB-6DE966A106AF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
525A6756-6118-4100-9FF2-0CF5012DA1CB,M54.2,Cervicalgia,-
6B35CD71-60F4-40D1-86F0-EB90943080B0,R51,Headache,-
D8C9ADD1-8D4A-4AC0-B00F-FED058AF5DE6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9208A333-F96B-4915-AF8D-73740056F3FA,K62,Other diseases of anus and rectum,-
62782E0F-3AE1-4BA5-BE57-3996D18D3646,R50.9,"Fever, unspecified",-
21E62941-BD3D-4C96-976A-6CE13926BB3F,H81.1,Benign paroxysmal vertigo,-
DE27EB17-E881-4087-ACAC-3C3B439CF541,N94.6,"Dysmenorrhoea, unspecified",-
DE27EB17-E881-4087-ACAC-3C3B439CF541,A09.9,Gastroenteritis and colitis of unspecified origin,-
3040E984-14DB-4318-B447-B7CE32EEAED7,N39.0,"Urinary tract infection, site not specified",-
21F431B2-B1E3-47B7-AF22-F77D36FF4D7B,R51,Headache,-
4CBF707E-365A-412A-A19B-4830857FF580,R51,Headache,-
2E32207F-7517-4709-8F1C-0797FBB4F225,A09.9,Gastroenteritis and colitis of unspecified origin,-
D8646DB5-9327-41B4-891F-314C7A8FDDD1,A09.9,Gastroenteritis and colitis of unspecified origin,-
4D944980-4477-4FA0-BEFC-58711D560034,A09.9,Gastroenteritis and colitis of unspecified origin,-
B5323080-870C-4C46-AD67-19D4230BFB24,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
FB5C2763-A782-4738-A974-94F261A7F0F9,F41.9,"Anxiety disorder, unspecified",-
FB5C2763-A782-4738-A974-94F261A7F0F9,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
EB2493D8-2E4B-48FB-9FE0-48A037FFD101,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
5B2D34B8-4785-430E-95FC-BA6586D2830B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1ACE37B7-1F42-44BC-A57A-63722E79E3E0,J06,Acute upper respiratory infections of multiple and unspecified sites,-
C4E4A4A1-724A-4C32-BCCB-526E7BE68085,A09.9,Gastroenteritis and colitis of unspecified origin,-
CE492253-290C-4F17-A5DE-2AF5C77CDA26,M54,Dorsalgia,-
009C222C-1A48-44E3-9045-AAF8101C8F54,M54.5,Low back pain,-
CC075F45-21A8-4B01-AACE-B75847AC2EA1,S70.8,Other superficial injuries of hip and thigh,-
2E2C8893-C459-4C37-A833-316FC967CA52,Z71.2,Person consulting for explanation of investigation findings,-
329A32EF-B56E-48D5-96C5-D0F89D398A39,Z71.2,Person consulting for explanation of investigation findings,-
D5C288C1-4D86-46A7-892E-0EBDFC6380D7,R94.5,Abnormal results of liver function studies,-
D5C288C1-4D86-46A7-892E-0EBDFC6380D7,I10,Essential (primary) hypertension,Hypertension
84D8A93B-87F7-4B4A-ADA3-A26E7D6B2322,A09.9,Gastroenteritis and colitis of unspecified origin,-
84D8A93B-87F7-4B4A-ADA3-A26E7D6B2322,R50.9,"Fever, unspecified",-
10CA1A56-E716-4689-ACD4-60A2BBBCCB85,H10.9,"Conjunctivitis, unspecified",-
6709825C-AA9B-4F75-A867-3F8966B78681,R51,Headache,-
6709825C-AA9B-4F75-A867-3F8966B78681,N94.6,"Dysmenorrhoea, unspecified",-
98C3B31A-6064-41CD-BC20-CB81302299A4,R51,Headache,-
C5F6E15D-D2CE-43EB-807E-2D0BEE833F63,A09.9,Gastroenteritis and colitis of unspecified origin,-
D5970E91-6D63-4D5A-98F2-CBC6212FA09D,R51,Headache,-
D9039C81-68E9-4805-ABBF-01CF09727ABF,R50.9,"Fever, unspecified",-
D9039C81-68E9-4805-ABBF-01CF09727ABF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F1E0A04D-4C20-40F7-9262-A36FD44050A4,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
04DD3962-0C4A-4B4B-883D-6F8719368EA4,T88.1,"Other complications following immunization, not elsewhere classified",-
1FA9F755-A7C7-4668-ADB4-BC2C1C82E9C8,L70,Acne,-
76B133D0-D590-4579-A913-E68C9C63305A,K29.7,"Gastritis, unspecified",-
EC6DECE2-4D38-425A-BB15-4865B3E5677F,J06.9,"Acute upper respiratory infection, unspecified",-
349C1F33-D5C0-4342-8820-8540373BA175,J06.9,"Acute upper respiratory infection, unspecified",-
F4E08ACC-2605-44F0-B45A-DC44240D1C10,J06.9,"Acute upper respiratory infection, unspecified",-
A74EE776-F83A-4CB9-9C69-1AB49D8E605A,J06.9,"Acute upper respiratory infection, unspecified",-
98117718-D9FE-4BCD-92D4-55A1013D3C5F,U07.1,"COVID-19, virus identified",-
98117718-D9FE-4BCD-92D4-55A1013D3C5F,J06.9,"Acute upper respiratory infection, unspecified",-
A74EE776-F83A-4CB9-9C69-1AB49D8E605A,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
98C8199F-4C03-4DDC-8ED0-CB4FBC16A297,R53,Malaise and fatigue,-
DCE38761-0F1B-4235-B808-59E1C323827F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DCE38761-0F1B-4235-B808-59E1C323827F,J06.9,"Acute upper respiratory infection, unspecified",-
4AEA19BE-E82D-4F92-A898-2F8C6E922B76,N39.0,"Urinary tract infection, site not specified",-
A8E03C35-81A9-4709-BA63-002ED85D86BA,J06.9,"Acute upper respiratory infection, unspecified",-
AEA0CA7D-B14B-4070-A786-FC7C69BF46D5,J06.9,"Acute upper respiratory infection, unspecified",-
E303EA2F-36E6-4D5A-9569-5D87CB2934F4,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
44BAEE2A-A88D-4928-8F2F-FCFD7AF5FBD1,N94.6,"Dysmenorrhoea, unspecified",-
BDCB1D5E-9FB1-4CC4-A882-37DE87AE1B5B,M79.1,Myalgia,-
BDCB1D5E-9FB1-4CC4-A882-37DE87AE1B5B,H57.9,"Disorder of eye and adnexa, unspecified",-
EC508898-5691-414E-9356-DB745582078A,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
D8AC6B11-8EC8-4636-B603-CEBB31E5BDC2,R51,Headache,-
A245CE1A-1D57-4716-AE5A-3DDF296F1D95,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
AC124D08-98C1-4941-87EC-B1044A4F1CFE,I10,Essential (primary) hypertension,Hypertension
8D3A87A8-EB51-4976-88D4-36D5F6C8B3ED,M62.6,Muscle strain,-
B90F53C7-D15D-4DB5-A3D2-DCC27593C04C,P39.0,Neonatal infective mastitis,-
5AC2C2B7-FF7B-401B-80AD-2984295B2789,Z76.0,Issue of repeat prescription,-
AB3AC5F8-411C-45F9-AA13-FDD60F8AF2CC,J06.9,"Acute upper respiratory infection, unspecified",-
594599FB-3793-495C-B574-22EE9ED77A19,U07.1,"COVID-19, virus identified",-
3D1E1E0C-88C7-473C-97CC-2BCF8371ADA1,K30,Functional dyspepsia,-
5ED4C89F-0E87-4414-B971-4D54EDDC16EB,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
5ED4C89F-0E87-4414-B971-4D54EDDC16EB,T88.1,"Other complications following immunization, not elsewhere classified",-
3C4CB693-75AC-44A7-B2A4-4C04F1449AA6,T88.1,"Other complications following immunization, not elsewhere classified",-
821305AC-6F50-4E5B-A966-8A6C2A25E12C,M79.1,Myalgia,-
821305AC-6F50-4E5B-A966-8A6C2A25E12C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6E57A9B1-7203-48B7-BFB7-B952970A262E,K06.2,Gingival and edentulous alveolar ridge lesions associated with trauma,-
2D405E64-5329-4A12-B5EE-328D23AAA7E4,J06.9,"Acute upper respiratory infection, unspecified",-
DD765421-4657-4317-8702-58D8B45DD2D3,R21,Rash and other nonspecific skin eruption,-
FC0131ED-08FC-40D9-BAD8-D3A8B3719AA1,T88.1,"Other complications following immunization, not elsewhere classified",-
344C960E-F20E-430B-93AD-441F60F91CFC,R21,Rash and other nonspecific skin eruption,-
344C960E-F20E-430B-93AD-441F60F91CFC,L50.9,"Urticaria, unspecified",-
360A037E-B2EF-4E9D-86E5-E3A2F7290769,R51,Headache,-
30E4EC81-DE80-4864-97B4-617EF0206F4D,J06.9,"Acute upper respiratory infection, unspecified",-
78062CD5-B455-4FFB-9311-615F5B4B0D94,J01,Acute sinusitis,-
78062CD5-B455-4FFB-9311-615F5B4B0D94,Z76.0,Issue of repeat prescription,-
AE95FD8B-EBF2-4B67-806F-14D8BE13847E,B02,Zoster [herpes zoster],-
FA997872-993F-4957-967B-7061C9A5D4E6,B02,Zoster [herpes zoster],-
AE95FD8B-EBF2-4B67-806F-14D8BE13847E,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
0F41F6E9-6725-407D-AD9C-FD9A2F170EBD,T63.6,Toxic effect: Toxic effect of contact with other marine animals,-
DE61B542-A6B6-4872-8EEE-2551B0E75DDD,H81.3,Other peripheral vertigo,-
E8E3AEC7-E7BC-4D72-88E9-9EFE48219ACB,A09.9,Gastroenteritis and colitis of unspecified origin,-
16605DE5-3863-4B3C-B3D2-33E113E4C290,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
D756D6F2-2888-46B2-A6F3-82271E75593B,T88.1,"Other complications following immunization, not elsewhere classified",-
8E451EE1-ADE6-47E8-B477-17A173563FC0,A09.9,Gastroenteritis and colitis of unspecified origin,-
237A0B3F-2DE6-4C57-BAA9-32669EF831F2,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
2249719A-817B-406B-92B8-AE348F7F90D3,A09.9,Gastroenteritis and colitis of unspecified origin,-
CDE7E7D0-6018-41AD-8B6E-7C7D6FA9EE88,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CDE7E7D0-6018-41AD-8B6E-7C7D6FA9EE88,L70,Acne,-
536E58E7-C357-4DED-9734-B472ED6F63CA,T88.1,"Other complications following immunization, not elsewhere classified",-
375C7AC5-F7B7-4788-ABF2-D1635BBCD006,K59.1,Functional diarrhoea,-
B1407678-8FF4-4F58-AF0A-FCE8E8E9C707,R31,Unspecified haematuria,-
E83EF8A8-D63C-40FB-BA7F-24F9132FA7A9,R51,Headache,-
5F0BBAEB-4E1C-4213-B418-3C6AE0ABC68D,A09.9,Gastroenteritis and colitis of unspecified origin,-
9B6F2DFC-F04B-4279-84E7-59CEA7C2F1AF,A09.9,Gastroenteritis and colitis of unspecified origin,-
3E04FA68-8A3C-48B8-BBB8-58CB7547F444,N64,Other disorders of breast,-
ABEE7619-AEB3-4E90-86EF-A4A8875AB89B,R51,Headache,-
E1D93C2F-7B16-435C-BEA8-0DDB748126AD,A09.9,Gastroenteritis and colitis of unspecified origin,-
B4F89089-5104-4F10-8470-5168CB021934,H11.3,Conjunctival haemorrhage,-
CE6F2AA6-92F3-418B-9059-E571C0DD1689,R21,Rash and other nonspecific skin eruption,-
2150C7D4-7700-4173-830C-18162B1DD44E,M54.5,Low back pain,-
4D45B153-6D16-4102-914F-A7BAF5411C9B,M62.6,Muscle strain,-
FD2DEF7A-E103-45D2-B1B2-F0D0FD1B29A6,J06.9,"Acute upper respiratory infection, unspecified",-
45727B6A-891D-49D0-81E7-0BBAC9CF2796,H10.1,Acute atopic conjunctivitis,-
41548FEC-CA27-4C88-AE2F-200E8FB1C61C,J06,Acute upper respiratory infections of multiple and unspecified sites,-
EE7036F0-7A5C-4725-AC80-12A0CA0EE6AA,L50,Urticaria,-
D12F42B8-6073-4CA3-A865-019C5538F7A4,N94.6,"Dysmenorrhoea, unspecified",-
747CFC4E-DE31-4AB4-8AE8-DD68CCDFCF95,N94.6,"Dysmenorrhoea, unspecified",-
DE9DBBC4-6E66-49D7-9C1C-E2DA020BBB01,N91,"Absent, scanty and rare menstruation",-
89BE45E9-F3CA-4325-8944-3D42BE941FC5,K59.1,Functional diarrhoea,-
89BE45E9-F3CA-4325-8944-3D42BE941FC5,A09.9,Gastroenteritis and colitis of unspecified origin,-
6BD92E60-8725-4079-953A-184402F1AF13,K64.9,"Haemorrhoids, unspecified",-
1D6CF5E1-526F-490D-8DAD-6457C37B7736,U07.1,"COVID-19, virus identified",-
8BAAA719-A966-42C5-8C66-CEFF0A54B01B,K30,Functional dyspepsia,-
D604E7D8-42DB-4D33-9D93-3EE3AA7728C9,N94.6,"Dysmenorrhoea, unspecified",-
A0C55FBA-8CBA-4D9A-84D2-F1DB6490E747,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
A0C55FBA-8CBA-4D9A-84D2-F1DB6490E747,G44.2,Tension-type headache,-
A0C55FBA-8CBA-4D9A-84D2-F1DB6490E747,M62.6,Muscle strain,-
7B5CEEA3-ECA1-4D10-AE14-1B7B2444CCE9,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
C1970CF1-1A87-4060-8B95-C05408F88DB1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FEBC6A11-6362-4665-A5AE-6385B673621A,J06.9,"Acute upper respiratory infection, unspecified",-
6A7E1EC8-53FB-4B29-BBFF-4017E9B74E4D,H00,Hordeolum and chalazion,-
E4972F30-6386-497A-B099-9003AA342EF7,U07.1,"COVID-19, virus identified",-
21CD67FB-F34F-4F65-9947-D01547D64978,A09.9,Gastroenteritis and colitis of unspecified origin,-
5941DC68-712E-493A-B3FE-6A7CE03A8246,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
21CD67FB-F34F-4F65-9947-D01547D64978,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
5941DC68-712E-493A-B3FE-6A7CE03A8246,A09.9,Gastroenteritis and colitis of unspecified origin,-
28186842-A062-483C-B834-D0E4E7FCB3FD,T88.1,"Other complications following immunization, not elsewhere classified",-
AB374ABF-77EE-4827-BB03-52A648CD8719,K29.7,"Gastritis, unspecified",-
49EC4EA0-F514-487D-80B7-8454055395F2,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
49EC4EA0-F514-487D-80B7-8454055395F2,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
39619764-0EF3-4826-A349-A840F411F989,R51,Headache,-
EAA16567-B908-4B82-A222-4BC4120A5113,R11,Nausea and vomiting,-
9C3E7BB6-C3F1-4700-A6B1-CB32D5CD9FCA,H01.0,Blepharitis,-
F5EC808F-148E-4722-9664-16F4B9409938,N39.0,"Urinary tract infection, site not specified",-
F5EC808F-148E-4722-9664-16F4B9409938,A09.9,Gastroenteritis and colitis of unspecified origin,-
E68A6205-ACF8-4AC5-927D-FE87BD0CD4BD,H01.0,Blepharitis,-
D27B5087-C029-4DD6-B233-217EFBAD8956,Z71.2,Person consulting for explanation of investigation findings,-
965422FC-6352-4A87-B02C-0FE78B97B0ED,R21,Rash and other nonspecific skin eruption,-
965422FC-6352-4A87-B02C-0FE78B97B0ED,N94.6,"Dysmenorrhoea, unspecified",-
965422FC-6352-4A87-B02C-0FE78B97B0ED,K29.7,"Gastritis, unspecified",-
31383C8E-0A66-4146-9383-FB6CD0D5344F,J06.9,"Acute upper respiratory infection, unspecified",-
7C4F1AF0-A261-442F-BF61-18E35DFA3392,M10,Gout,Gout
FA2AD64A-8B20-4747-A155-E901E8994C55,N92,"Excessive, frequent and irregular menstruation",-
3358F194-FABD-43CA-9D8A-408D25FD0E71,R51,Headache,-
3C350614-4409-4847-A46A-2F624C85346A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3C350614-4409-4847-A46A-2F624C85346A,R50.9,"Fever, unspecified",-
9CB2AD64-16C6-4200-AED7-FE1B5DEEF399,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
ABE5A9D7-B3A4-4DCA-B4F3-483D44916E9E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3B77B277-631A-42C9-B447-13697823EE31,L20,Atopic dermatitis,Atopic dermatitis
C0C283DE-CCB9-4753-BB64-39CED55F4035,R10.4,Other and unspecified abdominal pain,-
63508792-F1B7-4566-976C-57F767F15D31,J06.9,"Acute upper respiratory infection, unspecified",-
F3618424-7CC3-4255-9F80-D1A5D2D56BB5,J30.3,Other allergic rhinitis,Vasomotor and allergic rhinitis
A98165D4-71F4-429B-A497-816A97A057C0,J06.9,"Acute upper respiratory infection, unspecified",-
CEE4AEA8-F7E8-4209-BB2B-FA734E3D969A,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
2FEA8D75-A19A-4062-A8DB-F48FB12C2829,M62.6,Muscle strain,-
2FEA8D75-A19A-4062-A8DB-F48FB12C2829,R21,Rash and other nonspecific skin eruption,-
59828829-1A66-4B6D-980A-D5CC4C7F7970,G44,Other headache syndromes,-
698F4F73-4051-487E-9665-52C341DDE560,J06.9,"Acute upper respiratory infection, unspecified",-
643B54FF-A5D1-4B5F-8DDE-D083A1E11438,T88.1,"Other complications following immunization, not elsewhere classified",-
842DEF01-E16E-4794-A937-998AAEB2B683,K30,Functional dyspepsia,-
C3D75086-74D8-4FF1-9831-804CDCD34695,R51,Headache,-
8F8F499A-6DD8-428D-AC80-9BB8D794AB84,N94.6,"Dysmenorrhoea, unspecified",-
C3D75086-74D8-4FF1-9831-804CDCD34695,H01.0,Blepharitis,-
02B01484-975F-4B69-862A-C62AF62333B9,R51,Headache,-
8F7CA63A-8EC7-4F70-A735-247084DA0B7F,J06,Acute upper respiratory infections of multiple and unspecified sites,-
74D0DE6D-85E7-475F-9E69-1409FA283227,J06,Acute upper respiratory infections of multiple and unspecified sites,-
2C8C7C83-EFA0-43EA-8A6E-0DEA882A7396,J06.9,"Acute upper respiratory infection, unspecified",-
3C0E9C6D-3855-4A99-AF0B-9D8CAC416630,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3C0E9C6D-3855-4A99-AF0B-9D8CAC416630,R50.9,"Fever, unspecified",-
4D9F92A4-16A7-49BC-8E1E-32DD5F6B6345,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B021BA56-A0D6-493C-A26B-DF0492BEB729,J06.9,"Acute upper respiratory infection, unspecified",-
68B655B1-0C90-466A-80BE-0D2232E7C571,K30,Functional dyspepsia,-
20418E39-FE75-4278-ACB6-801D1E666DF6,Y42.4,Oral contraceptives,-
BAF2BE45-9F7C-4BA5-BFF4-85AA63893415,R51,Headache,-
1FFD0949-967B-42E6-A0F0-572FAF0E32AF,R21,Rash and other nonspecific skin eruption,-
39F7BA0C-63BB-4754-A428-7F950BFC814F,K29.7,"Gastritis, unspecified",-
ED848515-3A51-4641-90AE-3E21AB454720,A09.9,Gastroenteritis and colitis of unspecified origin,-
0F2C5888-17D3-4F0E-B719-15E6223B24D1,J06.9,"Acute upper respiratory infection, unspecified",-
443633B0-1E8D-480C-8789-AE7449B3B38E,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
CB642324-053F-424C-8393-2E91C367B36A,N94.4,Primary dysmenorrhoea,-
A62B2732-9096-4CD0-B797-5AFF3BB5BEAC,J06.9,"Acute upper respiratory infection, unspecified",-
8160395F-C38D-42E7-81C7-7C3BEB339C26,J06.9,"Acute upper respiratory infection, unspecified",-
7C0AED77-BCB2-4BBB-930E-5B2543637E69,M54.5,Low back pain,-
C5620A63-76D3-449C-8D23-6634D84162AD,R21,Rash and other nonspecific skin eruption,-
385C14DE-0658-4244-8D26-7BBDCD801F75,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C5620A63-76D3-449C-8D23-6634D84162AD,N94.6,"Dysmenorrhoea, unspecified",-
C5620A63-76D3-449C-8D23-6634D84162AD,A09.9,Gastroenteritis and colitis of unspecified origin,-
2D639588-107D-423B-B5F9-25C9412E18DD,M65.4,Radial styloid tenosynovitis [de Quervain],-
320CFCF8-4DB2-465D-8B91-E2F4F9AF041E,J06.9,"Acute upper respiratory infection, unspecified",-
2BC8674A-FF39-4920-A450-72814EE99E04,A09.9,Gastroenteritis and colitis of unspecified origin,-
29EF70BF-9148-40F5-845C-CCD3AFF9DC0C,T88.1,"Other complications following immunization, not elsewhere classified",-
CF6ED8B3-4D35-4E4C-9E07-E93F5E56A4C1,T88.1,"Other complications following immunization, not elsewhere classified",-
CF6ED8B3-4D35-4E4C-9E07-E93F5E56A4C1,M79.1,Myalgia,-
954F5858-B941-4DAE-B881-144CBD639EAB,M79.1,Myalgia,-
954F5858-B941-4DAE-B881-144CBD639EAB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6B8201D9-7F95-46A9-9054-DCEBD2DF3C57,N94.9,Unspecified condition associated with female genital organs and menstrual cycle,-
DF7FFE8D-9108-49CA-BABD-51E87B4CED49,J06.9,"Acute upper respiratory infection, unspecified",-
D97AE3BC-2CE2-4260-8C73-871B1C7AF015,M25.5,Pain in joint,-
582E516C-8654-4876-98DC-8CA03A8E87C7,A09.9,Gastroenteritis and colitis of unspecified origin,-
3C0C9630-791F-4FB3-918C-B59DEE2D5A12,M79.1,Myalgia,-
31E454AD-BFD9-4526-9657-ABEBFE9C671C,A09.9,Gastroenteritis and colitis of unspecified origin,-
E0DF94A4-A053-4C0D-87EE-27DDE11DDB20,K58,Irritable bowel syndrome,-
ED65E9DD-024D-4C0D-912D-7101820914F5,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
20D8B95C-05A4-4178-A96D-86DE96AF7BF4,S93,"Dislocation, sprain and strain of joints and ligaments at ankle and foot level",-
9283B4F7-DFDF-48DC-863D-6E9FE7B7CDCD,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
4DF97674-32A6-4579-813D-19346DB233E4,J03.9,"Acute tonsillitis, unspecified",-
801E64CF-89C6-4766-BC22-512CB7217033,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
B66A01A1-0403-4E62-8D03-E10FAC1C3383,R51,Headache,-
AA4A603D-7B59-4726-A8DC-7B4558F3B95C,I10,Essential (primary) hypertension,Hypertension
9D407E89-A9F7-4575-A570-17DEEF6B33CA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E7C4D25B-3EB2-44A4-8439-BEA197AC3AF0,B37,Candidiasis,-
D94FA331-FE76-4553-A024-7395C659D12F,R50.9,"Fever, unspecified",-
D94FA331-FE76-4553-A024-7395C659D12F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F4E0E2E3-A715-476F-B498-E26AB05075B5,N94.6,"Dysmenorrhoea, unspecified",-
20C19CA1-661B-4058-9675-CC6B0D677C83,M62.6,Muscle strain,-
20C19CA1-661B-4058-9675-CC6B0D677C83,H57,Other disorders of eye and adnexa,-
0423C18A-6161-40E7-9D5C-5C79F8F780E5,N94.6,"Dysmenorrhoea, unspecified",-
6C809237-F761-4B75-9A8C-355FC0663413,R50.9,"Fever, unspecified",-
6C809237-F761-4B75-9A8C-355FC0663413,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
39A78DB4-8C22-4F46-B24F-D233FD144E37,T88.1,"Other complications following immunization, not elsewhere classified",-
A31F0783-0CDE-4C20-BC61-30B435A69CF2,S05.0,Injury of conjunctiva and corneal abrasion without mention of foreign body,-
A31F0783-0CDE-4C20-BC61-30B435A69CF2,S61,Open wound of wrist and hand,-
39427ACD-372D-4FE0-9B86-A7DF8A169489,J02,Acute pharyngitis,-
CF59201E-F63D-4C82-B9D9-6192E9F4A1E0,R73,Elevated blood glucose level,-
32DE773F-9459-4BB0-92B0-B9A421AF871C,Z71.2,Person consulting for explanation of investigation findings,-
120867EF-C21E-4272-9BCA-5F5F40A2DD00,B35.1,Tinea unguium,-
120867EF-C21E-4272-9BCA-5F5F40A2DD00,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
120867EF-C21E-4272-9BCA-5F5F40A2DD00,I10,Essential (primary) hypertension,Hypertension
DE34C68F-0D88-4972-842C-1F6DF806E6D8,K30,Functional dyspepsia,-
CA3A3877-8DA7-4C9D-BB10-B8B2C7EE3CD6,M54.5,Low back pain,-
FDFBECDD-4059-415A-8E1E-F934A2EEF642,M54.5,Low back pain,-
CC4E495B-C6B0-4606-90FE-5F0954D0BE54,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
FDFBECDD-4059-415A-8E1E-F934A2EEF642,R51,Headache,-
0AE109A1-D7E0-4067-96E2-92EECD58700B,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
CA3A3877-8DA7-4C9D-BB10-B8B2C7EE3CD6,R51,Headache,-
BEA621D2-3D82-41DB-B217-FB8F6E48A50C,M54.5,Low back pain,-
BE85FCD2-6F74-4299-8E71-46AC3A470FBC,K30,Functional dyspepsia,-
DDE8C83C-6A80-4CA7-B3CF-E7C7B03E9384,K12.1,Other forms of stomatitis,-
E72FB031-D053-4194-B5D3-8EF40F9D4BF4,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
05D448FA-2CBA-449C-A77E-94F80FCB803A,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
E72FB031-D053-4194-B5D3-8EF40F9D4BF4,J34.0,"Abscess, furuncle and carbuncle of nose",-
8B4942B5-FF4B-4D06-B587-C3982E694E64,Z76.8,Persons encountering health services in other specified circumstances,-
F492C33C-A0FB-4D89-897E-B81D4427EAF0,J06.9,"Acute upper respiratory infection, unspecified",-
D46077DB-610E-4C00-A741-F3BDCEA0CBF7,A09.9,Gastroenteritis and colitis of unspecified origin,-
4A9EF522-34FF-4C22-9CFC-0D8A8D1DD3D3,L30.9,"Dermatitis, unspecified",-
3CA4ED02-25F1-4CCF-BE0C-75B334B107C6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
446335C4-50CF-458D-9EA9-AE3E9661FA2E,S82.9,"Fracture of lower leg, part unspecified",-
8997E9B2-60D5-4915-8A47-D86D242D1C65,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
352D110E-6784-43FA-BA3A-E7588A56967F,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
352D110E-6784-43FA-BA3A-E7588A56967F,J06,Acute upper respiratory infections of multiple and unspecified sites,-
8F048807-3AD4-4C0B-BE27-410602456CDE,K30,Functional dyspepsia,-
273D6789-9871-42AB-9B75-72E17D43A00B,K30,Functional dyspepsia,-
54978691-9157-4C46-BD52-5497AE3E8C22,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
197D06D2-052E-4949-AAF0-0A2524655C4B,H57,Other disorders of eye and adnexa,-
197D06D2-052E-4949-AAF0-0A2524655C4B,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
197D06D2-052E-4949-AAF0-0A2524655C4B,K29.7,"Gastritis, unspecified",-
31940839-5BFE-4FEC-A7BF-3527499426B7,N39.0,"Urinary tract infection, site not specified",-
2F05032D-B4F0-494A-82FA-2E74FB95B3CF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
AF85CDB1-7568-4821-B029-0037A2A01934,R21,Rash and other nonspecific skin eruption,-
274237DD-4F46-48A1-A431-F7767B129F43,R51,Headache,-
274237DD-4F46-48A1-A431-F7767B129F43,T88.1,"Other complications following immunization, not elsewhere classified",-
9D90BDA4-344A-4290-9424-8E7D742F849E,A09.9,Gastroenteritis and colitis of unspecified origin,-
C86BD7FA-CB6C-43CB-BEDC-93E2D78DFE3D,R51,Headache,-
D3D63C7E-B24C-4560-A75A-6E71F5A8B7BF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B80502A3-C1AB-4B3E-B1EA-E29B755EA9B2,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
9B12CDB9-726D-4596-B93B-19E76370BB3F,T88.1,"Other complications following immunization, not elsewhere classified",-
AC4431B6-406F-485F-88C0-EDAD0E1C4612,A09.9,Gastroenteritis and colitis of unspecified origin,-
CE4E0430-044B-4BAA-8B06-AEB49DE19A14,U07.1,"COVID-19, virus identified",-
C4825319-66CA-4AB4-B677-86B7FEFABFBF,J06.9,"Acute upper respiratory infection, unspecified",-
BCF4145C-302B-4E42-BC0D-14B40C40FF0D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A59F6667-2A37-4D9B-BD42-DEB1A0142E29,A09.9,Gastroenteritis and colitis of unspecified origin,-
5A3A97B5-5145-4D35-BAB6-BB7623131BFF,L70,Acne,-
5A3A97B5-5145-4D35-BAB6-BB7623131BFF,T24.2,"Burn of second degree of hip and lower limb, except ankle and foot",-
D6B4FC1A-E82C-46BC-BAE2-8C2DE94AB9D0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
99B68033-4583-4999-BF24-5FDBB36105C5,R51,Headache,-
89377489-5B61-4FA4-B064-2684E740639F,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
CEAA3C87-69BB-40CE-9534-9DF29F425FDB,G44,Other headache syndromes,-
B65B0E7B-67CA-43DC-BF5F-EAC1E8AA9F15,R51,Headache,-
A30F4838-F512-4D62-A4C9-9744CC712E8C,N92.6,"Irregular menstruation, unspecified",-
182950AB-A8AB-4D38-AD13-2A1BFBE179A9,T88.1,"Other complications following immunization, not elsewhere classified",-
910FBF80-C173-4BFC-9A90-FF200E24B5DE,K07.6,Temporomandibular joint disorders,-
7001458F-F9E9-42A4-A8A2-A0F483836FC8,K07.6,Temporomandibular joint disorders,-
88D43BA6-0561-4E6A-8591-D5454EEAF92A,J06,Acute upper respiratory infections of multiple and unspecified sites,-
69E783B2-8339-4140-A985-CBC23F72203E,H00,Hordeolum and chalazion,-
0125DEE5-68D1-437E-A512-C52165BB04A2,G43,Migraine,Migraine
2D9FC1ED-A25F-43F4-8542-B5BAB7AE5FBB,J03,Acute tonsillitis,-
92EE0BB8-F2FE-4B66-A479-80375A8E6DA0,J06,Acute upper respiratory infections of multiple and unspecified sites,-
FCE1044A-C32D-44AD-BAFC-8986366CF3A1,U07.1,"COVID-19, virus identified",-
9037DA14-AE28-4A49-AD08-CE06EC7D6BF8,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
0A9D7A1F-3672-49A7-92FE-B1BD49CF1CB0,L20,Atopic dermatitis,Atopic dermatitis
0A9D7A1F-3672-49A7-92FE-B1BD49CF1CB0,J06.9,"Acute upper respiratory infection, unspecified",-
56EB4213-283F-487B-AE9B-7796EE83039E,R42,Dizziness and giddiness,-
43D82B1F-C7AC-4268-ADB7-70FA7D11727D,A09.9,Gastroenteritis and colitis of unspecified origin,-
AE1A045C-E57F-4DA3-8D8F-8EE0BA333302,M77.1,Lateral epicondylitis,-
157AD5B1-E89C-443E-8341-E3589C300ED4,I10,Essential (primary) hypertension,Hypertension
157AD5B1-E89C-443E-8341-E3589C300ED4,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
8B245FBF-D327-4DF2-BD18-F4C8334F92C2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7EEF6115-32A1-49CF-B516-8B71C1D05570,A09.9,Gastroenteritis and colitis of unspecified origin,-
1F2925BB-3EF0-4F94-954F-ED0E681B4C49,R50.9,"Fever, unspecified",-
1F2925BB-3EF0-4F94-954F-ED0E681B4C49,J06.9,"Acute upper respiratory infection, unspecified",-
0F3A1343-D04F-455E-B5A2-1F3BECD69EEE,N94.6,"Dysmenorrhoea, unspecified",-
F663BE45-6ED8-433A-8B0B-A5B82DCC1E30,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
C7C2382A-D6D7-428B-942F-7E494BDCF10A,R51,Headache,-
45427297-1013-439C-87CA-FD5E464FC639,L30.9,"Dermatitis, unspecified",-
E84BAB7B-A308-4B5A-AD09-5BEC5588510E,S81,Open wound of lower leg,-
CE8EBC6F-B8C3-4A78-8EDD-78A27D5EF68F,R51,Headache,-
67B60556-77B3-4AC7-8198-78AC423E6393,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D4A07603-B04C-4346-B0AC-85827E225FFC,J06.9,"Acute upper respiratory infection, unspecified",-
A11208B8-8CCC-4E79-84F2-2D265D66FF49,J06.9,"Acute upper respiratory infection, unspecified",-
0394EEF0-FCF9-485E-9E13-9FEBA1DEC30E,J06.9,"Acute upper respiratory infection, unspecified",-
3DEC1DB9-1F95-4700-AD42-E601F26223B8,R51,Headache,-
D9582BB0-EBAF-452B-9C14-D6773603BD38,S93.4,Sprain and strain of ankle,-
B93B0B96-7043-4849-8804-4EA927FFE95B,M76.6,Achilles tendinitis,-
B93B0B96-7043-4849-8804-4EA927FFE95B,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
B93B0B96-7043-4849-8804-4EA927FFE95B,K12.0,Recurrent oral aphthae,-
EF02AEE0-65CF-4097-9403-DEBF66C56CCF,R51,Headache,-
C5BF7950-50E1-442B-B453-1D6A3B12BDEA,A09.9,Gastroenteritis and colitis of unspecified origin,-
F991833E-9C5E-40DC-8CE7-147599F07DFB,J06.9,"Acute upper respiratory infection, unspecified",-
72EB45EC-9517-4CD6-87B6-3CC49D87F35D,M25.5,Pain in joint,-
72EB45EC-9517-4CD6-87B6-3CC49D87F35D,J06.9,"Acute upper respiratory infection, unspecified",-
72EB45EC-9517-4CD6-87B6-3CC49D87F35D,K64,Haemorrhoids and perianal venous thrombosis,-
61524381-4DE6-4744-8DA7-22209ED9D11C,N94.6,"Dysmenorrhoea, unspecified",-
61524381-4DE6-4744-8DA7-22209ED9D11C,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
D9E3DE83-66B9-4205-A3C2-5330732B7200,J45,Asthma,Asthma
74F64307-1180-46CD-8464-29DADD2696C7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2F9074DD-0D99-40F3-8A42-2DB51EC803C0,J02,Acute pharyngitis,-
97967245-0EF3-4283-BDF0-C77B436882B1,N30.0,Acute cystitis,-
170A0EE4-8AC3-4774-9BDB-73DD0569619F,L55,Sunburn,-
3D50F22D-5680-47D6-A574-D464B5E6FCFF,J06.9,"Acute upper respiratory infection, unspecified",-
ED383A6D-2961-4600-AF55-4D6764B55609,R51,Headache,-
FF2FF48E-8C30-4EF6-9AC3-2346EC2748DF,K30,Functional dyspepsia,-
872FF6D6-036E-4C6C-84EE-D67B00970BD5,G44.2,Tension-type headache,-
0B97C8C2-8DFE-411E-ADAB-10B13C5007E1,J02,Acute pharyngitis,-
4CC2BAB6-821A-422B-90DD-EF9C496AC865,Z71.2,Person consulting for explanation of investigation findings,-
258921DA-E687-4F64-860C-35FCEE963E1D,R51,Headache,-
258921DA-E687-4F64-860C-35FCEE963E1D,N94.4,Primary dysmenorrhoea,-
7D32255E-7418-40B4-91A8-384A2AEE78F1,A09.9,Gastroenteritis and colitis of unspecified origin,-
F3015BCF-B600-40E3-A1FD-167224D0A90F,K29.1,Other acute gastritis,-
F6AE21A3-5480-46A6-9CCC-10A6EC869B14,A09.9,Gastroenteritis and colitis of unspecified origin,-
34FC6E69-D04A-4299-9800-295A74D74E92,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
DF1C2EE4-2B25-437D-BCA8-81E29DDD7ADB,J06.9,"Acute upper respiratory infection, unspecified",-
BF32B66E-7EA7-4E03-B1DC-DF858A91152A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BF32B66E-7EA7-4E03-B1DC-DF858A91152A,R51,Headache,-
9A98CF6D-9421-44CF-AE7C-213CAAD4C2D5,R51,Headache,-
A477659E-DA35-4BB6-B5E7-698AB5933394,J06.9,"Acute upper respiratory infection, unspecified",-
A477659E-DA35-4BB6-B5E7-698AB5933394,U07.1,"COVID-19, virus identified",-
FD74FBEF-61A3-4FE7-8C14-49CFA29F4500,B30,Viral conjunctivitis,-
18AFD824-574E-4174-A339-7D7BECC72290,K29.6,Other gastritis,-
5BCFE708-761C-4E83-8E79-984FC7474C61,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5BCFE708-761C-4E83-8E79-984FC7474C61,R51,Headache,-
D7E60F81-E424-400E-9FCE-0F1FF3D53218,R50.9,"Fever, unspecified",-
D7E60F81-E424-400E-9FCE-0F1FF3D53218,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D7E60F81-E424-400E-9FCE-0F1FF3D53218,R11,Nausea and vomiting,-
CDA55CBF-49C6-456C-9313-C04004CF03BB,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
AEE77910-DFD2-4A2B-988F-104E6B60C84C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
CDA55CBF-49C6-456C-9313-C04004CF03BB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5DC886A0-8A6B-445E-8269-73AF7756FACA,N76.0,Acute vaginitis,-
ED804A75-32DB-4641-88F7-9153A73A26FE,A09.9,Gastroenteritis and colitis of unspecified origin,-
5127F1FD-4D7A-41DC-8BCC-7DB61A950C23,M79.1,Myalgia,-
00252CF4-27AC-4D68-A7EE-7CEB96177EAD,J06.9,"Acute upper respiratory infection, unspecified",-
9925FA92-E720-4473-9191-422CD8AAC9F7,G44.2,Tension-type headache,-
9925FA92-E720-4473-9191-422CD8AAC9F7,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
9925FA92-E720-4473-9191-422CD8AAC9F7,I10,Essential (primary) hypertension,Hypertension
E33BE7F1-910F-4531-892A-46214041F110,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D683486F-0763-4531-BF0F-85239D8BA98F,B35.3,Tinea pedis,-
D600B9BF-87B7-4CD1-BD84-438A83FB8FF9,B35.3,Tinea pedis,-
A4C47EE0-FFAB-4E0B-8CB9-09E7EA2EC1DC,R51,Headache,-
6962725D-6656-4DC3-BC8C-42F6800AC6E5,K29.7,"Gastritis, unspecified",-
6962725D-6656-4DC3-BC8C-42F6800AC6E5,A09.9,Gastroenteritis and colitis of unspecified origin,-
2AC1DF2E-2EDF-44A9-84AD-F40EF87A7BDB,M62.6,Muscle strain,-
116AAEC0-C031-4E83-B3B1-AA515053334F,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
AE2ADB88-893E-4AE8-B437-59770CDA0654,R51,Headache,-
7134B2C7-C05C-422F-9E08-22E43C97CE0B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7134B2C7-C05C-422F-9E08-22E43C97CE0B,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
9BDBD067-85D4-475E-9A30-A6E013369B4B,J06.9,"Acute upper respiratory infection, unspecified",-
22B8CC82-3528-4D1E-83EF-FE789386C15E,J06.9,"Acute upper respiratory infection, unspecified",-
C4B38556-1415-4BF7-97D0-1D90B7C25DA9,G43.9,"Migraine, unspecified",Migraine
3BF389D6-D73C-4EDC-810E-B68DA8776F04,R51,Headache,-
F8CB75D9-88EA-450C-B6F5-FA7D7B8B3035,R51,Headache,-
3AF7CCB8-3F45-4B87-A2CB-F4F160B85BF8,R51,Headache,-
3685FED3-8839-4B29-9244-AFB1A6AAAD9C,B30,Viral conjunctivitis,-
6376CB0B-FCBF-4C91-9D9B-4161D197B9F9,J06.9,"Acute upper respiratory infection, unspecified",-
4C740D4D-3887-4BB6-9EC8-CB4C19B24D6D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2E8ACB6E-6654-47EA-8461-08AAE3B3C317,A09.9,Gastroenteritis and colitis of unspecified origin,-
853C08B0-9254-4171-92E5-EC9EEA8C6540,J06.9,"Acute upper respiratory infection, unspecified",-
2F5055F1-5EE9-4422-9387-6271E2A9A855,A09.9,Gastroenteritis and colitis of unspecified origin,-
334CBBD5-D0E7-43FA-B3D4-8EF34EE3149C,G44,Other headache syndromes,-
D077EB6C-F51C-411E-B2B2-88CD5E787B0D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
187BBAD5-935D-4059-8C6D-4416B7DB9531,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
266D028B-3F71-422B-B217-FD1A2F96432A,A09.9,Gastroenteritis and colitis of unspecified origin,-
ACFC3BB3-05EE-41F1-AFEB-F6357D4B202D,J06.9,"Acute upper respiratory infection, unspecified",-
9D4C57ED-8228-42A2-85CE-0D9390A21EDB,K12.1,Other forms of stomatitis,-
F1A414A8-1093-4899-8A78-31CDC9191601,J06.9,"Acute upper respiratory infection, unspecified",-
2477237B-7F43-4179-A86C-3BE0596B6472,N94.6,"Dysmenorrhoea, unspecified",-
E4D81AD8-3D4D-4197-8273-ABF8071724FC,H57,Other disorders of eye and adnexa,-
332F5C2C-07E8-4491-9F04-03ADB98B2071,R51,Headache,-
C25F75BA-C492-4818-9B4E-8DC8333FC87D,J06.9,"Acute upper respiratory infection, unspecified",-
FEF8F94A-4E5D-4139-80E2-9FC41FE73DD3,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
FEF8F94A-4E5D-4139-80E2-9FC41FE73DD3,S63.5,Sprain and strain of wrist,-
26B3EAF4-4CDC-4E51-B9A9-D08E703D13EE,R51,Headache,-
FEDCF341-52F0-4FF1-A278-B2BC61E63F7F,G44,Other headache syndromes,-
314C2F22-DBE1-4A33-A78A-F59E8BAD2996,A09.9,Gastroenteritis and colitis of unspecified origin,-
5A8582BD-3810-4987-853C-7CCCA410B734,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
5889AF75-6F9F-48FB-B22B-ADB11D912798,J06.9,"Acute upper respiratory infection, unspecified",-
9DF5CF3A-DFBA-4C42-AB80-E989015F8541,N94.6,"Dysmenorrhoea, unspecified",-
07F42412-95CE-4CDC-BFE1-7CCC22480376,J06.9,"Acute upper respiratory infection, unspecified",-
F5F3649F-1071-4EC3-8D32-3459E659F22F,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
DA295753-A2BD-4662-88BB-649154895076,K29.6,Other gastritis,-
73B4E8AA-514D-4EC7-A15B-6F3E4C5FE5E5,T88.1,"Other complications following immunization, not elsewhere classified",-
5C8914EF-0D4A-40C1-84F0-9292A8159B46,R21,Rash and other nonspecific skin eruption,-
573DDAF1-FA9C-4440-B578-E8892E9F7F0F,M10,Gout,Gout
FAABDAD3-47A7-402B-AF4B-01C36F82E5F9,I10,Essential (primary) hypertension,Hypertension
C2A9735C-5FC0-497C-A584-6991D18D9DD6,R51,Headache,-
8C8678FB-06A1-43D2-967D-D6AE7707A34E,L50.9,"Urticaria, unspecified",-
CAEEDB49-D1F6-4DD1-A975-8861F15ABBBB,Z71.2,Person consulting for explanation of investigation findings,-
12AFA32F-5436-49B5-A964-8A24766894CF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3EFE8256-6D53-42AD-BE89-2487B136E94D,J01,Acute sinusitis,-
2F3EDEB9-08CA-4168-B0A5-1A59702E7968,J06.9,"Acute upper respiratory infection, unspecified",-
96A90C19-8D0C-4A36-9558-2E8E80A632EE,J06,Acute upper respiratory infections of multiple and unspecified sites,-
9F3A93D6-2055-4EAD-AB57-32DD0CB1F738,J06.9,"Acute upper respiratory infection, unspecified",-
5C7B5CE2-42EA-4A15-8821-F072384A790D,R51,Headache,-
58B98089-85AD-4714-8DBD-C70E9C4461A4,R51,Headache,-
58B98089-85AD-4714-8DBD-C70E9C4461A4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
84FB6445-69A4-4366-8641-694E183C29F2,J06.9,"Acute upper respiratory infection, unspecified",-
6A92D28D-0F51-4A70-99E4-674768947007,G71.8,Other primary disorders of muscles,-
08E545B7-CE9D-4705-9C1B-979D7CDA4A4F,J06.9,"Acute upper respiratory infection, unspecified",-
24755CFE-439F-4F06-A88A-992B59D2FFD3,N94.6,"Dysmenorrhoea, unspecified",-
1DC9D5E6-B3B7-4919-AF62-527314E9AE11,R51,Headache,-
1DC9D5E6-B3B7-4919-AF62-527314E9AE11,R42,Dizziness and giddiness,-
AD0C1C84-5EED-4D29-A8E1-38920F5BD76E,R51,Headache,-
8583E2CC-2474-4673-91FC-9663502F5823,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
859BFCCC-0FA3-49B7-9807-175FE5DDC090,J45,Asthma,Asthma
CFEF0101-CC97-4F32-B90E-7C2B3FB53A5C,J06.9,"Acute upper respiratory infection, unspecified",-
8D268D3F-E35C-400F-8136-1455CF61963B,R51,Headache,-
F7B7CD79-C57F-4B41-94AB-003227722E25,R42,Dizziness and giddiness,-
D5D92116-3EED-498E-8EF5-363BEF61C3F7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EFC36C5D-3B8D-428D-93C7-134E9C0C943D,R50.9,"Fever, unspecified",-
EFC36C5D-3B8D-428D-93C7-134E9C0C943D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
66EBE636-D313-4FC2-BB7F-CF38BCCFEB0D,Z71.2,Person consulting for explanation of investigation findings,-
BC13DD37-97B7-48A4-B18D-00A432FE75A7,O91.2,Nonpurulent mastitis associated with childbirth,-
B299B165-E074-446A-AC8E-B4EE03E2FB07,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
10A1CD7A-A1F7-4BC0-9DD9-3543EFB846D7,T88.1,"Other complications following immunization, not elsewhere classified",-
0FCE038B-8F8E-441D-80C2-7BE1DB4EA574,M79.1,Myalgia,-
F0823BFC-F0D9-460B-84F4-033C5F087020,M54.5,Low back pain,-
F0823BFC-F0D9-460B-84F4-033C5F087020,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
133A3B4D-3337-4E9E-B3A6-337931728527,A09.9,Gastroenteritis and colitis of unspecified origin,-
87869E0B-C1CE-4E7A-85A0-8BD1A80C1138,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
F3EDEF86-6BD5-4695-A77F-5261F27E545F,R42,Dizziness and giddiness,-
8C781C87-A1C0-4D97-AAD8-E236DAD6BFAC,R51,Headache,-
82A8EE16-79C2-41C3-BA1E-35123726EA04,T88.1,"Other complications following immunization, not elsewhere classified",-
E2522459-CEC7-4957-B3F0-6C96490C4468,H10.1,Acute atopic conjunctivitis,-
E2522459-CEC7-4957-B3F0-6C96490C4468,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
054FE382-31D5-4842-A9A4-CB3DA18F5857,T78.4,"Allergy, unspecified",-
054FE382-31D5-4842-A9A4-CB3DA18F5857,L50.9,"Urticaria, unspecified",-
054FE382-31D5-4842-A9A4-CB3DA18F5857,R21,Rash and other nonspecific skin eruption,-
84877182-AF99-4E4D-81A7-A54A404735D8,M79.1,Myalgia,-
0B4F4E81-0FE1-45BF-9BFC-48C49380F0AC,R21,Rash and other nonspecific skin eruption,-
E6D484A4-5E93-443E-98DF-D8D5E609C1C0,G44.2,Tension-type headache,-
E6D484A4-5E93-443E-98DF-D8D5E609C1C0,N94.6,"Dysmenorrhoea, unspecified",-
249019A3-4C3A-417E-8E9B-ECE9E512B48C,Z02.9,"Examination for administrative purposes, unspecified",-
D0DBFE1D-8B31-4BFE-A3A9-E3449228FD59,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
431177E5-674D-46B4-86D5-888A336DFD5C,H10.9,"Conjunctivitis, unspecified",-
D5765AEB-620E-4EAF-BC25-882D7EF5DF6F,K30,Functional dyspepsia,-
BFAC54A6-B9CB-47CD-96C4-193B5C205CFF,A09.9,Gastroenteritis and colitis of unspecified origin,-
61AA5A3A-E67B-4BDC-88BB-EF216899A237,M79.1,Myalgia,-
8EE7E979-BBBC-44F7-B36E-3D429A3DFDB7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1CB34705-8804-4121-9046-BC7A9129FD1A,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
F7077912-8421-48E6-9F84-C646AC65F526,R42,Dizziness and giddiness,-
F7077912-8421-48E6-9F84-C646AC65F526,R51,Headache,-
341323D2-B863-4EA9-814B-61A76DF8AA7D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4FFB3A67-9738-4184-B7AA-93AA05B48A89,A09.9,Gastroenteritis and colitis of unspecified origin,-
086BEE79-5E3C-4A6B-8AFF-8EFCD697488B,R51,Headache,-
E190045A-825B-4A87-99E0-786939CF7F6F,L23,Allergic contact dermatitis,-
E190045A-825B-4A87-99E0-786939CF7F6F,M79.1,Myalgia,-
127BF7F0-32DB-4DEB-BEAE-0D8855AB6BEC,U07.1,"COVID-19, virus identified",-
BD592911-1E1C-4826-8EBB-24D271C7ABD5,K13,Other diseases of lip and oral mucosa,-
BD592911-1E1C-4826-8EBB-24D271C7ABD5,R10.4,Other and unspecified abdominal pain,-
98D64ACD-A33E-4CB7-930A-08AD7007158A,J02,Acute pharyngitis,-
3AD95279-5EA0-4A3B-90FF-886FDC8E4658,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4FCCDD81-DD00-4916-A647-F4581D7259FE,H57,Other disorders of eye and adnexa,-
B0026466-2DAF-4E83-AD39-5216E6B38BEF,M76.6,Achilles tendinitis,-
6E8A954E-EC03-4546-A6C4-9B26D4A5A50B,M54.5,Low back pain,-
B0D228CC-4C96-4A73-9615-FF81650A3D03,H10.9,"Conjunctivitis, unspecified",-
4D69AAE5-9E07-437E-8E58-24288E350371,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
0E7C7994-A378-4CB7-B390-978C84B5B3DA,A09.9,Gastroenteritis and colitis of unspecified origin,-
4007DE2C-161B-4133-B343-B61EC04D0545,N94.6,"Dysmenorrhoea, unspecified",-
4132391A-89EB-4CB8-84D9-DF4D22310A47,J06.9,"Acute upper respiratory infection, unspecified",-
88051B1C-A56E-4AC5-8EF3-B432E1FE124A,N63,Unspecified lump in breast,-
A181A11F-4B1F-4A37-B8D2-71CC20D63FCE,N94.6,"Dysmenorrhoea, unspecified",-
F9387974-3A03-498F-91C5-E6945377A33B,T88.1,"Other complications following immunization, not elsewhere classified",-
27F20B82-60C8-4DC8-B695-EA92D5CD5891,R51,Headache,-
27F20B82-60C8-4DC8-B695-EA92D5CD5891,K29.7,"Gastritis, unspecified",-
30D986BC-A5B4-453B-B41C-378C79F8D80F,A09.9,Gastroenteritis and colitis of unspecified origin,-
874C1D6D-205E-47C7-83B6-C156CEC9A399,R51,Headache,-
9CCA554B-6CF5-4EED-805D-2193E762CA23,M62.6,Muscle strain,-
04A47734-2A5E-4881-A1A1-97C1E9FBDE7B,H00,Hordeolum and chalazion,-
95711217-2683-4DC3-8596-E523D853488B,N39.0,"Urinary tract infection, site not specified",-
084A4E53-DE6E-47F5-87F9-2099B9E9A2CC,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
F2EA2F43-7C42-42B5-B2B3-0CBF44CEE87E,R21,Rash and other nonspecific skin eruption,-
19231F8F-9544-45E4-A823-D87DD179EA89,B08.4,Enteroviral vesicular stomatitis with exanthem,-
4B5A6B57-1D82-4447-A78B-7650B6E02E53,B37,Candidiasis,-
1A7B2A7F-A542-460E-BB9A-FE9D88C7759F,J06.9,"Acute upper respiratory infection, unspecified",-
B512FA02-AFEB-4700-9475-22A017E5F57E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B512FA02-AFEB-4700-9475-22A017E5F57E,R51,Headache,-
1C0B0BA1-FBAF-4E47-855D-01203066C88D,H10.1,Acute atopic conjunctivitis,-
6723A33B-B0DE-48EA-B64E-AF55327DA09D,R50.9,"Fever, unspecified",-
6723A33B-B0DE-48EA-B64E-AF55327DA09D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D6A81DEA-BE7B-49CA-AA05-5C7C43D5DE28,J06.9,"Acute upper respiratory infection, unspecified",-
0B15C7DB-394E-471D-9B59-67079C15D320,R51,Headache,-
0B15C7DB-394E-471D-9B59-67079C15D320,R42,Dizziness and giddiness,-
0B15C7DB-394E-471D-9B59-67079C15D320,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
0089419C-FE97-475C-AC07-B4C29325340B,H57,Other disorders of eye and adnexa,-
22CB2733-8CD3-419B-8CB2-F31085A5D008,N39.0,"Urinary tract infection, site not specified",-
BEA179E2-849C-4122-B807-DCA81291C1DB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2B1FD143-E840-42AD-9FD3-B11BADBB230D,T88.1,"Other complications following immunization, not elsewhere classified",-
3EE42B7D-4846-4DB3-AE32-10AEC67C3AD6,A09.9,Gastroenteritis and colitis of unspecified origin,-
ED49A622-C6D7-457A-963A-68CFAB5D154B,R51,Headache,-
D7C1E811-E98D-45CC-A3C4-12E57469F880,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D7C1E811-E98D-45CC-A3C4-12E57469F880,A09.9,Gastroenteritis and colitis of unspecified origin,-
8FA5CE62-78A5-476A-A37A-06340EE650D9,L30.9,"Dermatitis, unspecified",-
8FA5CE62-78A5-476A-A37A-06340EE650D9,A09.9,Gastroenteritis and colitis of unspecified origin,-
1D849C60-E6B3-43D5-B8FD-A504361BF6A5,H10.9,"Conjunctivitis, unspecified",-
1D849C60-E6B3-43D5-B8FD-A504361BF6A5,H57.9,"Disorder of eye and adnexa, unspecified",-
459BDE6D-F347-4810-8511-9B9F2F3B97F5,H00,Hordeolum and chalazion,-
7C9522E4-3FE1-4299-B473-A424F1D55568,L60,Nail disorders,-
018EFC64-3F7E-4094-A097-6D11CBF685BE,R11,Nausea and vomiting,-
018EFC64-3F7E-4094-A097-6D11CBF685BE,G44.2,Tension-type headache,-
744EF3CE-3448-4ACA-A458-4BAEFDDAAA0B,S70,Superficial injury of hip and thigh,-
98B8DC81-7A1E-4886-B4BF-8F64736DF3DB,A09.9,Gastroenteritis and colitis of unspecified origin,-
14591516-6252-48F2-9C01-ED2A694C8BA0,R51,Headache,-
ABA40111-02C0-4088-9A07-0993AFDCFD96,M54.5,Low back pain,-
7AAE7ABB-62F1-46EC-BE04-1CC102978DD6,J06.9,"Acute upper respiratory infection, unspecified",-
11F07A07-1311-4B9A-96A6-0EBF7410CD2E,J06,Acute upper respiratory infections of multiple and unspecified sites,-
97079CED-EC90-4CD6-8450-06A1BD8A04F4,R51,Headache,-
A69D7EC7-C298-4D4C-ADAB-B35757BE6564,G43,Migraine,Migraine
9BDFAC9D-232B-4800-947E-C5C6906EBDD8,Z01.7,Laboratory examination,-
F26066F0-C227-42DE-9B5C-C81EFE5ABB52,R51,Headache,-
0AA0E230-B747-4440-823F-343D4BF43510,T88.1,"Other complications following immunization, not elsewhere classified",-
C7D399B9-CEE2-4CCC-98A0-7CC4A7986963,U07.1,"COVID-19, virus identified",-
4FB93CCE-75EC-46AD-ADD1-D62BBD731847,J06,Acute upper respiratory infections of multiple and unspecified sites,-
B9F6B4B4-1471-4A0C-8F9D-B39ED7EA58CA,R10.4,Other and unspecified abdominal pain,-
1BE995A3-7A74-4C48-BD5D-A43039A0D8E8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
109A7AE9-22C9-4F17-B8F0-475CC1617965,N94.6,"Dysmenorrhoea, unspecified",-
60A23654-9007-4E6E-8088-9D75C9515048,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3F4BB863-DBA0-4878-B28B-4D6B92BC5D64,A09.9,Gastroenteritis and colitis of unspecified origin,-
7CD1FCE0-2092-4C1F-9E0E-512A7FD0250C,B35.1,Tinea unguium,-
7CD1FCE0-2092-4C1F-9E0E-512A7FD0250C,N39.0,"Urinary tract infection, site not specified",-
BFF320E0-20F7-4FEB-88F6-1A3E6CD7DFF9,Z71.2,Person consulting for explanation of investigation findings,-
754BE11D-157E-4286-86AF-09AAC41C3F1C,L20,Atopic dermatitis,Atopic dermatitis
754BE11D-157E-4286-86AF-09AAC41C3F1C,G44.1,"Vascular headache, not elsewhere classified",-
AB0B76BC-49E9-487B-8B09-89CC9D0D5D5F,R51,Headache,-
ADA4FEB2-A0D1-4E47-8862-70E9219A4A14,A09.9,Gastroenteritis and colitis of unspecified origin,-
4E620EBE-0B7F-493C-B02F-A8A03F0A1729,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
98129E7A-1BA3-43B1-961F-0D1D5FD8483E,D50,Iron deficiency anaemia,-
98129E7A-1BA3-43B1-961F-0D1D5FD8483E,N94.4,Primary dysmenorrhoea,-
7378260A-6D17-4626-A3A9-D399706FA8CF,K29.7,"Gastritis, unspecified",-
5773BCE4-B7AB-4938-ABA7-32DDED3C0C8E,J98.7,"Respiratory infections, not elsewhere classified",-
5773BCE4-B7AB-4938-ABA7-32DDED3C0C8E,H81.1,Benign paroxysmal vertigo,-
386ABE6A-C83E-4795-9850-EC86A4DB0466,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E37C1E2F-A9F1-483C-8387-5B9B62F4D75F,T88.1,"Other complications following immunization, not elsewhere classified",-
CB6EB6A5-1F15-4EFB-94BD-C7C2F55D4895,H10.9,"Conjunctivitis, unspecified",-
900C80C0-67C4-44EC-8142-4240A23A0848,E78.0,Pure hypercholesterolaemia,-
F7894BAF-413D-4AD7-B4EA-A7C3CCC04003,R51,Headache,-
2B7C0DAD-3775-4629-AF32-C0F5EA191769,H10.9,"Conjunctivitis, unspecified",-
4E1A1AEE-03C5-4607-9DDD-6846FA17C87A,A09.9,Gastroenteritis and colitis of unspecified origin,-
3F7F6107-7331-466A-9672-9BD4F2B58866,J06.9,"Acute upper respiratory infection, unspecified",-
3F7F6107-7331-466A-9672-9BD4F2B58866,M79.1,Myalgia,-
3F7F6107-7331-466A-9672-9BD4F2B58866,K59.1,Functional diarrhoea,-
D5D41ECA-F113-4004-BADB-0947DA9B74E7,T88.1,"Other complications following immunization, not elsewhere classified",-
7CBCA78F-3343-488B-AE05-DC1E3459F35E,J06.9,"Acute upper respiratory infection, unspecified",-
73DBAAE8-AD1B-4646-9329-CFB96E8FCACC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A0FE168B-9D06-4A97-94CB-98713DF0B352,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
A76B1F8C-CAA2-4873-B502-27CE1A393157,J06.9,"Acute upper respiratory infection, unspecified",-
A76B1F8C-CAA2-4873-B502-27CE1A393157,U07.1,"COVID-19, virus identified",-
932D3A96-DED3-4604-B025-B29B7A1F79BA,R21,Rash and other nonspecific skin eruption,-
84B4E427-CD14-45EF-B089-922AB9BD7A66,J06.9,"Acute upper respiratory infection, unspecified",-
7245FC36-FABE-4680-9A4D-AA176A8BD1CA,Z71.2,Person consulting for explanation of investigation findings,-
3812879A-F59B-478B-A078-1BECD7699384,R50.9,"Fever, unspecified",-
3812879A-F59B-478B-A078-1BECD7699384,A09.9,Gastroenteritis and colitis of unspecified origin,-
AD95A5D0-2160-454F-9E89-3E3C5A625CD0,G58.9,"Mononeuropathy, unspecified",-
AD95A5D0-2160-454F-9E89-3E3C5A625CD0,T13.1,"Open wound of lower limb, level unspecified",-
6E24790E-6DB8-4D65-9D60-2797BBA982C1,J06,Acute upper respiratory infections of multiple and unspecified sites,-
CE871642-38CB-45A0-8FD8-D1B3A931E150,U11,Need for immunization against COVID-19,-
9200C4B7-E2DC-4452-A60C-BFCD7ADA6DC2,N39.0,"Urinary tract infection, site not specified",-
6753B4BA-E2DD-4EDD-B5C3-B28E83D0E889,J06.9,"Acute upper respiratory infection, unspecified",-
4ECE16EA-1050-4913-932F-EDA513C67C33,J06.9,"Acute upper respiratory infection, unspecified",-
2C4C2417-62E4-4B4A-AB83-04EC37FC54D3,Z30,Contraceptive management,-
F3306EA9-BB06-46B7-9006-57711D6283B0,N39.0,"Urinary tract infection, site not specified",-
2820E38E-4C8D-41F3-B8B9-BD4F1139FDB3,G44,Other headache syndromes,-
AE8AB3DD-6D90-4DAC-B0DD-7F33ABB1759C,A09.9,Gastroenteritis and colitis of unspecified origin,-
54B77E5F-0D6F-43EE-81A6-0196272D1991,J06.9,"Acute upper respiratory infection, unspecified",-
7979F530-7893-4262-9B74-ECE2006CCE07,L20,Atopic dermatitis,Atopic dermatitis
B3CAAC0D-A73B-4C1E-9373-8815B272372B,L02.2,"Cutaneous abscess, furuncle and carbuncle of trunk",-
4E86064D-BCDB-4F58-8EE3-E8AACB0ACE74,M54.5,Low back pain,-
40032F6E-3A6B-48CF-9A0E-85506E3156EB,K29.7,"Gastritis, unspecified",-
D7B7E7C9-C5CB-488A-9898-A392AE75C6A5,O21.0,Mild hyperemesis gravidarum,-
4B8F3E62-266E-45F0-8D7C-DD9312DFE906,O21.9,"Vomiting of pregnancy, unspecified",-
062BCE8F-7404-4E98-98E2-73467AC274FD,I10,Essential (primary) hypertension,Hypertension
51FDF7D1-AAF6-49BC-B882-F56B094A079B,R50.9,"Fever, unspecified",-
7E1D61D1-0799-4D79-989B-34037E1258A2,R50.9,"Fever, unspecified",-
7E1D61D1-0799-4D79-989B-34037E1258A2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
606969F5-27EA-4507-A7EF-3BD5E8332772,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C832D35D-393C-48D7-87C2-B7D52CE92CA6,R42,Dizziness and giddiness,-
DA81789C-BF80-4122-8CB9-E9D7D8CD52FC,A09.9,Gastroenteritis and colitis of unspecified origin,-
F2B9D53E-096E-435F-8B84-06B51535710A,M79.1,Myalgia,-
F2B9D53E-096E-435F-8B84-06B51535710A,R20.2,Paraesthesia of skin,-
5233246C-FAD3-4BA4-90BF-D7397BB0BF88,R21,Rash and other nonspecific skin eruption,-
5304B909-6C32-4782-8149-8B21E1BE4BFA,A09.9,Gastroenteritis and colitis of unspecified origin,-
95047AB4-270D-42AB-A0DB-9ED2A6E31C54,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
85F76CD0-FC1A-4300-B086-85CB90E99F5C,F41.9,"Anxiety disorder, unspecified",-
CE105805-48B4-4E32-89FF-E8604153DA90,R51,Headache,-
9BF5841B-B72C-42CF-8D80-BF64DB2BE324,Z71.2,Person consulting for explanation of investigation findings,-
97A405E1-6AE3-41ED-83D9-B696C086126A,Z30.0,General counselling and advice on contraception,-
97A405E1-6AE3-41ED-83D9-B696C086126A,Z92.0,Personal history of contraception,-
A270CF03-545F-4361-9DBC-1D966A4A373E,R51,Headache,-
0D16F105-7688-4FC1-ADF1-B0820EFD7845,A09.9,Gastroenteritis and colitis of unspecified origin,-
A270CF03-545F-4361-9DBC-1D966A4A373E,R11,Nausea and vomiting,-
933BE3FE-CF54-4992-9CDB-921E1B49F64C,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F3D088E7-773B-42FF-BF70-C6205565FE5D,M79.1,Myalgia,-
F3D088E7-773B-42FF-BF70-C6205565FE5D,A09.9,Gastroenteritis and colitis of unspecified origin,-
616AB7B8-DAFF-47C7-B0B5-F9ED0329C393,Y42.4,Oral contraceptives,-
B613428A-C0FC-4F9C-8C1F-F5BA4B9DEF0E,R51,Headache,-
02AC86DE-9749-453F-B6FC-9AF4301BC02F,H10.3,"Acute conjunctivitis, unspecified",-
9FA1918E-5BA9-4B7E-BA2E-D66BC7C89363,A09.9,Gastroenteritis and colitis of unspecified origin,-
93ADF7C6-629C-4638-8CB5-54AEB499A0B8,I10,Essential (primary) hypertension,Hypertension
27D34DA4-DB6C-4B01-BBEE-5124F4047088,J06.9,"Acute upper respiratory infection, unspecified",-
1332AB31-A5DA-42D4-8692-2750616A748D,L30.9,"Dermatitis, unspecified",-
81E96872-7FE5-410C-9719-C5EE94F79739,R50.9,"Fever, unspecified",-
D0BEDBF7-E731-4D11-8336-2D55886452EF,M79.1,Myalgia,-
EC7AF82D-1CD0-43E4-B750-585076EE30EE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EC7AF82D-1CD0-43E4-B750-585076EE30EE,R51,Headache,-
2766AA48-6139-41AC-B65B-57E28F3122A0,H57,Other disorders of eye and adnexa,-
609F67ED-9D33-49DF-BC9B-0A619E973AE3,K51,Ulcerative colitis,-
0CB39095-EECE-403A-B633-C323547AA1D0,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
0CB39095-EECE-403A-B633-C323547AA1D0,R11,Nausea and vomiting,-
487175FE-044B-4A2A-B5AD-50D7657CCA8D,N94.4,Primary dysmenorrhoea,-
79B6822C-35A4-4540-A996-D675FD68A835,N39.0,"Urinary tract infection, site not specified",-
F349A653-A34F-4AAB-8307-E7ACF2B8C931,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
0AF3E9B7-2CBC-4EDC-9BD5-C2175F4B34DE,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
E76DE326-94EB-46D6-947E-9FA5250A43C1,K12.0,Recurrent oral aphthae,-
FF5E8307-3944-4B5E-8E5D-FD8390D77F12,L30.9,"Dermatitis, unspecified",-
031AC2F4-AF83-4E66-B586-F989A2719C96,K64.9,"Haemorrhoids, unspecified",-
DCAE8245-17BE-4B2F-A0DF-077219B4D9D4,K52,Other noninfective gastroenteritis and colitis,-
9F98AC28-05AF-4E17-B6EE-8A829BC058B3,J06.9,"Acute upper respiratory infection, unspecified",-
37221885-EA86-419B-A798-C92DC7EE0603,A09.9,Gastroenteritis and colitis of unspecified origin,-
D1A02468-ED97-4178-8AD1-DD25968A7F3F,T78.4,"Allergy, unspecified",-
D1A02468-ED97-4178-8AD1-DD25968A7F3F,R21,Rash and other nonspecific skin eruption,-
D1A02468-ED97-4178-8AD1-DD25968A7F3F,K13,Other diseases of lip and oral mucosa,-
38C07E5C-D164-43A0-9C1E-21CEE0D2D39C,Y42.4,Oral contraceptives,-
38C07E5C-D164-43A0-9C1E-21CEE0D2D39C,T88.1,"Other complications following immunization, not elsewhere classified",-
751BE593-C327-49F8-8CF9-5B11ED256F5C,H81.1,Benign paroxysmal vertigo,-
061BF898-A2AD-4BB0-BFBF-15823B67A37D,U07.1,"COVID-19, virus identified",-
061BF898-A2AD-4BB0-BFBF-15823B67A37D,J06.9,"Acute upper respiratory infection, unspecified",-
F1284267-5EE2-4710-8479-110FF3E7F7FB,J02,Acute pharyngitis,-
05F40050-5D96-48FC-B410-3C825530247C,I10,Essential (primary) hypertension,Hypertension
05F40050-5D96-48FC-B410-3C825530247C,H57,Other disorders of eye and adnexa,-
643A87C7-AA42-4CB4-97F2-5CB9D770FDCF,R51,Headache,-
99ADAF19-9703-42DE-84C5-BAFC4F742425,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
85E61643-1CF3-4C4C-BC79-428132DC1FEC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
AFF146FA-3D45-424E-8B9D-FABD48E793D3,K59.0,Constipation,-
AFF146FA-3D45-424E-8B9D-FABD48E793D3,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
D3D20655-761A-4B10-810A-7F576AF2EF0B,R51,Headache,-
202A3B3E-7910-437D-9060-C875E16FB7D7,B00,Herpesviral [herpes simplex] infections,-
D3D20655-761A-4B10-810A-7F576AF2EF0B,R42,Dizziness and giddiness,-
D9DEEC88-2AD1-4BB0-ACD8-3F1B74CA98E0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D9DEEC88-2AD1-4BB0-ACD8-3F1B74CA98E0,R50.9,"Fever, unspecified",-
6CCCCC17-66C5-480D-AF9C-26EA6BFA32D1,A09.9,Gastroenteritis and colitis of unspecified origin,-
8925667C-154D-4592-8255-88DE1ACE6596,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C23C0372-2669-43C0-9378-870D33BBDAAD,M79.1,Myalgia,-
693AAA55-469D-4FE9-AEC0-FCCEDE6EC5C9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
693AAA55-469D-4FE9-AEC0-FCCEDE6EC5C9,R50.9,"Fever, unspecified",-
62595BB9-D43F-4624-BF76-B7C7B8842146,J06,Acute upper respiratory infections of multiple and unspecified sites,-
BB06144E-4430-445B-9DBD-E7EEB99D4E6B,R07.4,"Chest pain, unspecified",-
413F0EBB-EB12-4444-A129-F85D4EA5B3F6,N39.0,"Urinary tract infection, site not specified",-
174496A8-973F-4038-8E73-71FBC92935F0,N39.0,"Urinary tract infection, site not specified",-
F8554812-FF76-4C5F-ABD1-037B159D3791,U07.2,"COVID-19, virus not identified",-
0BE3E5F3-65E6-4EE4-B3E9-2AC9EC3069DD,M54.9,"Dorsalgia, unspecified",-
DCA698CE-AD44-4191-A771-4E3DA2DCEA82,J06,Acute upper respiratory infections of multiple and unspecified sites,-
CD422A84-27EA-40AF-B3A3-24E819E72BDD,U07.2,"COVID-19, virus not identified",-
AAC014A7-AC7F-4E65-8D09-75D7ED5A33C3,Z71.2,Person consulting for explanation of investigation findings,-
6D537B13-52DF-43EA-B165-DCB241264B66,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6D537B13-52DF-43EA-B165-DCB241264B66,R51,Headache,-
CC6065EE-3F62-425F-AE4E-BC6053E20B3D,J06,Acute upper respiratory infections of multiple and unspecified sites,-
5CD14B5F-785E-46CF-86DC-9E56B4EDC660,H00,Hordeolum and chalazion,-
E5CA3FC1-6EFA-421C-AFF1-799C9D411B8A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E06F02F6-BE51-4639-8B15-AC0CA4956621,N94.6,"Dysmenorrhoea, unspecified",-
E5CA3FC1-6EFA-421C-AFF1-799C9D411B8A,J45,Asthma,Asthma
24500B93-0CA8-4752-9328-F8BBEB9A4A80,K64.9,"Haemorrhoids, unspecified",-
EB7721A9-E6E4-4194-9525-7591198A43E3,M62.6,Muscle strain,-
FFED0E76-B89C-47BF-9D3C-444C38AA64A6,J06.9,"Acute upper respiratory infection, unspecified",-
BE0CCD2D-5CD2-49F3-82BD-1B9D00B35F46,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C71403B5-EE9C-4CC0-A85A-BC594EA05371,N39.0,"Urinary tract infection, site not specified",-
D4C40A2A-D935-4627-99FD-85D80D7322AD,M77.5,Other enthesopathy of foot,-
D4C40A2A-D935-4627-99FD-85D80D7322AD,H10.1,Acute atopic conjunctivitis,-
D4C40A2A-D935-4627-99FD-85D80D7322AD,H57,Other disorders of eye and adnexa,-
32E91066-4E2D-444E-BC5E-4E49D9A0ADBE,T88.1,"Other complications following immunization, not elsewhere classified",-
353D0C6C-1663-4F30-B1FB-80CD33025CA7,G44.2,Tension-type headache,-
C800BC39-0A17-494E-8C2A-05CC5552EDD5,R51,Headache,-
B936C703-080D-4EE9-9C2B-7A12121D3EE4,M62.6,Muscle strain,-
B936C703-080D-4EE9-9C2B-7A12121D3EE4,R51,Headache,-
A1245824-A942-4B14-B0AB-EA8E5171841C,B08.4,Enteroviral vesicular stomatitis with exanthem,-
375E0135-A4BF-450D-912F-E575179C7587,H00.1,Chalazion,-
CDB9050E-7FC9-4981-B778-3B19AD8CCF53,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9BD56972-4D6E-4634-BCF0-873B682F388A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
873579AE-3C18-438E-B755-B8D3B99D6253,J06.9,"Acute upper respiratory infection, unspecified",-
2C33D78E-D4E3-48D1-B47D-B67D6303B74D,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
796EE1F6-D3AB-403B-BB6F-5FD6883F9935,A09.9,Gastroenteritis and colitis of unspecified origin,-
796EE1F6-D3AB-403B-BB6F-5FD6883F9935,R50.9,"Fever, unspecified",-
8B1E16C9-F029-4FC0-B93E-E0746CBF051F,N76.0,Acute vaginitis,-
57E6EC8C-30FC-46D3-9686-EE718EC8691C,N94.6,"Dysmenorrhoea, unspecified",-
671D7E45-847C-45F4-8E7C-3A75147F9BF0,M54.5,Low back pain,-
72E80C99-404A-4F8C-A2F5-E01B82BBA93B,R21,Rash and other nonspecific skin eruption,-
BA7B138D-E9C6-4D3B-B7BE-A23C70A5833E,N94.6,"Dysmenorrhoea, unspecified",-
BA7B138D-E9C6-4D3B-B7BE-A23C70A5833E,R51,Headache,-
72E80C99-404A-4F8C-A2F5-E01B82BBA93B,L50.9,"Urticaria, unspecified",-
413E54D4-4923-4251-9506-9EE10E0AAE6F,N94.6,"Dysmenorrhoea, unspecified",-
67A5471C-74DE-4D0D-B987-A0A8D4373036,J06,Acute upper respiratory infections of multiple and unspecified sites,-
E6988426-51B9-4C0E-A0AC-A798D8E09509,Y42.4,Oral contraceptives,-
46AE5461-4330-4A91-B478-87E2D1CF1BDC,N94.6,"Dysmenorrhoea, unspecified",-
CAAC636D-8BA3-4AC6-BC93-81CF9B8601FC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C5DF5752-6B38-44E6-8899-AA230737A858,J06.9,"Acute upper respiratory infection, unspecified",-
9073DD91-6982-4F2A-B3B3-6D1BD1DDFD39,J06.9,"Acute upper respiratory infection, unspecified",-
75E058FC-407C-49C2-B5DB-CC48CB78EF58,G44.2,Tension-type headache,-
431C84E6-13F9-4AE5-BE03-B7BD86CAF785,K59.0,Constipation,-
431C84E6-13F9-4AE5-BE03-B7BD86CAF785,R51,Headache,-
C6826BE8-990E-43C8-9AD6-36851900DFDD,M62.6,Muscle strain,-
14700966-81B3-4498-9FA2-C30D92925FE0,T88.1,"Other complications following immunization, not elsewhere classified",-
C977D6DA-1711-4385-9974-D8EFF07A2FF7,N39.0,"Urinary tract infection, site not specified",-
033C2F70-C255-4AF5-A805-EE5506FEE612,J06.9,"Acute upper respiratory infection, unspecified",-
9A9D8DEF-58C6-4397-984F-CB67187CAE03,Z71.2,Person consulting for explanation of investigation findings,-
764B44B8-65C2-4A4B-B8B7-B9CAB14A4756,A09.9,Gastroenteritis and colitis of unspecified origin,-
B95FE70F-154B-48FF-B6F9-E031DDD1CABC,J06.9,"Acute upper respiratory infection, unspecified",-
CFC9EFAE-9D43-464E-943C-B50D77927C70,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2A55358F-1DB8-4F34-9D28-1F39DCE08CDF,N94.6,"Dysmenorrhoea, unspecified",-
2A55358F-1DB8-4F34-9D28-1F39DCE08CDF,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
29733CE4-9504-44A7-B189-7446C9F81731,I10,Essential (primary) hypertension,Hypertension
7B6202BF-5F53-4AA1-82D7-C8935F0CA202,R21,Rash and other nonspecific skin eruption,-
0705A9F5-9311-4BFB-9319-6E7CCBDAE6D1,T88.1,"Other complications following immunization, not elsewhere classified",-
EF533DC5-0701-481B-B8F6-8984E8BA9E66,J06.9,"Acute upper respiratory infection, unspecified",-
8E56FB4C-D7DE-4036-94BE-0BF8C9C9C3C8,M79.1,Myalgia,-
8E56FB4C-D7DE-4036-94BE-0BF8C9C9C3C8,R11,Nausea and vomiting,-
7F4B8FB1-B06A-4F13-A115-02168C407CBB,H61.2,Impacted cerumen,-
7F4B8FB1-B06A-4F13-A115-02168C407CBB,B37.3,Candidiasis of vulva and vagina,-
8336D802-E419-4E43-9F55-6B3B8348E21C,M62.6,Muscle strain,-
52C8A2C5-7C9F-46F1-9D50-7D4BD53E24FB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6F10F85B-46BC-4ED5-BE75-78AAC508056F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
90DAEC54-023F-4898-9FAC-F70CC04D91BC,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
D86C9867-9287-4969-96EC-FDC43DCA39AB,J06.9,"Acute upper respiratory infection, unspecified",-
D86C9867-9287-4969-96EC-FDC43DCA39AB,U07.2,"COVID-19, virus not identified",-
306E2B76-74BA-4AD2-B222-CC7DD00650C9,M23.8,Other internal derangements of knee,-
3DCA4A72-B4E9-4882-B9EC-5FE8037C04CD,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
194FF755-B20D-45E3-8BC4-AC94BCF63400,J06.9,"Acute upper respiratory infection, unspecified",-
BE538046-B1A9-466A-9D27-EDD11C181B5B,U07.1,"COVID-19, virus identified",-
B97FCE67-59C0-4CD6-879A-C8B7F94C3255,A09.9,Gastroenteritis and colitis of unspecified origin,-
6BF176AC-C1D7-46D7-A969-BF573DEA9564,A09.9,Gastroenteritis and colitis of unspecified origin,-
18A2823D-B30C-4595-9F02-CB4A71E371DF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
30C6F1EC-DC5D-46B7-B7D1-35C07C86EDBA,F41.9,"Anxiety disorder, unspecified",-
E2FB2929-A740-488A-B855-016F88EFB98B,K30,Functional dyspepsia,-
84779CD2-91CC-4F36-8B7C-56560DA9EAF6,T88.1,"Other complications following immunization, not elsewhere classified",-
C054FD65-177F-4F91-96B8-914F07406050,H81.1,Benign paroxysmal vertigo,-
30F6A398-A067-4ACA-A1E4-94D5026B8927,R14,Flatulence and related conditions,-
30F6A398-A067-4ACA-A1E4-94D5026B8927,K29.7,"Gastritis, unspecified",-
44C6DCD2-FCFD-4D38-BC9A-BFEFB3AE04D8,J06,Acute upper respiratory infections of multiple and unspecified sites,-
0C2B080F-0DC0-421C-9D89-FCD75AD8F37B,Y42.4,Oral contraceptives,-
67CA33C1-622B-4537-8FCA-66ACD0D7F512,R52.9,"Pain, unspecified",-
D128B15A-A780-498C-B755-7F330EE80DFF,R51,Headache,-
FB01E313-FB99-46B2-8F0F-CCE81D95364E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C1827338-3678-4538-B1FE-5F2A584837F9,S90,Superficial injury of ankle and foot,-
6329C1D8-6303-43E4-A065-7089032C5663,M62.6,Muscle strain,-
C2E38E15-4E2E-4EA1-8C24-B95CBA5E7A39,A09.9,Gastroenteritis and colitis of unspecified origin,-
A30076BF-E614-425B-A622-60CA5F2334B1,J06.9,"Acute upper respiratory infection, unspecified",-
57829804-E458-4ED1-AF85-81213807B6C7,J06.9,"Acute upper respiratory infection, unspecified",-
57829804-E458-4ED1-AF85-81213807B6C7,R51,Headache,-
ADE7786D-9527-4E77-87C9-73741B185D0F,N94.4,Primary dysmenorrhoea,-
0CA0D3B6-1989-4E60-BC95-16E49DDDEEE3,R51,Headache,-
CD9D1A96-3E8B-48F4-B237-1E2978379482,R51,Headache,-
867609D1-C878-4BD8-A0F7-A171965C30AB,R51,Headache,-
867609D1-C878-4BD8-A0F7-A171965C30AB,M54.5,Low back pain,-
771F3B3C-46A8-4B46-884F-35DCCBE19627,J06.9,"Acute upper respiratory infection, unspecified",-
A2A1C61E-AD3F-4085-A0B2-1BE3A6EA3EAB,Y42.4,Oral contraceptives,-
A596C750-CF89-4404-A391-1DF5FD830999,J06,Acute upper respiratory infections of multiple and unspecified sites,-
68733909-E82D-4642-92A3-2DCBF1716B7C,J06.9,"Acute upper respiratory infection, unspecified",-
19166CF0-C5F4-475A-99FF-B2A80C98342B,P39.0,Neonatal infective mastitis,-
D167140F-F31F-4B44-8522-CDF7900B7FCF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9973D662-C818-4C5D-BF53-160A007BA30B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
749CF514-DE1D-4F9D-8408-F5A70042188D,K29.7,"Gastritis, unspecified",-
676CE273-1043-4F7C-9700-042BEB45C576,M54.4,Lumbago with sciatica,-
676CE273-1043-4F7C-9700-042BEB45C576,M75.4,Impingement syndrome of shoulder,-
0A6FB9D6-B938-4DBE-AF04-1FAB1C20B42C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0A6FB9D6-B938-4DBE-AF04-1FAB1C20B42C,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
F0ECB91D-CA5D-4A9D-A4CB-294C2D13C42F,L50.9,"Urticaria, unspecified",-
F0ECB91D-CA5D-4A9D-A4CB-294C2D13C42F,A09.9,Gastroenteritis and colitis of unspecified origin,-
26EFF509-B2A1-47C2-9525-885A28AAF88A,U07.1,"COVID-19, virus identified",-
26EFF509-B2A1-47C2-9525-885A28AAF88A,J06.9,"Acute upper respiratory infection, unspecified",-
C021CB90-FF0B-4956-95F0-188FCB7E6C73,J06.9,"Acute upper respiratory infection, unspecified",-
42D2353F-D71A-4A3F-881C-EFE27EE60F50,K64.9,"Haemorrhoids, unspecified",-
803363EC-1A9B-42E2-B1E1-5627DB2663B8,R51,Headache,-
1EEE7E89-F1D8-412E-BCC8-5126DEF8FC72,J06.9,"Acute upper respiratory infection, unspecified",-
FFB50B80-D89A-4250-8AB9-B62EAA35CC9B,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
A68AD352-8A96-4FD8-9CC0-C18C29CE73A9,R42,Dizziness and giddiness,-
87A4D245-0227-42C8-8F09-EEC4F913588D,R51,Headache,-
156D7531-3419-498E-8CBA-7F610E04E372,M62.6,Muscle strain,-
5977605A-4E18-4F43-B7DD-726678EAC9F1,B35.3,Tinea pedis,-
5977605A-4E18-4F43-B7DD-726678EAC9F1,R51,Headache,-
5977605A-4E18-4F43-B7DD-726678EAC9F1,H00,Hordeolum and chalazion,-
B6C28A95-FC1F-41B8-8779-E26B32B8D784,H00,Hordeolum and chalazion,-
CCA7E3EF-F779-4748-B746-0243DCE56EF2,L50.9,"Urticaria, unspecified",-
CCA7E3EF-F779-4748-B746-0243DCE56EF2,Z76.0,Issue of repeat prescription,-
20B853F7-A9BF-4C86-B2DA-F2C35000A588,R51,Headache,-
B866DC61-7CE6-4EEB-898C-11F8F277C142,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
75382D4E-E2B1-487C-8247-CF1ABA61092E,R10.4,Other and unspecified abdominal pain,-
F7681B38-781C-40CB-AA7C-3E1EF0000DF3,R21,Rash and other nonspecific skin eruption,-
F7681B38-781C-40CB-AA7C-3E1EF0000DF3,L20,Atopic dermatitis,Atopic dermatitis
C399BECE-3013-47B5-A037-0089B1C049E4,L30.4,Erythema intertrigo,-
074CD050-D134-48E4-804A-0165870A7B76,H81.1,Benign paroxysmal vertigo,-
C78D7D20-A405-40B9-8F51-E1F65AFD0B69,G43,Migraine,Migraine
C78D7D20-A405-40B9-8F51-E1F65AFD0B69,N94.6,"Dysmenorrhoea, unspecified",-
E01598CA-25EA-45DF-B195-0EBAB66F277A,J06.9,"Acute upper respiratory infection, unspecified",-
4225DDCC-B198-4989-A22F-69583602B837,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3EC0D714-5244-4D65-9AA4-CC08205B45F1,Y42.4,Oral contraceptives,-
B5720A55-258A-43AA-B291-520012BFA47E,N94.6,"Dysmenorrhoea, unspecified",-
96442101-B569-4CD9-ABB0-D75D46468DE5,M54.5,Low back pain,-
0436CDE8-B044-4347-8341-AF012C934A76,A09.9,Gastroenteritis and colitis of unspecified origin,-
A1A868E6-F63F-4988-9E33-319726EA112A,G44.2,Tension-type headache,-
A1A868E6-F63F-4988-9E33-319726EA112A,U09,Post COVID-19 condition,-
DC1B1AC5-2738-49C9-B486-39A4E385EB3C,J45,Asthma,Asthma
916A5B2D-94A7-4D39-B2EC-BF9F7A110D93,A09.9,Gastroenteritis and colitis of unspecified origin,-
DA0EAD31-8245-44F7-A7C0-24005F40A9CD,K62.3,Rectal prolapse,-
69E45A85-D71C-466D-9409-29A84FEEB383,R50.9,"Fever, unspecified",-
69E45A85-D71C-466D-9409-29A84FEEB383,S96.2,Injury of intrinsic muscle and tendon at ankle and foot level,-
69E45A85-D71C-466D-9409-29A84FEEB383,I10,Essential (primary) hypertension,Hypertension
C8F29995-C8A7-43C7-9C6E-143B9F057500,R51,Headache,-
C8F29995-C8A7-43C7-9C6E-143B9F057500,J06.9,"Acute upper respiratory infection, unspecified",-
BEC7BAC5-DBC2-4C7B-A3B4-9AAB73B75DBD,R51,Headache,-
BEC7BAC5-DBC2-4C7B-A3B4-9AAB73B75DBD,H81.1,Benign paroxysmal vertigo,-
C91439D5-3B04-41C2-A769-D2BFDD81FDBD,J06.9,"Acute upper respiratory infection, unspecified",-
61D320DB-0E62-466E-82A5-B95E11A8CA42,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
AA607A60-C131-415B-9883-2F8A37F2B7A8,R51,Headache,-
9BF5EE65-A2C7-4EFE-8F94-961A86A8BDD7,K52,Other noninfective gastroenteritis and colitis,-
AA607A60-C131-415B-9883-2F8A37F2B7A8,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
E6944067-4690-4B25-96D9-41AC87B7E968,J06,Acute upper respiratory infections of multiple and unspecified sites,-
DF501037-D7D8-4ECC-9014-CF0FC8725035,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
40A82A7C-74E2-46D8-9274-0B5E27C31D65,J06.9,"Acute upper respiratory infection, unspecified",-
CE04DD85-ECE3-4C19-81EB-73884671D01A,J06.9,"Acute upper respiratory infection, unspecified",-
CE04DD85-ECE3-4C19-81EB-73884671D01A,U07.1,"COVID-19, virus identified",-
22C133D3-2F56-4576-B5B3-1FD417E9FF04,A09.9,Gastroenteritis and colitis of unspecified origin,-
841A24F7-2C0D-44B5-954B-3F3BA6BE4A65,H10.9,"Conjunctivitis, unspecified",-
C412ABE5-9FBB-46B0-A5D0-5CB6A9F47EC4,T88.1,"Other complications following immunization, not elsewhere classified",-
6FFAA865-AF7C-41D9-8E00-1EDC4DAD202B,J06.9,"Acute upper respiratory infection, unspecified",-
6FFAA865-AF7C-41D9-8E00-1EDC4DAD202B,I10,Essential (primary) hypertension,Hypertension
A44EF80D-4AD9-4CC8-BFDA-7D606A74AF25,J06.9,"Acute upper respiratory infection, unspecified",-
70BE864F-0D12-48CA-8AF1-0496E3A4EC21,N94.6,"Dysmenorrhoea, unspecified",-
B64A5251-AFB7-495C-8503-287756BFE476,K29.7,"Gastritis, unspecified",-
61148DD2-C0D7-4D5A-9099-549FF3DE2A31,J06.9,"Acute upper respiratory infection, unspecified",-
BE534AB3-8D3E-4268-8B31-592196F95AD7,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
BE534AB3-8D3E-4268-8B31-592196F95AD7,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
BE534AB3-8D3E-4268-8B31-592196F95AD7,Z76.0,Issue of repeat prescription,-
BE534AB3-8D3E-4268-8B31-592196F95AD7,M76.6,Achilles tendinitis,-
30B853F4-2CF4-44E5-8E29-09ECB2B7D62C,J06.9,"Acute upper respiratory infection, unspecified",-
F5C2588E-A161-4CB2-A235-B4DC2958D2FF,R51,Headache,-
5B005E72-3093-49F2-A552-9924EE255EE4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D0AE6FB8-8F33-47EA-B79F-FAB5273B2ED8,Z71.2,Person consulting for explanation of investigation findings,-
3896E95B-928F-4EA1-B35C-316D2C8E9C88,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
72A67658-FAC6-4C6D-BCEB-FB0960BF1CFA,J06.9,"Acute upper respiratory infection, unspecified",-
87ECCB39-C56F-4201-9ABA-4F8A4EBF4DF5,H02.9,"Disorder of eyelid, unspecified",-
55DF66AE-7396-4CAC-85B3-0A0CE51E624A,E61.1,Iron deficiency,-
55DF66AE-7396-4CAC-85B3-0A0CE51E624A,N94.6,"Dysmenorrhoea, unspecified",-
48EFC00E-91DB-446D-9BA5-39B24020CB3B,T88.1,"Other complications following immunization, not elsewhere classified",-
BFEADDAD-EF03-4E91-BC6A-9834F18E924A,A09.9,Gastroenteritis and colitis of unspecified origin,-
0FC1A68F-CA9B-4A65-8CE1-D38C677B53FF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6C9ED857-04F1-4903-8C08-85B9250F5F64,A09.9,Gastroenteritis and colitis of unspecified origin,-
FB925329-7F13-4775-B931-92AE238985FE,R05,Cough,-
FB925329-7F13-4775-B931-92AE238985FE,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
76478644-1F79-410D-862F-CA2CCAA1CEA8,R51,Headache,-
521E0BAF-FD51-4D6A-84FE-6CF0BE9404FB,Z71.2,Person consulting for explanation of investigation findings,-
42C7E05C-1AE9-41EC-90CE-D15FC2B7A82A,A09.9,Gastroenteritis and colitis of unspecified origin,-
B7181B11-1D16-4709-9077-2DA2868B328E,J06.9,"Acute upper respiratory infection, unspecified",-
52E843D9-B071-41DB-9AC7-CE9A9BDA158E,N94.6,"Dysmenorrhoea, unspecified",-
96ABC810-01AF-43EE-A3F0-E45756F30260,Y42.4,Oral contraceptives,-
D0948C1D-0584-4221-A095-6D9C3249C888,A09.9,Gastroenteritis and colitis of unspecified origin,-
EB9368B3-182B-4A51-97A1-709214EF7C5E,M62.6,Muscle strain,-
EB9368B3-182B-4A51-97A1-709214EF7C5E,R51,Headache,-
D0948C1D-0584-4221-A095-6D9C3249C888,S93,"Dislocation, sprain and strain of joints and ligaments at ankle and foot level",-
EDC72386-1713-4417-BA6F-D5350DC5ECC1,K29.7,"Gastritis, unspecified",-
B123ACCD-248B-4BCE-B16E-E83E8F8A6136,B35.1,Tinea unguium,-
B123ACCD-248B-4BCE-B16E-E83E8F8A6136,B35.3,Tinea pedis,-
A11D865D-8233-44E3-8968-3F97465E63A4,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
CCC4D0B2-C638-44B3-B5DB-CA7DCD025A64,N76.0,Acute vaginitis,-
83A677BC-7EA4-4267-A6E7-9BEBD42BFA47,N76.0,Acute vaginitis,-
6CA4B93C-BF15-48DB-9B80-B52343B32430,J06.9,"Acute upper respiratory infection, unspecified",-
9AFDAC9D-56D3-4B5E-97A7-7537C00EEC84,J06,Acute upper respiratory infections of multiple and unspecified sites,-
54C38866-349B-4D50-8A0F-B0D57BF9EF3A,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
0BAA01FF-BA3C-4A89-B715-AC484EA6A5DF,B37,Candidiasis,-
10D56851-2664-436D-9CA9-7C38E0DBD78D,J06.9,"Acute upper respiratory infection, unspecified",-
2A8E0FC1-EF36-423D-8D8F-3C68BD14B1F1,J06.9,"Acute upper respiratory infection, unspecified",-
84EECF6D-3A05-417A-8895-8613582FF9C3,Y42.4,Oral contraceptives,-
3883F454-8E15-43C3-A526-ACDD084ADEEB,G44.2,Tension-type headache,-
3883F454-8E15-43C3-A526-ACDD084ADEEB,M54.5,Low back pain,-
5B9DB304-026D-444F-9FE3-3D25B715A45A,A09.9,Gastroenteritis and colitis of unspecified origin,-
59F70B98-9091-46FA-94D6-8D22A8768CF4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9865EC64-7923-400C-9351-0A2AA9861D72,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
917D5003-D07A-4794-8293-37313445FC95,Y42.4,Oral contraceptives,-
EE37882E-44FE-4B2E-BC46-798FEB8B5815,J06.9,"Acute upper respiratory infection, unspecified",-
FBFE80A4-B5BE-4C4F-91B4-FA43FDB0386C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
52CDBBD1-A07D-44B8-8013-3DC85637EE1D,R51,Headache,-
6CCE47A7-0C3B-4573-B9DC-2308561BE1A5,R51,Headache,-
6CCE47A7-0C3B-4573-B9DC-2308561BE1A5,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
CA1521E5-4937-4450-BEE5-B87568DC80C2,J06.9,"Acute upper respiratory infection, unspecified",-
CDFE69D1-1ED7-4699-A207-3E7818221049,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
096A02B8-8FE1-4F14-A17D-8718CAC947CC,K11.6,Mucocele of salivary gland,-
096A02B8-8FE1-4F14-A17D-8718CAC947CC,R21,Rash and other nonspecific skin eruption,-
F8989606-E2D6-4870-A5BE-8CF5B76BA0AF,A09.9,Gastroenteritis and colitis of unspecified origin,-
5453E4E1-8279-43B3-B63E-52F2D0611708,I10,Essential (primary) hypertension,Hypertension
A9923900-621E-4ECA-B4E2-6BBE1EA385DE,M25.5,Pain in joint,-
A97C1F80-D6AE-4276-8849-7B7AFFDF17D4,A09.9,Gastroenteritis and colitis of unspecified origin,-
451964A9-A7B5-4FF1-81CD-653D1319552F,T88.1,"Other complications following immunization, not elsewhere classified",-
B934E4FF-9B6F-47EC-9657-B86C64E50F2F,S90.2,Contusion of toe(s) with damage to nail,-
5D96585D-6FA8-42F8-A165-22E611B15F18,A09.9,Gastroenteritis and colitis of unspecified origin,-
5D96585D-6FA8-42F8-A165-22E611B15F18,R50.9,"Fever, unspecified",-
4BE32B30-F615-48AC-9BF4-FA6338F86703,J06.9,"Acute upper respiratory infection, unspecified",-
3D8335E6-5F31-48B7-B1B8-CE0019A16FD1,R50.9,"Fever, unspecified",-
3D8335E6-5F31-48B7-B1B8-CE0019A16FD1,R51,Headache,-
3D8335E6-5F31-48B7-B1B8-CE0019A16FD1,M62.6,Muscle strain,-
2DD47A34-6FFF-4DBF-9D4F-4B9E1635EA1F,O21.0,Mild hyperemesis gravidarum,-
2DD47A34-6FFF-4DBF-9D4F-4B9E1635EA1F,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
0711DABB-D4D9-4A65-9638-DDAE71C2DBF5,M10,Gout,Gout
899FA039-DCAB-479C-B214-21CEEE2E1CEC,M10,Gout,Gout
A5E0B00C-AED1-4C0E-9E42-EF92459C6FF3,J06.9,"Acute upper respiratory infection, unspecified",-
C234B769-2A6E-45F1-A4A8-2695691390FE,T88.1,"Other complications following immunization, not elsewhere classified",-
4BA213F0-5125-47B3-A62D-85595B2D4D89,L23,Allergic contact dermatitis,-
8D696A33-64B5-4316-BB69-E740FB05EA6A,G43,Migraine,Migraine
394B5F5B-0D22-456F-9A99-44AA42BCD9A3,J06.9,"Acute upper respiratory infection, unspecified",-
B6836308-1085-4B97-9341-2B784500CF76,H00,Hordeolum and chalazion,-
F5AB4726-B41D-48B5-8D8A-4A6C4D59DD4B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F5AB4726-B41D-48B5-8D8A-4A6C4D59DD4B,M79.1,Myalgia,-
3662BBEA-11B5-454A-9AEF-F05624A3EAA3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3662BBEA-11B5-454A-9AEF-F05624A3EAA3,R50.9,"Fever, unspecified",-
AD213CB8-38B0-43D4-887A-0DCB26A060CC,M79.1,Myalgia,-
AD213CB8-38B0-43D4-887A-0DCB26A060CC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
041FB7FB-664B-45F1-93EC-95366630C062,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
1E18F159-A584-4C11-990B-EF8074DA51C5,R51,Headache,-
48821AF5-7F85-47F8-9A1A-1A1F08AD3FDA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
773D5B5D-BFF1-4537-A35D-7EA7DEBA02CA,J06.9,"Acute upper respiratory infection, unspecified",-
773D5B5D-BFF1-4537-A35D-7EA7DEBA02CA,G43,Migraine,Migraine
A1AFB201-1C96-493F-B6DD-994752157CC6,J45,Asthma,Asthma
E1E35B83-DCBE-441C-B88F-9FA65D5478EE,J06.9,"Acute upper respiratory infection, unspecified",-
E9701A3A-C9AF-448F-A2E9-2DDD0620A476,R06.0,Dyspnoea,-
42E9466C-3226-4317-B336-9770AED789BE,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
363E0B2E-88A6-4855-9DC3-C3A2F800B0EE,Z71.2,Person consulting for explanation of investigation findings,-
6927C596-5336-4808-8C49-BFEE1FAD54BE,R50.9,"Fever, unspecified",-
6927C596-5336-4808-8C49-BFEE1FAD54BE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3CFFC8B5-47B2-4C0F-9093-CF9227B4143A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
75A9D753-B373-4085-99C1-22CB0ABD8AC5,Z76.0,Issue of repeat prescription,-
75A9D753-B373-4085-99C1-22CB0ABD8AC5,L30.9,"Dermatitis, unspecified",-
984EFA57-D384-4A14-8936-8B9E87ECBAEE,G44.2,Tension-type headache,-
29540FFC-BF03-425B-B9FC-45DCD7DD8326,A09.9,Gastroenteritis and colitis of unspecified origin,-
19D2839D-DF44-4E3E-8D3F-C6D2C63D29E1,J06.9,"Acute upper respiratory infection, unspecified",-
3A60BA17-191F-469A-B16D-975F7983D71E,S93.4,Sprain and strain of ankle,-
3A60BA17-191F-469A-B16D-975F7983D71E,B00,Herpesviral [herpes simplex] infections,-
E74EE886-3D7D-47B2-A5DC-3AF413340EBB,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
71E9343F-EE2C-4C2F-932F-DD49E3D3A8FB,A09.9,Gastroenteritis and colitis of unspecified origin,-
C4932A32-D7CF-4910-B7BE-83D5DE015753,J06,Acute upper respiratory infections of multiple and unspecified sites,-
9C65A38D-D649-4754-824C-6D7CA42F5198,A09.9,Gastroenteritis and colitis of unspecified origin,-
E8172AE5-4D9C-4D8D-870F-A2EAEB2EF2EC,J01.0,Acute maxillary sinusitis,-
E8172AE5-4D9C-4D8D-870F-A2EAEB2EF2EC,R51,Headache,-
FCCE4443-56BD-4801-972F-8827B1828C00,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
1E54664E-91B8-4230-B2F5-BF1223C37C9C,O21.9,"Vomiting of pregnancy, unspecified",-
CEB15715-F941-41D0-B0CC-AAA8B2BA040A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1734254B-44A6-4AA8-9AB8-84731A6C6AE8,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
1734254B-44A6-4AA8-9AB8-84731A6C6AE8,R21,Rash and other nonspecific skin eruption,-
BE56C7FC-841C-428E-8AC6-A1867FF27EBB,K29.7,"Gastritis, unspecified",-
4993317B-548C-475B-9C4C-4538CF9A6EC4,N92.6,"Irregular menstruation, unspecified",-
DCE66E79-6F2D-441C-9849-3470D884E11A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
43257C7F-A1A5-482D-BBC4-D336DB748590,J06.9,"Acute upper respiratory infection, unspecified",-
A714604C-D6B4-4AE4-BE72-275D05B352E0,R10.2,Pelvic and perineal pain,-
43257C7F-A1A5-482D-BBC4-D336DB748590,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
8ECF8BCF-A571-4F52-8253-B8E0AAD28448,R50.9,"Fever, unspecified",-
8ECF8BCF-A571-4F52-8253-B8E0AAD28448,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5BF1F96A-C970-487D-BC21-3A160F746DA9,J06.9,"Acute upper respiratory infection, unspecified",-
2E441FC8-C385-4D19-93A2-8902DCF59C8A,N76.0,Acute vaginitis,-
3AA84512-17C7-4C9C-A565-43A9B68AF87A,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
2EB0E0D0-2D92-41C9-8A72-72785571EBE4,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
322E3F5B-ED06-4288-B99A-EC9650948E71,R21,Rash and other nonspecific skin eruption,-
9F2A8BD9-1F34-494E-983D-BCEAA908F32A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D8C1C96A-DBFD-40ED-B1EF-825A31344908,T88.1,"Other complications following immunization, not elsewhere classified",-
EF3CC863-1F1B-494C-981D-B0DDC12CF4B8,M79.1,Myalgia,-
EF3CC863-1F1B-494C-981D-B0DDC12CF4B8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
002034BD-F601-4FF3-B76F-704D041B3AB0,J06.9,"Acute upper respiratory infection, unspecified",-
002034BD-F601-4FF3-B76F-704D041B3AB0,R21,Rash and other nonspecific skin eruption,-
72487F8E-2EBA-4B64-BF17-3B9A133B4EC1,T88.1,"Other complications following immunization, not elsewhere classified",-
BA70E459-43A4-4772-9398-7C64B79BA4A5,K29.7,"Gastritis, unspecified",-
BA70E459-43A4-4772-9398-7C64B79BA4A5,A09.9,Gastroenteritis and colitis of unspecified origin,-
61C648B3-E5EE-4300-8008-9D4C1F094E0F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2705ABEF-E434-4402-9388-496F44FE59FE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2705ABEF-E434-4402-9388-496F44FE59FE,M79.1,Myalgia,-
2705ABEF-E434-4402-9388-496F44FE59FE,R50.9,"Fever, unspecified",-
3A2E5E2D-043D-4180-B5A5-5D17E62BC43E,Y42.4,Oral contraceptives,-
95726379-3E04-4E96-A512-837BFD04E39D,N94.6,"Dysmenorrhoea, unspecified",-
AD30A1D9-6F0C-473E-8876-43C16306BEF5,M62.6,Muscle strain,-
9EAAAB8B-798A-4A7B-9689-DB82987E3504,K10.0,Developmental disorders of jaws,-
4E9D5299-FAB9-40CC-86AF-583F343E371E,M62.6,Muscle strain,-
E3176D11-D69F-49EB-A560-750B153BD2F2,J06.9,"Acute upper respiratory infection, unspecified",-
9C8CC4AC-A836-498A-8B26-6560202D5FD7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0FEE3315-CFB9-42E9-B5E1-29EDC92D7F58,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0FEE3315-CFB9-42E9-B5E1-29EDC92D7F58,M79.1,Myalgia,-
C0D6F9D5-5218-4831-B84B-F467A952A40E,K29.7,"Gastritis, unspecified",-
C0D6F9D5-5218-4831-B84B-F467A952A40E,Y42.4,Oral contraceptives,-
CB9E1B32-E2A3-4D4F-AF67-42071CA69D62,Z71.2,Person consulting for explanation of investigation findings,-
09B068E9-FD9D-442B-A059-6CC54A5F1D34,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
38FD0C3C-A0A9-4CBB-BD0F-7F79F0AE66E1,T88.1,"Other complications following immunization, not elsewhere classified",-
44937ED9-EAF4-4D4A-A312-45B8F923E579,G71,Primary disorders of muscles,-
CEB011D9-83F8-4DD4-B9D5-01F0A357533A,R53,Malaise and fatigue,-
7A4FA660-75C2-4EC0-9080-C5DF8B04E93F,M79.1,Myalgia,-
C73B805F-423F-4AFB-BBC1-D6A3A5C33890,J06.9,"Acute upper respiratory infection, unspecified",-
C73B805F-423F-4AFB-BBC1-D6A3A5C33890,R51,Headache,-
D347A0F9-34F5-4670-921A-40C48A830FB2,T88.1,"Other complications following immunization, not elsewhere classified",-
D82A28DB-501E-4BF1-892A-BE0609BE5923,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
64313667-2774-48A4-8325-AB45D4132E56,G44.2,Tension-type headache,-
64313667-2774-48A4-8325-AB45D4132E56,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
3ED3456D-D1F3-40AF-AB2B-36C075CBF8A1,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
4ADF187A-8A17-4CF1-BF7A-0CF7E858CDB6,R51,Headache,-
B4CD8B29-BA05-4BBE-B3F4-88D22A2B355E,A09.9,Gastroenteritis and colitis of unspecified origin,-
07DF3F05-D764-451E-8C00-E267D2046868,B35.1,Tinea unguium,-
029FE06F-B5B0-442E-8897-379B0DAE09FC,A09.9,Gastroenteritis and colitis of unspecified origin,-
8FBB4D00-58A3-4ED9-8C26-FBF1F43288B7,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F1422CAC-90B4-48FD-8ABF-937A2AFB9F7E,L24.4,Irritant contact dermatitis due to drugs in contact with skin,-
0F89AE57-1BEB-47DE-A45B-AEF50BF62A63,S03,"Dislocation, sprain and strain of joints and ligaments of head",-
E6B8E5EB-4131-4C46-A6F4-4A96B381CB6F,M79.1,Myalgia,-
D6FE8D51-DBCB-40C1-8D93-49E081D4D3E3,I88,Nonspecific lymphadenitis,-
3C9A0F93-CDC2-49CE-B0F9-2A2B77C2E83B,R51,Headache,-
50E7B1B3-21AC-4061-932A-ADC677F0E44E,H00,Hordeolum and chalazion,-
80AF5D01-558D-4771-80CF-64086CAD2D0A,M62.6,Muscle strain,-
760CC7E2-8828-4177-B55C-D7B697D5BF7E,J45,Asthma,Asthma
E8FD3F9F-92FC-44A9-AD65-2D1CEBCE8E73,A09.9,Gastroenteritis and colitis of unspecified origin,-
1F0CDC1A-2EFC-47EB-AFF9-6D9E5D05340F,T78.4,"Allergy, unspecified",-
A9C08F77-75FD-4882-B3AB-579819B92E0D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8563F71D-2FCB-4182-ABBD-6A4E33596D34,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
75E3DB84-EC4A-457E-A7FE-F2B9BBDFA0F5,F41.0,Panic disorder [episodic paroxysmal anxiety],-
54F17A61-BC2B-4F84-9513-B0124D7F47CF,R51,Headache,-
4E679881-700B-443A-BA36-A738159D18C6,R51,Headache,-
4BCDD0A4-9D91-4C0F-A819-D70EA0DCE9FD,T88.1,"Other complications following immunization, not elsewhere classified",-
D62B122B-FE83-4146-B8BB-B70AB6F7CB2D,L60.9,"Nail disorder, unspecified",-
355E25A9-51E2-4533-9CAD-EB2CC3BB4D0B,J06.9,"Acute upper respiratory infection, unspecified",-
8FD4ABAC-B2B6-4337-9BD3-3D33068B0A96,A09.9,Gastroenteritis and colitis of unspecified origin,-
23591DC2-5DA6-4098-BED4-ACA5729CAB34,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
23591DC2-5DA6-4098-BED4-ACA5729CAB34,R21,Rash and other nonspecific skin eruption,-
E7FEF683-3F0E-4031-9E13-DF72E3A6FE03,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9E8D0F81-5BE6-4C96-A2AF-95D795F5C836,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
69761C6B-DC3E-4132-9C35-B35313C0B66A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9CF2236A-1A6C-422E-B498-1D5C4D9BE29B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
099BFF4F-F66F-4ED6-B061-C81E3FB21189,Z71.2,Person consulting for explanation of investigation findings,-
64B2C6E9-E125-4951-8E17-2846E8F1EABD,J06.9,"Acute upper respiratory infection, unspecified",-
F27012BA-2D00-4877-8F5C-51F172C3F5D5,K12.0,Recurrent oral aphthae,-
EC7890EB-07DF-449B-B407-22A9C7DDF139,A09.9,Gastroenteritis and colitis of unspecified origin,-
929E4776-EA9F-45BD-A385-21AA5E5F0473,A09.9,Gastroenteritis and colitis of unspecified origin,-
2FCA787D-BE5D-432D-9548-6DF18EBCE2B0,M79.1,Myalgia,-
5119A0BB-E983-4288-96AA-9EC56EFD1C0E,R51,Headache,-
2E040BA6-1551-4DE4-82E9-66E8DF45B89D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C6B726FE-E291-4693-918D-5EEDDEC34DA2,T88.1,"Other complications following immunization, not elsewhere classified",-
D4663577-C3A7-4FCD-9D20-F07AEAB0855E,J06.9,"Acute upper respiratory infection, unspecified",-
177C809D-3E42-4E39-B645-24E6E1B51B92,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
177C809D-3E42-4E39-B645-24E6E1B51B92,L20.9,"Atopic dermatitis, unspecified",Atopic dermatitis
177C809D-3E42-4E39-B645-24E6E1B51B92,H10.1,Acute atopic conjunctivitis,-
D2D04DAD-610A-4E1F-8005-D52D269BBEEF,R50.9,"Fever, unspecified",-
D2D04DAD-610A-4E1F-8005-D52D269BBEEF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
383C28B7-9681-43FB-AD4B-DA7A28097729,A09.9,Gastroenteritis and colitis of unspecified origin,-
556F6E25-A12E-4EAC-AFA8-238240825BD8,J06,Acute upper respiratory infections of multiple and unspecified sites,-
88D6593E-04CB-4048-A0F1-C6A2CA9CD1DA,I10,Essential (primary) hypertension,Hypertension
CB6CFC14-8973-47B4-A238-B7DA42208912,H00.1,Chalazion,-
D7E5E9CF-3D61-439F-8EFB-0521BC809FC4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
04918469-FA66-4676-9416-791D70CBF25B,N39.0,"Urinary tract infection, site not specified",-
FE4F6C72-DE6C-4C72-A736-D5647D539AE3,K29.1,Other acute gastritis,-
F156416D-8BD1-493C-8568-1EB476821394,N94.6,"Dysmenorrhoea, unspecified",-
0153BA22-33D6-4C7C-94DF-AE6018CC6F2D,R21,Rash and other nonspecific skin eruption,-
AA11A59D-F8D0-465E-9F99-B347FA141FBD,U07.1,"COVID-19, virus identified",-
CB8CEA30-53BE-48F9-87DF-FBFCD5B2E51C,J06.9,"Acute upper respiratory infection, unspecified",-
30C7BCB5-CD9B-446A-8A47-EAA95E093750,B30,Viral conjunctivitis,-
D60435E9-6753-4B47-8227-33BA9844F1FF,A09.9,Gastroenteritis and colitis of unspecified origin,-
D60435E9-6753-4B47-8227-33BA9844F1FF,K29.7,"Gastritis, unspecified",-
C32D1432-9441-457D-B992-B6D25E8D766C,J06.9,"Acute upper respiratory infection, unspecified",-
A5A2CC42-7742-43FB-BD82-557ACA5788C2,J06.9,"Acute upper respiratory infection, unspecified",-
43A6F7AE-AB02-45E0-A990-07C4931CA179,L20,Atopic dermatitis,Atopic dermatitis
3183E9B3-4D2F-4255-B488-21843D15C575,R21,Rash and other nonspecific skin eruption,-
1987382A-C94E-433A-8589-2908516D63DD,R21,Rash and other nonspecific skin eruption,-
D91D30CA-86C8-4470-986E-E6FDFA24778D,L98.8,Other specified disorders of skin and subcutaneous tissue,-
70B3D7A0-B42F-4F93-98AD-79217D798F2C,N94.6,"Dysmenorrhoea, unspecified",-
E33D2DD9-D753-454D-B825-7C15D565FC87,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EE332CB8-0E6F-42BD-AFEA-A720B7B3AB8E,J06.9,"Acute upper respiratory infection, unspecified",-
EE332CB8-0E6F-42BD-AFEA-A720B7B3AB8E,U07.1,"COVID-19, virus identified",-
151D94FF-E98E-4FCC-A133-8A295C258C32,S13.4,Sprain and strain of cervical spine,-
A1C389C9-BA6E-44FE-981A-7851CDC708C4,A09.9,Gastroenteritis and colitis of unspecified origin,-
DE0FEBE4-FB97-44C3-B8A7-18EC38AE462D,A09.9,Gastroenteritis and colitis of unspecified origin,-
30B96752-AB53-43FB-AEA5-BEDABA8DE128,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FB3E60F8-082B-480B-8451-0D09AFA1D008,J06.9,"Acute upper respiratory infection, unspecified",-
00478DF4-C2D4-4F3F-9905-CC059FA7D5CD,R51,Headache,-
98A1B6F1-BC7B-43A1-B472-3847B2A0A472,M79.1,Myalgia,-
A71D0DC5-C084-4512-942A-5ACA91C8F4E4,B30,Viral conjunctivitis,-
A71D0DC5-C084-4512-942A-5ACA91C8F4E4,H57,Other disorders of eye and adnexa,-
4DB03B7D-71C1-4CB7-A3F1-E9445B03AFB7,N76.0,Acute vaginitis,-
B60F6F50-4180-44C1-B562-45CF73209DB1,A09.9,Gastroenteritis and colitis of unspecified origin,-
6D753147-3166-42E8-BA49-80AC88DD47C4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9051E6D9-227F-4767-947D-69544F2C0EBE,R51,Headache,-
B70302E2-B101-465B-B931-BB13628481F9,R51,Headache,-
1F8C2D65-544B-4831-9472-A3A32717ADB4,G43,Migraine,Migraine
F21BE669-DD5D-410B-B797-6C2AC517F29C,A09.9,Gastroenteritis and colitis of unspecified origin,-
4CE55A9C-1EAC-4DAC-B3D9-210617E3C649,M22.2,Patellofemoral disorders,-
61916683-22E6-4B1B-89D4-A17BA227BAFF,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
CDADEB92-2863-4984-BDD4-1F154069AD88,R51,Headache,-
EDE9C933-3BB2-4443-8F71-EEBBC5648A9F,J06.9,"Acute upper respiratory infection, unspecified",-
7C09ED89-1F17-4EC2-8294-19DD1DFD3650,N76.0,Acute vaginitis,-
60D5A5F0-4B3A-4EEA-A15E-5E9357DE5D53,K29.6,Other gastritis,-
0A95DF91-43C3-4679-B08A-0352497723EE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5C9FB16E-E96B-4AE9-85C0-CA146D44BC12,M79.1,Myalgia,-
0FFD8403-B98B-4C42-8DB1-DD9EAF070B43,T88.1,"Other complications following immunization, not elsewhere classified",-
2DD2CC92-D183-46DB-9315-6BF51807FD0E,M79.1,Myalgia,-
2DD2CC92-D183-46DB-9315-6BF51807FD0E,R50.9,"Fever, unspecified",-
5A4146F4-C93E-4BE9-BD20-9414B1506CF7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DBF64667-E979-4E77-AD21-92D883C6E477,H57,Other disorders of eye and adnexa,-
DBF64667-E979-4E77-AD21-92D883C6E477,R21,Rash and other nonspecific skin eruption,-
CCA34543-356B-4900-BEB1-482E9FFBB314,K30,Functional dyspepsia,-
1686A8AF-27BC-419F-9F7A-8A8F999E45A0,H00,Hordeolum and chalazion,-
36FE6056-AD9A-42C6-9E0A-46B63A0861F0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BEE145CF-7D93-4C71-8AE9-F130BD84C90B,K29.1,Other acute gastritis,-
210D70E7-096F-4488-ADBC-256FE86540C5,H81.1,Benign paroxysmal vertigo,-
3199BBEB-F954-4BD7-8551-27C948431A5D,M54.5,Low back pain,-
F9BE1D54-AEDC-4CF2-87B3-DF1305B711BF,L50.9,"Urticaria, unspecified",-
F9BE1D54-AEDC-4CF2-87B3-DF1305B711BF,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
8EDAB7F5-C00B-4157-BA51-3D45F49D71D2,M79.1,Myalgia,-
8EDAB7F5-C00B-4157-BA51-3D45F49D71D2,G44.2,Tension-type headache,-
878A2451-22FD-4439-B539-76B5AD97ECAA,R50.9,"Fever, unspecified",-
A6EEF2DB-054B-48AE-8ABD-7AF026CDEBE3,A09.9,Gastroenteritis and colitis of unspecified origin,-
3AEE620B-F385-4B13-BC0D-A47D6F4C6413,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
6CACA77C-1829-4A87-8E1D-F14AF22F9160,T88.1,"Other complications following immunization, not elsewhere classified",-
EC135758-4044-44DC-8374-6C0652E18479,A09.9,Gastroenteritis and colitis of unspecified origin,-
ED14FFB6-9BFD-44E0-BEED-98FD65A48520,R51,Headache,-
03520E04-CE88-4AE3-AEFD-165CC5D60EAE,R51,Headache,-
537A6136-B789-439B-AA07-841E76DBAC1A,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
537A6136-B789-439B-AA07-841E76DBAC1A,Z71.2,Person consulting for explanation of investigation findings,-
12649709-3306-40D1-9597-5B17E36390D4,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
6FF50C14-76A2-4A58-BAB4-6991D701F4D3,Z71.2,Person consulting for explanation of investigation findings,-
E6CAD182-5B68-4054-A7E8-6AC8D8B9073E,R51,Headache,-
D4AF9B67-321F-4E54-86ED-15BA321497AD,R51,Headache,-
887352E2-616E-4486-A575-B0D1F6022980,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2F055729-36FD-417B-ABE7-04668450F435,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C2300A60-278B-47C6-A1E5-D67816682986,T88.1,"Other complications following immunization, not elsewhere classified",-
AC7847FD-6CB0-486D-A343-7A4EA9A07781,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
013D733E-4EC2-47D3-9B80-7CC33C9BC193,R50.9,"Fever, unspecified",-
AC7847FD-6CB0-486D-A343-7A4EA9A07781,R50.9,"Fever, unspecified",-
F033C3AD-B343-4260-B8C1-BD12AC5CBFCB,R21,Rash and other nonspecific skin eruption,-
85C38AA0-8923-4E49-B72A-92D9E7208426,J06.9,"Acute upper respiratory infection, unspecified",-
1D1113AC-CD10-4058-8101-313863B8C2FE,Z71.2,Person consulting for explanation of investigation findings,-
2B7C6744-5CD3-4357-8890-9DD0E0016322,M10,Gout,Gout
A84EE4F4-8028-4957-A7A7-40BCF35DBB58,N94.6,"Dysmenorrhoea, unspecified",-
2FB873A9-603F-4550-A1FD-A3691D66B41E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1013A32D-FF3C-424D-A8E0-91F339E11E90,R21,Rash and other nonspecific skin eruption,-
1013A32D-FF3C-424D-A8E0-91F339E11E90,A09.9,Gastroenteritis and colitis of unspecified origin,-
3800DB29-E494-444E-84BE-D9ACA517FB35,A09.9,Gastroenteritis and colitis of unspecified origin,-
7A9772E9-0140-4527-9552-AD08BA0EF05B,R21,Rash and other nonspecific skin eruption,-
463A6B9D-C61D-4E0A-8A23-1556CE434E07,H60,Otitis externa,-
F0CF8C8D-CEA8-4B9F-9BBB-3B7BD1E386C2,J06.9,"Acute upper respiratory infection, unspecified",-
0FF505A0-3222-47AD-8D97-573A624EF740,R11,Nausea and vomiting,-
57648D75-684D-4113-9B5C-63928366C8E6,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
19FD1553-757C-40FB-9B83-E8AF2B2F24A4,L73.9,"Follicular disorder, unspecified",-
2D7C531D-A76A-4671-B7F8-E215B5E7219B,R50.9,"Fever, unspecified",-
C5B49A9D-9467-44A4-BAAA-DD65A0C6BA1A,J06.9,"Acute upper respiratory infection, unspecified",-
57BFDF4E-C447-4C65-B1EE-E6879D5EE658,R21,Rash and other nonspecific skin eruption,-
07B8E691-04C0-43A2-9AD7-5A20F1C9B104,A09.9,Gastroenteritis and colitis of unspecified origin,-
1DC1171B-9316-42FE-B97A-8EA98A642504,A09.9,Gastroenteritis and colitis of unspecified origin,-
48AAFCAF-ED13-4981-A3C8-24B30FF3B3ED,J06.9,"Acute upper respiratory infection, unspecified",-
D72B3083-75EF-46B0-842E-74C1846B0D0D,J06.9,"Acute upper respiratory infection, unspecified",-
7F677EA0-8B54-4C9D-9AAD-B420E43D4F92,J06.9,"Acute upper respiratory infection, unspecified",-
3B357D52-0987-423D-B289-CCCF04D3E1EA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3B357D52-0987-423D-B289-CCCF04D3E1EA,R51,Headache,-
05013D4C-A970-42A6-AF92-3ADE3D493BD9,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
4D4A122C-664F-4DBE-AB93-9CD72EBDBDFA,N94.6,"Dysmenorrhoea, unspecified",-
94FDBD82-332B-46F1-A4A2-B1221EA2EF7C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C9D7DCAD-2F7A-4215-A94D-3E2165DC1216,N94.6,"Dysmenorrhoea, unspecified",-
C9D7DCAD-2F7A-4215-A94D-3E2165DC1216,R51,Headache,-
E4672E1B-A422-4819-A2C7-46FE04F7002D,T88.1,"Other complications following immunization, not elsewhere classified",-
B7649F89-6E02-4E69-A80C-663C02B897D5,J06.9,"Acute upper respiratory infection, unspecified",-
CF491021-D175-4FE3-9C86-F1F5F9B19771,G44.1,"Vascular headache, not elsewhere classified",-
D9E43C1D-33B0-4B7F-A225-501D8CB8413F,T88.1,"Other complications following immunization, not elsewhere classified",-
2F547DE4-0EEF-49EA-AD68-C1F4F7E91030,R21,Rash and other nonspecific skin eruption,-
030A30AF-37C0-4ED4-A3A6-348776F8879C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6329C1D8-6303-43E4-A065-7089032C5663,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
257123CE-B4F4-4BAB-8E21-B4420F1BF34A,J06,Acute upper respiratory infections of multiple and unspecified sites,-
3BCF51BF-03A5-49AC-AE06-9203787A0FB0,K29.7,"Gastritis, unspecified",-
3BCF51BF-03A5-49AC-AE06-9203787A0FB0,G43,Migraine,Migraine
3BCF51BF-03A5-49AC-AE06-9203787A0FB0,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
9994CBB9-9380-4F62-9680-D2A480F75A29,R51,Headache,-
BE0F4F10-A1A3-4F04-90B6-13B844B29C86,P39.0,Neonatal infective mastitis,-
80CE6B07-BA18-483E-8581-1E6799169CEA,S23.3,Sprain and strain of thoracic spine,-
2B4403C8-34A3-425F-9CED-98DBFC8BA222,J02,Acute pharyngitis,-
2B4403C8-34A3-425F-9CED-98DBFC8BA222,J06.9,"Acute upper respiratory infection, unspecified",-
539FB057-14E6-4D72-A9F3-D158C4A9CD3F,A09.9,Gastroenteritis and colitis of unspecified origin,-
B40067E7-FF9B-42F2-9F87-7DAC6EBD4F09,M79.1,Myalgia,-
B40067E7-FF9B-42F2-9F87-7DAC6EBD4F09,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9BB23F99-AC2E-4A62-A83D-899C10538E38,J06.9,"Acute upper respiratory infection, unspecified",-
D0002467-A91A-4033-9CC4-BE83C57CD0CB,J06.9,"Acute upper respiratory infection, unspecified",-
B885EB69-A49E-4118-AF8D-6C1928F2285B,M62.6,Muscle strain,-
6BD894D7-FDC5-4655-9DE7-E4993BB5E556,K30,Functional dyspepsia,-
4BFBC484-8C55-4F03-B806-E025BC75C158,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
EB587144-6948-49B8-A99F-5095F30F7AFD,G43,Migraine,Migraine
FFF17EE1-D318-43AE-8195-6869435831CB,J06,Acute upper respiratory infections of multiple and unspecified sites,-
5CB2B291-D49F-4298-A5D5-6A16A9B95138,K05,Gingivitis and periodontal diseases,-
1C60536F-4BC6-4B02-A775-7942A835CBCC,Z71.2,Person consulting for explanation of investigation findings,-
E889D081-0205-4B46-A06E-0EE6D8DF4BFA,R21,Rash and other nonspecific skin eruption,-
2E48A4D3-8EEE-48E7-B83E-01AEEB0D0550,M65.9,"Synovitis and tenosynovitis, unspecified",-
F47C817A-D4AB-4673-8825-C593F484A121,J30.3,Other allergic rhinitis,Vasomotor and allergic rhinitis
10B1ABFA-25E4-415C-9388-0216D6EC0193,L20,Atopic dermatitis,Atopic dermatitis
D65C3EEA-3539-4416-9DEB-84F306EBF27C,Z76.0,Issue of repeat prescription,-
D72A1035-950C-4B54-807D-288757C71F6F,Z76.0,Issue of repeat prescription,-
A32FF2C9-5011-432C-B5AA-8386FCD84D6A,R42,Dizziness and giddiness,-
5280F5A1-2D9F-4788-BC45-E381E43EFA8C,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
E32A8CC1-9BA2-47B3-B0C2-30D7192859A2,J06.9,"Acute upper respiratory infection, unspecified",-
9424FC1B-4F9D-45EA-87F6-3613D0917A75,R05,Cough,-
8D677B94-568F-466D-860A-647173272DA5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
035FCAA9-D54C-4461-A854-DF267958CAC3,S93,"Dislocation, sprain and strain of joints and ligaments at ankle and foot level",-
035FCAA9-D54C-4461-A854-DF267958CAC3,J32,Chronic sinusitis,-
2202D7C9-9E73-4038-B424-B52C7ECADD1B,J06,Acute upper respiratory infections of multiple and unspecified sites,-
2202D7C9-9E73-4038-B424-B52C7ECADD1B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
06BD3363-6EEC-434E-B74A-3EEA06E1BF5E,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
C6CCAFA5-5286-4B1C-8231-EC365BCA8722,T88.1,"Other complications following immunization, not elsewhere classified",-
38A26C39-00A7-431D-A269-006125557933,T88.1,"Other complications following immunization, not elsewhere classified",-
9FDB3608-524D-42EF-852E-1E081AD99872,H00,Hordeolum and chalazion,-
83479FAE-704E-4CEA-8038-E608DEA0B07F,T88.1,"Other complications following immunization, not elsewhere classified",-
972D6404-36A5-45B0-8D57-04BD56924471,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D501DE96-471C-44AF-8A9F-2C164E9E9E14,M10,Gout,Gout
41F0E863-16F4-4DEF-9F45-9324D5A20750,A09.9,Gastroenteritis and colitis of unspecified origin,-
5F634AFF-9733-43E8-8384-21453A7A6703,K30,Functional dyspepsia,-
EC8D0435-EDB4-415B-BD87-D92D9F6DA8EF,A09.9,Gastroenteritis and colitis of unspecified origin,-
5F634AFF-9733-43E8-8384-21453A7A6703,R10.4,Other and unspecified abdominal pain,-
FE202FA6-9D4A-464E-A71A-512C034F9AED,J06.9,"Acute upper respiratory infection, unspecified",-
CC3CF896-4118-483C-9D19-0BEFC7FEA569,A09.9,Gastroenteritis and colitis of unspecified origin,-
5F54C5AA-56AE-4AE4-8D23-62DBB041AEAA,M54.3,Sciatica,-
8BBFF2B8-6F83-4D15-BFED-91AAD3E9F90D,T88.1,"Other complications following immunization, not elsewhere classified",-
714DB559-3827-4BB1-90E3-176ABBD731DA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8EEFBF66-FB1B-4DD4-9158-DB6E78E9ED78,R51,Headache,-
DDFCDBA0-54A6-4604-8347-52A91BAB1E8A,R51,Headache,-
CE98B592-E63D-4617-B166-E647428A649C,R51,Headache,-
816F5907-2B0F-41DA-B866-248DAB4A4A0E,R51,Headache,-
7F429EF6-D6A1-4B91-8175-D1759E2F625C,J06.9,"Acute upper respiratory infection, unspecified",-
7F429EF6-D6A1-4B91-8175-D1759E2F625C,U07.1,"COVID-19, virus identified",-
93DE0A7C-98E6-470C-9AF5-07282DB8B6C2,J06.9,"Acute upper respiratory infection, unspecified",-
2AA693D8-69C0-4DD8-96CC-2585F986D49F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2AA693D8-69C0-4DD8-96CC-2585F986D49F,R21,Rash and other nonspecific skin eruption,-
159393B1-2C6F-4155-85F6-1AC688399BA6,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
7502CA23-63D0-43D2-B2FC-012CA3616335,A09.9,Gastroenteritis and colitis of unspecified origin,-
AC699E3C-540F-4C86-9B33-FBAB19B8C703,Z71.2,Person consulting for explanation of investigation findings,-
FDF791BB-C3FF-4BCD-A31E-436DC752CEB6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DD8A1A46-5548-4180-9FF1-F62D68BAD379,S53,"Dislocation, sprain and strain of joints and ligaments of elbow",-
DD8A1A46-5548-4180-9FF1-F62D68BAD379,M62.6,Muscle strain,-
4A4310A7-B3C1-4E6B-9D3C-CFFD2C2F463D,J02,Acute pharyngitis,-
4A4310A7-B3C1-4E6B-9D3C-CFFD2C2F463D,U07.1,"COVID-19, virus identified",-
13F7D751-F9F5-4E46-8987-8C21C36BF746,J06.9,"Acute upper respiratory infection, unspecified",-
16740D69-484D-4F50-8E91-03470EA01F31,L02,"Cutaneous abscess, furuncle and carbuncle",-
DB80C107-5DA9-4AC2-9279-D9C16069633D,J06,Acute upper respiratory infections of multiple and unspecified sites,-
9EDB6D0D-2E86-4125-9E97-83DA9EDE0BCD,T88.1,"Other complications following immunization, not elsewhere classified",-
93699100-DAF4-43FF-AED7-17649B102E38,J06.9,"Acute upper respiratory infection, unspecified",-
3E8DFF1C-88A3-4132-A971-FE22A0D43E2A,J06.9,"Acute upper respiratory infection, unspecified",-
8C3917FE-19F6-46EF-915C-B90A40D678A3,K29.6,Other gastritis,-
8A041575-CAEA-434A-8DF8-F03366FD118A,J06.9,"Acute upper respiratory infection, unspecified",-
C2B1D9A5-0995-4978-903E-383EA6FAC23E,R50.9,"Fever, unspecified",-
1907EE64-1F0D-458C-B22F-1412038CEE6D,L70,Acne,-
210B01F6-8C69-42E8-99CC-752D58910D27,R51,Headache,-
6EA1E00D-08E9-447B-8772-9B6E90A785B3,J06,Acute upper respiratory infections of multiple and unspecified sites,-
28DFE9D1-0103-4E66-8D48-CFCB60F8197E,U07.1,"COVID-19, virus identified",-
28DFE9D1-0103-4E66-8D48-CFCB60F8197E,J06.9,"Acute upper respiratory infection, unspecified",-
CAD2E1F4-F821-4D4B-AC3A-D93A672BF0D9,R21,Rash and other nonspecific skin eruption,-
7188C5A9-E223-4FDF-B952-B6E23D78C11E,J06.9,"Acute upper respiratory infection, unspecified",-
7188C5A9-E223-4FDF-B952-B6E23D78C11E,A09.9,Gastroenteritis and colitis of unspecified origin,-
11DE323D-C926-4181-A0FB-7F2D13AE91BD,R51,Headache,-
D5276A39-8034-4D25-A146-399FB1EF9A3B,J06.9,"Acute upper respiratory infection, unspecified",-
AD09D57A-1186-4655-8270-E4AD2F58395B,N39.0,"Urinary tract infection, site not specified",-
036E8AEA-1619-42AF-8674-257D59326DEF,U07.1,"COVID-19, virus identified",-
036E8AEA-1619-42AF-8674-257D59326DEF,J06.9,"Acute upper respiratory infection, unspecified",-
B3A0303C-9D2C-4EC8-A01B-4882DF683C7D,R53,Malaise and fatigue,-
B3A0303C-9D2C-4EC8-A01B-4882DF683C7D,N94.6,"Dysmenorrhoea, unspecified",-
71A51909-D3CB-4406-B354-176B7CBC556A,J06.9,"Acute upper respiratory infection, unspecified",-
DD00E6BA-E14B-412A-B0C5-BEEBD8A8DE1E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F1A4CC60-A2A4-4C8A-952D-A593FA3E2954,R50.9,"Fever, unspecified",-
F1A4CC60-A2A4-4C8A-952D-A593FA3E2954,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8CCC8B4D-8E2E-4F18-999F-B9D9B2EF3599,U08,Personal history of COVID-19,-
5F063FAF-9BFE-4FFF-B540-46A03F814B00,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
596E16B9-9E63-4D5E-A951-364396B655EC,R21,Rash and other nonspecific skin eruption,-
FC4E9C49-934A-4BCA-8896-E2B82D6184A9,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
8AFCFABE-3081-4AF7-A2E9-CF9443BE2D5E,G44.2,Tension-type headache,-
6A195548-3AF7-41ED-B6B7-7F7399AA4B39,G25.2,Other specified forms of tremor,-
87433519-7536-451A-919D-097EC614BADE,M25.5,Pain in joint,-
C71543AD-C24A-4ED2-85F3-C4BD953E92E2,M25.5,Pain in joint,-
78A9009D-D9FF-40A6-9BE0-05705E8A6E05,N94.6,"Dysmenorrhoea, unspecified",-
8B95663C-1ACF-46D8-92AE-5AA23D69F22C,R50.9,"Fever, unspecified",-
DADC4614-0103-4CB5-9B49-C2B72098F9CF,M10,Gout,Gout
52D97C14-77FF-4BD6-8ACE-1903AF67B7BE,N39.0,"Urinary tract infection, site not specified",-
2DF8B0E3-C445-41D6-BA09-BB8BEB93D100,M62.6,Muscle strain,-
2DF8B0E3-C445-41D6-BA09-BB8BEB93D100,M75.9,"Shoulder lesion, unspecified",-
8665595F-C74D-4FD9-8894-7C7B50B58E95,U07.1,"COVID-19, virus identified",-
09CAFADB-772A-40C4-83CF-AD9AEB0EB875,M62.6,Muscle strain,-
136D873B-0AAB-4BAE-A7D9-4D662BD02EAB,N94.6,"Dysmenorrhoea, unspecified",-
028AAF59-2C76-45B5-838C-49A6CEA953A5,R51,Headache,-
EE1F4ECD-FC14-4ED9-B3F5-264F233FC0A2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6BA441DF-8F2C-4F1E-B839-615A64FFF5C8,Y42.4,Oral contraceptives,-
8FD9B11A-0DCC-40A6-992D-B4A947B67A63,J02.9,"Acute pharyngitis, unspecified",-
8FD9B11A-0DCC-40A6-992D-B4A947B67A63,L20,Atopic dermatitis,Atopic dermatitis
F165F414-FCF5-4790-BB56-FD5E785BD2FF,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F165F414-FCF5-4790-BB56-FD5E785BD2FF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C355FEF9-910F-4507-AFCD-F44B40AE48B9,L60.8,Other nail disorders,-
19D5A4F9-D62C-4EFE-A99F-34EABC0AA688,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
ED0A3D2D-33DB-495F-90B8-1EAD07481BFD,M79.1,Myalgia,-
B2883A12-21DD-4650-95BC-1E6DB57702F9,Z71.2,Person consulting for explanation of investigation findings,-
C4FAB7F7-DA15-4E95-9B49-C849BC682C54,R51,Headache,-
8D85A22B-CF22-40AD-9A0C-7DEAAB26714C,J06.9,"Acute upper respiratory infection, unspecified",-
A7EA21EC-3D7C-4FA9-A079-1705686095D0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
79D35845-6891-4775-94E9-28C76FBD8BDB,R51,Headache,-
7D7DFA70-4C68-4220-8E3F-DBE2AD0F7078,K64,Haemorrhoids and perianal venous thrombosis,-
218C1666-363C-416C-B5FB-83C79D58DC51,R42,Dizziness and giddiness,-
218C1666-363C-416C-B5FB-83C79D58DC51,R50.9,"Fever, unspecified",-
C08B373F-34B5-40EA-A826-98E7F30290D5,R51,Headache,-
D61B559B-2327-4340-80B7-701CFCDD9E1D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
27997F46-A5F1-4970-AEB2-84225A5C8B4F,Z71.2,Person consulting for explanation of investigation findings,-
68A3CF0E-F995-4CE9-9F2A-AA2A19A4F93C,Y42.4,Oral contraceptives,-
9F526C9F-3F76-4179-86C0-53227734A530,K29.6,Other gastritis,-
66DF8EF1-38AE-41F6-93AF-BF826921D090,G44.2,Tension-type headache,-
183F6D41-0AC5-496C-84C6-80E09FD80846,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
66DF8EF1-38AE-41F6-93AF-BF826921D090,L29,Pruritus,-
02DFDCAE-561C-4A47-BDCD-85092E825161,J02,Acute pharyngitis,-
64198FD3-89C9-4E2F-B794-6ADC952D7E75,J06,Acute upper respiratory infections of multiple and unspecified sites,-
4BD518C5-9300-493F-ACF5-F79291327D43,R51,Headache,-
94473A5D-472F-4C8D-8C2B-B1105FD0646E,Z02,Examination and encounter for administrative purposes,-
AE27CC7E-DCD4-41AF-8F4F-69C611EACA10,K59.0,Constipation,-
BB50713F-A505-40EA-AC53-9BD59FB03767,U07.2,"COVID-19, virus not identified",-
D96ECC71-A3B2-47BB-B32F-AA2426655D89,J06.9,"Acute upper respiratory infection, unspecified",-
065C6BDC-A1C3-41A0-BA78-352FEF9C4511,L20,Atopic dermatitis,Atopic dermatitis
065C6BDC-A1C3-41A0-BA78-352FEF9C4511,X51,Travel and motion,-
2F89A319-7EC9-4FC4-8817-385433802E77,N94.6,"Dysmenorrhoea, unspecified",-
2F89A319-7EC9-4FC4-8817-385433802E77,T88.1,"Other complications following immunization, not elsewhere classified",-
0C34C632-D871-4FA2-A809-3A2EE8B04065,J06.9,"Acute upper respiratory infection, unspecified",-
1A744940-1858-49E1-B544-35FEF0B98FB5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DF07FF7B-99FA-462E-A3A5-56563CDE35B6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8D8EBFF7-EFFF-48EA-ACEE-1C209213FE2B,S43,"Dislocation, sprain and strain of joints and ligaments of shoulder girdle",-
8B6DC429-344C-4939-B372-7CDE38EEB296,T88.1,"Other complications following immunization, not elsewhere classified",-
32EF13B2-949C-4E6B-96F5-E47002F5D14D,N76.0,Acute vaginitis,-
C147E9DC-6DCC-44C6-A959-C3182F0AA53F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
AEFB6352-6725-477C-9334-023FA795CE8A,J06.9,"Acute upper respiratory infection, unspecified",-
C2283581-2574-42CB-8F69-5CA048040388,J06,Acute upper respiratory infections of multiple and unspecified sites,-
1B13C0E2-5BD4-45D8-9EC8-2ACF0DA09BF6,R21,Rash and other nonspecific skin eruption,-
5A818DDC-CE8C-422D-9368-25BAD2528872,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
0A6563C4-B4DF-4254-8E8B-1943CC00A862,R51,Headache,-
05BC258B-D03F-4794-88EE-B570BB489B99,J06,Acute upper respiratory infections of multiple and unspecified sites,-
32E18B54-975A-4E0F-80EF-7EC7CB20E1EF,L30.9,"Dermatitis, unspecified",-
32E18B54-975A-4E0F-80EF-7EC7CB20E1EF,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
32E18B54-975A-4E0F-80EF-7EC7CB20E1EF,G43,Migraine,Migraine
32E18B54-975A-4E0F-80EF-7EC7CB20E1EF,L02.3,"Cutaneous abscess, furuncle and carbuncle of buttock",-
632B07A9-96BE-4DE2-875E-BB68B39AE92D,T88.1,"Other complications following immunization, not elsewhere classified",-
4C9D1432-18BF-4BDD-988C-FC43E4E54031,U11,Need for immunization against COVID-19,-
83597050-AEC3-4DFF-BA11-CB24A77ACFE2,G43,Migraine,Migraine
83597050-AEC3-4DFF-BA11-CB24A77ACFE2,R51,Headache,-
83597050-AEC3-4DFF-BA11-CB24A77ACFE2,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
77D9FDD9-63D4-46F0-A095-9D8B6F7EB4CB,M62.6,Muscle strain,-
50C523B1-0C93-4068-8D97-F376180599DB,L03.0,Cellulitis of finger and toe,-
34A12209-3CC7-4139-B7B8-E02A4F3FA251,L03.0,Cellulitis of finger and toe,-
1DFC3A11-9769-444E-9097-BBE00E6184AE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DC84B583-B1C1-4AB2-A8BF-AAC013FEEDCE,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
DC84B583-B1C1-4AB2-A8BF-AAC013FEEDCE,K59.1,Functional diarrhoea,-
B37ECA79-3BD8-48B1-B2AF-D84E061F42BE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5AF46AFE-1BE6-4594-99FF-B531F4F34DA4,J06.9,"Acute upper respiratory infection, unspecified",-
02784FD4-72B7-4AE1-9E93-5E5EAD313DE8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
380F74A8-7C6C-4222-B604-557741FE25BC,A09.9,Gastroenteritis and colitis of unspecified origin,-
D283E77D-E73A-4CFA-A7A1-47AB9C7214FA,T88.1,"Other complications following immunization, not elsewhere classified",-
6B189AA2-7FE4-4F26-8509-B945862A61EE,J06.9,"Acute upper respiratory infection, unspecified",-
44A59163-5DDF-4396-A525-5CC777B2912B,A09.9,Gastroenteritis and colitis of unspecified origin,-
44A59163-5DDF-4396-A525-5CC777B2912B,K58.1,Irritable bowel syndrome with predominant diarrhoea [IBS-D],-
2AB88F84-FB8D-45F3-B09B-0C6E175DA1CF,J06.9,"Acute upper respiratory infection, unspecified",-
220E503F-2239-4C84-B3AF-229F533D1E9A,M62.6,Muscle strain,-
39E99710-C093-43AE-9F3D-630E82D26924,N94.4,Primary dysmenorrhoea,-
39E99710-C093-43AE-9F3D-630E82D26924,K59.1,Functional diarrhoea,-
FAC83B08-2E9F-4BE5-908C-69C68642EE11,B35.4,Tinea corporis,-
FAC83B08-2E9F-4BE5-908C-69C68642EE11,L85.3,Xerosis cutis,-
FAC83B08-2E9F-4BE5-908C-69C68642EE11,B35.1,Tinea unguium,-
B613428A-C0FC-4F9C-8C1F-F5BA4B9DEF0E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
81F07E66-CF82-4C28-8177-970D8CD74659,R51,Headache,-
3D7DB461-61D2-47A8-A8B8-8461FAFAD510,Z71.2,Person consulting for explanation of investigation findings,-
5667826B-8C16-4A9E-991B-3348E9F652A8,D22,Melanocytic naevi,-
67E4C615-1711-4C33-A822-7FBF1A32E392,Z02,Examination and encounter for administrative purposes,-
2416F9E3-8195-4FD2-A9F7-541387F0F32D,T88.1,"Other complications following immunization, not elsewhere classified",-
462E8FF5-3C02-4C81-AD19-72F2E8218D7F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
52DDC8DF-F9BA-48B8-956A-D93E63307D4C,J06.9,"Acute upper respiratory infection, unspecified",-
DDC43D60-BB18-4AD1-B569-D615347C03DC,J06.9,"Acute upper respiratory infection, unspecified",-
03A0A8B1-6C13-468B-B419-31D56A39DF6E,N42.9,"Disorder of prostate, unspecified",-
FF139C0F-3B54-4C37-8B35-9C94DEC8FBA0,G44.2,Tension-type headache,-
4FD45555-A821-4A9B-8ABE-69FB3C39F154,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4FD45555-A821-4A9B-8ABE-69FB3C39F154,R50.9,"Fever, unspecified",-
6DB2083C-1DEC-4471-BC76-95CD9EA6C34B,M10.9,"Gout, unspecified",Gout
995E551A-4A13-4B8E-B6EA-B85557F8D27A,R51,Headache,-
F2EA9C87-4A60-4CC6-8614-101D80DC891B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
65CDAB18-4D5C-41B8-A5DA-C1B0A3FD5F23,K64.9,"Haemorrhoids, unspecified",-
6E1AC399-2B5F-4932-9691-986DA5E2873F,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
E0D6CDB3-A39B-4930-91E5-B8172CFCFF21,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
E0D6CDB3-A39B-4930-91E5-B8172CFCFF21,R21,Rash and other nonspecific skin eruption,-
6E1AC399-2B5F-4932-9691-986DA5E2873F,H10.1,Acute atopic conjunctivitis,-
E0D6CDB3-A39B-4930-91E5-B8172CFCFF21,E05,Thyrotoxicosis [hyperthyroidism],Thyroid
6E1AC399-2B5F-4932-9691-986DA5E2873F,J45,Asthma,Asthma
F4985905-6B8D-4451-B193-388C53E5B952,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FA546BE9-A978-4044-ABDC-DA3867471E6A,M79.1,Myalgia,-
9EBD89EB-9C3D-45EE-AB92-4B518767AE7D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
82942E5F-6F33-41B2-BFA6-3FD97CFC6FAB,I25,Chronic ischaemic heart disease,-
82942E5F-6F33-41B2-BFA6-3FD97CFC6FAB,I10,Essential (primary) hypertension,Hypertension
F1787AFF-4584-4F57-B7B2-A2C5867784B0,L50,Urticaria,-
AB001196-1E9D-4C65-94C5-8259930D0153,M23,Internal derangement of knee,-
1E142FF5-335B-4ECF-AC5D-C71928A028E5,A09.9,Gastroenteritis and colitis of unspecified origin,-
D4E1EE39-BD39-4BD8-B901-6ECABA23410A,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
D87EABBE-49D8-4847-8453-B990CA4D09D7,Z02,Examination and encounter for administrative purposes,-
34B89310-94FF-4E51-8CB0-F4D7F42EF636,L20,Atopic dermatitis,Atopic dermatitis
0F357B4F-E031-4D32-909A-DAC1FDEF9C9E,Z71.2,Person consulting for explanation of investigation findings,-
C1CCB72F-8AE7-4EFB-AACA-0B66DD77719A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C4EA04C4-2FD5-4022-8320-3D1794917A1A,N39.0,"Urinary tract infection, site not specified",-
3700ED9D-CE14-45A6-B467-784B5637E6A4,R51,Headache,-
C934EB72-F056-45FA-BFD5-AF3838F62603,S93,"Dislocation, sprain and strain of joints and ligaments at ankle and foot level",-
68ED0A01-1226-4629-AD12-8336F3522024,N32,Other disorders of bladder,-
B74814AF-372E-4614-AAA7-C3ADEED941C6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BA8C281D-AB3D-4DD7-9183-272D4705CA4C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8AFD2BB6-A186-404D-BC39-ADF81E844635,J06.9,"Acute upper respiratory infection, unspecified",-
5D2289B8-39F0-49E7-9712-32BA8648E167,A09.9,Gastroenteritis and colitis of unspecified origin,-
22C6857C-0AAA-487D-9A2F-62FB5E08633E,K30,Functional dyspepsia,-
EF1B9D60-AEC1-4D4E-9BDD-5333682C0C23,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9EDB1636-B319-491D-BBC1-EFA78C179780,R51,Headache,-
B2B6D3E6-0C62-4E3C-BCAB-4ED83B8C60D6,N92.1,Excessive and frequent menstruation with irregular cycle,-
5B6F223A-C7E2-44FD-ABFD-8C8AF9F78F19,J06.9,"Acute upper respiratory infection, unspecified",-
E26AD5E9-E400-4F2E-BE40-D24EF2D92C7C,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
89A18A3B-62CA-49E3-A2B2-B1C0FD9B32C0,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
F7D69CCA-2621-436C-893D-BDA7CF288213,D50,Iron deficiency anaemia,-
F7D69CCA-2621-436C-893D-BDA7CF288213,N94.9,Unspecified condition associated with female genital organs and menstrual cycle,-
23073E18-0D27-4741-A7EC-793537B2F2E3,H01.8,Other specified inflammation of eyelid,-
08C1EDF7-B2BD-4966-9532-C2FE8A3CC4F8,N39.0,"Urinary tract infection, site not specified",-
34B9A4C2-92EE-4AD8-91C2-E96C0C1DC8C0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
34B9A4C2-92EE-4AD8-91C2-E96C0C1DC8C0,R50.9,"Fever, unspecified",-
A20982D0-E8AE-41EC-BF5B-39A0BB319287,N94.6,"Dysmenorrhoea, unspecified",-
B44B1306-6ADC-46FB-8875-0A0D0E6C2441,T88.1,"Other complications following immunization, not elsewhere classified",-
C12F94CD-95FB-433B-AB4D-238920649057,R51,Headache,-
A68265E0-0C3D-41AE-BA1B-A18AB87B193A,J06.9,"Acute upper respiratory infection, unspecified",-
C58595E6-FC30-48AF-A167-CEA12E012A0B,R51,Headache,-
AB3B976C-3EA6-4148-9DB5-0AFB4DD2E3E2,J06,Acute upper respiratory infections of multiple and unspecified sites,-
A5284BE5-9F4C-4801-ACA7-F94887D174D4,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
8080D453-7D1B-4F4E-9329-26CEC7F0E21E,R51,Headache,-
989DDA5B-4A7F-40FB-A5D6-5259E3F4C311,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
17454C57-4689-4AF5-B5F1-369F4F81B73B,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
82B4D668-9F20-43E8-BBEB-F56C8784E551,A09.9,Gastroenteritis and colitis of unspecified origin,-
4895EB7C-DE43-4EA5-B6C9-BE8A1B1F285C,O21.9,"Vomiting of pregnancy, unspecified",-
AFA54A1F-623D-4D8B-8920-E1F6A3ED4BB4,R51,Headache,-
497CA7E0-99F0-42CA-9FE8-1486AB0E1D18,R21,Rash and other nonspecific skin eruption,-
1471F97D-4F89-49E0-83C8-1439B541AE6D,J02,Acute pharyngitis,-
1471F97D-4F89-49E0-83C8-1439B541AE6D,A09.9,Gastroenteritis and colitis of unspecified origin,-
A71A1515-51BD-442A-AB18-4A011E7652B3,J02,Acute pharyngitis,-
A71A1515-51BD-442A-AB18-4A011E7652B3,U07.2,"COVID-19, virus not identified",-
D03659ED-E902-4979-934A-0023B4942A97,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6D705A03-5D3D-480E-8A4D-06B156AE71F3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
24DACE3C-C792-409C-9394-85743F1068B8,Z71.2,Person consulting for explanation of investigation findings,-
7A9B9A96-E332-478A-A785-739B283AB86D,J02,Acute pharyngitis,-
7A9B9A96-E332-478A-A785-739B283AB86D,R53,Malaise and fatigue,-
A12F3116-FE61-4593-B7EC-1A3CCBF339CD,T88.1,"Other complications following immunization, not elsewhere classified",-
A6BA331F-6718-4F53-8735-971F82BF3FB5,R51,Headache,-
AEA315C2-5975-4711-B0FC-496E09623661,M62.6,Muscle strain,-
79F45860-4DAC-402E-87E8-299C7475E36D,R05,Cough,-
79F45860-4DAC-402E-87E8-299C7475E36D,H11.3,Conjunctival haemorrhage,-
79F45860-4DAC-402E-87E8-299C7475E36D,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
79F45860-4DAC-402E-87E8-299C7475E36D,H57.9,"Disorder of eye and adnexa, unspecified",-
31515028-B84F-4744-85D5-C3EB1C93B475,N94.6,"Dysmenorrhoea, unspecified",-
3AF80AE2-E14A-41B8-9D6E-FDC3F35D77D6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5FE39C1B-F817-4A17-AB59-FE90E3B764DF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
738BFC6E-1A47-4656-9A56-29F378551AAB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8BA84B18-E145-4D93-A3F9-EF10D90C6DB3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6CB0D9DC-77D9-4BF9-BB35-6CF2033F9CA0,K30,Functional dyspepsia,-
6CB0D9DC-77D9-4BF9-BB35-6CF2033F9CA0,R11,Nausea and vomiting,-
FA73E6FD-A296-468F-AC5B-9CC2656309F5,M62.6,Muscle strain,-
B1370B73-9458-40F6-83B2-24A8B8692157,R51,Headache,-
B1370B73-9458-40F6-83B2-24A8B8692157,R06.7,Sneezing,-
AB0C7BF5-5252-480B-9BB9-FBB7A2DD07A7,J06.9,"Acute upper respiratory infection, unspecified",-
B38CD476-FE05-4BCA-8786-2EE9F8211C18,A09.9,Gastroenteritis and colitis of unspecified origin,-
648226F3-4CB9-4E13-81EA-BB2B46148CC0,J06.9,"Acute upper respiratory infection, unspecified",-
FE6EBE00-488D-428E-83D3-414F92B49EB0,R51,Headache,-
EF6C2B99-3D10-4A1D-9CDE-850413858E13,J06.9,"Acute upper respiratory infection, unspecified",-
EF6C2B99-3D10-4A1D-9CDE-850413858E13,U07.1,"COVID-19, virus identified",-
01B0329E-F968-4B33-A55E-F01C4212B574,N94.6,"Dysmenorrhoea, unspecified",-
6C5D958B-E2F2-4D9E-A159-7A9CE80FE342,R42,Dizziness and giddiness,-
95AD09F2-5A26-4D35-A39D-A45D052F8D85,R51,Headache,-
E81B51F6-F0AD-4767-8497-BA5B316641AC,T88.1,"Other complications following immunization, not elsewhere classified",-
565C7EC4-6AEB-4417-A16B-36FA023D2DE3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
95AD09F2-5A26-4D35-A39D-A45D052F8D85,J06.9,"Acute upper respiratory infection, unspecified",-
38B53625-A13D-45D1-8407-1859E6AF77B8,K29.7,"Gastritis, unspecified",-
E8532EBB-063D-4E53-BB30-55919A2A2F9B,K59.0,Constipation,-
1D06DA69-2B7B-44DC-A626-AA40D74B9CB7,J02,Acute pharyngitis,-
1D06DA69-2B7B-44DC-A626-AA40D74B9CB7,U07.1,"COVID-19, virus identified",-
ED45670E-F119-40DE-A6CE-AF75D2A5270A,Z01.7,Laboratory examination,-
53862C45-B1DD-4525-AFCB-6E44CEB7394B,M62.6,Muscle strain,-
DB4CA8FC-2ED6-4316-847A-4850D6CF9C8C,M54.5,Low back pain,-
DB4CA8FC-2ED6-4316-847A-4850D6CF9C8C,R07.0,Pain in throat,-
89A48A2C-B4DB-4419-BC70-EF0B02F4A85D,I10,Essential (primary) hypertension,Hypertension
A3B0EC71-5287-4D78-B871-F3F54400518E,R51,Headache,-
8B39019B-F07C-46CA-8922-16C2454FA215,M62.6,Muscle strain,-
FB34FF84-3B91-4090-B6B8-657359DA592F,E11.9,Type 2 diabetes mellitus without complications,Diabetes
D6A3438B-E09B-4DF2-9539-815443C28A62,R51,Headache,-
1AB24752-E5F1-4557-B290-21A5371C7A51,S81,Open wound of lower leg,-
1AB24752-E5F1-4557-B290-21A5371C7A51,G43,Migraine,Migraine
1AB24752-E5F1-4557-B290-21A5371C7A51,W09,Fall involving playground equipment,-
1AB24752-E5F1-4557-B290-21A5371C7A51,R52,"Pain, not elsewhere classified",-
0CB6B7E6-CB66-4A6F-BA6C-52C197730138,K62,Other diseases of anus and rectum,-
9E11717A-00BC-4038-B0D2-3B7DD61D01B2,U07.1,"COVID-19, virus identified",-
9E11717A-00BC-4038-B0D2-3B7DD61D01B2,J06.9,"Acute upper respiratory infection, unspecified",-
8CF84F71-DC20-418C-A26B-C53276B52C57,J06.9,"Acute upper respiratory infection, unspecified",-
1C9D4970-B1B8-454E-B7B6-061A5EA1422B,R50.9,"Fever, unspecified",-
1C9D4970-B1B8-454E-B7B6-061A5EA1422B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0355D572-EA14-43CA-94D4-C8B93E4C3A7E,M62.6,Muscle strain,-
6129C975-541F-4F53-B8B0-35919860FC6C,A09.9,Gastroenteritis and colitis of unspecified origin,-
8EE983C0-38AA-4C6A-9369-8015B33C817B,A09.9,Gastroenteritis and colitis of unspecified origin,-
9EAD4A52-6F78-470C-8E7C-66FB2CE5909C,Z71.2,Person consulting for explanation of investigation findings,-
2293B530-E460-4FDD-9FE7-DC17E6DEA8FD,L71.0,Perioral dermatitis,-
2293B530-E460-4FDD-9FE7-DC17E6DEA8FD,B00,Herpesviral [herpes simplex] infections,-
D4EE7A9A-3181-4E20-A1FA-7645E8DC3E3B,K29.1,Other acute gastritis,-
D4EE7A9A-3181-4E20-A1FA-7645E8DC3E3B,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
BE405D31-1550-40F1-9BBB-068DCDF3D6A4,R51,Headache,-
BE405D31-1550-40F1-9BBB-068DCDF3D6A4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
76D1D530-E7DF-4B56-96FB-917D94EB9F08,K30,Functional dyspepsia,-
76D1D530-E7DF-4B56-96FB-917D94EB9F08,R21,Rash and other nonspecific skin eruption,-
11775166-02BE-4C91-9BF1-D98F809B34A6,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
11775166-02BE-4C91-9BF1-D98F809B34A6,I10,Essential (primary) hypertension,Hypertension
11775166-02BE-4C91-9BF1-D98F809B34A6,I88.9,"Nonspecific lymphadenitis, unspecified",-
A0BEA7BC-9BFF-4DCF-A3CD-475EAEFF8635,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BAE2FA48-6EE1-4D10-B9E9-B0C11AADF589,W55,Bitten or struck by other mammals,-
1239D0F5-A643-4F25-B906-25BE5C13F977,J06.9,"Acute upper respiratory infection, unspecified",-
1239D0F5-A643-4F25-B906-25BE5C13F977,L20,Atopic dermatitis,Atopic dermatitis
6CFBD395-98A4-4DE1-95EF-262DD8158BA0,K29.7,"Gastritis, unspecified",-
6CFBD395-98A4-4DE1-95EF-262DD8158BA0,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
B3BF0B92-A429-44C0-96C8-136009353403,H60.0,Abscess of external ear,-
B3BF0B92-A429-44C0-96C8-136009353403,L02,"Cutaneous abscess, furuncle and carbuncle",-
6129F7BE-3CD0-431B-A79C-178EC469A8B9,R51,Headache,-
1AD19782-47EB-4504-9F0E-28AAF61B89FD,M79.1,Myalgia,-
1AD19782-47EB-4504-9F0E-28AAF61B89FD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8957D1E0-EFDA-4E7D-88D9-7A976AB6F4FE,A09.9,Gastroenteritis and colitis of unspecified origin,-
F14FC694-F5B5-46CF-8582-061BD73C50DB,L74.0,Miliaria rubra,-
11EEBDF0-8084-423B-8CCE-AB75E493C39B,A09.9,Gastroenteritis and colitis of unspecified origin,-
11EEBDF0-8084-423B-8CCE-AB75E493C39B,K30,Functional dyspepsia,-
5A0E7350-A5A8-4F37-A841-4C160FC8021F,G44.1,"Vascular headache, not elsewhere classified",-
E22DD148-213E-4DF2-BA8E-E2DDD89821B9,R07.0,Pain in throat,-
526978CB-1626-4127-B251-143437914732,J06.9,"Acute upper respiratory infection, unspecified",-
8EA247ED-7DDE-489C-975E-E9701796A25D,U07.1,"COVID-19, virus identified",-
FCC672F0-7F53-430A-9282-64DA9183B84D,G44.2,Tension-type headache,-
5E956A5D-0A1D-4EF9-8BF2-D76DE343E2BA,L02.9,"Cutaneous abscess, furuncle and carbuncle, unspecified",-
20DE36F4-A132-4010-807B-B3A20F3649FA,Z71.2,Person consulting for explanation of investigation findings,-
841A24F7-2C0D-44B5-954B-3F3BA6BE4A65,H57.9,"Disorder of eye and adnexa, unspecified",-
FDC7D03D-F119-4FD9-A1C7-09AA46AAAF06,R51,Headache,-
158854E4-8473-4D25-8DE7-7BE380E2EB26,T88.1,"Other complications following immunization, not elsewhere classified",-
DA3BEBFA-8FEB-4C0C-86F9-B593DE0F9E67,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6D089C29-5159-4924-B7AC-B632E7A8E951,M62.6,Muscle strain,-
91DAB636-B628-45FB-B239-57182EEED387,J06.9,"Acute upper respiratory infection, unspecified",-
EE26BFA5-362D-471C-BCCD-B735BDF51CE4,K29.7,"Gastritis, unspecified",-
E04A4254-3150-4ECD-B877-6BB1E1E77171,H10.9,"Conjunctivitis, unspecified",-
E04A4254-3150-4ECD-B877-6BB1E1E77171,H57.9,"Disorder of eye and adnexa, unspecified",-
9A40AB5E-4806-49B4-88BD-A2EC16A75121,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
663F6511-391F-49CA-BC98-88B526779B97,A09.9,Gastroenteritis and colitis of unspecified origin,-
C617322D-9B45-4D5E-94CF-D06E04CC4E39,L70,Acne,-
F186110B-5859-41A3-9D9F-88F49C2274A6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
894AE077-BCE2-4828-90CE-F98787BEAD33,M54.5,Low back pain,-
A43B767B-8D6F-4FB1-94A3-15F2716DF54C,N76.0,Acute vaginitis,-
D9E47A30-9D75-4774-ABED-CFEDED88D876,L03,Cellulitis,-
CC975548-778E-4326-962A-5FF291B3A89D,R51,Headache,-
CC975548-778E-4326-962A-5FF291B3A89D,J06.9,"Acute upper respiratory infection, unspecified",-
FA2DB3CF-7971-4D47-9B4F-4A5440403D49,K64.9,"Haemorrhoids, unspecified",-
FA2DB3CF-7971-4D47-9B4F-4A5440403D49,K59.1,Functional diarrhoea,-
771857FA-2DBF-42CB-BDE9-DA85F937683E,U07.1,"COVID-19, virus identified",-
55581473-7CB5-4BE2-AF75-35AE9657EEF1,Z30,Contraceptive management,-
4FC0DB6C-9EA4-484D-9B73-0E0114A13B4C,N39.0,"Urinary tract infection, site not specified",-
FD7127D3-65B6-4236-9580-E1E48876533D,K29.7,"Gastritis, unspecified",-
D33192E8-B010-4C3E-AFCF-92F95BD74CA9,A09.9,Gastroenteritis and colitis of unspecified origin,-
565E86B7-5D94-49E2-93AB-F86A59B07703,U07.1,"COVID-19, virus identified",-
2E789DAA-47C4-4989-984C-2EB8941D5BBE,U07.1,"COVID-19, virus identified",-
5A8306B2-26E5-4FD6-815F-E1A202AEFCFC,H57,Other disorders of eye and adnexa,-
74527712-01F6-4A7A-AC1E-818C1000D772,K59.0,Constipation,-
E7FF5B9A-71C0-49DE-AFF4-56D8C3F39810,U07.1,"COVID-19, virus identified",-
708BA3A6-C253-4646-AC87-11B73D8C69BF,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
C195F7F7-C516-4DCD-82B6-C62033D5B659,N39.0,"Urinary tract infection, site not specified",-
50558C5B-A93B-45FE-BE0F-0A9CD5977347,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
517BBCE2-7FAB-4ECC-B5D9-4C220A37CA1D,R50.9,"Fever, unspecified",-
517BBCE2-7FAB-4ECC-B5D9-4C220A37CA1D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0AD48391-9193-469C-B63A-E8BFF32692C3,L30.9,"Dermatitis, unspecified",-
0AD48391-9193-469C-B63A-E8BFF32692C3,K29.7,"Gastritis, unspecified",-
0AD48391-9193-469C-B63A-E8BFF32692C3,H57.9,"Disorder of eye and adnexa, unspecified",-
DD466BDB-D271-4813-B4F5-1FF8EC4FD15B,T88.1,"Other complications following immunization, not elsewhere classified",-
89F270C3-057F-444F-898F-4E08B036790D,L50.9,"Urticaria, unspecified",-
89F270C3-057F-444F-898F-4E08B036790D,Z76.0,Issue of repeat prescription,-
89F270C3-057F-444F-898F-4E08B036790D,K13,Other diseases of lip and oral mucosa,-
89F270C3-057F-444F-898F-4E08B036790D,M62.6,Muscle strain,-
89F270C3-057F-444F-898F-4E08B036790D,M25.5,Pain in joint,-
E466432D-E493-42CA-9998-48A673BA5F7E,D50,Iron deficiency anaemia,-
D169AEC2-37D8-4BBD-8625-2F7218D83DF0,H02,Other disorders of eyelid,-
5F3198D5-2F18-4CB6-A4F4-0633BADBA81E,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
F16EDC54-044E-4F57-845A-224956F02B14,T88.1,"Other complications following immunization, not elsewhere classified",-
B9D35B11-E199-4B55-AAB2-B210EC0C04A6,R51,Headache,-
AE90737F-C9E5-46E9-9889-F1FDFA1E1ACB,G44.1,"Vascular headache, not elsewhere classified",-
7DA25678-735C-474B-9E96-C4EC837CC923,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1B830BEF-8FB8-48A2-B50C-7D30F19F72A8,M51.1,Lumbar and other intervertebral disc disorders with radiculopathy,-
7AABCA45-7501-4A5E-812D-7A25E325B684,M79.6,Pain in limb,-
2FB402F8-7B25-4EA0-BF26-BAF1A2539E0B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
461D4CA7-0517-48D8-A7CA-AEBB11C6F2FE,Z02,Examination and encounter for administrative purposes,-
C5FE66A5-70F9-4009-B93D-59E5BF043DE1,J06.9,"Acute upper respiratory infection, unspecified",-
1040AAD7-B823-45C1-8C80-83D4441AB520,S46.0,Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder,-
1040AAD7-B823-45C1-8C80-83D4441AB520,M75.1,Rotator cuff syndrome,-
83C80E75-41A1-4623-98BA-8B555AAA33E6,R51,Headache,-
674823AF-928D-4E59-8489-1F75B978172D,R50.9,"Fever, unspecified",-
674823AF-928D-4E59-8489-1F75B978172D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
76BF4519-4ABA-4B8E-9E00-36559A2F8BA5,A09.9,Gastroenteritis and colitis of unspecified origin,-
BAE768BB-162C-48B1-811B-7ED7E683B486,P39.0,Neonatal infective mastitis,-
F362E53D-891E-448F-A587-D128C1413667,P39.0,Neonatal infective mastitis,-
2C456084-1B2C-47F9-B789-7BDD2FB54816,Y42.4,Oral contraceptives,-
2C456084-1B2C-47F9-B789-7BDD2FB54816,N77.1,"Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere",-
65D4A2B7-E362-4C96-B3EE-19653C962D1A,Z71.2,Person consulting for explanation of investigation findings,-
4C2BC160-560C-48AE-AA84-297175E83E48,S93.4,Sprain and strain of ankle,-
589BEDB5-8237-4376-8790-1277CC3D7F53,R51,Headache,-
FA9B8FAE-2C17-4FF8-BE46-996B98D0A59E,A09.9,Gastroenteritis and colitis of unspecified origin,-
41DC7776-87C4-4C64-9B66-61233FF5C17D,E03.9,"Hypothyroidism, unspecified",Thyroid
1F1BD224-ACE1-4EBB-A033-ED3D5831F7CC,A09.9,Gastroenteritis and colitis of unspecified origin,-
4D11D1F0-D73A-4BC9-B461-1AB95287556F,R22.9,"Localized swelling, mass and lump, unspecified",-
040FB6B0-0EED-44FF-BC53-71262D90E3C3,T88.1,"Other complications following immunization, not elsewhere classified",-
8F6E3805-3A05-49B1-85AF-E897144C9491,T88.1,"Other complications following immunization, not elsewhere classified",-
036A0F09-D1DD-4BE8-8308-FD2250937879,M54.5,Low back pain,-
C4B84215-AFCC-41B9-AE6F-0E8F591E00DB,A09.9,Gastroenteritis and colitis of unspecified origin,-
C4B84215-AFCC-41B9-AE6F-0E8F591E00DB,T88.1,"Other complications following immunization, not elsewhere classified",-
3AA84512-17C7-4C9C-A565-43A9B68AF87A,Z02,Examination and encounter for administrative purposes,-
5CB88868-8B19-4FA5-9E87-1E200283038A,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
921DE2C4-6E40-4A09-B972-4853B1EF0D83,Y42.4,Oral contraceptives,-
921DE2C4-6E40-4A09-B972-4853B1EF0D83,A09.9,Gastroenteritis and colitis of unspecified origin,-
FDFE0FDB-4705-47A1-A3FE-FD080903DB7A,J06.9,"Acute upper respiratory infection, unspecified",-
CBC4BD0F-205E-4137-A2AF-9287E3106A6B,J06.9,"Acute upper respiratory infection, unspecified",-
56772412-9FF8-4E14-82AC-9D102691F898,R53,Malaise and fatigue,-
7AE851EF-0FC0-4230-993C-1F0F423E173A,U07.1,"COVID-19, virus identified",-
56772412-9FF8-4E14-82AC-9D102691F898,U07.1,"COVID-19, virus identified",-
335EF7A7-F074-4F49-B99A-F880C08F19AB,J06.9,"Acute upper respiratory infection, unspecified",-
EFB617B7-9734-47EC-8BB7-D234EE9DE80A,M62.6,Muscle strain,-
152140D5-7102-4B41-9F16-68A54CFC184D,J06,Acute upper respiratory infections of multiple and unspecified sites,-
68DD8103-4A67-4ED6-969A-A0958EC5BD8D,J06.9,"Acute upper respiratory infection, unspecified",-
29C54701-667B-4C99-A13E-24E5B913FA08,J06.9,"Acute upper respiratory infection, unspecified",-
2D271723-B500-4775-8CC4-E5D52D4A8F2C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8CA2769F-5E06-4AF2-8AD5-A6337130455F,J30.3,Other allergic rhinitis,Vasomotor and allergic rhinitis
8CA2769F-5E06-4AF2-8AD5-A6337130455F,G44.2,Tension-type headache,-
7FE81E8D-8165-4549-A5CC-EA6058A286BB,S00.5,Superficial injury of lip and oral cavity,-
BB1FC55B-8820-4002-80E2-CBF59D8E1EB7,A09.9,Gastroenteritis and colitis of unspecified origin,-
6BD5F926-FACE-4A42-9C12-1AF71991C40A,Z71.2,Person consulting for explanation of investigation findings,-
9B2B0242-0FFC-44DF-A660-F8B465E9C996,U07.2,"COVID-19, virus not identified",-
2C21CE10-8227-4721-B70F-7CD7C10C1CD1,J45,Asthma,Asthma
74D33620-A271-4255-8B6D-4C66607A2EF2,R51,Headache,-
74D33620-A271-4255-8B6D-4C66607A2EF2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
766258A1-B7D2-43B6-BE78-251EE65EBFB2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EDBFF5AE-12BE-4C68-BF77-5DD1E3D6511E,J06.9,"Acute upper respiratory infection, unspecified",-
8332EDAC-3FA1-4E02-802D-88241BC02E99,I88.9,"Nonspecific lymphadenitis, unspecified",-
BF6F4B95-EA62-4916-8A63-1F4A65F9A060,K13,Other diseases of lip and oral mucosa,-
92114D92-F6A8-4389-8826-7EDABCD9ECC2,J06.9,"Acute upper respiratory infection, unspecified",-
F654701A-AB96-4481-AF28-F5F1EDE016A7,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
2756D1F4-7841-4D42-87A4-AE7D3D957C99,K30,Functional dyspepsia,-
2756D1F4-7841-4D42-87A4-AE7D3D957C99,R50.9,"Fever, unspecified",-
E3888F2A-00E2-4137-A595-C81F00AB69C6,R51,Headache,-
16FF4656-72CE-491A-840C-A4241048AA99,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
714BDDBF-1AAF-4973-B5E8-0E85EB3EB7E6,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
70DC54C9-3B5B-4444-81A4-65EF29968713,N92.6,"Irregular menstruation, unspecified",-
949ACD8A-93C2-4F5D-A21E-8FDA7286901C,G44.2,Tension-type headache,-
6416C2D3-54D7-49F4-864B-EDF65A24187C,N39.0,"Urinary tract infection, site not specified",-
F521B12B-FEE6-4A1E-881F-B771F5899B0B,Z02.9,"Examination for administrative purposes, unspecified",-
CBE3F04B-FDBF-4778-B384-A6992BA0A884,J02,Acute pharyngitis,-
036FACD4-2BDD-4EBC-8660-F0A468D524B7,M79.1,Myalgia,-
E2F4DF8F-0214-438E-95A8-18CFC9C0DC7B,L30.9,"Dermatitis, unspecified",-
E2F4DF8F-0214-438E-95A8-18CFC9C0DC7B,K30,Functional dyspepsia,-
23894D1E-9F89-450F-AFA8-62F9B02E5AA4,R51,Headache,-
36020A1E-54DC-4215-A8C9-1A65B9E002B5,N94.6,"Dysmenorrhoea, unspecified",-
8847284E-76C1-4327-AD16-3600A7040052,N94.6,"Dysmenorrhoea, unspecified",-
FF6201E0-E83F-4BC9-8F95-FE4D31C7259F,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
FF6201E0-E83F-4BC9-8F95-FE4D31C7259F,I70.8,Atherosclerosis of other arteries,-
BF63332C-01C3-4053-B54C-18B8E1EB7887,R51,Headache,-
01C5F9D9-838F-43C8-86B7-18C68FCD7512,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
94B9676E-9462-42BA-9041-84267B1617BA,P39.0,Neonatal infective mastitis,-
BF7AB993-6ACA-4A8C-ADB6-16FD3A08DCFB,Z71.2,Person consulting for explanation of investigation findings,-
79200ECD-24A7-4DD1-A11B-B5F04D18847E,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
3E6ECB83-24E3-4538-BFF3-24CC31CFAB43,Z71.2,Person consulting for explanation of investigation findings,-
B576698A-109E-4671-B3DC-39D2F1B425DB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7F6B9959-D6D2-4EC1-9926-B08747C053B4,T88.1,"Other complications following immunization, not elsewhere classified",-
35D88DE4-CD35-460E-8142-DA31A5ACC61C,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
35D88DE4-CD35-460E-8142-DA31A5ACC61C,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
3EF8EFA4-6478-493C-ACE3-337D7858603C,H57,Other disorders of eye and adnexa,-
4339BB21-2177-4083-A9D5-A267C31F4A02,T88.1,"Other complications following immunization, not elsewhere classified",-
4FD31BCD-CF60-4704-8D8F-A5DFF529E076,S13.4,Sprain and strain of cervical spine,-
1A025B4F-3FE3-4245-9E33-F566A91BAB18,N94.6,"Dysmenorrhoea, unspecified",-
B16FBBE7-0265-4113-8D6F-E1BBAF997427,A09.9,Gastroenteritis and colitis of unspecified origin,-
0812C799-2483-42F1-92BC-B325477FE630,J06.9,"Acute upper respiratory infection, unspecified",-
99DA6C22-848C-4182-A2B7-830079E32C5B,K29.6,Other gastritis,-
52AB1A48-A112-4BBF-9A0E-C9B7FF288E69,U07.1,"COVID-19, virus identified",-
2674A8ED-DEF6-42C9-8C49-26FDC2BB884B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1AE9966A-1AF3-4776-ABA7-6FD2F1DA1AAC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2CBDB834-AC44-439A-BC3A-7882F6E29E01,A09.9,Gastroenteritis and colitis of unspecified origin,-
369468DA-D939-4E69-94E6-82391EFB325E,K29.7,"Gastritis, unspecified",-
44E19892-05FF-4AF6-9A0E-379A9B82F818,Z30,Contraceptive management,-
E5C7D648-CFEC-4B90-957D-A90D6BF4C287,N94.6,"Dysmenorrhoea, unspecified",-
883A8EDF-BFCC-4C4C-B1B5-7931AEC2F113,J06.9,"Acute upper respiratory infection, unspecified",-
49462065-F817-43F0-B7D9-B5E9646D4052,R51,Headache,-
DEC646E0-F8E1-4757-8453-A8C1EC9D909E,T88.1,"Other complications following immunization, not elsewhere classified",-
CA27CB71-5A76-45D5-B9AB-0FB8EAD9E66A,R00.2,Palpitations,-
A736E395-AE90-47F0-831D-2BC942526B17,J06.9,"Acute upper respiratory infection, unspecified",-
8AEF5520-BB74-4594-8DC1-C51664B9697A,H01,Other inflammation of eyelid,-
4BA213F0-5125-47B3-A62D-85595B2D4D89,M79.1,Myalgia,-
4BA213F0-5125-47B3-A62D-85595B2D4D89,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
ACC1F5DE-615D-4235-9DF1-8EA8EEDA104E,R51,Headache,-
D66B579E-0EC2-4689-9294-0E4803C36DED,R51,Headache,-
5DBFDCFD-6943-45DA-9CDC-DBA1B2C9AD69,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
C6229EAC-E048-44DB-90DA-B3FF599DFFA3,A09.9,Gastroenteritis and colitis of unspecified origin,-
806F3236-2BFA-41DA-9727-3CD665FBBC66,Z71.2,Person consulting for explanation of investigation findings,-
B4AC8E0D-FDDD-46C0-81E0-3658B19B9E4D,Z71.2,Person consulting for explanation of investigation findings,-
900BEEC3-B79C-4419-BA44-8D7577D0543B,M79.1,Myalgia,-
E12126A4-EA26-450B-BD6B-596D2A72978C,J06.9,"Acute upper respiratory infection, unspecified",-
E2A95FC0-DA55-4FEC-B349-7D811840A415,J06.9,"Acute upper respiratory infection, unspecified",-
7BFC1DF1-C3D9-4A6B-A138-B6520F282CAC,J06.9,"Acute upper respiratory infection, unspecified",-
B81C62DB-25AC-4852-8C69-4988BB85FEC1,J06.9,"Acute upper respiratory infection, unspecified",-
D5C307A7-B180-4997-9D2F-6DB9EF2F14F5,J06.9,"Acute upper respiratory infection, unspecified",-
0F7633AD-C832-47BA-9D2B-A6FFFFFCE482,U09,Post COVID-19 condition,-
D1905D2C-A3FD-414F-BE68-A4EA57070D66,F41,Other anxiety disorders,-
88F0F760-ABEB-4CA2-A8C0-146EE04B699E,N94.6,"Dysmenorrhoea, unspecified",-
D72FC8F6-5DCC-4C6C-8B6B-97510243F9DA,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
8B559355-78DC-4A41-A138-E2424AEFE078,R51,Headache,-
341CB553-5118-47CB-B9F7-CAFE3C8AE838,A09.9,Gastroenteritis and colitis of unspecified origin,-
2E6A3DEC-25A7-48C7-8D96-3A095D5DA43F,J06.9,"Acute upper respiratory infection, unspecified",-
58B7EC9A-41C4-4295-885F-D9D083F20BF1,J02,Acute pharyngitis,-
C1628C09-2F07-40C9-A196-DB1307D6A6CE,Z02.9,"Examination for administrative purposes, unspecified",-
79144862-D84E-459B-99A2-EB6FD34ADDE0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5B05763B-6111-4415-98EC-B4E10ECEF95D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7391055D-BBB2-4411-A6E8-485D61CE5882,H81.1,Benign paroxysmal vertigo,-
ABA9746B-E3E4-43F7-88F0-8A03B0B42F0B,H81.1,Benign paroxysmal vertigo,-
E929D7DA-F825-49B9-A2AA-38D58B85BBFE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A586A7A4-7382-4715-8AF2-090CCF8BCD2B,N94.6,"Dysmenorrhoea, unspecified",-
A586A7A4-7382-4715-8AF2-090CCF8BCD2B,Z76.0,Issue of repeat prescription,-
6D3FB203-B1F3-4307-BB96-CBB1B87C2032,K50.9,"Crohn disease, unspecified",-
90A004E2-785F-475D-9058-8B6038E3128C,H02.9,"Disorder of eyelid, unspecified",-
06FBF7F5-1A9A-41BB-87B9-9B191B85C956,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
547C00DF-A9BA-4794-8D35-D0955CA9FFB2,H57.9,"Disorder of eye and adnexa, unspecified",-
547C00DF-A9BA-4794-8D35-D0955CA9FFB2,J02.9,"Acute pharyngitis, unspecified",-
ED4484D2-9E9E-4574-AC06-4EC2EF256D41,J06.9,"Acute upper respiratory infection, unspecified",-
7983812F-51D4-466A-B472-C66A9366FC04,J06.9,"Acute upper respiratory infection, unspecified",-
7B7AD36E-FA44-4819-B106-56BFE288372C,K29.7,"Gastritis, unspecified",-
1B3333DF-99DD-47ED-9FFB-FCDD799539C1,K29.7,"Gastritis, unspecified",-
072B924B-12BF-4AD8-B5C9-A0B5A683ADC0,T88.1,"Other complications following immunization, not elsewhere classified",-
CB16924E-AC23-4CD3-953E-915D0A431843,J06.9,"Acute upper respiratory infection, unspecified",-
B62AB501-202E-4D91-AD45-9A374467E413,S92.5,Fracture of other toe,-
C4938057-97A7-4714-B37F-830C952D7BB8,L20,Atopic dermatitis,Atopic dermatitis
8A3D583A-7719-4F8C-A277-1DC95B059B61,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C4938057-97A7-4714-B37F-830C952D7BB8,K59.0,Constipation,-
4E4DBBB3-88A0-4402-A641-0F45743C2353,Z02.9,"Examination for administrative purposes, unspecified",-
1F0D466C-5774-4840-8F3B-69A17879B89A,N94.6,"Dysmenorrhoea, unspecified",-
F7771BC8-30FC-4D4E-AAC5-B86C9CD12C35,G44.1,"Vascular headache, not elsewhere classified",-
58815D67-D78B-409D-B33B-57C0B7635FD6,J06.9,"Acute upper respiratory infection, unspecified",-
F243D43C-D426-4B1A-812B-66602F327781,J06.9,"Acute upper respiratory infection, unspecified",-
A3A7809B-64BB-45F0-9D86-0FAA7D8DBE8A,A09.9,Gastroenteritis and colitis of unspecified origin,-
5F54C5AA-56AE-4AE4-8D23-62DBB041AEAA,S33.5,Sprain and strain of lumbar spine,-
FF679F8D-D761-46CA-8AB0-291205E7925E,N94.6,"Dysmenorrhoea, unspecified",-
28453779-989C-4197-86E7-F576F4B25230,G43,Migraine,Migraine
F912FD31-5186-448A-ADCE-3D4B40328BF1,J06.9,"Acute upper respiratory infection, unspecified",-
20DB2693-B237-4A44-AB80-9ABF39B5E721,G44.2,Tension-type headache,-
FF960F1F-5948-4FC2-A96E-B7A08C3D2525,R51,Headache,-
FF960F1F-5948-4FC2-A96E-B7A08C3D2525,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9196EE88-F754-480E-A4C5-E49CA13C716E,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
C8454961-16B3-4B5F-9B93-DBD6F503BA56,H57,Other disorders of eye and adnexa,-
5367E4CB-15DD-4BC2-9129-39A2E38291C3,Z71.2,Person consulting for explanation of investigation findings,-
D47003DC-4C30-433D-B01B-E3D3BB34D0F2,K64.9,"Haemorrhoids, unspecified",-
B75212B9-DB05-4788-8280-64DDCAD1C731,N39.0,"Urinary tract infection, site not specified",-
DFC475BD-55D8-4B55-9AF8-362D14D4D44A,U07.1,"COVID-19, virus identified",-
DFC475BD-55D8-4B55-9AF8-362D14D4D44A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7A73C864-20E9-4257-B816-06D0DA3C6907,J06.9,"Acute upper respiratory infection, unspecified",-
7A73C864-20E9-4257-B816-06D0DA3C6907,J45,Asthma,Asthma
F9DF9E19-7686-49D4-BA74-CCA5F025C298,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
DFCF9819-589C-418D-B9BF-74B79412A5E6,L03.9,"Cellulitis, unspecified",-
AB8CB450-A7F1-4260-8007-EC2752F9F9D4,J06.9,"Acute upper respiratory infection, unspecified",-
EC0A7289-79C0-4F9D-ACD3-3576D82FD0B6,R51,Headache,-
90A2F141-CE3B-44D1-8CD4-9D9A9D2DAC54,J06.9,"Acute upper respiratory infection, unspecified",-
C7038B0F-6C01-4F23-ADCD-34823E3F168D,K14.0,Glossitis,-
4190F76A-A637-43DC-8E08-DFAEA1D02807,A09.9,Gastroenteritis and colitis of unspecified origin,-
43632A8E-BFEB-4B60-9E2E-E576D448B2B4,R10.4,Other and unspecified abdominal pain,-
1E07BBE4-0CEC-4413-9670-AF4C47B3DEA5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
313A4D9D-49D1-4EDA-880B-5FA704EB8D18,J06.9,"Acute upper respiratory infection, unspecified",-
D01EA821-640A-486E-98FB-F49AD449C529,J06.9,"Acute upper respiratory infection, unspecified",-
2AA04066-DCE5-448E-8A53-4725CB55453D,Z71.2,Person consulting for explanation of investigation findings,-
04E1CA64-6F80-46B2-9ADA-D44AF528B533,N94.6,"Dysmenorrhoea, unspecified",-
8FD8E275-C225-4FA8-9869-C6B04AEE71A6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7B661EE4-E14A-4798-9DC9-C20E043F04F1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
047D797B-3C52-4697-8CA8-D6E07AD8D7E9,A09.9,Gastroenteritis and colitis of unspecified origin,-
D7000D78-D9AD-4058-8149-2204A2161727,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
9C3F4D91-1083-43E8-BEBF-72AD1D512E09,R51,Headache,-
88EE078F-402C-4BF5-9358-B225CFB4278C,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
88EE078F-402C-4BF5-9358-B225CFB4278C,E11.9,Type 2 diabetes mellitus without complications,Diabetes
88EE078F-402C-4BF5-9358-B225CFB4278C,K30,Functional dyspepsia,-
88EE078F-402C-4BF5-9358-B225CFB4278C,I10,Essential (primary) hypertension,Hypertension
88EE078F-402C-4BF5-9358-B225CFB4278C,H02,Other disorders of eyelid,-
F7A19985-6B12-41F7-9301-8E1CCC79267C,I10,Essential (primary) hypertension,Hypertension
FB1907DD-FFF3-43F7-B55A-37E77B14F204,A09.9,Gastroenteritis and colitis of unspecified origin,-
19ED25A8-3B83-4FA5-8CD9-13E139C24116,A09.9,Gastroenteritis and colitis of unspecified origin,-
5F50478C-C7D0-4BD3-97F2-A183919498FC,G44.2,Tension-type headache,-
DCAEDC10-32E1-48D1-8FF1-20F0B94B1AB6,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
80DEC33D-FCFD-4363-9900-2CD73922D9A8,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
80DEC33D-FCFD-4363-9900-2CD73922D9A8,N64.9,"Disorder of breast, unspecified",-
25CDAF34-DD60-4227-A072-D28541FFD240,R21,Rash and other nonspecific skin eruption,-
F563F58F-CCDB-416B-A613-212F9ED367E8,J06.9,"Acute upper respiratory infection, unspecified",-
D7678BB3-E0F9-4E86-932C-718EE7806CD2,J06,Acute upper respiratory infections of multiple and unspecified sites,-
AC8F9EA3-2931-4ED9-A16F-3D3526E3E6B3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
27EB0D83-4235-411C-9D37-9B9E4BC4876E,A09.9,Gastroenteritis and colitis of unspecified origin,-
760CC7E2-8828-4177-B55C-D7B697D5BF7E,R11,Nausea and vomiting,-
55898D7E-2680-4006-A003-951F0BE8F15D,G44,Other headache syndromes,-
F022A046-1654-41AA-B2A5-3457FDD25EAE,T88.1,"Other complications following immunization, not elsewhere classified",-
211A5CD0-DE7C-44E7-B20B-6533D800AC2F,R50.9,"Fever, unspecified",-
211A5CD0-DE7C-44E7-B20B-6533D800AC2F,A09.9,Gastroenteritis and colitis of unspecified origin,-
6F4E67AB-2E66-43EF-98BC-63808F8AB552,J06.9,"Acute upper respiratory infection, unspecified",-
D084D28B-872D-4C52-80B2-48D050DADF8A,T88.1,"Other complications following immunization, not elsewhere classified",-
658D54E4-4E61-4A32-B4DC-8664CBBFB2F7,M79.1,Myalgia,-
A894203F-382A-4900-AB4E-D7CDF4CAF0E2,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
A894203F-382A-4900-AB4E-D7CDF4CAF0E2,K58,Irritable bowel syndrome,-
DD218B93-F539-4385-878B-09311F8DC3E3,L24,Irritant contact dermatitis,-
5BB09612-75DB-4DE8-92CA-F29264ED0D52,N80.9,"Endometriosis, unspecified",-
5BB09612-75DB-4DE8-92CA-F29264ED0D52,N39.0,"Urinary tract infection, site not specified",-
9C89AD9C-0A07-4F77-A234-B7C0C1CECD6E,L29.0,Pruritus ani,-
9C89AD9C-0A07-4F77-A234-B7C0C1CECD6E,K12,Stomatitis and related lesions,-
16C2F822-D33B-4FDD-B939-A92F8E9B9AEA,A09.9,Gastroenteritis and colitis of unspecified origin,-
AC2D1E3B-8C95-4639-B38C-FF6FEB6A3110,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
36BDCF4E-D8B8-4DAA-AB09-4DFA603B0BE9,T88.1,"Other complications following immunization, not elsewhere classified",-
394BAA21-D3E9-46B0-A984-7CF9F5068890,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
DD477E87-ABC9-4879-A135-D44123E98E49,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
CFF817BD-D6AC-4C08-A83D-2CD91776FD0F,K64.9,"Haemorrhoids, unspecified",-
D1B4BD83-A980-4EB3-8E73-A55D63B32927,R51,Headache,-
87C6E153-70EB-4D1B-BB79-9929E5E87516,G44,Other headache syndromes,-
3F2B7C82-0005-4956-9948-69AF3E067AE8,T88.1,"Other complications following immunization, not elsewhere classified",-
7C89A378-BC1C-4BF9-92FA-578D14F89E86,R51,Headache,-
C91B34CA-759C-40CA-92B6-3FED63D9B40B,R51,Headache,-
65D1CBD8-8E12-4A06-B59D-5BB825D681A5,A09.9,Gastroenteritis and colitis of unspecified origin,-
65D1CBD8-8E12-4A06-B59D-5BB825D681A5,R51,Headache,-
C27AB128-D5B5-415D-B3F3-C8119B06AA9B,A09.9,Gastroenteritis and colitis of unspecified origin,-
8E80D303-D4BC-44A3-B7C4-56FC3813D19B,R51,Headache,-
1C7E456B-CA13-4BF4-80B5-08C16692F3B4,J06.9,"Acute upper respiratory infection, unspecified",-
2BD3C7F2-FFB1-4135-AF3D-D757287311DC,J06.9,"Acute upper respiratory infection, unspecified",-
2F86B281-C28A-4FCF-A2E6-B1743852E17C,A09.9,Gastroenteritis and colitis of unspecified origin,-
60B717FA-F55E-4548-9B1F-1D5D29CCCDC5,K29.7,"Gastritis, unspecified",-
57541342-A844-408C-8352-ABE9E64E202A,R51,Headache,-
1AB7F6ED-E368-49A9-AB85-7EF3DA13DD6B,S60.2,Contusion of other parts of wrist and hand,-
E4DA24AF-E348-42E5-B930-2AAA99E8E620,U07.1,"COVID-19, virus identified",-
E4DA24AF-E348-42E5-B930-2AAA99E8E620,J06.9,"Acute upper respiratory infection, unspecified",-
0449260D-25FB-499B-9BD2-3BB32B9C60D4,T88.1,"Other complications following immunization, not elsewhere classified",-
89C3A04B-E1A3-4B06-83F2-5B2421AC04C1,H10.1,Acute atopic conjunctivitis,-
57104C0C-48B7-4A9D-8419-D24553B69ABA,H10.1,Acute atopic conjunctivitis,-
CACFC1FB-DA05-4EC2-A814-754FAA139FD6,N39.0,"Urinary tract infection, site not specified",-
89C3A04B-E1A3-4B06-83F2-5B2421AC04C1,L30.9,"Dermatitis, unspecified",-
04416897-3F94-4C4D-B71A-9B514D2E76CC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
04416897-3F94-4C4D-B71A-9B514D2E76CC,R51,Headache,-
F06357C4-8D4F-4130-A0E3-E6374596A23D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0CC8EB05-35F7-4799-BF49-AD828574009A,R51,Headache,-
0CC8EB05-35F7-4799-BF49-AD828574009A,A09.9,Gastroenteritis and colitis of unspecified origin,-
AA27FE2C-505F-4F93-9AB0-0C79CC7BD6B8,M54.5,Low back pain,-
7140DFD7-3317-4C1C-B54C-172876CC17F0,R51,Headache,-
5A607633-EE74-4FA5-B927-4E342983A97C,M54.5,Low back pain,-
2696B87A-E217-4195-9F48-B007C3A318DB,R42,Dizziness and giddiness,-
2696B87A-E217-4195-9F48-B007C3A318DB,R11,Nausea and vomiting,-
163FBB0B-9D7E-4213-BACD-376D9C1628FB,N39.0,"Urinary tract infection, site not specified",-
140F8B88-9E28-45A4-B293-172A3F85C835,A09.9,Gastroenteritis and colitis of unspecified origin,-
D023A454-98FA-491D-AF25-7DBEE331B1D2,R51,Headache,-
EA8719BA-F833-4F87-A4A3-15172D4B1883,L99.8,Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere,-
AD889D7E-E9A6-49B3-A65F-40A68F57E7F4,J38.2,Nodules of vocal cords,-
5EAF4B50-9EA5-4AA4-B590-F70B6052CC06,J03,Acute tonsillitis,-
AD889D7E-E9A6-49B3-A65F-40A68F57E7F4,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
1201160D-6D13-4278-8443-9C34017A0AE8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E3B6CCCE-4C40-42FB-90E6-23E8591BB63B,R51,Headache,-
E3B6CCCE-4C40-42FB-90E6-23E8591BB63B,H81.1,Benign paroxysmal vertigo,-
208CF6F7-E410-47A4-AE0B-5B69936541B7,G44,Other headache syndromes,-
71054427-D69E-4104-9680-6BC9DFA37310,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1D835021-B079-4A05-B3D2-9263A83C31F3,M54.5,Low back pain,-
E0274B4C-82EF-4D08-9448-C73AFBFA58A4,L20,Atopic dermatitis,Atopic dermatitis
AAEF7510-C62B-4D80-8D6E-67A5E1C4D347,J30.3,Other allergic rhinitis,Vasomotor and allergic rhinitis
84D1DEBA-23BB-48DD-AAA0-FA5ECFBF3790,R51,Headache,-
12782CDB-A646-4ACA-B0B0-95230B4B60DA,J06.9,"Acute upper respiratory infection, unspecified",-
432BD1DA-68F2-4F5D-95DA-AE8399410273,K29.7,"Gastritis, unspecified",-
800A9064-38E9-43EF-B85D-D3376E956494,R51,Headache,-
800A9064-38E9-43EF-B85D-D3376E956494,M62.6,Muscle strain,-
716E78FA-4097-4514-B1A3-A1E40B02A17B,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
E31BB1D6-6763-4A2D-B6D8-D954651B4CD1,R51,Headache,-
53E9AEE0-A585-4D18-A72C-9C1AE7E3CB76,Z71.2,Person consulting for explanation of investigation findings,-
0957DC00-62B7-4CE6-9B93-0298399CD434,K12.0,Recurrent oral aphthae,-
B766E07A-A4AB-4309-BE85-2ED7398C8728,G44,Other headache syndromes,-
58F62FEB-640D-4EB3-AC7A-40065E47D548,N94.6,"Dysmenorrhoea, unspecified",-
F7EA8B88-4F87-4F66-BD79-83146C44EA69,A09.9,Gastroenteritis and colitis of unspecified origin,-
2994C853-4636-4F3F-8DCA-E68F401BC543,A09.9,Gastroenteritis and colitis of unspecified origin,-
2994C853-4636-4F3F-8DCA-E68F401BC543,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E6A6EA87-CB68-4199-A0F9-EA44EB007F90,J06.9,"Acute upper respiratory infection, unspecified",-
562E3EF2-CE52-4D18-8E96-7B8F3EB9F9B7,J06,Acute upper respiratory infections of multiple and unspecified sites,-
E6A6EA87-CB68-4199-A0F9-EA44EB007F90,H00.1,Chalazion,-
55498B50-D165-44D7-9A20-85834A0C01B3,M79.1,Myalgia,-
E68D4016-A435-4820-BEAC-3E45AD86A217,R42,Dizziness and giddiness,-
DD12C9AD-1BB4-40C1-8006-51B6F6657CA7,K59.1,Functional diarrhoea,-
C6982691-E8A3-4B9B-8791-4F7AEE3A1FDD,H01,Other inflammation of eyelid,-
0EEE38EB-5907-4478-A715-8353115E158E,U07.1,"COVID-19, virus identified",-
FEB77109-567D-428F-AC94-02CCFE5E7707,A09.9,Gastroenteritis and colitis of unspecified origin,-
12278713-250E-4A96-9CB5-48F765F3DCE2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A70B04E9-ABF2-470A-9FC1-527FB547E8CA,L50,Urticaria,-
A70B04E9-ABF2-470A-9FC1-527FB547E8CA,K59.1,Functional diarrhoea,-
5C4F5CA3-8500-4BC1-8396-B4EAF6A6D43E,R21,Rash and other nonspecific skin eruption,-
A70B04E9-ABF2-470A-9FC1-527FB547E8CA,R21,Rash and other nonspecific skin eruption,-
0F0269A9-43DA-4F0F-A5B9-01004D2BBB76,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
3127B4D0-A998-4491-91D8-DBB063F4396C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
ED66764B-4E02-4105-919D-A84F1B57B793,R21,Rash and other nonspecific skin eruption,-
ED66764B-4E02-4105-919D-A84F1B57B793,R51,Headache,-
F85366C6-AEAC-45F5-BB49-8789CB061CD9,A09.9,Gastroenteritis and colitis of unspecified origin,-
F19CC63D-2301-4886-91D6-0DDF2CFA8612,J45,Asthma,Asthma
6BDFCB93-73E6-4E3F-A977-4026B31809D1,J06.9,"Acute upper respiratory infection, unspecified",-
2F9E71C1-9DFD-4AEF-8AF0-FE833D4BFFF9,H10.1,Acute atopic conjunctivitis,-
BBA7C34B-AE7D-48BC-A2C7-C29454DC0BC7,S60.0,Contusion of finger(s) without damage to nail,-
BEC9DFCC-3761-4D24-9974-D110517AC7E4,S60.0,Contusion of finger(s) without damage to nail,-
F2B974A6-E2C5-429E-A1E8-E319A1F8317D,H00,Hordeolum and chalazion,-
A976D5CE-FB34-4D3D-8EE2-87978080C1C2,T88.1,"Other complications following immunization, not elsewhere classified",-
A4E513F1-CF7B-4BC7-ABDD-41A7A615F030,R42,Dizziness and giddiness,-
A4E513F1-CF7B-4BC7-ABDD-41A7A615F030,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D2D0EEE9-CA1C-4721-8E79-C8BF03400261,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B6832654-71C5-4A6C-BA84-A9EFFCD02D0F,R10.4,Other and unspecified abdominal pain,-
B6832654-71C5-4A6C-BA84-A9EFFCD02D0F,K59.0,Constipation,-
87E2ADFB-F8C2-4118-B52F-1B23EFF3CAC7,G43,Migraine,Migraine
C153A602-FAB9-459C-8C01-6AAB087F52B6,T88.1,"Other complications following immunization, not elsewhere classified",-
A6B088E5-6610-45BA-803F-1BC4C03983F2,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
A6B088E5-6610-45BA-803F-1BC4C03983F2,Z76.0,Issue of repeat prescription,-
A6B088E5-6610-45BA-803F-1BC4C03983F2,M10,Gout,Gout
A6B088E5-6610-45BA-803F-1BC4C03983F2,H00.1,Chalazion,-
A6B088E5-6610-45BA-803F-1BC4C03983F2,J45,Asthma,Asthma
4B9A314D-B3B3-4A14-9C12-5982E64103DB,J06.9,"Acute upper respiratory infection, unspecified",-
C146C1B0-00F2-40A1-A476-D5EC86E2EB44,A09.9,Gastroenteritis and colitis of unspecified origin,-
C146C1B0-00F2-40A1-A476-D5EC86E2EB44,K30,Functional dyspepsia,-
2E3ADDC4-8D19-49E2-8F7B-E8CBF37A8EEF,R51,Headache,-
10B0441E-81B0-4303-A82C-3836306C7D1B,R51,Headache,-
3814CDCF-BFE3-4551-AEF9-2682BC8BC8CA,T88.1,"Other complications following immunization, not elsewhere classified",-
FF63BAD5-8E05-45ED-A8D8-343C76A7DE84,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E3993C83-ED51-46A8-B088-B52DCF40C9A9,J06.9,"Acute upper respiratory infection, unspecified",-
E3993C83-ED51-46A8-B088-B52DCF40C9A9,U07.1,"COVID-19, virus identified",-
6DEBEAA3-5BF7-4114-97DF-9DE5225B9CBD,H57.9,"Disorder of eye and adnexa, unspecified",-
983F4940-B1A2-47B1-8CB1-F55CB6EE1E84,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
04C169BF-A53D-49EA-9509-B2513BA14E6E,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
A897A7C9-A1F8-46F4-92BD-AAAF5B79606C,R51,Headache,-
04C169BF-A53D-49EA-9509-B2513BA14E6E,R51,Headache,-
04C169BF-A53D-49EA-9509-B2513BA14E6E,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
24C66B39-CFC9-4216-AF5F-6F33B8365FFB,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
24C66B39-CFC9-4216-AF5F-6F33B8365FFB,R19.4,Change in bowel habit,-
24C66B39-CFC9-4216-AF5F-6F33B8365FFB,M54.5,Low back pain,-
DD4371F9-9549-47AA-B18F-ADE163DA115D,L02.9,"Cutaneous abscess, furuncle and carbuncle, unspecified",-
0F6D2D82-30B1-4D6A-A24B-9581B6CE257A,R50.9,"Fever, unspecified",-
0F6D2D82-30B1-4D6A-A24B-9581B6CE257A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0AEA53AF-CA32-4BA5-892B-E5F8885FFC25,J06.9,"Acute upper respiratory infection, unspecified",-
333E8A8F-20F3-49F4-ADFA-37464CD36B9D,R51,Headache,-
600D868F-A804-42A9-82D1-4FF3716AE4BD,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
1F00C93F-2967-4BEA-B7A5-942F2A2E25FC,K59.0,Constipation,-
D6F22729-8169-485E-9B6D-8003BE1E6AC1,J06.9,"Acute upper respiratory infection, unspecified",-
2FC183F2-3A9B-46C4-B76D-1CFC90D7E718,J06.9,"Acute upper respiratory infection, unspecified",-
014D2B8E-4D61-4C91-AFF0-062C60D6933A,J06.9,"Acute upper respiratory infection, unspecified",-
179C610A-085F-4F6E-8F0B-CFB5A01EDF53,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B52183A3-1621-4AB8-9394-F8BA28BB64B6,Z71.2,Person consulting for explanation of investigation findings,-
CCECD7B3-A406-4987-AA7D-96B91C99DDBD,R51,Headache,-
00F34ECD-A7DE-4413-AD61-10174B598BB0,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
00F34ECD-A7DE-4413-AD61-10174B598BB0,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
59F31893-5E45-497E-9AD0-499324870390,T88.1,"Other complications following immunization, not elsewhere classified",-
3F8A13F5-D424-4CD1-BDAA-F72A4EEEEF9C,J06.9,"Acute upper respiratory infection, unspecified",-
38F10E78-0DA1-4055-8737-A98B2BA528FD,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
FC0D7A6E-6CF4-4682-A15A-5D2D9A2DB495,A09.9,Gastroenteritis and colitis of unspecified origin,-
00B69F57-7E11-4F42-9E96-3BCC8362FF91,N94.6,"Dysmenorrhoea, unspecified",-
B5F3155C-5133-4584-B8BB-24A17BB8E9AB,R51,Headache,-
B0EBD536-BBA4-4FA7-8F65-DF6680E79A75,M76.6,Achilles tendinitis,-
A700A872-F1CE-4114-80E5-CF75E09993BD,G44.2,Tension-type headache,-
B0EBD536-BBA4-4FA7-8F65-DF6680E79A75,M72.2,Plantar fascial fibromatosis,-
8007DFC0-540F-46CD-BB1D-EDFBD76669DA,M54.5,Low back pain,-
C996C38D-8226-4FD2-AD01-78419EB8D0E6,R51,Headache,-
C996C38D-8226-4FD2-AD01-78419EB8D0E6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6BB19B97-6423-4769-A200-99EB4FB9A255,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
6BB19B97-6423-4769-A200-99EB4FB9A255,K29.7,"Gastritis, unspecified",-
02784FD4-72B7-4AE1-9E93-5E5EAD313DE8,R50.9,"Fever, unspecified",-
90816711-3562-4915-8231-9314F796EB59,J06.9,"Acute upper respiratory infection, unspecified",-
D9D52C9E-9314-4E24-9779-65DC5AFE8815,X51,Travel and motion,-
B0F153D1-7C7C-45B5-97DF-12F93C5AD129,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B0F153D1-7C7C-45B5-97DF-12F93C5AD129,H57,Other disorders of eye and adnexa,-
3234FCFA-6995-4A8D-818D-3D477008D793,L04,Acute lymphadenitis,-
EBD8D47D-A323-4452-BA25-DEB142F04E62,N94.6,"Dysmenorrhoea, unspecified",-
3E2338B7-B226-48DC-A2D7-6BE82B727880,J06.9,"Acute upper respiratory infection, unspecified",-
D2FE127F-D1FA-4A21-8C0B-4DF78DF4938E,J06.9,"Acute upper respiratory infection, unspecified",-
66A9D424-F75C-45BC-B11F-E0C522016628,U08,Personal history of COVID-19,-
C5853D0F-C973-49DF-A8B1-1D175D0318D4,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
C5853D0F-C973-49DF-A8B1-1D175D0318D4,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
C5853D0F-C973-49DF-A8B1-1D175D0318D4,I10,Essential (primary) hypertension,Hypertension
3D0B2CB9-750F-4A6C-9E10-3396C18921D9,N94.6,"Dysmenorrhoea, unspecified",-
2FE6A184-5917-4BF9-9CB9-6F146AD1E5AE,A09.9,Gastroenteritis and colitis of unspecified origin,-
2D3BB4C7-2520-4E88-A3DF-1A0908582E9E,A09.9,Gastroenteritis and colitis of unspecified origin,-
3CE283A5-DF3A-4D27-B61D-01B11CFBB92F,M79.1,Myalgia,-
7B8545E9-6707-40E9-9AEA-462FE4F330F3,N94.6,"Dysmenorrhoea, unspecified",-
D3A20287-7B52-4343-A57A-B46249CB3A14,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
D3A20287-7B52-4343-A57A-B46249CB3A14,R51,Headache,-
91CA2C68-EAD3-44B2-90E2-54D2794E1E6B,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
91CA2C68-EAD3-44B2-90E2-54D2794E1E6B,J45,Asthma,Asthma
FC6496E8-2C89-4B94-8B3C-31DA508F502C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7B19D0F4-C8CD-4271-A73B-CF6F2EA0C7EB,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
E68E664A-2035-4EFA-97C1-969E2BFE39F4,R51,Headache,-
8AD48E86-5776-4443-A8D7-1ADA4B3382C7,J06,Acute upper respiratory infections of multiple and unspecified sites,-
693A2945-4C8B-47C3-8440-F2662B46FF20,J45,Asthma,Asthma
AB54E630-F0FC-4FB1-B095-60090CECFB4A,Y42.4,Oral contraceptives,-
811D9A34-5BF7-4A10-AD5A-A49F547DE6F9,A09.9,Gastroenteritis and colitis of unspecified origin,-
251272DB-6198-48E5-B5A2-9DAAADADB24D,J06.9,"Acute upper respiratory infection, unspecified",-
D8B79903-E300-4583-8B8E-ED2AFB8CA797,A09.9,Gastroenteritis and colitis of unspecified origin,-
92075D09-09AD-4E42-AF2E-47F7676DD6AF,J06.9,"Acute upper respiratory infection, unspecified",-
82CADA1B-49CB-44B0-9A79-5291190CA14F,J06.9,"Acute upper respiratory infection, unspecified",-
CB5137FB-2031-45C5-A7A5-B58B929BF1BA,H57.9,"Disorder of eye and adnexa, unspecified",-
5604774C-22A9-445A-8402-ABB6C208E42F,R21,Rash and other nonspecific skin eruption,-
568C276D-F5CB-4208-A5AB-FFB6C31566BD,Y42.4,Oral contraceptives,-
2EAE1848-99F7-441C-AC9E-71F4DD804299,L70,Acne,-
2EAE1848-99F7-441C-AC9E-71F4DD804299,N94.6,"Dysmenorrhoea, unspecified",-
12C8CEFB-01CF-4F84-A98B-1D81C74C698B,N94.6,"Dysmenorrhoea, unspecified",-
12C8CEFB-01CF-4F84-A98B-1D81C74C698B,A09.9,Gastroenteritis and colitis of unspecified origin,-
D62C4637-88C2-4F90-B240-7B5FB144D107,G44,Other headache syndromes,-
5B03AC5D-D5E2-4800-8A82-F2CFD9933F6A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D094A326-19EF-4B3C-8E7C-3895540B0B05,G43,Migraine,Migraine
3BC26FE6-A45A-4CDD-BA2E-47758E65B1CD,S93.4,Sprain and strain of ankle,-
C98FCFF7-78DE-4EE0-B300-187AC0F82B88,J06.9,"Acute upper respiratory infection, unspecified",-
E071E9CC-9A4B-42F8-9C79-EA12CE703C2E,A09.9,Gastroenteritis and colitis of unspecified origin,-
07BEC711-974A-4123-8E11-6FE5F3147F31,R21,Rash and other nonspecific skin eruption,-
B66C8372-5BC1-4AC0-9714-514CF66749CD,R50.9,"Fever, unspecified",-
B66C8372-5BC1-4AC0-9714-514CF66749CD,M79.1,Myalgia,-
6284A8FC-2EB3-4C5C-BBDA-F711FD2EA2FB,J06.9,"Acute upper respiratory infection, unspecified",-
6284A8FC-2EB3-4C5C-BBDA-F711FD2EA2FB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EB2985D8-A29B-4F46-A100-E10591A87BC4,K52,Other noninfective gastroenteritis and colitis,-
B8662EC0-2F6A-4F9F-9B28-F0DCE807AEBB,R51,Headache,-
599FBC44-E612-4036-BAB4-981F139FA7C4,R51,Headache,-
599FBC44-E612-4036-BAB4-981F139FA7C4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E5AFAD63-58B4-4A7F-9154-B637C3EA25EC,J06.9,"Acute upper respiratory infection, unspecified",-
BC236776-2A78-4895-AA2E-A8FF503E6EA8,J06,Acute upper respiratory infections of multiple and unspecified sites,-
69900A2B-7173-4789-9CA6-D9906D4F2DF8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
72FDF8AF-4654-4081-A304-BF89A985A84E,B08.5,Enteroviral vesicular pharyngitis,-
72FDF8AF-4654-4081-A304-BF89A985A84E,J03.9,"Acute tonsillitis, unspecified",-
06504726-509C-4A1E-8B70-8CFCB61B427A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
B19B4FFD-13EA-4B2B-A786-4027600E8BB9,N94.6,"Dysmenorrhoea, unspecified",-
8333473D-60EB-44A7-84B3-DC0D94192FB8,Z71.2,Person consulting for explanation of investigation findings,-
EE61E3EE-F263-4FC7-9829-A82F6ED8D589,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
EE61E3EE-F263-4FC7-9829-A82F6ED8D589,I10,Essential (primary) hypertension,Hypertension
19942562-56C5-4EF7-85A1-D2A72B498E6E,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
19942562-56C5-4EF7-85A1-D2A72B498E6E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
19942562-56C5-4EF7-85A1-D2A72B498E6E,J45,Asthma,Asthma
253820B1-74D7-46E9-B1B8-730ACF45BF9B,N39.0,"Urinary tract infection, site not specified",-
FB533F2E-2554-46FC-AF18-A878E4D4BAE7,Y42.4,Oral contraceptives,-
E7BD311D-EAC9-4239-92E7-37E4BE955D7C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E07E5D4E-BA7E-48EB-A9FD-F06BF1E72572,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DB3080A6-E3E7-4E21-9F7E-CFCD1FDCEBE8,M10,Gout,Gout
7AD9969F-F3EE-444A-8365-B486328C2165,A09.9,Gastroenteritis and colitis of unspecified origin,-
1BD3F1AF-104F-453B-AF82-D7C123CAC268,M62.6,Muscle strain,-
1BD3F1AF-104F-453B-AF82-D7C123CAC268,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4DF06547-4C43-42A0-8B0D-DABD752B869D,R21,Rash and other nonspecific skin eruption,-
0B1C5B2E-C29E-4F9A-9F99-F2AC3A2EE1D9,L03.1,Cellulitis of other parts of limb,-
B65250DA-5AEC-49FC-BCE3-E9058E44B3E4,G44.2,Tension-type headache,-
256F68A8-39CF-4A65-9559-BA5398A00137,L29,Pruritus,-
764BBAD6-9B6A-40CF-ADEA-D7A3F9341DFB,R51,Headache,-
99F485DE-D4AB-4FEB-B3FB-3BF48FA604FC,M79.1,Myalgia,-
99F485DE-D4AB-4FEB-B3FB-3BF48FA604FC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A472A04D-BB0D-4E08-B3AB-4266211C6E79,S60,Superficial injury of wrist and hand,-
C3B2B3F8-35B7-4A2F-866C-F2CD0AD78FC6,R50.9,"Fever, unspecified",-
D0548F90-E0ED-46D6-8273-97E3D940FEBB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D7268D06-D81F-4813-B189-13C523B2A924,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
AEA4B276-CE95-42FA-BA14-475E302B6903,Z76,Persons encountering health services in other circumstances,-
8D173E17-A4F7-415C-8D05-759BDB49AE46,Z71.2,Person consulting for explanation of investigation findings,-
45C93CE1-ACC9-492B-B7BE-89AD7681CAD5,A09.9,Gastroenteritis and colitis of unspecified origin,-
6EE7831D-9842-4EA3-8DF4-0D888CA4D52B,E03.9,"Hypothyroidism, unspecified",Thyroid
F44EC0FD-36EC-4922-B40E-1345541A7058,E03.9,"Hypothyroidism, unspecified",Thyroid
77D69AA3-A2B0-4E80-9DEB-C628D3264A78,R51,Headache,-
BBF0600F-8BA0-421A-A178-3CA6E2E10387,B00,Herpesviral [herpes simplex] infections,-
C853FBC8-2E41-437E-A1C1-94D9D888EE34,L50.9,"Urticaria, unspecified",-
8A8DFB77-3237-44F0-B736-54D6E71A2C3B,L50,Urticaria,-
D9422731-B5ED-4A8C-8689-6743DC706E8F,R21,Rash and other nonspecific skin eruption,-
D9422731-B5ED-4A8C-8689-6743DC706E8F,N39.0,"Urinary tract infection, site not specified",-
BE405D31-1550-40F1-9BBB-068DCDF3D6A4,H10.1,Acute atopic conjunctivitis,-
4656ED77-4D43-44F5-90A6-B93E50D7343F,N94.4,Primary dysmenorrhoea,-
0E3A6B2A-6CD4-4417-B8CE-B1A14FEBD025,N94.6,"Dysmenorrhoea, unspecified",-
BE7C0D6F-9B97-40EE-9106-06C2E048D48D,N39.0,"Urinary tract infection, site not specified",-
1A714A0C-B238-4B5C-AAEC-CCC3EA68ACE1,R22.4,"Localized swelling, mass and lump, lower limb",-
2F9D9672-7467-43EE-B939-AEDC70D229BE,J06.9,"Acute upper respiratory infection, unspecified",-
95888414-6964-4480-A905-4E9432DE39FB,R51,Headache,-
2CA2FDEC-9AF0-40FA-B178-A10E2089FADF,J06.9,"Acute upper respiratory infection, unspecified",-
565E86B7-5D94-49E2-93AB-F86A59B07703,J06.9,"Acute upper respiratory infection, unspecified",-
89410585-6E6A-4258-8386-AE4D86BF9296,H01.0,Blepharitis,-
AF88A893-8B6E-49D0-88FD-48773C59E39C,J06.9,"Acute upper respiratory infection, unspecified",-
26426A2B-6906-433F-827A-CD22D06DC580,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
109CD216-4C61-49BF-AF65-855005947C4F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A0BE82AA-A294-4368-B92A-78B4A78FC624,L50.9,"Urticaria, unspecified",-
60A0D23A-A4C1-4713-A096-6A5987DC1125,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
964655C4-8F23-4F5A-9464-CEFCAA07A181,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
964655C4-8F23-4F5A-9464-CEFCAA07A181,R50.9,"Fever, unspecified",-
52ACD706-3E03-41F1-96CD-66A2D6C1DB6E,Z71.2,Person consulting for explanation of investigation findings,-
0CB93C46-AFD2-45B0-9C7D-F5BC2BB89BCC,R51,Headache,-
7FFD2951-0CA6-4C9C-9A7C-8D19BC1DC6A6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0917F0BD-2E3E-4C75-B6CF-1DB237F0C389,H57,Other disorders of eye and adnexa,-
91E01D32-3919-456D-9F5E-6446B801DF47,K08.9,"Disorder of teeth and supporting structures, unspecified",-
C1A05EAC-6C7B-4AB8-80E8-3A3CFDB63A89,L50,Urticaria,-
F28E7A3E-9550-4269-8985-EB081C8CAD37,T88.1,"Other complications following immunization, not elsewhere classified",-
F4A97B82-031D-4650-B158-0F15F9D64B1E,T88.1,"Other complications following immunization, not elsewhere classified",-
E634065F-B7E8-403D-8E4E-84D45DAA9308,H57,Other disorders of eye and adnexa,-
E634065F-B7E8-403D-8E4E-84D45DAA9308,N94.6,"Dysmenorrhoea, unspecified",-
77FCAAD2-E45E-4C00-89E0-9E85FF6DD314,H02.9,"Disorder of eyelid, unspecified",-
77FCAAD2-E45E-4C00-89E0-9E85FF6DD314,H00,Hordeolum and chalazion,-
3F75061B-2507-44AF-B6FA-6138130B3628,A09.9,Gastroenteritis and colitis of unspecified origin,-
1774DF96-BB1A-4611-B409-F121C73605D8,U07.1,"COVID-19, virus identified",-
581AF2C9-A6E1-4175-9DE6-21E10A74A93C,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
581AF2C9-A6E1-4175-9DE6-21E10A74A93C,I10,Essential (primary) hypertension,Hypertension
D67731F9-E9F3-40A9-A6C9-BA8191CCAFEB,R51,Headache,-
B7859274-EBC9-48C5-BE4B-7CEEEFBD46A3,K12.0,Recurrent oral aphthae,-
AE590949-DA5E-4B0E-A71C-2E1D7C57ED2E,K13,Other diseases of lip and oral mucosa,-
B9F9B062-C35B-4D87-8887-EAAA0DCEA7F8,R21,Rash and other nonspecific skin eruption,-
C92A544B-611E-44EE-A43E-547C405A8747,J06,Acute upper respiratory infections of multiple and unspecified sites,-
5BA412D7-C5D7-4B54-BB84-8932608AF3A1,J06.9,"Acute upper respiratory infection, unspecified",-
52F14182-F54E-43C9-AE11-DE07D9603AAF,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
52F14182-F54E-43C9-AE11-DE07D9603AAF,K30,Functional dyspepsia,-
5221AEDF-7C72-48F4-B8AC-87F49CB5711C,R50.9,"Fever, unspecified",-
5B2F0236-50E1-4F10-B325-17339980B605,R11,Nausea and vomiting,-
17D412C9-3541-4F1F-9ABF-93CE2AC71957,J06.9,"Acute upper respiratory infection, unspecified",-
E56EFC5E-0C34-4FF8-962F-E60AFF8028AD,J06.9,"Acute upper respiratory infection, unspecified",-
E56EFC5E-0C34-4FF8-962F-E60AFF8028AD,L30.9,"Dermatitis, unspecified",-
426DC04F-83C0-42E5-855D-E441F7034848,H57,Other disorders of eye and adnexa,-
BE130331-6972-4C1F-A9B2-48E14CF12F1E,J06.9,"Acute upper respiratory infection, unspecified",-
98A39E0C-0911-4240-A8DA-4CFDCB205AE7,T88.1,"Other complications following immunization, not elsewhere classified",-
DCF81EC3-ECA3-4644-AF34-11165647EEAC,H00.1,Chalazion,-
7BB669DD-F011-43D4-9ADF-C731C59E2904,R50.9,"Fever, unspecified",-
7BB669DD-F011-43D4-9ADF-C731C59E2904,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BCB58DDD-B78E-49E8-B7B1-9E07374076CF,Z71.2,Person consulting for explanation of investigation findings,-
C63D4993-CD8C-405C-B628-30D2F59B0003,H00.1,Chalazion,-
8E6A57FB-4A8A-4C6B-A7F1-4211E4E795A7,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
F5B151FC-2234-4088-B2BB-E1A04CEBE5C5,A09.9,Gastroenteritis and colitis of unspecified origin,-
65E58002-D884-4F84-A8D1-6E90EB9DA538,U07.1,"COVID-19, virus identified",-
7896EDC5-CD9D-4229-A349-18DF72BB859C,J06.9,"Acute upper respiratory infection, unspecified",-
D2BBCBF0-05D9-4149-AE80-2D63C00C3CEA,M54.5,Low back pain,-
45ABC9ED-77DB-4D55-A2B5-2CEC7BA74A5E,G44.2,Tension-type headache,-
0B1C5B2E-C29E-4F9A-9F99-F2AC3A2EE1D9,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
2EFDFB60-C607-4A85-98DE-1D0ECD3993CC,T88.1,"Other complications following immunization, not elsewhere classified",-
F0F52DBA-B134-45B9-B1D5-764EE53CD6EA,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
45704D14-C5EE-4AEA-9409-BDD684DCF2F6,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
74DC08AD-924C-4B19-BCC6-E97D30C6E71F,T88.1,"Other complications following immunization, not elsewhere classified",-
EC491138-9685-456C-ADFF-8E04C41D79BD,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
5B953E2C-CDD8-4F64-B9E2-643C84F14358,J06.9,"Acute upper respiratory infection, unspecified",-
C695398B-EB7A-4592-B9AC-2DE7A1596172,Y56.0,"Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified",-
C695398B-EB7A-4592-B9AC-2DE7A1596172,B36.1,Tinea nigra,-
B95BE8CA-100C-441F-88CD-7413754EA048,K29.7,"Gastritis, unspecified",-
D66B0585-BBC8-4EBF-8A05-E856C8BE4B52,H00,Hordeolum and chalazion,-
D66B0585-BBC8-4EBF-8A05-E856C8BE4B52,H02.9,"Disorder of eyelid, unspecified",-
29944012-5BBA-4DE5-8E82-6B6BE52ADB35,L30.9,"Dermatitis, unspecified",-
29944012-5BBA-4DE5-8E82-6B6BE52ADB35,R21,Rash and other nonspecific skin eruption,-
51C898E9-43C2-4361-9632-5C9E2341D6A3,T88.1,"Other complications following immunization, not elsewhere classified",-
0D334736-BD31-4D0F-8965-CB80650D24FA,U07.1,"COVID-19, virus identified",-
3A1A4AD5-9E46-464C-BBDE-793E0C29B947,A09.9,Gastroenteritis and colitis of unspecified origin,-
3A1A4AD5-9E46-464C-BBDE-793E0C29B947,K30,Functional dyspepsia,-
453A8F8D-D094-447C-B0DF-F99B8C5AE8EB,E61.1,Iron deficiency,-
453A8F8D-D094-447C-B0DF-F99B8C5AE8EB,Z71.2,Person consulting for explanation of investigation findings,-
4AB7F03A-B43E-4D4F-99E4-875825E12977,L20,Atopic dermatitis,Atopic dermatitis
5CEB4251-A27C-4D1D-9EC6-B158222F5EA5,N39.0,"Urinary tract infection, site not specified",-
32A9F4B7-2362-4643-8E1B-EFFC2776AE02,R51,Headache,-
340A0D0A-E08F-440D-A710-BA418473C2A7,Z02.9,"Examination for administrative purposes, unspecified",-
C3299E8D-F9CF-4CEE-98DD-5F88A5BD9D7F,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
7DFEA4D8-81D8-4030-82D9-1409DEAE8D3F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
94C552B0-EB44-4FC6-9BD9-2308245A0453,T88.1,"Other complications following immunization, not elsewhere classified",-
F2C124D3-DD03-48F2-8488-E2C952C941B4,T22,"Burn and corrosion of shoulder and upper limb, except wrist and hand",-
CAC8A24E-10AE-4B9D-91B1-31B2E9986096,M79.1,Myalgia,-
F8FD0080-2583-4FCE-A81A-EBAF01323443,A09.9,Gastroenteritis and colitis of unspecified origin,-
1F3EE49B-7103-4E19-BF22-D841AAACDCD1,K59.0,Constipation,-
F56A24AF-97EF-4964-82BB-E0DCE1412A18,A09.9,Gastroenteritis and colitis of unspecified origin,-
B6781AF0-8832-4031-AC7F-8959742BE6F4,M10,Gout,Gout
764C7A7C-0A5F-44BB-9724-DAAA14F22EB4,L20,Atopic dermatitis,Atopic dermatitis
D3015ECA-3942-404B-AD09-A51A0E405B05,J06.9,"Acute upper respiratory infection, unspecified",-
1F3B3EAD-013B-4EBF-82A6-03C80BC32F50,N39.0,"Urinary tract infection, site not specified",-
FB936A36-C5EC-450E-BF93-5C56ADC0D550,U07.1,"COVID-19, virus identified",-
FB936A36-C5EC-450E-BF93-5C56ADC0D550,J06.9,"Acute upper respiratory infection, unspecified",-
F756B5C3-E00A-4692-ABB9-E4F03D81D388,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E8B7F156-DBF1-4BF7-864A-F31C8A84FCC6,J06.9,"Acute upper respiratory infection, unspecified",-
B58B2B3E-0D36-4B5D-9F7E-00B32ABF2F66,M54.5,Low back pain,-
5D8645FD-C0E7-4460-9FEA-45B36BF40750,T88.1,"Other complications following immunization, not elsewhere classified",-
7FF5E41B-C73B-401A-AE50-F102833CE628,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D2BE668D-2476-4FB3-B4DF-D080FABDE918,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0250B85A-27B1-412F-9712-2646C14DA4A2,L03.2,Cellulitis of face,-
992B6672-7F06-49DA-9B3C-36FF34ED3AE2,M62.6,Muscle strain,-
9C982FD9-3B72-4279-B743-D50F7560811B,R51,Headache,-
457167AA-81FB-49D1-B71A-A7A7499E3861,Z30,Contraceptive management,-
2056FE01-6DBC-417A-BE1B-1661E6043BCF,G44.2,Tension-type headache,-
9126F41B-A618-42CE-9EB9-9D0BDA6696D3,A09.9,Gastroenteritis and colitis of unspecified origin,-
06A449CD-CD84-448B-A008-BD1DEC36C433,J06.9,"Acute upper respiratory infection, unspecified",-
A1650355-4D2B-4649-AD7D-252F3DA77AF1,J06,Acute upper respiratory infections of multiple and unspecified sites,-
ABC6F9A0-DE1C-4515-87DB-8FED489BA899,R51,Headache,-
ABC6F9A0-DE1C-4515-87DB-8FED489BA899,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
C28602BA-C145-4DDD-AD95-A59E7D9E0F4D,Y42.4,Oral contraceptives,-
C28602BA-C145-4DDD-AD95-A59E7D9E0F4D,A09.9,Gastroenteritis and colitis of unspecified origin,-
492303B9-17AD-4EC1-9A3B-7F9B47BE9E85,T88.1,"Other complications following immunization, not elsewhere classified",-
AAA79638-8BB5-4D6D-B0F0-68A32BEBD9F4,A09.9,Gastroenteritis and colitis of unspecified origin,-
804C740B-5FC8-4054-BCDD-796967987274,B37.3,Candidiasis of vulva and vagina,-
3F1CAA67-58CB-4CD2-A650-E1D2B52A7330,S93.4,Sprain and strain of ankle,-
1B0114DA-B003-440D-B37B-FAC6C4CDAB9E,L20,Atopic dermatitis,Atopic dermatitis
A7163532-3A46-479A-B9D9-52FBD82966E3,N94.6,"Dysmenorrhoea, unspecified",-
8C45CFBF-B33B-4786-917E-BFE3842CA058,K29.7,"Gastritis, unspecified",-
2C4CA18F-7266-406C-9A1D-86EC21F80D3A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
76271909-1367-465F-BEE9-95E928A7EBAD,G44,Other headache syndromes,-
BA013AED-733E-44C4-A723-D62E41ED3CBE,R51,Headache,-
D083848E-2AD2-4874-A375-71E134E38B64,N39.0,"Urinary tract infection, site not specified",-
30B45777-456F-4776-9803-819B299DCE99,Z71.2,Person consulting for explanation of investigation findings,-
7BF543CD-C1EB-4990-B1D9-1BC74E0E1F53,R51,Headache,-
E7A229F2-45DC-4FF1-AEDC-5297513B7A8A,R51,Headache,-
9C6855DE-B310-40F7-AB44-A93C4C410997,M62.6,Muscle strain,-
3409F2F5-6701-4CC6-A077-4CDC5259C056,R21,Rash and other nonspecific skin eruption,-
3409F2F5-6701-4CC6-A077-4CDC5259C056,N94.8,Other specified conditions associated with female genital organs and menstrual cycle,-
FC462F2E-FF37-4059-A3FC-2232251CAECC,R42,Dizziness and giddiness,-
7A877857-1E27-4617-86DB-1094F3A899C0,G44.2,Tension-type headache,-
6284A8FC-2EB3-4C5C-BBDA-F711FD2EA2FB,H00.0,Hordeolum and other deep inflammation of eyelid,-
ADF2A13F-6BBE-4EFB-A719-FC53519B5080,A09.9,Gastroenteritis and colitis of unspecified origin,-
D0DF632F-B921-4FF9-BCD0-249986B82DF4,R51,Headache,-
AF190085-331F-425A-A09D-6AC9A9AB4FF3,Z71.2,Person consulting for explanation of investigation findings,-
B3FA6591-CF52-4E99-AC2E-B864B6C1A5A4,P39.0,Neonatal infective mastitis,-
0EF062A1-9E1D-46F8-9ABA-1F5B2C6C7A15,A09.9,Gastroenteritis and colitis of unspecified origin,-
E5BED5E6-3BFC-4852-A438-E759989C5F42,R11,Nausea and vomiting,-
69DC6632-42D6-4924-9CF4-B60CCFB81144,R42,Dizziness and giddiness,-
69DC6632-42D6-4924-9CF4-B60CCFB81144,R50.9,"Fever, unspecified",-
5604A8A1-3CC3-463A-8454-3E5F05F732CD,E03.9,"Hypothyroidism, unspecified",Thyroid
4BFB949B-3E5F-4FCF-A360-E6A97C2592A1,K30,Functional dyspepsia,-
4BFB949B-3E5F-4FCF-A360-E6A97C2592A1,M62.6,Muscle strain,-
9E4775D2-C54E-46CF-A40A-0D24968A3224,B37.2,Candidiasis of skin and nail,-
19FE5F26-2828-4763-984F-E6C938717827,Z02.9,"Examination for administrative purposes, unspecified",-
2D2069EB-D1B8-42A2-AE0A-DD6B06130380,G44.1,"Vascular headache, not elsewhere classified",-
2D2069EB-D1B8-42A2-AE0A-DD6B06130380,M79.1,Myalgia,-
FC8293B3-1DF3-4116-8A4E-613B3222706B,N94.6,"Dysmenorrhoea, unspecified",-
0ED85E6D-6969-49BF-B63A-409D20D772AE,H57,Other disorders of eye and adnexa,-
83D70289-B4ED-43E7-8F67-0D886F6A9974,U07.1,"COVID-19, virus identified",-
A74C55B3-9D18-4859-8594-07A2BCB06B77,Z71.2,Person consulting for explanation of investigation findings,-
0C2F6B52-C7B8-4EFF-B1FC-19DA2F97510B,T88.1,"Other complications following immunization, not elsewhere classified",-
9562C223-8F1B-461C-B0C7-7A7483E1063F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C5A746F2-5D36-4941-A876-1DF42FE7C06A,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
C5A746F2-5D36-4941-A876-1DF42FE7C06A,T78.4,"Allergy, unspecified",-
17A284C0-C5B6-4029-9EA6-F9E7CD748DDB,A09.9,Gastroenteritis and colitis of unspecified origin,-
5EC55FA0-5013-4CEF-8BCC-38BB2616FD38,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
57689DB0-5689-4B41-8AD1-65B896467EDC,J02,Acute pharyngitis,-
57689DB0-5689-4B41-8AD1-65B896467EDC,R51,Headache,-
A218B000-29C1-43F7-8FD4-A2497053BB1B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3C13AC3D-27F5-49A6-85EC-3F805F1E2FCF,N94.6,"Dysmenorrhoea, unspecified",-
5B19D29A-9C53-472E-B8FB-B48819A2507A,A09.9,Gastroenteritis and colitis of unspecified origin,-
06EA0572-D3DC-4A3F-B455-66DDF3D11D44,R51,Headache,-
06EA0572-D3DC-4A3F-B455-66DDF3D11D44,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
852D972A-2F7B-4A8F-B447-A55E7C3BBFB7,Z71.2,Person consulting for explanation of investigation findings,-
A1E66B0C-CDD5-405C-9DB1-D8A5995A3CF9,N94.6,"Dysmenorrhoea, unspecified",-
30B2D28A-CF6E-4394-8D28-7A2BE334D416,U07.1,"COVID-19, virus identified",-
30B2D28A-CF6E-4394-8D28-7A2BE334D416,J06.9,"Acute upper respiratory infection, unspecified",-
BAC2BF65-D399-45F7-BDEF-91DBD6CB7F2E,J06.9,"Acute upper respiratory infection, unspecified",-
ED5F5A73-276D-4142-8883-A0114514445F,N94.6,"Dysmenorrhoea, unspecified",-
D464FC20-C198-4F43-8349-E560EBB049FE,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
0A2FE52D-B3C9-4A94-883F-38C3DBEA4B82,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E9BA125D-979C-4292-ABDD-C2AF2C6F723B,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
02042586-BECF-4DAE-999F-260093446D58,N92.6,"Irregular menstruation, unspecified",-
19630CC6-8E9E-42DB-87D2-6674B91427EE,Z71.2,Person consulting for explanation of investigation findings,-
972CE529-E38E-4131-B6FE-E660733A1FBA,Z71.2,Person consulting for explanation of investigation findings,-
E08DE7A3-D260-424B-977C-A11673305029,D03.4,Melanoma in situ of scalp and neck,-
60D1F69D-5483-4D0B-8421-7889B52D3D0B,Z71.2,Person consulting for explanation of investigation findings,-
6D341FFC-CFAD-45CF-81DD-DEF5CAF485FC,R51,Headache,-
9D0F8957-3557-4970-B1D0-9CC58E7C4D12,R21,Rash and other nonspecific skin eruption,-
C0760277-BA7E-4B19-92BC-30B2DAB97426,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
781DDCFE-4F2A-4610-9ED4-FFF66446A2A8,R52.9,"Pain, unspecified",-
27BBC812-2E04-4DD4-98F7-B2B34AF910E8,U07.1,"COVID-19, virus identified",-
F4AD39D9-FEA4-4F67-A4BB-3FE1C3421AC2,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
7C88DC15-39C4-4906-9F1C-1A392B19495C,M79.1,Myalgia,-
A788F91C-FA15-4F0E-B134-CDE6F375CD49,N94.6,"Dysmenorrhoea, unspecified",-
9561C641-E220-447A-ABB4-5F70A88995BD,R51,Headache,-
F359C8F6-9416-4673-A587-56C20C757F1E,H10.3,"Acute conjunctivitis, unspecified",-
6CE5F972-F80F-4DE2-82BB-1CC2403770D8,J06.9,"Acute upper respiratory infection, unspecified",-
B895BB5A-6953-415F-94F6-5334C42286D2,J02,Acute pharyngitis,-
B895BB5A-6953-415F-94F6-5334C42286D2,R51,Headache,-
19D986D6-0A72-4A4E-813C-82BA03F5B451,N94.6,"Dysmenorrhoea, unspecified",-
55CA0454-51CE-4347-B14B-5939F39CD53A,N94.6,"Dysmenorrhoea, unspecified",-
ED5637D2-607F-4118-B45D-1550B98613EA,N39.0,"Urinary tract infection, site not specified",-
29EAEF41-994B-458F-8077-B5759D2D8EAF,N94.6,"Dysmenorrhoea, unspecified",-
E730F347-C091-41F7-9D66-988FB7108919,R21,Rash and other nonspecific skin eruption,-
E730F347-C091-41F7-9D66-988FB7108919,T88.1,"Other complications following immunization, not elsewhere classified",-
E2F22924-9F71-452A-8568-D4A4ACFDD069,R51,Headache,-
E2A3E775-A459-4B33-A589-2878C6E4B2FD,J06.9,"Acute upper respiratory infection, unspecified",-
B9A2018E-6BD8-4967-88B2-866527CE6C35,A09.9,Gastroenteritis and colitis of unspecified origin,-
89E44CD4-2330-493D-82C6-22F5441DDB4A,R51,Headache,-
89E44CD4-2330-493D-82C6-22F5441DDB4A,S90.3,Contusion of other and unspecified parts of foot,-
9AFD8BA8-082A-476B-904E-1092801BA62D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
080927FA-C662-42CB-88DD-F6F095951C37,J06.9,"Acute upper respiratory infection, unspecified",-
E3DD89D4-5CB7-4A1A-BE7C-105EEAB154A5,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
2E6362BA-D722-47E2-9BA7-709593AEB677,L42,Pityriasis rosea,-
77116CE3-03A8-44FE-97BF-473C9DFE53F1,T23.1,Burn of first degree of wrist and hand,-
6B158FEF-13F9-4BA8-921C-C907ADFDEBBC,T78.4,"Allergy, unspecified",-
4B5DE337-5B47-4961-A6DF-3233C40036E5,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
51ED1908-2DF6-4E58-BC39-F1D6DBA6B747,M79.1,Myalgia,-
51ED1908-2DF6-4E58-BC39-F1D6DBA6B747,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
51469D6D-FDE6-4793-BD8E-D695B3D58384,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
90407847-1666-41A0-9E4D-06C8E6560EB6,R51,Headache,-
C0F56822-E54B-4846-9CBF-67E3AE43C4A7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FDDC7DAB-614C-4C38-9F15-AC4808A91628,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
4CA36DD0-92E8-4EB5-B88C-0D9DB2616519,Z01.7,Laboratory examination,-
A832C532-25B9-47E5-9651-8DCDC6488CF2,H57,Other disorders of eye and adnexa,-
F66A2552-BA36-4E9A-8301-B3A04BED482C,R42,Dizziness and giddiness,-
65AB7D72-3B79-4B06-96DD-40F583C422C1,R49.8,Other and unspecified voice disturbances,-
ACAEC8D5-9900-4EC7-934C-C97A969316AF,Z71.2,Person consulting for explanation of investigation findings,-
1CA385C7-63DB-4851-86A3-AF2454EDEED1,E11.9,Type 2 diabetes mellitus without complications,Diabetes
1CA385C7-63DB-4851-86A3-AF2454EDEED1,I10,Essential (primary) hypertension,Hypertension
1CA385C7-63DB-4851-86A3-AF2454EDEED1,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
13D31A57-9444-42BB-BA80-D4CF89E1A609,Z02.9,"Examination for administrative purposes, unspecified",-
B174ABA1-63B4-43F1-B03B-61B35E055A91,R11,Nausea and vomiting,-
B174ABA1-63B4-43F1-B03B-61B35E055A91,K30,Functional dyspepsia,-
B174ABA1-63B4-43F1-B03B-61B35E055A91,K59.1,Functional diarrhoea,-
EBE0B3A7-CD7E-4E59-A8DC-137C63CDDD66,T88.1,"Other complications following immunization, not elsewhere classified",-
B1F8FBA8-9A70-49A3-818E-43798AEB8D70,A09.9,Gastroenteritis and colitis of unspecified origin,-
B1F8FBA8-9A70-49A3-818E-43798AEB8D70,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
3C24ADEB-0374-4A16-BEDA-C3546EB7B38B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
AD7E6CAC-923D-44C3-BB2D-B96E1A26F812,S90.1,Contusion of toe(s) without damage to nail,-
F7A74B1A-6689-42D6-8FF4-81EAAE64DD45,N92,"Excessive, frequent and irregular menstruation",-
A2207686-71AD-4BEA-8FD5-95FDAE0B8D4D,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
F1F1E767-5D77-4D0D-9A6A-CB189165CCFA,H57.9,"Disorder of eye and adnexa, unspecified",-
BAE7D4CD-CE3C-4DB1-B678-38A33860AB09,J06.9,"Acute upper respiratory infection, unspecified",-
417041EC-280B-4B89-A338-E90BE9193E3A,R51,Headache,-
E2E647BE-67A9-4F30-800B-17020351A1C0,A09.9,Gastroenteritis and colitis of unspecified origin,-
F4E00F53-C347-4F1B-B55A-164D0BB43E56,H90,Conductive and sensorineural hearing loss,-
8BCBE2BB-FAA1-4676-8D3C-53616027A4AE,J02,Acute pharyngitis,-
2438E446-AA2C-4A7C-94CC-534AACE10AAE,N76.0,Acute vaginitis,-
A640CB52-3CA7-44F1-8BEF-E26E0EE6B9E7,H57,Other disorders of eye and adnexa,-
84EB29B1-5B30-4A89-A9EC-8221B628DE47,S63.5,Sprain and strain of wrist,-
BA0C7921-4871-4B10-AE44-B78F5869FCF1,R51,Headache,-
BA0C7921-4871-4B10-AE44-B78F5869FCF1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7D2CEC84-A0FE-477E-9D4C-826ACFD97A34,M54.5,Low back pain,-
9A1EE2CE-FEFA-4E15-9A7E-D11B9C1B7198,J06.9,"Acute upper respiratory infection, unspecified",-
C62E866A-3FC3-48F4-8D45-3D6273F6CEEF,M54.5,Low back pain,-
DB74BD03-F632-4F78-BBDF-E942DD718CAF,M54.5,Low back pain,-
EAF754AB-4AC5-4E79-8210-E876E3BC8F6C,B37,Candidiasis,-
9E83FB58-87D9-43CD-8D93-77AF46A8FF91,L02.8,"Cutaneous abscess, furuncle and carbuncle of other sites",-
3ED57281-B343-4F8D-83A1-767105FB7E1C,T88.1,"Other complications following immunization, not elsewhere classified",-
BFFFB61D-C75A-4E98-ADB8-EACBC713A509,G44.2,Tension-type headache,-
77BF9973-AA38-4DB1-8E5F-5F4034EDFE67,R21,Rash and other nonspecific skin eruption,-
B20E52FC-FB21-45BC-AB00-A5249FC61A6E,J06.9,"Acute upper respiratory infection, unspecified",-
43A269DD-7D3F-4347-8B4F-8362F9B3116F,A09.9,Gastroenteritis and colitis of unspecified origin,-
D40CED6C-5428-4764-82E1-101D5FB8F5A0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FB07FC95-B57D-4122-963E-630696D8C66A,J06.9,"Acute upper respiratory infection, unspecified",-
20DF3C3B-DFC0-41F8-8F38-A9D154CB58D9,J06.9,"Acute upper respiratory infection, unspecified",-
453DABC2-3801-4C7D-9202-78B4F0CCE291,J22,Unspecified acute lower respiratory infection,-
6EF5B6B1-01AD-40A6-84C9-155175F74196,M54.5,Low back pain,-
D4EF1470-B59E-475D-A788-F85FC2B975DE,B37,Candidiasis,-
E38A5E47-BD2B-465B-AAEF-3344854E82C6,R21,Rash and other nonspecific skin eruption,-
3A69762B-61B3-423D-A90D-45637B17A268,R51,Headache,-
74D36A1B-6758-42A3-BE10-E6382C8C4A40,A09.9,Gastroenteritis and colitis of unspecified origin,-
9C461467-709F-4C5D-97C6-69DEFC2812B5,N94.6,"Dysmenorrhoea, unspecified",-
9C461467-709F-4C5D-97C6-69DEFC2812B5,M54.5,Low back pain,-
5420972C-04D3-454C-9D4D-AB2DF77C3162,J06.9,"Acute upper respiratory infection, unspecified",-
1F3BA8DB-30BB-4F5A-ACC5-D5FB020ABC98,L03.0,Cellulitis of finger and toe,-
04CE5987-29D1-44F9-8ECC-03D1598D65A4,K29.7,"Gastritis, unspecified",-
490A6A5B-4845-4F79-AC34-745B71CD3144,H57,Other disorders of eye and adnexa,-
490A6A5B-4845-4F79-AC34-745B71CD3144,B30,Viral conjunctivitis,-
9200AC9C-4569-4612-B6C4-2B957D9B7B29,A09.9,Gastroenteritis and colitis of unspecified origin,-
792E9CDB-5055-4260-A8D5-F8DAACE279EB,R51,Headache,-
4FE70B2B-449D-42CB-BC60-A9641F79AF53,R51,Headache,-
6EDF5777-71ED-4EF5-855F-846A54191D46,N94.6,"Dysmenorrhoea, unspecified",-
DD64B50F-3D97-4416-BFE3-10B39909E45E,J06.9,"Acute upper respiratory infection, unspecified",-
B5DEDFA5-9A73-4FDB-9510-D6AC169CF97A,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
BEF71AF1-06AB-491C-9CEC-5B25908A5D14,E11,Type 2 diabetes mellitus,Diabetes
6880E097-5CBF-4A71-A707-BB453857D418,N76.0,Acute vaginitis,-
3779C33C-7CFF-4505-B4EA-C8D4E77B10E3,R21,Rash and other nonspecific skin eruption,-
AB1BA0D7-2739-4AD6-A44E-28B41C205BAE,R50.9,"Fever, unspecified",-
AB1BA0D7-2739-4AD6-A44E-28B41C205BAE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D864740A-9C6F-45A2-926D-31D8672062F0,A09.9,Gastroenteritis and colitis of unspecified origin,-
D771668E-1E60-4F3D-B3A3-EEAA1F499E46,K30,Functional dyspepsia,-
E5C65374-31ED-4816-ADC8-7572D435535C,N92.6,"Irregular menstruation, unspecified",-
59D577D9-7C5B-4CBF-B3F6-9038A46CBDC0,R11,Nausea and vomiting,-
8D9ED0AE-7CFF-47DD-A791-4A1AE1DD84C6,R21,Rash and other nonspecific skin eruption,-
4B5DE337-5B47-4961-A6DF-3233C40036E5,R21,Rash and other nonspecific skin eruption,-
4B5DE337-5B47-4961-A6DF-3233C40036E5,J02,Acute pharyngitis,-
4B5DE337-5B47-4961-A6DF-3233C40036E5,H93.9,"Disorder of ear, unspecified",-
1B9543AF-8150-401E-977F-318E545CD3B0,R23.3,Spontaneous ecchymoses,-
47478618-DD9C-4863-9D80-014BD950D35B,J06.9,"Acute upper respiratory infection, unspecified",-
75C7151D-51E6-4308-B86D-114B184FF02C,J06.9,"Acute upper respiratory infection, unspecified",-
75C7151D-51E6-4308-B86D-114B184FF02C,T88.1,"Other complications following immunization, not elsewhere classified",-
9581288A-4088-4321-BB5B-7D27882CC7A2,J06.9,"Acute upper respiratory infection, unspecified",-
51CA71FA-1B2D-4C72-870E-A6A393396942,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E5C95637-1436-4457-AF48-74F3B757A459,L03.0,Cellulitis of finger and toe,-
57E7483C-D4C4-4B45-8F08-7495748F0CC2,G44.2,Tension-type headache,-
57E7483C-D4C4-4B45-8F08-7495748F0CC2,A09.9,Gastroenteritis and colitis of unspecified origin,-
F9E56289-6329-4687-826A-B434EE130387,J06.9,"Acute upper respiratory infection, unspecified",-
35B1B126-7369-4AF5-BF65-E3AFCA71A418,F41,Other anxiety disorders,-
427F27AC-42B9-4875-92BC-D8A83860B8E8,R50.9,"Fever, unspecified",-
E71874A1-51B2-4E00-ABBD-A912DA0CD9C8,J06.9,"Acute upper respiratory infection, unspecified",-
94D2F7B2-1312-45DC-972B-D0C1F456EA89,M54.5,Low back pain,-
D0BAD095-D1F3-469E-B893-8AE5786C926C,M62.6,Muscle strain,-
D36A705A-6E8B-4D8A-9A5E-35E2F86F6A09,G43,Migraine,Migraine
C5C193DC-C474-4C53-80CB-B8809669DD5E,A09.9,Gastroenteritis and colitis of unspecified origin,-
04A2C711-D1DA-44A2-A601-D9E5C673E74C,T88.1,"Other complications following immunization, not elsewhere classified",-
28106C77-3FAC-4071-8358-C5FCD57165E1,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
28106C77-3FAC-4071-8358-C5FCD57165E1,N76.0,Acute vaginitis,-
FEB72D60-EBAD-42FC-AE23-DE2FB044380B,B30,Viral conjunctivitis,-
887D1C8A-40F8-457F-B10B-516D261A322F,U07.2,"COVID-19, virus not identified",-
AF16DA29-3F17-441F-837C-B92EEE172E1A,J06,Acute upper respiratory infections of multiple and unspecified sites,-
88ACA75F-9370-4518-8821-2F5E958C6375,N94.6,"Dysmenorrhoea, unspecified",-
7231C82B-E770-4E6E-A7C9-A89C8603D56C,R10.4,Other and unspecified abdominal pain,-
922BF90E-EAD1-4A49-8CEE-F0AF9A9F8AE0,N39.0,"Urinary tract infection, site not specified",-
69FBC32A-149C-4C5D-B890-0174D53579E6,O91.2,Nonpurulent mastitis associated with childbirth,-
319D9059-638D-4492-9F0F-8DA96599E61D,J02,Acute pharyngitis,-
23F2A58F-331F-4845-8D6A-075662F2D360,J06.9,"Acute upper respiratory infection, unspecified",-
504EBF12-7C1D-4C59-85BE-64ABF785D783,J06.9,"Acute upper respiratory infection, unspecified",-
EC2C46B6-EDFC-4C1D-91F0-EE66B628754B,R05,Cough,-
D6F11227-F06D-4B56-94EA-15FB903C6DDE,J06.9,"Acute upper respiratory infection, unspecified",-
97E08090-2724-47E4-8362-401C15B5D6A9,X51,Travel and motion,-
EDB72063-A989-4FEC-928D-47DD0FF152C8,Z02.9,"Examination for administrative purposes, unspecified",-
F1DF7339-11F8-4E13-8C9D-11A4F3A4B925,A09.9,Gastroenteritis and colitis of unspecified origin,-
9A62F039-94AF-4D83-83AF-1B80970F4322,T88.1,"Other complications following immunization, not elsewhere classified",-
202725C6-224E-43C1-81ED-DE44D13573D8,G51.0,Bell palsy,-
769200A3-F063-4AAF-B246-75732FB272B5,R21,Rash and other nonspecific skin eruption,-
769200A3-F063-4AAF-B246-75732FB272B5,R11,Nausea and vomiting,-
4E586C48-9895-4F16-AD34-8CBA89AF65B8,A09.9,Gastroenteritis and colitis of unspecified origin,-
481F257C-6A05-48D9-AA1C-B51510DAD25D,A09.9,Gastroenteritis and colitis of unspecified origin,-
08596C6F-875D-40D4-BCE8-BA6063A4B44C,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
08596C6F-875D-40D4-BCE8-BA6063A4B44C,M79.1,Myalgia,-
96918CF8-CC8C-4AF3-9CA4-A32FC7B189E3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
72258782-1EC1-4B20-91EA-5BD08FF18185,J06.9,"Acute upper respiratory infection, unspecified",-
2D51470A-C022-4A81-B649-D139F0F637E0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
3910BE5E-EBDA-4E5D-9C45-E291B525B4BF,J06.9,"Acute upper respiratory infection, unspecified",-
B1548AE8-9881-4673-ABF9-79FB78518AE3,N39.0,"Urinary tract infection, site not specified",-
F0D8D192-7548-4B15-A5E6-8EDD4295AFF6,Y42.4,Oral contraceptives,-
F75208F8-FAC5-47F6-84A6-5CB4CCC67108,K29.7,"Gastritis, unspecified",-
48AB7CF7-C3F5-4231-94F0-8A4F20E1B078,T88.1,"Other complications following immunization, not elsewhere classified",-
27DE28B1-7712-4A16-AC63-319017CFED8B,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
97C6EAB2-8089-4DFD-8F9F-D32C8D162183,J06.9,"Acute upper respiratory infection, unspecified",-
8D2B90BF-01D2-453D-86C8-A5089D3A7BA3,H81.1,Benign paroxysmal vertigo,-
3E417144-168C-4AF5-8449-77F23C4FC062,K12.3,Oral mucositis (ulcerative),-
A4729062-7A6B-4131-8CE4-FF84DA6593FE,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
484F20BB-790B-4B59-9007-EDCA71EC93FA,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
FBACD270-537A-4B1C-933E-CA3CE9E2A742,L30.9,"Dermatitis, unspecified",-
D067279A-C796-4A09-B723-C25FFBC2C687,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6C867892-6D0D-4D11-9EDB-3A25BE7A1DA0,J06.9,"Acute upper respiratory infection, unspecified",-
58606438-14A7-436A-B6D3-535A34026F89,T88.1,"Other complications following immunization, not elsewhere classified",-
EDDF235E-9C76-494F-98FE-BD13FB7D5A6B,N94.6,"Dysmenorrhoea, unspecified",-
659447AB-999E-409D-B2D8-087B72D3477F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
215F3D7B-EEDE-46D4-9198-1897ED77BFBF,J06.9,"Acute upper respiratory infection, unspecified",-
04F6F350-A34A-4A74-A01D-C7FFC1C3DF74,A09.9,Gastroenteritis and colitis of unspecified origin,-
0C6BFFA1-BC96-4F4E-8F03-EC8EF95FDF6A,B07,Viral warts,-
AD7D1E64-F584-4651-B7BC-FC65ED48BA9A,R51,Headache,-
FC68B800-7569-4F33-ABCE-1615DFDFFE85,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6542A916-B340-4A96-9960-9DA38FD97F37,Z71.2,Person consulting for explanation of investigation findings,-
D396D5F2-188E-48C8-A485-72077C98471A,K64.9,"Haemorrhoids, unspecified",-
6542A916-B340-4A96-9960-9DA38FD97F37,Z76.0,Issue of repeat prescription,-
D396D5F2-188E-48C8-A485-72077C98471A,J06.9,"Acute upper respiratory infection, unspecified",-
6542A916-B340-4A96-9960-9DA38FD97F37,N94.8,Other specified conditions associated with female genital organs and menstrual cycle,-
1AA0D837-F7A8-439D-81F8-FE36E09BF7CC,R51,Headache,-
2AD403F5-4E52-458C-BCE8-B87E5BFD6474,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
412EBBB7-3138-4729-9B9B-1E4EC2EE2D84,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
82091F45-C99E-4C21-8C9C-FA8E7819AA5B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
82091F45-C99E-4C21-8C9C-FA8E7819AA5B,R21,Rash and other nonspecific skin eruption,-
C591D97A-A268-4F60-B995-7C557B8BE3A9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4AF7DDB9-3291-4F09-BACE-4966CD9C2EE9,R21,Rash and other nonspecific skin eruption,-
4AF7DDB9-3291-4F09-BACE-4966CD9C2EE9,T78.4,"Allergy, unspecified",-
03A402B1-8959-4BA5-849C-8FCC2B93294F,M79.1,Myalgia,-
EEAE690D-CA0C-4819-96D3-792C6AA4ED1C,N94.6,"Dysmenorrhoea, unspecified",-
FE7F022A-4C21-423D-8500-221941EF8970,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
FE7F022A-4C21-423D-8500-221941EF8970,I10,Essential (primary) hypertension,Hypertension
FE7F022A-4C21-423D-8500-221941EF8970,E11,Type 2 diabetes mellitus,Diabetes
1248546C-9F49-4E78-B751-7A2326DC2BD9,S33.5,Sprain and strain of lumbar spine,-
4B3EAB94-B2E7-40EC-A2C3-E7FF1914DCF7,S33.5,Sprain and strain of lumbar spine,-
F271A113-2F24-44EF-8A2F-81C296D08A70,R51,Headache,-
F271A113-2F24-44EF-8A2F-81C296D08A70,N94.6,"Dysmenorrhoea, unspecified",-
2D560B9E-F485-42A4-B3C3-23B8C7B4EE7C,Z71.2,Person consulting for explanation of investigation findings,-
E5629412-191B-44BA-A7F6-52B924F32C8C,U07.1,"COVID-19, virus identified",-
E5629412-191B-44BA-A7F6-52B924F32C8C,J06.9,"Acute upper respiratory infection, unspecified",-
C88DEA10-E6B6-4FAA-9B71-154F3F031B7C,Z76,Persons encountering health services in other circumstances,-
5E399408-32D6-4304-AE38-D572A3379658,S30.0,Contusion of lower back and pelvis,-
94F52E4C-36DE-40CD-9CEF-2967BFD27D87,N94.6,"Dysmenorrhoea, unspecified",-
94F52E4C-36DE-40CD-9CEF-2967BFD27D87,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
ED87F9C6-A53D-4401-B571-55ADDF81FFCB,T88.1,"Other complications following immunization, not elsewhere classified",-
8FD590A2-B9DB-4E2B-9088-797B1118D948,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D88EC287-A752-40F5-845F-BF01809535D2,U07.1,"COVID-19, virus identified",-
B84167D8-109A-432C-95E5-7658E4FF609B,K64.9,"Haemorrhoids, unspecified",-
56AE3045-F035-4BAC-9119-0462A4BB822F,K64.9,"Haemorrhoids, unspecified",-
B84167D8-109A-432C-95E5-7658E4FF609B,K59.0,Constipation,-
4AE6E8B4-4313-412F-BAA5-B9E1ED4175B2,A09.9,Gastroenteritis and colitis of unspecified origin,-
7FCDDF2F-5B1E-486A-8453-518FB2C111BE,N94.6,"Dysmenorrhoea, unspecified",-
4AE6E8B4-4313-412F-BAA5-B9E1ED4175B2,R51,Headache,-
E0C374F1-361C-46E8-8457-2452EC2F5B34,R51,Headache,-
E0C374F1-361C-46E8-8457-2452EC2F5B34,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
87186620-5641-420D-9431-7D69AE3D88E0,J06.9,"Acute upper respiratory infection, unspecified",-
7DA6E416-7BD4-453C-932F-14CE928AEA26,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4179FF16-859B-4597-92A9-76FD660E8F80,R51,Headache,-
F14930E9-465F-4C3D-A619-65165EC575AE,G44.2,Tension-type headache,-
E4AB20B3-2DDF-4F98-A92A-4A22A2AAB891,B30,Viral conjunctivitis,-
E4AB20B3-2DDF-4F98-A92A-4A22A2AAB891,J06.9,"Acute upper respiratory infection, unspecified",-
E4AB20B3-2DDF-4F98-A92A-4A22A2AAB891,H57,Other disorders of eye and adnexa,-
05E37B78-B465-4C73-9B0E-CDED584BDC4C,T88.1,"Other complications following immunization, not elsewhere classified",-
409ABFA4-0258-49A7-B231-9DD47AD6EF61,L93,Lupus erythematosus,-
94B5BE0B-7A6C-497D-8A42-F54E6A6B2FEC,R10.4,Other and unspecified abdominal pain,-
94B5BE0B-7A6C-497D-8A42-F54E6A6B2FEC,K59.0,Constipation,-
94B5BE0B-7A6C-497D-8A42-F54E6A6B2FEC,R51,Headache,-
935ED7E8-9D3B-4091-9256-62662FEB43B8,R52.9,"Pain, unspecified",-
9FEA0D63-FCAD-4AF8-AF55-7AF24D5D66D5,M54.5,Low back pain,-
CC585B1F-F82A-4A42-94F0-27D6A3E66FAF,R11,Nausea and vomiting,-
E7FEBA66-FE9F-486C-B4CF-CF55117A3110,J06.9,"Acute upper respiratory infection, unspecified",-
4D2ADA98-AAD6-4E77-949A-163A35318503,J06.9,"Acute upper respiratory infection, unspecified",-
1C78C5B5-80F3-4552-AD9C-258FF13C7E6D,R51,Headache,-
9B9B250E-A67C-4DFB-B4FD-FC3A7388C63F,R50.9,"Fever, unspecified",-
9B9B250E-A67C-4DFB-B4FD-FC3A7388C63F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D2608E3A-B266-431D-8F63-D68D95831172,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
207C1880-A1FF-4A3A-A61E-CA9861DF2BED,N94.4,Primary dysmenorrhoea,-
646CD3FC-BCEB-4D00-854F-F055C12B45CA,T88.1,"Other complications following immunization, not elsewhere classified",-
A5301DEF-D1FB-4D05-9DB9-8E9D154CD75C,K30,Functional dyspepsia,-
8B009772-0A75-489D-B61B-F60740091B97,U07.2,"COVID-19, virus not identified",-
8B009772-0A75-489D-B61B-F60740091B97,J06.9,"Acute upper respiratory infection, unspecified",-
1614A82A-E55E-4C25-B155-B6B61ECB5BCB,J06.9,"Acute upper respiratory infection, unspecified",-
89B0D027-F04D-4006-9915-9D9BA0D162F9,R53,Malaise and fatigue,-
1FDA4C68-A180-473A-9A5E-96555DA30ECF,U07.1,"COVID-19, virus identified",-
0AB586A7-FED4-4BA8-A761-39684CFC8F32,K29.7,"Gastritis, unspecified",-
A9C6BFFA-1813-4918-9E06-E5D6D3F3CE9D,A09.9,Gastroenteritis and colitis of unspecified origin,-
FA157CA1-4914-42A3-965D-407DDA0DB6B0,J06.9,"Acute upper respiratory infection, unspecified",-
A0E69145-39D9-4A99-96F2-5CC76FC3540B,J06.9,"Acute upper respiratory infection, unspecified",-
A0E69145-39D9-4A99-96F2-5CC76FC3540B,U07.1,"COVID-19, virus identified",-
A0F995C6-5781-475C-A089-AE9B94F2F293,Y42.4,Oral contraceptives,-
9B18210D-9BDE-4CD0-9367-6931303B291F,Y42.4,Oral contraceptives,-
3E245F63-E8FD-4752-BD9B-D47CD44C929C,Y42.4,Oral contraceptives,-
0993905B-4714-45D7-B22D-DF45F8593C0A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0993905B-4714-45D7-B22D-DF45F8593C0A,R50.9,"Fever, unspecified",-
E5CF53EF-1579-4687-BE3E-E3E21D5E0BD6,J06.9,"Acute upper respiratory infection, unspecified",-
E5CF53EF-1579-4687-BE3E-E3E21D5E0BD6,T88.1,"Other complications following immunization, not elsewhere classified",-
6783FFFA-2C00-4A33-BCEB-F81632D90093,R51,Headache,-
D806E396-E83C-4A66-B89B-DAC9CAD7770E,G44.2,Tension-type headache,-
D806E396-E83C-4A66-B89B-DAC9CAD7770E,M54.5,Low back pain,-
FDFE03D6-4320-443E-A738-C07EA50A336F,K08.9,"Disorder of teeth and supporting structures, unspecified",-
FA87B18E-7397-415B-BFC8-E17D0670AB25,M23,Internal derangement of knee,-
7842C93D-1171-4A50-B34E-35D52AFBAC36,T88.1,"Other complications following immunization, not elsewhere classified",-
FA2A61ED-3BAF-4AEF-802F-C9AD4F06AC16,U07.1,"COVID-19, virus identified",-
572ED1A5-DF50-4F85-A338-4A9A1B48EBAE,J06.9,"Acute upper respiratory infection, unspecified",-
49291A14-400F-40C3-9586-1EE59AA7B0D4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DE913BCE-A888-4817-8DC4-BA90835333BB,T88.1,"Other complications following immunization, not elsewhere classified",-
D7D905A4-5E1C-4D8F-891F-5F9928763850,M54.5,Low back pain,-
F1753FA6-EC4A-4680-AE87-8C27998A5CA8,R50.9,"Fever, unspecified",-
135F83F2-15A9-4171-992D-331851496F17,J06.9,"Acute upper respiratory infection, unspecified",-
20DF4E04-050D-436D-9B99-9CB4FC0A4FB5,J06.9,"Acute upper respiratory infection, unspecified",-
030AE0C5-0235-4BFF-A619-2CAD6034C182,G44.2,Tension-type headache,-
EB239DAA-0258-474C-BEB6-346A1C64C266,H70,Mastoiditis and related conditions,-
1B7FE3D8-0082-4677-9F58-6A816029CDBA,T88.1,"Other complications following immunization, not elsewhere classified",-
9086D801-F269-4780-A121-4F7A16142D82,J45,Asthma,Asthma
9086D801-F269-4780-A121-4F7A16142D82,K58,Irritable bowel syndrome,-
9086D801-F269-4780-A121-4F7A16142D82,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
4B8F6B2E-3265-458D-9938-8066E3CB79D2,R10.4,Other and unspecified abdominal pain,-
B73E125F-209B-4F39-9AD4-7877D42F7BE2,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
CC5B5C0A-5E6B-4888-88B5-C7E1FCC463E4,P39.0,Neonatal infective mastitis,-
AA75C23A-8007-4323-B33A-991A698CF3B4,T88.1,"Other complications following immunization, not elsewhere classified",-
2ACE2ADE-05BD-4E4B-9D89-26805290DD88,H10.1,Acute atopic conjunctivitis,-
2ACE2ADE-05BD-4E4B-9D89-26805290DD88,D22.9,"Melanocytic naevi, unspecified",-
79837352-BA56-4846-8326-8E80EB8423F8,J06.9,"Acute upper respiratory infection, unspecified",-
B4D8998D-E528-4725-91C6-F9F6E54A3DC0,U07.1,"COVID-19, virus identified",-
C7571AF2-EFC9-4425-9750-3145C7D2E108,M54.5,Low back pain,-
C7571AF2-EFC9-4425-9750-3145C7D2E108,M62.6,Muscle strain,-
AAFB4DEA-B12D-4E3F-9D45-9CF25A41214F,G43,Migraine,Migraine
EEAA9473-EBC9-445E-AA4D-11BFD11DC123,L03,Cellulitis,-
BC97DA28-8298-45AF-8573-6042BB7654FF,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
6CE96D60-E03D-4CEC-A937-1D788F8598E7,T88.1,"Other complications following immunization, not elsewhere classified",-
581AF2C9-A6E1-4175-9DE6-21E10A74A93C,M10,Gout,Gout
7C07AD67-F476-458D-913A-6A5F7CB2F9E3,J06.9,"Acute upper respiratory infection, unspecified",-
028DDEC9-79C2-41C7-AA30-E68435F42EE2,J45,Asthma,Asthma
028DDEC9-79C2-41C7-AA30-E68435F42EE2,A09.9,Gastroenteritis and colitis of unspecified origin,-
5CCA1594-3402-451F-9E46-CAF09EFBB64B,A09.9,Gastroenteritis and colitis of unspecified origin,-
5CCA1594-3402-451F-9E46-CAF09EFBB64B,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
EC86A943-F222-4443-B666-016382CD1F26,A09.9,Gastroenteritis and colitis of unspecified origin,-
394D1EDE-8ABB-4D9C-9A96-D92F792DA4BF,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6A18B444-630B-443B-9D4F-A34B81CAE265,G44.2,Tension-type headache,-
5AC1D243-FB56-4CF1-A3FB-BCAD1AD8B412,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5AC1D243-FB56-4CF1-A3FB-BCAD1AD8B412,R50.9,"Fever, unspecified",-
68262BB7-1B6F-4209-B5BC-268C5CD1037F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
62F08699-7CB2-4A1E-B6D2-0BBE89562F09,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
54032140-B83A-47F7-9050-B27BC1BEC57B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D4DE991C-89E0-4530-BFD7-143BE6B078D1,K30,Functional dyspepsia,-
455A5006-EF83-4CD8-A757-FA914770FD65,J06,Acute upper respiratory infections of multiple and unspecified sites,-
15DB0EE6-A237-40E0-85AE-6B0DBF9E408C,N76.0,Acute vaginitis,-
15DB0EE6-A237-40E0-85AE-6B0DBF9E408C,N39.0,"Urinary tract infection, site not specified",-
0A288745-F198-4A8B-8C44-36EAADB9B23A,U07.1,"COVID-19, virus identified",-
F44A39A0-B31B-4C1C-8B02-9C9415B46ECE,M10,Gout,Gout
C85BFBAB-928C-4040-ADFE-74243BA31B6F,H57.9,"Disorder of eye and adnexa, unspecified",-
C85BFBAB-928C-4040-ADFE-74243BA31B6F,R51,Headache,-
198129AB-418D-4121-AD59-C19C600876F5,K52.9,"Noninfective gastroenteritis and colitis, unspecified",-
9FA9D5CE-17D3-4982-AE16-4E3294DC30F8,Y42.4,Oral contraceptives,-
23569037-9455-4414-A6F5-CB778A85DE0B,R51,Headache,-
462D1C0F-240E-4150-BA61-CE3566028468,K30,Functional dyspepsia,-
394B7944-2EFD-4295-94DA-53D7716B1575,B07,Viral warts,-
A45E3896-00DE-48EC-A4AB-C71D0A2AC03C,H61.0,Perichondritis of external ear,-
A45E3896-00DE-48EC-A4AB-C71D0A2AC03C,H60.1,Cellulitis of external ear,-
8BD5407E-7C08-49EE-9647-42C18040CD1C,H60.1,Cellulitis of external ear,-
6AAF2E95-BD0D-49DD-9D38-93F6DA26C56E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DBC62DFA-A7C7-409C-84E6-D3CE0082D749,K29.1,Other acute gastritis,-
60442619-88A9-4E21-9ABB-AE6C385D430A,K64.9,"Haemorrhoids, unspecified",-
60442619-88A9-4E21-9ABB-AE6C385D430A,A09.9,Gastroenteritis and colitis of unspecified origin,-
CB19BA7C-1D74-473D-9373-963C01107B79,T88.1,"Other complications following immunization, not elsewhere classified",-
AE7FDCDA-8FA5-4648-BC26-1D941CA5E44C,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
5C246BA2-33C2-48BF-A637-6B95C13DCC01,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
05DF3C81-8802-4F34-9B92-6D26A56E6A2B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4EB77D78-7982-4CDB-A153-DF592B491D27,A09.9,Gastroenteritis and colitis of unspecified origin,-
011BC645-1924-4EDE-A1E2-2BD72DCC658F,J06.9,"Acute upper respiratory infection, unspecified",-
B2A723EB-2CC7-4DEA-AFC5-757CF4B4D08C,L02.9,"Cutaneous abscess, furuncle and carbuncle, unspecified",-
E6A61DFB-D089-42A7-A415-DF5232E675D3,R51,Headache,-
AFC171F1-3461-42E0-866F-4A1B0BEBA761,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8E94FF99-7591-48EC-8A46-D98238074772,J06.9,"Acute upper respiratory infection, unspecified",-
8E94FF99-7591-48EC-8A46-D98238074772,U07.1,"COVID-19, virus identified",-
4F3DBF46-1892-48AC-B19C-42600D637DD7,M79.1,Myalgia,-
53C2D803-4D03-496A-9F6F-F4E913021CB9,T88.1,"Other complications following immunization, not elsewhere classified",-
6AD793FA-0013-42F1-8CFC-DBF5F7263717,M10,Gout,Gout
836BC7D2-F677-4499-859B-63EDC07832EF,L50.9,"Urticaria, unspecified",-
2BB1050F-DDAA-4221-9BA9-914716FB4D18,L50,Urticaria,-
21C6E5B5-FC92-4673-B803-4B6E7B78C53A,J06.9,"Acute upper respiratory infection, unspecified",-
6816AE7E-30A3-47EF-9E50-5616FCD625DE,J06.9,"Acute upper respiratory infection, unspecified",-
6775DA01-D516-4E51-A3C2-6C8828413403,L03,Cellulitis,-
7A877857-1E27-4617-86DB-1094F3A899C0,J22,Unspecified acute lower respiratory infection,-
7A877857-1E27-4617-86DB-1094F3A899C0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E12F76C0-F223-4F14-A88D-06440CFC7459,R51,Headache,-
05C12A6F-5578-4FC2-8E80-8835FA4AE1E0,J06.9,"Acute upper respiratory infection, unspecified",-
C5206DB8-6CA4-4581-8E0F-99D7A36CAFBA,Z02.9,"Examination for administrative purposes, unspecified",-
959C072B-C35F-4646-8773-309157E2788F,A09.9,Gastroenteritis and colitis of unspecified origin,-
CB43C56A-37AC-46A6-933E-B14663308895,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
612B6E3D-EDD4-4D59-A02D-9EB97C05B6F3,J06.9,"Acute upper respiratory infection, unspecified",-
761AD157-4A61-44FC-85EA-404A0FF28B08,A09.9,Gastroenteritis and colitis of unspecified origin,-
A2B87D05-22B2-495C-A3F4-9D3424D035FE,N94.8,Other specified conditions associated with female genital organs and menstrual cycle,-
2418A904-B912-4DFF-BC22-D11944D988AE,N87.0,Mild cervical dysplasia,-
2418A904-B912-4DFF-BC22-D11944D988AE,F41.2,Mixed anxiety and depressive disorder,-
2418A904-B912-4DFF-BC22-D11944D988AE,M20.6,"Acquired deformity of toe(s), unspecified",-
2418A904-B912-4DFF-BC22-D11944D988AE,R00.2,Palpitations,-
8E9A43BC-4902-4DE1-980C-9277976D821B,R50.9,"Fever, unspecified",-
8E9A43BC-4902-4DE1-980C-9277976D821B,A09.9,Gastroenteritis and colitis of unspecified origin,-
87B5DFB2-46DD-45A5-8EA4-488A96DD40C4,S90,Superficial injury of ankle and foot,-
87B5DFB2-46DD-45A5-8EA4-488A96DD40C4,L50,Urticaria,-
DCBCD6FA-CC40-4CDB-BD50-1298E98D6D8A,T88.1,"Other complications following immunization, not elsewhere classified",-
4180F702-66BF-48CE-9432-B56A9050D343,A09.9,Gastroenteritis and colitis of unspecified origin,-
8900F609-5BF5-4D53-8268-7BD626DBE548,H01.0,Blepharitis,-
4EC93468-6CF2-4327-B1B0-4440D77C2634,M54.5,Low back pain,-
108E9125-FF49-4C4E-AB35-437D9C28ADCC,Z02.9,"Examination for administrative purposes, unspecified",-
54BE8473-713E-4926-AA9F-FA64903DBE4B,B02,Zoster [herpes zoster],-
DE70DDB3-3A9E-4409-BE63-8C6D6290849F,B02,Zoster [herpes zoster],-
DAB6BC1A-CC89-4AC7-B69E-4757A6B4E5BE,R51,Headache,-
F16C8001-BEBD-4DE0-AAA6-1D9E5F785E46,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
F16C8001-BEBD-4DE0-AAA6-1D9E5F785E46,H10.1,Acute atopic conjunctivitis,-
7E6C6BAC-49A2-4427-967C-EDAC3BA75176,J45,Asthma,Asthma
7E6C6BAC-49A2-4427-967C-EDAC3BA75176,J06.9,"Acute upper respiratory infection, unspecified",-
4348DAEA-B67A-4491-ADAF-A75EFB5DA220,M47.9,"Spondylosis, unspecified",-
71C8510E-C2FE-4E78-8895-BA7EA3459945,L71.0,Perioral dermatitis,-
F5612B40-4FE8-40F3-962D-033AC43D4AEA,R21,Rash and other nonspecific skin eruption,-
F5612B40-4FE8-40F3-962D-033AC43D4AEA,L20,Atopic dermatitis,Atopic dermatitis
2942142F-EB21-4B72-B2E9-FA335071DDB9,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
CC55740C-E826-453B-B6DB-8920FCCF201C,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
3B726623-8646-48AF-9186-AF3A2CACCDF5,G44.2,Tension-type headache,-
F1F97EA2-4242-48DD-9C02-F6B4D7D1D40D,M79.6,Pain in limb,-
625CB60B-72E9-4026-A6B2-D5A310CD8AC9,J06.9,"Acute upper respiratory infection, unspecified",-
CC1DA8CE-11BD-43A9-AB59-4F71C9486684,A09.9,Gastroenteritis and colitis of unspecified origin,-
8F7164AC-FE5F-4871-9845-097A86344BB1,A09.9,Gastroenteritis and colitis of unspecified origin,-
4A5C6BCA-0A90-4970-BF54-B9E526034988,J06.9,"Acute upper respiratory infection, unspecified",-
6E8B8A81-2E20-4F24-8145-659023579F91,P39.0,Neonatal infective mastitis,-
452693CD-6053-410F-9D18-F8EAEA51C2C9,A09.9,Gastroenteritis and colitis of unspecified origin,-
F0A25185-2D03-44CC-A1F1-579034C82FB6,U07.1,"COVID-19, virus identified",-
F59011B3-9E35-40DE-B1D1-D9AF13788B57,B35.6,Tinea inguinalis [Tinea cruris],-
1A8FDF3C-5825-462E-BA38-0F8E517D88E0,R51,Headache,-
03F524C2-EC8E-43DB-8FB7-A1AC951DE45C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
76F9A90A-0BC7-4341-A2B6-A2643106D962,N39.0,"Urinary tract infection, site not specified",-
6FAAEB08-19DF-4FBC-81F3-4130621E5E2E,B35.6,Tinea inguinalis [Tinea cruris],-
1C18B6AB-DB2E-4F89-9A56-E0B5BDFB136A,G44,Other headache syndromes,-
6FAAEB08-19DF-4FBC-81F3-4130621E5E2E,R21,Rash and other nonspecific skin eruption,-
E2EB4103-E12A-438B-9514-3F7C67BAB1A2,T88.1,"Other complications following immunization, not elsewhere classified",-
4F3E4AA6-123E-4F64-9199-D0020F404DF1,K05.0,Acute gingivitis,-
64C11828-89AA-4933-B6B6-A65051230CE7,R51,Headache,-
D0676DD9-6421-41B6-AC64-13C3464100BE,L50.0,Allergic urticaria,-
D0676DD9-6421-41B6-AC64-13C3464100BE,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
D0676DD9-6421-41B6-AC64-13C3464100BE,I10,Essential (primary) hypertension,Hypertension
2290900C-4677-4AFC-B238-EDA471FAB6EA,J06.9,"Acute upper respiratory infection, unspecified",-
5C9A2B88-D200-46D1-AC94-DA0909FA402E,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
4FE43211-643C-44F5-942B-792738D5FEC5,J06.9,"Acute upper respiratory infection, unspecified",-
9274F866-90C6-4784-8440-254B10D1F12C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DCCCD78F-3B5B-4995-850C-38E72EC98BE8,J06.9,"Acute upper respiratory infection, unspecified",-
AEDBAFE2-471E-43FA-87CB-3839B192A9B4,A09.9,Gastroenteritis and colitis of unspecified origin,-
B5A93ACF-5B06-4984-B473-1D30CC179031,H00.0,Hordeolum and other deep inflammation of eyelid,-
E3E0D25B-2447-48CC-A509-602A97B5034D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5062146B-6A7D-4AF2-87C7-5F50A2DA7688,N94.6,"Dysmenorrhoea, unspecified",-
7C683A67-546D-40CD-B4D6-40CE9245A87B,T88.1,"Other complications following immunization, not elsewhere classified",-
9F795A53-3AE4-49EC-BC46-E8662FBDA02B,K29.1,Other acute gastritis,-
52932705-718C-4D76-85FE-AF05766B14C5,M62.6,Muscle strain,-
842F7317-3F2B-49D3-A526-7A3EC7561158,J06.9,"Acute upper respiratory infection, unspecified",-
ADE03650-096A-46C2-A08D-435BBF427631,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EA1E5532-D9EC-4F75-BD70-EBB6B696E12E,R51,Headache,-
6203C48A-E66E-4D5B-942E-3355454725D0,B35.4,Tinea corporis,-
01E9FBD2-2E77-4C1B-9420-3CB1BB019D8D,K59.0,Constipation,-
7B223712-C0FE-4E7C-B2B5-35D10E244CC9,L65.8,Other specified nonscarring hair loss,-
7B223712-C0FE-4E7C-B2B5-35D10E244CC9,A09.9,Gastroenteritis and colitis of unspecified origin,-
3DB36F97-0EE1-43E5-81B7-EAB2CE6662E3,N94.6,"Dysmenorrhoea, unspecified",-
5EBDB359-0A04-4643-88A5-5475B9595093,J06.9,"Acute upper respiratory infection, unspecified",-
D8893138-582F-4900-A4E4-BD9AD3BD5660,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
D8893138-582F-4900-A4E4-BD9AD3BD5660,I10,Essential (primary) hypertension,Hypertension
EFCC3A13-C84C-49E2-BB5B-DDFEAAD96D5E,J06,Acute upper respiratory infections of multiple and unspecified sites,-
B3CA7FE7-F479-40B0-A690-A08B3F75569C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DB972959-ADEE-4D41-81AC-2E0712A35808,R51,Headache,-
DB972959-ADEE-4D41-81AC-2E0712A35808,M79.1,Myalgia,-
DB972959-ADEE-4D41-81AC-2E0712A35808,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
93E26ACA-5FC9-4FF3-96D9-19F46B347048,R51,Headache,-
3F4A0D9F-876C-4DF8-BAF3-5A00A3C3192F,B00.1,Herpesviral vesicular dermatitis,-
3F4A0D9F-876C-4DF8-BAF3-5A00A3C3192F,Y42.4,Oral contraceptives,-
EE3C94C7-860C-4920-B0A0-075E56DAD705,R51,Headache,-
244FBA81-BDF8-4C97-B735-B98812871A16,J06.9,"Acute upper respiratory infection, unspecified",-
7AE4A884-C649-4919-A833-D8F8721C48EF,A09.9,Gastroenteritis and colitis of unspecified origin,-
F1DA9310-CC8C-47EE-9CD9-C83B08C97FC9,U07.1,"COVID-19, virus identified",-
F1DA9310-CC8C-47EE-9CD9-C83B08C97FC9,J06,Acute upper respiratory infections of multiple and unspecified sites,-
54A9A122-94D0-4575-9897-BF0220CE979C,M79.1,Myalgia,-
54A9A122-94D0-4575-9897-BF0220CE979C,T88.1,"Other complications following immunization, not elsewhere classified",-
870AC3A9-30AF-461A-AE2C-41CE06FD35A6,R51,Headache,-
DA91A38D-44DD-4D33-A917-63B1B25D1325,L24,Irritant contact dermatitis,-
21157C16-B7B3-45FF-9AF1-4AC190616377,J06.9,"Acute upper respiratory infection, unspecified",-
6F51ED5F-2A92-45F0-A667-0ADE831ED0F5,Z76.0,Issue of repeat prescription,-
1356ABCA-6A5A-42EC-B71E-7AAA0888691A,M79.1,Myalgia,-
F52D5A80-B7C4-473D-BD20-A5DECF18DC6C,J06.9,"Acute upper respiratory infection, unspecified",-
2CB10CB9-67CA-465A-B1AE-1335CBBD59AB,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
2CB10CB9-67CA-465A-B1AE-1335CBBD59AB,L50.8,Other urticaria,-
71A2DC99-1A2E-43FA-82FB-7C946583B765,N94.6,"Dysmenorrhoea, unspecified",-
1560671D-6E24-4C5F-9BBF-EEFFC3714A7C,Z02,Examination and encounter for administrative purposes,-
B88C5D02-E36D-42E5-9153-9AA3DD7B3F24,N94.6,"Dysmenorrhoea, unspecified",-
5D213CD6-1A47-4570-A465-C740D824C67F,N94.6,"Dysmenorrhoea, unspecified",-
5D213CD6-1A47-4570-A465-C740D824C67F,R51,Headache,-
FA014E9B-517F-4083-94CC-CD93D07EEBF9,H01.0,Blepharitis,-
24C6FA01-0D8B-4A70-A3FC-7CED7E3E6163,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
24C6FA01-0D8B-4A70-A3FC-7CED7E3E6163,M79.1,Myalgia,-
3B8A8839-E422-48E4-B04C-8C94B8E53643,A09.9,Gastroenteritis and colitis of unspecified origin,-
F9044FA2-037B-4825-BAF7-49D77F895916,T78.4,"Allergy, unspecified",-
9C021972-2809-410E-977A-17D527412FB3,R51,Headache,-
9C021972-2809-410E-977A-17D527412FB3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8693C504-350A-4501-90C7-A205D661D48D,N39.0,"Urinary tract infection, site not specified",-
8693C504-350A-4501-90C7-A205D661D48D,H57,Other disorders of eye and adnexa,-
D2472DF9-78B3-488E-82B9-9538D72A1F40,I10,Essential (primary) hypertension,Hypertension
8513168D-4972-43EE-A496-BD310F9F81D3,Z71.2,Person consulting for explanation of investigation findings,-
4F9E43EF-E3E5-4FA8-87D3-8B924A8A2155,L03.2,Cellulitis of face,-
4F9E43EF-E3E5-4FA8-87D3-8B924A8A2155,R21,Rash and other nonspecific skin eruption,-
59EA9642-BDDD-4559-8290-4ACE09749B7D,B37.3,Candidiasis of vulva and vagina,-
D7A4F505-C622-42E8-BA97-789327863B9B,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
83231B00-6230-4543-A7AA-979A9D994CB6,J06.9,"Acute upper respiratory infection, unspecified",-
948CC825-0F03-41D1-99EC-899D755F801A,N94.6,"Dysmenorrhoea, unspecified",-
AFD4B3D0-407A-4A53-A158-C2BBDF5344D1,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
9FF3208F-0979-42D0-BEAB-3E6A6F921F10,K29.7,"Gastritis, unspecified",-
43B16BAB-4096-4B8D-82F4-82B051F67FE7,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
43B16BAB-4096-4B8D-82F4-82B051F67FE7,L24.9,"Irritant contact dermatitis, unspecified cause",-
EABF52E5-C0A2-4255-9AD8-4BDA145282E5,R50.9,"Fever, unspecified",-
75CBDC14-7E25-4799-91FD-10BD19A7D705,K13,Other diseases of lip and oral mucosa,-
D0AD1E5F-DC50-4035-886A-69EC8C92E018,S90,Superficial injury of ankle and foot,-
31672346-6234-4FFA-8C4E-2B5901F021B3,K29.7,"Gastritis, unspecified",-
0985098C-3888-4876-88D7-97BBFF0AB60B,M23,Internal derangement of knee,-
36CFAF19-6702-4380-A32B-CF8B60EA7278,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
36CFAF19-6702-4380-A32B-CF8B60EA7278,R51,Headache,-
1781D649-36EA-432C-BDBD-90BBD192F352,A09.9,Gastroenteritis and colitis of unspecified origin,-
F1B11610-B962-4924-B042-B04D905D79F4,J06,Acute upper respiratory infections of multiple and unspecified sites,-
F1B11610-B962-4924-B042-B04D905D79F4,U07.1,"COVID-19, virus identified",-
95018EF1-A617-4061-9D85-492DEC506426,K06.8,Other specified disorders of gingiva and edentulous alveolar ridge,-
7D98ED97-ED1A-42B8-AD1A-617FE9752962,J01.8,Other acute sinusitis,-
362D57F1-573D-431B-99C7-203584D08B7B,J06.9,"Acute upper respiratory infection, unspecified",-
CC9A3357-C58D-4C19-8855-0A689D570B75,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
CC9A3357-C58D-4C19-8855-0A689D570B75,I10,Essential (primary) hypertension,Hypertension
BAE2B325-9248-4C3B-B1A6-A8EF8E35DEAF,Z71.2,Person consulting for explanation of investigation findings,-
A314E261-C0A7-4032-94E3-51242EBA76A0,A09.9,Gastroenteritis and colitis of unspecified origin,-
C7236655-DF60-47B6-B66F-0518DB7415A8,R51,Headache,-
7FEEDB57-C064-479B-88EE-30E0E975DD78,R51,Headache,-
0D2B0AA0-31D1-422B-A450-F8A70CC99422,J06.9,"Acute upper respiratory infection, unspecified",-
F3626826-E672-40BD-9088-4A47496FCE62,M79.1,Myalgia,-
F3626826-E672-40BD-9088-4A47496FCE62,R51,Headache,-
F3626826-E672-40BD-9088-4A47496FCE62,A09.9,Gastroenteritis and colitis of unspecified origin,-
FE1E928B-A0D6-4EFB-9DBA-993B2CCCEBA5,R51,Headache,-
FE1E928B-A0D6-4EFB-9DBA-993B2CCCEBA5,H00,Hordeolum and chalazion,-
2D0CBE8B-1985-440C-A2BC-5C561DD9ED5F,J06.9,"Acute upper respiratory infection, unspecified",-
18B88CC1-562C-4B40-9BD4-E5901AECF3CE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
18B88CC1-562C-4B40-9BD4-E5901AECF3CE,M79.1,Myalgia,-
7EECF135-4FAC-45A2-81F4-7E1E607DB083,K29.7,"Gastritis, unspecified",-
92ED91A1-A583-4156-9F94-C09B333E68C1,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
92ED91A1-A583-4156-9F94-C09B333E68C1,M62.6,Muscle strain,-
92ED91A1-A583-4156-9F94-C09B333E68C1,A09.9,Gastroenteritis and colitis of unspecified origin,-
92ED91A1-A583-4156-9F94-C09B333E68C1,J45,Asthma,Asthma
72CE64BF-5048-46A0-9F61-5952EEDF64FE,Z71.2,Person consulting for explanation of investigation findings,-
FF555365-320C-437B-BFD5-A9562BC63101,U07.1,"COVID-19, virus identified",-
FF555365-320C-437B-BFD5-A9562BC63101,J06.9,"Acute upper respiratory infection, unspecified",-
03DC10D3-3ED9-4A7A-BB7D-1C001EBDDA85,M79.1,Myalgia,-
03DC10D3-3ED9-4A7A-BB7D-1C001EBDDA85,R21,Rash and other nonspecific skin eruption,-
03DC10D3-3ED9-4A7A-BB7D-1C001EBDDA85,T88.1,"Other complications following immunization, not elsewhere classified",-
A30D854D-18A5-432A-A6B8-18E95276215D,S93,"Dislocation, sprain and strain of joints and ligaments at ankle and foot level",-
D494104D-AF26-43F1-AA06-5FAE26C346E7,J02,Acute pharyngitis,-
4C0D3ECB-9950-4800-A73B-FDA6A72DF780,R51,Headache,-
74606C78-69FF-4A12-BA03-92128872788B,I10,Essential (primary) hypertension,Hypertension
74606C78-69FF-4A12-BA03-92128872788B,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
C3A35CB9-59BC-4BD9-9FDE-787197DBF4B9,J06.9,"Acute upper respiratory infection, unspecified",-
2E113D3C-606C-4F3B-A008-7C773888D240,N94.6,"Dysmenorrhoea, unspecified",-
2E113D3C-606C-4F3B-A008-7C773888D240,A09.9,Gastroenteritis and colitis of unspecified origin,-
B4779663-4C5C-40C5-A3E9-559324993340,E11,Type 2 diabetes mellitus,Diabetes
4CA64A87-3039-4738-89FB-93CFB5B03850,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
4CA64A87-3039-4738-89FB-93CFB5B03850,R51,Headache,-
FEC1C9AA-366F-40D0-A4BE-6B8C5D99543C,T88.1,"Other complications following immunization, not elsewhere classified",-
E5ED764A-8CF5-429B-9F2A-F66524C77A2A,R51,Headache,-
71E1CF45-566C-4367-9DEA-386B89297164,M79.1,Myalgia,-
DCDD7F14-D1D3-4CF2-B549-A0C9A1C397FD,L20,Atopic dermatitis,Atopic dermatitis
B367D34C-9A5C-4217-9824-DE7AA018D952,R10.4,Other and unspecified abdominal pain,-
DCDD7F14-D1D3-4CF2-B549-A0C9A1C397FD,B35.4,Tinea corporis,-
C6294BCB-2FFA-4151-A55B-B051769F3DBD,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
8AAB27DA-AF08-490F-91BC-6B7A3619FFAC,A09.9,Gastroenteritis and colitis of unspecified origin,-
5D7E7D21-6AF7-45C8-A45C-7B7D21F7E483,A09.9,Gastroenteritis and colitis of unspecified origin,-
5D7E7D21-6AF7-45C8-A45C-7B7D21F7E483,J02,Acute pharyngitis,-
C312DFBF-8DB8-4139-88AB-F3AB64009451,A09.9,Gastroenteritis and colitis of unspecified origin,-
3ACCB2F6-CBE0-422D-B688-F2274D23B366,U11,Need for immunization against COVID-19,-
AF520C07-F11A-4B85-A268-3AE382C67C6A,U07.1,"COVID-19, virus identified",-
AF520C07-F11A-4B85-A268-3AE382C67C6A,J06.9,"Acute upper respiratory infection, unspecified",-
9D09CFD5-A4DE-4659-8B0B-12595D998F2F,T88.1,"Other complications following immunization, not elsewhere classified",-
6EF8AB5C-4C89-47F0-A9F1-351182531395,J06.9,"Acute upper respiratory infection, unspecified",-
D956D309-41A0-4519-BD91-3C49216FAC9A,J06.9,"Acute upper respiratory infection, unspecified",-
9225DCB8-26D4-43F5-919B-01D5D823FE15,U07.1,"COVID-19, virus identified",-
5F8BC364-6408-490B-AE0D-509887D431F6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
5F8BC364-6408-490B-AE0D-509887D431F6,R51,Headache,-
394B7944-2EFD-4295-94DA-53D7716B1575,M65.4,Radial styloid tenosynovitis [de Quervain],-
7B366113-E23B-4B9D-8D36-2DA7D7F29A19,M65.4,Radial styloid tenosynovitis [de Quervain],-
C9916C99-0FF5-4D85-91A4-28E9C36F0883,Z02.9,"Examination for administrative purposes, unspecified",-
DEC68B93-3224-4E5E-8BA3-5624A5B93A82,Z02.9,"Examination for administrative purposes, unspecified",-
DEC68B93-3224-4E5E-8BA3-5624A5B93A82,Z30,Contraceptive management,-
C9916C99-0FF5-4D85-91A4-28E9C36F0883,Z30,Contraceptive management,-
05AF6C8A-B65E-4BA4-AB2A-14AD7DB551B0,R51,Headache,-
F615E743-7556-45CD-AC74-F0B7097415A3,J06.9,"Acute upper respiratory infection, unspecified",-
586D2C26-9D85-45E2-BE55-F1F502889051,R51,Headache,-
81A023A1-6315-4E93-A56E-458E96F02472,R50.9,"Fever, unspecified",-
586D2C26-9D85-45E2-BE55-F1F502889051,R42,Dizziness and giddiness,-
AE2E8B70-DF68-40DB-A98E-CB98FFFB14DE,R51,Headache,-
AB00C3AB-12F1-418B-A6C4-FF51B4F8B4E9,J06.9,"Acute upper respiratory infection, unspecified",-
AB00C3AB-12F1-418B-A6C4-FF51B4F8B4E9,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
DE531F00-1928-4B9B-B163-13433848F4D0,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
DE531F00-1928-4B9B-B163-13433848F4D0,R21,Rash and other nonspecific skin eruption,-
873047EC-EB14-4641-90EB-1FEB496309AA,G44.1,"Vascular headache, not elsewhere classified",-
3E9D9613-9881-44C1-99E2-E60AC85BAA18,J06.9,"Acute upper respiratory infection, unspecified",-
D521C4BD-8298-49C9-903B-1D0500F3CF59,B81,"Other intestinal helminthiases, not elsewhere classified",-
37F47E25-968D-419C-938A-4780A8DC9CBA,J06.9,"Acute upper respiratory infection, unspecified",-
37F47E25-968D-419C-938A-4780A8DC9CBA,R51,Headache,-
2C8293B5-C1B5-4974-81FE-C3DFA59C01C2,R51,Headache,-
A1B548CF-801E-4E95-B3C6-CD6688F87550,I10,Essential (primary) hypertension,Hypertension
033DBE77-1357-4481-957E-0D952D0833B5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
67CE6A0E-F053-45FA-BFE3-A99EFF8DA1B5,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
840E8A55-7962-4B7D-8149-EE0244076BCF,A09.9,Gastroenteritis and colitis of unspecified origin,-
840E8A55-7962-4B7D-8149-EE0244076BCF,N94.6,"Dysmenorrhoea, unspecified",-
840E8A55-7962-4B7D-8149-EE0244076BCF,R51,Headache,-
7A9DB9BA-1332-45A2-B827-1B584C871B28,G44.2,Tension-type headache,-
E1726D66-D966-4882-BC3D-974AFCA37E1C,J06.9,"Acute upper respiratory infection, unspecified",-
FD895093-661F-4F7D-922D-99B87893317E,Z71.2,Person consulting for explanation of investigation findings,-
E5EDF878-F9BC-4D43-8C99-0C1F2CD48722,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C231E450-821A-455B-B072-1AD35E7B7193,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
306B045F-DB06-474E-BE17-7933FBFA1F80,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
A5DB525A-6CFA-48A7-AF92-7074BE294388,R51,Headache,-
9FD3C505-625C-4A2E-86D0-BBF33C11C82B,R51,Headache,-
916E7DC9-8C32-4A7D-8B49-450CBDA3469F,Z71.2,Person consulting for explanation of investigation findings,-
89897E9D-422E-4221-9DE0-0B09E8C8A7E2,J06.9,"Acute upper respiratory infection, unspecified",-
D2698C0D-7B95-4CC9-B330-901EFFA4B32C,Z71,"Persons encountering health services for other counselling and medical advice, not elsewhere classified",-
B38D84B2-6F0A-452B-A38B-5F92AC80B1C6,J06.9,"Acute upper respiratory infection, unspecified",-
FD9BAAED-7F2A-4791-8941-2960C9BF4D9D,J06.9,"Acute upper respiratory infection, unspecified",-
90907C08-BBDE-475F-B7C7-D465AE44AC3A,G44.2,Tension-type headache,-
DBCA88C3-5255-4961-8E0B-03B166725120,K59.0,Constipation,-
DBCA88C3-5255-4961-8E0B-03B166725120,O90.2,Haematoma of obstetric wound,-
678D32EF-8545-4A06-A141-712371896D8E,K12.0,Recurrent oral aphthae,-
678D32EF-8545-4A06-A141-712371896D8E,A09.9,Gastroenteritis and colitis of unspecified origin,-
C44D2527-D8FC-4A7D-8664-A1CB3A38031F,Z02.9,"Examination for administrative purposes, unspecified",-
62F3AEB6-1C6F-46CB-B366-FA4E8AB28BF1,E03.9,"Hypothyroidism, unspecified",Thyroid
0CC93838-9388-4BBC-9073-CECA43E1F26C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
62F3AEB6-1C6F-46CB-B366-FA4E8AB28BF1,T88.1,"Other complications following immunization, not elsewhere classified",-
EF5EEFEC-345D-4AA3-AB84-DDDCCE22A88E,J06.9,"Acute upper respiratory infection, unspecified",-
7D3FBA37-E3A9-49D6-A852-E386FA60C703,A09.9,Gastroenteritis and colitis of unspecified origin,-
826BCA05-792D-4360-886B-08287153F850,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
72993602-21C9-48BC-AC39-DDD2F189F6B7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
685733D6-EA89-41EC-8F27-CE89947FB698,Z53,"Persons encountering health services for specific procedures, not carried out",-
1408DDBC-9984-4EF5-B87D-208F9BD5B13F,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
4B0C7636-15FC-4926-B8B6-4A513A1F87C5,N94.6,"Dysmenorrhoea, unspecified",-
1408DDBC-9984-4EF5-B87D-208F9BD5B13F,K59.0,Constipation,-
CE426F32-4B61-4EDA-BBAB-9A512361B1A6,R51,Headache,-
BEFE4437-436E-44EA-A59B-AE42300FC1B4,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
18E0FA42-0961-4989-96E8-CD37BB0F3A9A,R05,Cough,-
FE7D7B71-1D94-4E3A-9916-BBEE60F7A605,U07.1,"COVID-19, virus identified",-
D5E74C90-BC7A-4F79-9043-B53F5158BC60,J06.9,"Acute upper respiratory infection, unspecified",-
8DDD84D0-357F-429F-ACAC-52CE0A7F67B1,J06.9,"Acute upper respiratory infection, unspecified",-
F4474865-B64A-4E88-A491-2C669A8D2203,L03,Cellulitis,-
29B6A666-9682-4039-903E-FD9D74174CFD,R51,Headache,-
EABF52E5-C0A2-4255-9AD8-4BDA145282E5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
844EEABE-C01D-4DBE-9D84-3BB85964918D,G43,Migraine,Migraine
56E8BD0A-92BF-45F3-AAD3-87A0C9F03151,R51,Headache,-
9B3CB59A-E8E3-4D8E-AB9E-E2A02F4BC7B8,A09.9,Gastroenteritis and colitis of unspecified origin,-
77F3872E-96A1-4E07-A0AA-803394B19C93,R51,Headache,-
D3B69A03-64B7-490D-8E69-7D225F62FCE0,R51,Headache,-
E21BDB25-2BE9-4545-99A2-AACAC09EF019,A09.9,Gastroenteritis and colitis of unspecified origin,-
7BA5A10F-DCCC-4048-AEDD-E0481E90BA27,Z53,"Persons encountering health services for specific procedures, not carried out",-
38E90190-0F33-4EB8-8B89-5B0C350B6CCE,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
639C2B5C-F4D4-44FD-8D39-B6EF13FFFF3C,R22.4,"Localized swelling, mass and lump, lower limb",-
FF230316-3E99-4BC5-92E5-079733548B9D,T88.1,"Other complications following immunization, not elsewhere classified",-
EC77AFFD-2C77-4709-834B-C10F181BB6CB,B35.3,Tinea pedis,-
EC77AFFD-2C77-4709-834B-C10F181BB6CB,M75.1,Rotator cuff syndrome,-
BF8316B1-A7AA-46E6-BA32-B1F484B1DDB7,M75.1,Rotator cuff syndrome,-
F6412C75-7DFC-4B76-BDE8-E7A24AF646F8,M75.1,Rotator cuff syndrome,-
F6412C75-7DFC-4B76-BDE8-E7A24AF646F8,H00,Hordeolum and chalazion,-
EC77AFFD-2C77-4709-834B-C10F181BB6CB,M62.6,Muscle strain,-
E8F6DAC4-8873-41F9-9D3C-8F7D7E1E8143,G43,Migraine,Migraine
1C169563-8F5E-4402-B964-A2ECDAADFCE6,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
5A7BBBE9-CA07-4FA0-8CC6-A44E983AC084,R05,Cough,-
5A7BBBE9-CA07-4FA0-8CC6-A44E983AC084,U07.1,"COVID-19, virus identified",-
9AA49108-C9D2-484B-9352-2B647235C018,J22,Unspecified acute lower respiratory infection,-
2417B606-E8E0-4219-996E-D61F3E32D4C6,J06.9,"Acute upper respiratory infection, unspecified",-
25A09B91-71BD-4C9F-A4F0-4F223EDAA7A5,T88.1,"Other complications following immunization, not elsewhere classified",-
B17273E9-7952-4628-9F90-C401F8DEF9BA,J06.9,"Acute upper respiratory infection, unspecified",-
D24C0D46-592D-4D54-BBCA-086F4698596F,T78.4,"Allergy, unspecified",-
EA620D83-6DBE-442A-A9BC-1112B28FA762,K29.7,"Gastritis, unspecified",-
D0676DD9-6421-41B6-AC64-13C3464100BE,I65.2,Occlusion and stenosis of carotid artery,-
5AFA96AE-5FA7-4AA4-999E-CDBA4833E23C,S93.4,Sprain and strain of ankle,-
3D2899E3-7D47-488B-A74F-0A8145296489,H81.1,Benign paroxysmal vertigo,-
390FD21C-201A-49EE-8AAE-A9E19C118D47,J06.9,"Acute upper respiratory infection, unspecified",-
D7BEE95D-5435-4DB7-8955-A0237B08AB30,Z02,Examination and encounter for administrative purposes,-
2871DED6-6E65-4DA8-8D8B-F522BC7AF794,M62.6,Muscle strain,-
2871DED6-6E65-4DA8-8D8B-F522BC7AF794,G44.2,Tension-type headache,-
48594991-AA87-4017-9F46-0E32A4D653B6,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
211326A6-ED96-45E8-939F-6BAE048D9558,J06.9,"Acute upper respiratory infection, unspecified",-
D2DC8270-678D-4EA4-A971-B20F9FEB774B,R51,Headache,-
26A9B474-22A6-43E7-A2C9-B010B0101ED4,J06.9,"Acute upper respiratory infection, unspecified",-
F858E2B9-FD3A-4964-935D-D56702AE7D5D,J06.9,"Acute upper respiratory infection, unspecified",-
970E4882-711A-406A-985C-09FC32DA6057,J06,Acute upper respiratory infections of multiple and unspecified sites,-
575CCC69-34F8-4615-8170-71FC9B69E62A,J06.9,"Acute upper respiratory infection, unspecified",-
2C04B8BF-DF07-4EC3-83E0-61F0F7D36042,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
B2C69A1D-13B5-4A01-9193-95087D198BBE,K12.3,Oral mucositis (ulcerative),-
4CDBA9ED-BB39-4A3D-AAC6-564A6304495B,U07.2,"COVID-19, virus not identified",-
4CDBA9ED-BB39-4A3D-AAC6-564A6304495B,J06.9,"Acute upper respiratory infection, unspecified",-
0733FA6E-B765-4ED2-866E-74A6A4B5FB95,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
0733FA6E-B765-4ED2-866E-74A6A4B5FB95,J06.9,"Acute upper respiratory infection, unspecified",-
19361BAC-F99E-4B8E-BE80-F2AA3611CD54,J02,Acute pharyngitis,-
D811617D-B66C-479C-9215-7A97B218856B,N94.6,"Dysmenorrhoea, unspecified",-
B5802AE9-2623-45E0-8F36-51B06DCC88C4,S63.5,Sprain and strain of wrist,-
1642AE44-5080-445C-A579-7E057A14AB78,A09.9,Gastroenteritis and colitis of unspecified origin,-
0AC2D6FE-89BC-4B7B-A0F8-0B431C95B796,Y42.4,Oral contraceptives,-
2D06909D-13B5-4AFC-A821-1D8116D97A8A,A09.9,Gastroenteritis and colitis of unspecified origin,-
E87F6C07-396B-4304-9A67-0285B1A58B3C,Z71.2,Person consulting for explanation of investigation findings,-
05B66BC8-5DF5-4604-AD48-2255BEBF29E7,R21,Rash and other nonspecific skin eruption,-
137A55A1-2D5A-4E0B-A87D-3CE3A3D9AE27,J06.9,"Acute upper respiratory infection, unspecified",-
617371F4-8521-4006-9B70-81BFBCAAEE9F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
16CD3C9C-BAEC-404B-85D0-1EBF4F82775F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
FC2033B6-D119-410D-A560-58AEF76FBF59,T88.1,"Other complications following immunization, not elsewhere classified",-
AEAC479A-A37B-441E-BCB9-94F0199D0FE4,R07.0,Pain in throat,-
AEAC479A-A37B-441E-BCB9-94F0199D0FE4,K12.0,Recurrent oral aphthae,-
AEAC479A-A37B-441E-BCB9-94F0199D0FE4,H92.0,Otalgia,-
11E048BF-6131-423D-AD85-C22A9B38783B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
11E048BF-6131-423D-AD85-C22A9B38783B,R50.9,"Fever, unspecified",-
F801DBE0-709D-4303-AB24-A58EEA9EE757,K00.9,"Disorder of tooth development, unspecified",-
B5804D40-62FB-4DC0-BAE5-AE13DA1FC49E,L70,Acne,-
97C44AD1-7609-4153-8E5F-08C9F25D4BAF,Z71.2,Person consulting for explanation of investigation findings,-
E9883B5A-0C79-4534-A8E7-E6277D37D590,I10,Essential (primary) hypertension,Hypertension
AF301214-A056-480F-830A-B76C7F7C203D,M62.6,Muscle strain,-
3CD8D61C-524E-412D-9006-D891FCF9149D,A09.9,Gastroenteritis and colitis of unspecified origin,-
35D8454D-B2C8-481C-BBE8-98C9F018220E,R51,Headache,-
6A5F27FC-44A2-4570-BC1C-890D9F3D07D9,N94.6,"Dysmenorrhoea, unspecified",-
68ACED47-4DBF-4FF1-95C6-146DB12D6C2A,J06.9,"Acute upper respiratory infection, unspecified",-
373579B5-A9A9-42E2-A72F-FBEADAA81B3B,A09.9,Gastroenteritis and colitis of unspecified origin,-
3CA4F655-CC1C-48E5-8B87-69C3B5DDC424,A09.9,Gastroenteritis and colitis of unspecified origin,-
C0619634-D151-4E69-9CF4-01DA8A23B215,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
233E6781-9DDA-4498-937C-8593F8D0BD5F,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
630AD3C0-946A-44AE-B498-BB5CC932690E,A09.9,Gastroenteritis and colitis of unspecified origin,-
F289ACCF-4F27-4AA5-A75F-14A34757AAF3,J06.9,"Acute upper respiratory infection, unspecified",-
F289ACCF-4F27-4AA5-A75F-14A34757AAF3,R21,Rash and other nonspecific skin eruption,-
E1BD7196-3243-4B13-A70C-9F2BE89F29C5,Z71.2,Person consulting for explanation of investigation findings,-
14453C48-A10B-4CC7-A6DF-03A4AAC8D7FD,J06.9,"Acute upper respiratory infection, unspecified",-
B7C91A16-6746-498C-A0DA-F01DE870E212,K29.7,"Gastritis, unspecified",-
B7C91A16-6746-498C-A0DA-F01DE870E212,R50.9,"Fever, unspecified",-
EC6AD5AE-16DF-47BE-B59D-B306C91A49AE,R50.9,"Fever, unspecified",-
7D5BFAC0-9718-4A08-95FA-F83CB36FB80B,Z71.2,Person consulting for explanation of investigation findings,-
F3FB9A47-FB02-450E-B140-2A0898E6A440,B30,Viral conjunctivitis,-
D683CBB6-F477-408A-9428-4D94892AD0B8,R51,Headache,-
DE18B642-18A8-4EF8-965C-F4E384C6AE6C,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
1072FCF7-0F04-4BB0-8FD0-288DDF50E1B9,T88.1,"Other complications following immunization, not elsewhere classified",-
563F6A47-0CB6-4CED-86FC-0DAC161E4007,M10,Gout,Gout
E2F3CB92-EA4A-4438-ABEA-5A2D983622BB,J06,Acute upper respiratory infections of multiple and unspecified sites,-
0D36AF63-8DC8-43E1-8DFD-D55A4D02ABDB,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
8665D42D-BD09-4576-A99B-585D8236B360,R50.9,"Fever, unspecified",-
1533A6F5-8E5C-49E9-984A-C15E68DE1023,K29.7,"Gastritis, unspecified",-
E45D47BB-170C-41D4-A254-3478C00F132A,A09.9,Gastroenteritis and colitis of unspecified origin,-
1533A6F5-8E5C-49E9-984A-C15E68DE1023,R10.4,Other and unspecified abdominal pain,-
C35C42BB-BB55-4601-81D3-D9D7DB51E147,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2AF853FA-82CA-409B-9AA9-E498B7825149,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
D0779F0A-A920-4435-A614-33F2C9206C4E,S70.1,Contusion of thigh,-
29890DC8-AFC9-4A30-BB7C-15810650EBAB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
54DDB920-F7FF-426E-928A-518023F70B60,G43,Migraine,Migraine
A34EECFE-4453-4E04-B793-310528EF412B,U07.1,"COVID-19, virus identified",-
493B06A7-D755-4D37-B82E-6FB0286E6A46,M65.3,Trigger finger,-
8C3AFAA2-8431-410C-9447-29F711F3FE49,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1B06C067-938C-487E-8989-05FA09A1E944,L55,Sunburn,-
44A785DC-556B-469D-AEAE-965716B10E43,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F6F29412-66EE-44B4-AB0E-BBFCA98BB912,R51,Headache,-
E74EFBFA-8B36-4517-B79A-4CE8DC9A5332,F06.3,Organic mood [affective] disorders,-
3B413C77-6F78-4BAF-85EF-C2340230AD14,J06.9,"Acute upper respiratory infection, unspecified",-
FAFB4CFA-6842-4A6B-B0C2-08240EFB1247,H01.8,Other specified inflammation of eyelid,-
9981BECE-08CD-48B3-AB5B-887AD508916D,J06.9,"Acute upper respiratory infection, unspecified",-
30C3778C-EE73-40AC-838B-621A929FCF7F,T78.4,"Allergy, unspecified",-
42A4639F-D251-4A00-914D-BDDF6E66EF6D,H57.9,"Disorder of eye and adnexa, unspecified",-
B866F089-3CBE-4EAD-B7CC-B965BA231B06,N39.0,"Urinary tract infection, site not specified",-
FF5753D9-AB10-4629-8F1E-F65DC15C93ED,R21,Rash and other nonspecific skin eruption,-
FF5753D9-AB10-4629-8F1E-F65DC15C93ED,L50,Urticaria,-
D983DCF0-509D-4507-A437-9C451235DB69,B30,Viral conjunctivitis,-
D983DCF0-509D-4507-A437-9C451235DB69,I88.9,"Nonspecific lymphadenitis, unspecified",-
190162AF-42E0-4B9E-8105-87A0F86A0933,Z01.7,Laboratory examination,-
B0DF700D-8ECE-472B-ACD2-6ED7940A9FBA,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1A28D319-6DD7-4FB5-BF62-44CC11C29056,T88.1,"Other complications following immunization, not elsewhere classified",-
4BDB9717-9DBF-4F62-9F86-0342A1B86201,S90.1,Contusion of toe(s) without damage to nail,-
C38D00F5-6875-4AB4-9550-3677505D8EF1,S93.4,Sprain and strain of ankle,-
5D6E8088-48D0-42D5-AE68-C3DEC13F6972,Z71.2,Person consulting for explanation of investigation findings,-
8C3FA4B8-A77D-45A9-863A-70BC35F244C6,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
739C9250-03CD-4566-AEB5-73E14177C5F7,R52.9,"Pain, unspecified",-
7AF46BB5-CD2C-4697-BEB3-E146F5878400,B35.6,Tinea inguinalis [Tinea cruris],-
AF19B57E-6C84-4D65-A234-4B4E94B441A7,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D89E9A4F-8338-4CC5-8C10-C4B3E70CD5CE,B02,Zoster [herpes zoster],-
5C642937-0404-4EB3-9225-312A5C4E2571,L20,Atopic dermatitis,Atopic dermatitis
24A68F2C-8EAE-4CBB-9A83-CDCC17757977,M54.5,Low back pain,-
24A68F2C-8EAE-4CBB-9A83-CDCC17757977,M17,Gonarthrosis [arthrosis of knee],-
18B8042A-9CA4-4EB1-BC20-E7F8459F5836,R51,Headache,-
9B9A8B93-4FAC-4E56-9C73-611F503D76C3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
AE1D8703-8EFE-4AA5-AD8F-48835E37DE0D,N94.6,"Dysmenorrhoea, unspecified",-
BF6FE428-BC9B-4D43-A4FA-35B3BBDEF61B,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
BF6FE428-BC9B-4D43-A4FA-35B3BBDEF61B,J06.9,"Acute upper respiratory infection, unspecified",-
84FC8487-BD7E-4938-A2A1-9BA377B573F2,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
84FC8487-BD7E-4938-A2A1-9BA377B573F2,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
111740F0-C786-402D-B510-E5F2CC38A632,M62.6,Muscle strain,-
173FD7D6-72A8-461C-8640-696AFD7B77CD,U07.1,"COVID-19, virus identified",-
A08BE165-A228-4889-8B11-4E9B806A0F82,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A3A6D8CB-CEE4-467D-8F82-9FFF8E37C6F7,J06,Acute upper respiratory infections of multiple and unspecified sites,-
30F4E7BD-9589-4A53-8CE6-174AB71DD4E4,J06.9,"Acute upper respiratory infection, unspecified",-
30F4E7BD-9589-4A53-8CE6-174AB71DD4E4,U07.1,"COVID-19, virus identified",-
1E6C3ECD-BD30-4EFF-A8F9-1CD2D1E1CE68,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
A5877139-7E4D-4C4C-B052-E53C4759FF1D,R51,Headache,-
A5877139-7E4D-4C4C-B052-E53C4759FF1D,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
7E7CF528-67F7-48D2-995B-FDDFD0ECCC60,A09.9,Gastroenteritis and colitis of unspecified origin,-
320CAD64-955B-4B54-9DC2-A4B3085ECF25,A09.9,Gastroenteritis and colitis of unspecified origin,-
38EE1ECA-D886-4726-8A05-5809542874E4,A09.9,Gastroenteritis and colitis of unspecified origin,-
5CA30442-085F-4B46-8C08-EC4A0F04CBBF,R21,Rash and other nonspecific skin eruption,-
F2181212-22B8-4440-B15E-216CFA131D13,Z71.2,Person consulting for explanation of investigation findings,-
CC048A8C-1BC9-415F-8560-97E5D6E62566,B35.6,Tinea inguinalis [Tinea cruris],-
739C9250-03CD-4566-AEB5-73E14177C5F7,B35.6,Tinea inguinalis [Tinea cruris],-
CC048A8C-1BC9-415F-8560-97E5D6E62566,M75.9,"Shoulder lesion, unspecified",-
8C3FA4B8-A77D-45A9-863A-70BC35F244C6,B35.3,Tinea pedis,-
7AF46BB5-CD2C-4697-BEB3-E146F5878400,B35.3,Tinea pedis,-
739C9250-03CD-4566-AEB5-73E14177C5F7,B35.3,Tinea pedis,-
6BD59461-822F-4715-81B4-281F7DB92270,R51,Headache,-
F8D07EB9-5DF5-4680-AC52-2683B8320D6D,U07.1,"COVID-19, virus identified",-
F8D07EB9-5DF5-4680-AC52-2683B8320D6D,J06.9,"Acute upper respiratory infection, unspecified",-
78BACE65-625E-4D4A-A7E1-2BD476CC8BAB,R10.4,Other and unspecified abdominal pain,-
C333CB84-500F-4D6B-B935-5251A8469185,G44.2,Tension-type headache,-
C333CB84-500F-4D6B-B935-5251A8469185,M62.6,Muscle strain,-
2A0DCB59-C781-4E7C-9B5A-5C9D31EC7AD3,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
5E304F33-B85B-49DC-815C-0EC19A70D0D2,A09.9,Gastroenteritis and colitis of unspecified origin,-
AC6AB6F2-A4D4-4CD8-9B4E-7AEBA0520673,K25,Gastric ulcer,-
2B262441-98F0-4D44-BB32-90916167FCD2,U07.1,"COVID-19, virus identified",-
EE9110D2-D68F-4430-A24C-C5F2CE736F8E,Z01.7,Laboratory examination,-
8E8C9A15-EE3D-4A2C-88CA-797CA3CC5D3D,B02,Zoster [herpes zoster],-
25D4F5DC-ED60-43FF-9C6E-12B437FA90B8,L21,Seborrhoeic dermatitis,-
D970FE88-42A5-4C11-86DC-8342A3BF8C77,N94.8,Other specified conditions associated with female genital organs and menstrual cycle,-
8805B146-6B3B-492F-802D-D369492A1A87,J06.9,"Acute upper respiratory infection, unspecified",-
39E22E6F-185A-4F3A-B599-0FD6B8CF78B8,A09.9,Gastroenteritis and colitis of unspecified origin,-
C3FDC547-79BD-4E37-B0D8-6A6077FF906B,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
43634CE3-B0EC-4D6F-8A31-3BEAB28FEAC1,M62.6,Muscle strain,-
72CC548C-AC86-4EF2-947A-A72BF4F5A462,T88.1,"Other complications following immunization, not elsewhere classified",-
AA4A9F5C-91C6-4FBF-88EF-75BFED4FBBFC,T88.1,"Other complications following immunization, not elsewhere classified",-
63049B7C-A38B-40B9-BD31-6CAFB1935259,S53,"Dislocation, sprain and strain of joints and ligaments of elbow",-
1E1227F1-E1AC-435F-8539-CF302505230B,S33.7,Sprain and strain of other and unspecified parts of lumbar spine and pelvis,-
28BAB565-42AC-473E-A259-F4E3E9ADE650,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
28BAB565-42AC-473E-A259-F4E3E9ADE650,E78.2,Mixed hyperlipidaemia,Hyperlipidaemia
ED2B957C-75EB-4E64-ABFE-6C342DFAB04E,I10,Essential (primary) hypertension,Hypertension
0B0CEC14-EC04-4401-B41B-0578B0A458CF,J06.9,"Acute upper respiratory infection, unspecified",-
6658BE43-2E68-4CB6-BE18-BF4D02E62943,M79.1,Myalgia,-
A93C5165-3E21-43A7-8A0B-21CBF0774B49,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
5F974F9A-A3CB-4672-929F-C82E43691E07,J06.9,"Acute upper respiratory infection, unspecified",-
03C72481-E77C-4C8B-BDBF-2099A071007A,T88.1,"Other complications following immunization, not elsewhere classified",-
2A8D089A-7940-4E5E-8968-EDB540A897F9,J02,Acute pharyngitis,-
25120833-044B-4E55-A216-647EE6D18F19,J06.9,"Acute upper respiratory infection, unspecified",-
25DE196F-9462-44CA-9D34-DE4953DF9212,J06.9,"Acute upper respiratory infection, unspecified",-
39FE3BD5-355A-4CCD-B8E9-692D14D0985D,A09.9,Gastroenteritis and colitis of unspecified origin,-
872C83BC-D5FF-46ED-9919-014D507BAF31,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E4E7AE29-7E65-4687-BC74-960B4987B864,Z02.9,"Examination for administrative purposes, unspecified",-
53E3B5C9-C851-42ED-AB0E-25E68187A107,N39.0,"Urinary tract infection, site not specified",-
0AC5839E-8D53-4ED7-801D-F7FBE7F0247C,R22.9,"Localized swelling, mass and lump, unspecified",-
F41D183F-4B38-4B48-A1C0-2049A66C15A1,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A08A3D4D-CEF2-4903-AA4F-B01A0A4612B5,R51,Headache,-
B07EB94A-6964-4063-A79E-120021C82422,A09.9,Gastroenteritis and colitis of unspecified origin,-
EEF3B9D1-93A9-4FE6-AC5B-8C19332D840B,Y42.4,Oral contraceptives,-
A6574EE4-F697-4E65-9FDA-9D47E697A28D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D13E1612-44B9-46C8-9254-0E99C607EF97,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D3A790D0-90CF-41E4-AC4F-FEDF39D863AF,R51,Headache,-
D3A790D0-90CF-41E4-AC4F-FEDF39D863AF,N94.6,"Dysmenorrhoea, unspecified",-
B775FBD4-0A2A-4528-8818-DEFBCB4C0120,B37,Candidiasis,-
BA2861A1-33B7-43D2-9F1E-F9A5C5ADF894,K30,Functional dyspepsia,-
D0ECFC13-DE4A-4F3D-AD41-DC3B29C99BE5,K30,Functional dyspepsia,-
A90F6682-96D9-44C3-8EC4-C5A336643605,N39.0,"Urinary tract infection, site not specified",-
D019E62D-23BB-41E6-86D8-098D25AD75B3,J06.9,"Acute upper respiratory infection, unspecified",-
2C7705A7-6917-4A5B-9C8E-722753C8AA3C,E11,Type 2 diabetes mellitus,Diabetes
2C7705A7-6917-4A5B-9C8E-722753C8AA3C,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
42ED2E1B-3E01-4BE0-8D77-498A735F1770,M79.1,Myalgia,-
99026BCA-4D73-4E38-A010-3FDC2CF24E92,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8B8195DE-6468-4706-BAF0-C2B44E6D9154,L50.9,"Urticaria, unspecified",-
8B8195DE-6468-4706-BAF0-C2B44E6D9154,B36.0,Pityriasis versicolor,-
99026BCA-4D73-4E38-A010-3FDC2CF24E92,B35.4,Tinea corporis,-
74BBD70A-1744-4F10-AB22-273F7044FD20,N94.6,"Dysmenorrhoea, unspecified",-
527CAFAE-193B-4226-A11D-C6043F4E2B67,A09.9,Gastroenteritis and colitis of unspecified origin,-
482AA45B-99F9-4986-AAA9-DACF32D8EAC2,G44.2,Tension-type headache,-
5F089623-57B3-420D-840F-B9D12E19E3F8,O21.0,Mild hyperemesis gravidarum,-
FC13C8DA-7D7C-4EC7-905C-9F439028AF49,O21.0,Mild hyperemesis gravidarum,-
00694982-634E-4EA7-A660-3E5623144233,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
A019607A-89D4-42BA-908F-0FF17574ED24,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
00694982-634E-4EA7-A660-3E5623144233,N94.6,"Dysmenorrhoea, unspecified",-
A019607A-89D4-42BA-908F-0FF17574ED24,R51,Headache,-
E8A2D75D-1133-44C1-9C6B-2259AB9A8E84,R21,Rash and other nonspecific skin eruption,-
9B590930-0F43-494A-B845-0DB0BCBB0E7E,J06.9,"Acute upper respiratory infection, unspecified",-
68523EAE-5299-4E71-8D7C-5E8DB094CE9C,T78.4,"Allergy, unspecified",-
BD8BCAD0-5D81-4B68-B45F-291B7D132BAE,L50.9,"Urticaria, unspecified",-
73320AE3-1701-4597-A5B7-0111B9A2F17B,O91.2,Nonpurulent mastitis associated with childbirth,-
A84E8152-AF92-4059-A796-21B55BC4621C,O91.2,Nonpurulent mastitis associated with childbirth,-
42837060-A9ED-4756-AAE8-D3E04A9EE9E9,R50.9,"Fever, unspecified",-
42837060-A9ED-4756-AAE8-D3E04A9EE9E9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A816074D-3FE8-4A61-A078-6FCF2B536AE1,R50.9,"Fever, unspecified",-
A816074D-3FE8-4A61-A078-6FCF2B536AE1,G44.2,Tension-type headache,-
CFDEA6F0-BEAE-43D1-88C6-6FAD9379E9FA,J06.9,"Acute upper respiratory infection, unspecified",-
73B8146F-8017-468C-A5AB-273AA4954365,A09.9,Gastroenteritis and colitis of unspecified origin,-
EBF248E0-919B-4613-9995-0C473D8BAAB7,M25.5,Pain in joint,-
EBF248E0-919B-4613-9995-0C473D8BAAB7,M10,Gout,Gout
B0BBE756-01FC-4399-8F97-81F8E4B0D0E4,L20,Atopic dermatitis,Atopic dermatitis
36A46CAF-560E-4649-B951-828E8C08EE36,J06,Acute upper respiratory infections of multiple and unspecified sites,-
2472C94D-F63F-43B0-A474-2400DE9795A8,M79.1,Myalgia,-
67BEB6E6-D0F2-4781-8D7D-6D4CEF8F8352,Z71.2,Person consulting for explanation of investigation findings,-
C7010A67-EC68-4D02-A6EE-AD0424EF937F,R51,Headache,-
4522547B-0BAF-4137-B93C-14BBEA86A74A,K29.6,Other gastritis,-
8C345048-4356-4A01-A9FE-AE5E26467553,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
BB79A64A-D8ED-4351-BAE3-FAB9E4318518,A09.9,Gastroenteritis and colitis of unspecified origin,-
887E4598-9E9E-4091-9CB9-AF0ABA5C0D80,T88.1,"Other complications following immunization, not elsewhere classified",-
EA095223-D223-430C-A8DB-66A4F405D29F,N39.0,"Urinary tract infection, site not specified",-
70D7E5A6-94F4-429C-9EFD-C8DBBE3BCB12,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2A8A5559-D2DB-402C-BA1E-9F049B276E37,H81.1,Benign paroxysmal vertigo,-
6EF99DF1-829E-467F-8004-B29C00FEC926,X50,Overexertion and strenuous or repetitive movements,-
238E86EC-918A-4111-8A53-DED3496CF951,A09.9,Gastroenteritis and colitis of unspecified origin,-
FA7FB5BF-6DFB-4637-8C7D-951B645F4C44,R51,Headache,-
1BE92142-250C-4BCA-BB33-53A62CC9373A,N94.6,"Dysmenorrhoea, unspecified",-
DE2C5992-AAF5-4C3D-89E2-EFCA51F6F980,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
134A891B-C1EB-4D7C-A880-01914980F96A,A09.9,Gastroenteritis and colitis of unspecified origin,-
CBCA8E06-1FA8-4F0D-AA04-7A922DDDB96B,N94.6,"Dysmenorrhoea, unspecified",-
CBCA8E06-1FA8-4F0D-AA04-7A922DDDB96B,G43,Migraine,Migraine
0E8AA435-18D6-44D4-8273-A50E05F8EB36,J06.9,"Acute upper respiratory infection, unspecified",-
5C95731B-BDF9-41DE-86E5-E45C13BDAF49,M79.1,Myalgia,-
3B3CC82E-AA18-4791-9F2C-2B060C4B6848,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
6BE03C14-F6EB-4CED-955D-2884DD238926,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E9CEF980-2991-4B1B-BB97-0DD128838E4A,R51,Headache,-
EFCD7EB9-3674-47F5-8619-812D86CA8A0D,Z71.2,Person consulting for explanation of investigation findings,-
B1F8A5BE-4379-4F36-BCC3-185F4A086B34,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
9DCF13B9-BE2B-4A6E-AD46-8479DDEC1F2D,N94.8,Other specified conditions associated with female genital organs and menstrual cycle,-
5E3A9E7A-444F-4808-958B-202D5BF96E22,J06.9,"Acute upper respiratory infection, unspecified",-
7C99B9A8-C28A-4CA9-878B-A8D1029DCA5F,R50.9,"Fever, unspecified",-
7C99B9A8-C28A-4CA9-878B-A8D1029DCA5F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
7F00427F-AC86-4EBC-A440-A71713F7BA5A,A09.9,Gastroenteritis and colitis of unspecified origin,-
17A41BB2-2EF9-4065-A16F-3F962770F826,R21,Rash and other nonspecific skin eruption,-
8181647D-7B15-480C-816C-7EC302933537,J06.9,"Acute upper respiratory infection, unspecified",-
0BBE287C-C6ED-46C5-ABE9-B732640DB39F,S90.3,Contusion of other and unspecified parts of foot,-
9594E355-5752-4839-B192-5719FA17488F,R51,Headache,-
D633EE0C-1E86-4148-AE66-26D5592B8631,J06.9,"Acute upper respiratory infection, unspecified",-
C3D785A1-1C63-4D8B-B29A-47F8CA3F4A40,A09.9,Gastroenteritis and colitis of unspecified origin,-
163753A0-8FE1-4F8F-ACF2-5102FCE0E6CA,R50.9,"Fever, unspecified",-
C2C9EA16-BD8C-4ED3-95A0-F71CFDAC8BFF,Y42.4,Oral contraceptives,-
C2C9EA16-BD8C-4ED3-95A0-F71CFDAC8BFF,R07.0,Pain in throat,-
6A26DD28-8E2D-4417-8029-2A19DB7F02DD,A09.9,Gastroenteritis and colitis of unspecified origin,-
9AD8F561-B83A-4611-BD2C-1F8ED04E07FD,M65.4,Radial styloid tenosynovitis [de Quervain],-
3CC75E8D-F0C7-4FD6-A55D-4286B4F38E33,J06.9,"Acute upper respiratory infection, unspecified",-
00211C7C-0F30-40A8-8ABF-4DEF21B700D1,L20,Atopic dermatitis,Atopic dermatitis
D3664A38-F263-408D-9F64-1AD547E09A63,A09.9,Gastroenteritis and colitis of unspecified origin,-
C884DF92-EB8F-44B5-832A-F1185DA6F715,J06.9,"Acute upper respiratory infection, unspecified",-
C884DF92-EB8F-44B5-832A-F1185DA6F715,P39.0,Neonatal infective mastitis,-
F14E4A30-6833-47A0-A063-C5F486803630,J06.9,"Acute upper respiratory infection, unspecified",-
1D953F1E-F746-47C8-B561-F1F9229C737C,N94.6,"Dysmenorrhoea, unspecified",-
60878220-2B05-4E73-8514-D373DB470529,M79.1,Myalgia,-
8B5553AC-F5A4-45E6-B7E7-989679D9831B,A09.9,Gastroenteritis and colitis of unspecified origin,-
FCCC5924-D790-4526-BEBC-B68BEBE4FA43,A09.9,Gastroenteritis and colitis of unspecified origin,-
DEA5DB18-5E61-4A2C-965F-9A04DA87D61E,R21,Rash and other nonspecific skin eruption,-
C7C3138E-37E7-49D5-BEC8-FEBF02ABA57F,L20,Atopic dermatitis,Atopic dermatitis
058EC2D7-DE2B-475A-97FA-C38A1FD4521B,T88.1,"Other complications following immunization, not elsewhere classified",-
D82E9F15-4E86-49A1-B6A2-29E210FEC369,J06.9,"Acute upper respiratory infection, unspecified",-
1EB652F1-8FA8-4B82-B651-B94C22D61D8C,R51,Headache,-
7468A41D-B80B-498D-8303-A3C9C218F471,R51,Headache,-
235E910D-1849-4EF7-802E-7FC32D130A7A,R51,Headache,-
7BA0A770-27A1-4D06-BD02-0A2A0BE5AFC1,L03.0,Cellulitis of finger and toe,-
3D58FE30-9FB1-48C7-B9C2-AC4F37E5FFBC,R51,Headache,-
3D58FE30-9FB1-48C7-B9C2-AC4F37E5FFBC,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
13191783-5BC4-4C36-B5F2-F04571D24809,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F8921ACA-3082-40BA-B9D8-885A6FFCC842,R51,Headache,-
1785CE00-6EE7-41E0-B745-34B74A0E41B6,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
CE224D9B-1AB2-4E11-9974-252684CC37C3,G47.0,Disorders of initiating and maintaining sleep [insomnias],-
CE224D9B-1AB2-4E11-9974-252684CC37C3,G44.1,"Vascular headache, not elsewhere classified",-
EF3E5639-67EF-47DF-948C-8CAFBD47C20E,J06.9,"Acute upper respiratory infection, unspecified",-
20174685-8C2F-4ED9-8410-5C6ABB864FA3,A09.9,Gastroenteritis and colitis of unspecified origin,-
177390E7-F7BE-4BD2-A4C9-E11E049C2A2E,A09.9,Gastroenteritis and colitis of unspecified origin,-
7CDE67C2-BB61-4039-9F48-78F645EECE6F,R50.9,"Fever, unspecified",-
7CDE67C2-BB61-4039-9F48-78F645EECE6F,A09.9,Gastroenteritis and colitis of unspecified origin,-
8423FE06-62D6-4E54-A239-8B1F4C59EED1,T88.1,"Other complications following immunization, not elsewhere classified",-
BCF5F44D-672A-444C-83A8-0F6C1A65E59F,T88.1,"Other complications following immunization, not elsewhere classified",-
B9381D2A-59DA-40D4-B4F5-2D3A630B3BB9,R21,Rash and other nonspecific skin eruption,-
A9EB86F1-22D0-4783-8099-656C8A47A8BF,Z71.2,Person consulting for explanation of investigation findings,-
9946EEBD-FE9F-4991-AB33-3BF40FC66FD4,N94.6,"Dysmenorrhoea, unspecified",-
C4C5B321-19FB-4F46-B9AC-D366FE6450BE,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
61DA45F0-109A-4A20-8AA1-2C580E317FC5,K00,Disorders of tooth development and eruption,-
BD62EE8B-C613-4182-85B1-2E7C64600D36,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
BD62EE8B-C613-4182-85B1-2E7C64600D36,R50.9,"Fever, unspecified",-
EDEC4C05-5F1B-4B68-AC19-0F813DC90F5E,U07.2,"COVID-19, virus not identified",-
21B6627F-A6C8-49E8-91D7-55201BF1A2F4,N94.6,"Dysmenorrhoea, unspecified",-
F53B91C1-174F-49DB-A8C8-77F18FA52E71,K59.0,Constipation,-
C91E9581-3FC8-47E3-9E35-20271DDB9DBF,J06.9,"Acute upper respiratory infection, unspecified",-
36343954-D415-4D25-ACE5-57FE823D25AB,R50.9,"Fever, unspecified",-
549FF0A1-BD53-4AF6-8A05-255BD5430582,M79.1,Myalgia,-
549FF0A1-BD53-4AF6-8A05-255BD5430582,R51,Headache,-
070449AC-B9F0-464C-99FC-A255C96686A9,M54.5,Low back pain,-
7D425855-D0D0-45CD-BD92-1BB4B1DE3038,R21,Rash and other nonspecific skin eruption,-
5F0EF3D7-D24B-479F-8088-986B33266CBB,K05.0,Acute gingivitis,-
00E404DD-8740-4111-BB75-3573994080A9,F52.8,"Other sexual dysfunction, not caused by organic disorder or disease",-
0067030D-C059-4757-8BE5-53F42D3E1CBC,J06.9,"Acute upper respiratory infection, unspecified",-
433B6F66-188A-44ED-AA70-26A9E61E7B20,U08,Personal history of COVID-19,-
C84A6578-5D2D-472C-B86C-A04A8940E440,M54.5,Low back pain,-
C84A6578-5D2D-472C-B86C-A04A8940E440,R21,Rash and other nonspecific skin eruption,-
C84A6578-5D2D-472C-B86C-A04A8940E440,H57.9,"Disorder of eye and adnexa, unspecified",-
909CA926-BAEF-4244-BF39-70E4756B366D,R51,Headache,-
D29CA83D-EA6D-4EA7-826A-21F9209BECE8,N94.6,"Dysmenorrhoea, unspecified",-
76704065-CA25-43F3-A552-06A6F2B67527,R51,Headache,-
12B74211-194E-4138-AD9C-95A3310627C7,R51,Headache,-
771DB5E7-8C8B-4FBD-8599-9005717D3FC6,H02.9,"Disorder of eyelid, unspecified",-
3F91D72D-0D4C-4EBA-AEDF-EC4636327F0F,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
D51AFF81-BE7B-4080-8087-E44EFBD17F57,K00,Disorders of tooth development and eruption,-
D51AFF81-BE7B-4080-8087-E44EFBD17F57,R51,Headache,-
23A8E74E-4087-417F-ADA3-0F685BA30E58,M79.1,Myalgia,-
23A8E74E-4087-417F-ADA3-0F685BA30E58,M62.6,Muscle strain,-
1D8F8D9D-56FB-4BEC-9E9A-188B640A60EC,A09.9,Gastroenteritis and colitis of unspecified origin,-
1D8F8D9D-56FB-4BEC-9E9A-188B640A60EC,R51,Headache,-
4296C6ED-A6B2-4A12-8375-1623739375CD,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
146C81C2-B40F-4139-AD00-0F6EFD99D3CB,N30.0,Acute cystitis,-
E7A1CE51-AA5B-4101-9FC1-3B617C45942B,N39.0,"Urinary tract infection, site not specified",-
4F5169B8-E3B7-4151-9A09-AA9414876AAB,A09.9,Gastroenteritis and colitis of unspecified origin,-
CA77CEE0-322C-48E4-BC21-653EA02C5B42,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
E103976B-E569-4305-B19B-3342F4F5F657,R51,Headache,-
EF898225-3DD0-4349-AF67-C630F1108630,M54.5,Low back pain,-
54A69DDA-9F9A-4690-A756-59C01010186D,Z71.2,Person consulting for explanation of investigation findings,-
E37E71B1-A234-486B-8390-DF67E5DB8E53,R21,Rash and other nonspecific skin eruption,-
2D40841A-E513-4C2D-AB18-357F3E395892,G44.2,Tension-type headache,-
2D40841A-E513-4C2D-AB18-357F3E395892,N94.6,"Dysmenorrhoea, unspecified",-
90CA921F-B88F-412F-86E1-2CF36A380084,R50.9,"Fever, unspecified",-
90CA921F-B88F-412F-86E1-2CF36A380084,T88.1,"Other complications following immunization, not elsewhere classified",-
FC430A0F-308E-4AAA-B451-A596EB98A14F,N94.6,"Dysmenorrhoea, unspecified",-
57C62A25-576C-4439-B3F5-C1DE226B3915,L20,Atopic dermatitis,Atopic dermatitis
9D89C857-9FBD-4125-8394-B42455F3D866,R51,Headache,-
37CB88F8-CCFB-4C6D-B4B7-3FA1C4BD51B6,N39.0,"Urinary tract infection, site not specified",-
B02B6619-D1AE-40FE-9403-D31A6B54C980,L50,Urticaria,-
2DE78B1C-F02D-4CA8-B6AC-3E319409B4D0,A09.9,Gastroenteritis and colitis of unspecified origin,-
53C573D8-3B34-4954-8FE5-D7942263E45F,T88.1,"Other complications following immunization, not elsewhere classified",-
257F0487-8E5F-4A6C-B48B-A71A685FC43E,R21,Rash and other nonspecific skin eruption,-
6CC9B824-6550-4745-9B55-CEF8C459F402,A09.9,Gastroenteritis and colitis of unspecified origin,-
7403D983-34D8-488B-9E80-3BCB268C4A3D,H57,Other disorders of eye and adnexa,-
7403D983-34D8-488B-9E80-3BCB268C4A3D,T88.1,"Other complications following immunization, not elsewhere classified",-
27C7436D-EF12-4E05-A418-EB71CB2D4D43,N94.6,"Dysmenorrhoea, unspecified",-
E848CD2E-7999-4910-8F3E-046DD26E7FF0,R51,Headache,-
930FEBA5-3B49-4C7C-933C-758993D81B3F,J06.9,"Acute upper respiratory infection, unspecified",-
63FD3CFA-B73F-4E28-BFF2-745C729C77F5,Y42.4,Oral contraceptives,-
975A1B0C-76C1-42C8-B3AE-0FED6C5C59EB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D666D730-20B0-4A15-872A-77844A8A38BA,M79.1,Myalgia,-
D666D730-20B0-4A15-872A-77844A8A38BA,R51,Headache,-
06B6F823-9ADD-4C9D-9A2D-42FDD6776EF7,R51,Headache,-
58C7353B-7124-41DF-A4D1-17868422CE35,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
7C8697C5-7E6D-4B40-AA48-FBB9A5EC7D1A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C46D8C89-9D0F-4C2D-BC16-5760F4851A1C,R51,Headache,-
EA969187-8ED0-45A9-9812-322A39B1C777,R50.9,"Fever, unspecified",-
EA969187-8ED0-45A9-9812-322A39B1C777,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
A3711000-5E53-4B09-AA7B-A26226D6EAE8,R51,Headache,-
FD033AD3-DBFB-4A07-8F35-371F5A0EC992,A09.9,Gastroenteritis and colitis of unspecified origin,-
8718F03F-3537-4726-A99D-7DD0D873A6C1,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
EB58DDC7-DACE-46C8-B46F-72C893C0FA14,R50.9,"Fever, unspecified",-
8347262D-7E4B-4018-9423-B871A59F35E8,G44.2,Tension-type headache,-
F48EE96A-2C85-4DA7-9EC2-5F28F4BCED0D,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
7D95E8B3-3902-4A60-BDB9-B7872365EA2C,A09.9,Gastroenteritis and colitis of unspecified origin,-
C43FC9FA-AD7D-4BC3-B9FA-6E2E82777F84,R51,Headache,-
3C82BF53-E695-410A-A7F6-E09F8A21E2A0,A09.9,Gastroenteritis and colitis of unspecified origin,-
3C82BF53-E695-410A-A7F6-E09F8A21E2A0,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
EB7DA3D9-796B-4CFD-A5E0-3A2BE29420D4,R51,Headache,-
2F826164-67B6-433A-8831-3B3F7D2AD94E,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D3139565-0783-49DA-9030-74BE1880A675,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
56163F4A-8D0F-4EEB-9230-B374D1EEDE14,L30.9,"Dermatitis, unspecified",-
9ECA07BD-A356-403D-B24C-792CB3C08DBC,J06.9,"Acute upper respiratory infection, unspecified",-
9ECA07BD-A356-403D-B24C-792CB3C08DBC,T88.1,"Other complications following immunization, not elsewhere classified",-
1AC50CBD-28A0-4D80-BC64-8FF9D0D0B19B,A09.9,Gastroenteritis and colitis of unspecified origin,-
87A522F0-8933-43DF-9AB0-ACF0FEC3D228,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
0B0D1CBD-62F2-4757-AD72-1AB76F495D29,A09.9,Gastroenteritis and colitis of unspecified origin,-
EE870F02-D7A2-45D2-B00E-A1963C2FD881,U08,Personal history of COVID-19,-
EE870F02-D7A2-45D2-B00E-A1963C2FD881,J06.9,"Acute upper respiratory infection, unspecified",-
5859145A-EC07-4262-9B14-623E4BAA93CD,Z71.2,Person consulting for explanation of investigation findings,-
CF0AC8CB-C86D-462D-8025-B3245D1A992D,R21,Rash and other nonspecific skin eruption,-
25F3D7E4-A677-4D51-BCDF-CF0F2CC6DE4A,L20,Atopic dermatitis,Atopic dermatitis
E0575942-12E3-4B11-AAF7-EA900A6CEFD8,R51,Headache,-
F821EBFF-2BA7-4955-9CFD-23C21ED8E34A,H02.9,"Disorder of eyelid, unspecified",-
36724BB2-04F2-4ABC-B463-EDA71BB0E6C0,T88.1,"Other complications following immunization, not elsewhere classified",-
BF897FD6-C814-464C-B4C6-8EFC592777E8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2EC28D66-061B-4E83-86A1-7C79481232D9,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2EC28D66-061B-4E83-86A1-7C79481232D9,M79.1,Myalgia,-
228491A7-E591-4256-A843-874F240FCBA4,R51,Headache,-
E4CD93A0-9DC1-44AF-AB0F-5063847D8428,R51,Headache,-
E4CD93A0-9DC1-44AF-AB0F-5063847D8428,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
62387029-F89B-41BA-8AB4-2F3A5045DFCB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F693259E-AC7B-4FCC-B8FF-4DA88F248871,H57,Other disorders of eye and adnexa,-
CC56DA60-9B73-4B17-9A9A-D8AA20766FA6,H01.0,Blepharitis,-
B8B00A48-9543-4C15-8226-95ADBA7FA699,H81.1,Benign paroxysmal vertigo,-
31B5CB89-117B-4535-833E-9F907B08FD09,G44,Other headache syndromes,-
31B5CB89-117B-4535-833E-9F907B08FD09,N92.5,Other specified irregular menstruation,-
52E3AECA-6E07-40E4-995B-DAB39A6D55F5,Z53,"Persons encountering health services for specific procedures, not carried out",-
37DA2D09-B985-411E-A0D3-8934235C64C0,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
5B5DE42B-78C5-40DA-88B5-9DD915F437A6,K29.7,"Gastritis, unspecified",-
37DA2D09-B985-411E-A0D3-8934235C64C0,K29.7,"Gastritis, unspecified",-
5B5DE42B-78C5-40DA-88B5-9DD915F437A6,E66,Obesity,-
584D8BB6-D713-4DDA-8AC5-D5DC25CE2760,R51,Headache,-
0977D1A4-56DD-4D69-975C-BD332371EE4E,R51,Headache,-
E5CA1F20-EFC5-45B2-9422-581DFE6FB563,K64.9,"Haemorrhoids, unspecified",-
42425038-234C-489B-91E1-0A2A9CB1F819,H00,Hordeolum and chalazion,-
D4683A80-3399-4DA5-BCE0-92EFA2E82E06,H00,Hordeolum and chalazion,-
CCA368EC-AB0B-4B74-8DD6-32C3C18729ED,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1451A22A-D696-4CF3-92B4-44F82E892374,S83,"Dislocation, sprain and strain of joints and ligaments of knee",-
E2A3F4AB-5B9B-4BCD-9680-BBE14E8C3AE5,G43,Migraine,Migraine
A545436B-CF63-4215-963D-EF1B2709BD26,A09.9,Gastroenteritis and colitis of unspecified origin,-
60CD6886-DC54-40A8-A892-AC0CD78E8793,A09.9,Gastroenteritis and colitis of unspecified origin,-
198DD6D1-05D7-46E8-A266-BAED8F6349CA,J06.9,"Acute upper respiratory infection, unspecified",-
F502B12D-8D95-463D-AA18-E5EBD191527F,J06,Acute upper respiratory infections of multiple and unspecified sites,-
03D44C23-EC41-4785-AC42-E98F0C7CF01D,R51,Headache,-
099B9C51-A3C2-4B18-8250-9685B14A1785,U07.1,"COVID-19, virus identified",-
4F6FECA0-F138-4A86-9659-CF8B8A0D9CBB,L20,Atopic dermatitis,Atopic dermatitis
08C65894-65A9-4EFE-ACFD-E6C90F183FA3,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
08C65894-65A9-4EFE-ACFD-E6C90F183FA3,R05,Cough,-
83D02D73-7324-49A6-AD6A-ABBE592BE2BF,N48,Other disorders of penis,-
16E46E12-85E5-4D9A-B961-180B58C7A8F2,L24,Irritant contact dermatitis,-
16E46E12-85E5-4D9A-B961-180B58C7A8F2,B35.2,Tinea manuum,-
B44174B4-A189-4784-B64B-3E599399CF92,U07.1,"COVID-19, virus identified",-
955E59FE-3A5D-4BCA-85B5-954442E4FB5E,J06.9,"Acute upper respiratory infection, unspecified",-
B1600968-F3F7-4CC8-A63B-43BBD7571AAA,A09.9,Gastroenteritis and colitis of unspecified origin,-
5B45F6BF-0629-4B6F-A415-9E37DADBD7B3,L70,Acne,-
5B45F6BF-0629-4B6F-A415-9E37DADBD7B3,J06.9,"Acute upper respiratory infection, unspecified",-
54B7577D-7C50-4B51-B468-B9C41A197C1D,J06.9,"Acute upper respiratory infection, unspecified",-
C1408E86-BD4C-4BA4-AD7E-12BA4F7C84D7,J06,Acute upper respiratory infections of multiple and unspecified sites,-
508BC115-BCEE-4464-9011-C4FD18241ACB,T88.1,"Other complications following immunization, not elsewhere classified",-
74C5CA86-22A6-446C-8FFC-2A6C4222D3E2,M25.5,Pain in joint,-
AE853DCF-51F1-4644-8EF0-FE51ACAFB794,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DA1585A6-5FF2-45C1-B937-CA2CBA5596C8,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
DA1585A6-5FF2-45C1-B937-CA2CBA5596C8,J06.9,"Acute upper respiratory infection, unspecified",-
309E6D76-5860-4FC6-9868-39DA97FB6B73,Z02.9,"Examination for administrative purposes, unspecified",-
764F1013-35CE-4305-9C2E-14BC4162D9F7,N94.6,"Dysmenorrhoea, unspecified",-
38F5DC71-4B49-4EAD-AFFB-48E826BB7172,J45,Asthma,Asthma
4E575D9E-1DA7-45AD-9CDE-CC2E19CD0D3F,S06.0,Concussion,-
754290B5-A850-4A16-8187-B2887485AD1C,R50.9,"Fever, unspecified",-
754290B5-A850-4A16-8187-B2887485AD1C,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
53578CF1-C3B2-4710-9D08-7DC29C17985F,K29.7,"Gastritis, unspecified",-
679E8F0D-165D-4A70-B4E2-28DF344172A2,K29.7,"Gastritis, unspecified",-
4899BECE-19E0-4B62-8158-D27722C42E8A,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
4899BECE-19E0-4B62-8158-D27722C42E8A,M54.5,Low back pain,-
D1C963C9-E38B-4242-9467-2908CA340CF5,R11,Nausea and vomiting,-
D1C963C9-E38B-4242-9467-2908CA340CF5,M79.1,Myalgia,-
538A5646-CFAE-4A9B-B148-C2A40F4D0D89,J06.9,"Acute upper respiratory infection, unspecified",-
61E6A547-D832-4F99-B032-D760B1714437,J06.9,"Acute upper respiratory infection, unspecified",-
A423B7F1-C12A-4E0E-8C7C-4A48F4BD73DA,N39.0,"Urinary tract infection, site not specified",-
2CD0F1D9-AB92-4467-A9EC-75FFC99E302F,N94.6,"Dysmenorrhoea, unspecified",-
9083DB63-FA27-4F9E-89A1-B8B9E69A8A9F,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
9083DB63-FA27-4F9E-89A1-B8B9E69A8A9F,M62.6,Muscle strain,-
A916D20D-B872-44D5-928B-1FFF62F3FB57,N94.6,"Dysmenorrhoea, unspecified",-
3D7BB756-9D07-476C-B192-2EB8B46DE7AC,K29.7,"Gastritis, unspecified",-
CD03C1C2-A105-4710-A95C-09DBCA90D674,J06.9,"Acute upper respiratory infection, unspecified",-
1F1BEC3D-B21E-4058-A9FD-B718C997106F,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
1F1BEC3D-B21E-4058-A9FD-B718C997106F,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
1F1BEC3D-B21E-4058-A9FD-B718C997106F,K05.0,Acute gingivitis,-
F42A06CE-0811-4FC8-A3A5-E5D40C0B718F,H93.1,Tinnitus,-
F3B5CF6B-59F2-49AE-A265-7F1A26F13C7F,N94.6,"Dysmenorrhoea, unspecified",-
DDADAA46-4632-4001-9C42-54C32B016C0A,G43,Migraine,Migraine
D558F7CD-6B1C-4A1A-90D5-E871AD472798,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
7D22ADCC-B22D-4055-8EA8-A0FA1DEF40FF,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
7D22ADCC-B22D-4055-8EA8-A0FA1DEF40FF,G44.2,Tension-type headache,-
045612ED-9EAB-43B7-9FD2-8C020982BC77,N76.0,Acute vaginitis,-
7E0FF0D0-BEE1-467B-84AE-5F4E64884B2F,W57,Bitten or stung by nonvenomous insect and other nonvenomous arthropods,-
CDAEC5DA-7DD4-42EE-AF1E-AE17A1BEE508,R50.9,"Fever, unspecified",-
CCBA7651-AB67-4636-8EC1-2E0C2E96C375,R21,Rash and other nonspecific skin eruption,-
380F8126-9EE3-48D3-8DBB-69E62338404D,A09.9,Gastroenteritis and colitis of unspecified origin,-
C3148052-6F69-4619-9322-7FA1D46A98E5,N39.0,"Urinary tract infection, site not specified",-
1D4CE51E-46BA-4775-A5AE-60D79B5D17DE,J06,Acute upper respiratory infections of multiple and unspecified sites,-
5FDE5FE3-4996-487B-8969-3A5962FE2DA9,J06,Acute upper respiratory infections of multiple and unspecified sites,-
05D6D4CF-1428-41AB-8A43-ED3EC28F29A9,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
91246B49-55D8-4ACF-A14F-B61D7F04B130,J06.9,"Acute upper respiratory infection, unspecified",-
583944EC-7CFA-4146-92C6-8110B2F177C8,G43,Migraine,Migraine
2B1457A7-A9FE-4804-9B40-B0CF185BEFA6,S83,"Dislocation, sprain and strain of joints and ligaments of knee",-
AED1EA9A-22FB-4C7D-B95C-54B7F0F1FB55,K12.3,Oral mucositis (ulcerative),-
CDC862E7-7863-4E44-973A-A7F170E098DE,L50.9,"Urticaria, unspecified",-
9083DB63-FA27-4F9E-89A1-B8B9E69A8A9F,I10,Essential (primary) hypertension,Hypertension
82C85FF5-B22C-4103-8446-E3FD6BCEBAD3,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
48B37A89-F7AD-4CF2-87B2-2FF9DF552652,N94.4,Primary dysmenorrhoea,-
601122D0-6FBF-4BBB-96B6-85E18A61B2E5,R21,Rash and other nonspecific skin eruption,-
328991DC-9510-4245-A79E-3A60F1EFF886,R51,Headache,-
DDB9929F-01A7-4279-BE1A-A0047F672793,J03.9,"Acute tonsillitis, unspecified",-
DD8AF405-3380-440A-9B18-4BADDE0DEAC2,G44.1,"Vascular headache, not elsewhere classified",-
DD8AF405-3380-440A-9B18-4BADDE0DEAC2,L20,Atopic dermatitis,Atopic dermatitis
4AAD271F-CCE4-4724-91C6-97887DE74E2D,J06,Acute upper respiratory infections of multiple and unspecified sites,-
7F62941D-C5CF-4C40-97A6-FE0466FFE46A,J06.9,"Acute upper respiratory infection, unspecified",-
073823B1-1180-4021-93DD-F1B4A1314241,N94.6,"Dysmenorrhoea, unspecified",-
55718600-89EC-4B0A-8C57-C272103F46A7,E03.9,"Hypothyroidism, unspecified",Thyroid
F5C126B2-F08B-46AD-AA55-16134EB11D6C,K13,Other diseases of lip and oral mucosa,-
A0D3B23C-59B0-4052-B0A7-EEE68A7013A8,U07.2,"COVID-19, virus not identified",-
A0D3B23C-59B0-4052-B0A7-EEE68A7013A8,J06.9,"Acute upper respiratory infection, unspecified",-
C45383F1-D93F-4EC7-B4C4-61B592B8E4E5,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
C45383F1-D93F-4EC7-B4C4-61B592B8E4E5,R51,Headache,-
A11458DB-487C-4697-BFD6-FEDB98D1C97A,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2E489177-9BC3-4B92-BDFC-3B16720F9FB2,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
2E489177-9BC3-4B92-BDFC-3B16720F9FB2,B35.1,Tinea unguium,-
8B008446-D408-4404-B9CD-ED40CBEFC8A9,R51,Headache,-
8B008446-D408-4404-B9CD-ED40CBEFC8A9,M62.6,Muscle strain,-
03541230-4A3E-4DC8-B126-F572B3AC131B,R51,Headache,-
2F8D475A-34D9-47E4-902C-0D0FA56C1BAD,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
8746237B-08DD-487C-BAD7-88DA7AAD19F7,T88.1,"Other complications following immunization, not elsewhere classified",-
52EA1F4B-C2E3-4729-A9A7-082ACFA9645F,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
52EA1F4B-C2E3-4729-A9A7-082ACFA9645F,Z76.0,Issue of repeat prescription,-
38632A19-6467-42D4-BE58-1B22D05BD5A0,R21,Rash and other nonspecific skin eruption,-
0EFCEDBC-6ACD-4596-B820-A1E670FBAD50,J06.9,"Acute upper respiratory infection, unspecified",-
F334BD62-D824-4126-AE33-A49D7BF1152F,A09.9,Gastroenteritis and colitis of unspecified origin,-
7B0AA041-EBF5-436F-9747-A26C6E761EF3,A09.9,Gastroenteritis and colitis of unspecified origin,-
DCD16D85-17AB-44D9-9C59-EAD58FD4FFB2,R50.9,"Fever, unspecified",-
02335C53-3D23-4330-9887-74E121777A86,A09.9,Gastroenteritis and colitis of unspecified origin,-
DE4B0807-5DF7-47BC-96E1-1E83F52B2D01,T88.1,"Other complications following immunization, not elsewhere classified",-
5EDF6F35-76FA-4725-B7FB-FA7501D6A597,T88.1,"Other complications following immunization, not elsewhere classified",-
DD93ECF8-2F56-4B54-BA64-867B2FC18EF3,M79.1,Myalgia,-
9F7FAA4B-46B9-49DE-9E8B-B77F703B2E7B,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
D1C22762-72C9-4BD2-8BC0-402552C3FF92,R11,Nausea and vomiting,-
D1C22762-72C9-4BD2-8BC0-402552C3FF92,G44.2,Tension-type headache,-
441D3261-E4DE-43E7-87F1-0E03AAFF33CD,J06.9,"Acute upper respiratory infection, unspecified",-
683E2C8A-D19B-4BDD-B4E1-4F6709B8539E,M25.5,Pain in joint,-
FA287CE8-E777-4C43-B49E-C683D2FA199B,J45,Asthma,Asthma
87A70AC4-06E7-4970-BF4C-A0A6BB1E41CF,R51,Headache,-
87A70AC4-06E7-4970-BF4C-A0A6BB1E41CF,M62.6,Muscle strain,-
4B483E3F-9C18-46B1-8F80-B63FC385F704,U07.1,"COVID-19, virus identified",-
3593D6F3-74CE-407A-9541-5CEC6A7C19E3,J06.9,"Acute upper respiratory infection, unspecified",-
3593D6F3-74CE-407A-9541-5CEC6A7C19E3,R51,Headache,-
D3B3D116-B823-4006-BEC3-5D7A49BE34A4,N94.6,"Dysmenorrhoea, unspecified",-
EEADC062-EDEB-4BAD-BBCF-665011F2DE2C,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
DA1A3071-20E1-44E2-BAA1-B620360A9FB4,A09.9,Gastroenteritis and colitis of unspecified origin,-
7A239782-2DF7-402F-8134-D228244B12F5,R51,Headache,-
3A417408-EB11-43DC-BC39-5F9040F0C6A5,T88.1,"Other complications following immunization, not elsewhere classified",-
21717DC4-E5DD-45C0-963A-F0E3F31B50AA,A09.9,Gastroenteritis and colitis of unspecified origin,-
0551646D-C99E-4F4B-B6E8-2F4F374B2222,K21,Gastro-oesophageal reflux disease,Gastro-oesophageal reflux disease
7529DEAF-F6FA-464A-8CAA-1A2120FEB2B3,K29.7,"Gastritis, unspecified",-
E82768B0-30A5-492B-8111-9496E6E8F16A,H57,Other disorders of eye and adnexa,-
ECDA8EF1-CFA5-4C19-AE48-04D7291B8C88,U07.1,"COVID-19, virus identified",-
ECDA8EF1-CFA5-4C19-AE48-04D7291B8C88,I10,Essential (primary) hypertension,Hypertension
ECDA8EF1-CFA5-4C19-AE48-04D7291B8C88,E11.9,Type 2 diabetes mellitus without complications,Diabetes
C6001BDD-F5E9-4243-B5E6-F7B5BF91337C,H74,Other disorders of middle ear and mastoid,-
724DDDFB-A37C-440A-A4F9-D5AB6579A626,B00,Herpesviral [herpes simplex] infections,-
724DDDFB-A37C-440A-A4F9-D5AB6579A626,M79.1,Myalgia,-
724DDDFB-A37C-440A-A4F9-D5AB6579A626,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
580E1EE5-84FD-4818-947B-BD937A41A132,L24,Irritant contact dermatitis,-
5B902235-92E0-49B0-8424-A19CDB18080E,J06.9,"Acute upper respiratory infection, unspecified",-
43B4D628-133F-4FA4-AD32-7CC9781CC9A7,S00.8,Superficial injury of other parts of head,-
43B4D628-133F-4FA4-AD32-7CC9781CC9A7,J30,Vasomotor and allergic rhinitis,Vasomotor and allergic rhinitis
554BD5B1-75BB-492B-B1FD-6D1BFE0591E2,J06,Acute upper respiratory infections of multiple and unspecified sites,-
0C66B291-1312-4AC0-A19C-9E20B7FCE304,S93.4,Sprain and strain of ankle,-
D95784F5-7AC2-4143-84E5-8904EF048229,J06.9,"Acute upper respiratory infection, unspecified",-
45783A63-1913-4BEE-854B-207A3C8059B1,I10,Essential (primary) hypertension,Hypertension
B09E0630-D25A-4D49-BB82-919EB0B5CAA4,R21,Rash and other nonspecific skin eruption,-
45783A63-1913-4BEE-854B-207A3C8059B1,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
95AE4248-1D64-413C-AC92-208D8DAB396E,M54.5,Low back pain,-
B4592A08-B593-4165-A61F-B3802851615C,N94.6,"Dysmenorrhoea, unspecified",-
567B2535-6FCD-4A6C-8503-456D879B4BF5,J45,Asthma,Asthma
1E7742C2-513E-42BB-964E-FF5407BF8624,B00,Herpesviral [herpes simplex] infections,-
1E7742C2-513E-42BB-964E-FF5407BF8624,J06.9,"Acute upper respiratory infection, unspecified",-
92A3B2DA-8400-46AB-ADDF-25D9AB4544EB,J06.9,"Acute upper respiratory infection, unspecified",-
29C1E89A-5056-455C-B422-9D3A9E548B3B,J06.9,"Acute upper respiratory infection, unspecified",-
623F7A1B-E778-4A47-BAF6-D02DD2A63C88,R21,Rash and other nonspecific skin eruption,-
EF1C12E8-5E95-446D-AADE-378BAF0DE446,R51,Headache,-
629AB474-87F1-498A-9F3C-9C6FCC1C32DC,T88.1,"Other complications following immunization, not elsewhere classified",-
B806F965-8DF0-42A7-8A11-996311450698,A09.9,Gastroenteritis and colitis of unspecified origin,-
1427E263-532A-4501-949D-435B4A5F5DD1,K29.7,"Gastritis, unspecified",-
B9D95931-4049-45AC-B972-F1F6C372D085,A09.9,Gastroenteritis and colitis of unspecified origin,-
7AEE7342-7083-48CC-B0EE-64F1110310ED,R51,Headache,-
DAA24DE8-18FC-47AC-B397-1884779F2046,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
678CC2FA-0558-490B-B738-629A4B8A0556,L98.9,"Disorder of skin and subcutaneous tissue, unspecified",-
320EDDFE-9DF6-429B-A3A7-7623C392061E,J06.9,"Acute upper respiratory infection, unspecified",-
EDA376D0-5BF7-4022-A678-31F59134CE3D,M79.1,Myalgia,-
852B8432-00F9-46A9-A6D3-5117B0C40535,A09.9,Gastroenteritis and colitis of unspecified origin,-
F17B699B-E3FC-4800-B89E-E2073E24CE4D,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
2B521715-2DA6-41AC-93C5-944734510555,H00,Hordeolum and chalazion,-
1C80A8BE-950C-48CD-A5DE-36F0AB883471,N39.0,"Urinary tract infection, site not specified",-
BA201DB5-D30B-4297-89C0-E8F1270281E9,N39.0,"Urinary tract infection, site not specified",-
3A10F48C-7771-4408-A0A2-37AB87C7CA7C,B37.3,Candidiasis of vulva and vagina,-
33A506CE-5873-4F24-B407-2084E9E28378,B37.3,Candidiasis of vulva and vagina,-
8972D0CD-DEC4-4C53-A81F-7C4F0F043BC4,I10,Essential (primary) hypertension,Hypertension
7EB1B2DE-C4E5-4398-B5F2-CCD14E9011B7,U07.1,"COVID-19, virus identified",-
8F97FBCB-A74E-4889-8DF1-66D6B576C4A0,J06.9,"Acute upper respiratory infection, unspecified",-
985EF7E3-F27E-4AB8-8CC9-B54CA02FAD9C,J06.9,"Acute upper respiratory infection, unspecified",-
7EADA2F0-3F0F-4C23-8626-7A3BBFF3FD89,L66,Cicatricial alopecia [scarring hair loss],-
7EADA2F0-3F0F-4C23-8626-7A3BBFF3FD89,L70.0,Acne vulgaris,-
CC86FFD6-3296-4AA7-99C4-B3B2CA4C9E81,M54.5,Low back pain,-
7260E584-6661-447C-AFF1-B908BE80E985,M54.5,Low back pain,-
A95128D7-28A5-4DB9-9DA6-3AFE9DA2F2CF,M62.6,Muscle strain,-
87B0FD0F-801C-4A58-99DE-1128B664C90C,R21,Rash and other nonspecific skin eruption,-
87B0FD0F-801C-4A58-99DE-1128B664C90C,S00.5,Superficial injury of lip and oral cavity,-
917B8EEB-FE81-41D2-856A-5B2234E7C276,B08.4,Enteroviral vesicular stomatitis with exanthem,-
22DB8762-8B2C-40F4-AE6B-4A1CFD3AB4CF,Z71.2,Person consulting for explanation of investigation findings,-
04AF933E-E45D-4FAB-A5DA-8C1A9833953B,H01.0,Blepharitis,-
FD422355-365B-45D0-A199-9C7BF8DA1DC9,R51,Headache,-
FD422355-365B-45D0-A199-9C7BF8DA1DC9,J34,Other disorders of nose and nasal sinuses,-
64CB1B19-7C90-4D3B-AE74-63F01D854C26,L50,Urticaria,-
116EA078-8AC1-4545-82A0-8B9F18AB0F66,R11,Nausea and vomiting,-
0E951FC9-44D1-4937-A772-BB82A6301892,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
7F544771-3031-4E89-8170-EDF2F9F01966,M10,Gout,Gout
FC571F03-51EE-4534-8759-4F93E7CC14A1,K13,Other diseases of lip and oral mucosa,-
FC571F03-51EE-4534-8759-4F93E7CC14A1,K05.0,Acute gingivitis,-
E70ADEE2-0C8B-42B4-8940-DE5C50F7F98B,L30.9,"Dermatitis, unspecified",-
E70ADEE2-0C8B-42B4-8940-DE5C50F7F98B,Z76.0,Issue of repeat prescription,-
8EA31A2F-AC19-4430-883B-A79677CF4782,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
255068E5-8342-4AD4-A6CC-B5BFCEEDD616,Z71.2,Person consulting for explanation of investigation findings,-
255068E5-8342-4AD4-A6CC-B5BFCEEDD616,E78.5,"Hyperlipidaemia, unspecified",Hyperlipidaemia
9CDD6E0A-972B-48E7-ABC9-DB853E4DCA9A,A09,Other gastroenteritis and colitis of infectious and unspecified origin,-
D8D34786-9D1E-42A6-95AA-179D56C49895,N94.4,Primary dysmenorrhoea,-
85D4737F-F2D0-463D-8FB7-E8EDC2411458,R50.9,"Fever, unspecified",-
85D4737F-F2D0-463D-8FB7-E8EDC2411458,M79.1,Myalgia,-
8F8C76BC-F3C0-4A83-A51F-F1441DF61D01,A09.9,Gastroenteritis and colitis of unspecified origin,-
28BFF323-F7A3-4F0B-AC0D-E77B9C8D43D7,J06.9,"Acute upper respiratory infection, unspecified",-
6E18CCA6-4918-45BF-B50D-A40C26942DBE,J06.9,"Acute upper respiratory infection, unspecified",-
839FE79A-1339-412B-873B-4F80D0AF6F45,K52,Other noninfective gastroenteritis and colitis,-
E4304229-2D12-47C2-B9C0-0A58BB786652,A09.9,Gastroenteritis and colitis of unspecified origin,-
814618A1-D368-4AD3-9E93-A86EF0B00B6F,U07.2,"COVID-19, virus not identified",-
71E51046-311A-492A-8DA2-91527140E572,J06.9,"Acute upper respiratory infection, unspecified",-
14C45600-424C-4AE6-8D80-9540D55C2816,U09,Post COVID-19 condition,-
14C45600-424C-4AE6-8D80-9540D55C2816,S23.3,Sprain and strain of thoracic spine,-
14C45600-424C-4AE6-8D80-9540D55C2816,R00.2,Palpitations,-
53264DF6-83BF-42F1-BEFF-E1E4982B9C75,A09.9,Gastroenteritis and colitis of unspecified origin,-
03CD8F79-2D94-464A-ABE7-A4A0A77EC1C9,R51,Headache,-
EE45DE22-A171-4506-B84F-44E17A53FD3B,A09.9,Gastroenteritis and colitis of unspecified origin,-
AB6B02B8-9626-4A80-8465-18C30396C99D,Z71.2,Person consulting for explanation of investigation findings,-
5CF01DD3-7B7C-4054-B0BD-B2946FD18E5C,R11,Nausea and vomiting,-
5CF01DD3-7B7C-4054-B0BD-B2946FD18E5C,A09.9,Gastroenteritis and colitis of unspecified origin,-
8B074E8E-0A48-4157-B57D-471BC5540812,M79.1,Myalgia,-
290FE090-0F7A-4AA6-8DBA-870EC2B83EDB,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
F8A3EBEF-F8C1-43BE-8816-B881BF09F1EF,T88.1,"Other complications following immunization, not elsewhere classified",-
925F1888-AF76-4A65-8EE8-B9A34323B9D4,J06.9,"Acute upper respiratory infection, unspecified",-
82D2E70E-07BD-4CB7-9014-9A547E697846,R21,Rash and other nonspecific skin eruption,-
B3056BC1-723A-40C6-8862-ECFE07DFE12C,J06.9,"Acute upper respiratory infection, unspecified",-
ECEA6C44-08F9-4C11-BCAF-C0B10822FC1A,U12.9,"COVID-19 vaccines causing adverse effects in therapeutic use, unspecified",-
57E11BCC-1F26-46AF-A404-83C543F4782D,R51,Headache,-
C425BED3-62CC-4D24-A282-D37196B3BE98,J30.4,"Allergic rhinitis, unspecified",Vasomotor and allergic rhinitis
C425BED3-62CC-4D24-A282-D37196B3BE98,J06.9,"Acute upper respiratory infection, unspecified",-
B9E7194F-8083-4B74-8911-B2F884FD63A5,H26,Other cataract,-
E9348364-6909-4D5A-A5F2-65E3F69403BB,R51,Headache,-
8FF0FED9-7A2C-4D91-BCF8-8F86FF99CDE7,M54.5,Low back pain,-
8DB3E3D3-F811-4402-B1A7-551E0E7D3CED,R51,Headache,-
297773BB-F655-43A3-AE3F-A910C6D2D950,K59.1,Functional diarrhoea,-
F7AF246C-AD1A-4260-8AD0-BBB9B0FC1ABA,B30,Viral conjunctivitis,-
77C46329-1A14-43BD-B18C-42C794E59AD1,R51,Headache,-
19C8116D-7993-4AC2-8259-B40E4EAF415B,N94.6,"Dysmenorrhoea, unspecified",-
0B041B45-B23F-4E81-A158-014E7B9FC369,U12,COVID-19 vaccines causing adverse effects in therapeutic use,-
302E9653-D69C-41A2-9D19-8304882344FF,T88.1,"Other complications following immunization, not elsewhere classified",-
D5CBC4E3-3616-4D65-B495-04648D555417,R51,Headache,-
080CE681-FC53-410D-8CC4-CA12E433025F,R51,Headache,-
6939F7D6-D52B-4E16-862A-E7D4BDC96C92,A09.0,Other and unspecified gastroenteritis and colitis of infectious origin,-
569866D1-17B1-4338-8753-87E7C591C7A1,R51,Headache,-
D71FCA7C-83E9-4650-A6AB-3B159B3A95A4,J06,Acute upper respiratory infections of multiple and unspecified sites,-
07375055-F5E5-4E11-A327-48ADAF1B061F,A09.9,Gastroenteritis and colitis of unspecified origin,-
D8C74E51-7C47-4697-AA1B-9782FC0FC4FB,Z02,Examination and encounter for administrative purposes,-
41884C8D-B778-4F0B-AA62-8AF9D755FAF9,E11.9,Type 2 diabetes mellitus without complications,Diabetes
7A70AF60-3007-4157-88EB-ABA2E6E38A99,R51,Headache,-
7A70AF60-3007-4157-88EB-ABA2E6E38A99,A09.9,Gastroenteritis and colitis of unspecified origin,-
98EB7163-6FDF-4F21-8C5B-D45D6F46C80C,R42,Dizziness and giddiness,-
7A507921-AFD6-4D26-A1FF-58EB195F54E2,H81.1,Benign paroxysmal vertigo,-
